Citrus Sinensis ID: 018891
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 349 | 2.2.26 [Sep-21-2011] | |||||||
| O49839 | 426 | Protein kinase 2A, chloro | yes | no | 0.922 | 0.755 | 0.621 | 1e-118 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.839 | 0.687 | 0.677 | 1e-117 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.922 | 0.827 | 0.595 | 1e-116 | |
| Q8H186 | 389 | Probable receptor-like pr | no | no | 0.871 | 0.781 | 0.608 | 1e-109 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.868 | 0.767 | 0.599 | 1e-109 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.833 | 0.706 | 0.623 | 1e-108 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.833 | 0.709 | 0.610 | 1e-107 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.845 | 0.598 | 0.616 | 1e-104 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.845 | 0.602 | 0.612 | 1e-103 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.825 | 0.702 | 0.597 | 7e-97 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 426 bits (1094), Expect = e-118, Method: Compositional matrix adjust.
Identities = 207/333 (62%), Positives = 251/333 (75%), Gaps = 11/333 (3%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF D LLGEGGFGCVFKGWIDQ + ++PGSGIVVA+K+LK E FQGHKEWLT
Sbjct: 80 KNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLT 139
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLGQL H NLV L+GYC+E +NRLLVYEFMPKGSLENHLFR QP++W R+K+A+
Sbjct: 140 EVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAV 199
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GL+FLH + VIYRD KA+N+LLD++FNAKLSDFGLA+ GPTGDNTHVST+++GT
Sbjct: 200 GAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGT 259
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYVATG LT KSDVYSFGVVLLEL+SGRRA+D GG E +LV+WA P+L D
Sbjct: 260 HGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGG-NEYSLVDWATPYLGDK 318
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL--------- 306
R++ RIMDT+LGGQY +K A A + LQCL+ D K RP M +VL +LEQL
Sbjct: 319 RKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESVAKPGTK 378
Query: 307 HTSKDMPRTPPPAKLHHHHHHHNHHQGIKHTNP 339
HT + PR + + ++H + + H P
Sbjct: 379 HTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTP 411
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-117, Method: Compositional matrix adjust.
Identities = 200/295 (67%), Positives = 239/295 (81%), Gaps = 2/295 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D LLGEGGFG VFKGWID T +KPGSGIVVA+K+LK E +QGHKEWLT
Sbjct: 77 KNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQGHKEWLT 136
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLGQL H NLVKL+GYC E +NRLLVYEFMPKGSLENHLFR QP++W R+K+AI
Sbjct: 137 EVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAI 196
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GL+FLH + VIYRD KA+N+LLD+ FN+KLSDFGLA+ GPTGD THVST+++GT
Sbjct: 197 GAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGT 256
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYVATG LT KSDVYSFGVVLLELLSGRRA+D+ + G+ EQ+LV+WA P+L D
Sbjct: 257 HGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGM-EQSLVDWATPYLGDK 315
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310
R++ RIMDTRLGGQY +K A A++ LQCL+ D K RP M +VL L+QL ++K
Sbjct: 316 RKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 417 bits (1072), Expect = e-116, Method: Compositional matrix adjust.
Identities = 194/326 (59%), Positives = 252/326 (77%), Gaps = 4/326 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D ++GEGGFGCVFKGWID+++ AP+KPG+GIV+A+KRL E FQGH+EWL
Sbjct: 62 KSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLA 121
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKI 133
E+ YLGQL H NLVKLIGYC E ++RLLVYEFM +GSLENHLFR QP+SW TRV++
Sbjct: 122 EINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRM 181
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A+ ARGL+FLH VIYRD KASN+LLDSN+NAKLSDFGLARDGP GDN+HVSTR++
Sbjct: 182 ALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVM 241
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT+GYAAPEY+ATGHL+ KSDVYSFGVVLLELLSGRRA+D+++ + E LV+WA P+L
Sbjct: 242 GTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQ-PVGEHNLVDWARPYLT 300
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313
+ RR+LR+MD RL GQYS A +A + L C+ +D K+RP+M +++ ++E+LH K+
Sbjct: 301 NKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEAS 360
Query: 314 RTPPPAKLHHHHHHHNHHQGIKHTNP 339
+ ++ + + Q + + P
Sbjct: 361 KEQQNPQISIDNIINKSPQAVNYPRP 386
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 396 bits (1017), Expect = e-109, Method: Compositional matrix adjust.
Identities = 188/309 (60%), Positives = 237/309 (76%), Gaps = 5/309 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF SD ++GEGGFGCVF+GW+D+ T PTK SG+V+A+KRL + FQGH+EWLT
Sbjct: 55 KLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNPDGFQGHREWLT 114
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF----RSVQPISWPTRVK 132
E+ YLGQL H NLVKLIGYC E + RLLVYEFM KGSLENHLF + +P+SW R+K
Sbjct: 115 EINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFKPLSWILRIK 174
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
+A+D A+GL+FLH VIYRD+KASN+LLDS+FNAKLSDFGLARDGP G+ ++VSTR+
Sbjct: 175 VALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQSYVSTRV 234
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
+GT GYAAPEYV+TGHL +SDVYSFGVVLLELL GR+ALD +R EQ LV+WA P+L
Sbjct: 235 MGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPA-KEQNLVDWARPYL 293
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312
R+VL I+DTRL QY + A +A++ +QCL +PK+RP+M V+ +L QL S
Sbjct: 294 TSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQLQDSVVK 353
Query: 313 PRTPPPAKL 321
P P K+
Sbjct: 354 PANVDPLKV 362
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 393 bits (1010), Expect = e-109, Method: Compositional matrix adjust.
Identities = 184/307 (59%), Positives = 239/307 (77%), Gaps = 4/307 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF D ++GEGGFGCVFKGW+D++T PTKPG+G+V+A+K+L E FQGH+EWLT
Sbjct: 61 KLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHREWLT 120
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKI 133
E+ YLGQL H NLVKLIGYC E ++RLLVYEFM KGSLENHLFR +P+ W RV +
Sbjct: 121 EINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLRVNV 180
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A+D A+GL+FLH VIYRD+KASN+LLD+++NAKLSDFGLARDGP GD ++VSTR++
Sbjct: 181 ALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVSTRVM 240
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT GYAAPEY+++GHL +SDVYSFGV+LLE+LSG+RALD +R E+ LV+WA P+L
Sbjct: 241 GTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPA-KEENLVDWARPYLT 299
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313
R+VL I+D RL QY +EA +A+V +QCL +PK+RP+M V+ +L+QL + P
Sbjct: 300 SKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQDNLGKP 359
Query: 314 RTPPPAK 320
P K
Sbjct: 360 SQTNPVK 366
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 390 bits (1003), Expect = e-108, Method: Compositional matrix adjust.
Identities = 184/295 (62%), Positives = 232/295 (78%), Gaps = 4/295 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D +LGEGGFG VFKGWID+ T +KPG+G+V+A+K+L + +QGH+EWL
Sbjct: 63 KAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLA 122
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKI 133
EV YLGQ H NLVKLIGYC E ++RLLVYEFMP+GSLENHLFR QP+SW R+K+
Sbjct: 123 EVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKV 182
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A+ A+GL+FLH + +VIYRD K SN+LLDS +NAKLSDFGLA+DGPTGD +HVSTRI+
Sbjct: 183 ALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIM 242
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT GYAAPEY+ATGHLT KSDVYS+GVVLLE+LSGRRA+D++R EQ LVEWA P L
Sbjct: 243 GTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPP-GEQKLVEWARPLLA 301
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308
+ R++ R++D RL QYS +EA VA + L+CL + K RP+M +V++ LE + T
Sbjct: 302 NKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQT 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (999), Expect = e-107, Method: Compositional matrix adjust.
Identities = 180/295 (61%), Positives = 232/295 (78%), Gaps = 4/295 (1%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D +LGEGGFGCVFKGWID+ + ++PG+G+V+A+K+L + +QGH+EWL
Sbjct: 62 KSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQGHQEWLA 121
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKI 133
EV YLGQ H +LVKLIGYC E ++RLLVYEFMP+GSLENHLFR QP+SW R+K+
Sbjct: 122 EVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKV 181
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A+ A+GL+FLH + VIYRD K SN+LLDS +NAKLSDFGLA+DGP GD +HVSTR++
Sbjct: 182 ALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVM 241
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT GYAAPEY+ATGHLT KSDVYSFGVVLLELLSGRRA+D++R E+ LVEWA P+L
Sbjct: 242 GTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPS-GERNLVEWAKPYLV 300
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308
+ R++ R++D RL QYS +EA VA + L+CL + K RP+M +V++ LE + +
Sbjct: 301 NKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQS 355
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 379 bits (974), Expect = e-104, Method: Compositional matrix adjust.
Identities = 183/297 (61%), Positives = 221/297 (74%), Gaps = 2/297 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K++T+NF + LLGEGGFGCVFKGWI++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 136 KLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 195
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
E+ +LG L H NLVKL+GYC E D RLLVYEFMP+GSLENHLFR P+ W R+KIA+
Sbjct: 196 EINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 255
Query: 137 VARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GLSFLH VIYRD K SN+LLD+++NAKLSDFGLA+D P THVSTR++GT
Sbjct: 256 AAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGT 315
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D++R E LVEWA P L D
Sbjct: 316 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARPHLLDK 374
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312
RR R++D RL G +S K AQ V + QCL DPK RP M DV+ +L+ L KDM
Sbjct: 375 RRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDM 431
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 374 bits (961), Expect = e-103, Method: Compositional matrix adjust.
Identities = 182/297 (61%), Positives = 217/297 (73%), Gaps = 2/297 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF + LLGEGGFGCVFKGW+++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 130 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 189
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
E+ YLG L H NLVKL+GYC E D RLLVYEFMP+GSLENHLFR P+ W R+KIA+
Sbjct: 190 EINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 249
Query: 137 VARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GLSFLH VIYRD K SN+LLD +NAKLSDFGLA+D P THVSTR++GT
Sbjct: 250 AAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGT 309
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D++R E LVEWA P L D
Sbjct: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARPHLLDK 368
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312
RR R++D RL G +S K AQ V + QCL D K RP M +V+ L+ L KDM
Sbjct: 369 RRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDM 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 353 bits (907), Expect = 7e-97, Method: Compositional matrix adjust.
Identities = 175/293 (59%), Positives = 217/293 (74%), Gaps = 5/293 (1%)
Query: 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI 79
TK+F DY+LGEGGFG V+KG+ID N K + VA+K L E QGH+EWLTEV
Sbjct: 66 TKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK---SLPVAVKVLNKEGLQGHREWLTEVN 122
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVA 138
+LGQLRH NLVKLIGYC E D+RLLVYEFM +GSLENHLFR + P+SW R+ IA+ A
Sbjct: 123 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMMIALGAA 182
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
+GL+FLH + VIYRD K SN+LLDS++ AKLSDFGLA+ GP GD THVSTR++GT GY
Sbjct: 183 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 242
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258
AAPEYV TGHLT +SDVYSFGVVLLE+L+GR+++D+ R EQ LV+WA P L D R++
Sbjct: 243 AAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPS-KEQNLVDWARPKLNDKRKL 301
Query: 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311
L+I+D RL QYS + AQ ++ CL +PK RP M DV+ +LE L + D
Sbjct: 302 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGD 354
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 349 | ||||||
| 224104557 | 340 | predicted protein [Populus trichocarpa] | 0.882 | 0.905 | 0.825 | 1e-143 | |
| 225435985 | 403 | PREDICTED: protein kinase 2B, chloroplas | 0.914 | 0.791 | 0.778 | 1e-142 | |
| 296083955 | 422 | unnamed protein product [Vitis vinifera] | 0.914 | 0.755 | 0.778 | 1e-142 | |
| 449463895 | 403 | PREDICTED: protein kinase 2B, chloroplas | 0.876 | 0.759 | 0.736 | 1e-136 | |
| 357493723 | 407 | Protein kinase 2B [Medicago truncatula] | 0.882 | 0.756 | 0.757 | 1e-135 | |
| 356574647 | 382 | PREDICTED: protein kinase 2A, chloroplas | 0.891 | 0.814 | 0.735 | 1e-130 | |
| 356549815 | 382 | PREDICTED: protein kinase 2A, chloroplas | 0.859 | 0.785 | 0.770 | 1e-130 | |
| 242039753 | 433 | hypothetical protein SORBIDRAFT_01g02240 | 0.839 | 0.676 | 0.701 | 1e-119 | |
| 357113846 | 421 | PREDICTED: protein kinase 2B, chloroplas | 0.839 | 0.695 | 0.705 | 1e-119 | |
| 308080840 | 436 | uncharacterized LOC100502290 [Zea mays] | 0.859 | 0.688 | 0.685 | 1e-119 |
| >gi|224104557|ref|XP_002313478.1| predicted protein [Populus trichocarpa] gi|222849886|gb|EEE87433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1324), Expect = e-143, Method: Compositional matrix adjust.
Identities = 256/310 (82%), Positives = 280/310 (90%), Gaps = 2/310 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF S+ LLGEGGFGCVFKGWID NTFAPTKPGSG++VA+K+LK ES QGHKEWLT
Sbjct: 17 KNATKNFRSETLLGEGGFGCVFKGWIDLNTFAPTKPGSGVIVAVKKLKPESCQGHKEWLT 76
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLGQL HENLVKLIGYCSESDNRLLVYEFMPKGSLE HLFR VQPI+W R+ IAI
Sbjct: 77 EVTYLGQLHHENLVKLIGYCSESDNRLLVYEFMPKGSLEQHLFRKGVQPITWTMRMNIAI 136
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
DVARGLSFLHGLDANVIYRDLKASNVLLDS++NAKLSDFGLARDGPTGDNTHVST+++GT
Sbjct: 137 DVARGLSFLHGLDANVIYRDLKASNVLLDSDYNAKLSDFGLARDGPTGDNTHVSTKVLGT 196
Query: 196 RGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254
RGYAAPEYVAT GHLTPKSDVYS+GVVLLELLSGRRA+DE+RGG ++TLV+WA PFL D
Sbjct: 197 RGYAAPEYVATAGHLTPKSDVYSYGVVLLELLSGRRAMDEERGGFDDETLVDWAKPFLID 256
Query: 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 314
SRRVLRIMDTRLGGQY KK AQA AA+ LQCLH DPKNRP M+DVLT+LE+L TSKD+PR
Sbjct: 257 SRRVLRIMDTRLGGQYPKKAAQAAAALALQCLHTDPKNRPPMIDVLTTLEKLITSKDIPR 316
Query: 315 TPPPAKLHHH 324
T P KL +H
Sbjct: 317 TARPVKLDNH 326
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435985|ref|XP_002272310.1| PREDICTED: protein kinase 2B, chloroplastic-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1311), Expect = e-142, Method: Compositional matrix adjust.
Identities = 250/321 (77%), Positives = 283/321 (88%), Gaps = 2/321 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K A+KNF S+ LLGEGGFGCVFKGW+D+NT APTKPG+G+VVAIK+LK ESFQGHKEWL
Sbjct: 74 KNASKNFRSESLLGEGGFGCVFKGWLDENTLAPTKPGTGMVVAIKKLKTESFQGHKEWLA 133
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAI 135
EV YLGQL HENLVKLIGYCSES+NRLLVYEFM KGSLENHLF+ VQPI+W TR+ IAI
Sbjct: 134 EVNYLGQLHHENLVKLIGYCSESENRLLVYEFMSKGSLENHLFKKGVQPITWATRMSIAI 193
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
DVA+G+SFLH LDANVIYRDLKASN+LLDS+F AKLSDFGLARDGPTGDNTHVSTR+VGT
Sbjct: 194 DVAQGISFLHSLDANVIYRDLKASNILLDSDFKAKLSDFGLARDGPTGDNTHVSTRVVGT 253
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA+D+++ G E+TLV+WA PFL D+
Sbjct: 254 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAMDDEKAGGVEETLVDWAKPFLSDN 313
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315
RRVLRIMDTRLGGQYSKK AQA A++ LQCLH DPKNRP M DVL +LE+L TSKD+PRT
Sbjct: 314 RRVLRIMDTRLGGQYSKKGAQAAASLALQCLHTDPKNRPLMTDVLAALERLPTSKDIPRT 373
Query: 316 PPPAKLHHHHHHHNHHQGIKH 336
P P ++ +H H+ + G H
Sbjct: 374 PSP-RVEYHIMKHSSNPGHTH 393
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083955|emb|CBI24343.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1311), Expect = e-142, Method: Compositional matrix adjust.
Identities = 250/321 (77%), Positives = 283/321 (88%), Gaps = 2/321 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K A+KNF S+ LLGEGGFGCVFKGW+D+NT APTKPG+G+VVAIK+LK ESFQGHKEWL
Sbjct: 74 KNASKNFRSESLLGEGGFGCVFKGWLDENTLAPTKPGTGMVVAIKKLKTESFQGHKEWLA 133
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAI 135
EV YLGQL HENLVKLIGYCSES+NRLLVYEFM KGSLENHLF+ VQPI+W TR+ IAI
Sbjct: 134 EVNYLGQLHHENLVKLIGYCSESENRLLVYEFMSKGSLENHLFKKGVQPITWATRMSIAI 193
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
DVA+G+SFLH LDANVIYRDLKASN+LLDS+F AKLSDFGLARDGPTGDNTHVSTR+VGT
Sbjct: 194 DVAQGISFLHSLDANVIYRDLKASNILLDSDFKAKLSDFGLARDGPTGDNTHVSTRVVGT 253
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA+D+++ G E+TLV+WA PFL D+
Sbjct: 254 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAMDDEKAGGVEETLVDWAKPFLSDN 313
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315
RRVLRIMDTRLGGQYSKK AQA A++ LQCLH DPKNRP M DVL +LE+L TSKD+PRT
Sbjct: 314 RRVLRIMDTRLGGQYSKKGAQAAASLALQCLHTDPKNRPLMTDVLAALERLPTSKDIPRT 373
Query: 316 PPPAKLHHHHHHHNHHQGIKH 336
P P ++ +H H+ + G H
Sbjct: 374 PSP-RVEYHIMKHSSNPGHTH 393
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463895|ref|XP_004149666.1| PREDICTED: protein kinase 2B, chloroplastic-like [Cucumis sativus] gi|449515432|ref|XP_004164753.1| PREDICTED: protein kinase 2B, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 490 bits (1261), Expect = e-136, Method: Compositional matrix adjust.
Identities = 232/315 (73%), Positives = 268/315 (85%), Gaps = 9/315 (2%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF S+ LLGEGGFGCVFKGWID++++ PTKPG+GIVVA+K+LK ES QG+KEWL
Sbjct: 88 KNATKNFRSESLLGEGGFGCVFKGWIDEHSYLPTKPGTGIVVAVKKLKRESLQGYKEWLA 147
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAI 135
EV YLGQLRHENLV+LIGYCSESDNRLLVYE+MPKGSLENHLFR V PISW R+ IA+
Sbjct: 148 EVNYLGQLRHENLVRLIGYCSESDNRLLVYEYMPKGSLENHLFRKGVTPISWRVRMDIAV 207
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
DVARGL+FLH + NVIYRDLKASN+LLDS FNAKLSDFGLAR+GPTGD THVSTR++GT
Sbjct: 208 DVARGLAFLHSSEPNVIYRDLKASNILLDSEFNAKLSDFGLAREGPTGDKTHVSTRVMGT 267
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG+RALD ++ G E+TLV+W P L D
Sbjct: 268 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGKRALDHEKVGRVEETLVDWGKPLLSDG 327
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315
+R+LRIMDTR+GGQYS+KEAQA A++ L CLH DPKNRPSM +VL LE+LHT+KD+ T
Sbjct: 328 KRMLRIMDTRMGGQYSRKEAQAAASLALNCLHTDPKNRPSMAEVLDELERLHTAKDILGT 387
Query: 316 P--------PPAKLH 322
P PP++
Sbjct: 388 PNAHAIRRTPPSRFQ 402
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493723|ref|XP_003617150.1| Protein kinase 2B [Medicago truncatula] gi|355518485|gb|AET00109.1| Protein kinase 2B [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 488 bits (1257), Expect = e-135, Method: Compositional matrix adjust.
Identities = 234/309 (75%), Positives = 266/309 (86%), Gaps = 1/309 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF + L+GEGGFG V+KGWID+NT APTKPG+GIVVAIK+LK ESFQGHKEWL
Sbjct: 64 KEATRNFRQENLIGEGGFGFVYKGWIDENTGAPTKPGNGIVVAIKKLKPESFQGHKEWLA 123
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLGQL HENLVKLIGYCSE NRLLVYEFM KGSLENHLFR VQPISW TR+ IAI
Sbjct: 124 EVNYLGQLHHENLVKLIGYCSEGKNRLLVYEFMQKGSLENHLFRKGVQPISWMTRISIAI 183
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
VARGL+FLH LDANVIYRDLKASN+LLDS+FNA LSDFGLARDGPTGDNTHVSTRI+GT
Sbjct: 184 GVARGLAFLHSLDANVIYRDLKASNILLDSDFNANLSDFGLARDGPTGDNTHVSTRIIGT 243
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYVATGHLT +SDVYSFGVVLLELL+GRR +++DR E+TLV+WA PFL DS
Sbjct: 244 HGYAAPEYVATGHLTLRSDVYSFGVVLLELLTGRRVVEDDRQVYTEETLVDWAMPFLSDS 303
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315
RR+LRIMDT+LGGQYSKK AQA AA+VL+CL+ DPK+RP+MV+VL +LE LH+S P+
Sbjct: 304 RRILRIMDTKLGGQYSKKGAQAAAALVLKCLNTDPKHRPTMVNVLAALEALHSSNSFPKK 363
Query: 316 PPPAKLHHH 324
P +H+
Sbjct: 364 PKSGTDNHN 372
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574647|ref|XP_003555457.1| PREDICTED: protein kinase 2A, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1211), Expect = e-130, Method: Compositional matrix adjust.
Identities = 234/318 (73%), Positives = 267/318 (83%), Gaps = 7/318 (2%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF + L+GEGGFG VFKGWID+NT+ PTKPG+GIVVAIK LK ESFQGHKEWL
Sbjct: 66 KEATKNFRQENLIGEGGFGRVFKGWIDENTYGPTKPGTGIVVAIKNLKPESFQGHKEWLQ 125
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLGQL+HENLVKLIGYC E NRLLVYEFM KGSLENHLFR VQP++W TRV IAI
Sbjct: 126 EVNYLGQLQHENLVKLIGYCLEGKNRLLVYEFMQKGSLENHLFRKGVQPMAWVTRVNIAI 185
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
VARGL+ LH LD NVI+RDLKASN+LLDS+FNAKLSDFGLARDGPTGDNTHVSTR++GT
Sbjct: 186 GVARGLTLLHSLDQNVIFRDLKASNILLDSDFNAKLSDFGLARDGPTGDNTHVSTRVLGT 245
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
+GYAAPEYVATGHLTP+SDVYS+GVVLLELL+GRRA+++DR G +E+TLV+WA PFL D+
Sbjct: 246 QGYAAPEYVATGHLTPRSDVYSYGVVLLELLTGRRAVEDDRPGFSEETLVDWAKPFLSDN 305
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315
RRVLRIMDT+LGGQYSKK AQA AA+ LQCL++DPK RP MV+VL +LE L++S RT
Sbjct: 306 RRVLRIMDTKLGGQYSKKGAQAAAALALQCLNIDPKFRPPMVEVLAALEALNSSNSFTRT 365
Query: 316 PPPAKLHHHHHHHNHHQG 333
P H H G
Sbjct: 366 P------KHESHATKQSG 377
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549815|ref|XP_003543286.1| PREDICTED: protein kinase 2A, chloroplastic-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 470 bits (1210), Expect = e-130, Method: Compositional matrix adjust.
Identities = 232/301 (77%), Positives = 262/301 (87%), Gaps = 1/301 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF + L+GEGGFG VFKGWID+NT+ PTKPG+GIVVAIK LK ESFQGHKEWL
Sbjct: 66 KEATKNFRRENLIGEGGFGRVFKGWIDENTYGPTKPGTGIVVAIKNLKPESFQGHKEWLQ 125
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLG L+HENLVKLIGYC E NRLLVYEFM KGSLENHLFR VQP++W TRV IAI
Sbjct: 126 EVNYLGMLQHENLVKLIGYCLEGKNRLLVYEFMQKGSLENHLFRKGVQPMAWVTRVNIAI 185
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
VARGL+FLH LD NVI+RDLKASN+LLDS+FNAKLSDFGLARDGPTGDNTHVSTR++GT
Sbjct: 186 GVARGLTFLHSLDQNVIFRDLKASNILLDSDFNAKLSDFGLARDGPTGDNTHVSTRVIGT 245
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
+GYAAPEYVATGHLTP+SDVYSFGVVLLELL+GRRA+++D G +E+TLV+WA PFL D+
Sbjct: 246 QGYAAPEYVATGHLTPRSDVYSFGVVLLELLTGRRAVEDDGPGFSEETLVDWAKPFLNDN 305
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315
RRVLRIMDTRLGGQYSKK AQA AA+ LQCL+ DPK RP MV+VL +LE L++S RT
Sbjct: 306 RRVLRIMDTRLGGQYSKKGAQAAAALALQCLNTDPKFRPPMVEVLAALEALNSSNSFTRT 365
Query: 316 P 316
P
Sbjct: 366 P 366
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|242039753|ref|XP_002467271.1| hypothetical protein SORBIDRAFT_01g022400 [Sorghum bicolor] gi|241921125|gb|EER94269.1| hypothetical protein SORBIDRAFT_01g022400 [Sorghum bicolor] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1116), Expect = e-119, Method: Compositional matrix adjust.
Identities = 207/295 (70%), Positives = 243/295 (82%), Gaps = 2/295 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K A+KNF SD L+GEGGFG VFKGWID+ T AP+KPGSG+VVAIK+LK E FQGHKEWLT
Sbjct: 78 KSASKNFRSDSLIGEGGFGYVFKGWIDEQTLAPSKPGSGMVVAIKKLKPEGFQGHKEWLT 137
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTRVKIAI 135
EV YLGQL H+NLVKLIGYCS+ DNRLLVYE+MPKGSLENHLF R P+ W R+K+AI
Sbjct: 138 EVDYLGQLHHQNLVKLIGYCSDGDNRLLVYEYMPKGSLENHLFRRGADPLPWGIRLKVAI 197
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GLSFLH + VIYRD KASN+LLD+ FNAKLSDFGLA+ GPTGD THVST+++GT
Sbjct: 198 GAAKGLSFLHDAENQVIYRDFKASNILLDTEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 257
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
RGYAAPEYVATG L+ K+DVYSFGVVLLELL+GRRALD+ + ++EQ LVEWA P+L D
Sbjct: 258 RGYAAPEYVATGRLSVKADVYSFGVVLLELLTGRRALDKSK-PVSEQNLVEWAKPYLGDK 316
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310
RR+ RIMD++LGGQY KK A AVA + LQC+ D KNRP+M +V+ LEQL K
Sbjct: 317 RRLYRIMDSKLGGQYPKKGAHAVAGIALQCIRNDGKNRPAMSEVVEKLEQLQDPK 371
|
Source: Sorghum bicolor Species: Sorghum bicolor Genus: Sorghum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357113846|ref|XP_003558712.1| PREDICTED: protein kinase 2B, chloroplastic-like [Brachypodium distachyon] | Back alignment and taxonomy information |
|---|
Score = 434 bits (1115), Expect = e-119, Method: Compositional matrix adjust.
Identities = 208/295 (70%), Positives = 241/295 (81%), Gaps = 2/295 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF D LLGEGGFG VFKGWID++T AP+KPGSG+VVA+K+LK E FQGHKEWLT
Sbjct: 81 KNATKNFRPDSLLGEGGFGHVFKGWIDEHTLAPSKPGSGMVVAVKKLKPEGFQGHKEWLT 140
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTRVKIAI 135
EV YLGQL H NLVKLIGYC++ DNRLLVYEFMPKGSLENHLF R P+SW R+K+AI
Sbjct: 141 EVNYLGQLHHANLVKLIGYCTDGDNRLLVYEFMPKGSLENHLFRRGADPLSWAIRLKVAI 200
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
ARGLSFLH + VIYRD KASN+LLDS FN+KLSDFGLA+ GPTGD THVST+++GT
Sbjct: 201 GAARGLSFLHDAENQVIYRDFKASNILLDSEFNSKLSDFGLAKAGPTGDRTHVSTQVMGT 260
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEY+ATG L+ K+DVYSFGVVLLELL+GRRALD+ + G+ EQ LV+WA P LRD
Sbjct: 261 HGYAAPEYIATGRLSAKADVYSFGVVLLELLTGRRALDKSKPGI-EQNLVDWAKPHLRDK 319
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310
RR+ R+MDT+LGGQY KK A A+A + LQC+ D K RP M +VL LEQL SK
Sbjct: 320 RRLYRVMDTKLGGQYPKKGAHAIANLALQCICNDAKMRPQMSEVLEELEQLQESK 374
|
Source: Brachypodium distachyon Species: Brachypodium distachyon Genus: Brachypodium Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|308080840|ref|NP_001183697.1| uncharacterized LOC100502290 [Zea mays] gi|238013964|gb|ACR38017.1| unknown [Zea mays] gi|414871478|tpg|DAA50035.1| TPA: putative protein kinase superfamily protein [Zea mays] | Back alignment and taxonomy information |
|---|
Score = 432 bits (1112), Expect = e-119, Method: Compositional matrix adjust.
Identities = 207/302 (68%), Positives = 245/302 (81%), Gaps = 2/302 (0%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
+ A++NF SD LLGEGGFG VFKGWID+ T AP+KPGSG+VVAIK+LK E FQGHKEWLT
Sbjct: 77 RTASRNFRSDSLLGEGGFGYVFKGWIDEQTLAPSKPGSGMVVAIKKLKPEGFQGHKEWLT 136
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLGQL H+NLVKLIGYC++ D+RLLVYE+MPKGSLENHLFR P+SW TR+K+AI
Sbjct: 137 EVDYLGQLHHQNLVKLIGYCTDGDHRLLVYEYMPKGSLENHLFRRGADPLSWGTRLKVAI 196
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GLSFLH + VIYRD KASN+LLDS FNAKLSDFGLA+ GPTGD THVST+++GT
Sbjct: 197 GAAKGLSFLHDAENQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDRTHVSTQVMGT 256
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
RGYAAPEYVATG L+ K+DVYSFGVVLLELL+GRRALD+ + L EQ LVEWA P+L D
Sbjct: 257 RGYAAPEYVATGRLSVKADVYSFGVVLLELLTGRRALDKSK-PLTEQNLVEWARPYLSDK 315
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315
RR+ RIMD++LGGQY KK A AVA + LQC+ + K RP+M +V+ LEQL +
Sbjct: 316 RRLYRIMDSKLGGQYPKKGAHAVAGIALQCIRNEGKMRPAMSEVVEKLEQLQDPRYNVAA 375
Query: 316 PP 317
PP
Sbjct: 376 PP 377
|
Source: Zea mays Species: Zea mays Genus: Zea Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 349 | ||||||
| TAIR|locus:2012492 | 426 | APK2A "protein kinase 2A" [Ara | 0.833 | 0.683 | 0.679 | 5.7e-107 | |
| TAIR|locus:2058847 | 426 | APK2B "protein kinase 2B" [Ara | 0.839 | 0.687 | 0.674 | 6.5e-106 | |
| TAIR|locus:2205050 | 387 | AT1G69790 [Arabidopsis thalian | 0.848 | 0.764 | 0.657 | 1.2e-104 | |
| TAIR|locus:2180127 | 389 | NAK [Arabidopsis thaliana (tax | 0.922 | 0.827 | 0.592 | 1.2e-104 | |
| TAIR|locus:2205714 | 412 | AT1G26970 [Arabidopsis thalian | 0.905 | 0.766 | 0.618 | 3.3e-102 | |
| TAIR|locus:2039772 | 395 | BIK1 "botrytis-induced kinase1 | 0.868 | 0.767 | 0.592 | 1e-98 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.833 | 0.687 | 0.616 | 2e-97 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.845 | 0.598 | 0.612 | 3.3e-95 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.845 | 0.602 | 0.609 | 3.8e-94 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.842 | 0.649 | 0.597 | 1.3e-93 |
| TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1058 (377.5 bits), Expect = 5.7e-107, P = 5.7e-107
Identities = 199/293 (67%), Positives = 236/293 (80%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K ATKNF D LLGEGGFGCVFKGWIDQ + ++PGSGIVVA+K+LK E FQGHKEWLT
Sbjct: 80 KNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQGHKEWLT 139
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLGQL H NLV L+GYC+E +NRLLVYEFMPKGSLENHLFR QP++W R+K+A+
Sbjct: 140 EVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAV 199
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GL+FLH + VIYRD KA+N+LLD++FNAKLSDFGLA+ GPTGDNTHVST+++GT
Sbjct: 200 GAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGT 259
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYVATG LT KSDVYSFGVVLLEL+SGRRA+D GG E +LV+WA P+L D
Sbjct: 260 HGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGG-NEYSLVDWATPYLGDK 318
Query: 256 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHT 308
R++ RIMDT+LGGQY +K A LQCL+ D K RP M +VL +LEQL +
Sbjct: 319 RKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLES 371
|
|
| TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 6.5e-106, P = 6.5e-106
Identities = 199/295 (67%), Positives = 236/295 (80%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D LLGEGGFG VFKGWID T +KPGSGIVVA+K+LK E +QGHKEWLT
Sbjct: 77 KNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQGHKEWLT 136
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLGQL H NLVKL+GYC E +NRLLVYEFMPKGSLENHLFR QP++W R+K+AI
Sbjct: 137 EVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAI 196
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GL+FLH + VIYRD KA+N+LLD+ FN+KLSDFGLA+ GPTGD THVST+++GT
Sbjct: 197 GAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGT 256
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYVATG LT KSDVYSFGVVLLELLSGRRA+D+ + G+ EQ+LV+WA P+L D
Sbjct: 257 HGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGM-EQSLVDWATPYLGDK 315
Query: 256 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310
R++ RIMDTRLGGQY +K A LQCL+ D K RP M +VL L+QL ++K
Sbjct: 316 RKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK 370
|
|
| TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
Identities = 198/301 (65%), Positives = 241/301 (80%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF + ++GEGGFGCV+KGWI + + +P+KPGSG+VVA+K+LK+E FQGHKEWLT
Sbjct: 78 KTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVVAVKKLKSEGFQGHKEWLT 137
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAI 135
EV YLG+L H NLVKLIGYC E + RLLVYE+MPKGSLENHLFR +PI W TR+K+A
Sbjct: 138 EVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHLFRRGAEPIPWKTRMKVAF 197
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
ARGLSFLH +A VIYRD KASN+LLD +FNAKLSDFGLA+ GPTGD THV+T+++GT
Sbjct: 198 SAARGLSFLH--EAKVIYRDFKASNILLDVDFNAKLSDFGLAKAGPTGDRTHVTTQVIGT 255
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
+GYAAPEY+ATG LT KSDVYSFGVVLLELLSGR LD+ + G+ E+ LV+WA P+L D
Sbjct: 256 QGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKVGV-ERNLVDWAIPYLVDR 314
Query: 256 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS-KDMPR 314
R+V RIMDT+LGGQY K A L+CL+ +PK RP M DVL++L+QL TS K M
Sbjct: 315 RKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMADVLSTLQQLETSSKKMGS 374
Query: 315 T 315
T
Sbjct: 375 T 375
|
|
| TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1036 (369.7 bits), Expect = 1.2e-104, P = 1.2e-104
Identities = 193/326 (59%), Positives = 247/326 (75%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D ++GEGGFGCVFKGWID+++ AP+KPG+GIV+A+KRL E FQGH+EWL
Sbjct: 62 KSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLA 121
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKI 133
E+ YLGQL H NLVKLIGYC E ++RLLVYEFM +GSLENHLFR QP+SW TRV++
Sbjct: 122 EINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRM 181
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A+ ARGL+FLH VIYRD KASN+LLDSN+NAKLSDFGLARDGP GDN+HVSTR++
Sbjct: 182 ALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVM 241
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT+GYAAPEY+ATGHL+ KSDVYSFGVVLLELLSGRRA+D+++ + E LV+WA P+L
Sbjct: 242 GTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQP-VGEHNLVDWARPYLT 300
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313
+ RR+LR+MD RL GQYS A L C+ +D K+RP+M +++ ++E+LH K+
Sbjct: 301 NKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEAS 360
Query: 314 RTPPPAKLXXXXXXXXXXQGIKHTNP 339
+ ++ Q + + P
Sbjct: 361 KEQQNPQISIDNIINKSPQAVNYPRP 386
|
|
| TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1013 (361.7 bits), Expect = 3.3e-102, P = 3.3e-102
Identities = 199/322 (61%), Positives = 244/322 (75%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D ++GEGGFG V+KGWID+ T +P+KPGSG+VVA+K+LK E FQGH++WL
Sbjct: 77 KTATRNFRPDSVIGEGGFGYVYKGWIDERTLSPSKPGSGMVVAVKKLKEEGFQGHRQWLA 136
Query: 77 EVIYLGQLRHENLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIA 134
EV LG+L H NLVKLIGYCS+ D+ RLLVYE+MPKGSLENHLFR +PI W TR+K+A
Sbjct: 137 EVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENHLFRRGAEPIPWRTRIKVA 196
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 194
I ARGL+FLH +A VIYRD KASN+LLDS FNAKLSDFGLA+ GPTGD THVST+++G
Sbjct: 197 IGAARGLAFLH--EAQVIYRDFKASNILLDSEFNAKLSDFGLAKVGPTGDRTHVSTQVMG 254
Query: 195 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254
T+GYAAPEYVATG +T KSDVYSFGVVLLELLSGR +D+ + G+ E+ LV+WA P+L D
Sbjct: 255 TQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTKVGV-ERNLVDWAIPYLGD 313
Query: 255 SRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLH-TSKDMP 313
R+V RIMDT+LGGQY K A LQCL+ +PK RP M DVL++LE+L T K
Sbjct: 314 KRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMSDVLSTLEELEMTLKSGS 373
Query: 314 RTPPPAKLXXXXXXXXXXQGIK 335
+ KL Q ++
Sbjct: 374 ISNSVMKLTSSSSSFTAKQRVR 395
|
|
| TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 980 (350.0 bits), Expect = 1.0e-98, P = 1.0e-98
Identities = 182/307 (59%), Positives = 235/307 (76%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF D ++GEGGFGCVFKGW+D++T PTKPG+G+V+A+K+L E FQGH+EWLT
Sbjct: 61 KLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQEGFQGHREWLT 120
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKI 133
E+ YLGQL H NLVKLIGYC E ++RLLVYEFM KGSLENHLFR +P+ W RV +
Sbjct: 121 EINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLRVNV 180
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A+D A+GL+FLH VIYRD+KASN+LLD+++NAKLSDFGLARDGP GD ++VSTR++
Sbjct: 181 ALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVSTRVM 240
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT GYAAPEY+++GHL +SDVYSFGV+LLE+LSG+RALD +R E+ LV+WA P+L
Sbjct: 241 GTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPA-KEENLVDWARPYLT 299
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313
R+VL I+D RL QY +EA +QCL +PK+RP+M V+ +L+QL + P
Sbjct: 300 SKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQDNLGKP 359
Query: 314 RTPPPAK 320
P K
Sbjct: 360 SQTNPVK 366
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 2.0e-97, P = 2.0e-97
Identities = 182/295 (61%), Positives = 229/295 (77%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K AT+NF D +LGEGGFG VFKGWID+ T +KPG+G+V+A+K+L + +QGH+EWL
Sbjct: 74 KAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLA 133
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKI 133
EV YLGQ H NLVKLIGYC E ++RLLVYEFMP+GSLENHLFR QP+SW R+K+
Sbjct: 134 EVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLRLKV 193
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A+ A+GL+FLH + +VIYRD K SN+LLDS +NAKLSDFGLA+DGPTGD +HVSTRI+
Sbjct: 194 ALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIM 253
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT GYAAPEY+ATGHLT KSDVYS+GVVLLE+LSGRRA+D++R EQ LVEWA P L
Sbjct: 254 GTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPP-GEQKLVEWARPLLA 312
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHT 308
+ R++ R++D RL QYS +EA L+CL + K RP+M +V++ LE + T
Sbjct: 313 NKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQT 367
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 947 (338.4 bits), Expect = 3.3e-95, P = 3.3e-95
Identities = 182/297 (61%), Positives = 219/297 (73%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K++T+NF + LLGEGGFGCVFKGWI++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 136 KLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 195
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
E+ +LG L H NLVKL+GYC E D RLLVYEFMP+GSLENHLFR P+ W R+KIA+
Sbjct: 196 EINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 255
Query: 137 VARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GLSFLH VIYRD K SN+LLD+++NAKLSDFGLA+D P THVSTR++GT
Sbjct: 256 AAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGT 315
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D++R E LVEWA P L D
Sbjct: 316 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARPHLLDK 374
Query: 256 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312
RR R++D RL G +S K AQ QCL DPK RP M DV+ +L+ L KDM
Sbjct: 375 RRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDM 431
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 3.8e-94, P = 3.8e-94
Identities = 181/297 (60%), Positives = 215/297 (72%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF + LLGEGGFGCVFKGW+++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 130 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 189
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
E+ YLG L H NLVKL+GYC E D RLLVYEFMP+GSLENHLFR P+ W R+KIA+
Sbjct: 190 EINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLPLPWSIRMKIALG 249
Query: 137 VARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GLSFLH VIYRD K SN+LLD +NAKLSDFGLA+D P THVSTR++GT
Sbjct: 250 AAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGT 309
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D++R E LVEWA P L D
Sbjct: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARPHLLDK 368
Query: 256 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312
RR R++D RL G +S K AQ QCL D K RP M +V+ L+ L KDM
Sbjct: 369 RRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDM 425
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 932 (333.1 bits), Expect = 1.3e-93, P = 1.3e-93
Identities = 177/296 (59%), Positives = 216/296 (72%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K+AT+NF + LLGEGGFGCVFKGWI++N AP KPG+G+ VA+K L + QGHKEWL
Sbjct: 97 KLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 156
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
E+ +LG L H +LVKL+GYC E D RLLVYEFMP+GSLENHLFR P+ W R+KIA+
Sbjct: 157 EINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRRTLPLPWSVRMKIALG 216
Query: 137 VARGLSFLHG-LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
A+GL+FLH + VIYRD K SN+LLD +NAKLSDFGLA+D P +HVSTR++GT
Sbjct: 217 AAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVSTRVMGT 276
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D+ R EQ LVEW P L D
Sbjct: 277 YGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPN-GEQNLVEWVRPHLLDK 335
Query: 256 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311
+R R++D RL G YS K AQ QCL+ D K RP M +V+ +L+ L KD
Sbjct: 336 KRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALKPLPNLKD 391
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O49839 | APK2A_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6216 | 0.9226 | 0.7558 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00017351001 | SubName- Full=Chromosome chr6 scaffold_15, whole genome shotgun sequence; (388 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 349 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-62 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-61 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-58 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-57 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-38 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-34 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-34 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-31 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-31 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-31 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-30 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-30 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-29 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-29 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-29 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-28 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-27 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-26 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-26 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-25 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-24 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-23 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-23 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 9e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-22 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-21 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-19 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-16 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-16 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-15 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 8e-62
Identities = 87/277 (31%), Positives = 145/277 (52%), Gaps = 28/277 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG + + VA+K LK + S Q +E+L E + +L H
Sbjct: 7 LGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+VKL+G C+E + +V E+M G L ++L ++ +S + A+ +ARG+ +L
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 207
N I+RDL A N L+ N K+SDFGL+RD D + R + APE + G
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR-WMAPESLKEG 178
Query: 208 HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 266
T KSDV+SFGV+L E+ + G ++ G++ + ++E+ L++ R+ + +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLG----EQPYPGMSNEEVLEY----LKNGYRLPQPPNCP- 229
Query: 267 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
+ ++LQC DP++RP+ +++ L
Sbjct: 230 ---------PELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 2e-61
Identities = 91/278 (32%), Positives = 146/278 (52%), Gaps = 29/278 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG + G + VA+K LK + S Q +E+L E + +L H
Sbjct: 7 LGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSFLHG 146
N+VKL+G C+E + ++V E+MP G L ++L + +S + A+ +ARG+ +L
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE- 120
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
N I+RDL A N L+ N K+SDFGL+RD D V + R + APE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR-WMAPESLKE 178
Query: 207 GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
G T KSDV+SFGV+L E+ + G +E G++ ++E+ L+ R+ + +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLG----EEPYPGMSNAEVLEY----LKKGYRLPKPPNCP 230
Query: 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
+ ++LQC DP++RP+ +++ L
Sbjct: 231 ----------PELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 3e-58
Identities = 85/283 (30%), Positives = 140/283 (49%), Gaps = 39/283 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG + G+ VA+K LK S + +E+L E + +L H
Sbjct: 7 LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+V+L+G C++ + +V E+MP G L + L + + ++ +++A+ +A+G+ +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YAAPEYV 204
N ++RDL A N L+ N K+SDFGL+RD D G + + APE +
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAPESL 176
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP----FLRDSRRVLR 260
G T KSDV+SFGV+L E+ + L EQ ++ L D R+ R
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFT-----------LGEQPYPGMSNEEVLELLEDGYRLPR 225
Query: 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
+ + ++LQC DP++RP+ +++ L
Sbjct: 226 PENC----------PDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 6e-58
Identities = 90/277 (32%), Positives = 137/277 (49%), Gaps = 33/277 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRH 86
LG G FG V+K G+G +VA+K LK S + + E+ L +L H
Sbjct: 7 LGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH 57
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N+V+LI + D+ LV E+ G L ++L R P+S KIA+ + RGL +LH
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH- 115
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
+I+RDLK N+LLD N K++DFGLA+ ++ ++T VGT Y APE +
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTT-FVGTPWYMAPEVLLG 172
Query: 207 G-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
G PK DV+S GV+L ELL+G+ + L + + RI+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK--------------PPFSGENILDQLQLIRRILGPP 218
Query: 266 LGGQYSKK--EAQAVAAVVLQCLHMDPKNRPSMVDVL 300
L K ++ ++ +CL+ DP RP+ ++L
Sbjct: 219 LEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 5e-57
Identities = 85/278 (30%), Positives = 125/278 (44%), Gaps = 66/278 (23%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRHE 87
LGEGGFG V+ + G VAIK +K E E L E+ L +L H
Sbjct: 1 LGEGGFGTVYLARDKKT---------GKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+VKL G + ++ LV E+ GSL++ L + +S ++I + + GL +LH
Sbjct: 52 NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH-- 109
Query: 148 DANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-YVA 205
+I+RDLK N+LLDS N KL+DFGL++ + + IVGT Y APE +
Sbjct: 110 SNGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLG 167
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
G+ + KSD++S GV+L EL P L+D
Sbjct: 168 KGYYSEKSDIWSLGVILYEL------------------------PELKD----------- 192
Query: 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
++ + L DP+ RPS ++L L
Sbjct: 193 ---------------LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 1e-56
Identities = 90/293 (30%), Positives = 141/293 (48%), Gaps = 50/293 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG K G VA+K LK + S + K++L E + +L H
Sbjct: 3 LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRSVQPISWPTRVKIAIDVAR 139
N+V+L+G C+E + LV E+M G L ++L +S + AI +A+
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-RIVGTRGY 198
G+ +L ++RDL A N L+ + K+SDFGL+RD D T + R +
Sbjct: 117 GMEYLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-W 173
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWADPFLR 253
APE + G T KSDV+SFGV+L E+ + G GL+ + ++E +LR
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATPYPGLSNEEVLE----YLR 221
Query: 254 DSRRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
G + K E + ++L C +DP++RP+ +++ LE
Sbjct: 222 K------------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 6e-54
Identities = 77/280 (27%), Positives = 119/280 (42%), Gaps = 41/280 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRH 86
LGEG FG V+ D+ T G +VAIK +K + + +E L E+ L +L+H
Sbjct: 6 KLGEGSFGKVYLA-RDKKT--------GKLVAIKVIKKKKIKKDRERILREIKILKKLKH 56
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N+V+L + D LV E+ G L + L + +S + L +LH
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLH- 114
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
+++RDLK N+LLD + + KL+DFGLAR D T VGT Y APE +
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 207 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 266
D++S GV+L ELL+G+ PF ++L +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKP-------------------PF-PGDDQLLELFKKIG 210
Query: 267 GGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLT 301
+ ++ + L DP+ R + + L
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 38/271 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+GGFG V+K + +G VAIK +K ES + ++ + E+ L + +H N
Sbjct: 8 IGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPN 58
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+VK G + D +V EF GSL++ L + Q ++ + ++ +GL +LH
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN- 117
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH 208
+I+RD+KA+N+LL S+ KL DFGL+ + +VGT + APE +
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKP 173
Query: 209 LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGG 268
K+D++S G+ +EL G+ P + + + G
Sbjct: 174 YDYKADIWSLGITAIELAEGK--------------------PPYSELPPMKALFKIATNG 213
Query: 269 QY----SKKEAQAVAAVVLQCLHMDPKNRPS 295
+K + + +CL +P+ RP+
Sbjct: 214 PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-38
Identities = 68/272 (25%), Positives = 126/272 (46%), Gaps = 32/272 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLR 85
LLG G FG V+ +D++T G ++A+K L +S + + E+ L L+
Sbjct: 7 LLGRGSFGSVYLA-LDKDT--------GELMAVKSVELSGDSEEELEALEREIRILSSLQ 57
Query: 86 HENLVKLIG-YCSESDNRLLVY-EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
H N+V+ G E N L ++ E++ GSL + L + + P K + GL++
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL-SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH +++RD+K +N+L+DS+ KL+DFG A+ + + + GT + APE
Sbjct: 117 LH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
+ +D++S G ++E+ +G+ E +A + +I
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA----------------LYKIGS 218
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
+ + + ++ + +CL DPK RP+
Sbjct: 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 82/286 (28%), Positives = 132/286 (46%), Gaps = 20/286 (6%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRHE 87
LGEG FG V D P +G VA+K L + H ++ E+ L L HE
Sbjct: 12 LGEGHFGKVELCRYD-----PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
N+VK G C + R L+ E++P GSL ++L R I+ + + + +G+ +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST--RIVGTRGYAAPEY 203
I+RDL A N+L++S K+SDFGLA+ P + + Y APE
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
+ T + SDV+SFGV L EL + D + AE + R+L ++
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT---YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 264 TRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
G + + + V ++ C +P++RPS D++ +++L
Sbjct: 241 E--GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 84/283 (29%), Positives = 131/283 (46%), Gaps = 47/283 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V G + K VA+K LK +S + +L E + LRH
Sbjct: 13 TIGKGEFGDVMLG-----DYRGQK------VAVKCLKDDS-TAAQAFLAEASVMTTLRHP 60
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSFLHG 146
NLV+L+G + + +V E+M KGSL ++L R I+ ++ A+DV G+ +L
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
N ++RDL A NVL+ + AK+SDFGLA++ G S ++ + APE +
Sbjct: 121 --KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAPEALRE 173
Query: 207 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 266
+ KSDV+SFG++L E+ S R P+ R L+ + +
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIP---LKDVVPHV 212
Query: 267 GGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
Y + EA V V+ C +DP RP+ + L
Sbjct: 213 EKGY-RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 89/306 (29%), Positives = 149/306 (48%), Gaps = 50/306 (16%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF 68
DPS I K+ +G G FG V +G + P K I VAIK LKA S
Sbjct: 2 DPSYVTIEKV----------IGGGEFGEVCRGRLKL----PGKKE--IDVAIKTLKAGSS 45
Query: 69 QGHK-EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISW 127
+ ++LTE +GQ H N+++L G ++S +++ E+M GSL+ L + +
Sbjct: 46 DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTV 105
Query: 128 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 187
V + +A G+ +L + N ++RDL A N+L++SN K+SDFGL+R + T+
Sbjct: 106 GQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163
Query: 188 VSTRIVGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLA 240
T+G + APE +A T SDV+SFG+V+ E++S G R ++
Sbjct: 164 T------TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY----WDMS 213
Query: 241 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
Q +++ + D R+ MD A+ ++L C D RP+ ++
Sbjct: 214 NQDVIK----AVEDGYRLPPPMDC----------PSALYQLMLDCWQKDRNERPTFSQIV 259
Query: 301 TSLEQL 306
++L+++
Sbjct: 260 STLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 67/206 (32%), Positives = 108/206 (52%), Gaps = 27/206 (13%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V++G W ++ + VAIK LK++ +++ EV L +LRH+
Sbjct: 14 LGSGYFGEVWEGLWKNR-----------VRVAIKILKSDDLLKQQDFQKEVQALKRLRHK 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTR--VKIAIDVARGLSFLH 145
+L+ L CS + ++ E M KGSL RS + P + +A VA G+++L
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLL-AFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTHVSTRIVGTRGYAAP 201
+ N I+RDL A N+L+ + K++DFGLAR D + + + + AP
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAP 173
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLS 227
E + G + KSDV+SFG++L E+ +
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLR 85
L+G G FG V+KG ++ T G VAIK++ E + K + E+ L L+
Sbjct: 7 LIGRGAFGVVYKG-LNLET--------GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-DVARGLSFL 144
H N+VK IG SD+ ++ E+ GSL + + P + V + + V +GL++L
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFP-ESLVAVYVYQVLQGLAYL 115
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H + VI+RD+KA+N+L + KL+DFG+A D + +VGT + APE +
Sbjct: 116 H--EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVI 171
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGR 229
+ SD++S G ++ELL+G
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 84/282 (29%), Positives = 132/282 (46%), Gaps = 38/282 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRH 86
+G+G FG V+KG + NT VA+K ++ K +L E L Q H
Sbjct: 2 KIGKGNFGDVYKGVLKGNT----------EVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N+VKLIG C + +V E +P GSL L + ++ +++++D A G+ +L
Sbjct: 52 PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR----GYAAPE 202
N I+RDL A N L+ N K+SDFG++R+ G T VS G + + APE
Sbjct: 112 --KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-VSD---GLKQIPIKWTAPE 165
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
+ G T +SDV+S+G++L E S D G++ Q E + R
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSLG---DTPYPGMSNQQTRERIESGYRMPA------ 216
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
+ + + ++LQC DP+NRPS ++ L+
Sbjct: 217 --------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-32
Identities = 84/331 (25%), Positives = 130/331 (39%), Gaps = 36/331 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LGEG FG V+ + VA+K L + KE L E+ L L
Sbjct: 7 KLGEGSFGEVYLARDRKL------------VALKVLAKKLESKSKEVERFLREIQILASL 54
Query: 85 RHE-NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRSVQPISWPTRVKIAIDVARGL 141
H N+VKL + + + LV E++ GSLE+ L P+S + I + L
Sbjct: 55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 142 SFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLAR----DGPTGDNTHVSTRIVGTR 196
+LH +I+RD+K N+LLD + KL DFGLA+ G T + + VGT
Sbjct: 115 EYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 197 GYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GY APE + + + SD++S G+ L ELL+G + ++ A ++
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL-- 230
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313
+ + + SK A + ++ + L DPKNR S L L +
Sbjct: 231 PTPSLASPLSPSNPELISK----AASDLLKKLLAKDPKNRLSSSSDL--SHDLLAHLKLK 284
Query: 314 RTPPPAKLHHHHHHHNHHQGIKHTNPPRKTS 344
+ L +
Sbjct: 285 ESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 88/278 (31%), Positives = 138/278 (49%), Gaps = 39/278 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LG G FG V KG K G + VA+K LK E G KE+L E + QL H
Sbjct: 3 LGHGNFGSVVKGVYL------MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+V+LIG C + + +LV E P G L +L + + I ++A VA G+++L
Sbjct: 57 CIVRLIGVC-KGEPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLES- 113
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
+ ++RDL A NVLL + AK+SDFG++R G + + +T R + APE +
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWPLKWYAPECI 170
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
G + KSDV+S+GV L E S G + E +G AE V+ +++
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AE----------------VIAMLE 212
Query: 264 TRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDV 299
+ G + + E Q + +++L C P++RP+ ++
Sbjct: 213 S--GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 86/296 (29%), Positives = 137/296 (46%), Gaps = 53/296 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIV-VAIKRL-KAESFQGHKEWLTEVIYLGQLRH 86
LG+G FG V++G G VAIK + + S + E+L E + +
Sbjct: 14 LGQGSFGMVYEGLAKG-----VVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC 68
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP-------ISWPTRVKI---AID 136
++V+L+G S L+V E M KG L+++L RS +P + PT K A +
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQMAAE 127
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
+A G+++L ++RDL A N ++ + K+ DFG+ RD R G
Sbjct: 128 IADGMAYLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRD----IYETDYYRKGGKG 181
Query: 197 ----GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
+ APE + G T KSDV+SFGVVL E+ + LAEQ P+
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT-----------LAEQ-------PYQ 223
Query: 253 RDS-RRVLR-IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
S VL+ ++D GG E + ++ C +PK RP+ +++++SL+
Sbjct: 224 GLSNEEVLKFVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 7e-31
Identities = 83/294 (28%), Positives = 133/294 (45%), Gaps = 43/294 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPG-SGIVVAIKRLK-AESFQGHKEWLTEVIYLGQLRH 86
LGEG FG VF G +P +VA+K LK S K++ E L +H
Sbjct: 13 LGEGAFGKVFLG-----ECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLEN-------HLFRSVQPISWPTR------VKI 133
EN+VK G C+E D ++V+E+M G L P S ++I
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRI 192
A+ +A G+ +L + ++RDL N L+ + K+ DFG++RD T D V +
Sbjct: 128 AVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 251
+ R + PE + T +SDV+SFGVVL E+ + G++ GL+ + ++E
Sbjct: 186 LPIR-WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW----YGLSNEEVIECI--- 237
Query: 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305
R+L+ T V ++L C DP+ R ++ D+ L++
Sbjct: 238 --TQGRLLQRPRTC---------PSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 82/298 (27%), Positives = 136/298 (45%), Gaps = 50/298 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+LGEG FG V +G + Q+ + K VA+K +K + +E+L+E +
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 86 HENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRS---VQPISWPTR--VKIA 134
H N++KLIG C E+ + +++ FM G L + L S P P + +K
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD---NTHVSTR 191
+D+A G+ +L + N I+RDL A N +L + ++DFGL++ +GD ++
Sbjct: 120 VDIALGMEYLS--NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251
V + A E +A T KSDV++FGV + E+ + RG QT P
Sbjct: 178 PV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--------RG----QT----PYPG 218
Query: 252 LRDSRRVLRIMDTRLGGQYSKKEAQA---VAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ + I D G K+ + ++ C DPK+RP+ + LE +
Sbjct: 219 VENH----EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 22/215 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V+KG + P + S VAIK LK + +E+ E + L+H
Sbjct: 13 LGEGAFGKVYKGEL----TGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTRVK 132
N+V L+G C++ +++E++ G L L R+ + +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
IAI +A G+ +L + ++RDL A N L+ K+SDFGL+RD + D V ++
Sbjct: 129 IAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ + PE + G T +SD++SFGVVL E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 84/300 (28%), Positives = 143/300 (47%), Gaps = 43/300 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPT-------KPGSGIVVAIKRLKAESFQGHK-EWLTEVIY 80
LGEG FG V + PT + G ++VA+K L+ ++ + + ++L EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLE-----NHLFRSVQP----------- 124
L +L+ N+++L+G C + D ++ E+M G L +HL +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 125 --ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182
IS+ + + +A+ +A G+ +L L N ++RDL N L+ N K++DFG++R+
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSSL--NFVHRDLATRNCLVGENLTIKIADFGMSRNLYA 190
Query: 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242
GD + R V + A E + G T SDV++FGV L E+L + + G L ++
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE--QPYGELTDE 248
Query: 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA---QAVAAVVLQCLHMDPKNRPSMVDV 299
++E A F RD R + Y + Q + ++LQC D + RPS D+
Sbjct: 249 QVIENAGEFFRDQGRQV----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 22/286 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRHE 87
LGEG FG V D P G+G +VA+K LK E Q + W E+ L L HE
Sbjct: 12 LGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
N+VK G CSE + L+ E++P GSL ++L + ++ + A + G+++LH
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLH 124
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYV 204
+ I+RDL A NVLLD++ K+ DFGLA+ P G + V + A E +
Sbjct: 125 S--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264
+ SDV+SFGV L ELL+ + E ++ + V+R+++
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE--MIGPKQGQM----TVVRLIEL 236
Query: 265 RLGGQY---SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
G K Q V ++ C + K RP+ ++ L+++H
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 70/291 (24%), Positives = 118/291 (40%), Gaps = 58/291 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQGHKEWLTEVIYLGQLR 85
+G+G FG V+ + G + +K L S + ++ L EV L +L
Sbjct: 7 QIGKGSFGKVYLV---------RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN 57
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHL---FRSVQPISWPTRVKIAIDVARGLS 142
H N++K E +V E+ G L + + +P + + + L
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH +++RD+K N+ L SN KL DFG+++ ++ +VGT Y +PE
Sbjct: 118 YLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPE 173
Query: 203 ------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256
Y KSD++S G VL EL + + PF ++
Sbjct: 174 LCQNKPY------NYKSDIWSLGCVLYELCTLKH-------------------PFEGENL 208
Query: 257 R--VLRIMD---TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302
L+I+ + QYS + + +V L DP+ RPS+ +L S
Sbjct: 209 LELALKILKGQYPPIPSQYSSE----LRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 80/298 (26%), Positives = 148/298 (49%), Gaps = 35/298 (11%)
Query: 29 LGEGGFG----CVFKG---WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIY 80
LGEG FG C +G ++D++ ++VA+K L+ ++ + + ++L E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR----------SVQPISWPTR 130
+ +L+ N+++L+ C SD ++ E+M G L L R V IS+ T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
+ +A +A G+ +L L N ++RDL N L+ N+ K++DFG++R+ +GD +
Sbjct: 133 IFMATQIASGMKYLSSL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190
Query: 191 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250
R V + + E + G T SDV++FGV L E+L+ + ++ L+++ ++E
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK--EQPYSQLSDEQVIENTGE 248
Query: 251 FLRDSRRVLRIMDTRLGGQYSKKEA---QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305
F RD R + Y K A ++ ++L C + K RPS ++ +L +
Sbjct: 249 FFRDQGRQV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 74/211 (35%), Positives = 109/211 (51%), Gaps = 32/211 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-----AESFQGHKEWLTEVIYLGQ 83
LG G FG V+ G + T VA+K LK E+F L E + +
Sbjct: 14 LGAGQFGEVWMGTWNGTT----------KVAVKTLKPGTMSPEAF------LQEAQIMKK 57
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLS 142
LRH+ LV+L CSE + +V E+M KGSL + L + + P V +A +A G++
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYA 199
+L N I+RDL A N+L+ N K++DFGLAR ++ + R G + +
Sbjct: 118 YLE--SRNYIHRDLAARNILVGENLVCKIADFGLAR---LIEDDEYTAR-EGAKFPIKWT 171
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLS-GR 229
APE G T KSDV+SFG++L E+++ GR
Sbjct: 172 APEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-29
Identities = 68/210 (32%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLG 82
LGEG + V+K D+ T G +VAIK++K + K+ L E+ L
Sbjct: 7 KLGEGTYAVVYKA-RDKET--------GRIVAIKKIKLGERKEAKDGINFTALREIKLLQ 57
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGL 141
+L+H N++ L+ N LV+EFM LE + + + P +K + RGL
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
+LH +++RDLK +N+L+ S+ KL+DFGLAR + N ++ ++V TR Y AP
Sbjct: 116 EYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRAP 171
Query: 202 E--YVATGHLTPKSDVYSFGVVLLELLSGR 229
E + A H D++S G + ELL
Sbjct: 172 ELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 87/285 (30%), Positives = 143/285 (50%), Gaps = 35/285 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPG-SGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLR 85
++G G FG VF+G + PG + VAIK LK + + ++L+E +GQ
Sbjct: 12 VIGAGEFGEVFRGILKM-------PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N+++L G ++ +++ E+M G+L+ +L S V + +A G+ +L
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRGYAAPE 202
D N ++RDL A N+L++SN K+SDFGL+R D P G T +I + APE
Sbjct: 125 --DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPE 180
Query: 203 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261
+A T SDV+SFG+V+ E++S G R + ++ +++ + D R+
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD----MSNHEVMK----AINDGFRLPAP 232
Query: 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
MD AV ++LQC D RP VD++ L++L
Sbjct: 233 MDC----------PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 83/279 (29%), Positives = 137/279 (49%), Gaps = 39/279 (13%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG V+ G W+++ VAIK ++ E ++++ E + +L H
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-----------VAIKTIR-EGAMSEEDFIEEAQVMMKLSHP 59
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
LV+L G C+E LV+EFM G L ++L S T + + +DV G+++L
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE-- 117
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
+NVI+RDL A N L+ N K+SDFG+ R D+ + S+ GT+ +++PE
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTR--FVLDDQYTSST--GTKFPVKWSSPEVF 173
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264
+ + KSDV+SFGV++ E+ S + E+R + +VE R+
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR---SNSEVVE-------TINAGFRLYKP 223
Query: 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
RL +Q+V ++ C P++RPS +L L
Sbjct: 224 RLA-------SQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 78/280 (27%), Positives = 128/280 (45%), Gaps = 38/280 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRHE 87
LG+G G V+K PT G + A+K++ + K+ L E+ L
Sbjct: 9 LGQGSSGVVYKV-----RHKPT----GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP 59
Query: 88 NLVKLIG-YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+VK G + E + + V E+M GSL + L + V I P IA + +GL +LH
Sbjct: 60 YVVKCYGAFYKEGEISI-VLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVA 205
++I+RD+K SN+L++S K++DFG+++ T D + VGT Y +PE +
Sbjct: 118 -KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF---VGTVTYMSPERIQ 173
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRA-LDEDRGGLAE--QTLVEWADPFLRDSRRVLRIM 262
+ +D++S G+ LLE G+ L + E Q + + P L
Sbjct: 174 GESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPA-------- 225
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302
++S + ++A CL DPK RPS ++L
Sbjct: 226 -----EEFSPEFRDFISA----CLQKDPKKRPSAAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 6e-28
Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 38/278 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V+K T +G VAIK+++ Q + + E++ + +H N
Sbjct: 27 IGEGASGEVYKA---------TDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76
Query: 89 LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+V + L +V E+M GSL + + ++ ++ P + +V +GL +LH
Sbjct: 77 IVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 207
NVI+RD+K+ N+LL + + KL+DFG A + S +VGT + APE V
Sbjct: 136 --NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE-VIKR 190
Query: 208 HL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 266
PK D++S G++ +E+ G + A + P L++ +
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW-------- 242
Query: 267 GGQYSK--KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302
S K+ + +CL DP+ RPS ++L
Sbjct: 243 ----SPEFKD------FLNKCLVKDPEKRPSAEELLQH 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 79/287 (27%), Positives = 119/287 (41%), Gaps = 35/287 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA--ESFQGHKEWLTEVIYLGQLR 85
++GEG +G V K ++ T G +VAIK+ K + K L EV L QLR
Sbjct: 8 VVGEGAYGVVLKC-RNKAT--------GEIVAIKKFKESEDDEDVKKTALREVKVLRQLR 58
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
HEN+V L LV+E++ + LE L S + + + +++ H
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-YV 204
N+I+RD+K N+L+ + KL DFG AR + + T V TR Y APE V
Sbjct: 118 SH--NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLV 174
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGRRAL-----DEDR--------GGLAE-QTLVEWADP 250
+ DV++ G ++ ELL G L D D+ G L + ++P
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233
Query: 251 FLRDSRRVLRIMDTRLGGQ--YSKKEAQAVAAVVLQCLHMDPKNRPS 295
+ Y K + + CL MDPK R +
Sbjct: 234 RFAGVA--FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 2e-27
Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
LG+G FG V K +G + A+K LK + KE LTE L ++
Sbjct: 1 LGKGSFGKVL---------LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGLSF 143
H +VKL Y +++ +L LV E+ P G L +HL S R + A ++ L +
Sbjct: 52 HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFS-EERARFYAAEIVLALEY 108
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH L +IYRDLK N+LLD++ + KL+DFGLA++ + + + GT Y APE
Sbjct: 109 LHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEV 164
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGR 229
+ D +S GV+L E+L+G+
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 67/212 (31%), Positives = 110/212 (51%), Gaps = 26/212 (12%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRH 86
LG G FG V+KG WI P I VAIK L+ E+ + +KE L E + + H
Sbjct: 15 LGSGAFGTVYKGVWI------PEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL------FRSVQPISWPTRVKIAIDVARG 140
++V+L+G C S L+ + MP G L +++ S ++W + +A+G
Sbjct: 69 PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKG 121
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYA 199
+S+L + +++RDL A NVL+ + + K++DFGLA+ + H V + +
Sbjct: 122 MSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK-WM 178
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLS-GRR 230
A E + T KSDV+S+GV + EL++ G +
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 22/206 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V++G + T VA+K LK + K++L E + +LRH
Sbjct: 14 LGAGQFGEVWEGLWNNTT----------PVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPK 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGL 147
L++L C+ + +V E M GSL +L + + P + +A VA G+++L
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-- 120
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
N I+RDL A NVL+ N K++DFGLAR ++ + + G + + APE
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLAR--VIKEDIYEAR--EGAKFPIKWTAPEAA 176
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GR 229
+ KSDV+SFG++L E+++ GR
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 76/279 (27%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQGHKEWLTEVIYLGQL 84
+G+G FG VFK + V A+K+ L + + +E + E L +L
Sbjct: 6 NKIGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL 56
Query: 85 RHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGL 141
+++ Y S D L V E+ G L L +P+ + I + GL
Sbjct: 57 DSSYIIRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
+ LH +++RD+K+ N+ LD+ N K+ D G+A+ DNT+ + IVGT Y +P
Sbjct: 115 AHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSP 170
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261
E KSDV++ GVVL E +G+ D + G L+ +++R
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALI----------LKIIRG 216
Query: 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ + YS Q +A ++ QCL D + RP +L
Sbjct: 217 VFPPVSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-27
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V G W + I VAIK ++ E +++ E + +L H
Sbjct: 12 LGSGQFGVVHLGKWRGK-----------IDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHP 59
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
NLV+L G C++ +V E+M G L N+L + + + DV + +L
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE-- 117
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
I+RDL A N L+ + K+SDFGLAR D+ + S+ GT+ +A PE
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR--YVLDDQYTSS--QGTKFPVKWAPPEVF 173
Query: 205 ATGHLTPKSDVYSFGVVLLELLSG 228
+ KSDV+SFGV++ E+ S
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 75/284 (26%), Positives = 143/284 (50%), Gaps = 28/284 (9%)
Query: 29 LGEGGFG----CVFKGWID-QNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLG 82
LGEG FG C +G + AP G ++VA+K L+A+ + ++L E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-----------SVQPISWPTRV 131
+L++ N+++L+G C D ++ E+M G L L + ++ +S +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
+A+ +A G+ +L L N ++RDL N L+ +++ K++DFG++R+ +GD + R
Sbjct: 133 YMAVQIASGMKYLASL--NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190
Query: 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251
V + A E + G T SDV++FGV L E+ + + ++ L+++ ++E F
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK--EQPYSLLSDEQVIENTGEF 248
Query: 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
R+ R + + T L V ++++C D K+RP+
Sbjct: 249 FRNQGRQIYLSQTPLC-------PSPVFKLMMRCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-26
Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 46/286 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSG-IVVAIKRL-KAESFQGHKEWLTEVIYLGQLR 85
LG G FG V++G PGSG I VA+K L K + Q KE+L E +
Sbjct: 2 FLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTR-------VKIAIDVA 138
H N+VKL+G C ++ + ++ E M G L ++L R + + + I +DVA
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVA 116
Query: 139 RGLSFLHGLDANVIYRDLKASNVLL-----DSNFNAKLSDFGLARDGPTGDNTHV-STRI 192
+G +L + I+RDL A N L+ D++ K+ DFGLARD D +
Sbjct: 117 KGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF- 251
+ R + APE + G T +SDV+SFGV++ E+L+ L +Q P+
Sbjct: 175 LPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT-----------LGQQ-------PYP 215
Query: 252 LRDSRRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPS 295
+++ VL+ + GG+ K E + ++ C DP RP+
Sbjct: 216 ALNNQEVLQHVTA--GGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 83/286 (29%), Positives = 129/286 (45%), Gaps = 42/286 (14%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLR 85
LG+G FG V +G W G I VA+K LK++ ++L E + L
Sbjct: 2 KLGDGSFGVVRRGEWSTSG-------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWP--TRVKIAIDVARGLSF 143
HENL++L G + ++V E P GSL + L R + T A+ +A G+ +
Sbjct: 55 HENLIRLYGVVL-THPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRY 112
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST--RIVGTRGYAAP 201
L I+RDL A N+LL S+ K+ DFGL R P ++ +V V + AP
Sbjct: 113 LE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF-AWCAP 169
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL-RDSRRVL 259
E + T + SDV+ FGV L E+ + G +P+ ++L
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGE-------------------EPWAGLSGSQIL 210
Query: 260 RIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
+ +D G + + EA Q + V+LQC +P +RP+ + L
Sbjct: 211 KKIDKE-GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 69/201 (34%), Positives = 105/201 (52%), Gaps = 14/201 (6%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRH 86
LLG+G FG VFKG + T VA+K K + Q K ++L+E L Q H
Sbjct: 2 LLGKGNFGEVFKGTLKDKT----------PVAVKTCKEDLPQELKIKFLSEARILKQYDH 51
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N+VKLIG C++ +V E +P G + L + + VK A+D A G+++L
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE- 110
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
N I+RDL A N L+ N K+SDFG++R G + + + + + APE +
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNY 168
Query: 207 GHLTPKSDVYSFGVVLLELLS 227
G + +SDV+S+G++L E S
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-26
Identities = 72/209 (34%), Positives = 111/209 (53%), Gaps = 32/209 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK----AESFQGHKEWLTEVIYLGQL 84
+GEG FG V +G +G VA+K +K A++F L E + +L
Sbjct: 14 IGEGEFGAVLQG-----------EYTGQKVAVKNIKCDVTAQAF------LEETAVMTKL 56
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSF 143
H+NLV+L+G + +V E M KG+L N L R +S ++ ++DVA G+ +
Sbjct: 57 HHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG-DNTHVSTRIVGTRGYAAPE 202
L +++RDL A N+L+ + AK+SDFGLAR G G DN+ + + + APE
Sbjct: 116 LE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPE 167
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRA 231
+ + KSDV+S+GV+L E+ S RA
Sbjct: 168 ALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 80/280 (28%), Positives = 122/280 (43%), Gaps = 51/280 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
LG G G V K +P +G ++A+K ++ E K+ L E+ L +
Sbjct: 9 LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+V G + + + E+M GSL+ L I KIA+ V +GL++LH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE- 118
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV--------GTRGYA 199
+I+RD+K SN+L++S KL DFG VS ++V GT Y
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYM 166
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259
APE + + KSD++S G+ L+EL +GR DP +
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFPYP------------PENDPPDGIFELLQ 214
Query: 260 RIMDT---RL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
I++ RL G++S + Q V CL DP+ RPS
Sbjct: 215 YIVNEPPPRLPSGKFS-PDFQ---DFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 63/215 (29%), Positives = 111/215 (51%), Gaps = 36/215 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW------LTEVIYLG 82
+GEG +G V+K ++ T G +VA+K+++ E +++ + E+ L
Sbjct: 7 IGEGTYGQVYKA-RNKKT--------GELVALKKIRME----NEKEGFPITAIREIKLLQ 53
Query: 83 QLRHENLVKLIG-YCSESDNRL-LVYEFMP---KGSLENHLFRSVQPISWPTRVK-IAID 136
+LRH N+V+L S+ + +V+E+M G L++ + + ++K
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES-----QIKCYMKQ 108
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
+ GL +LH +++RD+K SN+L++++ KL+DFGLAR T N+ T V T
Sbjct: 109 LLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITL 165
Query: 197 GYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 229
Y PE + AT P+ D++S G +L EL G+
Sbjct: 166 WYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 69/209 (33%), Positives = 105/209 (50%), Gaps = 27/209 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGH-KEWLTEVIYLGQLR 85
+GEG +G V+K D+ T G +VAIK++K F +G K L E+ L +L
Sbjct: 7 IGEGTYGVVYKAR-DKLT--------GEIVAIKKIK-LRFESEGIPKTALREIKLLKELN 56
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGLSFL 144
H N++KL+ + LV+EFM L + + + + +K + +GL+F
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFC 114
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPE 202
H +++RDLK N+L+++ KL+DFGLAR P TH V TR Y APE
Sbjct: 115 H--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY----VVTRWYRAPE 168
Query: 203 --YVATGHLTPKSDVYSFGVVLLELLSGR 229
G+ + D++S G + ELLS R
Sbjct: 169 LLLGDKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 79/302 (26%), Positives = 140/302 (46%), Gaps = 42/302 (13%)
Query: 29 LGEGGFGCV-------FKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIY 80
LGEG FG V + + ++ + ++VA+K L+ S +++L EV
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV----------QPISWPTR 130
L +L N+ +L+G C+ ++ E+M G L L + V + +S+ T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
+ +A +A G+ +L L N ++RDL N L+ N+ K++DFG++R+ + D V
Sbjct: 133 LYMATQIASGMRYLESL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQG 190
Query: 191 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GRRALDEDRGGLAEQTLVEWA 248
R + A E V G T KSDV++FGV L E+L+ + + L +Q ++E A
Sbjct: 191 RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH----LTDQQVIENA 246
Query: 249 DPFLRD-SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
F RD R++ K+ + ++L+C D ++RP + ++H
Sbjct: 247 GHFFRDDGRQIYLPRPPN-----CPKD---IYELMLECWRRDEEDRP-------TFREIH 291
Query: 308 TS 309
Sbjct: 292 LF 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL-TEVIYLGQLRHE 87
LGEG FG V + + P +G VA+K LK ES H L E+ L L HE
Sbjct: 12 LGEGHFGKV-----ELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
N+VK G C+E L+ EF+P GSL+ +L R+ I+ ++K A+ + +G+ +L
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYV 204
++RDL A NVL++S K+ DFGL + T + V + + APE +
Sbjct: 127 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 205 ATGHLTPKSDVYSFGVVLLELLS 227
SDV+SFGV L ELL+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 87/298 (29%), Positives = 135/298 (45%), Gaps = 50/298 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+LG+G FG V + ++ GS VA+K LKA+ F +E+L E + +
Sbjct: 6 MLGKGEFGSV------REAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 86 HENLVKLIGYC--SESDNRL----LVYEFMPKGSLENHLFRSV---QPISWP--TRVKIA 134
H N++KLIG S + RL ++ FM G L L S +P + P T V+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 194
ID+A G+ +L N I+RDL A N +L+ N ++DFGL++ +GD
Sbjct: 120 IDIASGMEYLS--SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 195 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL---VEWADPF 251
+ A E +A T SDV++FGV + E+++ RG QT VE ++
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RG----QTPYAGVENSE-- 223
Query: 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAV---VLQCLHMDPKNRPSMVDVLTSLEQL 306
I + + G K+ + V + QC +PK RPS + LE +
Sbjct: 224 ---------IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 70/211 (33%), Positives = 120/211 (56%), Gaps = 19/211 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSG-IVVAIKRLKA-ESFQGHKEWLTEVIYLGQLR 85
++G G FG V +G + PG I VAIK LK+ + + +++L+E +GQ
Sbjct: 11 VIGAGEFGEVCRGRLKL-------PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 63
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N++ L G ++S +++ EFM G+L++ L ++ + V + +A G+ +L
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTR---GYAA 200
+ N ++RDL A N+L++SN K+SDFGL+R + T D T+ S+ +G + + A
Sbjct: 124 --EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKIPIRWTA 179
Query: 201 PEYVATGHLTPKSDVYSFGVVLLELLS-GRR 230
PE +A T SDV+S+G+V+ E++S G R
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 55/288 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G FG V G G VA+K +K ++ + +L E + QLRH N
Sbjct: 14 IGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSN 60
Query: 89 LVKLIGYCSESDNRL-LVYEFMPKGSLENHLF---RSVQPISWPTRVKIAIDVARGLSFL 144
LV+L+G E L +V E+M KGSL ++L RSV + +K ++DV + +L
Sbjct: 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYL 118
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEY 203
N ++RDL A NVL+ + AK+SDFGL ++ T D + + + APE
Sbjct: 119 EA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEA 170
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
+ + KSDV+SFG++L E+ S R P+ R L+ +
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRV------------------PY---PRIPLKDVV 209
Query: 264 TRLGGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
R+ Y K +A V V+ QC H+D RPS + + LE +
Sbjct: 210 PRVEKGY-KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 89/296 (30%), Positives = 141/296 (47%), Gaps = 49/296 (16%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLR 85
++G+G FGCV+ G ID + G I A+K L + + +++L E I +
Sbjct: 2 VIGKGHFGCVYHGTLIDSD-------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 86 HENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRSVQPISWPTRVK----IAIDVARG 140
H N++ L+G C S+ L+V +M G L + RS PT VK + VA+G
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLR-NFIRS--ETHNPT-VKDLIGFGLQVAKG 110
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGY 198
+ +L ++RDL A N +LD +F K++DFGLARD + H T +
Sbjct: 111 MEYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF-----LR 253
A E + T T KSDV+SFGV+L EL++ RG + D F L
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDV----DSFDITVYLL 216
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
RR+L+ +Y + V+L C H P+ RP+ ++++ +EQ+ ++
Sbjct: 217 QGRRLLQ-------PEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 82/311 (26%), Positives = 137/311 (44%), Gaps = 51/311 (16%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIV-VAIKRLKAESFQGH-KEWLTEVI 79
N LGEG FG V K T K +G VA+K LK + ++ L+E
Sbjct: 1 NLVLGKTLGEGEFGKVVKA-----TAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS------------------ 121
L Q+ H +++KL G CS+ LL+ E+ GSL + L S
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 122 -----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176
+ ++ + A ++RG+ +L + +++RDL A NVL+ K+SDFGL
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEM--KLVHRDLAARNVLVAEGRKMKISDFGL 173
Query: 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDED 235
+RD D+ ++ + A E + T +SDV+SFGV+L E+++ G
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP-- 231
Query: 236 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
G+A + L L+ R+ R + ++ + ++L C +P RP+
Sbjct: 232 --GIAPERLFN----LLKTGYRMER----------PENCSEEMYNLMLTCWKQEPDKRPT 275
Query: 296 MVDVLTSLEQL 306
D+ LE++
Sbjct: 276 FADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI----YLGQL 84
LG G FG V ++ + +K + + VA+K LK + +E L + +LG
Sbjct: 43 LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN- 97
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP-ISWPTRVKIAIDVARGLSF 143
HEN+V L+G C+ L++ E+ G L N L R + ++ + + VA+G++F
Sbjct: 98 -HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA---- 199
L N I+RDL A NVLL K+ DFGLARD D+ +V +G A
Sbjct: 157 LAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVV------KGNARLPV 207
Query: 200 ---APEYVATGHLTPKSDVYSFGVVLLELLS 227
APE + T +SDV+S+G++L E+ S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-24
Identities = 77/300 (25%), Positives = 128/300 (42%), Gaps = 47/300 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G+G FG VF+ P +P + +VA+K LK E S ++ E + + H
Sbjct: 13 IGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP----------------------I 125
N+VKL+G C+ L++E+M G L L R P +
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL-RHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 126 SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185
S ++ IA VA G+++L + ++RDL N L+ N K++DFGL+R+ + D
Sbjct: 128 SCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 186 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245
S + PE + T +SDV+++GVVL E+ S + G E+ +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--YGMQPYYGMAHEEVIY 243
Query: 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305
++RD VL D + ++ C P +RPS + L++
Sbjct: 244 -----YVRDG-NVLSCPDNC---------PLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-24
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRH 86
+GEG G VFK + G VA+K++ +G + L E+ L +H
Sbjct: 8 IGEGAHGIVFKAKDRET---------GETVALKKVALRRLEGGIPNQALREIKALQACQH 58
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+VKL+ +LV E+MP L L +P+ + +G++++H
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA 117
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV-A 205
+++RDLK +N+L+ ++ K++DFGLAR + S + V TR Y APE +
Sbjct: 118 N--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYG 174
Query: 206 TGHLTPKSDVYSFGVVLLELLSGR 229
P D+++ G + ELL+G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-24
Identities = 86/292 (29%), Positives = 142/292 (48%), Gaps = 45/292 (15%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQL 84
+ ++G G FG V G + P K I VAIK LKA + + +++L+E +GQ
Sbjct: 9 EKVIGAGEFGEVCSGRLK----LPGK--REIPVAIKTLKAGYTEKQRRDFLSEASIMGQF 62
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
H N++ L G ++S ++V E+M GSL+ L + + V + +A G+ +L
Sbjct: 63 DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL 122
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRG---- 197
D ++RDL A N+L++SN K+SDFGL+R D P T TRG
Sbjct: 123 S--DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT--------TRGGKIP 172
Query: 198 --YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254
+ APE +A T SDV+S+G+V+ E++S G R E ++ Q +++ + +
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE----MSNQDVIKAIE----E 224
Query: 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
R+ MD A+ ++L C D RP +++ L++L
Sbjct: 225 GYRLPAPMDC----------PAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-24
Identities = 86/296 (29%), Positives = 142/296 (47%), Gaps = 51/296 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRH 86
LGEG FG V +G ++Q+ S + VA+K +K + +++L+E + + + H
Sbjct: 7 LGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59
Query: 87 ENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRSV---QPISWPTR--VKIAI 135
N+++LIG C ++ +++ FM G L + L S P PT+ VK
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
D+A G+ +L + I+RDL A N +L+ N N ++DFGL++ GD + RI
Sbjct: 120 DIASGMEYLS--SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD-YYRQGRIAKM 176
Query: 196 R-GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWAD 249
+ A E +A T KSDV+SFGV + E+ + RG G+ + +
Sbjct: 177 PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT--------RGQTPYPGVENSEIYD--- 225
Query: 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305
+LR R+ + D L G YS ++ C ++PK+RPS + LE+
Sbjct: 226 -YLRQGNRLKQPPDC-LDGLYS---------LMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 9e-24
Identities = 65/210 (30%), Positives = 110/210 (52%), Gaps = 29/210 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-----EVIYLGQ 83
LGEG +G V+K D+ T G +VA+K+++ ++ +E + E+ L +
Sbjct: 7 LGEGTYGVVYKAR-DKKT--------GEIVALKKIRLDN---EEEGIPSTALREISLLKE 54
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGLS 142
L+H N+VKL+ LV+E+ L+ +L + P+S P +K I + RGL+
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS-PNLIKSIMYQLLRGLA 112
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAA 200
+ H +++RDLK N+L++ + KL+DFGLAR P TH V T Y A
Sbjct: 113 YCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE----VVTLWYRA 166
Query: 201 PE-YVATGHLTPKSDVYSFGVVLLELLSGR 229
PE + + H + D++S G + E+++G+
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-23
Identities = 78/295 (26%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V D P + +G VVA+K+L+ + + +++ E+ L L+H+
Sbjct: 11 QLGKGNFGSVELCRYD-----PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
N+VK G C + R LV E++P GSL ++L + + + + A + +G+ +L
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG--YAAPEY 203
++RDL N+L++S K+ DFGL + P D + R G + APE
Sbjct: 126 SK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWYAPES 182
Query: 204 VATGHLTPKSDVYSFGVVLLELLS------------GRRALDEDRGGLAEQTLVEWADPF 251
+ + SDV+SFGVVL EL + R ++ +G + L+E
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE----L 238
Query: 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
L+++ R+ + A++ +C + DP RPS ++ +E +
Sbjct: 239 LKNNGRLPAPPGC----------PAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-23
Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLR 85
+GEG FG V++G ++ I VA+K K + +E +L E + Q
Sbjct: 13 CIGEGQFGDVYQGVYMSPE-------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H ++VKLIG +E + +V E P G L ++L + + + + + ++ L++L
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
++RD+ A NVL+ S KL DFGL+R S + + + APE +
Sbjct: 125 SK--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-WMAPESIN 181
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSRRVLRIMD 263
T SDV+ FGV + E+L G PF ++++ + RI +
Sbjct: 182 FRRFTSASDVWMFGVCMWEILM--------LG----------VKPFQGVKNNDVIGRIEN 223
Query: 264 TRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
G + + +++ +C DP RP ++ L +
Sbjct: 224 ---GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 72/215 (33%), Positives = 110/215 (51%), Gaps = 32/215 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQL 84
+GEG +G V A KP +G+ VAIK++ F+ + L E+ L +
Sbjct: 12 YIGEGAYGMVCS--------ATHKP-TGVKVAIKKI--SPFEHQTFCQRTLREIKILRRF 60
Query: 85 RHENLVKL------IGYCSESDNRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAID 136
+HEN++ + + S +D +V E M E L++ + Q +S
Sbjct: 61 KHENIIGILDIIRPPSFESFND-VYIVQELM-----ETDLYKLIKTQHLSNDHIQYFLYQ 114
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGT 195
+ RGL ++H ANV++RDLK SN+LL++N + K+ DFGLAR P D+T T V T
Sbjct: 115 ILRGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 196 RGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 229
R Y APE + K+ D++S G +L E+LS R
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LGEG FG VF + + P + ++VA+K LK S +++ E L L+H++
Sbjct: 13 LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP---------------ISWPTRVKI 133
+V+ G C+E L+V+E+M G L N RS P ++ + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A +A G+ +L L + ++RDL N L+ K+ DFG++RD + D V R +
Sbjct: 128 ASQIASGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ PE + T +SD++SFGVVL E+ +
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-23
Identities = 74/291 (25%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL---KAESFQGHKEWLTEVIYLGQL 84
LG G FG VF + G +V +K L K E+ Q E+ E+ +L
Sbjct: 12 TLGRGEFGEVFLAKAK----GIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFRKL 65
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRSVQPISWPTRVKIAID 136
H+N+V+L+G C E++ ++ E+ G L+ L P+S +V +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
+A G+ L +A ++RDL A N L+ S K+S L++D + + ++ R
Sbjct: 126 IALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR 183
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRD 254
+ APE V + KSDV+SFGV++ E+ + E PF L D
Sbjct: 184 -WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-----------QGEL-------PFYGLSD 224
Query: 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305
+ R+ +L + + ++ +C ++PK+RPS +++++L +
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 73/233 (31%), Positives = 112/233 (48%), Gaps = 17/233 (7%)
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIA 134
+E+ +G+L+H N+VKLIG C L++E++ +L L + +SW R KIA
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIA 786
Query: 135 IDVARGLSFLH-GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
I +A+ L FLH V+ +L +++D L R G + +
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFI 840
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
+ Y APE T +T KSD+Y FG++L+ELL+G+ D + G ++VEWA
Sbjct: 841 SS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYS 897
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAA--VVLQCLHMDPKNRPSMVDVLTSLE 304
D + I D + G S + + V + L C DP RP DVL +LE
Sbjct: 898 DCHLDMWI-DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-23
Identities = 83/293 (28%), Positives = 149/293 (50%), Gaps = 45/293 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V++G K VAIK + +A S + E+L E + +
Sbjct: 14 LGQGSFGMVYEGIAK----GVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP-------ISWPT---RVKIAIDV 137
++V+L+G S+ L++ E M +G L+++L RS++P + P+ +++A ++
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 138 ARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
A G+++L +AN ++RDL A N ++ +F K+ DFG+ RD D + +
Sbjct: 129 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL-RDS 255
+ +PE + G T SDV+SFGVVL E+ + LAEQ P+ +
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ-------PYQGMSN 227
Query: 256 RRVLR-IMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305
+VLR +M+ GG K + + ++ C +PK RPS +++++S+++
Sbjct: 228 EQVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-23
Identities = 80/290 (27%), Positives = 127/290 (43%), Gaps = 41/290 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V++G + VA+K L ++ S Q ++L E + + + H+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQ----VAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLF----RSVQPISWPTR--VKIAIDVARGL 141
N+V+LIG E R ++ E M G L++ L R +P S + + A DVA+G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
+L + + I+RD+ A N LL AK++DFG+ARD R + +
Sbjct: 130 KYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 257
PE G T K+DV+SFGV+L E+ S G P+ R
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM-------------------PY--PGRT 226
Query: 258 VLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
+M+ GG K V ++ C P++RP+ +L ++
Sbjct: 227 NQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 4e-23
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 34/224 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE---SFQGHKEWLTEVIYLGQL 84
++GEG F V + + AIK L + K E L +L
Sbjct: 8 IIGEGSFSTVVLA---------KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL 58
Query: 85 -RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
H ++KL + +N V E+ P G L ++ R + A ++ L +
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEY 117
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD----NTHVSTRI------- 192
LH +I+RDLK N+LLD + + K++DFG A+ N +T I
Sbjct: 118 LHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 193 -------VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
VGT Y +PE + SD+++ G ++ ++L+G+
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-23
Identities = 88/283 (31%), Positives = 136/283 (48%), Gaps = 39/283 (13%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR 85
D LG+G FG V+ G + T VAIK LK + + +L E + +LR
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTT----------KVAIKTLKPGTMMP-EAFLQEAQIMKKLR 59
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFL 144
H+ LV L SE + +V EFM KGSL + L + + P V +A +A G++++
Sbjct: 60 HDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAP 201
+ N I+RDL+A+N+L+ N K++DFGLAR DN + + + G + + AP
Sbjct: 119 ERM--NYIHRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQ--GAKFPIKWTAP 172
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261
E G T KSDV+SFG++L EL++ R G+ + ++E + R
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRV---PYPGMVNREVLEQVERGYR-------- 221
Query: 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
M G S E ++ C DP RP+ + + LE
Sbjct: 222 MPCPQGCPESLHE------LMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-23
Identities = 82/272 (30%), Positives = 134/272 (49%), Gaps = 41/272 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V+ G + NT VA+K LK + + +L E + +LRH+
Sbjct: 14 LGNGQFGEVWMGTWNGNT----------KVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDK 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGL 147
LV+L SE + +V E+M KGSL + L + + P V +A VA G++++ +
Sbjct: 63 LVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
N I+RDL+++N+L+ K++DFGLAR DN + + + G + + APE
Sbjct: 122 --NYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQ--GAKFPIKWTAPEAA 175
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL-RDSRRVLRIMD 263
G T KSDV+SFG++L EL++ R P+ ++R VL ++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRV------------------PYPGMNNREVLEQVE 217
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
+ ++ ++LQC DP+ RP+
Sbjct: 218 RGYRMPCPQDCPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 6e-23
Identities = 68/202 (33%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHE 87
LG G FGCV KG + K I VAIK LK E+ + E + E + QL +
Sbjct: 3 LGSGNFGCVKKG-----VYKMRK--KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+V++IG C E++ +LV E G L L I+ V++ V+ G+ +L G
Sbjct: 56 YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG- 113
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT--RGYAAPEYVA 205
N ++RDL A NVLL + AK+SDFGL++ D+++ R G + APE +
Sbjct: 114 -KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 206 TGHLTPKSDVYSFGVVLLELLS 227
+ +SDV+S+G+ + E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 7e-23
Identities = 72/206 (34%), Positives = 111/206 (53%), Gaps = 22/206 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+ G + T VAIK LK + + +L E + +LRHE
Sbjct: 14 LGQGCFGEVWMGTWNGTT----------RVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEK 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTRVKIAIDVARGLSFLHGL 147
LV+L SE + +V E+M KGSL + L + + P V +A +A G++++ +
Sbjct: 63 LVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
N ++RDL+A+N+L+ N K++DFGLAR DN + + + G + + APE
Sbjct: 122 --NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GAKFPIKWTAPEAA 175
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGRR 230
G T KSDV+SFG++L EL + R
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 9e-23
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LGEG FG VF + +PTK ++VA+K LK + K++ E L L+HE+
Sbjct: 13 LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP----------------ISWPTRVK 132
+VK G C + D ++V+E+M G L N R+ P + +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
IA +A G+ +L + ++RDL N L+ +N K+ DFG++RD + D V
Sbjct: 128 IASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ + PE + T +SDV+SFGV+L E+ +
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-22
Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 28/205 (13%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G +G V++G W + + VA+K LK ++ + E+L E + +++H
Sbjct: 14 LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR----SVQPISWPTRVKIAIDVARGLSF 143
NLV+L+G C+ ++ EFM G+L ++L V + + +A ++ + +
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEY 119
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAA 200
L N I+RDL A N L+ N K++DFGL+R TGD T G + + A
Sbjct: 120 LEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGD---TYTAHAGAKFPIKWTA 173
Query: 201 PEYVATGHLTPKSDVYSFGVVLLEL 225
PE +A + KSDV++FGV+L E+
Sbjct: 174 PESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 2e-22
Identities = 73/215 (33%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGH-KEWLTEVIYLGQLR 85
+G G +G V +D+ T G VAIK++ K L E+ L LR
Sbjct: 7 PIGSGAYGVVCSA-VDKRT--------GRKVAIKKISNVFDDLIDAKRILREIKLLRHLR 57
Query: 86 HENLVKLIGY----CSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVAR 139
HEN++ L+ E N + +V E M + + + +S QP++ ++ + R
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKSPQPLT-DDHIQYFLYQILR 114
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGTRGY 198
GL +LH ANVI+RDLK SN+L++SN + K+ DFGLAR P D T V TR Y
Sbjct: 115 GLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172
Query: 199 AAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRAL 232
APE + + T D++S G + ELL R+ L
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-22
Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 39/279 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V G K + I VAIK + E ++++ E + +L H
Sbjct: 12 LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
LV+L G C++ +V EFM G L N+L + +S + + DV G+ +L
Sbjct: 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE--R 118
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYVA 205
+ I+RDL A N L+ S K+SDFG+ R D+ + S+ G + ++ PE
Sbjct: 119 NSFIHRDLAARNCLVSSTGVVKVSDFGMTR--YVLDDEYTSS--SGAKFPVKWSPPEVFN 174
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
+ KSDV+SFGV++ E+ + E PF + S + M +R
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFT------------------EGKMPFEKKSNYEVVEMISR 216
Query: 266 LGGQYSKKEA-QAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
Y K A V V+ C H P+ RP+ ++L ++
Sbjct: 217 GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 82/281 (29%), Positives = 129/281 (45%), Gaps = 41/281 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V G W Q VAIK +K E E++ E + +L HE
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
LV+L G C++ +V E+M G L N+L + +++ DV G+++L
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE-- 117
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
I+RDL A N L+D K+SDFGL+R D+ + S+ VG++ ++ PE +
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWSPPEVL 173
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
+ KSDV++FGV++ E+ S G+ + VE LR R L
Sbjct: 174 LYSKFSSKSDVWAFGVLMWEVYSLGKMPYER----FNNSETVEKVSQGLRLYRPHL---- 225
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
++ V A++ C H + RP+ +L+S+E
Sbjct: 226 ----------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 3e-22
Identities = 72/224 (32%), Positives = 113/224 (50%), Gaps = 51/224 (22%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-------EVIYL 81
LG+G +G V+K ID+ T VVA+K++ ++F+ T E+++L
Sbjct: 15 LGKGAYGIVWKA-IDRRT--------KEVVALKKI-FDAFRN----ATDAQRTFREIMFL 60
Query: 82 GQLR-HENLVKLIG-YCSESDNRL-LVYEFMP--------KGSLEN-HLFRSVQPISWPT 129
+L H N+VKL+ +E+D + LV+E+M LE+ H + I +
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH----KRYIMY-- 114
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-- 187
+ + L ++H NVI+RDLK SN+LL+S+ KL+DFGLAR +
Sbjct: 115 ------QLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
Query: 188 -VSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 229
V T V TR Y APE + + T D++S G +L E+L G+
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-22
Identities = 74/257 (28%), Positives = 114/257 (44%), Gaps = 33/257 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR 85
LG+GGFG V A +G + A K+L + +G + L E L ++
Sbjct: 1 LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQP-ISWPTRVKIAIDVARGLSF 143
+V L Y E+ + L LV M G L+ H++ +P + A + GL
Sbjct: 52 SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH ++YRDLK NVLLD + N ++SD GLA + G GT GY APE
Sbjct: 111 LHQR--RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEV 165
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGR-----RALDEDRGGLAEQTL---VEWADPFLRDS 255
+ D ++ G L E+++GR R ++ L +TL VE+ D F ++
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEA 225
Query: 256 RRVLRIM-----DTRLG 267
+ + + + RLG
Sbjct: 226 KDLCEALLQKDPEKRLG 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-22
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 28 LLGEGGFGCVFKGW-IDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH 86
LLG G FG V++G +D F K V++ + K+ E+ L +L+H
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N+V+ +G E DN + E +P GSL L + P + GL +LH
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLH- 119
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-----RIVGTRGYAAP 201
D N ++RD+K +N+L+D+N KL+DFG+A+ V G+ + AP
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAP 170
Query: 202 EYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
E +A G +D++S G +LE+ +G+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-22
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LGEG FG VF + P + I+VA+K LK S K++ E L L+HE+
Sbjct: 13 LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP-------------ISWPTRVKIAI 135
+VK G C E D ++V+E+M G L N R+ P ++ + IA
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
+A G+ +L + ++RDL N L+ N K+ DFG++RD + D V +
Sbjct: 128 QIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ PE + T +SDV+S GVVL E+ +
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-22
Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 23/206 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V+ G+ + +T VAIK LK S + +L E + QL+H
Sbjct: 14 LGAGQFGEVWMGYYNGHT----------KVAIKSLKQGSMS-PEAFLAEANLMKQLQHPR 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGL 147
LV+L ++ + ++ E+M GSL + L ++ + +A +A G++F+
Sbjct: 63 LVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE-- 119
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
N I+RDL+A+N+L+ K++DFGLAR DN + + G + + APE +
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTARE--GAKFPIKWTAPEAI 175
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GR 229
G T KSDV+SFG++L E+++ GR
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 7e-22
Identities = 84/308 (27%), Positives = 132/308 (42%), Gaps = 69/308 (22%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AESFQGHKEWLTEVIYLGQLR 85
LL EG FG +F G + + V +K +K A Q L E L L
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEE-----VFVKTVKDHASEIQVTL-LLQESCLLYGLS 66
Query: 86 HENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHL-------FRSVQPISWPTRVKIAIDV 137
H+N++ ++ C E + ++Y +M G+L+ L + Q +S V +AI +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPT-----GDNTHVSTR 191
A G+S+LH VI++D+ A N ++D K++D L+RD P GDN + +
Sbjct: 127 ACGMSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251
+ A E + + SDV+SFGV+L EL++ L + VE DPF
Sbjct: 185 ------WMALESLVNKEYSSASDVWSFGVLLWELMT-----------LGQTPYVE-IDPF 226
Query: 252 -----LRDSRRVLRIMDTRLGGQYSKKEAQAVA------AVVLQCLHMDPKNRPSMVDVL 300
L+D R+ AQ + AV+ C +DP+ RPS ++
Sbjct: 227 EMAAYLKDGYRL----------------AQPINCPDELFAVMACCWALDPEERPSFSQLV 270
Query: 301 TSLEQLHT 308
L H
Sbjct: 271 QCLTDFHA 278
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-21
Identities = 84/297 (28%), Positives = 147/297 (49%), Gaps = 44/297 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V++G N K + VA+K + ++ S + E+L E +
Sbjct: 14 LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISW-------PT---RVKIAIDV 137
++V+L+G S+ L+V E M G L+++L RS++P + PT +++A ++
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYL-RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
A G+++L+ ++RDL A N ++ +F K+ DFG+ RD D + +
Sbjct: 129 ADGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDS 255
+ APE + G T SD++SFGVVL E+ S LAEQ P+ L +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNE 228
Query: 256 RRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSL-EQLHTS 309
+ + +MD GG + + + V ++ C +PK RP+ ++++ L + LH S
Sbjct: 229 QVLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 83/296 (28%), Positives = 128/296 (43%), Gaps = 45/296 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL--KAESFQGHKEWLTEVIYLGQLR 85
L+GEG +G V K +G +VAIK+ + K + E+ L QLR
Sbjct: 8 LVGEGSYGMVMKC---------KHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
HENLV LI LV+EF+ L + L + + K + RG+ F H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEY 203
N+I+RD+K N+L+ + KL DFG AR P G+ V T V TR Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GE---VYTDYVATRWYRAPEL 171
Query: 204 VATGHLTPKS-DVYSFGVVLLELLSGRRALDEDR------------GGLAE--QTLVEWA 248
+ ++ D+++ G ++ E+L+G D G L Q + +
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 249 DPFLRDSRRVLRIMDTR----LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
F +R+ + + L ++ K + + QCL +DP +RPS +L
Sbjct: 232 PLFA-----GMRLPEVKEIEPLEKRFPKLSGLVL-DLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 27/210 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR-LKAESFQGHKEWLTEVIYLGQLRHE 87
LGEG G V K + G++ A+K + K+ L E+ +
Sbjct: 9 LGEGAGGSVTKCRLKNT---------GMIFALKTITTDPNPDLQKQILRELEINKSCKSP 59
Query: 88 NLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPT--RV--KIAIDVARGL 141
+VK G + ES + + + E+ GSL++ +++ V+ +V KIA V +GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD--NTHVSTRIVGTRGYA 199
S+LH +I+RD+K SN+LL KL DFG+ +G+ N+ T GT Y
Sbjct: 119 SYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGV-----SGELVNSLAGT-FTGTSFYM 170
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGR 229
APE + + SDV+S G+ LLE+ R
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 80/286 (27%), Positives = 125/286 (43%), Gaps = 57/286 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRH 86
+G+G FG V+K ID+ T VVAIK + E + E + E+ +L Q R
Sbjct: 8 CIGKGSFGEVYKA-IDKRT--------NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+ K G + ++ E+ GS L + + I +V GL +LH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKP-GKLDETYIAFILREVLLGLEYLHE 116
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEY 203
I+RD+KA+N+LL + KL+DFG++ G T ++ VGT + APE
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEV 169
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD--SRRVLRI 261
+ K+D++S G+ +EL G +P L D RVL +
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKG--------------------EPPLSDLHPMRVLFL 209
Query: 262 M-----DTRLGGQYSK--KEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ + G ++SK K+ V CL+ DPK RPS ++L
Sbjct: 210 IPKNNPPSLEGNKFSKPFKD------FVSLCLNKDPKERPSAKELL 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-21
Identities = 63/203 (31%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V+ G+ + +T VA+K LK + + +L E + L+H+
Sbjct: 14 LGAGQFGEVWMGYYNNST----------KVAVKTLKPGTMS-VQAFLEEANLMKTLQHDK 62
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGL 147
LV+L ++ + ++ E+M KGSL + L + P + + +A G++++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE-- 120
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
N I+RDL+A+NVL+ + K++DFGLAR DN + + G + + APE +
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTARE--GAKFPIKWTAPEAI 176
Query: 205 ATGHLTPKSDVYSFGVVLLELLS 227
G T KSDV+SFG++L E+++
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 4e-21
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 45/218 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
LG+G FG V+ ++ T G +VAIK++K + W L EV L +
Sbjct: 7 LGDGTFGSVYLA-RNKET--------GELVAIKKMKKKF----YSWEECMNLREVKSLRK 53
Query: 84 L-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-----RSVQPISWPTRVKIAIDV 137
L H N+VKL E+D V+E+M E +L+ R +P S I +
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQI 108
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-----TRI 192
+GL+ +H +RDLK N+L+ K++DFGLAR + T
Sbjct: 109 LQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--------EIRSRPPYTDY 158
Query: 193 VGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 229
V TR Y APE + + + D+++ G ++ EL + R
Sbjct: 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-21
Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--- 84
LGEG FG V K P VA+K LK ++ + K+ V + +
Sbjct: 19 PLGEGAFGQVVKA----EAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMI 72
Query: 85 -RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---------------SVQPISWP 128
+H+N++ L+G C++ +V E+ G+L + L + ++
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 188
V A VARG+ FL I+RDL A NVL+ + K++DFGLARD D
Sbjct: 133 DLVSFAYQVARGMEFLA--SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 189 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+T + APE + T +SDV+SFGV+L E+ +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 73/289 (25%), Positives = 117/289 (40%), Gaps = 49/289 (16%)
Query: 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLT-EVIYLGQL 84
+G+G FG V K K G ++ K + + K+ L EV L +L
Sbjct: 6 ETIGKGSFGTVRK--------VRRKS-DGKILVWKEIDYGNMTEKEKQQLVSEVNILREL 56
Query: 85 RHENLVKLIGYCSESDNRLL--VYEFMPKGSLEN---HLFRSVQPISWPTRVKIAIDVAR 139
+H N+V+ + N+ L V E+ G L + + I +I +
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 140 GLSFLHGLDAN---VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
L H V++RDLK +N+ LD+N N KL DFGLA+ G ++ + VGT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAKTYVGTP 174
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256
Y +PE + KSD++S G ++ EL + PF ++
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS-------------------PPFTARNQ 215
Query: 257 RVLRIM-----DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
L R+ +YS + V+ L++DP RPS ++L
Sbjct: 216 LQLASKIKEGKFRRIPYRYSS----ELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-21
Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 32 GGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLRHEN 88
G +G VF K +G + AIK +K + LTE L Q +
Sbjct: 4 GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54
Query: 89 LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+VKL Y + L LV E++P G L L +V + ++ L +LH
Sbjct: 55 VVKLY-YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIVLALEYLHSN 112
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS------TRIVGTRGYAAP 201
+I+RDLK N+L+DSN + KL+DFGL++ G +++ RIVGT Y AP
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 202 EYV-ATGHLTPKSDVYSFGVVLLELLSG 228
E + GH + D +S G +L E L G
Sbjct: 171 EVILGQGH-SKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-20
Identities = 79/284 (27%), Positives = 134/284 (47%), Gaps = 36/284 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
+G G FG V G + S V +K L+A + +L EV +L H
Sbjct: 3 IGNGWFGKVLLGEAHRGM-------SKARVVVKELRASATPDEQLLFLQEVQPYRELNHP 55
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS----VQPISWP-TRVKIAIDVARGLS 142
N+++ +G C ES LLV EF P G L+N+L RS V ++ ++A +VA GL
Sbjct: 56 NVLQCLGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLL 114
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH A+ I+ DL N L ++ + K+ D+GLA + D + APE
Sbjct: 115 WLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPE 172
Query: 203 YVATGH-------LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
V T KS+++S GV + EL + A D+ L+++ +++ +R+
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT---AADQPYPDLSDEQVLKQV---VRE- 225
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 299
+ +++ +L +YS + + V+Q +DP+ RP+ +V
Sbjct: 226 -QDIKLPKPQLDLKYSDRWYE-----VMQFCWLDPETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-20
Identities = 61/212 (28%), Positives = 110/212 (51%), Gaps = 23/212 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL------KAESFQGHKEWLTEVIYL 81
+LG+G +G V+ G +Q G ++A+K++ + + +++ EV L
Sbjct: 7 VLGKGAYGTVYCGLTNQ----------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 82 GQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
L+H N+V+ +G C + + + EF+P GS+ + L R P+ P K + G+
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGV 115
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD----GPTGDNTHVSTRIVGTRG 197
++LH + V++RD+K +NV+L N KL DFG AR G G ++++ + GT
Sbjct: 116 AYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
+ APE + KSD++S G + E+ +G+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 39/222 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQL-R 85
++GEG FG V + I K G + AIK LK S H+++ E+ L +L
Sbjct: 9 VIGEGNFGQVIRAMI-------KKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTR 130
H N++ L+G C + E+ P G+L + L +S ++
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
++ A DVA G+ +L + I+RDL A NVL+ N +K++DFGL+R G+ +V
Sbjct: 122 LQFASDVATGMQYLS--EKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKK 175
Query: 191 RIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLS 227
T G ++A L T KSDV+SFGV+L E++S
Sbjct: 176 ----TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K +G+ A K ++ ES + ++++ E+ L + +H N
Sbjct: 13 LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+V L + ++ EF G+L++ + + ++ P + + L+FLH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH--S 121
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--T 206
VI+RDLKA N+LL + + KL+DFG++ + + +GT + APE VA T
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACET 179
Query: 207 GHLTP---KSDVYSFGVVLLELLSGR 229
P K+D++S G+ L+EL
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 39/222 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQL-R 85
++GEG FG V K I K G + AIKR+K + + H+++ E+ L +L
Sbjct: 14 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTR 130
H N++ L+G C L E+ P G+L + L +S +S
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
+ A DVARG+ +L I+RDL A N+L+ N+ AK++DFGL+R G +V
Sbjct: 127 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 180
Query: 191 RIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLS 227
T G ++A L T SDV+S+GV+L E++S
Sbjct: 181 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 63/182 (34%), Positives = 89/182 (48%), Gaps = 14/182 (7%)
Query: 57 VVAIKRLKAESFQGH-KEWLTEVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGS 113
VAIKR+ E Q E EV + Q H N+VK Y S L V ++ GS
Sbjct: 28 KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY--YTSFVVGDELWLVMPYLSGGS 85
Query: 114 LENHLFRSVQPISWPTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170
L + +S P IA +V +GL +LH I+RD+KA N+LL + + K
Sbjct: 86 LL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVK 142
Query: 171 LSDFGL-ARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLS 227
++DFG+ A GD T V VGT + APE + H K+D++SFG+ +EL +
Sbjct: 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202
Query: 228 GR 229
G
Sbjct: 203 GA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-20
Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE-VIYLGQLR 85
LLG G FG V KG WI P I VAIK ++ S + + +T+ ++ +G L
Sbjct: 14 LLGSGVFGTVHKGIWI------PEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD 67
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H +V+L+G C + +L V + P GSL +H+ + + + + +A+G+ +L
Sbjct: 68 HAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
+ +++R+L A N+LL S+ +++DFG+A D + + + A E +
Sbjct: 127 --EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 206 TGHLTPKSDVYSFGVVLLELLS 227
G T +SDV+S+GV + E++S
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 20/213 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEW-LTEVIYLGQL 84
+LG+G FG V A K G+ + A+K LK + E +TE L
Sbjct: 2 VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52
Query: 85 -RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
+H L +L C ++ +RL V E++ G L H+ RS + P A ++ GL
Sbjct: 53 GKHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQ 110
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
FLH + +IYRDLK NVLLDS + K++DFG+ ++G G T ++ GT Y APE
Sbjct: 111 FLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE 166
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDED 235
++ P D ++ GV+L E+L+G+ + D
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 72/279 (25%), Positives = 119/279 (42%), Gaps = 37/279 (13%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR 85
LGEG +G V+K +G VVAIK + + +E + E+ L Q
Sbjct: 8 LEKLGEGSYGSVYKA---------IHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCD 56
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI---DVARGLS 142
+VK G ++ + +V E+ GS+ + + + T +IA +GL
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITN--KTLTEEEIAAILYQTLKGLE 113
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH I+RD+KA N+LL+ AKL+DFG++ G D ++GT + APE
Sbjct: 114 YLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPE 169
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
+ K+D++S G+ +E+ G+ + A + P L D
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD-------- 221
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301
+K + V +CL DP+ RPS + +L
Sbjct: 222 --------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 31 EGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQLR 85
EG +G V++ D+ T G +VA+K+LK E KE L E+ L +L+
Sbjct: 15 EGTYGVVYRA-RDKKT--------GEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62
Query: 86 HENLVKL--IGYCSESDNRLLVYEFMP---KGSLENHLFRSVQPISWPTRVKIAIDVARG 140
H N+V + + S D +V E++ K +E QP + + + G
Sbjct: 63 HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM----KQPFLQSEVKCLMLQLLSG 118
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 200
++ LH D +++RDLK SN+LL++ K+ DFGLAR G T++V T Y A
Sbjct: 119 VAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYRA 174
Query: 201 PE-YVATGHLTPKSDVYSFGVVLLELLSGR 229
PE + + D++S G + ELL+ +
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
+LG G FG + +G + P+K + VAI L+A S + + +L E + LGQ H
Sbjct: 12 ILGTGRFGELCRGCLK----LPSK--RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH 65
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N+V+L G + + ++V E+M G+L++ L + + + + +A G+ +L
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS- 124
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFG-LARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
+ +++ L A VL++S+ K+S F L D T +S + +AAPE +
Sbjct: 125 -EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL--WAAPEAIQ 181
Query: 206 TGHLTPKSDVYSFGVVLLELLS-GRR 230
H + SDV+SFG+V+ E++S G R
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 68/205 (33%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA--ESFQGHKEWLTEVIYLGQLRH 86
+GEG +G VFK +G +VAIK+ + K L E+ L QL+H
Sbjct: 9 IGEGSYGVVFKC---------RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
NLV LI LV+E+ ++ N L ++ + + KI + ++F H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEY- 203
N I+RD+K N+L+ KL DFG AR GP D T V TR Y APE
Sbjct: 119 H--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY----VATRWYRAPELL 172
Query: 204 VATGHLTPKSDVYSFGVVLLELLSG 228
V P DV++ G V ELL+G
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 75/289 (25%), Positives = 123/289 (42%), Gaps = 56/289 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKE-WLTEVIYLGQLR 85
LG+G +G V+K + A+K + S Q +E + E+ L +
Sbjct: 7 KLGKGSYGSVYK---------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 86 HENLVKLIGYCSES---DNRL-LVYEFMPKGSLENHLFRSVQ---PISWPTRVKIAIDVA 138
H N+ I Y E+ N+L +V E+ P G L + + + I +I I +
Sbjct: 58 HPNI---ISY-KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
RGL LH + +++RDLK++N+LL +N K+ D G+++ T+I GT Y
Sbjct: 114 RGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKTQI-GTPHY 167
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF----LRD 254
APE + KSD++S G +L E+ + PF ++D
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP-------------------PFEARSMQD 208
Query: 255 SR-RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302
R +V R + YS Q + + L + PK RP+ +L S
Sbjct: 209 LRYKVQRGKYPPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 61/312 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRH 86
LGEG FG V+K Q +G VVA+K++ + + L E+ L +L+H
Sbjct: 16 LGEGTFGEVYKA--RQIK-------TGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 87 ENLVKLIGYCSE-----SDNRLLVYEFMP------KGSLENHLFRSVQPISWPTRVK-IA 134
N+V LI E R VY P G LEN + + ++K
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES-----QIKCYM 121
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---------DGPTGDN 185
+ + G+++LH + ++++RD+KA+N+L+D+ K++DFGLAR G G
Sbjct: 122 LQLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 186 THVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRAL----DEDR---- 236
T T +V TR Y PE + T D++ G V E+ + R L D D+
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239
Query: 237 ----GGLAEQTLVEWAD----PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM 288
G E+T W + R ++ R G + ++ + L +
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE-----GLDLLSKLLSL 294
Query: 289 DPKNRPSMVDVL 300
DP R + D L
Sbjct: 295 DPYKRLTASDAL 306
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-19
Identities = 76/286 (26%), Positives = 139/286 (48%), Gaps = 45/286 (15%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR 85
+ LG G FG V+ +++T VA+K +K S + +L E + L+
Sbjct: 11 EKKLGAGQFGEVWMATYNKHT----------KVAVKTMKPGSMS-VEAFLAEANVMKTLQ 59
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLS 142
H+ LVKL ++ + ++ EFM KGSL + L S QP+ P + + +A G++
Sbjct: 60 HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMA 116
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYA 199
F+ N I+RDL+A+N+L+ ++ K++DFGLAR DN + + G + +
Sbjct: 117 FIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTARE--GAKFPIKWT 170
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL-RDSRRV 258
APE + G T KSDV+SFG++L+E+++ R P+ + V
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRI------------------PYPGMSNPEV 212
Query: 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
+R ++ + + + ++++C P+ RP+ + + L+
Sbjct: 213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 5e-19
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK---RLKAESFQGHKEWLTEVIYLGQ 83
++G+G FG V I Q K + + A+K + K + L E L +
Sbjct: 6 RVIGKGAFGKV---CIVQ------KRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-DVARGLS 142
L H LV L + +N LV + + G L HL + V S +VK I ++ L
Sbjct: 57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV-KFS-EEQVKFWICEIVLALE 114
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH +I+RD+K N+LLD + ++DF +A T T GT GY APE
Sbjct: 115 YLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPE 169
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRR 230
+ + D +S GV E L G+R
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-19
Identities = 75/283 (26%), Positives = 135/283 (47%), Gaps = 32/283 (11%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLR 85
+LG G FG V+KG WI P I VAIK L+ S + +KE L E + +
Sbjct: 14 VLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 67
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
+ +L+G C S +L V + MP G L +++ + I + + +A+G+S+L
Sbjct: 68 SPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYV 204
+ +++RDL A NVL+ S + K++DFGLAR + H V + + A E +
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESI 183
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
T +SDV+S+GV + EL++ G + D G+ + + + + R + + +D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYD----GIPAREIPDLLEKGERLPQPPICTID 239
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
V ++++C +D + RP +++ ++
Sbjct: 240 --------------VYMIMVKCWMIDSECRPRFRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 7e-19
Identities = 68/217 (31%), Positives = 96/217 (44%), Gaps = 48/217 (22%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ----- 83
LG G FG V K SG A+K L K +++ L Q
Sbjct: 9 LGTGSFGRVM--------LVRHKG-SGKYYALKIL-------SKA---KIVKLKQVEHVL 49
Query: 84 --------LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI 135
+RH LV L G + N LV E++P G L +HL R P A
Sbjct: 50 NEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAA 108
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---I 192
V L +LH LD ++YRDLK N+LLDS+ K++DFG A+ V R +
Sbjct: 109 QVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTL 158
Query: 193 VGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSG 228
GT Y APE + + G+ D ++ G+++ E+L+G
Sbjct: 159 CGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 68/185 (36%), Positives = 96/185 (51%), Gaps = 19/185 (10%)
Query: 58 VAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLIGY----CSESDNRL-LVYEFM 109
VAIK++ A +F K L E+ L L HEN++ + E+ N + +VYE M
Sbjct: 33 VAIKKI-ANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM 91
Query: 110 PKGSLENH-LFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168
+ H + RS Q +S + RGL ++H ANV++RDLK SN+LL++N +
Sbjct: 92 ---DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCD 146
Query: 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLS 227
K+ DFGLAR T + T V TR Y APE + T DV+S G + ELL
Sbjct: 147 LKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL- 203
Query: 228 GRRAL 232
GR+ L
Sbjct: 204 GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 73/258 (28%), Positives = 116/258 (44%), Gaps = 43/258 (16%)
Query: 54 SGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKG 112
+G V+A K + + K+ L E+ + + R +V G +N + EFM G
Sbjct: 29 TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG 88
Query: 113 SLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172
SL+ +++ PI KIA+ V GL++L+ + +++RD+K SN+L++S KL
Sbjct: 89 SLDR-IYKKGGPIPVEILGKIAVAVVEGLTYLYNVH-RIMHRDIKPSNILVNSRGQIKLC 146
Query: 173 DFGLARDGPTGD--NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 230
DFG+ +G+ N+ ++ VGT Y +PE + G T KSDV+S G+ ++EL G+
Sbjct: 147 DFGV-----SGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKF 200
Query: 231 ALDE----DRGGLAE-------QTLVEWADPFLRDSR--RVLRIMDTRLGGQYSKKEAQA 277
D G Q +V+ P L S LR
Sbjct: 201 PFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF--------------- 245
Query: 278 VAAVVLQCLHMDPKNRPS 295
V CL DP RP+
Sbjct: 246 ----VDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 13/208 (6%)
Query: 23 FCSDYLLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEVIY 80
F +LG G FG V+KG WI P I VAIK L+ A S + +KE L E
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARG 140
+ + + ++ +L+G C S +L + + MP G L +++ I + + +A+G
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGTRGYA 199
+++L + +++RDL A NVL+ + + K++DFGLA+ G H V + +
Sbjct: 122 MNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-WM 178
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLS 227
A E + T +SDV+S+GV + EL++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 65/277 (23%), Positives = 121/277 (43%), Gaps = 38/277 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG + + T+ S +V L S + ++ L E++ L L+H N
Sbjct: 8 LGKGAFG-------EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIA--IDVARGLSFLHG 146
++ + + + L+ E+ G+L + + R + + + + + +S++H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIH- 118
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
A +++RD+K N+ L KL DFG+++ G ++ +VGT Y +PE
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQG 175
Query: 207 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD--- 263
KSD+++ G VL ELL+ +R D V++I+
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDAT-----------------NPLNLVVKIVQGNY 218
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
T + YS + ++V L DP+ RP+ +VL
Sbjct: 219 TPVVSVYS----SELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 68/211 (32%), Positives = 87/211 (41%), Gaps = 32/211 (15%)
Query: 29 LGEGGFGCVF--KGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIY-----L 81
LG GGFG V K TFA +V Q H I+ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG------QQEH-------IFSEKEIL 47
Query: 82 GQLRHENLVKLIGYCSESDNRLLVY---EFMPKGSLENHLFRSVQPISWPTRVKIAIDVA 138
+ H +VKL Y + D + +Y E+ G L L + R IA V
Sbjct: 48 EECNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VV 103
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
+LH +IYRDLK N+LLDSN KL DFG A+ +G T GT Y
Sbjct: 104 LAFEYLHNR--GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEY 158
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
APE + D +S G++L ELL+GR
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 26/216 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQGHKEWL--------TE 77
L+G+G +G V+ ++ T G ++A+K+ L A H +E
Sbjct: 8 LIGKGTYGRVYLA-LNVTT--------GEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRSVQPISWPTRVKIAID 136
+ L L H N+V+ +G ++ L ++ E++P GS+ + R+
Sbjct: 59 IETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGS-CLRTYGRFEEQLVRFFTEQ 116
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
V GL++LH +++RDLKA N+L+D++ K+SDFG+++ + + + G+
Sbjct: 117 VLEGLAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 197 GYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRR 230
+ APE + + + K D++S G V+LE+ +GRR
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-18
Identities = 71/222 (31%), Positives = 106/222 (47%), Gaps = 39/222 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQL-R 85
++GEG FG V K I K G + AIKR+K S H+++ E+ L +L
Sbjct: 2 VIGEGNFGQVLKARI-------KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTR 130
H N++ L+G C L E+ P G+L + L +S +S
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
+ A DVARG+ +L I+RDL A N+L+ N+ AK++DFGL+R G +V
Sbjct: 115 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 168
Query: 191 RIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLS 227
T G ++A L T SDV+S+GV+L E++S
Sbjct: 169 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-18
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 27/219 (12%)
Query: 29 LGEGGFGCVFKG---WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL- 84
LGEG FG V ID++ KP + VA+K LK ++ + L + + ++
Sbjct: 23 LGEGCFGQVVMAEALGIDKD-----KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77
Query: 85 -RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---------------SVQPISWP 128
+H+N++ L+G C++ ++ E+ KG+L +L + +++
Sbjct: 78 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 188
V VARG+ +L I+RDL A NVL+ N K++DFGLARD D
Sbjct: 138 DLVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 189 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+T + APE + T +SDV+SFGV++ E+ +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 7e-18
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRH 86
LG G FG V KG T VA+K LK ++ E L E + QL +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKT-------VAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+V++IG C E+++ +LV E G L L ++ + ++ ++ V+ G+ +L
Sbjct: 56 PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLE- 112
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT--RGYAAPEYV 204
+ N ++RDL A NVLL + AK+SDFGL++ D + + G + APE +
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECM 170
Query: 205 ATGHLTPKSDVYSFGVVLLELLS 227
+ KSDV+SFGV++ E S
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 24/205 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K QN +G++ A K + +S + ++++ E+ L H N
Sbjct: 13 LGDGAFGKVYKA---QNK------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+VKL+ +N ++ EF G+++ + +P++ P + L++LH +
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH--E 121
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV- 204
+I+RDLKA N+L + + KL+DFG+ + NT R +GT + APE V
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 205 -ATGHLTP---KSDVYSFGVVLLEL 225
T P K+DV+S G+ L+E+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 73/278 (26%), Positives = 130/278 (46%), Gaps = 51/278 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LG G G V+K + + ++A+K + + + + K+ ++E+ L +
Sbjct: 9 LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRV--KIAIDVARGLSFL 144
++ G +NR+ + EFM GSL+ ++R + P V +IA+ V +GL++L
Sbjct: 60 YIIGFYG-AFFVENRISICTEFMDGGSLD--VYRKI-----PEHVLGRIAVAVVKGLTYL 111
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
L +++RD+K SN+L+++ KL DFG++ ++ VGT Y APE +
Sbjct: 112 WSL--KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERI 165
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGR---RALDEDRGGLAE----QTLVEWADPFLRDSRR 257
+ SDV+S G+ +EL GR + +++G L Q +V+ P L
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV--- 222
Query: 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
GQ+S+K + QC+ PK RP+
Sbjct: 223 ----------GQFSEKFVHFIT----QCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 41/282 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLR 85
L+G G +G V++G PT G VVA+K L EV L QLR
Sbjct: 8 LIGRGAYGAVYRG-----KHVPT----GRVVALKIINLDTPDDDVSDIQ-REVALLSQLR 57
Query: 86 H---ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
N+ K G RL ++ E+ GS+ L ++ PI+ I +V L
Sbjct: 58 QSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKA-GPIAEKYISVIIREVLVAL 114
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
++H VI+RD+KA+N+L+ + N KL DFG+A N+ + VGT + AP
Sbjct: 115 KYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKRSTFVGTPYWMAP 170
Query: 202 EYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260
E + G K+D++S G+ + E+ +G + A + + P L D+
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDN----- 225
Query: 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302
YSK + VAA CL +PK R S ++L S
Sbjct: 226 --------GYSKLLREFVAA----CLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 70/220 (31%), Positives = 105/220 (47%), Gaps = 23/220 (10%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEV 78
NF +LG+G FG V + G+ + AIK LK + + + E
Sbjct: 3 NFLM--VLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEK 51
Query: 79 IYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDV 137
L + + C ++ +RL V E++ G L H+ + V P V A ++
Sbjct: 52 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEI 110
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTR 196
A GL FLH +IYRDLK NV+LD+ + K++DFG+ ++ G T TR GT
Sbjct: 111 AIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTP 165
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD-ED 235
Y APE +A D ++FGV+L E+L+G+ D ED
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 72/228 (31%), Positives = 100/228 (43%), Gaps = 36/228 (15%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK---------AESFQGHK 72
+ +LG G FG V A K +G + AIK LK ES K
Sbjct: 2 RCLA--VLGRGHFGKVL--------LAEYKK-TGELYAIKALKKGDIIARDEVESLMCEK 50
Query: 73 EWLTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRV 131
RH LV L C ++++ + V E+ G L H+ V S P V
Sbjct: 51 RIFETA---NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV--FSEPRAV 104
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP-TGDNTHVST 190
A V GL +LH + ++YRDLK N+LLD+ K++DFGL ++G GD T ST
Sbjct: 105 FYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST 160
Query: 191 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR---RALDED 235
GT + APE + T D + GV++ E+L G DE+
Sbjct: 161 -FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--RH 86
LGEG FG V + + ++P + VA+K LK + L + L +L +H
Sbjct: 20 LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP----------------ISWPTR 130
+N++ L+G C++ ++ E+ KG+L L R+ +P +S+
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
V A VARG+ +L I+RDL A NVL+ + K++DFGLAR D ++
Sbjct: 137 VSCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 191 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ APE + T +SDV+SFG+++ E+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 79/271 (29%), Positives = 122/271 (45%), Gaps = 35/271 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL 84
+LG+GGFG V A +G + A K+L+ + + G L E L ++
Sbjct: 7 VLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 57
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI-AIDVARGLS 142
+V L Y E+ + L LV M G L+ H++ P R A ++ GL
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
LH ++YRDLK N+LLD + ++SD GLA + P G+ + R VGT GY APE
Sbjct: 117 DLH--RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR-VGTVGYMAPE 171
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
V T D + G ++ E++ G+ + + E+ E + RRV
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK----EKVKREEVE------RRVKEDQ 221
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 293
+ YS+K ++A ++ Q L DP R
Sbjct: 222 EE-----YSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-17
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLR 85
+LG G FG V+KG W+ P I VAIK L + + + E++ E + + +
Sbjct: 14 VLGSGAFGTVYKGIWV------PEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H +LV+L+G C S LV + MP G L +++ I + + +A+G+ +L
Sbjct: 68 HPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
+ +++RDL A NVL+ S + K++DFGLAR + + + + A E +
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 206 TGHLTPKSDVYSFGVVLLELLS 227
T +SDV+S+GV + EL++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 27/210 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK--EWLTEVIYLGQLRH 86
+GEG +G V++ SG +VA+K+++ ++ + L E+ L LRH
Sbjct: 15 IGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 87 ENLVKL----IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGL 141
N+V+L +G D+ LV E+ + L + L P S +VK + + + RGL
Sbjct: 66 PNIVELKEVVVG--KHLDSIFLVMEYCEQ-DLASLLDNMPTPFSES-QVKCLMLQLLRGL 121
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
+LH + +I+RDLK SN+LL K++DFGLAR G T V T Y AP
Sbjct: 122 QYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAP 177
Query: 202 EYV--ATGHLTPKSDVYSFGVVLLELLSGR 229
E + T + T D+++ G +L ELL+ +
Sbjct: 178 ELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT--EVIYLGQLR 85
+LG+G FG VF T P +G + A+K LK + + T E L ++
Sbjct: 3 VLGQGSFGKVFL------VRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
H +VKL Y +++ +L L+ +F+ G L L + V + +A ++A L L
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHL 114
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H L +IYRDLK N+LLD + KL+DFGL+++ + S GT Y APE V
Sbjct: 115 HSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVV 170
Query: 205 -ATGHLTPKSDVYSFGVVLLELLSG 228
GH T +D +SFGV++ E+L+G
Sbjct: 171 NRRGH-TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 67/250 (26%), Positives = 101/250 (40%), Gaps = 34/250 (13%)
Query: 51 KPGSGIVVAIKRLKAESFQGHKEWLTEV-----IYLGQLRHENLVKLIGYCSESDNRLLV 105
K +G AIK LK + +T V I + Q + KL D LV
Sbjct: 17 KRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV 75
Query: 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165
E++ G + L +++ + + +V G+ LH +I+RD+K N+L+D
Sbjct: 76 MEYLNGGDCAS-LIKTLGGLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQ 132
Query: 166 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 225
+ KL+DFGL+R+G + + VGT Y APE + SD +S G V+ E
Sbjct: 133 TGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
Query: 226 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVL-- 283
L G AE + I+ R+ KE + AV L
Sbjct: 187 LFGYPPFH------AETPDAVFD-----------NILSRRINWPEEVKEFCSPEAVDLIN 229
Query: 284 QCLHMDPKNR 293
+ L MDP R
Sbjct: 230 RLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 62/226 (27%), Positives = 112/226 (49%), Gaps = 47/226 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQG---HKEWLT----EV 78
L+G G FG V+ G SG ++A+K+ L + S + L E+
Sbjct: 7 LIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREI 57
Query: 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS----------LENHLFRSVQPISWP 128
L +L+HEN+V+ +G ++D+ + E++P GS E L R+
Sbjct: 58 ALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF------ 111
Query: 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-----GPTG 183
V+ + +GL++LH +I+RD+K +N+L+D+ K+SDFG+++ T
Sbjct: 112 --VR---QILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTK 164
Query: 184 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
N + + G+ + APE V T K+D++S G +++E+L+G+
Sbjct: 165 TNGARPS-LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 4e-17
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--RH 86
LGEG FG V + KP VA+K LK+++ + L + + ++ +H
Sbjct: 26 LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP----------------ISWPTR 130
+N++ L+G C++ ++ E+ KG+L +L R+ +P +S+
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
V A VARG+ +L I+RDL A NVL+ + K++DFGLARD D +T
Sbjct: 143 VSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200
Query: 191 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ APE + T +SDV+SFGV+L E+ +
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-17
Identities = 58/260 (22%), Positives = 116/260 (44%), Gaps = 32/260 (12%)
Query: 53 GSGIVVAIKRLK------AESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVY 106
+G ++A+K++ +E + + E+ + +L H ++++++G E + L
Sbjct: 23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82
Query: 107 EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 166
E+M GS+ +HL + + RGLS+LH + +I+RD+K +N+L+DS
Sbjct: 83 EWMAGGSV-SHLLSKYGAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDST 139
Query: 167 -FNAKLSDFG----LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 221
+++DFG LA G +++GT + APE + DV+S G V
Sbjct: 140 GQRLRIADFGAAARLAAKGTGAG--EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCV 197
Query: 222 LLELLSGRRALDEDRGGLAEQTLVEW-ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA 280
++E+ + + W A+ + +I + + +
Sbjct: 198 IIEMATAK---------------PPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRD 242
Query: 281 VVLQCLHMDPKNRPSMVDVL 300
V L+CL + P++RP ++L
Sbjct: 243 VTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 24/216 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEVIYLGQLRHE 87
LGE FG ++KG + + P + +V AIK LK + Q E+ E + +L H
Sbjct: 13 LGECAFGKIYKG----HLYLPGMDHAQLV-AIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRSVQ---------------PISWPTRV 131
N+V L+G ++ +++E++ +G L L RS + +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
IAI +A G+ +L +++DL A N+L+ + K+SD GL+R+ + D V +
Sbjct: 128 HIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ + PE + G + SD++SFGVVL E+ S
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-17
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 22/208 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-----KEWLTEVIYLG 82
LLG+G FG V+ + D +T G +A+K++ + E+ L
Sbjct: 9 LLGQGAFGRVYLCY-DVDT--------GRELAVKQVPFDPDSPETKKEVNALECEIQLLK 59
Query: 83 QLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
L+HE +V+ G C D L ++ E+MP GS+++ L ++ ++ K + G+
Sbjct: 60 NLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGV 117
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT--GDNTHVSTRIVGTRGYA 199
+LH +++RD+K +N+L DS N KL DFG ++ T T + + + GT +
Sbjct: 118 EYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWM 174
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLS 227
+PE ++ K+DV+S G ++E+L+
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 79/273 (28%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRHE 87
+G+G FG V+KG ID T VVAIK + E + E + E+ L Q
Sbjct: 12 IGKGSFGEVYKG-IDNRTKE--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+ + G + ++ E++ GS + L P+ I ++ +GL +LH
Sbjct: 63 YITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLH-- 118
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 207
I+RD+KA+NVLL + KL+DFG+A G D VGT + APE +
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 208 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG 267
K+D++S G+ +EL G + D + L+ P L
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP-NSDLHPMRVLFLIPKNSP-------------PTLE 222
Query: 268 GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
GQYSK + V A CL+ DP+ RP+ ++L
Sbjct: 223 GQYSKPFKEFVEA----CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 30/211 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--H-KEWLTEVIYLGQLR 85
+G G +G V D +G VAIK+L + FQ H K E+ L +
Sbjct: 23 VGSGAYGQVCSA-FDT--------KTGRKVAIKKL-SRPFQSAIHAKRTYRELRLLKHMD 72
Query: 86 HENLVKLIG-YCSESDNR-----LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
HEN++ L+ + S LV M G+ N++ + Q +S + + R
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKC-QKLSDDHIQFLVYQILR 129
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
GL ++H A +I+RDLK SN+ ++ + K+ DFGLAR T V TR Y
Sbjct: 130 GLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYR 182
Query: 200 APEYVAT-GHLTPKSDVYSFGVVLLELLSGR 229
APE + H D++S G ++ ELL+G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 23/217 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--RH 86
LGEG FG V + KP + VA+K LK ++ L + + ++ +H
Sbjct: 20 LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP----------------ISWPTR 130
+N++ L+G C++ ++ E+ KG+L +L R+ +P +++
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
V A VARG+ +L I+RDL A NVL+ + K++DFGLARD D +T
Sbjct: 137 VSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194
Query: 191 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ APE + T +SDV+SFGV+L E+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 39/273 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
+G G FG VF G + + VA+K + K ++L E L Q H
Sbjct: 3 IGRGNFGEVFSGRLRADN---------TPVAVKSCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+V+LIG C++ +V E + G L + +++ + A G+ +L
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE-- 111
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST---RIVGTRGYAAPEYV 204
+ I+RDL A N L+ K+SDFG++R+ D + ST + + + + APE +
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVK-WTAPEAL 168
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264
G + +SDV+SFG++L E S A P+ S + R
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFS------------------LGAVPYANLSNQQTREAIE 210
Query: 265 RLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPS 295
+ G + E AV ++ +C DP RPS
Sbjct: 211 Q-GVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-16
Identities = 82/271 (30%), Positives = 121/271 (44%), Gaps = 35/271 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL 84
+LG+GGFG V A +G + A KRL+ + + G L E L ++
Sbjct: 7 VLGKGGFGEVC---------ACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV 57
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI-AIDVARGLS 142
+ +V L Y E+ + L LV M G L+ H++ P R A ++ GL
Sbjct: 58 NSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
LH N +YRDLK N+LLD + ++SD GLA P G++ + R VGT GY APE
Sbjct: 117 DLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGR-VGTVGYMAPE 171
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
+ T D + G ++ E++ G+ G E+ E D RRVL
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR----GRKEKVKREEVD------RRVLETE 221
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 293
+ YS K ++ ++ L DPK R
Sbjct: 222 EV-----YSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 51/284 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT--EVIYLGQLRH 86
+GEG FG ++ A K S V IK + ++ + EVI L +++H
Sbjct: 8 IGEGSFGKIY--------LAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKH 58
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENH-------LFRSVQPISWPTRVKIAIDVAR 139
N+V E+ +V E+ G L LF Q +SW + ++
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISL 112
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
GL +H D +++RD+K+ N+ L N AKL DFG+AR D+ ++ VGT Y
Sbjct: 113 GLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYY 168
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS--R 256
+PE K+D++S G VL EL + + PF ++ +
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKH-------------------PFEGNNLHQ 209
Query: 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
VL+I S ++ + +++ Q + P++RPS+ +L
Sbjct: 210 LVLKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 29 LGEGGFG--CVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH 86
LG+GGFG C + +A K + KRLK +S G K L E L ++
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK------LDKKRLKKKS--GEKMALLEKEILEKVNS 52
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQ-PISWPTRVKIAIDVARGLSFL 144
+V L Y ES L LV M G L+ H++ + + + + + G+ L
Sbjct: 53 PFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL 111
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H +D ++YRD+K NVLLD N +LSD GLA + G T+ GT GY APE +
Sbjct: 112 HSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEIL 166
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGR 229
+ D ++ G + E+++GR
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQLR 85
+G G FG V DQ T G VAIK++ + F K E+ L LR
Sbjct: 18 VGMGAFGLVCSAR-DQLT--------GQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLR 67
Query: 86 HENLVKLIG-YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
HEN++ L + S ++ V E + + H + +P+ + RGL ++
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYV 124
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H A V++RDLK SN+L++ N + K+ DFGLAR T V TR Y APE +
Sbjct: 125 H--SAGVVHRDLKPSNILINENCDLKICDFGLAR-----IQDPQMTGYVSTRYYRAPEIM 177
Query: 205 ATGH-LTPKSDVYSFGVVLLELLSGR 229
T + D++S G + E+L G+
Sbjct: 178 LTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 68/212 (32%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
LG+G +G V A T VAIK++ F K L E+ L R
Sbjct: 8 LGQGAYGIVC-----SARNAETSEEET--VAIKKI-TNVFSKKILAKRALRELKLLRHFR 59
Query: 86 -HENLVKLIGY---CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
H+N+ L + N L +YE + + L + + RS QP++ + GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADL-HQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRGY 198
++H ANV++RDLK N+L++++ K+ DFGLAR + P G+N T V TR Y
Sbjct: 119 KYIH--SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVATRWY 175
Query: 199 AAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 229
APE + + K+ DV+S G +L ELL +
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V T +G VA+K++ Q + EV+ + +H N
Sbjct: 27 IGEGSTGIVC---------IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+V++ D +V EF+ G+L + + + ++ + + V + LSFLH
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLAVLKALSFLHA-- 133
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH 208
VI+RD+K+ ++LL S+ KLSDFG +VGT + APE ++
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLP 191
Query: 209 LTPKSDVYSFGVVLLELLSG 228
+ D++S G++++E++ G
Sbjct: 192 YGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 72/231 (31%), Positives = 112/231 (48%), Gaps = 22/231 (9%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEV 78
+F +LG+G FG V A K G+ + AIK LK + + + E
Sbjct: 1 DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51
Query: 79 IYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDV 137
L + + C ++ +RL V E++ G L H+ + V P V A ++
Sbjct: 52 RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEI 110
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTR 196
+ GL FLH +IYRDLK NV+LDS + K++DFG+ ++ V+TR GT
Sbjct: 111 SVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTP 165
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVE 246
Y APE +A D +++GV+L E+L+G+ D ED L Q+++E
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF-QSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 74/291 (25%), Positives = 126/291 (43%), Gaps = 39/291 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
LGE FG V+KG + F VAIK LK ++ +E+ E + +L+H
Sbjct: 13 LGEDRFGKVYKG----HLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--------------RSVQPISWPTR-VK 132
N+V L+G ++ +++ + L L ++V+ P V
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
I +A G+ FL +V+++DL NVL+ N K+SD GL R+ D +
Sbjct: 129 IVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
+ + +PE + G + SD++S+GVVL E+ S + G + Q ++E +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL---QPYCGYSNQDVIE-----M 238
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
+R+VL D Y ++L+C + P RP D+ + L
Sbjct: 239 IRNRQVLPCPDDCPAWVY---------TLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-16
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 18/205 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
+LG+G FG V A K SG + A+K LK + + +TE L
Sbjct: 2 VLGKGSFGKVM--------LARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA 52
Query: 85 RHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
R+ + + C ++ +RL V EF+ G L H+ +S + A ++ L F
Sbjct: 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMF 111
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH D +IYRDLK NVLLD + KL+DFG+ ++G N ++ GT Y APE
Sbjct: 112 LH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCGTPDYIAPEI 167
Query: 204 VATGHLTPKSDVYSFGVVLLELLSG 228
+ P D ++ GV+L E+L G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 41/278 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ FA T + VVA+K++ Q +++W + EV +L QL+
Sbjct: 29 IGHGSFGAVY--------FA-TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N ++ G + LV E+ GS + L +P+ I +GL++LH
Sbjct: 80 HPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
N+I+RD+KA N+LL KL+DFG A ++ VGT + APE +
Sbjct: 139 --SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVIL 190
Query: 206 T---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
G K DV+S G+ +EL + L A + + P L+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ--------- 241
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
S + + V CL P+ RP+ ++L
Sbjct: 242 --------SNEWTDSFRGFVDYCLQKIPQERPASAELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 87/316 (27%), Positives = 140/316 (44%), Gaps = 42/316 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V ID + G VAIK++ +F K L E+ L +
Sbjct: 13 IGSGAYGVVCSA-IDTRS--------GKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFK 62
Query: 86 HENLVKL--IGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
H+N++ + I +D + +V + M S +H+ S QP++ + RGL
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLM--ESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYA 199
++H ANVI+RDLK SN+L++ + ++ DFG+AR ++ + T V TR Y
Sbjct: 121 KYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 200 APEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDR-------------GGLAEQTLV 245
APE + + T D++S G + E+L GRR L + G +E+ L
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237
Query: 246 EWADPFLRDSRRVL-RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS-- 302
+R + L R + K +A+ ++ Q L DP+ R ++ L
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEAL-DLLSQMLQFDPEERITVEQALQHPF 296
Query: 303 LEQLHTSKDMPRTPPP 318
L Q H D P PPP
Sbjct: 297 LAQYHDPDDEPTCPPP 312
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-16
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FG V G ++ + P + V +K L+ S Q ++L E L+H
Sbjct: 3 IGNGWFGKVILGEVNSG-YTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRSVQPISWPTRV--KIAIDVARGLSF 143
NL++ +G C+E LLV EF P G L+ +L R + ++ ++A ++A GL
Sbjct: 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLH 115
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH N I+ DL N LL ++ K+ D+GL+ + D ++ + APE
Sbjct: 116 LH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 204 VATGH-------LTPKSDVYSFGVVLLELL 226
V H T +S+V+S GV + EL
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 79/273 (28%), Positives = 119/273 (43%), Gaps = 34/273 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRHE 87
+G+G FG VFKG ID T VVAIK + E + E + E+ L Q
Sbjct: 12 IGKGSFGEVFKG-IDNRTQK--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+ K G + ++ E++ GS + L P+ I ++ +GL +LH
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLH-- 118
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 207
I+RD+KA+NVLL + KL+DFG+A G D VGT + APE +
Sbjct: 119 SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 208 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG 267
K+D++S G+ +EL G E + L+ +P L
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELH-PMKVLFLIPKNNP-------------PTLE 222
Query: 268 GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
G YSK + V A CL+ +P RP+ ++L
Sbjct: 223 GNYSKPLKEFVEA----CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 5e-16
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
+LG+G FG V G+ V AIK LK + + +TE L
Sbjct: 2 VLGKGSFGKVMLA---------ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA 52
Query: 85 RHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
+ + C ++ +RL V E++ G L + RS + P A +V L F
Sbjct: 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMF 111
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH VIYRDLK N+LLD+ + KL+DFG+ ++G T +T GT Y APE
Sbjct: 112 LH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEI 167
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDED 235
+ P D ++ GV++ E+++G+ + D
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 50/187 (26%), Positives = 92/187 (49%), Gaps = 15/187 (8%)
Query: 58 VAIKRLKAESFQGHKE---WLTEVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGS 113
VAIK L+ ++ + + + E +L H N+V L+ L V+E++P +
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 114 LENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAK 170
L L + + ++ + V L+ H + +++RDLK N+++ +AK
Sbjct: 66 LREVL-AADGALPAGETGRLMLQVLDALACAH--NQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 171 LSDFGLARDGP-TGDNTHV----STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 225
+ DFG+ P D +T ++GT Y APE + +TP SD+Y++G++ LE
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLEC 182
Query: 226 LSGRRAL 232
L+G+R +
Sbjct: 183 LTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 7e-16
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 47/281 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL-TEVIYLGQLRHE 87
+G+G G V+ ID T G VAIK++ + Q KE + E++ + + +H
Sbjct: 27 IGQGASGTVYTA-IDVAT--------GQEVAIKQMNLQQ-QPKKELIINEILVMRENKHP 76
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI---DVARGLSFL 144
N+V + D +V E++ GSL + + + +IA + + L FL
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFL 131
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTHVSTRIVGTRGYAAPEY 203
H VI+RD+K+ N+LL + + KL+DFG A+ P + +VGT + APE
Sbjct: 132 HS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR-RVLRIM 262
V PK D++S G++ +E +VE P+L ++ R L ++
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIE-------------------MVEGEPPYLNENPLRALYLI 227
Query: 263 DTRLGGQYSKKEAQAVA--AVVLQCLHMDPKNRPSMVDVLT 301
T + E + + +CL MD + R S ++L
Sbjct: 228 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 8e-16
Identities = 46/123 (37%), Positives = 71/123 (57%), Gaps = 6/123 (4%)
Query: 107 EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 166
E M GSL+ L + I KI+I V RGL++L +++RD+K SN+L++S
Sbjct: 79 EHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSR 136
Query: 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 226
KL DFG++ G D+ ++ VGTR Y +PE + H T +SD++S G+ L+E+
Sbjct: 137 GEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMA 192
Query: 227 SGR 229
GR
Sbjct: 193 IGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-16
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 24/205 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K A K +G + A K ++ +S + ++++ E+ L H
Sbjct: 20 LGDGAFGKVYK--------AKNKE-TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+VKL+G ++ EF P G+++ + + ++ P I + L +LH +
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM- 129
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV- 204
+I+RDLKA NVLL + + KL+DFG+ + N R +GT + APE V
Sbjct: 130 -KIIHRDLKAGNVLLTLDGDIKLADFGV-----SAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 205 -ATGHLTP---KSDVYSFGVVLLEL 225
T TP K+D++S G+ L+E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 31/214 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+K A K +G VVA+K RL E+ + E+ L +L H
Sbjct: 8 IGEGTYGVVYK--------ARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 58
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAI------DVAR 139
N+VKL+ ++N+L LV+EF+ + + S + + + + + +
Sbjct: 59 PNIVKLLDVI-HTENKLYLVFEFL------HQDLKKFMDASPLSGIPLPLIKSYLFQLLQ 111
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
GL+F H V++RDLK N+L+++ KL+DFGLAR G T V T Y
Sbjct: 112 GLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYR 167
Query: 200 APE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 232
APE + + + D++S G + E+++ RRAL
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 42/298 (14%)
Query: 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLT 76
NF + +G+G F V+K G VVA+K+++ K + L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---ICLL------DGRVVALKKVQIFEMMDAKARQDCLK 51
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLE---NHLFRSVQPISWPTRVKI 133
E+ L QL H N++K + E++ +V E G L H + + I T K
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
+ + L +H +++RD+K +NV + + KL D GL R T + +V
Sbjct: 112 FVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLV 167
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT Y +PE + KSD++S G +L E + PF
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYE-------------------MAALQSPFYG 208
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAA----VVLQCLHMDPKNRPSMVDVLTSLEQLH 307
D + + Y A + +V +C++ DP+ RP + VL +++H
Sbjct: 209 DKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 78/273 (28%), Positives = 122/273 (44%), Gaps = 34/273 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRHE 87
+G+G FG VFKG ID T VVAIK + E + E + E+ L Q
Sbjct: 12 IGKGSFGEVFKG-IDNRTQQ--------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+ K G + ++ E++ GS + L R+ P + ++ +GL +LH
Sbjct: 63 YVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRA-GPFDEFQIATMLKEILKGLDYLH-- 118
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 207
I+RD+KA+NVLL + KL+DFG+A G D VGT + APE +
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQS 176
Query: 208 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG 267
K+D++S G+ +EL G + D + L+ +P L
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP-NSDMHPMRVLFLIPKNNP-------------PTLT 222
Query: 268 GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
G++SK + + A CL+ DP RP+ ++L
Sbjct: 223 GEFSKPFKEFIDA----CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 90/332 (27%), Positives = 136/332 (40%), Gaps = 65/332 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA--ESFQGHKEWLTEVIYLGQLR 85
++G+G +G V ID +T G VAIK++ E L E+ L LR
Sbjct: 7 VIGKGSYGVVCSA-IDTHT--------GEKVAIKKINDVFEHVSDATRILREIKLLRLLR 57
Query: 86 HENLVKLIGYCSESDNR-----LLVYEFMPKG-----------SLENHLFRSVQPISWPT 129
H ++V++ R +V+E M + E+H F Q
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQ------ 111
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDN 185
+ R L ++H ANV +RDLK N+L +++ K+ DFGLAR D PT
Sbjct: 112 -------LLRALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT--- 159
Query: 186 THVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGR---------RALDE 234
T V TR Y APE + TP D++S G + E+L+G+ LD
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL 219
Query: 235 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK--EAQAVAAVVLQ-CLHMDPK 291
L + + +RR L M + +S+K A +A +L+ L DPK
Sbjct: 220 ITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPK 279
Query: 292 NRPSMVDVLTS--LEQLHTSKDMPRTPPPAKL 321
+RP+ + L + L + P P KL
Sbjct: 280 DRPTAEEALADPYFKGLAKVEREPSAQPITKL 311
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 67/225 (29%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V + +G A+K L+ E E +TE L
Sbjct: 2 LLGKGTFGKVI---------LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI-AIDVARGLS 142
RH L L Y ++ +RL V E+ G L HL R + + R + ++ L
Sbjct: 53 RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALE 109
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH +V+YRD+K N++LD + + K++DFGL ++G + T + GT Y APE
Sbjct: 110 YLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPE 165
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 246
+ D + GVV+ E++ GR ++D L E L+E
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 24/208 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-LTEVIYLGQLRHE 87
LGEG + V+KG +N +G +VA+K + ++ +G + E+ + +L+HE
Sbjct: 8 LGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 88 NLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRSVQPISWPTRVK-IAIDVARGLSF 143
N+V+L + +LV+E+M K ++ H R P VK + +G++F
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALD---PNTVKSFTYQLLKGIAF 115
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
H + V++RDLK N+L++ KL+DFGLAR NT S +V T Y AP+
Sbjct: 116 CH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TLWYRAPD- 170
Query: 204 VATGHLTPKS--DVYSFGVVLLELLSGR 229
V G T + D++S G ++ E+++GR
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLG 82
D +G G FG V W + T P G VA+K++ FQ K E+ L
Sbjct: 5 DRPIGYGAFGVV---W------SVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLC 54
Query: 83 QLRHENLVKLI-----GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-D 136
+H+N++ + + + +V E M + L + S QP+S VK+ +
Sbjct: 55 FFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHK-IIVSPQPLS-SDHVKVFLYQ 111
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
+ RGL +LH A +++RD+K N+L++SN K+ DFGLAR ++ H++ +V T+
Sbjct: 112 ILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQ 168
Query: 197 GYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 229
Y APE + G H T D++S G + ELL R
Sbjct: 169 YYRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 78/275 (28%), Positives = 121/275 (44%), Gaps = 43/275 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL 84
+LG+GGFG V A +G + A K+L+ + + G L E L ++
Sbjct: 7 VLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV 57
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQP-ISWPTRVKIAIDVARGLS 142
+V L Y E+ + L LV M G L+ H++ + V A ++ GL
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE 116
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
LH ++YRDLK N+LLD + + ++SD GLA P G + R VGT GY APE
Sbjct: 117 DLH--QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR-VGTVGYMAPE 171
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
V T D ++ G +L E+++G+ PF + +++ R
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ-------------------SPFQQRKKKIKREE 212
Query: 263 DTRL----GGQYSKKEAQAVAAVVLQCLHMDPKNR 293
RL +YS+K + ++ L DPK R
Sbjct: 213 VERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--- 84
+LG+G FG VF A K G+ AIK LK + + ++ L
Sbjct: 2 MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52
Query: 85 -RHENLVKLIGYCS--ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
H L L YC+ +N V E++ G L H+ +S P A ++ GL
Sbjct: 53 WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHI-QSCHKFDLPRATFYAAEIICGL 109
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
FLH ++YRDLK N+LLD++ + K++DFG+ ++ GD + GT Y AP
Sbjct: 110 QFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAP 165
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGR 229
E + D +SFGV+L E+L G+
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+KG +G +VA+K RL++E + E+ L +L+H
Sbjct: 8 IGEGTYGVVYKG---------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHL--FRSVQPISWPTRVKIAI-DVARGLS 142
N+V L + ++RL L++EF+ L+ +L Q + VK + + +G+
Sbjct: 59 PNIVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYLDSLPKGQYMD-AELVKSYLYQILQGIL 115
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
F H V++RDLK N+L+D+ KL+DFGLAR G V T V T Y APE
Sbjct: 116 FCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPE 171
Query: 203 YV--ATGHLTPKSDVYSFGVVLLELLSGR 229
+ + + TP D++S G + E+ + +
Sbjct: 172 VLLGSPRYSTP-VDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 73/224 (32%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V + SG A+K LK E E LTE L
Sbjct: 2 LLGKGTFGKVI---------LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
RH L L Y ++ +RL V E++ G L HL R TR A ++ L +
Sbjct: 53 RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDY 110
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH ++YRDLK N++LD + + K++DFGL ++G T T + GT Y APE
Sbjct: 111 LH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEV 166
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 246
+ D + GVV+ E++ GR ++D L E L+E
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V T SG +VA+K++ Q + EV+ + +HEN
Sbjct: 28 IGEGSTGIVC---------IATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRSVQPISWPTRVKIAIDVARGLSFLH 145
+V++ D +V EF+ G+L + H + + I+ + + V + LS LH
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH 133
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR--IVGTRGYAAPEY 203
VI+RD+K+ ++LL + KLSDFG + V R +VGT + APE
Sbjct: 134 A--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV----SKEVPRRKSLVGTPYWMAPEL 187
Query: 204 VATGHLTPKSDVYSFGVVLLELLSG 228
++ P+ D++S G++++E++ G
Sbjct: 188 ISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT---EVIYLGQL 84
LLG+G FG V+ + D +T G + + ES + KE E+ L L
Sbjct: 9 LLGQGAFGRVYLCY-DVDT------GRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 85 RHENLVKLIGYCSESDNRLLV--YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
+HE +V+ G + + L E+MP GS+++ L ++ ++ K + G+S
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMS 120
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAAP 201
+LH +++RD+K +N+L DS N KL DFG ++ T + R + GT + +P
Sbjct: 121 YLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGR 229
E ++ K+DV+S G ++E+L+ +
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+LG+G +G V+ + +AIK + + + E+ L+H
Sbjct: 15 VLGKGTYGIVYAARDLSTQ---------VRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISW--PTRVKIAIDVARGLSFLH 145
N+V+ +G SE+ + E +P GSL L P+ T + + GL +LH
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 146 GLDANVIYRDLKASNVLLDSNFNA-KLSDFG----LARDGPTGDNTHVSTRIVGTRGYAA 200
D +++RD+K NVL+++ K+SDFG LA P + GT Y A
Sbjct: 126 --DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMA 177
Query: 201 PEYVATGH--LTPKSDVYSFGVVLLELLSGR 229
PE + G +D++S G ++E+ +G+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 48/146 (32%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 95 YCS--ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVI 152
+C+ ++ V E++ G L H+ S + R A ++ GL FLH +I
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-YAAEIICGLQFLH--KKGII 118
Query: 153 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK 212
YRDLK NVLLD + + K++DFG+ ++ G+ ++ GT Y APE +
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNES 176
Query: 213 SDVYSFGVVLLELLSGRRAL---DED 235
D +SFGV+L E+L G+ DED
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 23/201 (11%)
Query: 81 LGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVA 138
L ++ H +++L + +E D R L + E++P G L ++L R+ S T + A ++
Sbjct: 55 LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIV 111
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
L +LH ++YRDLK N+LLD + KL+DFG A+ D T + GT Y
Sbjct: 112 CALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LCGTPEY 164
Query: 199 AAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTL---VEWA---DP 250
APE + GH D ++ G+++ E+L G D++ G+ E+ L +E+ D
Sbjct: 165 LAPEVIQSKGHNK-AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDL 223
Query: 251 FLRDSRRVLRIMD--TRLGGQ 269
+ +D + L ++D RLG
Sbjct: 224 YAKDLIKKLLVVDRTRRLGNM 244
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 73/257 (28%), Positives = 99/257 (38%), Gaps = 80/257 (31%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIY 80
+F ++G G FG V+ +G V A+K L+ ++I
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKS----------DMIK 41
Query: 81 LGQLRH---EN----------LVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRS-VQP 124
Q+ H E +VKL Y S D L V E+MP G L N L R V P
Sbjct: 42 RNQIAHVRAERDILADADSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFP 99
Query: 125 ISWPTRVKI-----AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179
R I A+D L F+H RD+K N+L+D++ + KL+DFGL +
Sbjct: 100 EET-ARFYIAELVLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKK 150
Query: 180 GPTG----------------DNTHVSTR-----------IVGTRGYAAPEYVATGH-LTP 211
DN V R VGT Y APE V G
Sbjct: 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGL 209
Query: 212 KSDVYSFGVVLLELLSG 228
+ D +S GV+L E+L G
Sbjct: 210 ECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 58/292 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+G G FG V+ ++ +T G ++A+K R++ + KE E+ L L+H
Sbjct: 8 IGGGTFGKVYTA-VNLDT--------GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLEN--HLFRSVQPISWPTRVKIAIDVARGLSFL 144
NLVK G + + E+ G+LE R + RV + + GL++L
Sbjct: 59 PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRV-YTLQLLEGLAYL 115
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRGYAAP 201
H +++RD+K +N+ LD N KL DFG A + T V + + GT Y AP
Sbjct: 116 H--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYMAP 172
Query: 202 EYVATGHLTPK---SDVYSFGVVLLELLSGRR---ALDEDRGGLAEQTLVEWADPFLRDS 255
E + G +D++S G V+LE+ +G+R LD E+
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----------EFQ------- 214
Query: 256 RRVLRIMDTRLGGQY------SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301
IM +G + S + + + +CL DPK RP+ ++L
Sbjct: 215 -----IM-FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 42/286 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRH 86
+G G FG V K SG ++A+KR+++ + K L ++ + +
Sbjct: 11 EIGRGAFGTVNKML---------HKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD 61
Query: 87 -ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRV--KIAIDVARG 140
+VK G + + E M SL+ ++ V P + KIA+ +
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDI-SLDK-FYKYVYEVLKSVIPEEILGKIAVATVKA 119
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD--NTHVSTRIVGTRGY 198
L++L + +I+RD+K SN+LLD N N KL DFG++ G ++ TR G R Y
Sbjct: 120 LNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPY 173
Query: 199 AAPEYVATGHLTP---KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
APE + +SDV+S G+ L E+ +G+ + + T V DP
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP----- 228
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301
I+ ++S + CL D RP ++L
Sbjct: 229 ----PILSNSEEREFSPSFVNFINL----CLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 78/275 (28%), Positives = 121/275 (44%), Gaps = 43/275 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL 84
+LG+GGFG V A +G + A K+L+ + + G L E L ++
Sbjct: 7 VLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV 57
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTR-VKIAIDVARGLS 142
+V L Y E+ + L LV M G L+ H++ P R + A ++ GL
Sbjct: 58 NSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE 116
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
L ++YRDLK N+LLD + ++SD GLA P G+ V R VGT GY APE
Sbjct: 117 DLQ--RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGR-VGTVGYMAPE 171
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI- 261
+ T D + G ++ E++ G+ PF + RV R
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ-------------------SPFRKRKERVKREE 212
Query: 262 MDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNR 293
+D R+ +YS+K ++ ++ L +PK R
Sbjct: 213 VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 92/353 (26%), Positives = 141/353 (39%), Gaps = 105/353 (29%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEV---IYLGQ 83
+LG G FG V ++ + F K S VA+K LK + HK ++E+ I++G
Sbjct: 14 VLGHGAFGKV----VEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGN 69
Query: 84 LRHENLVKLIGYCSESDNRLLV-YEF---------------------------------- 108
H N+V L+G C++ + L+V EF
Sbjct: 70 --HLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAM 127
Query: 109 --------MPKGSLENHLF--------RSVQPIS-----WPTRVKI------AIDVARGL 141
+ + LF S P W + + + + VARG+
Sbjct: 128 VEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGM 187
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV---STRIVGTRGY 198
FL I+RDL A N+LL N K+ DFGLARD D +V S R+ +
Sbjct: 188 EFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGSARL--PLKW 242
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF---LRDS 255
APE + T +SDV+SFGV+L E+ S G + V+ + F L+D
Sbjct: 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LGASPYPGVQINEEFCQRLKDG 293
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS---MVDVLTSLEQ 305
R+ + + + ++L C DPK RP+ +V++L L Q
Sbjct: 294 TRM----------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 4e-15
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G G VF +G VAIK++ + + + E++ + +L++ N
Sbjct: 27 IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+V + D +V E++ GSL + + + + + + + L FLH
Sbjct: 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC--MDEAQIAAVCRECLQALEFLHA-- 133
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH 208
VI+RD+K+ NVLL + + KL+DFG T + + ST +VGT + APE V
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGTPYWMAPEVVTRKA 191
Query: 209 LTPKSDVYSFGVVLLELLSG 228
PK D++S G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 71/289 (24%), Positives = 119/289 (41%), Gaps = 58/289 (20%)
Query: 28 LLGEGGFGCVF--KGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW--LTEVIYLGQ 83
++G G FG V + DQ +V IK++ E + E L
Sbjct: 7 VVGRGAFGIVHLCRRKADQK-----------LVIIKQIPVEQMTKDERLAAQNECQVLKL 55
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLE-------NHLFRSVQPISWPTRVKIAID 136
L H N+++ E ++V E+ P G+L N L + + ++ +A+
Sbjct: 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGT 195
H +++RDLK N+LLD + K+ DFG+++ + T +VGT
Sbjct: 116 --------HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGT 164
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
Y +PE KSD+++ G VL EL S +RA + A P L
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE------AANL------PAL--- 209
Query: 256 RRVLRIMDTR---LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301
VL+IM + +YS + ++L L++DP RP + ++
Sbjct: 210 --VLKIMSGTFAPISDRYSPD----LRQLILSMLNLDPSKRPQLSQIMA 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 5e-15
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 22 NFCSDYLLGEGGFGCVF----KGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE 77
NF +LG G +G VF G D K + K AE H TE
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE----HT--RTE 54
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
L +R + + Y ++D +L L+ +++ G L HL++ RV IA +
Sbjct: 55 RQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-E 113
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVG 194
+ L LH L +IYRD+K N+LLDS + L+DFGL+++ + + G
Sbjct: 114 IVLALDHLHQL--GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCG 168
Query: 195 TRGYAAPEYVATGHLTPKS--DVYSFGVVLLELLSG 228
T Y APE + G D +S GV+ ELL+G
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G +G V+K +G +VAIK +K E + E+ L + RH N
Sbjct: 11 IGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+V G D +V E+ GSL++ + P+S + + +GL++LH
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET- 120
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYVA 205
I+RD+K +N+LL + + KL+DFG++ T + +GT + APE A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 206 ---TGHLTPKSDVYSFGVVLLEL 225
G K D+++ G+ +EL
Sbjct: 175 VERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 6e-15
Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G+GG+G VF K +G +VA+KR+K E LTE L +
Sbjct: 9 VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
E LVKL+ Y + D L L E++P G L R +A + L
Sbjct: 60 SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE-AVDAL 117
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H L I+RDLK N L+D++ + KL+DFGL++ T N+ +VG+ Y APE +
Sbjct: 118 HEL--GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVL 170
Query: 205 ATGHLTPKSDVYSFGVVLLELLSG 228
D +S G +L E L G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 65/258 (25%), Positives = 118/258 (45%), Gaps = 21/258 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V T+ +G VA+K++ Q + EV+ + HEN
Sbjct: 30 IGEGSTGIVC---------IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRSVQPISWPTRVKIAIDVARGLSFLH 145
+V + D +V EF+ G+L + H + + I+ + + V R LS+LH
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLH 135
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
+ VI+RD+K+ ++LL S+ KLSDFG +VGT + APE ++
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVIS 191
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
+ D++S G++++E++ G + A + + + P ++DS +V ++
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGF 251
Query: 266 LGGQYSKKEAQAVAAVVL 283
L ++ +Q A L
Sbjct: 252 LDLMLVREPSQRATAQEL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-15
Identities = 53/148 (35%), Positives = 77/148 (52%), Gaps = 17/148 (11%)
Query: 96 CSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 154
C ++ +RL V E++ G L + + V P V A ++A GL FLH +IYR
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLH--SKGIIYR 125
Query: 155 DLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT 210
DLK NV+LDS + K++DFG+ + DG T + GT Y APE +A
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDGVT------TKTFCGTPDYIAPEIIAYQPYG 179
Query: 211 PKSDVYSFGVVLLELLSGRRAL---DED 235
D ++FGV+L E+L+G+ DED
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ FA + VVAIK++ Q +++W + EV +L QLR
Sbjct: 23 IGHGSFGAVY--------FA-RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N ++ G LV E+ GS + L +P+ I +GL++LH
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGTRGYAAPEYV 204
I+RD+KA N+LL KL+DFG A P + VGT + APE +
Sbjct: 133 SH--ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYWMAPEVI 183
Query: 205 AT---GHLTPKSDVYSFGVVLLEL 225
G K DV+S G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 72/225 (32%), Positives = 105/225 (46%), Gaps = 21/225 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V + +G A+K LK E E LTE L
Sbjct: 2 LLGKGTFGKVI---------LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI-AIDVARGLS 142
RH L L Y ++ +RL V E+ G L HL R + + R + ++ L
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALD 109
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH + NV+YRDLK N++LD + + K++DFGL ++G D + T GT Y APE
Sbjct: 110 YLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPE 166
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 246
+ D + GVV+ E++ GR ++D L E L+E
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 47/140 (33%), Positives = 77/140 (55%), Gaps = 8/140 (5%)
Query: 96 CSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 154
C ++++RL V EF+ G L H+ R + R + +++ L+FLH + +IYR
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISLALNFLH--ERGIIYR 120
Query: 155 DLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS 213
DLK NVLLD+ + KL+D+G+ ++G GD T + GT Y APE +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGEDYGFSV 177
Query: 214 DVYSFGVVLLELLSGRRALD 233
D ++ GV++ E+++GR D
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 48/140 (34%), Positives = 77/140 (55%), Gaps = 8/140 (5%)
Query: 96 CSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 154
C ++ +RL LV E++ G L H+ R + R A ++ L+FLH + +IYR
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH--ERGIIYR 120
Query: 155 DLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS 213
DLK NVLLD++ + KL+D+G+ ++G GD T + GT Y APE +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYGFSV 177
Query: 214 DVYSFGVVLLELLSGRRALD 233
D ++ GV++ E+++GR D
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 77/283 (27%), Positives = 125/283 (44%), Gaps = 43/283 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEV-IYLGQLRH 86
LG G +G V D+ PT G ++A+KR++A + Q K L ++ I + +
Sbjct: 9 LGRGAYGVV-----DKMRHVPT----GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDC 59
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRSVQPISWPTRVKIAIDVARGLSF 143
V G + + E M SL+ ++ I KIA+ + + L +
Sbjct: 60 PYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD--NTHVSTRIVGTRGYAAP 201
LH +VI+RD+K SNVL++ N KL DFG+ +G ++ T G + Y AP
Sbjct: 119 LHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGI-----SGYLVDSVAKTIDAGCKPYMAP 172
Query: 202 EYV----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257
E + KSDV+S G+ ++EL +GR D W PF + ++
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD------------SWKTPF-QQLKQ 219
Query: 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
V+ +L + E Q V +CL + K RP+ ++L
Sbjct: 220 VVEEPSPQLPAEKFSPEFQ---DFVNKCLKKNYKERPNYPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 53/291 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL----------KAESFQGHKEWLTE 77
LG G FGCV+K K ++A+K + K E + + ++E
Sbjct: 7 HLGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58
Query: 78 V-IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV----QPISWPTRVK 132
V I QLRH N+V+ E+D +V + + L H F S+ Q +
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEH-FNSLKEKKQRFTEERIWN 117
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
I + + L +LH + +++RDL +N++L + ++DFGLA+ + + T +
Sbjct: 118 IFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL-TSV 173
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
VGT Y+ PE V K+DV++FG +L + + PF
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQ-------------------MCTLQPPFY 214
Query: 253 RDSRRVLRIMDTRLGGQYSKKE----AQAVAAVVLQCLHMDPKNRPSMVDV 299
S +L + + Y ++ V V+ CL D + RP ++ V
Sbjct: 215 --STNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 78/260 (30%), Positives = 121/260 (46%), Gaps = 37/260 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL 84
++G GGFG V+ K +G + A+K L + QG L E I L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 85 RHEN--LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI-AIDVARG 140
+ + + Y + ++L + + M G L HL S + ++ A ++ G
Sbjct: 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL--SQHGVFSEAEMRFYAAEIILG 109
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 200
L +H + V+YRDLK +N+LLD + + ++SD GLA D + H S VGT GY A
Sbjct: 110 LEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMA 163
Query: 201 PEYVATGHLTPKS-DVYSFGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFL 252
PE + G S D +S G +L +LL G R+ +D+ + TL VE D F
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS 223
Query: 253 RDSRRVL-----RIMDTRLG 267
+ R +L R ++ RLG
Sbjct: 224 PELRSLLEGLLQRDVNRRLG 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V+ + D +T G + V + ES + KE E+ L L
Sbjct: 9 LLGQGAFGRVYLCY-DADT------GRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 85 RHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
HE +V+ G + R L E MP GS+++ L +S ++ K + G+S
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVS 120
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAAP 201
+LH +++RD+K +N+L DS N KL DFG ++ T + + + GT + +P
Sbjct: 121 YLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGR 229
E ++ K+D++S G ++E+L+ +
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+G+G FG VFK + +VA+K++ E+ KE L E+ L
Sbjct: 20 IGQGTFGEVFKARHKKT---------KQIVALKKVLMEN---EKEGFPITALREIKILQL 67
Query: 84 LRHENLVKLIGYC---SESDNR-----LLVYEFMP---KGSLENHLFRSVQPISWPTRVK 132
L+HEN+V LI C + NR LV+EF G L N + + K
Sbjct: 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVK----FTLSEIKK 123
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVST 190
+ + GL ++H +++RD+KA+N+L+ + KL+DFGLAR + T
Sbjct: 124 VMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 191 RIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLEL 225
V T Y PE + P D++ G ++ E+
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT--EVIYLGQLR- 85
+GEG +G VFK +N G VA+KR++ ++ + T EV L L
Sbjct: 9 IGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 86 --HENLVKLIGYCSES----DNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDV 137
H N+V+L C+ S + +L LV+E + + L +L + +P +K + +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
RGL FLH V++RDLK N+L+ S+ KL+DFGLAR T +V T
Sbjct: 120 LRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLW 174
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 232
Y APE + D++S G + E+ R+ L
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 4e-14
Identities = 71/224 (31%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG+G FG V + +G A+K LK E E LTE L
Sbjct: 2 LLGKGTFGKVI---------LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
RH L L Y ++ +RL V E+ G L HL R R A ++ L +
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALGY 110
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH +V+YRDLK N++LD + + K++DFGL ++G + T GT Y APE
Sbjct: 111 LH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEV 166
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 246
+ D + GVV+ E++ GR ++D L E L+E
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 70/230 (30%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK---------AESFQGHKEWLTEV 78
+LG+G FG V + G G A+K LK E K L
Sbjct: 2 VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA-- 50
Query: 79 IYLGQLRHEN--LVKLIGYCSESDNRLLVYEFMPKGSLENH--------LFRSVQPISWP 128
L EN L L ++ V EF+ G L H L+R+
Sbjct: 51 -----LAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRAT------ 99
Query: 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 188
A ++ GL FLH +IYRDLK NV+LD + + K++DFG+ ++ GDN
Sbjct: 100 ---FYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-- 152
Query: 189 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL---DED 235
++ GT Y APE + T D +SFGV+L E+L G+ DED
Sbjct: 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE----WLTEVIYLGQL 84
+G+G FG V A K G A+K L+ ++ KE + L +
Sbjct: 3 IGKGSFGKVL--------LAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
+H LV L +D V +++ G L HL R + P A ++A L +L
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYL 112
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H L N+IYRDLK N+LLDS + L+DFGL ++G T ++ GT Y APE +
Sbjct: 113 HSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVL 168
Query: 205 ATGHLTPKSDVYSFGVVLLELLSG 228
D + G VL E+L G
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-14
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR 85
LG+GGFG V A +G + A K+L + +G++ + E L ++
Sbjct: 1 LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50
Query: 86 HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQP---ISWPTRVKIAIDVARGL 141
H + + Y ++ L LV M G L H++ + P + GL
Sbjct: 51 HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
LH +IYRDLK NVLLD++ N ++SD GLA + G + + GT G+ AP
Sbjct: 111 EHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAP 166
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGR 229
E + D ++ GV L E+++ R
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 80/283 (28%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTE 77
NF +LG G +G VF + SG + A+K LK + + + TE
Sbjct: 1 NFELLKVLGTGAYGKVFL------VRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTE 54
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
L +R + + Y ++D +L L+ +++ G L HL + + ++ +
Sbjct: 55 RQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG-E 113
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
+ L LH L +IYRD+K N+LLDSN + L+DFGL+++ D + GT
Sbjct: 114 IVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTI 170
Query: 197 GYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRR--ALDEDRGGLAEQTLVEWADPF 251
Y AP+ V GH D +S GV++ ELL+G +D ++ AE
Sbjct: 171 EYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--------- 220
Query: 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM-DPKNR 293
SRR+L+ +E A+A ++Q L M DPK R
Sbjct: 221 ---SRRILK------SEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 6e-14
Identities = 47/140 (33%), Positives = 77/140 (55%), Gaps = 8/140 (5%)
Query: 96 CSESDNRLL-VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 154
C ++++RL V E++ G L H+ R + R A +++ L++LH + +IYR
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLH--ERGIIYR 120
Query: 155 DLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS 213
DLK NVLLDS + KL+D+G+ ++G GD T + GT Y APE +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGEDYGFSV 177
Query: 214 DVYSFGVVLLELLSGRRALD 233
D ++ GV++ E+++GR D
Sbjct: 178 DWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQG-HKEWLTEVIYLGQLRH 86
+GEG +G VFK ++ T +VA+KR++ + +G L E+ L +L+H
Sbjct: 8 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPK----------GSLENHLFRSVQPISWPTRVKIAI 135
+N+V+L SD +L LV+E+ + G ++ + +S
Sbjct: 59 KNIVRLYDVL-HSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKS-----------FMF 106
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
+ +GL+F H NV++RDLK N+L++ N KL+DFGLAR G + V T
Sbjct: 107 QLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVT 162
Query: 196 RGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGRRAL 232
Y P+ + L S D++S G + EL + R L
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE----WLTEVIYLGQ 83
++G+G FG V A K G A+K L+ ++ KE + L
Sbjct: 2 VIGKGSFGKVL--------LAKRK-SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
L+H LV L ++ V +++ G L HL R + P A +VA + +
Sbjct: 53 LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGY 111
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH L N+IYRDLK N+LLDS + L+DFGL ++G + T ++ GT Y APE
Sbjct: 112 LHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEV 167
Query: 204 VATGHLTPKSDVYSFGVVLLELLSG 228
+ D + G VL E+L G
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 50/150 (33%), Positives = 74/150 (49%), Gaps = 5/150 (3%)
Query: 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVA 138
+ L ++H LV L ++ V +F+ G L HL R + P A ++A
Sbjct: 48 VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIA 106
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
L +LH + N++YRDLK N+LLDS + L+DFGL ++G +T +T GT Y
Sbjct: 107 SALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEY 162
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
APE + D + G VL E+L G
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 24/203 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ FA + VVAIK++ Q +++W + EV +L +LR
Sbjct: 23 IGHGSFGAVY--------FA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N ++ G LV E+ GS + L +P+ + +GL++LH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
N+I+RD+KA N+LL KL DFG A + VGT + APE +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVIL 184
Query: 206 T---GHLTPKSDVYSFGVVLLEL 225
G K DV+S G+ +EL
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEW-LTEVIYLGQLR 85
++GEG +G V K + + +VAIK+ K +E + KE L E+ L L+
Sbjct: 8 VVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK 58
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-DVARGLSFL 144
EN+V+L LV+E++ K LE L + P +V+ I + + + +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H D +++RD+K N+L+ N KL DFG AR+ G N + T V TR Y +PE +
Sbjct: 117 HKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELL 173
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGR 229
D++S G +L EL G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 37/227 (16%)
Query: 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLG 82
+ LG G G VF +D + VA+K++ Q K L E+ +
Sbjct: 7 YMDLRPLGCGSNGLVFSA-VDSD--------CDKRVAVKKIVLTDPQSVKHALREIKIIR 57
Query: 83 QLRHENLVKL--------------IGYCSESDNRLLVYEFMPKGSLENHLFRSV--QPIS 126
+L H+N+VK+ +G +E ++ +V E+M E L + P+S
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLS 112
Query: 127 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLAR--DGPTG 183
+ RGL ++H ANV++RDLK +NV +++ + K+ DFGLAR D
Sbjct: 113 EEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYS 170
Query: 184 DNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 229
++S +V T+ Y +P + + + T D+++ G + E+L+G+
Sbjct: 171 HKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+K D+ T G +VA+K RL+ E + E+ L +L H
Sbjct: 7 IGEGTYGVVYKA-RDKLT--------GEIVALKKIRLETEDEGVPSTAIREISLLKELNH 57
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-DVARGLSFL 144
N+V+L+ S+N+L LV+EF+ L+ ++ S P +K + + +G+++
Sbjct: 58 PNIVRLLDVV-HSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H V++RDLK N+L+D KL+DFGLAR G T V T Y APE +
Sbjct: 116 HS--HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL 171
Query: 205 ATGHL--TPKSDVYSFGVVLLELLSGR 229
TP D++S G + E+++ R
Sbjct: 172 LGSRQYSTP-VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 74/270 (27%), Positives = 110/270 (40%), Gaps = 77/270 (28%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL-TEVIYLGQL-RH 86
LG G FG V ++ F K + + VA+K LKA + +E L +E+ L L +H
Sbjct: 46 LGAGAFGKV----VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 87 ENLVKLIG-------------YCSESD-------------NRLLVYEFMPKGS------- 113
+N+V L+G YC D N ++ + + S
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161
Query: 114 LENHLFRS--------------VQPIS------------------WPTRV----KIAIDV 137
LE RS ++P+S WP + + + V
Sbjct: 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQV 221
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
A+G+ FL N I+RD+ A NVLL AK+ DFGLARD N V
Sbjct: 222 AQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ APE + T +SDV+S+G++L E+ S
Sbjct: 280 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+K D+ T +A+K RL+ E + E+ L +++H
Sbjct: 10 IGEGTYGVVYKAR-DRVT--------NETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-DVARGLSFL 144
N+V+L S+ RL LV+E++ L+ H+ S P +K + + RG+++
Sbjct: 61 GNIVRLQDVV-HSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 145 HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE- 202
H V++RDLK N+L+D NA KL+DFGLAR G T V T Y APE
Sbjct: 119 H--SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEI 174
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGR 229
+ + H + D++S G + E+++ +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 44/123 (35%), Positives = 72/123 (58%), Gaps = 6/123 (4%)
Query: 107 EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 166
E M GSL+ + + + I K++I V RGL++L +++RD+K SN+L++S
Sbjct: 83 EHMDGGSLD-QVLKEAKRIPEEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSR 140
Query: 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 226
KL DFG++ G D+ ++ VGTR Y +PE + H + +SD++S G+ L+EL
Sbjct: 141 GEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA 196
Query: 227 SGR 229
GR
Sbjct: 197 IGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 65/207 (31%), Positives = 110/207 (53%), Gaps = 26/207 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE- 87
LG G G VFK KP SG+++A K + E + ++I Q+ HE
Sbjct: 13 LGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIR---NQIIRELQVLHEC 60
Query: 88 NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRV--KIAIDVARGLS 142
N ++G+ SD + + E M GSL+ L ++ + P ++ K++I V +GL+
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 117
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+L +++RD+K SN+L++S KL DFG++ G D+ ++ VGTR Y +PE
Sbjct: 118 YLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPE 172
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGR 229
+ H + +SD++S G+ L+E+ GR
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LLG G FG V+ + D +T G + V +S + KE E+ L L
Sbjct: 9 LLGRGAFGEVYLCY-DADT------GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 85 RHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
RH+ +V+ G + + + L E+MP GS+++ L ++ ++ + + +G+S
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVS 120
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT--GDNTHVSTRIVGTRGYAA 200
+LH +++RD+K +N+L DS N KL DFG ++ T T + + + GT + +
Sbjct: 121 YLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMS 177
Query: 201 PEYVATGHLTPKSDVYSFGVVLLELLS 227
PE ++ K+DV+S ++E+L+
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 37/221 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLG 82
+GEG +G V+K +G VA+K+++ +E L E+ L
Sbjct: 6 EIGEGAYGTVYKA---------RDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLK 53
Query: 83 QLR---HENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRSVQPISWPTRVK-I 133
QL H N+V+L+ C +D L LV+E + + L +L + +P P +K +
Sbjct: 54 QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDL 112
Query: 134 AIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
+ RG+ FLH ++ +++RDLK N+L+ S+ K++DFGLAR T +
Sbjct: 113 MRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSV 166
Query: 193 VGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 232
V T Y APE + + + TP D++S G + EL RR L
Sbjct: 167 VVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFR-RRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 46/125 (36%), Positives = 68/125 (54%), Gaps = 18/125 (14%)
Query: 114 LENHLFRSVQPISWPTRV--KIAIDVARGLSFL---HGLDANVIYRDLKASNVLLDSNFN 168
L+ L R PI P + K+ + + + L +L HG VI+RD+K SN+LLD++ N
Sbjct: 100 LDKLLKRIQGPI--PEDILGKMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGN 153
Query: 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK----SDVYSFGVVLLE 224
KL DFG++ G D + TR G Y APE + PK +DV+S G+ L+E
Sbjct: 154 VKLCDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVE 210
Query: 225 LLSGR 229
L +G+
Sbjct: 211 LATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 5e-13
Identities = 73/281 (25%), Positives = 119/281 (42%), Gaps = 41/281 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ FA + VVAIK++ Q +++W + EV +L +++
Sbjct: 33 IGHGSFGAVY--------FARDVRTNE-VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N ++ G LV E+ GS + L +P+ I +GL++LH
Sbjct: 84 HPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
N+I+RD+KA N+LL KL+DFG A ++ VGT + APE +
Sbjct: 143 --SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVIL 194
Query: 206 T---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
G K DV+S G+ +EL + L A + + P L+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--------- 245
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
S + + V CL P++RP+ ++L +
Sbjct: 246 --------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 42/222 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+GEG +G V+K D++T G +VA+K+++ ++ KE + E+ L Q
Sbjct: 15 IGEGTYGQVYKA-RDKDT--------GELVALKKVRLDN---EKEGFPITAIREIKILRQ 62
Query: 84 LRHENLVKLIGYCSESDNRL----------LVYEFMPK---GSLENHL--FRSVQPISWP 128
L H N+V L ++ + L LV+E+M G LE+ L F S+
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF- 121
Query: 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 188
+K ++ GL++ H N ++RD+K SN+LL++ KL+DFGLAR + ++
Sbjct: 122 --MKQLLE---GLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 189 STRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 229
+ +++ T Y PE + P DV+S G +L EL + +
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 51/209 (24%), Positives = 102/209 (48%), Gaps = 14/209 (6%)
Query: 54 SGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS 113
SG VA+K + Q + EV+ + +H+N+V++ + ++ EF+ G+
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 114 LENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173
L + + S ++ + V + L +LH VI+RD+K+ ++LL + KLSD
Sbjct: 105 LTDIV--SQTRLNEEQIATVCESVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSD 160
Query: 174 FG----LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
FG +++D P +VGT + APE ++ + D++S G++++E++ G
Sbjct: 161 FGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214
Query: 230 RALDEDRGGLAEQTLVEWADPFLRDSRRV 258
D A + L + P L+++ ++
Sbjct: 215 PPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQLR 85
+G G +G V + D T G+ VA+K+L + FQ K E+ L ++
Sbjct: 25 VGSGAYGSVCAAF-DTKT--------GLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMK 74
Query: 86 HENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
HEN++ L+ + E ++ LV M G+ N++ + Q ++ + + R
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK-CQKLTDDHVQFLIYQILR 131
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
GL ++H A++I+RDLK SN+ ++ + K+ DFGLAR T D T V TR Y
Sbjct: 132 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGYVATRWYR 184
Query: 200 APEYVATG-HLTPKSDVYSFGVVLLELLSGR 229
APE + H D++S G ++ ELL+GR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RH 86
++GEG +G V+K + T G +VAIK + +E E L + H
Sbjct: 13 VIGEGTYGKVYKA-RHKKT--------GQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62
Query: 87 ENLVKLIG------YCSESDNRLLVYEFMPKGS---LENHLFRSVQPISWPTRVKIAIDV 137
N+ G D LV E GS L L + + + I +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR--IVGT 195
RGL++LH + VI+RD+K N+LL N KL DFG++ D+T + R +GT
Sbjct: 123 LRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ---LDST-LGRRNTFIGT 176
Query: 196 RGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSG 228
+ APE +A +SDV+S G+ +EL G
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW--LTEVIYLGQLR- 85
+GEG F V K Q+ +G AIK +K F+ ++ L E+ L +L
Sbjct: 7 IGEGTFSEVLKA---QSR------KTGKYYAIKCMKK-HFKSLEQVNNLREIQALRRLSP 56
Query: 86 HENLVKLIG--YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
H N+++LI + ++ LV+E M +L + +P+ + + L
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
+H + +RD+K N+L+ + KL+DFG R + T + TR Y APE
Sbjct: 116 MHR--NGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPEC 169
Query: 204 VAT-GHLTPKSDVYSFGVVLLELLS 227
+ T G+ PK D+++ G V E+LS
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 30/166 (18%)
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
E+ L + H N+VK + ++ EFM GSLE Q ++ D
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA---------D 172
Query: 137 VAR----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTR 191
VAR G+++LH ++++RD+K SN+L++S N K++DFG++R T D + S
Sbjct: 173 VARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-- 228
Query: 192 IVGTRGYAAPEYVAT--------GHLTPKSDVYSFGVVLLELLSGR 229
VGT Y +PE + T G+ D++S GV +LE GR
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 26/174 (14%)
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV---STRIV 193
VARG+ FL I+RDL A N+LL N K+ DFGLARD D +V R+
Sbjct: 182 VARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARL- 237
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
+ APE + T +SDV+SFGV+L E+ S G + V+ + F R
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LGASPYPGVQIDEEFCR 287
Query: 254 DSRRVLRIMDTRLGG-QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ TR+ +Y+ E + +++L C H +P++RP+ +++ L L
Sbjct: 288 RLKE-----GTRMRAPEYATPE---IYSIMLDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 52/169 (30%), Positives = 75/169 (44%), Gaps = 37/169 (21%)
Query: 140 GLSFLHGLDA-------NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
GL F+ L A ++I+RD+K++N+LL SN KL DFG ++ + V
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
GT Y APE + K+D++S GV+L ELL+ +R PF
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR-------------------PF- 245
Query: 253 RDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPS 295
D + +M L G+Y E Q + +L DPK RPS
Sbjct: 246 -DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSS---DPKRRPS 290
|
Length = 496 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 1e-12
Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G G V+ ID T G VAIK++ + + + E++ + + ++ N
Sbjct: 27 IGQGASGTVYTA-IDIAT--------GQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+V + D +V E++ GSL + + + + + + + L FLH
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALDFLH--S 133
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH 208
VI+RD+K+ N+LL + + KL+DFG T + + ST +VGT + APE V
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGTPYWMAPEVVTRKA 191
Query: 209 LTPKSDVYSFGVVLLELLSG 228
PK D++S G++ +E++ G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 77/260 (29%), Positives = 120/260 (46%), Gaps = 37/260 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL 84
++G GGFG V+ K +G + A+K L + QG L E I L +
Sbjct: 1 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51
Query: 85 RHEN--LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI-AIDVARG 140
+ + + Y + ++L + + M G L HL S + ++ A ++ G
Sbjct: 52 STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFYATEIILG 109
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 200
L +H + V+YRDLK +N+LLD + + ++SD GLA D + H S VGT GY A
Sbjct: 110 LEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMA 163
Query: 201 PEYVATGHLTPKS-DVYSFGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFL 252
PE + G S D +S G +L +LL G R+ +D+ + TL VE D F
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFS 223
Query: 253 RDSRRVL-----RIMDTRLG 267
+ + +L R + RLG
Sbjct: 224 PELKSLLEGLLQRDVSKRLG 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQLR 85
LG G FG V A K G+G AIK LK K+ E L +L
Sbjct: 26 LGTGSFGRV--------RIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 86 HENLVKLIGYCS-ESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK--IAIDVARGL 141
H +V + CS + +NR+ + EF+ G L HL ++ + +P V ++
Sbjct: 77 HPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAF 131
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
+LH D +IYRDLK N+LLD+ + K++DFG A+ P D T + GT Y AP
Sbjct: 132 EYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAP 184
Query: 202 EYVAT-GHLTPKSDVYSFGVVLLELLSG 228
E + + GH D ++ GV+L E ++G
Sbjct: 185 EVIQSKGH-GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 76/291 (26%), Positives = 117/291 (40%), Gaps = 51/291 (17%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLK-----AESFQGHKEWLTEVIYL- 81
LG+G F ++KG Q+ PG + V +K L + +F E L
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFF-------ETASLM 55
Query: 82 GQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
QL H++LVKL G C +N ++V E++ G L+ L R +S ++ +A +A L
Sbjct: 56 SQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASAL 114
Query: 142 SFLHGLDANVIYRDLKASNVLL---DSNFN----AKLSDFGLARDGPTGDNTHVSTRIVG 194
+L D +++ ++ N+L+ N KLSD G+ RI
Sbjct: 115 HYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI-- 168
Query: 195 TRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
+ APE + G LT +D +SFG LLE+ S G TL
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEICS--------NGEEPLSTL-------- 210
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
S R + + +A ++ QC DP RPS +L L
Sbjct: 211 -SSSEKERFYQD--QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 47/224 (20%)
Query: 30 GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT---EVIYLGQLRH 86
G G +G V+K G AIK+ K + Q + E+ L +L+H
Sbjct: 9 GRGTYGRVYKAKRK-------NGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 87 ENLVKLIGYCSESDNRL--LVYEFMPKGSLENHLF------RSVQPISWPTR-VK-IAID 136
EN+V L+ E ++ L++++ E+ L+ R + +S P VK +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 137 VARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNA----KLSDFGLAR--DGP-----TGD 184
+ G+ +LH +N V++RDLK +N+L+ K+ D GLAR + P D
Sbjct: 117 ILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 185 NTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLS 227
+V T Y APE + H T D+++ G + ELL+
Sbjct: 174 ------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 49/150 (32%), Positives = 73/150 (48%), Gaps = 5/150 (3%)
Query: 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVA 138
+ L ++H LV L +D V +++ G L HL R + P A ++A
Sbjct: 48 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIA 106
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
L +LH L N++YRDLK N+LLDS + L+DFGL ++ + T ++ GT Y
Sbjct: 107 SALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEY 162
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
APE + D + G VL E+L G
Sbjct: 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-12
Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G G V+ +G VAI+++ + + + E++ + + ++ N
Sbjct: 28 IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+V + D +V E++ GSL + + + + + + + L FLH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH--S 134
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 207
VI+RD+K+ N+LL + + KL+DFG A+ P + +VGT + APE V
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRK 191
Query: 208 HLTPKSDVYSFGVVLLELLSG 228
PK D++S G++ +E++ G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 42/296 (14%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEV 78
NF + +G G F V++ T G+ VA+K+++ + + + E+
Sbjct: 3 NFRIEKKIGRGQFSEVYRA---------TCLLDGVPVALKKVQIFDLMDAKARADCIKEI 53
Query: 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRSVQPISWPTRVKIAI 135
L QL H N++K E + +V E G L H + + I T K +
Sbjct: 54 DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
+ L +H V++RD+K +NV + + KL D GL R + T + +VGT
Sbjct: 114 QLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 169
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255
Y +PE + KSD++S G +L E+ + PF D
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-------------------LQSPFYGDK 210
Query: 256 RRVLRIMDTRLGGQY----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
+ + Y S ++ + +V C++ DP+ RP + V +++H
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 24/212 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG FG K + ++ + G V+ + S + +E EV L ++H N
Sbjct: 8 IGEGSFG---KAILVKSK----EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSL-------ENHLFRSVQPISWPTRVKIAIDVARGL 141
+V+ E+ N +V ++ G L LF Q + W ++ +A+
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK----- 115
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
H D +++RD+K+ N+ L + KL DFG+AR ++ +GT Y +P
Sbjct: 116 ---HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSP 170
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGRRALD 233
E KSD+++ G VL E+ + + A +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + VFKG + +VA+K ++ E +G + EV L L+H
Sbjct: 13 LGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+V L LV+E++ L+ +L +S + RGLS+ H
Sbjct: 64 NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH-- 120
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV--A 205
+++RDLK N+L++ KL+DFGLAR T+ S +V T Y P+ + +
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLLGS 178
Query: 206 TGHLTPKSDVYSFGVVLLELLSGR 229
T + TP D++ G +L E+ +GR
Sbjct: 179 TEYSTP-IDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 40/216 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V +D+ T G VAIK+L FQ K E+ L ++
Sbjct: 23 VGSGAYGTVCSA-LDRRT--------GAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMK 72
Query: 86 HENLVKLIGYCSESDNR------LLVYEFMPK--GSLENHLFRSVQPISWPTRVKIAIDV 137
HEN++ L+ + + LV FM G L H S I + + +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-----LVYQM 127
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG--- 194
+GL ++H A +I+RDLK N+ ++ + K+ DFGLAR + + G
Sbjct: 128 LKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------QTDSEMTGYVV 177
Query: 195 TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 229
TR Y APE + H T D++S G ++ E+L+G+
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G +G V+K +N +G + AIK +K E + E+I + +H N
Sbjct: 17 IGSGTYGDVYKA---RNV------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+V G D + EF GSL++ ++ P+S ++ + +GL +LH
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH--S 124
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-- 206
++RD+K +N+LL N + KL+DFG++ +GT + APE A
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 207 -GHLTPKSDVYSFGVVLLEL 225
G D+++ G+ +EL
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 35/191 (18%)
Query: 55 GIVVAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPK 111
GI VA+K+L + FQ K E++ L + H+N++ L+ F P+
Sbjct: 46 GINVAVKKL-SRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQ 92
Query: 112 GSLEN----HLFRSVQPISWPTRVKIAIDVAR----------GLSFLHGLDANVIYRDLK 157
SLE +L + + + + +D R G+ LH A +I+RDLK
Sbjct: 93 KSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLK 150
Query: 158 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS 217
SN+++ S+ K+ DFGLAR T + T V TR Y APE + D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWS 207
Query: 218 FGVVLLELLSG 228
G ++ EL+ G
Sbjct: 208 VGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 29 LGEGGFGCVFKGW--IDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLR 85
LGEG + VFKG + +N +VA+K ++ E +G + EV L L+
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N+V L + LV+E++ K L+ ++ +S + RGL++ H
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-YV 204
V++RDLK N+L++ KL+DFGLAR T+ S +V T Y P+ +
Sbjct: 122 --RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-TLWYRPPDVLL 177
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGR 229
+ + + D++ G + E+ SGR
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 21/208 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWL---TEVIYLGQ 83
+LG+GG+G VF+ + + T A +G + A+K L KA + K+ E L
Sbjct: 3 VLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEA 56
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
++H +V LI Y ++ +L L+ E++ G L HL R + ++ +++ L
Sbjct: 57 VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLALE 114
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN-THVSTRIVGTRGYAAP 201
LH +IYRDLK N+LLD+ + KL+DFGL ++ TH GT Y AP
Sbjct: 115 HLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAP 169
Query: 202 EYVA-TGHLTPKSDVYSFGVVLLELLSG 228
E + +GH D +S G ++ ++L+G
Sbjct: 170 EILMRSGH-GKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 48/232 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--------------HKEW 74
LGEG +G V K D T G +VAIK++K H
Sbjct: 17 LGEGTYGKVEKA-YDTLT--------GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRSVQPISWPTRV 131
L E+ + +++HEN++ L+ E D LV + M K ++ + + +V
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTES------QV 121
Query: 132 K-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-------DGPTG 183
K I + + GL+ LH ++RDL +N+ ++S K++DFGLAR
Sbjct: 122 KCILLQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 184 DNTHVSTRI-----VGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 229
+ + R V T Y APE + D++S G + ELL+G+
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 63/196 (32%), Positives = 93/196 (47%), Gaps = 11/196 (5%)
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI 133
L E L Q+ +V L + +S +L LV F+ G L +HL R + R
Sbjct: 41 LAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYT 99
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A ++ L LH NVIYRDLK N+LLD + L DFGL + D+ +
Sbjct: 100 A-ELLCALENLHKF--NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFC 154
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE---WAD 249
GT Y APE + T D ++ GV+L E+L+G DE+ + + L E + D
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD 214
Query: 250 PFLRDSRRVLRIMDTR 265
F RD++ +L + +R
Sbjct: 215 GFDRDAKDLLIGLLSR 230
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA------ESFQGHKEWLTEVIYL 81
+LG G +G VF T +G + A+K L+ H TE L
Sbjct: 7 VLGTGAYGKVFL------VRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR--TERNVL 58
Query: 82 GQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARG 140
+R + + Y +++ +L L+ +++ G + HL++ R ++
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILA 117
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 200
L LH L ++YRD+K N+LLDS + L+DFGL+++ + + + GT Y A
Sbjct: 118 LEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMA 174
Query: 201 PEYV--ATGHLTPKSDVYSFGVVLLELLSG 228
PE + GH D +S G+++ ELL+G
Sbjct: 175 PEIIRGKGGH-GKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 59/250 (23%), Positives = 99/250 (39%), Gaps = 55/250 (22%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK---AESFQGHKEWLTEVIYLGQL 84
L+G+GG G V+ + P VA+K+++ +E+ K +L E L
Sbjct: 9 LIGKGGMGEVYLAY---------DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL 59
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMP--KGSLENHLFRSV-----------QPISWPTRV 131
H +V + CS+ D VY MP +G L +SV + S +
Sbjct: 60 IHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA-------------- 177
I + + ++H V++RDLK N+LL + D+G A
Sbjct: 117 SIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 178 --RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-------- 227
+ + +IVGT Y APE + + +D+Y+ GV+L ++L+
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234
Query: 228 -GRRALDEDR 236
GR+ D
Sbjct: 235 KGRKISYRDV 244
|
Length = 932 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 63/224 (28%), Positives = 101/224 (45%), Gaps = 41/224 (18%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTE 77
+ + S +G G +G V ID+ T G VAIK+L + FQ K E
Sbjct: 15 ERYTSLKQVGSGAYGSVCSA-IDKRT--------GEKVAIKKL-SRPFQSEIFAKRAYRE 64
Query: 78 VIYLGQLRHENLVKLIG-YCSES--DNRLLVYEFMPKGSLENHLFRSVQ-----PISWPT 129
+ L ++HEN++ L+ + S D Y MP ++ +Q P+S
Sbjct: 65 LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP------YMQTDLQKIMGHPLSEDK 118
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 189
+ + GL ++H A +I+RDLK N+ ++ + K+ DFGLAR H
Sbjct: 119 VQYLVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------HAD 168
Query: 190 TRIVG---TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 229
+ G TR Y APE + H D++S G ++ E+L+G+
Sbjct: 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 54/193 (27%), Positives = 74/193 (38%), Gaps = 50/193 (25%)
Query: 75 LTEVIYLGQLRHENLVKLIGYCS--ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK 132
LTE L L H L L Y S LV ++ P G L QP
Sbjct: 49 LTEQEILATLDHPFLPTL--YASFQTETYLCLVMDYCPGGEL--FRLLQRQPGK-----C 99
Query: 133 IAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-------- 176
++ +VAR L +LH L ++YRDLK N+LL + + LSDF L
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157
Query: 177 ------ARDGPTGDNTHVSTR-------------IVGTRGYAAPEYVA-TGHLTPKSDVY 216
R G + + VGT Y APE ++ GH D +
Sbjct: 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWW 216
Query: 217 SFGVVLLELLSGR 229
+ G++L E+L G
Sbjct: 217 TLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 18/192 (9%)
Query: 47 FAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105
F TKPG V +K G K L E + L + H +++++ +V
Sbjct: 83 FVATKPGQPDPVVLK-------IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135
Query: 106 YEFMP--KGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163
+P L +L + +P+ + I + GL +LH +I+RD+K N+ +
Sbjct: 136 ---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ--RIIHRDVKTENIFI 190
Query: 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL 223
+ + D G A+ P + + GT APE +A K+D++S G+VL
Sbjct: 191 NDVDQVCIGDLGAAQ-FPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247
Query: 224 ELLSGRRALDED 235
E+L+ + ED
Sbjct: 248 EMLAYPSTIFED 259
|
Length = 357 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 37/91 (40%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
VA+G+SFL N I+RDL A N+LL K+ DFGLARD N V
Sbjct: 223 VAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
+ APE + T +SDV+S+G++L E+ S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 52/283 (18%)
Query: 29 LGEGGFGCVFKG----WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL 84
LG+G F +FKG D T+ ++ R +ESF + QL
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESF------FEAASMMSQL 56
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR--SVQPISWPTRVKIAIDVARGLS 142
H++LV G C D ++V E++ GSL+ +L + ++ ISW ++++A +A L
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALH 114
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNA--------KLSDFGLARDGPTGDNTHVSTRIVG 194
FL D + + ++ A NVLL + KLSD G++ T + I+
Sbjct: 115 FLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI-------TVLPKEILL 165
Query: 195 TR-GYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
R + PE + +L+ +D +SFG L E+ SG ++ L
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----------GDKPLS------A 208
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
DS++ L+ + R Q + +A ++ QC+ +P RPS
Sbjct: 209 LDSQKKLQFYEDRH--QLPAPKWTELANLINQCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FG V I +T V +K LKA S + E+L + L+H
Sbjct: 3 IGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHP 55
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL------FRSVQPISWPTRVKIAIDVARGL 141
N+++ +G C E+ LLV+E+ G L+++L R+ Q + ++A ++A G+
Sbjct: 56 NILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGV 112
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
+ +H N ++ DL N L S+ K+ D+G+ D + AP
Sbjct: 113 THMHKH--NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 202 EYVATGH-------LTPKSDVYSFGVVLLELL 226
E V H T S+V++ GV L EL
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE----SFQGHKEWLTEVIYLGQL 84
LG+G +G V+K +P +G+ +A+K ++ E F + E+ L +
Sbjct: 9 LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLELDESKFNQ---IIMELDILHKA 56
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRV--KIAIDVARGLS 142
+V G + E+M GSL+ V P V +I V +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD-NTHVSTRIVGTRGYAAP 201
FL + N+I+RD+K +NVL++ N KL DFG+ +G+ ++ +G + Y AP
Sbjct: 117 FLKE-EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNIGCQSYMAP 170
Query: 202 EYVATGHL------TPKSDVYSFGVVLLELLSGR 229
E + +G T +SDV+S G+ +LE+ GR
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 71/293 (24%), Positives = 124/293 (42%), Gaps = 36/293 (12%)
Query: 22 NFCSDYLLGEGGFGCVFKG--WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI 79
NF + +G G F V++ +D+ A K V + + A++ Q + + E+
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKK-----VQIFEMMDAKARQ---DCVKEID 54
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRSVQPISWPTRVKIAID 136
L QL H N++K + E + +V E G L + + + I T K +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
+ + +H V++RD+K +NV + + KL D GL R + T + +VGT
Sbjct: 115 LCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTP 170
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE--QTLVEWADPFLRD 254
Y +PE + KSD++S G +L E+ + + D+ L Q + + P L
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLP- 229
Query: 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
YS+K + V+ C++ DP RP + V +Q+H
Sbjct: 230 ------------TEHYSEKLRELVS----MCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 24/176 (13%)
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
+ VA+G+ FL I+RDL A N+LL N K+ DFGLARD D +V R
Sbjct: 185 SFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYV--RKG 239
Query: 194 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250
R + APE + T +SDV+SFGV+L E+ S G + V+ +
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGVKIDEE 290
Query: 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
F R + R+ Y+ E + +L C H +P RP+ +++ L L
Sbjct: 291 FCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 19/216 (8%)
Query: 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW- 74
+K+ ++F LG G FG V F P VAIKR + K+
Sbjct: 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPP--------VAIKRFEKSKIIKQKQVD 76
Query: 75 --LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK 132
+E L + H V L G + LV EF+ G L R+ + +P V
Sbjct: 77 HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR---FPNDVG 133
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
L F + N++YRDLK N+LLD + K++DFG A+ T T +
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----L 188
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
GT Y APE + +D ++ G+ + E+L G
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 49/161 (30%), Positives = 72/161 (44%), Gaps = 12/161 (7%)
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI 135
E+ L + H ++ LI + V MPK + LF V S P ++ AI
Sbjct: 135 REIDILKTISHRAIINLIHAYR---WKSTVCMVMPKYKCD--LFTYVD-RSGPLPLEQAI 188
Query: 136 DVARGL----SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
+ R L ++LHG +I+RD+K N+ LD NA L DFG A +T
Sbjct: 189 TIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 232
GT +PE +A K+D++S G+VL E+ L
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 51/285 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEVIYLGQLRH 86
++GEG FG + + Q+ + K A+K ++ +S ++ E + L +++H
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQK------YAMKEIRLPKSSSAVEDSRKEAVLLAKMKH 57
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSL-------ENHLFRSVQPISWPTRVKIAIDVA 138
N+V E+D L +V E+ G L LF + W ++ + +
Sbjct: 58 PNIVAF-KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ-- 114
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTR 196
H + V++RD+K+ N+ L N KL DFG AR P + VGT
Sbjct: 115 ------HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----YACTYVGTP 164
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256
Y PE KSD++S G +L EL + + + W + L
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN----------SWKNLIL---- 210
Query: 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301
+V + L YS + + +++ Q +P++RPS +L+
Sbjct: 211 KVCQGSYKPLPSHYSYE----LRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + V+KG + +VA+K ++ E +G + EV L L+H
Sbjct: 14 LGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+V L + LV+E++ K L+ +L I+ + RGL++ H
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH-- 121
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-YVAT 206
V++RDLK N+L++ KL+DFGLAR T+ S +V T Y P+ + +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWYRPPDILLGS 179
Query: 207 GHLTPKSDVYSFGVVLLELLSGR 229
+ + D++ G + E+ +GR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 26/174 (14%)
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS--TRIVG 194
VARG+ FL N ++RDL A NVLL K+ DFGLARD D+ +VS + +
Sbjct: 246 VARGMEFL--ASKNCVHRDLAARNVLLAQGKIVKICDFGLARD-IMHDSNYVSKGSTFLP 302
Query: 195 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254
+ + APE + T SDV+S+G++L E+ S GG ++ D
Sbjct: 303 VK-WMAPESIFDNLYTTLSDVWSYGILLWEIFS--------LGGTPYPGMIV-------D 346
Query: 255 SRRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
S +I + G + +K + Q V ++++C + +P+ RPS + + +E L
Sbjct: 347 STFYNKI---KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 55/190 (28%), Positives = 86/190 (45%), Gaps = 37/190 (19%)
Query: 58 VAIKRLKA--ESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLE 115
VA+K+L +S + E+ L ++HEN++ L+ F P S+E
Sbjct: 43 VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV------------FTPATSIE 90
Query: 116 N----HLFRSVQPISWPTRVK-----------IAIDVARGLSFLHGLDANVIYRDLKASN 160
N +L ++ VK + + RGL ++H A +I+RDLK SN
Sbjct: 91 NFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSN 148
Query: 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFG 219
V ++ + ++ DFGLAR D T V TR Y APE + H D++S G
Sbjct: 149 VAVNEDCELRILDFGLARQ--ADDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 203
Query: 220 VVLLELLSGR 229
++ ELL G+
Sbjct: 204 CIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT--EVIYLGQLR- 85
+G G +G V+K P SG VA+K ++ ++ + T EV L +L
Sbjct: 8 IGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA 58
Query: 86 --HENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRSVQP-ISWPTRVKIAIDV 137
H N+V+L+ C S +D LV+E + + L +L + P + T +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF 117
Query: 138 ARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRIVGT 195
RGL FLH AN +++RDLK N+L+ S KL+DFGLAR + ++ T +V T
Sbjct: 118 LRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVT 170
Query: 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELL 226
Y APE + D++S G + E+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 46/141 (32%), Positives = 69/141 (48%), Gaps = 13/141 (9%)
Query: 95 YCSESDNRLL--VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVI 152
+ + D++ L V E+MP G L N + P W R A +V L +H + I
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW-ARFYTA-EVVLALDAIHSM--GFI 164
Query: 153 YRDLKASNVLLDSNFNAKLSDFGLA-RDGPTGDNTHVSTRIVGTRGYAAPEYVAT----G 207
+RD+K N+LLD + + KL+DFG + G T VGT Y +PE + + G
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDT-AVGTPDYISPEVLKSQGGDG 222
Query: 208 HLTPKSDVYSFGVVLLELLSG 228
+ + D +S GV L E+L G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 11/140 (7%)
Query: 95 YCSESDNRLL--VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVI 152
+C+ D++ L V E+MP G L N + P W +V L +H + +I
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFY--TAEVVLALDAIHSM--GLI 164
Query: 153 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----GH 208
+RD+K N+LLD + + KL+DFG T VGT Y +PE + + G+
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDGY 223
Query: 209 LTPKSDVYSFGVVLLELLSG 228
+ D +S GV L E+L G
Sbjct: 224 YGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 41/200 (20%)
Query: 58 VAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL 114
VAIK+L + FQ K E++ + + H+N++ L+ F P+ SL
Sbjct: 45 VAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKSL 91
Query: 115 EN----HLFRSVQPISWPTRVKIAIDVAR----------GLSFLHGLDANVIYRDLKASN 160
E +L + + +++ +D R G+ LH A +I+RDLK SN
Sbjct: 92 EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSN 149
Query: 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGV 220
+++ S+ K+ DFGLAR T + + T V TR Y APE + D++S G
Sbjct: 150 IVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 206
Query: 221 VLLE------LLSGRRALDE 234
++ E L GR +D+
Sbjct: 207 IMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 35/189 (18%)
Query: 58 VAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL 114
VAIK+L + FQ K E++ + + H+N++ L+ F P+ SL
Sbjct: 52 VAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKSL 98
Query: 115 EN----HLFRSVQPISWPTRVKIAIDVAR----------GLSFLHGLDANVIYRDLKASN 160
E ++ + + +++ +D R G+ LH A +I+RDLK SN
Sbjct: 99 EEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSN 156
Query: 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGV 220
+++ S+ K+ DFGLAR T + + T V TR Y APE + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 213
Query: 221 VLLELLSGR 229
++ E++ G
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 48/175 (27%), Positives = 71/175 (40%), Gaps = 35/175 (20%)
Query: 73 EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPIS------ 126
W+ ++ Y Q + DN LV E+ P G L + L R
Sbjct: 61 PWIPQLQYAFQ--------------DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQF 106
Query: 127 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 186
+ + +AI + ++H RD+K NVL+D + KL+DFG A T +
Sbjct: 107 YLAELVLAIHSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSAA-RLTANKM 157
Query: 187 HVSTRIVGTRGYAAPEYVATGHLTPKS------DVYSFGVVLLELLSGRRALDED 235
S VGT Y APE + T + K D +S GV+ E++ GR E
Sbjct: 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 18 IATKNFCSDYLL----GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE 73
I +N DY L G G +G V+K +G + A+K +K E
Sbjct: 2 ILRRNPQHDYELIQRVGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSL 52
Query: 74 WLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKI 133
E+ + + +H N+V G + + E+ GSL++ ++ P+S +
Sbjct: 53 IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYV 111
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
+ +GL++LH ++RD+K +N+LL N + KL+DFG+A +
Sbjct: 112 CRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFI 167
Query: 194 GTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLEL 225
GT + APE A G D+++ G+ +EL
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 26/227 (11%)
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLE---NHLFRSVQPISWPTRVKI 133
E L +L H +VK E D ++ E+ L+ L + + +S +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
I + G+ ++H +++RDLKA N+ L +N K+ DFG++R + ++T
Sbjct: 112 FIQLLLGVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLATTFT 166
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT Y +PE + KSD++S G +L E+ A + +VE P L
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP 226
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
++ YS++ + +++ L+ DP RPS ++L
Sbjct: 227 ET--------------YSRQ----LNSIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 42/127 (33%), Positives = 65/127 (51%), Gaps = 8/127 (6%)
Query: 104 LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163
LV ++M G L HL + + + IA ++ L LH +++YRDLK N+LL
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH--KYDIVYRDLKPENILL 129
Query: 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVV 221
D+ + L DFGL++ T + T + GT Y APE + G+ T D +S GV+
Sbjct: 130 DATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGY-TKHVDFWSLGVL 186
Query: 222 LLELLSG 228
+ E+ G
Sbjct: 187 VFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
G+ LH A +I+RDLK SN+++ S+ K+ DFGLAR T + + T V TR Y
Sbjct: 130 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGR 229
APE + D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 46/143 (32%), Positives = 69/143 (48%), Gaps = 27/143 (18%)
Query: 100 DNRLL--VYEFMPKGSLENHLFRSVQPISWP----TRVKIAIDVARGLSFLHGLDANVIY 153
D+R L V E+MP G L N + P W V +A+D + F+H
Sbjct: 114 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH-------- 165
Query: 154 RDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--- 206
RD+K N+LLD + + KL+DFG + ++G +T VGT Y +PE + +
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPEVLKSQGG 220
Query: 207 -GHLTPKSDVYSFGVVLLELLSG 228
G+ + D +S GV L E+L G
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 2e-09
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + V+KG N G +VA+K ++ + +G + E L L+H
Sbjct: 13 LGEGSYATVYKGKSKVN---------GKLVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-DVARGLSFLHG 146
N+V L + LV+E++ L ++ + + P VK+ + + RGLS++H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLH-PENVKLFLFQLLRGLSYIH- 120
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-YVA 205
+++RDLK N+L+ KL+DFGLAR +T+ S +V T Y P+ +
Sbjct: 121 -QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-SNEVV-TLWYRPPDVLLG 177
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRAL 232
+ + D++ G + +E++ G A
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 29 LGEGGFG----CVFKGWIDQ-------NTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE 77
L G FG C + ++ N+ KP ++A KR+KA S + + E
Sbjct: 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIA-KRVKAGS-RAAIQLENE 213
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLV--------YEFMPKGSLENHLFRSVQPISWPT 129
++ LG+L HEN++K+ N ++ Y FM + + +P+ T
Sbjct: 214 ILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDRPLLKQT 269
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 189
R I + + ++H D +I+RD+K N+ L+ + L DFG A + +
Sbjct: 270 R-AIMKQLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTAM---PFEKEREA 323
Query: 190 TRI--VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
VGT +PE +A +D++S G++LL++LS
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 79/297 (26%), Positives = 132/297 (44%), Gaps = 48/297 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + V+KG N G +VA+K + ++ +G + E L L+H
Sbjct: 13 LGEGSYATVYKGISRIN---------GQLVALKVISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-DVARGLSFLHG 146
N+V L + V+E+M L ++ + + P V++ + + RGL+++HG
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLH-PYNVRLFMFQLLRGLAYIHG 121
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV-- 204
++++RDLK N+L+ KL+DFGLAR T+ S V T Y P+ +
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE--VVTLWYRPPDVLLG 177
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA---------------- 248
AT + + D++ G + +E+L G+ A + EQ W
Sbjct: 178 ATDYSS-ALDIWGAGCIFIEMLQGQPAF-PGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235
Query: 249 -----DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ FL + LR++ RL +A+ +A+ Q L M PK+R S D L
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPP---KAEDLAS---QMLMMFPKDRISAQDAL 286
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 59/207 (28%), Positives = 101/207 (48%), Gaps = 24/207 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRHE 87
LGEG + V+KG G +VA+K ++ E +G + E L L+H
Sbjct: 13 LGEGSYATVYKGRSKLT---------GQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63
Query: 88 NLVKL--IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-DVARGLSFL 144
N+V L I + ++ LV+E++ L+ ++ +S V++ + + RGL++
Sbjct: 64 NIVTLHDIIHTKKTLT--LVFEYLDT-DLKQYMDDCGGGLS-MHNVRLFLFQLLRGLAYC 119
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H V++RDLK N+L+ KL+DFGLAR T+ S +V T Y P+ +
Sbjct: 120 H--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWYRPPDVL 175
Query: 205 --ATGHLTPKSDVYSFGVVLLELLSGR 229
+T + T D++ G + E+ +GR
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 60/247 (24%), Positives = 103/247 (41%), Gaps = 38/247 (15%)
Query: 63 LKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSL------- 114
L+ S + K E L QL+H N+V D L +V F G L
Sbjct: 35 LRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ 94
Query: 115 ENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174
+ L Q + W + +A L +LH + ++++RDLK NV L K+ D
Sbjct: 95 KGKLLPENQVVEW------FVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDL 146
Query: 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD- 233
G+AR + +++ ++GT Y +PE + KSDV++ G + E+ + + A +
Sbjct: 147 GIAR--VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204
Query: 234 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 293
+D L V RI++ +L K + + ++ L P+ R
Sbjct: 205 KDMNSL------------------VYRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKR 245
Query: 294 PSMVDVL 300
PS+ +L
Sbjct: 246 PSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 69/276 (25%), Positives = 110/276 (39%), Gaps = 33/276 (11%)
Query: 54 SGIVVAIKR--LKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMP 110
+ +VA+K+ L + S + K E+I QL+H N++ D+ L +V M
Sbjct: 24 TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVTSFIVDSELYVVSPLMA 82
Query: 111 KGSLENHLFRSVQPISWPTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167
GS E+ L ++ P P IA DV L ++H I+R +KAS++LL +
Sbjct: 83 YGSCED-LLKTHFPEGLPELA-IAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDG 138
Query: 168 NAKLSDFGLARD----GPTGDNTHVSTR-IVGTRGYAAPEYVATGHL--TPKSDVYSFGV 220
LS + G H + V + +PE + KSD+YS G+
Sbjct: 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198
Query: 221 VLLELLSG---------RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ-- 269
EL +G + L E G L + P DS R + +
Sbjct: 199 TACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDS 258
Query: 270 ----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301
Y++ ++ V CL DP++RPS +L
Sbjct: 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 76/231 (32%)
Query: 54 SGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-------------LVKLIGYCSESD 100
+G + A+K+L+ +E++ Q+ H +VKL Y S D
Sbjct: 25 TGHIYAMKKLRK----------SEMLEKEQVAHVRAERDILAEADNPWVVKL--YYSFQD 72
Query: 101 NR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158
L+ E++P G + L + TR IA + + +H L I+RD+K
Sbjct: 73 ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHKL--GYIHRDIKP 129
Query: 159 SNVLLDSNFNAKLSDFGLARDGPTG-DNTHVST--RI----------------------- 192
N+LLD+ + KLSDFGL TG +H + RI
Sbjct: 130 DNLLLDAKGHIKLSDFGLC----TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKA 185
Query: 193 --------------VGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSG 228
VGT Y APE ++ TG+ + D +S GV++ E+L G
Sbjct: 186 ETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 43/178 (24%), Positives = 72/178 (40%), Gaps = 20/178 (11%)
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-----FRSVQPISWPTRVKIAIDVARGLS 142
N+V L Y D+ LV + G L +H+ W + +A+D
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAP 201
LH ++ RDL +N+LLD + +L+ F + + D V Y AP
Sbjct: 101 -LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE------NMYCAP 151
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259
E T D +S G +L ELL+G+ ++ G+ T + + ++R +L
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLL 209
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 32/216 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG +G V+K D+NT G +VA+K RL+ + L E+ L L
Sbjct: 9 IGEGTYGKVYKA-RDKNT--------GKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 87 EN-LVKLIGYCSESDNR-----LLVYEFMP---KGSLENHLFRSVQPISWPTRVKIAIDV 137
+V+L+ + LV+E++ K ++++ +P+ T +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDG--PTGDNTHVSTRIVG 194
+G++ H V++RDLK N+L+D K++D GL R P TH IV
Sbjct: 120 LKGVAHCHKH--GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIV- 173
Query: 195 TRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSG 228
T Y APE + +T + TP D++S G + E+
Sbjct: 174 TLWYRAPEVLLGSTHYSTP-VDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 22/184 (11%)
Query: 58 VAIKRLKAESFQGHKEWL----TEVIYLGQLRHENLVKLIGYCSESDNRL----LVYEFM 109
V I+ K +GHK + E+ L ++ N++K+ G+ + + L L+ E+
Sbjct: 46 VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104
Query: 110 PKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169
+G L L + +S+ T++ +AID +GL L+ N Y++L + + L+ N+
Sbjct: 105 TRGYLREVL-DKEKDLSFKTKLDMAIDCCKGLYNLYKYT-NKPYKNLTSVSFLVTENYKL 162
Query: 170 KLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLEL 225
K+ GL + P N V Y + + + T K D+YS GVVL E+
Sbjct: 163 KIICHGLEKILSSPPFKN-------VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEI 215
Query: 226 LSGR 229
+G+
Sbjct: 216 FTGK 219
|
Length = 283 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 63/245 (25%), Positives = 99/245 (40%), Gaps = 47/245 (19%)
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL--------ENHL-FRSVQPIS 126
+E+ L H +VK D LL+ E+ G L + HL F+ +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 127 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 186
++ +A+D +H RDLK++N+ L KL DFG ++ +
Sbjct: 174 LFYQIVLALDEVHSRKMMH--------RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 187 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246
V++ GT Y APE + K+D++S GV+L ELL+ R
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR---------------- 269
Query: 247 WADPFLRDSRRVLRIMDTRLGGQYSK---KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
PF S+R IM L G+Y + + A++ L +P RP T+
Sbjct: 270 ---PFKGPSQR--EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRP------TTQ 318
Query: 304 EQLHT 308
+ LHT
Sbjct: 319 QLLHT 323
|
Length = 478 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 4e-08
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 35/218 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RH 86
L+G G +G V+KG +G + AIK + + +E E+ L + H
Sbjct: 13 LVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHH 62
Query: 87 ENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRSVQPISWPTR--VKIAIDVA 138
N+ G + D LV EF GS+ + L ++ + + I ++
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREIL 121
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTR 196
RGLS LH VI+RD+K NVLL N KL DFG++ D G +GT
Sbjct: 122 RGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR----NTFIGTP 175
Query: 197 GYAAPEYVATGHLTP------KSDVYSFGVVLLELLSG 228
+ APE +A P KSD++S G+ +E+ G
Sbjct: 176 YWMAPEVIACDE-NPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (130), Expect = 5e-08
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 37/200 (18%)
Query: 64 KAESFQGHKE-----WLTEVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLEN 116
KA S++G KE + EV + +L+H+N+V+ I + ++++ +L ++ EF G L
Sbjct: 44 KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103
Query: 117 HL---FRSVQPISWPTRVKIAIDVARGLSFLHGLD-----ANVIYRDLKASNVLLDS--- 165
++ ++ I V I + L++ H L V++RDLK N+ L +
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163
Query: 166 ----------NFN----AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV--ATGHL 209
N N AK+ DFGL+++ H VGT Y +PE + T
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSY 220
Query: 210 TPKSDVYSFGVVLLELLSGR 229
KSD+++ G ++ EL SG+
Sbjct: 221 DDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 37/103 (35%), Positives = 50/103 (48%), Gaps = 18/103 (17%)
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG--LARDGPTGDNTHVST 190
+AID L ++H RD+K NVLLD N + +L+DFG L D T S
Sbjct: 113 LAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLL---ADGTVQSN 161
Query: 191 RIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSG 228
VGT Y +PE + G P+ D +S GV + E+L G
Sbjct: 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 38/118 (32%), Positives = 56/118 (47%), Gaps = 2/118 (1%)
Query: 110 PKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169
P+ + + L +S+ V + VA G+ FL N ++RDL A NVL+
Sbjct: 221 PERTRRDTLINESPALSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLV 278
Query: 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227
K+ DFGLARD N + APE + T SDV+SFG++L E+ +
Sbjct: 279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 36/171 (21%)
Query: 70 GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEF---MPKGSLENHLFRSVQPIS 126
G +W+T + Y Q NL ++ Y D L+ +F +P+ +L V
Sbjct: 58 GDNQWITTLHYAFQ-DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV---- 112
Query: 127 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG----LARDGPT 182
IAID L ++H RD+K N+L+D N + +L+DFG L DG
Sbjct: 113 ------IAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-- 156
Query: 183 GDNTHVSTRIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSG 228
T S+ VGT Y +PE + G P+ D +S GV + E+L G
Sbjct: 157 ---TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 38/105 (36%), Positives = 54/105 (51%), Gaps = 17/105 (16%)
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTG-DNTHVS 189
I ++ RGL+ LH VI+RD+K NVLL N KL DFG++ D G NT
Sbjct: 126 ICREILRGLAHLHA--HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--- 180
Query: 190 TRIVGTRGYAAPEYVATGHLTP------KSDVYSFGVVLLELLSG 228
+GT + APE +A P +SD++S G+ +E+ G
Sbjct: 181 --FIGTPYWMAPEVIACDE-NPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 7/163 (4%)
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQ-PISWPTRVKIA 134
TE L + H ++++L G + + L+ +P+ + + + + + I+ + I
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 194
V R + +LH + +I+RD+KA N+ ++ + L DFG A P N + G
Sbjct: 189 RSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAAC-FPVDINANKYYGWAG 245
Query: 195 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 237
T APE +A P D++S G+VL E+ + +L E G
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288
|
Length = 391 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 48/161 (29%), Positives = 69/161 (42%), Gaps = 27/161 (16%)
Query: 86 HENLVKLIGYCSESDNRL-----LVYEFMPKGS---LENHLFRSVQPISWPTRVKIAIDV 137
H N+VK G ++D + LV E GS L L Q + I
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI----- 192
GL LH + +I+RD+K +N+LL + KL DFG++ STR+
Sbjct: 138 LLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNTS 188
Query: 193 VGTRGYAAPEYVATGH-----LTPKSDVYSFGVVLLELLSG 228
VGT + APE +A + DV+S G+ +EL G
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 14/86 (16%)
Query: 152 IYRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHVSTRIVGTRGYAAPEYV--- 204
++RD+K NVLLD N + +L+DFG + +DG T S+ VGT Y +PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPEILQAM 178
Query: 205 --ATGHLTPKSDVYSFGVVLLELLSG 228
G P+ D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 49/179 (27%), Positives = 71/179 (39%), Gaps = 48/179 (26%)
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKI-----AIDVARGLSF 143
+VK+ + N L+ EF+P G + L + T+ I AID L F
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA---------------RDGPTGD---- 184
+H RD+K N+LLD+ + KLSDFGL P D
Sbjct: 123 IH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 185 --------------NTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSG 228
++ VGT Y APE ++ TG+ D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 66/256 (25%), Positives = 95/256 (37%), Gaps = 72/256 (28%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIY 80
++F S ++G G FG V K +G V A+K L+ K + E
Sbjct: 1 EDFESLKVIGRGAFGEVR---------LVQKKDTGHVYAMKILR-------KADMLEKEQ 44
Query: 81 LGQLRHEN----------LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTR 130
+G +R E +VK+ + N L+ EF+P G + L + T+
Sbjct: 45 VGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQ 104
Query: 131 VKIA-----IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA-------- 177
IA ID L F+H RD+K N+LLDS + KLSDFGL
Sbjct: 105 FYIAETVLAIDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156
Query: 178 -----------------------RDGPT--GDNTHVSTRIVGTRGYAAPEYVATGHLTPK 212
R T + ++ VGT Y APE
Sbjct: 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL 216
Query: 213 SDVYSFGVVLLELLSG 228
D +S GV++ E+L G
Sbjct: 217 CDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
Q+ H+++V L G C ++V EF+ G L+ + R ++ P + K+A +A LS
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 143 FLHGLDANVIYRDLKASNVLL-----DSNFNA--KLSDFGLARDGPTGDNTHVSTR--IV 193
+L D ++++ ++ N+LL D KLSD G+ V +R V
Sbjct: 120 YLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169
Query: 194 GTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
+ APE V + +L+ +D +SFG L E+ +D+ LAE+
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE--------- 219
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 294
R + + + +A ++ C++ DP RP
Sbjct: 220 -------RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 4/118 (3%)
Query: 109 MPK--GSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 166
+PK L +L ++P+ +A + + ++HG +I+RD+K NVL++
Sbjct: 239 LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGP 296
Query: 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE 224
+ L DFG A +T I GT APE +A TP D++S G+V+ E
Sbjct: 297 EDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 59/241 (24%), Positives = 110/241 (45%), Gaps = 38/241 (15%)
Query: 13 SMISKIATKNFCSDYLLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH 71
+ I++ K++ ++G G FG V++ ID + VAIK++ Q
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSE----------KVAIKKV----LQDP 103
Query: 72 KEWLTEVIYLGQLRHENLVKLIGY----CSESDNRLL----VYEFMPKG--SLENHLFRS 121
+ E++ + L H N++ L Y C + + + + V EF+P+ H R+
Sbjct: 104 QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163
Query: 122 VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDG 180
+ + + R L+++H + +RDLK N+L+D N + KL DFG A++
Sbjct: 164 NHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221
Query: 181 PTGDNTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLE------LLSGRRALD 233
G S + +R Y APE + + T D++S G ++ E + SG+ ++D
Sbjct: 222 LAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
Query: 234 E 234
+
Sbjct: 279 Q 279
|
Length = 440 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 41/234 (17%)
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQ--PISWPTRVKIAIDVA 138
+ Q+ H +L + G C ++V EF+ G L+ L + P++W ++ +A +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127
Query: 139 RGLSFLHGLDANVIYRDLKASNVLL--------DSNFNAKLSDFGLARDGPTGDNTHVST 190
LS+L D N+++ ++ A N+LL S F KLSD G++ + +
Sbjct: 128 SALSYLE--DKNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVSFTALSREER---- 180
Query: 191 RIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249
V + APE V G L+ +D +SFG LLE+ D + L E+T E +
Sbjct: 181 --VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDGE-VPLKERTPSE-KE 231
Query: 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
F R+ + + +A ++ QCL +P RPS +L L
Sbjct: 232 RFYEKKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 73/287 (25%), Positives = 112/287 (39%), Gaps = 80/287 (27%)
Query: 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQ-- 69
SM KI T +G G FG V + + K + + A+K L KA+
Sbjct: 1 SMFVKIKT--------IGIGAFGEV---CLVR------KVDTNALYAMKTLRKADVLMRN 43
Query: 70 --GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPIS 126
H + E L + +E +VKL + DN V +++P G + + L R +
Sbjct: 44 QAAHVK--AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEED 101
Query: 127 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN- 185
R IA ++ + +H + I+RD+K N+L+D + + KL+DFGL TG
Sbjct: 102 L-ARFYIA-ELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLC----TGFRW 153
Query: 186 THVS---------------------------------------TRI-----VGTRGYAAP 201
TH S R VGT Y AP
Sbjct: 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213
Query: 202 EYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247
E + TG+ T D +S GV+L E+L G+ D + ++ W
Sbjct: 214 EVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 45/162 (27%), Positives = 66/162 (40%), Gaps = 17/162 (10%)
Query: 86 HENLVKLIGYCSESDNR-----LLVYEFMPKGS---LENHLFRSVQPISWPTRVKIAIDV 137
H N+VK G + D + LV E GS L + + + P I +
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
GL LH I+RD+K +N+LL + KL DFG++ VGT
Sbjct: 134 LMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPF 189
Query: 198 YAAPEYVATGH-----LTPKSDVYSFGVVLLELLSGRRALDE 234
+ APE +A + DV+S G+ +EL G L +
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 12/109 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEV---IYLGQL 84
LG G FG V I + F K S VA+K LK + +K +TE+ I++G
Sbjct: 15 LGRGAFGKV----IQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH- 69
Query: 85 RHENLVKLIGYCSESDNRLLV-YEFMPKGSLENHLFRSVQPISWPTRVK 132
H N+V L+G C++ L+V E+ G+L N+L RS + P R K
Sbjct: 70 -HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL-RSKRECFSPYRNK 116
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 15/101 (14%)
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-------STR-- 191
L +LH + +++RDLK N+L+ S + KL+DFGL++ G T++ TR
Sbjct: 114 LEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 192 ----IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
+ GT Y APE + D ++ G++L E L G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 46/199 (23%), Positives = 77/199 (38%), Gaps = 58/199 (29%)
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPIS----WPTRVKIAI 135
L + +E +V+L + DN V +++P G + + L R + P + + A+
Sbjct: 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAV 114
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL--------------ARDGP 181
+ + F+H RD+K N+L+D + + KL+DFGL + D
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 182 TGDNTHVSTR-------------------------------IVGTRGYAAPEYVATGHLT 210
D+ S +VGT Y APE + T
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 211 PKSDVYSFGVVLLELLSGR 229
D +S GV+L E+L G+
Sbjct: 227 QLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 30/104 (28%), Positives = 45/104 (43%), Gaps = 10/104 (9%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE--- 77
LG G FG V ++ + K + + VA+K LK + +E L
Sbjct: 35 NRLSFGKTLGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK 90
Query: 78 -VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR 120
+ YLG H N+V L+G C+ L++ E+ G L N L R
Sbjct: 91 VLSYLGN--HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRR 132
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 26/80 (32%), Positives = 44/80 (55%), Gaps = 7/80 (8%)
Query: 101 NRLLVYEFMPKGSLEN--HLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158
N LV E++ G +++ H++ VK +VA L +LH +I+RDLK
Sbjct: 78 NVYLVMEYLIGGDVKSLLHIYGYFDE---EMAVKYISEVALALDYLH--RHGIIHRDLKP 132
Query: 159 SNVLLDSNFNAKLSDFGLAR 178
N+L+ + + KL+DFGL++
Sbjct: 133 DNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 42/175 (24%), Positives = 59/175 (33%), Gaps = 58/175 (33%)
Query: 104 LVYEFMPKGSLENHLFRSVQPISWPTRVKIA-----IDVARGLSFLHGLDANVIYRDLKA 158
L+ EF+P G L L + TR +A I+ L F+H RD+K
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIH--------RDIKP 129
Query: 159 SNVLLDSNFNAKLSDFGL---------------------ARDGPTGDNTHVSTRI----- 192
N+L+D + KLSDFGL ++ N+ I
Sbjct: 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189
Query: 193 -------------------VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
VGT Y APE + D +S G ++ E L G
Sbjct: 190 SKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 63/260 (24%), Positives = 115/260 (44%), Gaps = 53/260 (20%)
Query: 29 LGEGGFGCVFKG----WIDQNTFAPTK-PGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ 83
+G G +G V+K D+ +A + G+GI ++ R E+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 84 LRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRSVQ----------PISWPTRV 131
L+H N++ L + S SD ++ L++++ E+ L+ ++ P+ P R
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPMQLP-RS 108
Query: 132 KIAIDVARGLSFLHGLDAN-VIYRDLKASNVLL----DSNFNAKLSDFGLAR--DGPTGD 184
+ + + L +H L AN V++RDLK +N+L+ K++D G AR + P
Sbjct: 109 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 168
Query: 185 NTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 243
+ +V T Y APE + H T D+++ G + ELL+ Q
Sbjct: 169 LADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH------CRQE 221
Query: 244 LVEWADPFLRDS-RRVLRIM 262
++ ++PF D R+ +M
Sbjct: 222 DIKTSNPFHHDQLDRIFSVM 241
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 44/223 (19%)
Query: 29 LGEGGFGCVFK-----GWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ 83
+G G +G V+K G D++ G+GI ++ R E+ L +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR--------------EIALLRE 54
Query: 84 LRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARG- 140
L+H N++ L + S +D ++ L++++ E+ L+ ++ K + + RG
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYA-----EHDLWHIIKFHRASKANKKPVQLPRGM 109
Query: 141 --------LSFLHGLDAN-VIYRDLKASNVLL----DSNFNAKLSDFGLAR--DGPTGDN 185
L +H L AN V++RDLK +N+L+ K++D G AR + P
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 186 THVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLS 227
+ +V T Y APE + H T D+++ G + ELL+
Sbjct: 170 ADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
+ N +KL + +L+ +++ G L + L + +S KI + L+ LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD-LLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 146 GLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIV--GTRGYAAPE 202
N+I+ D+K NVL D + L D+GL + + T GT Y +PE
Sbjct: 127 K--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYFSPE 176
Query: 203 YVATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRG 237
+ GH S D ++ GV+ ELL+G+ ED
Sbjct: 177 KIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 8e-04
Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 13/101 (12%)
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPIS----WPTRVKIAI 135
L + +E +VKL + DN V +++P G + + L R V P + + +AI
Sbjct: 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI 114
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176
+ + F+H RD+K N+L+D + + KL+DFGL
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 15/97 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW------LTEVIYLG 82
LG G FG V I+ + F K + VA+K LK + H E L +I++G
Sbjct: 15 LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIG 68
Query: 83 QLRHENLVKLIGYCSESDNRLLV-YEFMPKGSLENHL 118
H N+V L+G C++ L+V EF G+L N+L
Sbjct: 69 H--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 73/293 (24%), Positives = 119/293 (40%), Gaps = 48/293 (16%)
Query: 50 TKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFM 109
T G+ + V I L+ + + K EV+ RH N++ + ++ FM
Sbjct: 22 TPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81
Query: 110 PKGSLENHLFRSVQP--ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167
GS N L ++ P +S I RGL++LH I+R++KAS++L+ +
Sbjct: 82 AYGS-ANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDG 138
Query: 168 NAKLSD----FGLARDGPTG----DNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVY 216
LS + L R+G D ST ++ + +PE + G+ KSD+Y
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQDLYGY-NVKSDIY 194
Query: 217 SFGVVLLELLSGRRAL-DEDRGGLAEQTL------------VEWADPFLRDSR------- 256
S G+ EL +GR D R + Q L + +++S+
Sbjct: 195 SVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI 254
Query: 257 --RVLRIMDT------RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301
V+ T RL SK + A +V CL DP+ RPS +L+
Sbjct: 255 GESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 349 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.38 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.37 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.23 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.83 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.76 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.59 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.5 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.23 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.09 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.93 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.69 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.63 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.62 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.5 | |
| PLN02236 | 344 | choline kinase | 97.44 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.4 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.28 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.25 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.11 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.11 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.1 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.86 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.85 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.79 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.76 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.56 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.55 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.33 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.21 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.03 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.98 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.7 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.69 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.29 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.89 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.74 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-50 Score=364.67 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=217.9
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..+|...+.||+|+|+.||.+ .+..+|+.||+|++..... ...+.+.+|+++.++++||||++++++|
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~---------~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F 87 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEA---------RDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF 87 (592)
T ss_pred cceeeeeeeeccCcceEEEEE---------EEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe
Confidence 367999999999999999999 6667899999999977433 3457788999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
++.++.|+|.|.|..++|..++. .+++++|.+++.+++||+.||.||| +.+|+|||||..|+|++++.+|||+|||+
T Consensus 88 EDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH--~~~IiHRDLKLGNlfL~~~~~VKIgDFGL 164 (592)
T KOG0575|consen 88 EDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLH--SLGIIHRDLKLGNLFLNENMNVKIGDFGL 164 (592)
T ss_pred ecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHH--hcCceecccchhheeecCcCcEEecccce
Confidence 99999999999999999999885 6689999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
|......... ..+..|||.|+|||++.....+..+||||+||+||.||.|++||....-.+....|..
T Consensus 165 At~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~---------- 232 (592)
T KOG0575|consen 165 ATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL---------- 232 (592)
T ss_pred eeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh----------
Confidence 9876544332 2336899999999999999999999999999999999999999976543222222221
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
-.-..|..++.+..+||.+||+.||.+|||+++++.|
T Consensus 233 ---------~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 233 ---------NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---------cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1124566889999999999999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=350.24 Aligned_cols=258 Identities=25% Similarity=0.379 Sum_probs=216.1
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-------chHHHHHHHHHHhccCCCcc
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-------GHKEWLTEVIYLGQLRHENL 89 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i 89 (349)
+...+.|.+.+.||+|+||.|-+| .+..+|+.||||+++..... ......+|+++|++++||||
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla---------~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~I 238 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLA---------YEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNI 238 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEE---------EEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCE
Confidence 346788999999999999999999 77888999999999764322 12335799999999999999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC---
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--- 166 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~--- 166 (349)
++++++|+.....|+||||++||.|.+++..+ +.+.+.....+++|++.|+.||| ++||+||||||+|||++.+
T Consensus 239 V~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH--~~GI~HRDiKPeNILl~~~~e~ 315 (475)
T KOG0615|consen 239 VRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLH--SQGIIHRDIKPENILLSNDAED 315 (475)
T ss_pred EEEeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHH--HcCcccccCCcceEEeccCCcc
Confidence 99999999999999999999999999999665 77899999999999999999999 9999999999999999776
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCC---CccceehhhHHHHHHHhCCccCccccCcc-hhh
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLSGRRALDEDRGGL-AEQ 242 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~DiwslG~ll~~lltg~~pf~~~~~~~-~~~ 242 (349)
..+||.|||++.... ........+|||.|.|||++.++... .++|+|||||++|-+++|.+||.+...+. ...
T Consensus 316 ~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e 392 (475)
T KOG0615|consen 316 CLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE 392 (475)
T ss_pred eEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH
Confidence 669999999998644 33445567899999999999877543 47799999999999999999998877655 333
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
++....-. +.......++++..+||.+||..||++|||+.++|+|=|
T Consensus 393 QI~~G~y~---------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 393 QILKGRYA---------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred HHhcCccc---------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 33332111 112234578899999999999999999999999998644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=343.62 Aligned_cols=256 Identities=30% Similarity=0.404 Sum_probs=217.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++.+.++.||+|..|+||++ .+..++..+|+|++.... ....+++.+|+++++..+||+|+.+++.|..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv---------~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKV---------RHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred HHhhhhhhcccCCCcEEEEE---------EEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 48899999999999999999 788889999999995543 34567889999999999999999999999998
Q ss_pred Cc-eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DN-RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~-~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+. .+++|||+++|+|.+++... +.+++.....++.++++||.|||. +.+|+||||||.||||+..|.|||+|||.+.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~-~~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE-ERKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh-ccCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 84 99999999999999988544 789999999999999999999994 3899999999999999999999999999997
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
.+-.. .....+||..|+|||.+.+..|+.++||||||+.++|+.+|+.||..... .+.....-+
T Consensus 228 ~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~------------~~~~~~~Ll 291 (364)
T KOG0581|consen 228 ILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP------------PYLDIFELL 291 (364)
T ss_pred Hhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC------------CCCCHHHHH
Confidence 65443 33447899999999999999999999999999999999999999976411 112222223
Q ss_pred hhhhccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
..++... ....|.+ ++++++++|..||+.||.+|||+.++++|=.
T Consensus 292 ~~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpf 337 (364)
T KOG0581|consen 292 CAIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPF 337 (364)
T ss_pred HHHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHH
Confidence 3333322 2344554 8999999999999999999999999998643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=337.53 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=212.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceee-EE
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIG-YC 96 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~-~~ 96 (349)
-.+|+++++||.|.||.||++ .+..+|..+|.|.+..+... .......|+.+|++|+||||+++++ .|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv---------~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f 88 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKV---------QCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF 88 (375)
T ss_pred HHHHHHHHHHcCCcchheEEe---------eeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh
Confidence 458999999999999999999 77788999999999865433 4566889999999999999999998 55
Q ss_pred ecCCc-eEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCcEEEcCCCcEE
Q 018891 97 SESDN-RLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~~~-~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~--i~H~di~~~Nilv~~~~~v~ 170 (349)
.+++. ++||||++++|+|.+.+.. ..+.+++..+|.++.|++.||.++|+.-.. +.||||||.|||++.+|.||
T Consensus 89 ~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK 168 (375)
T KOG0591|consen 89 IEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK 168 (375)
T ss_pred hccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence 55555 8999999999999999864 346799999999999999999999931144 89999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|+|||+++.+.... ......+|||.|++||.+.+.+|+.+||||||||++|||+..+.||.+.+-..
T Consensus 169 LGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~----------- 235 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS----------- 235 (375)
T ss_pred eccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-----------
Confidence 99999998754433 22344799999999999999999999999999999999999999998764211
Q ss_pred hhhhhhhHhhhhccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 251 FLRDSRRVLRIMDTRLGGQYS-KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
+.+.+.......+| ..++.++..||..|+..||+.||+...+++.+.+
T Consensus 236 -------L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 236 -------LCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -------HHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111222223345 5789999999999999999999997666665555
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=331.63 Aligned_cols=268 Identities=26% Similarity=0.340 Sum_probs=218.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|+.+.++|.|++|+||+| ++..+|+.||||++.... ....+-..+|+++|++++|||++.++.+|..
T Consensus 2 ekYE~LgkvGEGSYGvV~KC---------rnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKC---------RNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR 72 (396)
T ss_pred cHHhhhhccccCcceEEEEe---------ccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence 47999999999999999999 888899999999885432 2233556899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
...+++|+||++. ++.+.+.+....++...+..+++|++.|+.|+| +++++||||||+||+|+.+|.+||||||+|+
T Consensus 73 krklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH--k~n~IHRDIKPENILit~~gvvKLCDFGFAR 149 (396)
T KOG0593|consen 73 KRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH--KNNCIHRDIKPENILITQNGVVKLCDFGFAR 149 (396)
T ss_pred cceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh--hcCeecccCChhheEEecCCcEEeccchhhH
Confidence 9999999999976 555557677788999999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
.+.. .....+.++.|..|+|||++.+ ..|...+||||+||++.||++|.+.|++.++-+....|...-.........
T Consensus 150 ~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 150 TLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred hhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 7654 3333455788999999999988 589999999999999999999999999988766655555443333322222
Q ss_pred Hhhhhcccc---------CCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRL---------GGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~---------~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+...-.-+. ... -.+.++..+.++++.||+.||.+|++.++++.|
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111000000 000 114566789999999999999999999999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=332.35 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=205.9
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
-++|.+.+.||+|.|++||+| .+..++..||||.+... .....+.+..|+.+|+.++|||||.++++..
T Consensus 9 ~~~y~~~~~iG~GsfavVykg---------~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~ 79 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKG---------RHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE 79 (429)
T ss_pred cccceehhhccCcceEEEEEe---------EeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence 369999999999999999999 66677899999999776 4455677889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC------CcEEE
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN------FNAKL 171 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~------~~v~l 171 (349)
.++.+|+|||||+||+|.+|+.+. +.+++..+..++.||+.|+++|| +++|+||||||+|||++.+ ..+||
T Consensus 80 ~~~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~--~~~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 80 DDDFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLH--ENNIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred cCCeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCcceEEeccCCCCCCCceEEe
Confidence 999999999999999999999654 68999999999999999999999 9999999999999999765 45899
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+|||+++.+...... ....|+|.|||||++....|+.++|+||+|+++|++++|..||...+..+-...+...
T Consensus 157 ADFGfAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~---- 229 (429)
T KOG0595|consen 157 ADFGFARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG---- 229 (429)
T ss_pred cccchhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc----
Confidence 999999987644332 3467999999999999999999999999999999999999999866543333211110
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 300 (349)
.......+...+..+.+|+...+..+|.+|.+..+-.
T Consensus 230 ------------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 230 ------------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ------------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 0111122234455566777777777777776665544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=328.65 Aligned_cols=254 Identities=25% Similarity=0.375 Sum_probs=216.2
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
..+..++|+++++||+|+||.||.+ ++..+++.+|+|++++...- ..+....|..+|.+++||.|+++
T Consensus 20 ~~~~~~dF~~lkviGkG~fGkV~~V---------rk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l 90 (357)
T KOG0598|consen 20 EMVGPDDFEILKVIGKGSFGKVFQV---------RKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKL 90 (357)
T ss_pred ccCChhheeeeeeeeccCCceEEEE---------EEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeee
Confidence 3677899999999999999999999 56677999999999776443 34667889999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
+..|++.+.+|+|+||+.||.|.-.+.+ .+.+++..+.-++..|+.||.||| +.+|+||||||+|||++.+|+++|+
T Consensus 91 ~ysFQt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH--~~gIiyRDlKPENILLd~~GHi~Lt 167 (357)
T KOG0598|consen 91 IYSFQTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLH--SKGIIYRDLKPENILLDEQGHIKLT 167 (357)
T ss_pred EEecccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHH--hCCeeeccCCHHHeeecCCCcEEEe
Confidence 9999999999999999999999998854 478999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||++....... ......+||+.|+|||++.+.+|+.++|.||||+++|+|++|..||.+.+.......+....
T Consensus 168 DFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---- 241 (357)
T KOG0598|consen 168 DFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---- 241 (357)
T ss_pred ccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----
Confidence 999998533332 22334689999999999999999999999999999999999999998766544443333311
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP----SMVDVLT 301 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~~ll~ 301 (349)
....+..++.+.+++++++|..||++|. ++.++.+
T Consensus 242 --------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 242 --------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred --------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1223344788999999999999999996 5666554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=342.03 Aligned_cols=271 Identities=27% Similarity=0.362 Sum_probs=218.0
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccC-CCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~ 94 (349)
...-++|...+.||.|.||.||+| ....++..||||.++..... ..-.-.+|+..|++++ ||||+++.+
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la---------~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~E 76 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLA---------KSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKE 76 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEe---------eecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHH
Confidence 344579999999999999999999 77778899999999776443 2333468999999998 999999999
Q ss_pred EEecCC-ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 95 YCSESD-NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 95 ~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
++.+.+ .+|+||||++ .+|++++..++..+++..+..|+.||++||+|+| ++|+.|||+||+||||..+..+||+|
T Consensus 77 vi~d~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiH--k~GfFHRDlKPENiLi~~~~~iKiaD 153 (538)
T KOG0661|consen 77 VIRDNDRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH--KHGFFHRDLKPENILISGNDVIKIAD 153 (538)
T ss_pred HhhccCceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH--hcCcccccCChhheEecccceeEecc
Confidence 998877 9999999994 5999999888899999999999999999999999 99999999999999999888999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccc-cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh-hchh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADPF 251 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~-~~~~ 251 (349)
||+|+.... ....+.++.|..|+|||++. .+.|+.+.|+||+||+++|+.+.++.|.|.+.-+....|-+. ..|.
T Consensus 154 FGLARev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 154 FGLAREVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD 230 (538)
T ss_pred ccccccccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence 999985433 34455578899999999874 567899999999999999999999999987764443333322 2222
Q ss_pred hhhh---hhHhhhhccccCCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDS---RRVLRIMDTRLGGQ-------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~---~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ..+...+.-.+... +-+..+.++.+||.+|+.+||.+||||.+++++
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 2111 11111121111111 113377899999999999999999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=338.42 Aligned_cols=260 Identities=33% Similarity=0.495 Sum_probs=224.9
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..+.+++.+.||+|.||.||.|+|++. ..||+|.++... ...+.+.+|+.++++|+|++|+++++++..
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 345667889999999999999999864 368999887653 445778899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
++.+||||||++.|+|.+++.. ....++..+.+.++.||++|++||+ +++++||||-.+||||++++.+||+|||++
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe--s~~~IHRDLAARNiLV~~~~~vKIsDFGLA 350 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE--SKNYIHRDLAARNILVDEDLVVKISDFGLA 350 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH--hCCccchhhhhhheeeccCceEEEcccccc
Confidence 8899999999999999999976 5577999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+...... ............|.|||.+..+.++.+||+||||++||||+| |+.|+.+++. .
T Consensus 351 r~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------------------~ 411 (468)
T KOG0197|consen 351 RLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------------------E 411 (468)
T ss_pred cccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------------------H
Confidence 8432221 111112234667999999999999999999999999999999 8888887764 3
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
.....+....+.+.|..+|+.+.+++..||+.+|++|||++.+...|+++....
T Consensus 412 ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 412 EVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 344566777888899999999999999999999999999999999999988763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=330.40 Aligned_cols=266 Identities=32% Similarity=0.552 Sum_probs=223.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc--hHHHHHHHHHHhccCCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
..+...+..+.+.||+|+||+||+|.|++. ..||+|.+....... .+.+.+|+.+|++++||||++++
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~----------~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~ 105 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGT----------DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFY 105 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCCc----------eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 334456777788899999999999998752 229999997654332 45899999999999999999999
Q ss_pred eEEecCC-ceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCC-eeeccCCCCcEEEcCCC-cE
Q 018891 94 GYCSESD-NRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNF-NA 169 (349)
Q Consensus 94 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~-i~H~di~~~Nilv~~~~-~v 169 (349)
+++.+.. ..++||||+++|+|.+++.. ....++...++.++.||++|+.||| +++ |+|+|||+.|||++.++ ++
T Consensus 106 G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH--~~~~iIHrDLK~~NiLv~~~~~~~ 183 (362)
T KOG0192|consen 106 GACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH--SEGPIIHRDLKSDNILVDLKGKTL 183 (362)
T ss_pred EEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCeeecccChhhEEEcCCCCEE
Confidence 9998877 78999999999999999977 3688999999999999999999999 888 99999999999999998 99
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccc--cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
||+|||+++...... .......||..|+|||++. ...|+.++|+||+|+++|||+||..||.+.....
T Consensus 184 KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-------- 253 (362)
T KOG0192|consen 184 KIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-------- 253 (362)
T ss_pred EECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--------
Confidence 999999997644322 1222257899999999999 6699999999999999999999999998766411
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 312 (349)
..........+...+..+++.+..++.+||..||.+||++.+++..|+.+......
T Consensus 254 ---------~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 254 ---------VASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ---------HHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 22223334455566677899999999999999999999999999999998886443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=307.91 Aligned_cols=268 Identities=25% Similarity=0.328 Sum_probs=220.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc--hHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.+|...+.||+|.||.||+| .+..+|+.||||+++.....+ .....+|+..|+.++|+||+.++++|..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka---------~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~ 72 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKA---------RDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH 72 (318)
T ss_pred chhhhhhhhcCcceEEEEEE---------EecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence 57999999999999999999 777789999999997764432 3557899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.+.+.+|+||+ ..+|...+..+...++..++..++.++++|++||| .+.|.||||||+|++++.+|.+||+|||+++
T Consensus 73 ~~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H--~~~IlHRDlKPnNLLis~~g~lKiADFGLAr 149 (318)
T KOG0659|consen 73 KSNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH--SKWILHRDLKPNNLLISSDGQLKIADFGLAR 149 (318)
T ss_pred CCceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHH--hhhhhcccCCccceEEcCCCcEEeecccchh
Confidence 99999999999 45999999888888999999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHH-hhhchhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV-EWADPFLRDSR 256 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~-~~~~~~~~~~~ 256 (349)
......... .+.+.|..|+|||++.| ..|+..+|+||.||++.||+-+.+.|.+.++=+....++ ....|..++..
T Consensus 150 ~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 150 FFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred ccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 765544332 23477889999999877 479999999999999999999998888877644444333 22233222221
Q ss_pred h--------HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 R--------VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~--------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ..+.........+.+..++++.+|+.+|+..||.+|+|+.+++++
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 112222222223556677888999999999999999999999975
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=336.19 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=219.3
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc---hHHHHHHHHHHhcc-CCCcccce
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQL-RHENLVKL 92 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l-~h~~i~~~ 92 (349)
.-...||.+++.||.|+|++|++| .+..++..||||++.+...-. .+.+..|=.+|.+| .||.|+++
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A---------~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLA---------REKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred cCChhhcchhheeccccceeEEEe---------eecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 556789999999999999999999 777789999999997764432 24466788888888 79999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
+..|.++..+|+|+||+++|.|.++|.+. +.+++..+..++.+|+.||+||| ++||+||||||+|||++++++++|+
T Consensus 140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH--~~GIIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 140 YFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLH--SNGIIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred EEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeEcCCCcEEEe
Confidence 99999999999999999999999999554 88999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCC---------cc--ccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 173 DFGLARDGPTGDNT---------HV--STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 173 Dfg~~~~~~~~~~~---------~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
|||.+..+...... .. ....+||..|.+||++.+...++++|||+|||++|+|+.|++||.+.++-...
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 99999765443222 11 13378999999999999999999999999999999999999999877654444
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+.|... .-..+.+.++.+.+||+++|..||.+|+|+.+|-+|
T Consensus 297 qkI~~l-------------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QKIQAL-------------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHh-------------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 444331 124566778999999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=326.40 Aligned_cols=263 Identities=27% Similarity=0.462 Sum_probs=214.1
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..+|...+.||+|.||.||++ ....+|...|+|.+........+.+.+|+.+|++++|||||++++.....
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~---------~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~ 86 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLA---------TNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR 86 (313)
T ss_pred cchhhhhccccCccceEEEEE---------EecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc
Confidence 467999999999999999999 55556889999988766444466788999999999999999999975444
Q ss_pred C--ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-CCcEEEecccc
Q 018891 100 D--NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGL 176 (349)
Q Consensus 100 ~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-~~~v~l~Dfg~ 176 (349)
. .++++|||+++|+|.+++.+....+++..+..+.+|+++||+||| ++|++|+||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH--s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 87 ENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH--SKGIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred cCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCcccceEEEeCCCCeEEeccCcc
Confidence 4 588999999999999999775448999999999999999999999 999999999999999999 79999999999
Q ss_pred cccCCC-CCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 177 ARDGPT-GDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 177 ~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
+..... ...........|++.|+|||++.++ ....++|||||||++.+|+||..||.+. ...
T Consensus 165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----------------~~~ 228 (313)
T KOG0198|consen 165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----------------FEE 228 (313)
T ss_pred ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----------------cch
Confidence 876543 1111122236799999999999853 3446999999999999999999999753 011
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
...............+|..++++..+++.+|+..||++|||+.++|+|--.-...
T Consensus 229 ~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 229 AEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 1112222222233467788999999999999999999999999999987654443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=330.95 Aligned_cols=273 Identities=25% Similarity=0.312 Sum_probs=221.8
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
..-.+.|+.++.||+|.||.||+| .+..+|..||+|++..+.. ....-..+|+.+|++++||||+++.+
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkA---------r~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~e 183 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKA---------RDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEE 183 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEe---------eecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceee
Confidence 334568999999999999999999 7888899999999977653 34466789999999999999999999
Q ss_pred EEecC--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 95 YCSES--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 95 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
+..+. ..+|+||||++. +|.-++....-.|++.++..++.||++||+||| ++||+|||||..||||+.+|.+||+
T Consensus 184 ivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 184 IVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred EEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEec
Confidence 98766 689999999955 898888776678999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
|||+++.+....... .+..+-|..|+|||++.|. .|+.++|+||.||||.||+.|+++|.+.+.-+....|.+.....
T Consensus 261 DFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 261 DFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred cccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 999999655544332 3446779999999999875 79999999999999999999999999998876666666543322
Q ss_pred hhhhhhHhhhh--ccc-cCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDSRRVLRIM--DTR-LGG-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~--~~~-~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..+.....++- ... ... +.....+....+|+..||..||.+|.|+.+.|++
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 22222111111 000 000 1124466788999999999999999999999863
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=334.48 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=220.4
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
...|.....||+|+.|.||.| ....+++.||||.+........+-+.+|+.+++..+|+||+.+++.|...
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A---------~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~ 342 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVA---------RKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG 342 (550)
T ss_pred hhhhcchhhhccccccceeee---------eeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc
Confidence 467888999999999999999 77788899999999888777778889999999999999999999999988
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+.+++||||++||+|.+.+.. ..++|.++..+++.++.||+||| .++|+|||||.+||+++.+|.+||+|||++..
T Consensus 343 deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFcaq 418 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQ 418 (550)
T ss_pred ceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeeeec
Confidence 999999999999999998855 45999999999999999999999 99999999999999999999999999999976
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...... ....-+|||.|+|||++..+.|+++.||||||++++||+-|++||-..++-.....+.....+.+.
T Consensus 419 i~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk------ 490 (550)
T KOG0578|consen 419 ISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK------ 490 (550)
T ss_pred cccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC------
Confidence 444332 334468999999999999999999999999999999999999999765543444444443333332
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.+..+++.+++|+.+||+.|+++|+++.+||+|
T Consensus 491 ----------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 ----------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ----------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 346788999999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=331.98 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=213.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc----ch-hchHHHHHHHHHHhccC-CCcccc
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE----SF-QGHKEWLTEVIYLGQLR-HENLVK 91 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~ 91 (349)
...++|++.+.||.|.||.|+.| .+..+++.||+|++... .. ...+.+.+|+.+++.+. ||||++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a---------~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~ 84 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLA---------KHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIR 84 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEe---------eeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeE
Confidence 55679999999999999999999 66667899999977654 11 23455668999999998 999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-CcEE
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAK 170 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-~~v~ 170 (349)
+++++......|+||||+.||.|.+++.+ .+++.+.++..+++||++|++||| ++||+||||||+||+++.+ +++|
T Consensus 85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H--~~gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 85 LLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH--SRGIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEecCCCCCEE
Confidence 99999999999999999999999999977 688999999999999999999999 9999999999999999999 9999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCC-CC-CccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
|+|||++.... ..........|++.|+|||++.+.. |+ .++|+||+|+++|.|++|..||...........+.
T Consensus 162 l~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~--- 236 (370)
T KOG0583|consen 162 LSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR--- 236 (370)
T ss_pred EeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh---
Confidence 99999998653 2223334468999999999999877 86 78999999999999999999998744222211111
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKE-AQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.....+|..+ ++++.+|+++||..||.+|+|+.+++.+=+
T Consensus 237 ----------------~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 237 ----------------KGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred ----------------cCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 1112344555 899999999999999999999999995433
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=317.89 Aligned_cols=287 Identities=28% Similarity=0.374 Sum_probs=226.1
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcc--ccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
....+|...+.||.|++|.|+.| .+..+|+.||||++. ..+....++..+|+.+|+.++|+||+.+.++
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA---------~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di 89 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSA---------KDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDI 89 (359)
T ss_pred eccceecccccccCcceeeEEEE---------EEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEee
Confidence 44567888899999999999999 677778999999997 4455567888999999999999999999999
Q ss_pred Eec-----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 96 CSE-----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 96 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
+.. -+..|+|+|++ +.+|.+.+. ....+++..+..+++|++.||.|+| +.+++||||||.|++++.+..+|
T Consensus 90 ~~p~~~~~f~DvYiV~elM-etDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiH--SAnViHRDLKPsNll~n~~c~lK 165 (359)
T KOG0660|consen 90 FRPPSRDKFNDVYLVFELM-ETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIH--SANVIHRDLKPSNLLLNADCDLK 165 (359)
T ss_pred cccccccccceeEEehhHH-hhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhh--cccccccccchhheeeccCCCEE
Confidence 854 35789999999 668999884 4466999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccc-cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||+++...........+..+.|..|+|||++. ...|+.+.||||+||+++||++|++.|.+.+.-...+.+.....
T Consensus 166 I~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lG 245 (359)
T KOG0660|consen 166 ICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLG 245 (359)
T ss_pred eccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcC
Confidence 99999998765442333345578899999999874 46899999999999999999999999999876555444443322
Q ss_pred hhhhh-hh--------hHhhhhccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhcCCCCCCC
Q 018891 250 PFLRD-SR--------RVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRT 315 (349)
Q Consensus 250 ~~~~~-~~--------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~~~~~~~~ 315 (349)
..-.+ .. ...+.+...... ...++.++...+|+++||.+||.+|+|+++.|+| |..++...+-|..
T Consensus 246 tP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~ 325 (359)
T KOG0660|consen 246 TPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC 325 (359)
T ss_pred CCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC
Confidence 11110 00 011111111111 1224667899999999999999999999999974 7777777666644
Q ss_pred CC
Q 018891 316 PP 317 (349)
Q Consensus 316 ~~ 317 (349)
..
T Consensus 326 ~~ 327 (359)
T KOG0660|consen 326 QP 327 (359)
T ss_pred CC
Confidence 33
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=317.71 Aligned_cols=273 Identities=25% Similarity=0.330 Sum_probs=220.3
Q ss_pred CCcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-hHHHHHHHHHHhccCCCc
Q 018891 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHEN 88 (349)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~ 88 (349)
............+|++...||.|..++||+| .....++.||||++..+.-.. ...+..|+..++.++|||
T Consensus 15 ~~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A---------~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPN 85 (516)
T KOG0582|consen 15 SSSEKEFPLNAKDYELQEVIGVGASAVVYLA---------RCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPN 85 (516)
T ss_pred ccccccCCCCccceeEEEEEeccceeEeeee---------eecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCC
Confidence 3344456667889999999999999999999 666678999999998774443 478899999999999999
Q ss_pred ccceeeEEecCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
|++++..|..+..+|+||+++.+|++.+.+.. ....++|..+..+++++++||.||| ++|.+|||||+.||||+.+|
T Consensus 86 Iv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--~~G~IHRdvKAgnILi~~dG 163 (516)
T KOG0582|consen 86 IVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--QNGHIHRDVKAGNILIDSDG 163 (516)
T ss_pred cceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--hcCceecccccccEEEcCCC
Confidence 99999999999999999999999999999965 3467999999999999999999999 99999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccc--cceecCCcccCcccccc--CCCCCccceehhhHHHHHHHhCCccCccccCcchhhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVS--TRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 243 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~ 243 (349)
.|+|+|||.+......+..... .+..|+++|+|||++.. ..|+.++||||||++..||.+|..||....+-...-.
T Consensus 164 ~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~ 243 (516)
T KOG0582|consen 164 TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL 243 (516)
T ss_pred cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence 9999999987544343322211 34689999999999644 5799999999999999999999999987765333222
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
-.+...|... ......+..+..+..++++|..||+.||++|||+++++++
T Consensus 244 tLqn~pp~~~---------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 244 TLQNDPPTLL---------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HhcCCCCCcc---------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111111111 0011112223455689999999999999999999999974
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=318.61 Aligned_cols=252 Identities=22% Similarity=0.342 Sum_probs=217.4
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchH---HHHHHHHHHhccCCCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
+.++|++.+.||+|.+|.|-+| ....+|+.||||.+..+...+.. .+.+|++++..|+||||+.++.+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A---------~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV 121 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLA---------YEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV 121 (668)
T ss_pred hhhHHHHHHHhcCCcccceeeh---------hhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence 4689999999999999999999 77888999999999877655444 47799999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
|++.+.++|||||..+|.|++|+. .++.+++.++..+++||.+|+.|+| +++++|||||.+||+++.++++||.|||
T Consensus 122 FENkdKIvivMEYaS~GeLYDYiS-er~~LsErEaRhfFRQIvSAVhYCH--knrVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 122 FENKDKIVIVMEYASGGELYDYIS-ERGSLSEREARHFFRQIVSAVHYCH--KNRVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred hcCCceEEEEEEecCCccHHHHHH-HhccccHHHHHHHHHHHHHHHHHHh--hccceecccchhheeecCCCCeeeeccc
Confidence 999999999999999999999994 4588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCC-CccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++..+..... .+..+|+|-|.+||++.+.+|. +.+|.||||+++|.|+.|..||++.+......+|..
T Consensus 199 LSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~-------- 267 (668)
T KOG0611|consen 199 LSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR-------- 267 (668)
T ss_pred hhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc--------
Confidence 9976544333 3446799999999999999885 899999999999999999999998764333222221
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
... ..+..+.+..-||+.||..||++|.|+.++..|.+-
T Consensus 268 ---------GaY---rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 268 ---------GAY---REPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred ---------ccc---cCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 111 112345578889999999999999999999999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=331.58 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=217.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+-|++++-||.|+.|.|-+| ++..+|+..|||++.... ......+.+|+.+++.+.|||++.++++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrla---------kh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe 82 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLA---------KHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE 82 (786)
T ss_pred cceeccccccCCCCceehhh---------hcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence 46899999999999999999 888999999999997762 223466889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+..++|+|.||++||-|++++.++ +++++.++..+++||+.|+.||| ..+|||||+||+|++++..+++||+|||.|
T Consensus 83 ~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH--~~~icHRDLKpENlLLd~~~nIKIADFGMA 159 (786)
T KOG0588|consen 83 NKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCH--AFNICHRDLKPENLLLDVKNNIKIADFGMA 159 (786)
T ss_pred cCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHh--hhcceeccCCchhhhhhcccCEeeecccee
Confidence 999999999999999999999766 88999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCC-CccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
..-..+. ....-+|.|.|.+||++.|.+|+ .++||||.|+++|.||+|..||++.+. ...+.+
T Consensus 160 sLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlK---------- 223 (786)
T KOG0588|consen 160 SLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLK---------- 223 (786)
T ss_pred ecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHH----------
Confidence 7533322 23345799999999999999986 789999999999999999999984432 111111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
. ..-.-.+|..++.++++||++||..||++|.|.++|++|-.-...
T Consensus 224 ----V--~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 224 ----V--QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ----H--HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 1 111124568899999999999999999999999999998665443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=328.14 Aligned_cols=248 Identities=30% Similarity=0.409 Sum_probs=213.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|.+.+.||+|.||.||+| +.+.+.+.||+|.+.+... .+.+.+.+|+++++.++||||+.++++|+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKg---------rrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt 72 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKG---------RRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET 72 (808)
T ss_pred cchhHHHHhcCCccceeeec---------ccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence 57899999999999999999 7888899999999976543 345778999999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..+.++|+||+.| +|..++. ..+.++++.+..++.+++.||.||| +.+|.|+|+||.||++...+.+|++|||+++
T Consensus 73 ~~~~~vVte~a~g-~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLh--s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 73 SAHLWVVTEYAVG-DLFTILE-QDGKLPEEQVRAIAYDLVSALYYLH--SNRILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred cceEEEEehhhhh-hHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHH--hcCcccccCCcceeeecCCCceeechhhhhh
Confidence 9999999999976 9999884 4588999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
. ...+........|+|.|+|||++.+.+|+..+|+|||||++||++.|++||-..+ +.........+
T Consensus 149 ~--m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d---- 215 (808)
T KOG0597|consen 149 A--MSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKD---- 215 (808)
T ss_pred h--cccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcC----
Confidence 6 3334455555789999999999999999999999999999999999999994322 11111111111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
....|...+..+..++..+|..||.+|.|..+++.|
T Consensus 216 --------~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 216 --------PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --------CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 123456889999999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.17 Aligned_cols=269 Identities=29% Similarity=0.394 Sum_probs=210.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
+..++|++.+.||.|+||.||+|.+.+. ....++..||+|.+..... .....+.+|+.+++.+ +||||++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGI----DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEecc----CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 4568999999999999999999965321 2334567899999875432 2345688999999999 89999999998
Q ss_pred EecC-CceEEEEEeCCCCChHHHHhccC----------------------------------------------------
Q 018891 96 CSES-DNRLLVYEFMPKGSLENHLFRSV---------------------------------------------------- 122 (349)
Q Consensus 96 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------- 122 (349)
+... ...++||||+++++|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8654 45789999999999999886421
Q ss_pred ---------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCcccccee
Q 018891 123 ---------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193 (349)
Q Consensus 123 ---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~ 193 (349)
..+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++................
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 24778888999999999999999 9999999999999999999999999999987543222211112234
Q ss_pred cCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCH
Q 018891 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK 272 (349)
Q Consensus 194 ~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (349)
++..|+|||++.+..++.++||||||+++|+|++ |..||.+......... .+........+.
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~-----------------~~~~~~~~~~~~ 300 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ-----------------RLKDGTRMRAPE 300 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-----------------HHhcCCCCCCCC
Confidence 5678999999999999999999999999999997 9999976543211110 011111122244
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 273 KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 273 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.+++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 5678899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=300.53 Aligned_cols=240 Identities=28% Similarity=0.404 Sum_probs=209.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
..-++|++.+.||.|+||.|.++ ++..+|..+|+|+++.... ...+...+|-.+|+.+.||.++++.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LV---------r~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~ 111 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLV---------REKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYG 111 (355)
T ss_pred cchhhhhheeeeccCccceEEEE---------EEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEE
Confidence 55679999999999999999999 6777799999999987643 33455678999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
.+.+.+.+|+||||++||.|..++.+ .+++++..+.-++.|++.||+||| +.+|++|||||+|||++.+|.+||+||
T Consensus 112 t~~d~~~lymvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH--~~~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 112 TFKDNSNLYMVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLH--SLDIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eeccCCeEEEEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHH--hcCeeeccCChHHeeeccCCcEEEEec
Confidence 99999999999999999999999954 488999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
|.+.+.... .-..+|||.|+|||.+..+++..++|.||||+++|||+.|.+||...+.-...+
T Consensus 189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~------------ 251 (355)
T KOG0616|consen 189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE------------ 251 (355)
T ss_pred cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH------------
Confidence 999874332 234689999999999999999999999999999999999999997766422222
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 293 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 293 (349)
+++... ...|...++++.+|++++|+.|-.+|
T Consensus 252 -----KI~~~~--v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 252 -----KILEGK--VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----HHHhCc--ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 222222 34677889999999999999999999
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=294.85 Aligned_cols=269 Identities=24% Similarity=0.351 Sum_probs=218.1
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccce
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
.-+.-+.+++|+|.+.||.|+|+-||++ ....+++.+|+|++......+.+...+|++..++++|||++++
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV---------~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l 83 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLV---------KGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRL 83 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeee---------cccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHH
Confidence 3445567899999999999999999999 7778899999999999888888899999999999999999999
Q ss_pred eeEEecCC-----ceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCcEE
Q 018891 93 IGYCSESD-----NRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVL 162 (349)
Q Consensus 93 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~--i~H~di~~~Nil 162 (349)
+++...+. ..|++++|+..|+|.+.+.. ....+++.++++|+.++++||.+|| ... ++|+||||.||+
T Consensus 84 ~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH--~~~~~yAH~DiKP~NIL 161 (302)
T KOG2345|consen 84 VDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH--EKEPPYAHRDIKPANIL 161 (302)
T ss_pred HHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh--ccCCcccccCCCcceeE
Confidence 98764433 48999999999999999965 3356999999999999999999999 667 999999999999
Q ss_pred EcCCCcEEEecccccccCCCCCCCcccc-------ceecCCcccCcccccc---CCCCCccceehhhHHHHHHHhCCccC
Q 018891 163 LDSNFNAKLSDFGLARDGPTGDNTHVST-------RIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRAL 232 (349)
Q Consensus 163 v~~~~~v~l~Dfg~~~~~~~~~~~~~~~-------~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~lltg~~pf 232 (349)
+++++.++|.|||.++..+..-...... ....+..|+|||++.- ...++++|||||||++|.|+.|..||
T Consensus 162 ls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPf 241 (302)
T KOG2345|consen 162 LSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPF 241 (302)
T ss_pred ecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcc
Confidence 9999999999999997544332222111 1346888999999864 45678999999999999999999999
Q ss_pred ccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 233 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
+........-.+. ........+....+++.+.++|+.||+.||.+||++.+++..++++.
T Consensus 242 e~~~~~GgSlaLA---------------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 242 ERIYQQGGSLALA---------------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hHHhhcCCeEEEe---------------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 7543322211111 11111122223348899999999999999999999999999998764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=322.97 Aligned_cols=251 Identities=23% Similarity=0.357 Sum_probs=218.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|+.++.+|+|+||.++++ .++.++..+++|.+...... ..+...+|+.++++++||||+.+.+.|.+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lv---------rhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLV---------RHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred chhhhhhhcCccccchhhhh---------hhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 68999999999999999999 77788889999998765433 34567899999999999999999999999
Q ss_pred CCc-eEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 99 SDN-RLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 99 ~~~-~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
++. .+|||+|++||++.+.+.+.. ..+++..+..|+.|++.|+.||| +++|+|||||+.|||++.++.|+|+|||+
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--~~~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--ENRVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hhhhhcccchhhhhhccccCceeecchhh
Confidence 888 999999999999999997754 67999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+....... ......+|||.|++||++.+.+|..++|||||||++|+|++-+++|...+.......+..
T Consensus 153 aK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~---------- 220 (426)
T KOG0589|consen 153 AKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR---------- 220 (426)
T ss_pred hhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh----------
Confidence 98755543 233447899999999999999999999999999999999999999976654332222221
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ...+.+..++.+++.+|+.||..+|+.||++.++|.+
T Consensus 221 -------~-~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 -------G-LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -------c-cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 1345677889999999999999999999999999975
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=315.66 Aligned_cols=268 Identities=22% Similarity=0.294 Sum_probs=205.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||.|+||.||+| .+..++..||+|.+...... ....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 75 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE 75 (288)
T ss_pred ccceEeeEEecCCCEEEEEE---------EECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 57999999999999999999 55556889999988654322 344677899999999999999999999998
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++ +|.+++......+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 76 RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARA 152 (288)
T ss_pred CeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence 899999999975 899988665566899999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh----
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD---- 254 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 254 (349)
...... ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+..........
T Consensus 153 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 153 KSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred ccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 322211 1122457889999998865 568899999999999999999999998765443333332221111100
Q ss_pred ---hhhHhhhhccccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 ---SRRVLRIMDTRLG----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ---~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
............+ ......+++++.+||.+||+.||.+|||++++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000 00112356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=320.08 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=208.9
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCccc
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~ 90 (349)
....+.-++|++.+.||+|+||.||+| ....+++.||+|.+..... .....+.+|+.+++.++||||+
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 81 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIA---------KHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCC
Confidence 445555689999999999999999999 4555688999999865432 2345678899999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
++++.+..++..++||||+.+++|.+++.+. ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~k 158 (329)
T PTZ00263 82 NMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLH--SKDIIYRDLKPENLLLDNKGHVK 158 (329)
T ss_pred cEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEECCCCCEE
Confidence 9999999999999999999999999988554 67899999999999999999999 99999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|+|||++....... ....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+
T Consensus 159 l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------ 227 (329)
T PTZ00263 159 VTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI------ 227 (329)
T ss_pred EeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH------
Confidence 99999987543221 1246889999999999999999999999999999999999999754421111111
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
... ....+..++..+.+||.+||+.||.+||+ +.++++|
T Consensus 228 -----------~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 228 -----------LAG--RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -----------hcC--CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 11223446678999999999999999987 7888876
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=316.27 Aligned_cols=248 Identities=23% Similarity=0.293 Sum_probs=206.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLV---------RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEE---------EEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 47999999999999999999 5555688999999865432 23456788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+.+..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~ 148 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLH--SKEIVYRDLKPENILLDKEGHIKLTDFGFA 148 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEEecCcc
Confidence 999999999999999999998554 67899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 149 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~----------- 212 (291)
T cd05612 149 KKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA----------- 212 (291)
T ss_pred hhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 7543221 124588999999999998999999999999999999999999976543221111111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTSLE 304 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~l~ 304 (349)
. ....+...++.+.+||++||+.||.+||+ +.++++|-+
T Consensus 213 ------~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 213 ------G--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred ------C--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcc
Confidence 0 11234455778999999999999999995 999887643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=316.92 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=215.8
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
...-++|++++.||+|+||.||+| +...+|+.+|+|++++.... .....+.|=.+|....+|.||+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLa---------rKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy 207 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLA---------RKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY 207 (550)
T ss_pred cCCcccchhheeeccccceeEEEE---------EEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence 446689999999999999999999 77888999999999876443 345577888899999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
..|++..++||||||++||++--+|.+. ..+++..+..++.+++-|++.+| +.|++||||||+|+||+..|++||.|
T Consensus 208 YsFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH--~~gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 208 YSFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIH--QLGYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred EEecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHH--HcCcccccCChhheeecCCCCEeecc
Confidence 9999999999999999999999988554 78999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCC----------------------CCCc----ccc-------------------ceecCCcccCccccccCC
Q 018891 174 FGLARDGPTG----------------------DNTH----VST-------------------RIVGTRGYAAPEYVATGH 208 (349)
Q Consensus 174 fg~~~~~~~~----------------------~~~~----~~~-------------------~~~~~~~~~aPE~~~~~~ 208 (349)
||++...... .... ... ..+|||.|+|||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 9998521110 0000 000 136999999999999999
Q ss_pred CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhccc
Q 018891 209 LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM 288 (349)
Q Consensus 209 ~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 288 (349)
|+...|.|||||+|||||.|.+||...++...-..|..|...+.... ...++++..+||.+||.
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---------------~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---------------EVDLSDEAKDLITRLLC- 428 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---------------cCcccHHHHHHHHHHhc-
Confidence 99999999999999999999999998887666666666554333221 23455899999999999
Q ss_pred CCCCCC---CHHHHHHH
Q 018891 289 DPKNRP---SMVDVLTS 302 (349)
Q Consensus 289 dp~~Rp---s~~~ll~~ 302 (349)
||++|. .+.||-+|
T Consensus 429 d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKH 445 (550)
T ss_pred CHHHhcCcccHHHHhcC
Confidence 999996 46666653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=311.04 Aligned_cols=269 Identities=23% Similarity=0.318 Sum_probs=205.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKC---------RHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CCceEEEEecccCCEEEEEE---------EECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 47999999999999999999 4555688999998865422 234567789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
++..++||||++++.+..+. .....+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~ 148 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFAR 148 (287)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEeeccCcc
Confidence 99999999999886665443 44467999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
........ ......+++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+.....+........
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 149 NLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred cccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 64332211 11224678899999999988899999999999999999999999987554333222222211111100000
Q ss_pred -------hhhhcccc------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 -------LRIMDTRL------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 -------~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........ .......++.++.+|+.+||+.||++|||+.++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 000112356789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=315.57 Aligned_cols=272 Identities=25% Similarity=0.310 Sum_probs=210.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||+|+||.||+| .+..++..+++|.+..... .....+.+|+.++++++||||+++++++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKV---------QHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEE---------EECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 34689999999999999999999 5556688999998876532 2346688999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~-~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
..++..++||||+++++|.+++... ..+++..+..++.|++.||.||| +. +++|+||||+||+++.++.++|+|||
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 149 (331)
T cd06649 73 YSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFG 149 (331)
T ss_pred EECCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh--hcCCEEcCCCChhhEEEcCCCcEEEccCc
Confidence 9999999999999999999998544 57899999999999999999999 64 69999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh-------
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA------- 248 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~------- 248 (349)
++....... .....+++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..-.
T Consensus 150 ~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (331)
T cd06649 150 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGE 225 (331)
T ss_pred ccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCC
Confidence 986543221 122458899999999999899999999999999999999999997544322211111000
Q ss_pred ----------------------chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 249 ----------------------DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 249 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
.+.......................+++++.+||.+||+.||++|||+.++++|-.-
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 000000000011111111111122467889999999999999999999999988654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=316.68 Aligned_cols=243 Identities=27% Similarity=0.392 Sum_probs=200.2
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEecCCceE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (349)
+.||+|+||.||+| .+..+|+.||+|++..... .....+.+|+.++++++||||+++++.+...+..+
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILV---------REKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC 71 (323)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence 47999999999999 5555689999999875432 23345678999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCC
Q 018891 104 LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183 (349)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~ 183 (349)
+||||+++++|.+++... ..+++..+..++.||+.||+||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 72 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC
Confidence 999999999999988544 67899999999999999999999 999999999999999999999999999998642221
Q ss_pred CCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhc
Q 018891 184 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263 (349)
Q Consensus 184 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (349)
. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+. .
T Consensus 149 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----------------~ 209 (323)
T cd05571 149 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-----------------M 209 (323)
T ss_pred C--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH-----------------c
Confidence 1 11223568999999999999999999999999999999999999996543211111111 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ....+..+++++.++|.+||+.||++|| ++.++++|
T Consensus 210 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 210 E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0 1233456788899999999999999999 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=315.95 Aligned_cols=252 Identities=26% Similarity=0.356 Sum_probs=215.7
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
....|+....||+|.||.||+| .+..+++.||+|++..+... ..+.+.+|+.+|.+++++||.++++.|.
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~---------~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl 81 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKA---------IDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL 81 (467)
T ss_pred cccccccchhccccccceeeee---------eeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence 3567899999999999999999 66677999999999887554 4578889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.+..++++|||+.||++.+.+. ....+++..+..++++++.|+.||| ..+.+|+|||+.||++..+|.++|+|||++
T Consensus 82 ~g~~LwiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~ylH--~~~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 82 KGTKLWIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDYLH--SEKKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred ecccHHHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhhhh--hcceecccccccceeEeccCcEEEEeccee
Confidence 9999999999999999999884 3355599999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
.......... ...+|||.|||||++.+..|+.++||||||+++++|.+|.+|+....+-..
T Consensus 159 ~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------- 219 (467)
T KOG0201|consen 159 GQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------- 219 (467)
T ss_pred eeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----------------
Confidence 7654433332 457899999999999988999999999999999999999999987664111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.-.+.+.....+....++.+++||..||+.||+.||||.++++|
T Consensus 220 -lflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 220 -LFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -EEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 11222222233344778899999999999999999999999974
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.81 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=207.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| ....+++.||+|++..... .....+..|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLA---------KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred CCcEEEEEEeecCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 47999999999999999999 4555688999999876532 23456778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..|+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a 148 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALH--ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEEEeCcCC
Confidence 999999999999999999998543 67899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
..... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..+...
T Consensus 149 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------- 216 (333)
T cd05600 149 KGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET------- 216 (333)
T ss_pred ccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-------
Confidence 75433 122346899999999999999999999999999999999999999765543322222211100
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
............+++++.++|.+||..+|.+||++.++++|
T Consensus 217 ----~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 217 ----LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00000000112467889999999999999999999999987
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=318.77 Aligned_cols=268 Identities=27% Similarity=0.395 Sum_probs=210.6
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
.+..++|++.+.||+|+||.||+|.+... ....++..||+|.+..... .....+.+|+.+++.+ +|+||+++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGL----GKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecC----CcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 35567899999999999999999965321 2334567899999875432 3345678899999999 8999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccC----------------------------------------------------
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSV---------------------------------------------------- 122 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------- 122 (349)
.+......++||||+++++|.+++....
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 9999999999999999999999885321
Q ss_pred -----------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 123 -----------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 123 -----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
.++++..++.++.|++.||.||| +++++||||||+||+++.++.++|+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 24778889999999999999999 89999999999999999999999999999875433222
Q ss_pred CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhcc
Q 018891 186 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264 (349)
Q Consensus 186 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (349)
........++..|+|||++.+..++.++|+||||+++|+|++ |..||........... ....
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~-----------------~~~~ 330 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK-----------------MVKR 330 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH-----------------HHHc
Confidence 111111234567999999988899999999999999999997 9999975433211111 1111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
......+...++++.+++.+||+.||.+|||+.++++.|+++.
T Consensus 331 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 331 GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1112223345688999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=298.08 Aligned_cols=266 Identities=26% Similarity=0.306 Sum_probs=214.4
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|+.+..|+.|.||.||+| +++.+++.||+|.++.+... -.-.-++|+.+|.+.+||||+.+..+...
T Consensus 76 ~efe~lnrI~EGtyGiVYRa---------kdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRA---------KDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG 146 (419)
T ss_pred HHHHHHhhcccCcceeEEEe---------ccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence 68999999999999999999 78888999999999766422 22345789999999999999999998754
Q ss_pred C--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 99 S--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
. +.+|+||||++ .+|...+....+++...++..++.|+++|++||| .+.|+|||||++|++++..|.+||+|||+
T Consensus 147 ~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH--~~wilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH--DNWILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred cccceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh--hceeEecccchhheeeccCCcEEecccch
Confidence 3 57899999995 4899999887789999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-hhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRD 254 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~ 254 (349)
|+..... ....+..+-|..|+|||++.+. .|+.+.|+||+||++.+|+++.+.|.+.+.-.....|+..-. |.-..
T Consensus 224 AR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 224 AREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred hhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 9975444 3334456789999999998774 689999999999999999999999999887555555553322 11111
Q ss_pred hhh---------------HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 255 SRR---------------VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 255 ~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
... ....+...+.. ..+++.-++|+..+|..||.+|.|+.+.|+|=
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~---~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGA---LSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccc---cccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 100 01111111111 11668899999999999999999999999763
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=302.73 Aligned_cols=262 Identities=23% Similarity=0.413 Sum_probs=211.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+...+|++.+.||+|+||.||+|+++. ....+..|++|.+..... .....+.+|+..+++++||||+++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 75 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKL------PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI 75 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEec------CCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 346789999999999999999997642 234578899999876532 2345688999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..++..++||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++++|||.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~iiH~dikp~nili~~~~~~~l~dfg~ 153 (266)
T cd05064 76 TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRR 153 (266)
T ss_pred ecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeeccccHhhEEEcCCCcEEECCCcc
Confidence 9999999999999999999999765567899999999999999999999 99999999999999999999999999997
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
.......... ......++..|+|||.+.+..++.++|+|||||++|++++ |..||.+.........+
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~----------- 221 (266)
T cd05064 154 LQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV----------- 221 (266)
T ss_pred cccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-----------
Confidence 7543211111 1111223567999999999999999999999999999775 99999765432211111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
........+..++..+.+++.+||+.+|++|||+.+|++.|.++
T Consensus 222 -------~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 -------EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11122234556788899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=317.99 Aligned_cols=265 Identities=28% Similarity=0.387 Sum_probs=208.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+|.+... ....++..||+|++.... ......+.+|+.+++.+ +||||+++++++
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred chHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 345899999999999999999965321 234557789999986543 23345678899999999 899999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccC------------------------------------------------------
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSV------------------------------------------------------ 122 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------ 122 (349)
...+..++||||+++++|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999885421
Q ss_pred --------------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 123 --------------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 123 --------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 24678889999999999999999 89999999999999999999999999999875433
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (349)
...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......... +.
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~-----------------~~ 329 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY-----------------KM 329 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH-----------------HH
Confidence 222111111234567999999999999999999999999999998 888886544221111 11
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
+........+...+.++.+++.+||+.||++|||+.++++.|++.
T Consensus 330 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 330 IKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111111222334567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=319.38 Aligned_cols=265 Identities=27% Similarity=0.459 Sum_probs=218.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
-++..++..+...||+|.||+||+|.|.++ ||||+++.+.. +..+.|+.|+..+++-+|.||+-+.
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd------------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHGD------------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFM 454 (678)
T ss_pred cccCHHHhhccceeccccccceeecccccc------------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeee
Confidence 345667888999999999999999999864 89999877644 3557899999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+++..... .||+.||+|-+|+.++.-...+++....++|+.|++.|+.||| .++|+|+|||.+|||+.+++.|||+|
T Consensus 455 G~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 455 GACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred hhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEccCCcEEEec
Confidence 99998777 8999999999999999777788999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCcccccc---CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
||++................|..+|+|||++.. .+|++.+||||+|+++|||++|..||.... ..+.|......
T Consensus 532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~---~dqIifmVGrG 608 (678)
T KOG0193|consen 532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN---RDQIIFMVGRG 608 (678)
T ss_pred ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC---hhheEEEeccc
Confidence 999974333322222233567888999999853 478999999999999999999999998322 23333332222
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
++.... .....+++.++.+|+..||..++++||.+.+|+..|+.+..+
T Consensus 609 ~l~pd~-----------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 609 YLMPDL-----------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccCccc-----------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 222111 122356788999999999999999999999999999988875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=327.06 Aligned_cols=265 Identities=24% Similarity=0.333 Sum_probs=218.6
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCccccee
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLI 93 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 93 (349)
...++..++++.++|.+|||+.||+| ...+.|..||+|.+-..+....+.+.+|+.++++|+ |+|||.++
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla---------~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yi 101 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLA---------QDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYI 101 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEE---------EecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEe
Confidence 35678899999999999999999999 444455889999887777677788999999999996 99999999
Q ss_pred e-EEec---C---CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC
Q 018891 94 G-YCSE---S---DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165 (349)
Q Consensus 94 ~-~~~~---~---~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~ 165 (349)
+ .... + -..+|+||||.|+.|.+++.+. ...|++.++++|++++++|+++||.++-.|+|||||-+|||+..
T Consensus 102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA 181 (738)
T ss_pred ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence 9 3321 1 2457899999999999999752 34599999999999999999999966666999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCccc-c------ceecCCcccCcccc---ccCCCCCccceehhhHHHHHHHhCCccCccc
Q 018891 166 NFNAKLSDFGLARDGPTGDNTHVS-T------RIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALDED 235 (349)
Q Consensus 166 ~~~v~l~Dfg~~~~~~~~~~~~~~-~------~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~ll~~lltg~~pf~~~ 235 (349)
+|.+||||||.++-.......... . ...-|+.|++||++ .+.+.++++|||+|||+||-|+....||++.
T Consensus 182 ~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 182 DGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 999999999999743222211110 0 13569999999986 5678899999999999999999999999765
Q ss_pred cCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 236 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.. ..+++..+..+-.+.++..+.+||+.||+.||.+||++-+++..+..+...
T Consensus 262 g~---------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 262 GK---------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cc---------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 32 234444444455578999999999999999999999999999999998877
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=307.72 Aligned_cols=269 Identities=23% Similarity=0.303 Sum_probs=201.9
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.++|++.+.||.|+||.||+| .+..++..||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKG---------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEE---------EECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence 478999999999999999999 5555688999999865432 233456789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
....++||||+. ++|.+++......+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 75 KETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred CCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 999999999995 5888888766677999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchh-hhHHh-hhchhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVE-WADPFLRDS 255 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~-~~~~~-~~~~~~~~~ 255 (349)
...... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+....... ..+.. ...+.....
T Consensus 152 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 152 AKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred eccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence 432221 11222457889999998865 45788999999999999999999999865431111 11110 000000000
Q ss_pred h---hHhhhhccccCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 R---RVLRIMDTRLGGQYSK---------KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~---~~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ..............+. ..++.+.+|+.+||+.||++|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 0000000000000000 124678899999999999999999999974
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=307.57 Aligned_cols=274 Identities=28% Similarity=0.452 Sum_probs=208.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcC-------CCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcc
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFA-------PTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENL 89 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~-------~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i 89 (349)
+..++|++.+.||+|+||.||+|.++...-. ....+.+..||+|.+..... .....+.+|+.++++++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 4567999999999999999999976542100 01234566899998876532 234568899999999999999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccC------------------CCCChHHHHHHHHHHHHHHHHHhcCCCCe
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV------------------QPISWPTRVKIAIDVARGLSFLHGLDANV 151 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i 151 (349)
+++++++...+..++||||+.+++|.+++.... ..++...++.++.|++.||.||| +.++
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i 159 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--SLNF 159 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH--HCCc
Confidence 999999999999999999999999999885421 23677889999999999999999 8999
Q ss_pred eeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh--CC
Q 018891 152 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GR 229 (349)
Q Consensus 152 ~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt--g~ 229 (349)
+|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999875433322222222345678999999988899999999999999999987 56
Q ss_pred ccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 230 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.||.+............ ..... ........+..++..+.+++.+||+.||++|||+.++.+.|+
T Consensus 240 ~p~~~~~~~~~~~~~~~----~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQVIENAGE----FFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHHHHHHHH----Hhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67765543222211111 00000 000001123356678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=306.51 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=204.6
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.|+..+.||+|+||.||+| ....+++.||+|.+...... ....+.+|+.+++.++|++++++.+.+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCEEEEEE---------EEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 3788999999999999999 55556889999988654322 23456789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
++..++||||+++++|.+.+... ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 99999999999999998877543 346899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ .....|+..|+|||++.+..++.++|+|||||++|+|++|..||...........+...
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---------- 216 (285)
T cd05631 150 VQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR---------- 216 (285)
T ss_pred EEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH----------
Confidence 76432221 12246889999999999999999999999999999999999999865542221111110
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
. .......+..+++++.+|+++||+.||++||+ +.++++|
T Consensus 217 ----~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 217 ----V-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ----h-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0 01112234456788999999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=302.91 Aligned_cols=263 Identities=29% Similarity=0.466 Sum_probs=212.1
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.++|++.+.||.|++|.||+|..... ........|++|.+..... .....+.+|+..++.++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGP----NERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecC----CCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 46899999999999999999965432 1223457899998865432 234567899999999999999999999998
Q ss_pred CCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
....+++|||+++++|.+++.... ..+++..++.++.|++.||.||| ..+++|+||||+||++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nil~ 157 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS--SHHFVHRDLAARNCLV 157 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccccceEEE
Confidence 889999999999999999986431 45788999999999999999999 9999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhh
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 242 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~ 242 (349)
+.++.++|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+........
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999875433322222223456778999999988899999999999999999998 999997654322111
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.+........+..+++++.+|+.+||+.||.+||++.+++++|+++
T Consensus 238 ------------------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 ------------------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ------------------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111122234567789999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=301.93 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=205.2
Q ss_pred hhcccCCc--ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc---hHHHHHHHHHHhccCCCccccee
Q 018891 19 ATKNFCSD--YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 19 ~~~~y~~~--~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
...++... ..||.|++|.||+|.++ |+.||+|.+....... .+.+.+|+.++++++||||++++
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIFN-----------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEEC-----------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34455555 78999999999999653 6789999987654333 35677999999999999999999
Q ss_pred eEEec----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCc
Q 018891 94 GYCSE----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 94 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~ 168 (349)
+++.+ ....++||||+++++|.+++.+. ..+++...+.++.|++.|+.||| + .+++|+||+|+||+++.++.
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHH--hcCCCCCCcCChhhEEECCCCc
Confidence 99866 34678999999999999999554 67899999999999999999999 6 48899999999999999999
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCcccccc--CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
++|+|||++........ ...++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.
T Consensus 162 ~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~- 235 (283)
T PHA02988 162 LKIICHGLEKILSSPPF-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLII- 235 (283)
T ss_pred EEEcccchHhhhccccc-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-
Confidence 99999999875432211 2357888999999876 678999999999999999999999997654322111111
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
........+..+++.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 236 ----------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 236 ----------------NKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ----------------hcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111223344578899999999999999999999999999998753
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=305.79 Aligned_cols=279 Identities=54% Similarity=0.932 Sum_probs=227.4
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
...++++|.-...||+|+||.||+|...+ +..||||.+..........|.+|+.++.+++|||+++++++
T Consensus 70 l~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 70 LRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred HHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 45567899999999999999999997653 47899998876543314459999999999999999999999
Q ss_pred EecCC-ceEEEEEeCCCCChHHHHhccCC-CCChHHHHHHHHHHHHHHHHHhcCCC--CeeeccCCCCcEEEcCCCcEEE
Q 018891 96 CSESD-NRLLVYEFMPKGSLENHLFRSVQ-PISWPTRVKIAIDVARGLSFLHGLDA--NVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 96 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~--~i~H~di~~~Nilv~~~~~v~l 171 (349)
|.+.+ ..++|+||++.|+|.+.+..... ++++..+..|+..++.||+|||. .. .|+|||||+.|||++++...||
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~-~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHE-GCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHcc-CCCCCEecCCCCHHHeeECCCCCEEc
Confidence 99988 49999999999999999976555 89999999999999999999995 23 4999999999999999999999
Q ss_pred ecccccccCCCCCCCccccce-ecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 172 SDFGLARDGPTGDNTHVSTRI-VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
+|||++...+.. ....... .|+.+|++||.+..+..+.++||||+|+++.|+++|+.+.+.... .....+..|..+
T Consensus 219 sDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~-~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 219 SDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP-RGELSLVEWAKP 295 (361)
T ss_pred cCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC-cccccHHHHHHH
Confidence 999999654331 1111112 689999999999999999999999999999999999988876542 222226666655
Q ss_pred hhhhhhhHhhhhccccC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 251 FLRDSRRVLRIMDTRLG-GQYSK-KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.+.+. ....++++... ...+. ..-..+..+..+|++.+|.+||++.++++.|+.+...
T Consensus 296 ~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 296 LLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 55554 66667777765 44443 4556688999999999999999999999999665544
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=297.95 Aligned_cols=261 Identities=29% Similarity=0.448 Sum_probs=210.6
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.++|++.+.||+|+||.||+|.+.. .......|++|.+...... ....+.+|+..++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKL------PGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEcc------CCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec
Confidence 4689999999999999999997642 1233568999988765433 34567889999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.+..++|||++++++|.+++......++...+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence 99999999999999999999776668999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
...............++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------------- 221 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV------------- 221 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-------------
Confidence 6542221111111234567999999998899999999999999999998 99998654422111111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
........+..+++.+.+++.+||+.+|++||++.+++++|.++
T Consensus 222 -----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 222 -----EDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111122345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.63 Aligned_cols=271 Identities=25% Similarity=0.340 Sum_probs=207.6
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||.|+||.||+| .+..++..+++|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKV---------SHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72 (333)
T ss_pred cchhhhheeccccCCCCEEEEEE---------EECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE
Confidence 45689999999999999999999 5556688899998865432 2345688999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
..++..++||||+++++|.+++... ..+++..+..++.|++.||.||| + .+++|+||||+||+++.++.++|+|||
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~ivH~dlkp~Nili~~~~~~kL~Dfg 149 (333)
T cd06650 73 YSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG 149 (333)
T ss_pred EECCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChhhEEEcCCCCEEEeeCC
Confidence 9999999999999999999998543 67899999999999999999999 6 479999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc------
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD------ 249 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~------ 249 (349)
++........ ....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+.....
T Consensus 150 ~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (333)
T cd06650 150 VSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225 (333)
T ss_pred cchhhhhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence 9865322211 124578899999999988899999999999999999999999975443222111100000
Q ss_pred -----------------hhhhhhh---hHhhhhccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 250 -----------------PFLRDSR---RVLRIMDTRLGGQYS-KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 250 -----------------~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
+...... ..............+ ...+.++.+|+.+||+.||++|||+.++++|-.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0000000 000000010111111 124678999999999999999999999997643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=300.34 Aligned_cols=270 Identities=24% Similarity=0.347 Sum_probs=208.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
-.|+-.+++|+|+||.||.|... .+++.||||+.-.+.. .-.+|+.+|+.++||||+++..+|....
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~---------e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLR---------ETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSST 90 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEc---------CCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecC
Confidence 46888999999999999999543 3478999998755432 2237999999999999999998885432
Q ss_pred -----ceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-CcEEE
Q 018891 101 -----NRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKL 171 (349)
Q Consensus 101 -----~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-~~v~l 171 (349)
+..+||||++ .+|.+++.. ....++.-.+.-+.+||++||+||| +.+||||||||.|++|+.+ |.+||
T Consensus 91 ~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh--~~~IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 91 ESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH--SHGICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred CCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH--hcCcccCCCChheEEEcCCCCeEEe
Confidence 4468999995 489998864 3577899999999999999999999 8999999999999999875 89999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
+|||.|.....+..+ ..++.+..|+|||++.+ ..|+.+.||||.||++.||+-|++.|.+.+.......+.+....
T Consensus 168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 999999876554443 33567888999999877 47999999999999999999999999997765555555443332
Q ss_pred hhhhhh-hHh---------hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhcC
Q 018891 251 FLRDSR-RVL---------RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT--SLEQLHTS 309 (349)
Q Consensus 251 ~~~~~~-~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~~~~~ 309 (349)
..++.. .+. ++.............++++.+|+.++|..+|.+|.++.+++. .++.++..
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 222211 110 011111111244567889999999999999999999999995 45555544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=304.84 Aligned_cols=260 Identities=28% Similarity=0.360 Sum_probs=210.9
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--------------hchHHHHHHHHHHhccC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--------------QGHKEWLTEVIYLGQLR 85 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~ 85 (349)
-+.|++.+.||+|.||.|-+| ++..++..||||++..... ...+...+|+.+++++.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLa---------r~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLA---------RDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred hhheehhhhhcCCccceEEEE---------eecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 378999999999999999999 7788899999999865321 11256789999999999
Q ss_pred CCcccceeeEEecC--CceEEEEEeCCCCChHHHHhccCCC-CChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEE
Q 018891 86 HENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRSVQP-ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 162 (349)
Q Consensus 86 h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nil 162 (349)
||||++++.+..+. +.+|+|+||+..|.+... ...++ +++.+++.+++.++.||+||| .+||+||||||.|+|
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH--~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLH--YQGIIHRDIKPSNLL 242 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheE
Confidence 99999999998654 689999999987765431 23345 899999999999999999999 999999999999999
Q ss_pred EcCCCcEEEecccccccCCCCCC---CccccceecCCcccCccccccCC----CCCccceehhhHHHHHHHhCCccCccc
Q 018891 163 LDSNFNAKLSDFGLARDGPTGDN---THVSTRIVGTRGYAAPEYVATGH----LTPKSDVYSFGVVLLELLSGRRALDED 235 (349)
Q Consensus 163 v~~~~~v~l~Dfg~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~ll~~lltg~~pf~~~ 235 (349)
++++|+|||.|||.+...+.+.. ........|||.|+|||+..++. .+.+.||||||+++|.|+.|+.||.+.
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 99999999999999986544321 11122368999999999987743 347899999999999999999999765
Q ss_pred cCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 236 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
..-+.. .++++..+..+..+++.+++.+||.+||+.||++|.++.++-.|.+-...-
T Consensus 323 ~~~~l~-----------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 323 FELELF-----------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred hHHHHH-----------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 532222 233344444444456788999999999999999999999999998876653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=283.58 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=222.5
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcc
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENL 89 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i 89 (349)
.....+.-++|++++.||+|.||.||+| ....++-.||+|++.+... .....+.+|+++-..|+||||
T Consensus 14 ~~~~~~~l~dfeigr~LgkgkFG~vYla---------rekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpni 84 (281)
T KOG0580|consen 14 RATKTWTLDDFEIGRPLGKGKFGNVYLA---------REKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNI 84 (281)
T ss_pred ccccccchhhccccccccCCccccEeEe---------eeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccH
Confidence 3456778899999999999999999999 6677788999999876533 345678899999999999999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
++++++|-++...|+++||..++.+...++. ....+++...+.++.|++.||.|+| .++++||||||+|++++.+|.
T Consensus 85 lrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~ 162 (281)
T KOG0580|consen 85 LRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGE 162 (281)
T ss_pred HhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCC
Confidence 9999999999999999999999999999974 3366999999999999999999999 999999999999999999999
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
+|++|||.+...+.. ......||..|.+||+..+...+..+|+|++|++.|+++.|.+||.....++-.+.|..
T Consensus 163 lkiAdfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k-- 236 (281)
T KOG0580|consen 163 LKIADFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK-- 236 (281)
T ss_pred eeccCCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--
Confidence 999999999764422 22336799999999999999999999999999999999999999975543222222221
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.....|..++....++|.+|+..+|.+|.+..+++.|-+..
T Consensus 237 -----------------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 237 -----------------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred -----------------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 12344578889999999999999999999999999987653
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=310.67 Aligned_cols=243 Identities=27% Similarity=0.388 Sum_probs=199.6
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEecCCceE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (349)
+.||+|+||.||+| .+..++..||+|++..... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILV---------REKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC 71 (328)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence 46999999999999 5556689999999875432 23356778999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCC
Q 018891 104 LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183 (349)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~ 183 (349)
+||||+++++|..++... ..+++..+..++.||+.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 72 lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 72 FVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc
Confidence 999999999999888543 67999999999999999999999 999999999999999999999999999998642221
Q ss_pred CCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhc
Q 018891 184 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263 (349)
Q Consensus 184 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (349)
........|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+ ..
T Consensus 149 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~-----------------~~ 209 (328)
T cd05593 149 --AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-----------------LM 209 (328)
T ss_pred --ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh-----------------cc
Confidence 11122346899999999999999999999999999999999999999754321111111 00
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
.....+..+++++.++|++||+.||++|+ ++.++++|
T Consensus 210 --~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 210 --EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11223456778899999999999999997 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=302.17 Aligned_cols=267 Identities=26% Similarity=0.438 Sum_probs=216.3
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|.+.+.||.|++|.||+|.+... ....++..+++|.+..........+.+|+..++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNL----SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeecc----CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 457899999999999999999965432 2344567799999877666666778899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
....++||||+++++|.+++.... ..+++..++.++.||+.||+||| +++++|+||+|+||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLV 156 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEE
Confidence 999999999999999999996431 34788999999999999999999 9999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhh
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 242 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~ 242 (349)
+.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999875433322222223445778999999998999999999999999999998 999986544321111
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
. .........+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 237 ~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 C------------------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H------------------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1 111111122334567899999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=310.77 Aligned_cols=243 Identities=26% Similarity=0.384 Sum_probs=199.2
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEecCCceE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (349)
+.||+|+||.||++ .+..+|..||+|.+..... .....+.+|+.+++.++||||+++++.+...+..|
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 71 (323)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence 46999999999999 5556689999999876432 23345678999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCC
Q 018891 104 LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183 (349)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~ 183 (349)
+||||+++++|..++... ..+++..++.++.||+.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 72 lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 72 FVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC
Confidence 999999999999888544 67899999999999999999999 899999999999999999999999999988642221
Q ss_pred CCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhc
Q 018891 184 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263 (349)
Q Consensus 184 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (349)
. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+. .
T Consensus 149 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~-----------------~ 209 (323)
T cd05595 149 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-----------------M 209 (323)
T ss_pred C--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh-----------------c
Confidence 1 11122468899999999999999999999999999999999999997544322111111 0
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ....+..+++++.++|.+||+.||++|| ++.++++|
T Consensus 210 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 210 E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred C--CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0 1123455678899999999999999998 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=311.81 Aligned_cols=252 Identities=25% Similarity=0.306 Sum_probs=206.6
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
..+.-++|++.+.||+|+||.||+|.+.. ..+..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~ 96 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKN--------EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEEC--------CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcce
Confidence 44456789999999999999999995432 2246899998865422 234567789999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++...+..++||||+.+++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+
T Consensus 97 ~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQ--SLNIVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999998554 67999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||++...... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 174 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~------- 241 (340)
T PTZ00426 174 DFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL------- 241 (340)
T ss_pred cCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh-------
Confidence 99998754321 123468999999999998889999999999999999999999997654321111111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
.. ....+..+++.+.++|++||+.||++|+ ++.++++|
T Consensus 242 ----------~~--~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 ----------EG--IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----------cC--CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11 1123445677899999999999999995 89999886
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.02 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=207.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLV---------RDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred CCceEEEEEEeCCcEEEEEE---------EECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 47999999999999999999 5555689999999875432 23456788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+++..++||||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~ 148 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH--KLGFIHRDIKPDNILIDADGHIKLADFGLC 148 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEeecCCCC
Confidence 999999999999999999998655 77999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCC---------------------------CCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCc
Q 018891 178 RDGPTGD---------------------------NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 230 (349)
Q Consensus 178 ~~~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~ 230 (349)
....... .........|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 7543332 0011223468999999999999999999999999999999999999
Q ss_pred cCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 018891 231 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLTS 302 (349)
Q Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~ 302 (349)
||...........+..+. ..........+++++.++|.+||. ||.+||+ +.++++|
T Consensus 229 Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 229 PFYSDTLQETYNKIINWK---------------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCCCHHHHHHHHhccC---------------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 997655322222222110 001111112257889999999997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=301.63 Aligned_cols=267 Identities=28% Similarity=0.428 Sum_probs=214.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|.+.+.||.|+||.||++..... ....++..+++|.+..........+.+|+.++++++||+++++++++..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 467899999999999999999964321 1234567799998876655556678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccC------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 166 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~ 166 (349)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH--~~~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGEN 156 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccCcceEEEccC
Confidence 999999999999999999986421 24899999999999999999999 9999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHH
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 245 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~ 245 (349)
+.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875433222112222345667999999998899999999999999999998 899886554322111111
Q ss_pred hhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
. . .....+..++.++.+++.+||+.||.+|||+.++++.|+++..+
T Consensus 237 ~-----------------~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 Q-----------------G-RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred c-----------------C-CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1 0 01112234567899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=308.05 Aligned_cols=241 Identities=26% Similarity=0.358 Sum_probs=197.1
Q ss_pred eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 29 lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
||+|+||.||+| .+..++..||+|.+.... ......+.+|+.++++++||||+++++.+...+..++|
T Consensus 1 lg~G~~g~Vy~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQV---------RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 699999999999 455568899999986542 22345677899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~- 147 (312)
T cd05585 72 LAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLH--KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD- 147 (312)
T ss_pred EcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-
Confidence 9999999999988553 67999999999999999999999 9999999999999999999999999999986532221
Q ss_pred CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccc
Q 018891 186 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265 (349)
Q Consensus 186 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (349)
.......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+......... ....
T Consensus 148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~-----------------~~~~- 208 (312)
T cd05585 148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK-----------------ILQE- 208 (312)
T ss_pred -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH-----------------HHcC-
Confidence 112234689999999999999999999999999999999999999975432111111 1111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 018891 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRP---SMVDVLTS 302 (349)
Q Consensus 266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~ 302 (349)
....+..+++.+.+++.+||..||.+|| ++.++++|
T Consensus 209 -~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 209 -PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 1233456778899999999999999997 46777765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.76 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=206.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCC-CcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGS-GIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..|.+.+.||+|++|.||+|. +..+ +..|++|.+..........+.+|+.+++.++||||+++++++...
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~---------~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVAT---------RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEE---------EcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 459999999999999999994 3333 678899987665555556678899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
+..|+||||+++++|.+++.. ...++++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~~~~~~kL~DFgl 215 (478)
T PTZ00267 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRKMMHRDLKSANIFLMPTGIIKLGDFGF 215 (478)
T ss_pred CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCcCHHhEEECCCCcEEEEeCcC
Confidence 999999999999999987743 2356899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+................|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+
T Consensus 216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~------------ 283 (478)
T PTZ00267 216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV------------ 283 (478)
T ss_pred ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------
Confidence 97654332222223356899999999999999999999999999999999999999754321111111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ......+..+++++.++|.+||..||++||++.+++.+
T Consensus 284 -----~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 284 -----LY-GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred -----Hh-CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 00 11112344567889999999999999999999998753
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=313.23 Aligned_cols=254 Identities=24% Similarity=0.287 Sum_probs=205.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.+++.++|++|+++++.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVV---------REKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred CCceEEEEEEeccCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 47999999999999999999 5556688999999876432 23455778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+.+..++||||+++++|.+++.+....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a 149 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH--QMGYVHRDIKPENVLIDRTGHIKLADFGSA 149 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCeEcccCchHheEECCCCCEEeccCCCC
Confidence 999999999999999999999776578999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccc------cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVA------TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
......... ......+++.|+|||++. +..++.++|||||||++|+|++|..||...........+...
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~---- 224 (330)
T cd05601 150 ARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF---- 224 (330)
T ss_pred eECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC----
Confidence 764332221 112246889999999986 456788999999999999999999999765432211111110
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...........+++.+.+|+.+||. +|.+|||+.++++|
T Consensus 225 -----------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 -----------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0001111123467889999999998 99999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=300.32 Aligned_cols=264 Identities=25% Similarity=0.429 Sum_probs=207.3
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||+|++|.||+|.+.+. .....+..|++|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~ 78 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 4678999999999999999999976542 233456789999886432 23345678899999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccC---------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSV---------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
......++||||+++++|.+++.... ..++...+..++.|++.||+||| +.+++|+||||+||++++++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDF 156 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCcchheEEEcCCC
Confidence 99899999999999999999985422 23567788999999999999999 89999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~ 246 (349)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+..
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999998865433222111111234667999999998899999999999999999999 6888865443211111110
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
......+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus 237 ------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 ------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ------------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00112233456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=300.13 Aligned_cols=262 Identities=28% Similarity=0.454 Sum_probs=210.3
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..++|.+.+.||.|+||.||+|..... .....+..|++|.+...... ....+.+|+.+++.++|+|++++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 78 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHL----EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT 78 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccc----cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe
Confidence 357899999999999999999965321 12345678999998765444 4467889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
.....++||||+++++|.+++... ...+++..+..++.|++.++.+|| +.+++|+||+|+||+++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~h~dlkp~nili~ 156 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA--SQHFVHRDLATRNCLVG 156 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeeccccccceEEEc
Confidence 999999999999999999998643 234788899999999999999999 99999999999999999
Q ss_pred CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhh
Q 018891 165 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 243 (349)
Q Consensus 165 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~ 243 (349)
.++.++|+|||.+................+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999875433222111222345678999999999999999999999999999998 9999875543221111
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
+. .......+..++..+.+++.+||+.||++||++.++++.|.
T Consensus 237 ~~------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 IT------------------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH------------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11 11111223456788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=306.50 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=222.0
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc--hHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.+=|.+.+-||+|.|..|-+| ++.-+|++||||++.+..... ...+.+|++.++..+||||++++.+..
T Consensus 17 AGLYDLekTlG~GHFAVVKLA---------rHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLA---------RHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred eeeehhhhhhcCCceehhhhh---------hhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 457999999999999999999 889999999999998765443 356789999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc-CCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~-~~~~v~l~Dfg~ 176 (349)
....+|+|.|.-++|+|++||.++...+++..+.+++.||+.|+.|+| +..+|||||||+|+... +-|-|||.|||+
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH--qLHVVHRDLKPENVVFFEKlGlVKLTDFGF 165 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH--QLHVVHRDLKPENVVFFEKLGLVKLTDFGF 165 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh--hhhhhcccCCcceeEEeeecCceEeeeccc
Confidence 999999999999999999999999999999999999999999999999 89999999999999764 578899999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCC-CccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+..+.++.... ...|...|-|||++.+..|+ +++||||||+++|.|++|+.||..-++.+-...|+++.
T Consensus 166 SNkf~PG~kL~---TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK------- 235 (864)
T KOG4717|consen 166 SNKFQPGKKLT---TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK------- 235 (864)
T ss_pred cccCCCcchhh---cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-------
Confidence 98765554433 35689999999999999997 68999999999999999999998777655555555421
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
...|..++.++++||.+||..||.+|.|.++|..+-|
T Consensus 236 ------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 236 ------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred ------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 2467889999999999999999999999999987544
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=307.92 Aligned_cols=246 Identities=28% Similarity=0.417 Sum_probs=197.6
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHH---HhccCCCcccceeeEE
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIY---LGQLRHENLVKLIGYC 96 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~---l~~l~h~~i~~~~~~~ 96 (349)
|++.+.||+|++|.||+| ....+++.||+|.+..... .....+.+|..+ ++.++||||+++++++
T Consensus 1 y~i~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLA---------EYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred CeEEEEEeecCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 788999999999999999 4455688999999875432 223445555554 4566899999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..|+||||+++++|...+.. ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrdlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGL 147 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCcEEeCcccC
Confidence 999999999999999999988743 57999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+....... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 148 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~---------- 215 (324)
T cd05589 148 CKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN---------- 215 (324)
T ss_pred CccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 86422211 112235688999999999999999999999999999999999999976543221111110
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ....+..+++.+.++|.+||+.||.+|| ++.+++++
T Consensus 216 -------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 216 -------D--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -------C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0 1123445678899999999999999999 68888775
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=309.71 Aligned_cols=268 Identities=25% Similarity=0.386 Sum_probs=200.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||+|+||.||+| .+..++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSA---------IDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred CeEEEEEEeecCCeEEEEE---------EECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 5899999999999999999 555668999999886432 23345678899999999999999999987533
Q ss_pred -----CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 100 -----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 100 -----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
...|+||||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 72 SRREFKDIYVVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIH--TANVFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred CCCCCceEEEEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEccC
Confidence 24799999995 6898888543 57999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCC-ccccceecCCcccCcccccc--CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 175 GLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 175 g~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
|++......... .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 227 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTP 227 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCC
Confidence 998753222211 11123568999999999865 678899999999999999999999997655322222111111100
Q ss_pred -hhh--------hhhHhhhhccccCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 -LRD--------SRRVLRIMDTRLGGQY---SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 -~~~--------~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... .......+........ .+.+++.+.+++.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 0000011111111110 12345778999999999999999999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=306.86 Aligned_cols=268 Identities=28% Similarity=0.397 Sum_probs=209.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
+..++|++.+.||.|+||.||+|...+. ....+++.||+|.+..... .....+..|+.+++++ +|+||++++++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~----~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGI----EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cCHHHhhhhcccccCcCceEEecccccc----ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 3467999999999999999999964321 2334568899999875432 2345677899999999 79999999998
Q ss_pred Eec-CCceEEEEEeCCCCChHHHHhccC----------------------------------------------------
Q 018891 96 CSE-SDNRLLVYEFMPKGSLENHLFRSV---------------------------------------------------- 122 (349)
Q Consensus 96 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------- 122 (349)
+.. +...++++||+++++|.+++....
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 754 456889999999999999885321
Q ss_pred --------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceec
Q 018891 123 --------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 194 (349)
Q Consensus 123 --------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~ 194 (349)
..+++..+..++.|++.||+||| +.+|+|+||||.||+++.++.++|+|||++................+
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 26788999999999999999999 99999999999999999999999999999976433222222222345
Q ss_pred CCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHH
Q 018891 195 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK 273 (349)
Q Consensus 195 ~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (349)
+..|+|||++.+..++.++|+|||||++|+|++ |..||.+....+... ..+........+..
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~ 300 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC-----------------RRLKEGTRMRAPEY 300 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH-----------------HHHhccCCCCCCcc
Confidence 667999999999999999999999999999998 999997543321110 01111111222345
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 274 EAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 274 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
.++++.+++.+||+.+|++||++.+++++|.++..
T Consensus 301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 301 ATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 56789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=306.13 Aligned_cols=269 Identities=22% Similarity=0.299 Sum_probs=205.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||.|+||.||+| .+..++..||+|.+...... ....+.+|+.++++++||||+++++++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 76 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKG---------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD 76 (309)
T ss_pred CceEEEEEecccCCEEEEEE---------EecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 67999999999999999999 45556788999988654322 334567899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++ +|.+++......+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++..
T Consensus 77 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 77 KSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred CeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence 999999999965 888888665566899999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh-hhh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD-SRR 257 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 257 (349)
...... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+.......... ...
T Consensus 154 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 154 KSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred cCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 322211 1122356888999998865 468899999999999999999999998766544333332221111100 000
Q ss_pred H---h--hhhccccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 258 V---L--RIMDTRLGG-----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 258 ~---~--~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
. . ......... .....+++++.+||.+||+.||.+|||+.++++|-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 287 (309)
T cd07872 232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287 (309)
T ss_pred hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence 0 0 000000000 01124577899999999999999999999999743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=311.41 Aligned_cols=267 Identities=27% Similarity=0.390 Sum_probs=210.8
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccC-CCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 96 (349)
..++|++++.||.|+||.||+|.+... .....+..||+|.+...... ....+.+|+.+++++. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGL----SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEccc----CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 367899999999999999999965322 23344567999999754332 3456889999999996 99999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccC------------------------------------------------------
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSV------------------------------------------------------ 122 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------ 122 (349)
......++||||+++++|.+++....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 99999999999999999998875421
Q ss_pred -----------------------------------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcE
Q 018891 123 -----------------------------------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 161 (349)
Q Consensus 123 -----------------------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Ni 161 (349)
..+++..+..++.|++.||+||| +.+++|+||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dikp~Ni 268 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA--SKNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHhE
Confidence 24677888999999999999999 89999999999999
Q ss_pred EEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcch
Q 018891 162 LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLA 240 (349)
Q Consensus 162 lv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~ 240 (349)
+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999999875433222111222345677999999988899999999999999999997 8899875432111
Q ss_pred hhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 241 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
.. ...........+..++..+.+++.+||+.||++|||+.++.+.|+++..
T Consensus 349 ~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 FY-----------------NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HH-----------------HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 10 0111111222345677889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=312.60 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=203.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||.|+||.||+| .+..+++.||||++..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLV---------QKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred CCceEEEEEEecCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 47999999999999999999 5556688999999875422 23355778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 148 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEeecccc
Confidence 999999999999999999998554 67999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCc------------------------------------cccceecCCcccCccccccCCCCCccceehhhHH
Q 018891 178 RDGPTGDNTH------------------------------------VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 221 (349)
Q Consensus 178 ~~~~~~~~~~------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~l 221 (349)
.......... ......|++.|+|||++.+..++.++|+|||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 228 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhH
Confidence 6432211000 0011358999999999999999999999999999
Q ss_pred HHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHH
Q 018891 222 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS---MVD 298 (349)
Q Consensus 222 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ 298 (349)
+|+|++|..||...........+..+. ..........+++++.++|.+|+. +|.+|++ +.+
T Consensus 229 l~el~~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ 292 (364)
T cd05599 229 MYEMLVGYPPFCSDNPQETYRKIINWK---------------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNE 292 (364)
T ss_pred HHHhhcCCCCCCCCCHHHHHHHHHcCC---------------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHH
Confidence 999999999997654322221111110 000011112457789999999996 9999997 999
Q ss_pred HHHH
Q 018891 299 VLTS 302 (349)
Q Consensus 299 ll~~ 302 (349)
+++|
T Consensus 293 ll~h 296 (364)
T cd05599 293 IKSH 296 (364)
T ss_pred HhcC
Confidence 9885
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=289.93 Aligned_cols=262 Identities=22% Similarity=0.306 Sum_probs=216.8
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhccCCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
+....+.|.+.+.||+|.|+.|+++ .+..+|+.+++|++.-. .....+.+.+|+++-+.++||||+++.
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc---------~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~ 76 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 76 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHH---------HhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehh
Confidence 3455688999999999999999999 78888999999988543 223567889999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---CCcEE
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAK 170 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~---~~~v~ 170 (349)
+.+.+....|+|+|++.|+.|..-|... .-.++..+..+++||++||.|+| .++|+|||+||.|+++.+ ..-+|
T Consensus 77 ~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH--~n~IvHRDvkP~nllLASK~~~A~vK 153 (355)
T KOG0033|consen 77 DSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH--SNGIVHRDLKPENLLLASKAKGAAVK 153 (355)
T ss_pred hhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH--hcCceeccCChhheeeeeccCCCcee
Confidence 9999999999999999999998766443 56789999999999999999999 999999999999999954 34599
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|+|||++.... .........|+|.|++||++...+|+..+|||+-|+++|-|+.|.+||.+.+.....+.|...
T Consensus 154 L~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--- 227 (355)
T KOG0033|consen 154 LADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--- 227 (355)
T ss_pred ecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc---
Confidence 99999998765 233344578999999999999999999999999999999999999999875432222222210
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
........-+.++++..+||++||..||.+|.|+.|.|+|=+...
T Consensus 228 ------------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 228 ------------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ------------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 111122234678899999999999999999999999998755433
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=303.03 Aligned_cols=266 Identities=24% Similarity=0.382 Sum_probs=210.5
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
...+|++.+.||+|+||.||+|.+... .......|++|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~ 79 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 79 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecC-----CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence 457899999999999999999976431 12224458999986543 234466888999999999999999999987
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.. ..++|++++.+++|.+++......++...++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 80 ~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 80 TS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred CC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH--hcCeeccccchhheEecCCCcEEEcccccc
Confidence 64 578999999999999999776667899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
.................+..|++||.+.+..++.++|+||||+++|+|++ |..||.+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-------------- 222 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------------- 222 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------------
Confidence 76543322111111223567999999999999999999999999999997 999987543221111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
..........+..++.++.+++.+||..||.+|||+.+++..+.++....
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 223 ----ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ----HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 11111122223445678999999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=307.56 Aligned_cols=248 Identities=29% Similarity=0.428 Sum_probs=200.6
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCC-CcccceeeEEe
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRH-ENLVKLIGYCS 97 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~ 97 (349)
+|++.+.||+|+||.||+| ....+++.||+|++..... .....+..|..+++.+.| ++|+++++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred CceEEEEEeeccCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 6899999999999999999 4555678999999875432 234556788889988875 56888999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..|+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~ 148 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMC 148 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEEcCCCCEEEeecCcc
Confidence 889999999999999999988544 67899999999999999999999 899999999999999999999999999988
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~----------- 215 (324)
T cd05587 149 KENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME----------- 215 (324)
T ss_pred eecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc-----------
Confidence 64222111 12234689999999999999999999999999999999999999976543222211111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 302 (349)
.....+..+++.+.+++.+||..||.+|++. .++++|
T Consensus 216 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 216 --------HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1122344567889999999999999999986 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=305.51 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=199.8
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hchHHHHHHHHHHhccCCCcccceeeEEecCCc
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
++.||+|+||.||+|+.. ....+++.||+|.+..... .....+..|+.+++.++||||+++++.+..++.
T Consensus 1 ~~~lg~G~~g~V~~~~~~------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 74 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKV------TGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK 74 (323)
T ss_pred CceeeecCCeEEEEEEEc------ccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe
Confidence 368999999999999643 1235688999999865422 223456789999999999999999999999999
Q ss_pred eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 102 RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
.|+||||+.+++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 75 LYLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLH--QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred EEEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 99999999999999988543 67889999999999999999999 9999999999999999999999999999986432
Q ss_pred CCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhh
Q 018891 182 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261 (349)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (349)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........... .
T Consensus 152 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~-----------------~ 212 (323)
T cd05584 152 HEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK-----------------I 212 (323)
T ss_pred cCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHH-----------------H
Confidence 2211 12224689999999999988899999999999999999999999976442111111 1
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
... ....+..+++.+.++|.+||+.||++|| ++.+++++
T Consensus 213 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 213 LKG--KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111 1233455678899999999999999999 89998875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=296.63 Aligned_cols=257 Identities=30% Similarity=0.469 Sum_probs=211.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
....+|++.+.||.|++|.||+|.+ .. +..+++|.+..........+..|+..++.++|+|++++++++.
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~---------~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLW---------KN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEe---------cC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe
Confidence 3567899999999999999999943 33 6789999998776656677889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.....++||||+++++|.+++... ...++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred cCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccCcceEEEcCCceEEEccccc
Confidence 999999999999999999999653 356899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... .....++..|++||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 151 ~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~----------- 217 (261)
T cd05148 151 ARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI----------- 217 (261)
T ss_pred hhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-----------
Confidence 8754322111 112234567999999988899999999999999999998 89999654421111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
........+..+++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 218 -------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 -------TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -------HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11112233456678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=309.13 Aligned_cols=243 Identities=28% Similarity=0.385 Sum_probs=198.4
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEecCCceE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (349)
+.||+|+||.||+| .+..++..||+|.+..... .....+..|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 71 (325)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence 46999999999999 5556689999999876432 22345678899999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 104 LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
+||||+++++|..++... ..+++..+..++.||+.||.||| + .+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH--~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 72 FVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC
Confidence 999999999999888543 67899999999999999999999 7 7999999999999999999999999998864322
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~---------------- 210 (325)
T cd05594 149 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM---------------- 210 (325)
T ss_pred CC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc----------------
Confidence 11 112224689999999999999999999999999999999999999975442211111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
.....+..+++++.++|.+||+.||++|+ ++.++++|
T Consensus 211 ---~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 211 ---EEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01123445678899999999999999996 89999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=306.37 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=203.3
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
+|++.+.||+|+||.||+|+.. ....++..||+|++..... .....+..|+.+++.+ +|++|+++++++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKV------TGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF 74 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEc------ccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence 5899999999999999998543 2345688999999865322 2234567899999999 599999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..++..++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+++||||||+||+++.++.++|+|||+
T Consensus 75 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 75 QTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred ecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence 9999999999999999999988554 67999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... ......|++.|+|||++.+. .++.++|||||||++|+|++|..||...........+..
T Consensus 152 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~--------- 221 (332)
T cd05614 152 SKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR--------- 221 (332)
T ss_pred CccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---------
Confidence 8754322221 11224689999999998765 478899999999999999999999975433221111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
.... .....+..+++.+.+++.+||+.||++|| ++.++++|
T Consensus 222 ----~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 222 ----RILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----HHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0000 11233445678899999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=294.09 Aligned_cols=273 Identities=27% Similarity=0.336 Sum_probs=214.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCc-ccceeeEE
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHEN-LVKLIGYC 96 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-i~~~~~~~ 96 (349)
-..|..++.||+|.+|+||+| ....+|+.||+|++..+... ......+|+.+|+.++|+| |+.+++++
T Consensus 10 ~~~~~~~eklGeGtyg~Vyka---------r~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~ 80 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKA---------RSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVI 80 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEE---------EEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeee
Confidence 456888899999999999999 66677899999999776442 4566789999999999999 99999999
Q ss_pred ecCC------ceEEEEEeCCCCChHHHHhccC---CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 97 SESD------NRLLVYEFMPKGSLENHLFRSV---QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
...+ .+++||||. ..+|..++.... ..++...+..+++||+.||+||| +++|+||||||.||+|+++|
T Consensus 81 ~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H--~~~IlHRDLKPQNlLi~~~G 157 (323)
T KOG0594|consen 81 HTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH--SHGILHRDLKPQNLLISSSG 157 (323)
T ss_pred eecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCcceEEECCCC
Confidence 7776 789999999 459999997654 46888899999999999999999 99999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
.+||+|||+++....... .....++|..|+|||++.+. .|+...||||+||++++|++++..|.+.+.......|..
T Consensus 158 ~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 158 VLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred cEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 999999999985432222 23446789999999999886 789999999999999999999999998887444443432
Q ss_pred h-hchhhhhhhhHhhhhccc--cCCCC-CHH-------HHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 018891 247 W-ADPFLRDSRRVLRIMDTR--LGGQY-SKK-------EAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQL 306 (349)
Q Consensus 247 ~-~~~~~~~~~~~~~~~~~~--~~~~~-~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~ 306 (349)
. ..|............+.. +.... +.. ..++..+++.+||+.+|.+|.|+..+++| +..+
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 2 222222222211111111 11111 112 22489999999999999999999999987 5554
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.71 Aligned_cols=263 Identities=27% Similarity=0.420 Sum_probs=220.9
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccce
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKL 92 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (349)
.+.-++|+++++||+|.||.|++| ...++++.+|||+++++.. .+.+....|-+++... +||.++.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~la---------e~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLA---------ELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred cccccceEEEEEeccCcCceEEEE---------EEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence 566789999999999999999999 5556688999999988744 3446667788887777 59999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
+..|+..+++|+||||+.||++... .+...+++..+.-++..++.||.||| +++|++||||.+||+++.+|.+||+
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH--~~~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLH--ENGIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred ccccccCCeEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHH--hcCceeeecchhheEEcccCcEEec
Confidence 9999999999999999999985442 34578999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||++......+ ...++..|||.|+|||++.+..|+.++|.||||++||+||.|+.||.+.+.++....|...
T Consensus 511 DFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----- 583 (694)
T KOG0694|consen 511 DFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----- 583 (694)
T ss_pred ccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----
Confidence 999998644333 3445678999999999999999999999999999999999999999988876666555541
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH-------HHhhhcCCCCC
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS-------LEQLHTSKDMP 313 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~-------l~~~~~~~~~~ 313 (349)
...+|..++.+...+++++|..||++|.- +.+|.+| ..++..++..|
T Consensus 584 --------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~P 642 (694)
T KOG0694|consen 584 --------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKP 642 (694)
T ss_pred --------------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCC
Confidence 23456788999999999999999999975 4566553 44455554444
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.21 Aligned_cols=254 Identities=36% Similarity=0.551 Sum_probs=201.6
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecCCceE
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (349)
+.+.||.|.||.||+|.+.. .....+..|+||.+..... .....+.+|++.+++++||||+++++++...+..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-----~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-----KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-----TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred EeeEEccCCCcEEEEEEEEc-----ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence 56789999999999998874 3455678899999966433 34678899999999999999999999999888899
Q ss_pred EEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 104 LVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 104 lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
+|+||+++++|.+++... ...++...++.++.|++.||.||| +.+++|++|+++||+++.++.+||+|||++.....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH--SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence 999999999999999775 578999999999999999999999 88999999999999999999999999999976532
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (349)
...............|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~----------------- 218 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL----------------- 218 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-----------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------
Confidence 222222223456677999999999889999999999999999999 67888655322211111
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
....+...+..++..+.+++.+||..||++|||+.++++.|
T Consensus 219 -~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 -KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 22222334556788899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.61 Aligned_cols=270 Identities=27% Similarity=0.385 Sum_probs=213.6
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccc
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVK 91 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~ 91 (349)
+...+..++|++.+.||.|+||.||+|.+... .....+..+++|.+..... .....+.+|+.+++++ +||||++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 103 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGL----SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVN 103 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecC----CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcce
Confidence 33456778999999999999999999965321 2344577899998875432 3345688999999999 7999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
+++.+...+..++||||+.+++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred EEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeehhhhccceEEEcCCCeEE
Confidence 9999999999999999999999999986533 34899999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~------- 254 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY------- 254 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH-------
Confidence 999999875433222111112335677999999998899999999999999999998 999986544321111
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
...........+...++.+.+++.+||..+|++|||+.++++.|+++
T Consensus 255 ----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 ----------KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111111222334567899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=312.89 Aligned_cols=265 Identities=22% Similarity=0.245 Sum_probs=200.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
...+|++.+.||+|+||.||+| .+..+++.||+|.... ..+.+|+.++++++||||+++++++..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~---------~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFAC---------IDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEE---------EECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 3468999999999999999999 5566688999996532 345689999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
....++|+|++. ++|..++... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH--~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 999999999995 6888888544 57899999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcc-------hhhhHHhhhch-
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL-------AEQTLVEWADP- 250 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~-------~~~~~~~~~~~- 250 (349)
....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||....... ....+......
T Consensus 231 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~ 309 (391)
T PHA03212 231 FPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309 (391)
T ss_pred ccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence 4222111 11223568999999999999999999999999999999999998875433211 01111110000
Q ss_pred ---h-hhhhhhHh----hhhccccC--C-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 251 ---F-LRDSRRVL----RIMDTRLG--G-----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 251 ---~-~~~~~~~~----~~~~~~~~--~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
. ........ ........ . .....++.++.+||.+||+.||++|||+.+++++=
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 0 00000000 00000000 0 01124577899999999999999999999999743
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.73 Aligned_cols=271 Identities=24% Similarity=0.340 Sum_probs=210.8
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-C-----Cc
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-H-----EN 88 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~ 88 (349)
..+.++.+|+++++||+|.||.|.+| .+.++++.||||+++... .-......|+.+|..++ | -|
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~---------~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n 249 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKA---------YDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYN 249 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEE---------EecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCee
Confidence 45566679999999999999999999 566679999999997653 33445567888888885 3 58
Q ss_pred ccceeeEEecCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-
Q 018891 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN- 166 (349)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~- 166 (349)
+|+++++|.-.+++|||+|.+ ..+|.+++..+ ..+++...+..++.||+.+|.+|| +.+|+|+||||+|||+...
T Consensus 250 ~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--~l~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 250 IVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--ELGIIHCDLKPENILLKDPK 326 (586)
T ss_pred EEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCChhheeeccCC
Confidence 999999999999999999999 66999999763 467999999999999999999999 9999999999999999653
Q ss_pred -CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHH
Q 018891 167 -FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245 (349)
Q Consensus 167 -~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~ 245 (349)
..||++|||+++.....- ..++.+..|+|||++.|.+|+.+.|||||||+++||++|.+.|.+.+..+....|.
T Consensus 327 r~~vKVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~ 401 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARII 401 (586)
T ss_pred cCceeEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHH
Confidence 369999999998633222 24678889999999999999999999999999999999999999887655554444
Q ss_pred hhhchhh----hhhhhHhhhhcc-----------------------------ccCCCCC-----------HHHHHHHHHH
Q 018891 246 EWADPFL----RDSRRVLRIMDT-----------------------------RLGGQYS-----------KKEAQAVAAV 281 (349)
Q Consensus 246 ~~~~~~~----~~~~~~~~~~~~-----------------------------~~~~~~~-----------~~~~~~l~~l 281 (349)
+.....- .......++++. ......| ......+.++
T Consensus 402 e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~df 481 (586)
T KOG0667|consen 402 EVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDF 481 (586)
T ss_pred HHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHH
Confidence 3322000 000000000000 0000011 1234568999
Q ss_pred HHHhcccCCCCCCCHHHHHHHH
Q 018891 282 VLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 282 i~~~l~~dp~~Rps~~~ll~~l 303 (349)
+.+||.+||.+|+|+.+.++|=
T Consensus 482 lk~~L~~dP~~R~tp~qal~Hp 503 (586)
T KOG0667|consen 482 LKRCLEWDPAERITPAQALNHP 503 (586)
T ss_pred HHHHhccCchhcCCHHHHhcCc
Confidence 9999999999999999999863
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=292.41 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=198.8
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||.|+||.||+| ....++..+++|.+..... .....+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSG---------RLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 71 (252)
T ss_pred CccCcccCccEEEE---------EEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence 46999999999999 4555688899998765432 2345688999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
|||+++++|.+++......+++..++.++.|+++||.||| +.+++|+||+|.||+++.++.++|+|||.+........
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 149 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY 149 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchheEEEcCCCcEEECccccCcccccccc
Confidence 9999999999998665567899999999999999999999 99999999999999999999999999999865332211
Q ss_pred CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhcc
Q 018891 186 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264 (349)
Q Consensus 186 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (349)
.........+..|+|||.+.++.++.++|+||||+++|+|++ |..||......... .....
T Consensus 150 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~------------------~~~~~ 211 (252)
T cd05084 150 ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR------------------EAIEQ 211 (252)
T ss_pred cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH------------------HHHHc
Confidence 111111122346999999988889999999999999999998 88888654321111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
......+..++..+.+++.+||+.||++|||+.++++.|+
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1122334456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=299.32 Aligned_cols=254 Identities=24% Similarity=0.349 Sum_probs=206.1
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.+.|++.+.||.|++|.||+| ....++..+++|.+..........+.+|+..++.++|||++++++.+..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred chhhhhhheecCCCCeEEEEE---------EECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 456999999999999999999 55556889999998776666667788899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++++|..++.+....+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH--SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--cCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999999888665677999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
..... .......+++.|+|||++. ...++.++|+||||+++|+|++|..||...........+..
T Consensus 160 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------- 229 (292)
T cd06644 160 NVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------- 229 (292)
T ss_pred ccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc--------
Confidence 32211 1112345788899999884 34567899999999999999999999965432111110000
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..++.++.+++.+||..||++||++.+++++
T Consensus 230 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 230 --------SEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --------CCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000112234567789999999999999999999999875
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.41 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=208.6
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
...+|.+.+.||.|++|.||+|.+. ..+..|++|.+.... .....+.+|+..++.++|++++++++++..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~---------~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEe---------cCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 4567999999999999999999543 447889999886543 334567889999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
++..++||||+++++|.+++... ...++...+..++.|++++|+||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~df~~~ 151 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLS 151 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCcEEeCCCccc
Confidence 99999999999999999998653 346899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~------------- 217 (263)
T cd05052 152 RLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL------------- 217 (263)
T ss_pred cccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------------
Confidence 7543322111 111223557999999988899999999999999999998 8899875432211111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.........+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 218 -----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 218 -----LEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----HHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 111112234456778999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=310.41 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=201.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..|++++.||+|+||+||+| .+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~ 71 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLA---------CKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ 71 (381)
T ss_pred CCceEEEEEeecCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe
Confidence 36899999999999999999 5556689999999865432 23456788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+.+..++||||+++++|.+++.+. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH--~~givHrDlKp~Nili~~~~~~kL~DFGl~ 148 (381)
T cd05626 72 DKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFGLC 148 (381)
T ss_pred cCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCcHHHEEECCCCCEEEeeCcCC
Confidence 999999999999999999998554 67899999999999999999999 899999999999999999999999999987
Q ss_pred ccCCCCCC---------------------------------------------CccccceecCCcccCccccccCCCCCc
Q 018891 178 RDGPTGDN---------------------------------------------THVSTRIVGTRGYAAPEYVATGHLTPK 212 (349)
Q Consensus 178 ~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~ 212 (349)
........ ........|++.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (381)
T cd05626 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL 228 (381)
T ss_pred cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence 53211000 000012468999999999998899999
Q ss_pred cceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcc--cCC
Q 018891 213 SDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLH--MDP 290 (349)
Q Consensus 213 ~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~--~dp 290 (349)
+|||||||++|+|++|..||...........+..+ ...........+++++.+||.+|+. .+|
T Consensus 229 ~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 229 CDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW---------------ENTLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred cceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcc---------------ccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 99999999999999999999765432222111110 0011111122467889999999654 455
Q ss_pred CCCCCHHHHHHH
Q 018891 291 KNRPSMVDVLTS 302 (349)
Q Consensus 291 ~~Rps~~~ll~~ 302 (349)
..||++.++++|
T Consensus 294 ~~R~~~~~~l~h 305 (381)
T cd05626 294 LGRNGADDIKAH 305 (381)
T ss_pred cCCCCHHHHhcC
Confidence 569999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=311.56 Aligned_cols=255 Identities=22% Similarity=0.310 Sum_probs=201.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLV---------QKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred CCceEeEEEeecCCEEEEEE---------EECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 47999999999999999999 5556688999998865422 23355778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+....|+||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH--~~givHrDlkp~NIll~~~~~~kl~DfGla 148 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999999988543 67899999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCC------------c---------------------------------cccceecCCcccCccccccCCCCCc
Q 018891 178 RDGPTGDNT------------H---------------------------------VSTRIVGTRGYAAPEYVATGHLTPK 212 (349)
Q Consensus 178 ~~~~~~~~~------------~---------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~ 212 (349)
......... . ......|++.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 228 (377)
T cd05629 149 TGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc
Confidence 532111000 0 0001358999999999999999999
Q ss_pred cceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 018891 213 SDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN 292 (349)
Q Consensus 213 ~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 292 (349)
+|+|||||++|+|++|..||...........+..+.. .........++.++.+||.+||. +|.+
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPDDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred eeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence 9999999999999999999976543222222211100 00011112456789999999997 7776
Q ss_pred C---CCHHHHHHHH
Q 018891 293 R---PSMVDVLTSL 303 (349)
Q Consensus 293 R---ps~~~ll~~l 303 (349)
| +|+.++++|-
T Consensus 293 r~~r~~~~~~l~hp 306 (377)
T cd05629 293 RLGRGGAHEIKSHP 306 (377)
T ss_pred cCCCCCHHHHhcCC
Confidence 5 5999999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=312.83 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=202.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++|+||+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLV---------RKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred CCceEEEEEEeCCCeEEEEE---------EECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 47999999999999999999 5556689999999865432 23355778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.++..++||||+++++|.+++... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~ikL~DFG~a 148 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHEEECCCCCEEEEeCCCC
Confidence 999999999999999999998554 67899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCC-----------------------------------------CccccceecCCcccCccccccCCCCCcccee
Q 018891 178 RDGPTGDN-----------------------------------------THVSTRIVGTRGYAAPEYVATGHLTPKSDVY 216 (349)
Q Consensus 178 ~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw 216 (349)
........ ........|++.|+|||++.+..++.++|||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 228 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeee
Confidence 42210000 0000124689999999999999999999999
Q ss_pred hhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC--
Q 018891 217 SFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-- 294 (349)
Q Consensus 217 slG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-- 294 (349)
||||++|+|++|..||.+.........+..+. ..........+++++.++|.+|+ .+|.+|+
T Consensus 229 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~ 292 (376)
T cd05598 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGK 292 (376)
T ss_pred eccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC
Confidence 99999999999999997655322221111110 00011112245778889999976 5999999
Q ss_pred -CHHHHHHH
Q 018891 295 -SMVDVLTS 302 (349)
Q Consensus 295 -s~~~ll~~ 302 (349)
|+.++++|
T Consensus 293 ~t~~ell~h 301 (376)
T cd05598 293 NGADEIKAH 301 (376)
T ss_pred CCHHHHhCC
Confidence 99999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=305.41 Aligned_cols=258 Identities=27% Similarity=0.333 Sum_probs=222.1
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccC-CCcccc
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLR-HENLVK 91 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~ 91 (349)
..-....|++.+.||.|.||.||+| .+..+|+.+|+|.+...... ....+.+|+.+|+++. ||||+.
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~---------~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~ 100 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLC---------REKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQ 100 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEE---------EecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEE
Confidence 3445678999999999999999999 67777999999999776543 3468899999999998 999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC----C
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN----F 167 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~----~ 167 (349)
+++.|+.....++|||++.||.|.+.+... .+++..+..++.|+++++.||| +.|++|+||||+|+++... +
T Consensus 101 l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH--~~gvvHrDlKpEN~L~~~~~~~~~ 176 (382)
T KOG0032|consen 101 LKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH--SLGVVHRDLKPENLLLASKDEGSG 176 (382)
T ss_pred EEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCHHHeeeccccCCCC
Confidence 999999999999999999999999999766 3999999999999999999999 8999999999999999543 4
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
.++++|||++..... .......+|++.|+|||++....|+..+|+||+|+++|.|++|..||.+.+.......+...
T Consensus 177 ~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~ 253 (382)
T KOG0032|consen 177 RIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG 253 (382)
T ss_pred cEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC
Confidence 799999999987554 33445578999999999999999999999999999999999999999887765554433321
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
. ..+......+++..+.++|++||..||.+|+|+.++|+|-+
T Consensus 254 ~---------------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 D---------------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred C---------------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 1 12334455678999999999999999999999999999744
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=320.95 Aligned_cols=259 Identities=25% Similarity=0.320 Sum_probs=208.5
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccce
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
+....+++|++.+.||+|+||+||+| .+..+++.||+|.+..... .....+.+|+..+..++|++++++
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a---------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~ 96 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCA---------KRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEE---------EEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence 44556789999999999999999999 5555688999999865432 334567789999999999999999
Q ss_pred eeEEecCC--------ceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcE
Q 018891 93 IGYCSESD--------NRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 161 (349)
Q Consensus 93 ~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Ni 161 (349)
+..+.... ..++||||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||
T Consensus 97 ~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH--~~~IiHrDLKP~NI 174 (496)
T PTZ00283 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH--SKHMIHRDIKSANI 174 (496)
T ss_pred ecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHE
Confidence 88765332 367999999999999988542 356899999999999999999999 89999999999999
Q ss_pred EEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 162 LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 162 lv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
+++.++.++|+|||++................|++.|+|||++.+..++.++||||||+++|+|++|..||.+.......
T Consensus 175 Ll~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~ 254 (496)
T PTZ00283 175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254 (496)
T ss_pred EEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999987543332222223356899999999999999999999999999999999999999754321111
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. .. .......+..+++++.+++.+||+.||.+|||+.+++++
T Consensus 255 ~~-----------------~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HK-----------------TL-AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HH-----------------Hh-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 01 111123455678899999999999999999999999875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=305.42 Aligned_cols=243 Identities=28% Similarity=0.421 Sum_probs=196.5
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| .+..++..||+|++..... .....+..|..+++.+ +||||+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLA---------RLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL 71 (320)
T ss_pred CeeeeCCCeEEEEE---------EEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence 47999999999999 4555688999999875432 2334566788888776 699999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
|+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 72 ~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH--~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc
Confidence 9999999999999888544 67999999999999999999999 99999999999999999999999999998864322
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~---------------- 210 (320)
T cd05590 149 NG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN---------------- 210 (320)
T ss_pred CC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc----------------
Confidence 11 112234689999999999988999999999999999999999999976543222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 302 (349)
. ....+..+++++.+++++||+.||++||++ +++++|
T Consensus 211 -~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 211 -D--EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred -C--CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0 112334567889999999999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=310.84 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=201.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.+|++++.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.+++.++||+|+++++.+.
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~ 71 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLA---------RKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ 71 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEE---------EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE
Confidence 36899999999999999999 5566789999999865432 23456778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+.+..++||||+++++|.+++.+. ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH--~~~ivHrDlKp~NILl~~~g~~kL~DFGla 148 (382)
T cd05625 72 DKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLC 148 (382)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEEeECCCC
Confidence 999999999999999999988554 67899999999999999999999 899999999999999999999999999987
Q ss_pred ccCCCCCC---------------------------------------------CccccceecCCcccCccccccCCCCCc
Q 018891 178 RDGPTGDN---------------------------------------------THVSTRIVGTRGYAAPEYVATGHLTPK 212 (349)
Q Consensus 178 ~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~ 212 (349)
........ ........|++.|+|||++.+..++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 228 (382)
T cd05625 149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 228 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence 43211000 000012358899999999999999999
Q ss_pred cceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCC
Q 018891 213 SDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN 292 (349)
Q Consensus 213 ~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 292 (349)
+|+|||||++|+|++|..||...........+..+ ...........+++++.++|.+|+ .+|++
T Consensus 229 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW---------------QTSLHIPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred eeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHcc---------------CCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence 99999999999999999999765432211111110 011111112356788999999976 59999
Q ss_pred CCC---HHHHHHH
Q 018891 293 RPS---MVDVLTS 302 (349)
Q Consensus 293 Rps---~~~ll~~ 302 (349)
|++ +.++++|
T Consensus 293 R~~~~~~~ei~~h 305 (382)
T cd05625 293 RLGKNGADEIKAH 305 (382)
T ss_pred cCCCCCHHHHhcC
Confidence 987 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.34 Aligned_cols=268 Identities=26% Similarity=0.362 Sum_probs=198.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhcc---CCCcccceeeE
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL---RHENLVKLIGY 95 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~ 95 (349)
++|++.+.||+|+||.||+|... ...+..||+|.+...... ....+.+|+..++.+ +||||++++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~ 72 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDL--------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 72 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEc--------CCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence 47999999999999999999432 224678999988654322 223455566666555 69999999998
Q ss_pred Ee-----cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 96 CS-----ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 96 ~~-----~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
+. .....++|||+++ ++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEcCCCCE
Confidence 75 3456899999996 5898888653 345899999999999999999999 9999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
+|+|||++...... .......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.....
T Consensus 150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~ 226 (290)
T cd07862 150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 226 (290)
T ss_pred EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence 99999998754322 112234678999999999888999999999999999999999999987665444333332211
Q ss_pred hhhh-hhhhHh----hhhccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLR-DSRRVL----RIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~-~~~~~~----~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... +..... ......... ...+++++.+.+++.+||+.||++|||+.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 1000 000000 000000000 1112456788999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=308.55 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=201.4
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||+||+| .+..+++.||+|++..... .....+..|..+++.++|++|+++++.+.
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLV---------QKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred CCceEeEEEEeCCCEEEEEE---------EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 47999999999999999999 5556689999999865432 22345778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+....|+||||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH--~~givHrDlKp~NILi~~~~~vkL~DFGla 148 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIH--QLGFIHRDIKPDNLLLDSKGHVKLSDFGLC 148 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEecCCCHHHeEECCCCCEEEeeccCc
Confidence 999999999999999999998654 67999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCC---------------------------------ccccceecCCcccCccccccCCCCCccceehhhHHHHH
Q 018891 178 RDGPTGDNT---------------------------------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE 224 (349)
Q Consensus 178 ~~~~~~~~~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ 224 (349)
......... .......|++.|+|||++.+..++.++|+|||||++|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~e 228 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHH
Confidence 643221100 00112468999999999999999999999999999999
Q ss_pred HHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCC---CCCCHHHHHH
Q 018891 225 LLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK---NRPSMVDVLT 301 (349)
Q Consensus 225 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~---~Rps~~~ll~ 301 (349)
|++|..||.+.........+..+... ........+++++.++|.+|+. +|. .||++.++++
T Consensus 229 ll~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 229 MLIGYPPFCSETPQETYKKVMNWKET---------------LIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT 292 (363)
T ss_pred HHhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC
Confidence 99999999765532222222211000 0000012356788899998775 444 4589999998
Q ss_pred H
Q 018891 302 S 302 (349)
Q Consensus 302 ~ 302 (349)
|
T Consensus 293 h 293 (363)
T cd05628 293 N 293 (363)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=292.52 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=207.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||.|+||.||+| ....++..|++|.+.... ......+.+|+.+++.++|||++++++++.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRA---------TCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72 (267)
T ss_pred cceeeeeeeccCCCeeEEEE---------EEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence 58999999999999999999 444557899999875432 223356788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
..+..++|+||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~nil~~~~~~~~l~d~ 150 (267)
T cd08228 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCCHHHEEEcCCCCEEECcc
Confidence 88999999999999999988743 3355889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
|.+........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ . +.
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~-~~--------- 217 (267)
T cd08228 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-S-LC--------- 217 (267)
T ss_pred ccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-H-HH---------
Confidence 98875432221 11124577889999999888899999999999999999999999854332110 0 00
Q ss_pred hhhHhhhhcc-ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 255 SRRVLRIMDT-RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 255 ~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
..+.. .........++..+.+++.+||+.+|++|||+.++++.+++++
T Consensus 218 -----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 218 -----QKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -----HHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00111 1111123456788999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=304.68 Aligned_cols=248 Identities=28% Similarity=0.411 Sum_probs=200.2
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (349)
+|++.+.||+|+||.||+| .+..++..||+|.+..... .....+..|..++..+ .|++++++++++.
T Consensus 1 df~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 6899999999999999999 5555688999999875432 1223456677777777 5899999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..++||||+++++|.+++... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kL~DfG~~ 148 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEecCCCHHHeEECCCCcEEEccCCCc
Confidence 999999999999999999988544 67899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~----------- 215 (323)
T cd05616 149 KENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----------- 215 (323)
T ss_pred eecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 64322111 12234688999999999999999999999999999999999999976543222211111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 302 (349)
. ....+..++.++.+++.+||+.||.+|++. .++++|
T Consensus 216 ------~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 216 ------H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ------C--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0 122345577889999999999999999985 666654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=292.36 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=206.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-----hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
++|.+.+.||.|++|.||.| ....+++.+++|.+..... .....+.+|+.++++++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~---------~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 72 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLC---------YDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72 (263)
T ss_pred CcccccceecCCCceEEEEE---------EEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence 57999999999999999999 5556688999998764422 123567889999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+..+...++|+|++++++|.+.+... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nilv~~~~~~~l~dfg 149 (263)
T cd06625 73 LRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFG 149 (263)
T ss_pred EccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 99999999999999999999988543 67899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
.+........... .....++..|+|||++.+..++.++|+||||+++|+|++|+.||........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------------- 215 (263)
T cd06625 150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-------------- 215 (263)
T ss_pred cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--------------
Confidence 9865432211111 0123467789999999998899999999999999999999999965432111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.............+..++..+.+++.+||..+|.+|||+.+++++.
T Consensus 216 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 216 ---IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred ---HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 1111111122334556778899999999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=296.29 Aligned_cols=268 Identities=27% Similarity=0.399 Sum_probs=211.8
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (349)
-.+..++|++.+.||+|++|.||++.+... ........+++|.+..... .....+.+|+.+++.+ +|+||++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~----~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 82 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGL----DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 82 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecC----CCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 345567899999999999999999966432 1124557899998875432 3345678899999999 799999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhcc---------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
+++..++..+++|||+++++|.+++... ...+++..+..++.|++.||+||| +.+++|+||+|
T Consensus 83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp 160 (293)
T cd05053 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA--SKKCIHRDLAA 160 (293)
T ss_pred EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCccccccce
Confidence 9999999999999999999999998532 346889999999999999999999 99999999999
Q ss_pred CcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccC
Q 018891 159 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 237 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~ 237 (349)
+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+|||||++|++++ |..||.....
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999999875433222111111234567999999988899999999999999999997 8899875443
Q ss_pred cchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 238 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
...... .........+..++..+.+|+.+||..||++|||+.++++.|+.+-
T Consensus 241 ~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 EELFKL------------------LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHH------------------HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 222111 1111112233455678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.43 Aligned_cols=262 Identities=26% Similarity=0.436 Sum_probs=209.5
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
...+|...+.||+|+||.||++..... ....++..+++|.+..........+.+|+..++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 457899999999999999999964321 2344577899998876665566788899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccC--------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV--------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~--------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
....+++|||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++|+||+|+||+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA--SLHFVHRDLATRNCLVG 156 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH--HCCeecccccHhhEEEc
Confidence 899999999999999999986532 34788999999999999999999 99999999999999999
Q ss_pred CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhh
Q 018891 165 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 243 (349)
Q Consensus 165 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~ 243 (349)
+++.++|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||...........
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 999999999999865432221111122234677999999998999999999999999999998 8888864432111111
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
+ ........+..+++.+.+++.+||+.||.+||++.++++.|+
T Consensus 237 ~------------------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 I------------------TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H------------------HcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 111112223456778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=308.04 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=198.9
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..++|++.+.||.|+||.||+| .+..+++.||||.+..... .....+.+|+.+++.++|+||+++++++.
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 142 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKV---------IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD 142 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEE---------EECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec
Confidence 3478999999999999999999 4555688999999865432 23456889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.++..++||||+++++|.+. ...++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 143 ~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 143 HNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred cCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEcccccc
Confidence 99999999999999988652 34567788899999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCcccccc-----CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
........ ......|+..|+|||++.. ...+.++|||||||++|+|++|+.||..............
T Consensus 216 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~------ 287 (353)
T PLN00034 216 RILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------ 287 (353)
T ss_pred eecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH------
Confidence 75432211 1122468899999998743 2345689999999999999999999974332111111100
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.........+..++.++.+||.+||+.||++|||+.++++|=
T Consensus 288 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 288 ---------ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ---------HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 011112233456778899999999999999999999999863
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=304.07 Aligned_cols=243 Identities=28% Similarity=0.415 Sum_probs=197.0
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| ....+++.||+|++..... .....+..|..+++.+ +||+|+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLA---------ELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL 71 (321)
T ss_pred CccccCCCeEEEEE---------EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence 46999999999999 4555688999999876432 2334566788888766 799999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
|+||||+++++|...+... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL 148 (321)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999999888544 67899999999999999999999 89999999999999999999999999998864322
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~---------------- 210 (321)
T cd05591 149 NGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH---------------- 210 (321)
T ss_pred CCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 211 12234688999999999988999999999999999999999999976543222211111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-------SMVDVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-------s~~~ll~~ 302 (349)
. ....+..++.++.+++.+||+.||++|| ++.++++|
T Consensus 211 -~--~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 211 -D--DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -C--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0 0122334567899999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=294.47 Aligned_cols=275 Identities=30% Similarity=0.445 Sum_probs=209.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+.|++.+.||.|+||+||++.++. ....++..|++|.+..... .....+.+|+..++.++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDP-----ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred hhceeceecccCCCcEEEEeeEcc-----ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345999999999999999876543 3455678899999876533 2346678899999999999999999987653
Q ss_pred --CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 100 --DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 100 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
...++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLH--SQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccChheEEEcCCCcEEEeecccc
Confidence 457899999999999999854 45999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
........... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ....... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~-~~~~~ 231 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE--MIGPKQG-QMTVV 231 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh--hhccccc-ccchh
Confidence 75443222111 11123456699999998888999999999999999999999998654321111 0000000 00011
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
..............+..++..+.+++.+||+.||++|||+.++++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111222222223344567789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=302.82 Aligned_cols=243 Identities=26% Similarity=0.412 Sum_probs=193.8
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| ....+++.||+|.+..... ........|..++... +||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLA---------ELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 47999999999999 4455688999999875432 2233445566666554 899999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++||||+++++|..++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC
Confidence 9999999999999988544 67999999999999999999999 89999999999999999999999999999875322
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~---------------- 210 (316)
T cd05592 149 GE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN---------------- 210 (316)
T ss_pred CC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----------------
Confidence 22 122235689999999999999999999999999999999999999976543221111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~ 302 (349)
.....+..++.++.+++.+||+.||.+||++. +++++
T Consensus 211 ---~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 211 ---DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11223455678899999999999999999875 55553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=294.58 Aligned_cols=278 Identities=24% Similarity=0.359 Sum_probs=210.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec-
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE- 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 98 (349)
..+|++.+.||+|+||.||+|.+.. ....++..|++|.+..........+.+|+.+++.++|||++++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 77 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC
Confidence 3589999999999999999996532 2455688999999877665556778899999999999999999987643
Q ss_pred -CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 -SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
....++||||+++++|.+++......+++..+..++.|++.||+||| ..+++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 34688999999999999999765567899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCcccc-ceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVST-RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
............. ...+...|+|||.+.+..++.++|+||||+++|+|++|..++......... .+..... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~ 233 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR-MMGNDKQ-GQMIVY 233 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhh-hcccccc-cccchH
Confidence 7654322211111 112334599999998888999999999999999999988776433211100 0000000 000001
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.....+........+..++..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11112222222333456778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=293.56 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=206.8
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..++|++.+.||.|+||.||+|.+... .......+++|.+..... .....+..|+..++++.||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~ 79 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPE-----GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP 79 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCC-----CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence 357899999999999999999966431 111223578888754332 23356777888999999999999999875
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
....++++|++++++|.+++......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 45678999999999999999766678999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
................++..|++||.+.+..++.++|+||||+++|++++ |..||.+.........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~------------ 224 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL------------ 224 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------------
Confidence 75433322222222345667999999988899999999999999999998 99999765432211111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
........+..++.++.+++.+|+..||.+|||+.++++.|..+...
T Consensus 225 ------~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 225 ------EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ------HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11111122233456789999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=283.38 Aligned_cols=255 Identities=25% Similarity=0.376 Sum_probs=210.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hch----HHHHHHHHHHhcc-CCCc
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGH----KEWLTEVIYLGQL-RHEN 88 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~----~~~~~e~~~l~~l-~h~~ 88 (349)
-...+|.-.+.||.|..+.|-++ .+..+|..+++|++..... ... +.-.+|+.+|+++ .||+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRc---------i~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~ 84 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRC---------IHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPY 84 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhh---------hhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCc
Confidence 34568999999999999999998 6777788899998854322 112 3346799999999 5999
Q ss_pred ccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
|+++.++|+.+...++|+|.++.|.|.+++.+. -.+++.+...+++|++++++||| .++|+||||||+||+++++-+
T Consensus 85 II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylH--a~~IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 85 IIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLH--ARNIVHRDLKPENILLDDNMN 161 (411)
T ss_pred EEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHH--HhhhhhcccChhheeeccccc
Confidence 999999999999999999999999999999654 77999999999999999999999 999999999999999999999
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCcccccc------CCCCCccceehhhHHHHHHHhCCccCccccCcchhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~ 242 (349)
++|.|||+++....+.... ..+|||+|+|||.+.. ..|+...|+|++|++||.++.|.+||-....-.+..
T Consensus 162 i~isDFGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR 238 (411)
T KOG0599|consen 162 IKISDFGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLR 238 (411)
T ss_pred eEEeccceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHH
Confidence 9999999999876665433 3679999999998854 468889999999999999999999995433211121
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.|++ -...+..+...+++....+||++||+.||++|.|++++|.|
T Consensus 239 ~Ime---------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 239 MIME---------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHh---------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1111 11122233446788999999999999999999999999975
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=290.61 Aligned_cols=257 Identities=30% Similarity=0.429 Sum_probs=206.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||.|++|.||+|.++ .+..|++|.+.... .....+.+|+.++++++|||++++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~----------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN----------NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec----------CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe
Confidence 45678999999999999999999532 24679999886543 33566888999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..+..++|||++++++|.+++.... ..++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 149 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQNYIHRDLAARNVLVGENNICKVADFGL 149 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCcceEEEcCCCCEEECCcce
Confidence 9999999999999999999986543 46899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+.......... .........|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----------- 217 (261)
T cd05068 150 ARVIKEDIYEA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV----------- 217 (261)
T ss_pred EEEccCCcccc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-----------
Confidence 87654221111 111122356999999988899999999999999999999 99999754421111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
........+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 218 -------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 218 -------DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -------HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11111123345678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=294.77 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=206.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||+|+||.||+|.+.. .....+..+++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~-----~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYL-----PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEec-----CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 689999999999999999996532 2334578899999875432 3335678899999999999999999999998
Q ss_pred CceEEEEEeCCCCChHHHHhcc----------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS----------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
...++||||+++++|.+++... ...+++..+..++.|++.||.||| +++++|+||+|+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~nili 157 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILI 157 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hcCeehhccccceEEE
Confidence 9999999999999999988532 134788889999999999999999 8999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhh
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 242 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~ 242 (349)
+.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+........
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999875433222111222334567999999988889999999999999999998 888886543211111
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
.+ ........+..+++.+.+++.+||+.||++||++.+++++|..
T Consensus 238 ~~------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MV------------------RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH------------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 1111122344567889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=291.41 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=207.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|++|.||+|...+ +..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456899999999999999999995432 4569999876543 23567889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..+..+++|||+++++|.+++... ...++...+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~dfg~ 149 (261)
T cd05072 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYIHRDLRAANVLVSESLMCKIADFGL 149 (261)
T ss_pred CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEecCCCcEEECCCcc
Confidence 999999999999999999998653 356888999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---------- 218 (261)
T cd05072 150 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ---------- 218 (261)
T ss_pred ceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH----------
Confidence 9764332211 1111234567999999988889999999999999999998 999997543221111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
..........++.++.+++.+||..+|++|||++++++.|+++
T Consensus 219 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 219 --------RGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --------cCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0111122234667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.88 Aligned_cols=259 Identities=23% Similarity=0.320 Sum_probs=205.7
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
....++|++.+.||+|+||.||+| ....+++.|++|++..........+.+|+..++.++|||++++++.+
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~ 75 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKA---------RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEE---------EECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE
Confidence 345678999999999999999999 45556889999998765544556678899999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..++||||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 76 ~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 76 LSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCCEEECcCcc
Confidence 9999999999999999999988543 67899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
+........ ......++..|+|||.+. ...++.++|+||+|+++|+|++|..||...........+.. ...
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~---~~~- 226 (267)
T cd06646 153 AAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK---SNF- 226 (267)
T ss_pred ceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec---CCC-
Confidence 875432211 112245778899999874 34577899999999999999999999865432111110000 000
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
. .........++..+.+++.+||+.||++|||+.++++++
T Consensus 227 ---------~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 ---------Q-PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ---------C-CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 000011224567899999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=295.17 Aligned_cols=254 Identities=31% Similarity=0.510 Sum_probs=203.3
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchH--HHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK--EWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
|++.+.||+|+||+||+| .+..+++.+|+|.+......... ...+|+..+++++||||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~---------~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKA---------KNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEE---------EETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred CEEeEEEEeCCCEEEEEE---------EECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence 788999999999999999 66667889999999776544332 3356999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++|||++++++|.+++. ....+++..+..++.|+++||++|| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 72 ~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLH--SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHH--HTTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred ccccccccccccccccccc-ccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc
Confidence 9999999999999999996 3477899999999999999999999 899999999999999999999999999998753
Q ss_pred CCCCCCccccceecCCcccCccccc-cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...........+++.|.|||++. +..++.++|+||||+++|+|++|..||...........+............
T Consensus 149 --~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 223 (260)
T PF00069_consen 149 --SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS--- 223 (260)
T ss_dssp --TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---
Confidence 12222233356788999999998 788999999999999999999999999866222222222111110000000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
......+..+.+++.+||+.||++|||+.+++++
T Consensus 224 ---------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 ---------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ---------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ---------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000113789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=302.74 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=197.2
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| .+..++..||+|+++.... .....+..|..+++.+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLV---------ELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeEeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence 47999999999999 4555688999999876432 2234567888999888 799999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
|+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEECcCcccccccc
Confidence 9999999999999888544 67999999999999999999999 99999999999999999999999999998864221
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcch-hhhHHhhhchhhhhhhhHhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLVEWADPFLRDSRRVLRI 261 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 261 (349)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ ...... ......
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~---------~~~~~~ 217 (329)
T cd05588 149 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED---------YLFQVI 217 (329)
T ss_pred CC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchH---------HHHHHH
Confidence 11 112234689999999999999999999999999999999999999964322110 000000 000011
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 018891 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS------MVDVLTS 302 (349)
Q Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~ll~~ 302 (349)
... ....+..++..+.++|.+||+.||.+|++ +.++++|
T Consensus 218 ~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 218 LEK--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred HcC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 111 12234556788999999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.52 Aligned_cols=243 Identities=27% Similarity=0.409 Sum_probs=194.1
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| .+..++..||+|.+..... ........|..++... +||+|+++++++...+..
T Consensus 1 ~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLA---------ELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL 71 (316)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence 47999999999999 4555688999999876432 2334456677777654 899999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
|+||||+.+++|..++... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF 148 (316)
T ss_pred EEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc
Confidence 9999999999999988553 67899999999999999999999 99999999999999999999999999998864222
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~---------------- 210 (316)
T cd05620 149 GD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV---------------- 210 (316)
T ss_pred CC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Confidence 11 112235689999999999999999999999999999999999999975543211111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~ 302 (349)
.....+..++.++.+++.+||+.||++||++. ++++|
T Consensus 211 ---~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 211 ---DTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 01122334677899999999999999999985 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.58 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=207.3
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
++.+++|.+.+.||+|++|.||+|.+... .....+..|++|.+..... .....+..|+.+++.++|+||++++++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 77 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGR----DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGV 77 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecC----CCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34568899999999999999999976431 1122578899998865432 234568889999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccC------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC--
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSV------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-- 167 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-- 167 (349)
+.+.+..++||||+++++|.+++.... ..+++..+..++.|++.+|+||| +.+++|+||+|+||+++.++
T Consensus 78 ~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 78 SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred EccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchheEEEeccCCC
Confidence 988889999999999999999986532 25889999999999999999999 89999999999999998654
Q ss_pred -cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHH
Q 018891 168 -NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 245 (349)
Q Consensus 168 -~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~ 245 (349)
.++|+|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||...........+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~- 234 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV- 234 (277)
T ss_pred cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-
Confidence 589999999876422221111111223457999999998999999999999999999997 99999765432211111
Q ss_pred hhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
........+..++..+.+++.+||+.+|++|||+.+++++|.
T Consensus 235 -----------------~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 -----------------TGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111112234456788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.67 Aligned_cols=243 Identities=29% Similarity=0.469 Sum_probs=197.4
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| ....++..||+|.+..... .....+..|..+++.+ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLA---------ELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL 71 (318)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence 47999999999999 4555688999999875432 2334566788888877 699999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++||||+++++|..++.+. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEccCCCHHHeEECCCCcEEecccCCCeecCc
Confidence 9999999999999888544 57999999999999999999999 99999999999999999999999999998864222
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
... ......+++.|+|||++.+..++.++|+|||||++|+|++|..||...........+.
T Consensus 149 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~----------------- 209 (318)
T cd05570 149 GGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL----------------- 209 (318)
T ss_pred CCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH-----------------
Confidence 111 1222468899999999999999999999999999999999999997554221111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 302 (349)
.. ....+..++..+.++|.+||+.||.+|||+ .+++++
T Consensus 210 ~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 210 ED--EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cC--CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 00 112344567889999999999999999999 888865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.51 Aligned_cols=268 Identities=21% Similarity=0.303 Sum_probs=203.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||.|++|.||+| .+..++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~ 76 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKG---------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 76 (301)
T ss_pred cceEEeeEeccCcCEEEEEE---------EEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence 68999999999999999999 4555688999998865432 2334567899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||++ ++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 77 KSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred CeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 99999999996 5899888766667899999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh-hhh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD-SRR 257 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 257 (349)
...... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+.......... ...
T Consensus 154 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 154 KSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred cCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 322211 11223567889999988654 57889999999999999999999997665432222222111100000 000
Q ss_pred H---hhhhc---cccC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 V---LRIMD---TRLG----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~---~~~~~---~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ..... +... ......+++.+.+||.+||+.||.+|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 232 ILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 00000 0000 01112456789999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=293.04 Aligned_cols=266 Identities=24% Similarity=0.383 Sum_probs=208.9
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+...+|++.+.||.|+||+||+|.+... .......||+|.+..... .....+.+|..+++.++||||+++++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPD-----GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGIC 78 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecC-----CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 4567999999999999999999965432 111234589998865433 2345678899999999999999999988
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.. ...+++++++++++|.+++......+++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 79 LT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE--EVRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred cC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccceEEEcCCCcEEECCCCc
Confidence 65 4578999999999999999766567999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+................++..|++||.+.+..++.++|+|||||++|+|++ |..||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------------- 222 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD------------- 222 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------------
Confidence 876533222111111234567999999988899999999999999999998 889986543211111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.+........+..++.++.+++.+||+.||++||++.++++.|..+...
T Consensus 223 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 223 -----LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred -----HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1111112223345677899999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=294.67 Aligned_cols=263 Identities=28% Similarity=0.407 Sum_probs=208.0
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
+|++.+.||+|+||.||+|..... ........+++|.+..... .....+.+|+..++.++||||+++++.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRL----KGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecC----CCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence 588999999999999999965421 1223446788998865433 23456888999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhcc-----------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCC
Q 018891 101 NRLLVYEFMPKGSLENHLFRS-----------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 157 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~-----------------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~ 157 (349)
..++++||+.+++|.+++... ...++...++.++.|++.||.||| +.+++|+||+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA--EMKLVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH--HCCeehhhhh
Confidence 999999999999999987532 134788899999999999999999 9999999999
Q ss_pred CCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCcccc
Q 018891 158 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDR 236 (349)
Q Consensus 158 ~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~ 236 (349)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999875433222111111234567999999988889999999999999999998 999997544
Q ss_pred CcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 237 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
...... ..........+..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 235 ~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 PERLFN------------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHH------------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 221111 111112223344567789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=289.62 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=202.6
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|++.+.||.|+||.||+|.++. +..+++|.+.... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccC
Confidence 3679999999999999999996532 4578999876443 2345678899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++++|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~ 149 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY 149 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcceEEEcCCCeEEECCCCCccc
Confidence 9999999999999999998665567899999999999999999999 99999999999999999999999999998875
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+..
T Consensus 150 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~------------ 216 (256)
T cd05114 150 VLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR------------ 216 (256)
T ss_pred cCCCceec-cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC------------
Confidence 42222111 111234557999999988889999999999999999999 8999975543222221111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
......+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus 217 ------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 217 ------GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 011112233456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.31 Aligned_cols=255 Identities=23% Similarity=0.261 Sum_probs=204.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
...++|++.+.||.|+||.||+| .+..++..||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLV---------RHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 44578999999999999999999 5556688999999865322 23345678999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++..++..++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~~kL~Df 186 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADF 186 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEcCCCCEEEEec
Confidence 99999999999999999999998854 46889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccC----CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|++........ .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...........+
T Consensus 187 G~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------ 259 (370)
T cd05596 187 GTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------ 259 (370)
T ss_pred cceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH------
Confidence 99875432211 111234689999999998653 4788999999999999999999999765432111111
Q ss_pred hhhhhhhHhhhhccccCCCC--CHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQY--SKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTSL 303 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~l 303 (349)
......... ...++.++.++|.+||+.+|.+ |+|+.++++|-
T Consensus 260 -----------~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 260 -----------MDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred -----------HcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 111111111 2246789999999999999988 99999999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=296.48 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=203.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.|++.+.||.|+||.||++ .+..++..||+|.+...... ....+.+|+.+++.++||+|+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEE---------EEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 4889999999999999999 44556889999998654322 22456789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
++..++||||+++++|.+.+... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RERIVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--HCCcEecCCCHHHEEECCCCCEEEeeCCCc
Confidence 89999999999999999887543 356899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ .....++..|+|||++.+..++.++|+||+|+++|+|++|..||.+.........+..
T Consensus 150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~----------- 215 (285)
T cd05605 150 VEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER----------- 215 (285)
T ss_pred eecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH-----------
Confidence 75432211 1224678899999999988999999999999999999999999976443211111111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
... ......+..+++.+.+|+.+||..||++|| ++.++++|
T Consensus 216 ---~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 216 ---RVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---Hhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 000 011223455788899999999999999999 88899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=320.13 Aligned_cols=269 Identities=29% Similarity=0.455 Sum_probs=230.6
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+...+.+..+.||.|.||.||+|...+- ........||||.++..... ...+|.+|++++..++|||||+++++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l----~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGL----LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCC----CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 34456778889999999999999975432 23456788999999887665 67889999999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhcc-------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEE
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRS-------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 162 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nil 162 (349)
+.+++-.++|+||++.|+|.+++... ..+++..+.+.++.||+.|+.||- +..+|||||-.+|++
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs--~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS--SHHFVHRDLATRNCL 635 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCcccccchhhhhce
Confidence 99999999999999999999999631 123889999999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchh
Q 018891 163 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAE 241 (349)
Q Consensus 163 v~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~ 241 (349)
|.++-.|||+|||+++.....+.........-...|+|||.+..+.|+.+|||||+|+++||+++ |..||.+.++++..
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 99999999999999987766665554434445678999999999999999999999999999999 88999887765555
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
..+.+ ..-...|.++|.++.+|+..||+.+|.+||++.+|-..|+.....
T Consensus 716 e~i~~------------------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 716 ECIRA------------------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHc------------------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 44433 222566789999999999999999999999999999999987665
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.78 Aligned_cols=263 Identities=25% Similarity=0.358 Sum_probs=208.6
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
...+|++.+.||.|+||.||+|.+.+. .....+..||+|.+...... ....+.+|..+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~ 78 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGT----APGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecC----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 346799999999999999999976432 12345678999998755322 2356788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc---------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEE
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 162 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nil 162 (349)
.....++++||+.+++|.+++... ...++...+..++.|++.||.||| +.+++|+||||.||+
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH--~~gi~H~dlkp~Nil 156 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVL 156 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH--HcCccccccchhheE
Confidence 989999999999999999988421 134788889999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchh
Q 018891 163 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAE 241 (349)
Q Consensus 163 v~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~ 241 (349)
++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.......
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999875433322222222345678999999988889999999999999999998 77888654321111
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
.. .........+.+++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 237 ~~------------------i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EM------------------IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HH------------------HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11 11111223445678889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=292.83 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=208.9
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||.|+||.||+|.+... .....+..|++|.+..... .....+.+|+.+++.++|||++++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~ 78 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGV----VKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV 78 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEecc----CCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 3467999999999999999999976532 1234568899999865432 3345678899999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccC---------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSV---------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
......++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~di~p~nill~~~~ 156 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--AKKFVHRDLAARNCMVAEDL 156 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccChheEEEcCCC
Confidence 99999999999999999999985421 23678889999999999999999 99999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~ 246 (349)
.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||...........+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~-- 234 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-- 234 (277)
T ss_pred CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH--
Confidence 999999999875433322112222345678999999988889999999999999999998 88898654432211111
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 ----------------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ----------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111122234445788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=289.33 Aligned_cols=252 Identities=32% Similarity=0.511 Sum_probs=207.0
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-hHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||+|+||.||+|.+... ...+..+++|.+....... ...+.+|+..++.++|++++++++++......++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~------~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGK------DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecC------CCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence 4699999999999965421 1347889999987765443 56788999999999999999999999998999999
Q ss_pred EEeCCCCChHHHHhcc--------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 106 YEFMPKGSLENHLFRS--------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~--------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
|||+++++|.+++... ...+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH--cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 9999999999999665 477999999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------------- 219 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY------------- 219 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------------
Confidence 86554332122223456788999999988889999999999999999999 5999976533221111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.........+..++.++.+++.+||+.||.+|||+.+++++|+
T Consensus 220 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 220 -----LRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----HHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112223345566889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=303.75 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=198.2
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEecCCceE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (349)
++.||+|+||.||+++.. ....+|..||+|++...... ....+..|+.++++++||||+++++.+..++..|
T Consensus 1 l~~lg~G~~g~Vy~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 74 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKI------TGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLY 74 (318)
T ss_pred CceeeeCCCEEEEEEEEe------ccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEE
Confidence 367999999999998542 22356889999998764322 2345678999999999999999999999999999
Q ss_pred EEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCC
Q 018891 104 LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183 (349)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~ 183 (349)
+||||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 75 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 75 LILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred EEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 999999999999988543 67899999999999999999999 899999999999999999999999999998653222
Q ss_pred CCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhc
Q 018891 184 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263 (349)
Q Consensus 184 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (349)
. .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||...........+ ..
T Consensus 152 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i-----------------~~ 212 (318)
T cd05582 152 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI-----------------LK 212 (318)
T ss_pred C--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH-----------------Hc
Confidence 1 1122246889999999999888999999999999999999999999754421111111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
. ....+..+++.+.+++++||+.||++||+ +.+++++
T Consensus 213 ~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 213 A--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 1 11234556788999999999999999999 5556654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=297.67 Aligned_cols=273 Identities=26% Similarity=0.374 Sum_probs=212.9
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
+..++|.+.+.||+|+||.||+|.+.+... ........+++|.+.... ......+..|+.+++.+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 335799999999999999999996543210 112345679999987643 23345677899999999 79999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
+...+..++||||+++++|.+++.... ..++...++.++.|++.||+||| +.+++|+||+|+|
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~N 170 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA--SKKCIHRDLAARN 170 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHHh
Confidence 999999999999999999999996532 24788899999999999999999 8999999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcc
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGL 239 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~ 239 (349)
|+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999999865432221111111223467999999988889999999999999999998 888886543211
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 312 (349)
... .+........+..++.++.+++.+||..+|.+|||+.++++.|+.+......
T Consensus 251 ~~~------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 251 LFK------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred HHH------------------HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 111 1111112233456678999999999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=302.62 Aligned_cols=243 Identities=26% Similarity=0.391 Sum_probs=192.7
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHH-HHhccCCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVI-YLGQLRHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| .+..+++.||+|.+...... ....+..|.. +++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLA---------KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL 71 (323)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence 47999999999999 55566899999998654322 2233444443 56788999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++||||+++++|..++.. ...+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 72 YFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc
Confidence 999999999999998854 367899999999999999999999 99999999999999999999999999998864222
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+ .
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i-----------------~ 209 (323)
T cd05575 149 HS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI-----------------L 209 (323)
T ss_pred CC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH-----------------H
Confidence 11 1122346899999999999999999999999999999999999999754422111111 1
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV----DVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~----~ll~~ 302 (349)
... ...+..+++.+.++|.+||+.||.+||++. +++++
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 210 NKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 111 122345678899999999999999999984 66543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=290.10 Aligned_cols=253 Identities=29% Similarity=0.424 Sum_probs=202.9
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|++.+.||+|++|.||.|.+.+ +..+++|.+..... ....+.+|+..++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 4689999999999999999996532 34599998875432 346688999999999999999999999988
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++||||+.+++|.+++......+++..++.++.|++.||+||| +.+++|+||+|.||+++.++.++|+|||.+..
T Consensus 72 ~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~ 149 (256)
T cd05113 72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149 (256)
T ss_pred CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCCEEECCCcccee
Confidence 8899999999999999999765557899999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
........ .....++..|++||.+.+..++.++|+||||+++|+|++ |..||...........+..
T Consensus 150 ~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------------ 216 (256)
T cd05113 150 VLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ------------ 216 (256)
T ss_pred cCCCceee-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc------------
Confidence 43222111 111234567999999988889999999999999999998 9999865443211111110
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
......+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 217 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 217 ------GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1111122334678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=288.65 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=205.6
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|.+.+.||+|++|.||+| ....++..|++|.+.... ......+.+|+.+++.++|||++++++.+...
T Consensus 1 ~~~~~~~l~~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred CceEeEEecCCCCeEEEEE---------EEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 5889999999999999999 444558899999886542 23456678899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..++||||+++++|.+++... ...++...++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEeCCCCEEEcccccce
Confidence 9999999999999999998664 467899999999999999999999 8999999999999999999999999999887
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
........ .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...........
T Consensus 150 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------------- 212 (256)
T cd08529 150 LLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK--------------- 212 (256)
T ss_pred eccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---------------
Confidence 54332221 1224578889999999999999999999999999999999999975442111110
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. .......+..++..+.+++.+||+.+|++||++.+++++
T Consensus 213 --~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 213 --II-RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --HH-cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01 111122334677889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=289.10 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=208.9
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|++.+.||.|++|.||+| ....++..+++|.+..........+.+|+.+++.++|||++++++.+...
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 72 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKA---------RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR 72 (262)
T ss_pred ccceEEEEEecCCCceEEEEe---------EecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC
Confidence 468999999999999999999 44455788999998776555667888999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..+++|||+++++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 73 ~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 73 DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH--ETGKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCChhhEEECCCCCEEECccccchh
Confidence 9999999999999999988666578999999999999999999999 89999999999999999999999999998875
Q ss_pred CCCCCCCccccceecCCcccCccccccC---CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
...... ......++..|++||.+.+. .++.++|+||||+++|+|++|..||...........+...
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~--------- 219 (262)
T cd06613 151 LTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS--------- 219 (262)
T ss_pred hhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------
Confidence 433211 11224577889999998776 7889999999999999999999999765432211111100
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ...........+.++.+++++||..+|.+|||+.+++.+
T Consensus 220 ----~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 220 ----NF-PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ----cC-CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000111234567889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=300.92 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=196.2
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| ....+++.||+|.+..... .....+..|..++.++ +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLV---------RLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 71 (329)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence 47999999999999 5555688999999876432 2334566788888776 799999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++||||+++++|..++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC
Confidence 9999999999999887543 67999999999999999999999 99999999999999999999999999999864322
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH-hhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV-LRI 261 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 261 (349)
... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||........... ...... ...
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~---------~~~~~~~~~i 217 (329)
T cd05618 149 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------NTEDYLFQVI 217 (329)
T ss_pred CCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc---------ccHHHHHHHH
Confidence 111 12234689999999999999999999999999999999999999964221110000 000000 001
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 018891 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 302 (349)
Q Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 302 (349)
.. .....+..++..+.+++.+||+.||++||++ .++++|
T Consensus 218 ~~--~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 218 LE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred hc--CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11 1123455677889999999999999999984 677665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=290.18 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=208.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||.|++|.||+| ....++..+++|.+..... .....+.+|+.+++.++|||++++++++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~---------~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 72 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRA---------TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72 (267)
T ss_pred chhhhhhhhcccCCeEEEEE---------eecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence 57999999999999999999 4455588999998765322 23456788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
.++..+++||++++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df 150 (267)
T cd08229 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEECcc
Confidence 99999999999999999998853 2356899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
|.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+...+.. ...
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~--------- 217 (267)
T cd08229 151 GLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SLC--------- 217 (267)
T ss_pred hhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HHh---------
Confidence 98865433221 11224578889999999888899999999999999999999999965432100 000
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
............+...++.+.+++.+||+.||++|||+.++++.+.++.
T Consensus 218 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 218 ----KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ----hhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0000111111122357789999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=305.15 Aligned_cols=273 Identities=25% Similarity=0.352 Sum_probs=213.8
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccC-CCcc
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HENL 89 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i 89 (349)
..+.-.+..++|.+.+.||.|+||.||+|.+.+. .....+..||+|++...... ....+..|+.++.++. ||||
T Consensus 28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGL----SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred CCCcceecHHHeehhhhccCCCceeEEEEEEcCC----CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCe
Confidence 3334556667899999999999999999976542 23345678999999765332 2346788999999997 9999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccC-----------------------------------------------
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV----------------------------------------------- 122 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------- 122 (349)
+++++.+...+..++||||+++++|.+++.+..
T Consensus 104 v~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 999999999899999999999999999985421
Q ss_pred --------------------------------------------------CCCChHHHHHHHHHHHHHHHHHhcCCCCee
Q 018891 123 --------------------------------------------------QPISWPTRVKIAIDVARGLSFLHGLDANVI 152 (349)
Q Consensus 123 --------------------------------------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~ 152 (349)
..++...++.++.|++.||+||| +.+++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~iv 261 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA--SKNCV 261 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCcC
Confidence 13566778889999999999999 89999
Q ss_pred eccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCcc
Q 018891 153 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA 231 (349)
Q Consensus 153 H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~p 231 (349)
|+||||.||+++.++.++|+|||++................++..|++||.+.+..++.++|+||||+++|+|++ |..|
T Consensus 262 Hrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P 341 (401)
T cd05107 262 HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341 (401)
T ss_pred cccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999875432222111112345678999999988889999999999999999998 8889
Q ss_pred CccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 232 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
|.......... .......+...+..++.++.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 342 ~~~~~~~~~~~-----------------~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 342 YPELPMNEQFY-----------------NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCchHHHH-----------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 86543211111 111111122334456789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=299.88 Aligned_cols=242 Identities=27% Similarity=0.438 Sum_probs=193.9
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| .+..++..||+|.+..... ........|..+++.. +||||+++++++...+..
T Consensus 1 ~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLA---------ELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL 71 (316)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence 47999999999999 4555688999999876422 2234455677777754 899999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH--~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLH--SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML 148 (316)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC
Confidence 999999999999998854 367899999999999999999999 99999999999999999999999999998864322
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~---------------- 210 (316)
T cd05619 149 GDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM---------------- 210 (316)
T ss_pred CCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Confidence 211 12234688999999999998999999999999999999999999976443211111100
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLT 301 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~ 301 (349)
.....+..++.++.+++.+||+.||++||++. ++++
T Consensus 211 ---~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 211 ---DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 01122344667899999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=294.90 Aligned_cols=274 Identities=26% Similarity=0.375 Sum_probs=215.2
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhcc-CCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (349)
..+..++|.+.+.||.|+||.||+|.+..... .....+..+++|.+.... ......+.+|+..++.+ +||||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 35778899999999999999999996532110 123345689999886543 23446788999999999 799999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
+++......++||||+.+++|.+++.... ..++...+..++.|++.||.||| +.+++|+||||
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~givH~dlkp 165 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA--SQKCIHRDLAA 165 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH--HCCeeeccccc
Confidence 99999999999999999999999986531 34778889999999999999999 89999999999
Q ss_pred CcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccC
Q 018891 159 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 237 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~ 237 (349)
+||+++.++.++|+|||.+................++..|+|||++.+..++.++|+||||+++|+|++ |..||.+...
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999876533322211222234567999999988889999999999999999998 7788865442
Q ss_pred cchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 238 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
......+ ........+..++..+.+++.+||..+|.+|||+.++++.|+++.....
T Consensus 246 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 246 EELFKLL------------------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred HHHHHHH------------------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 2211111 1111122334567889999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.06 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=207.2
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|++.+.||.|++|.||+|. ...++..+++|.+..........+..|+.++++++|||++++++.+..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQ---------HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEE---------EcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 4689999999999999999994 4445789999998766555667788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++||||+++++|.+++.+....+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEECCCCCEEEccCccchh
Confidence 9999999999999999998766677999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
...... ......+++.|++||.+. ...++.++|+||||+++|+|++|..||...........+..
T Consensus 153 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 222 (280)
T cd06611 153 NKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK-------- 222 (280)
T ss_pred hccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--------
Confidence 322211 122346788899999874 34567899999999999999999999976542111111100
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. .......+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 223 ------~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 ------S--EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------C--CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 000112234567789999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.93 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=203.6
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
|.+.+.||.|+||.||.|.... +.+.+..||+|.+..... .....+.+|+..++.++|||++++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQ------DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEec------CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 6789999999999999996542 223467899998875432 23456888999999999999999999876544
Q ss_pred c------eEEEEEeCCCCChHHHHhcc-----CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 101 N------RLLVYEFMPKGSLENHLFRS-----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 101 ~------~~lv~e~~~~~~L~~~l~~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
. .++++||+++++|..++... ...+++..+..++.|++.||.||| +.+++|+||||+||++++++.+
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH--~~~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchheEEECCCCeE
Confidence 3 78999999999999888432 246899999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~ 248 (349)
+|+|||++................++..|++||.+.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~----- 227 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY----- 227 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----
Confidence 9999999875433322111111234567999999988899999999999999999999 8888865443211111
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
+........+..+++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 228 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 -------------LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------------HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111112233456678899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=293.94 Aligned_cols=262 Identities=28% Similarity=0.415 Sum_probs=206.4
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhcc-CCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 98 (349)
++|++.+.||.|+||.||+|.... .+....+++|.++.. .......+.+|+.+++++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK-------DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC-------CCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 589999999999999999996532 122345788877643 223446688899999999 79999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
.+..++|+||+++++|.+++.+.. ..+++..++.++.|++.||+||| +.+++|+||||+||++
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLV 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCcCCcceEEE
Confidence 899999999999999999985421 34888999999999999999999 9999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhh
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 242 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~ 242 (349)
+.++.++|+|||++........ ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||..........
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 153 GENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999998853211111 011122446999999988889999999999999999997 999996554311111
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 312 (349)
..........+..++..+.+++.+||+.+|.+|||+.++++.|..+......
T Consensus 230 ------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 230 ------------------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred ------------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0111112233445778899999999999999999999999999998877533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=303.68 Aligned_cols=268 Identities=25% Similarity=0.324 Sum_probs=200.3
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+..++..||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 89 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAA---------FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVF 89 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEE---------EEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 3479999999999999999999 555668999999986542 23345677899999999999999999998
Q ss_pred ecCC------ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SESD------NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
.... ..|+||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH--~~~ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 90 TPQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred ccCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEE
Confidence 6443 46999999965 6766653 35788999999999999999999 99999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh-hhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE-WAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~-~~~ 249 (349)
|+|||++....... ......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.. ...
T Consensus 164 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 240 (359)
T cd07876 164 ILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240 (359)
T ss_pred EecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999986432211 12224678899999999999999999999999999999999999986543221111111 111
Q ss_pred hhhhhhhh----Hhhhhccc------------------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 250 PFLRDSRR----VLRIMDTR------------------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 250 ~~~~~~~~----~~~~~~~~------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
+....... ........ .........++.+.+||.+||+.||++|||+.++++|-.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 10000000 00000000 000111223567899999999999999999999998743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=289.28 Aligned_cols=261 Identities=27% Similarity=0.436 Sum_probs=207.3
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..+|++.+.||+|+||.||+|.+.. ....+..|++|.+.... ......+..|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKL------PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEec------CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 3578999999999999999996542 12224579999987653 2345678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+...++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH--~~g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccChheEEEcCCCcEEECCCcccc
Confidence 99999999999999999999766667899999999999999999999 8999999999999999999999999999886
Q ss_pred cCCCCCCCcccccee---cCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 179 DGPTGDNTHVSTRIV---GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
............... .+..|++||.+.+..++.++|+||||+++|++++ |..||...........+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i---------- 224 (269)
T cd05065 155 FLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI---------- 224 (269)
T ss_pred ccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH----------
Confidence 543322211111111 1346999999998999999999999999999886 99998654422111111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
........+.+++..+.+++.+||..+|.+||++.++++.|+++
T Consensus 225 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 --------EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111223345677899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=288.29 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=204.5
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
+|++.+.||.|++|.||++ .+..++..+++|.+... .....+.+.+|+.+++.++|+|++++++.+...+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLV---------QHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEE---------EEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 6899999999999999999 55556889999988543 2334566788999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 101 NRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
..++||||+++++|.+++.. ....+++..+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEECCCCcEEEcccCccee
Confidence 99999999999999998854 3356899999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||..........
T Consensus 150 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~----------------- 210 (255)
T cd08219 150 LTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL----------------- 210 (255)
T ss_pred eccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH-----------------
Confidence 433221 1122457888999999988889999999999999999999999997543211111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..........+..++..+.+++.+||+.||++|||+.+++..
T Consensus 211 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 211 -KVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -HHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011111223345567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=294.01 Aligned_cols=246 Identities=28% Similarity=0.428 Sum_probs=197.5
Q ss_pred eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 29 lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
||+|+||+||++ .+..+++.||+|.+...... ....+..|+.+++.++|++|+++.+++......++|
T Consensus 1 lg~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSAC---------QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEE---------EEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 699999999999 55556889999998654332 224567899999999999999999999998999999
Q ss_pred EEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 106 YEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
|||+++++|...+.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 999999999887743 3356899999999999999999999 99999999999999999999999999999875433
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.. ...
T Consensus 150 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~-------------~~~ 214 (280)
T cd05608 150 GQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------------RIL 214 (280)
T ss_pred CCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------------hhc
Confidence 2221 1224678899999999999999999999999999999999999975443211111110 011
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
.. ....+..+++.+.+++.+||+.||++|| +++++++|
T Consensus 215 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 215 ND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11 1223456788899999999999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=287.53 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=208.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||.|++|.||+| ....++..|++|.++.... .....+.+|+.++++++|++++++++.+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKA---------ICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred CceeeeeeeccCCceEEEEE---------EEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 58999999999999999999 4445688999998864322 23456889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
.++..++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~nil~~~~~~~~l~d~ 150 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDL 150 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecCCcChhhEEECCCCcEEEecc
Confidence 99999999999999999998853 2356899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
|.+......... .....++..|.|||.+.+..++.++|+||||+++|+|++|..||........ ..
T Consensus 151 ~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~---------- 216 (267)
T cd08224 151 GLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SL---------- 216 (267)
T ss_pred ceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH--HH----------
Confidence 988654332211 1224578889999999888899999999999999999999999864331100 00
Q ss_pred hhhHhhhhccccCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 255 SRRVLRIMDTRLGGQYSK-KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
............+. ..+..+.+++.+||..+|++|||+.++++.|++++
T Consensus 217 ----~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 217 ----CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----HhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 00011111122233 66778999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=300.23 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=199.4
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccC-CCcccceeeEEe
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR-HENLVKLIGYCS 97 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 97 (349)
+|++.+.||+|+||.||+| .+..++..||+|++..... .....+..|..+++.+. |++|+++++++.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLA---------ERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred CceEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 5788999999999999999 5556689999999875432 22345667888888875 677888999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..|+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH--~~~ivHrDikp~Nill~~~~~ikL~Dfg~~ 148 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMC 148 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEeccccc
Confidence 989999999999999999988543 67999999999999999999999 899999999999999999999999999988
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 149 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~----------- 215 (323)
T cd05615 149 KEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME----------- 215 (323)
T ss_pred cccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 64322211 11224588999999999999999999999999999999999999976543222111111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 302 (349)
. ....+..++.++.+++.+||+.||.+|++. .++++|
T Consensus 216 ------~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 216 ------H--NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ------C--CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 0 112345567889999999999999999974 555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=288.66 Aligned_cols=252 Identities=28% Similarity=0.416 Sum_probs=202.6
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..+|++.+.||.|++|.||+|.++ .+..+++|.+.... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~----------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR----------GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec----------CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 457999999999999999999543 24568999876433 2345677899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++|||++++++|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCcccccccHhhEEECCCCcEEECCccccee
Confidence 9999999999999999999765567899999999999999999999 89999999999999999999999999998875
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 150 ~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------------- 213 (256)
T cd05059 150 VLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES--------------- 213 (256)
T ss_pred cccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH---------------
Confidence 43221111 111123346999999998899999999999999999999 7888865443211111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.........+..++..+.+++.+||+.+|++|||+.++++.|
T Consensus 214 ---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 214 ---VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111112233445678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=293.72 Aligned_cols=254 Identities=23% Similarity=0.346 Sum_probs=205.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
+-|++.+.||.|++|.||+| ....++..+++|.+..........+.+|+.+++.++|||++++++.+...+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 75 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKA---------QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75 (282)
T ss_pred HHHHHHhhcccCCCeEEEEE---------EECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC
Confidence 34789999999999999999 455567889999987665555677888999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++|+||+++++|..++.....++++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 76 ~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 76 NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence 999999999999999888665577999999999999999999999 899999999999999999999999999998653
Q ss_pred CCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
.... .......++..|+|||++. +..++.++|+||+||++|+|++|..||...........+..
T Consensus 154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~--------- 222 (282)
T cd06643 154 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK--------- 222 (282)
T ss_pred cccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---------
Confidence 2221 1122245788899999873 34577899999999999999999999975442111111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
........+..++..+.++|.+||+.||.+|||+.+++++-
T Consensus 223 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 223 -------SEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -------cCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00111123445678899999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=306.16 Aligned_cols=271 Identities=22% Similarity=0.224 Sum_probs=206.5
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
..+...+|++.+.||.|+||.||+|... ....+..|++|.+.... ...+|+.+++.++||||+++++.
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~-------~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~ 154 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKH-------GDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHA 154 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEc-------CCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeee
Confidence 3345668999999999999999998542 23356789999876432 34579999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+......++|||++. ++|.+++ .....+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.++|+|||
T Consensus 155 ~~~~~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH--~~givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 155 YRWKSTVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred EeeCCEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEccCc
Confidence 999899999999995 5888888 44477999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch----h
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP----F 251 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~----~ 251 (349)
++................|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+...... .
T Consensus 231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~ 310 (392)
T PHA03207 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHP 310 (392)
T ss_pred cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCc
Confidence 987654433332233356899999999999999999999999999999999999999776543322222211110 0
Q ss_pred hh----hhhhH---hhhhccccCC--CCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LR----DSRRV---LRIMDTRLGG--QYS-----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~----~~~~~---~~~~~~~~~~--~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ..... ........+. ..+ ...+.++.++|.+||..||++|||+.+++.+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 311 LEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000 0000001111 011 1245678999999999999999999999986
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=304.25 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=202.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
...++|++.+.||+|+||.||+| .+..++..+|+|.+..... .....+.+|..+++.++||||+++++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~ 110 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLV---------RHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34579999999999999999999 5556688999999864322 23345778999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
.+..+...|+||||+++++|.+++.. ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.++|+||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH--~~~IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 111 AFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIH--SMGLIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999998854 46899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccC----CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|++........ .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...........
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~------- 258 (370)
T cd05621 187 GTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK------- 258 (370)
T ss_pred ccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH-------
Confidence 99876432221 111235689999999998654 377899999999999999999999976543211111
Q ss_pred hhhhhhhHhhhhccccCCCCC--HHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYS--KKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 302 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 302 (349)
..........+ ..++..+.+++.+||..++.+ |+++.++++|
T Consensus 259 ----------i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 259 ----------IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ----------HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111111112 245788999999999855543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=295.89 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=206.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..+|++.+.||+|++|.||+| .+..++..+++|.+..........+.+|+.+++.+.|+|++++++.+..+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred ccceeeEEEecCCCCeEEEEE---------EECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 369999999999999999999 45556889999998776555567788999999999999999999999988
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++||||+++++|.+++.. ..++..++..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH--~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 999999999999999998854 45889999999999999999999 89999999999999999999999999998865
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 166 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~-------------- 229 (296)
T cd06654 166 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------------- 229 (296)
T ss_pred cccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh--------------
Confidence 332211 1122457888999999988889999999999999999999999996543211110000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.........+..++..+.+++.+||..||++|||+.+++++
T Consensus 230 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 --TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00001112234567889999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.55 Aligned_cols=263 Identities=30% Similarity=0.458 Sum_probs=209.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|+..+.||+|++|.||+|.... .......+++|.+.... ......+..|+.+++.++|+|++++.+++
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKM------PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 346789999999999999999996431 12234579999886553 23356688899999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..++||||+++++|.+++......+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 76 TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred ccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhhEEEcCCCcEEECCCcc
Confidence 9999999999999999999999766677899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCcccc-ceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 177 ARDGPTGDNTHVST-RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 177 ~~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
+............. ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~--------- 224 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN--------- 224 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh---------
Confidence 87543322211111 1112346999999988889999999999999999997 999996543211111111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.......+.+++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus 225 ---------~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 225 ---------DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112222335677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=290.72 Aligned_cols=277 Identities=28% Similarity=0.404 Sum_probs=209.4
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
+.-|++.+.||+|+||.||.|.+.. ....++..|++|.+.... ......+.+|+.+++.++|||++++.+++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 77 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEcc-----CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 4568999999999999999996542 245568899999987553 2334668899999999999999999998876
Q ss_pred C--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 99 S--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
. ...++||||+++++|.+++.+....+++..+..++.|++.||+||| +++++|+||+|+||+++.++.++|+|||+
T Consensus 78 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 78 DGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred CCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccchheEEEcCCCCEEECCCcc
Confidence 5 5688999999999999998665556899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCc-cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+.......... ......++..|+|||.+.+..++.++|+||||+++|+|+++..|+......... ........ . ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~~-~-~~ 232 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHGQ-M-TV 232 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hccccccc-c-cH
Confidence 87644332211 111234566799999998888999999999999999999987664322110000 00000000 0 00
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
...............+..++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 233 TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 001111111222233455778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=288.21 Aligned_cols=261 Identities=28% Similarity=0.424 Sum_probs=208.3
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.++|++.+.||+|+||.||+|.+.. ....+..+++|.+..... .....+..|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKL------PGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEec------CCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 5689999999999999999996431 122355799998865432 234577889999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
++..++||||+++++|.+++......++...+..++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 99999999999999999999766667899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCCccc-cceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 179 DGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 179 ~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
........... ....++..|++||.+.+..++.++|+||||+++|++++ |..||.+.........+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~----------- 223 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE----------- 223 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-----------
Confidence 54332211110 11122457999999998899999999999999999886 999997654322111111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
...+...+..+++.+.+++.+|++.+|.+||++.++++.|.++
T Consensus 224 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 224 -------EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111222345677899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=298.74 Aligned_cols=256 Identities=20% Similarity=0.230 Sum_probs=200.9
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||++ ....++..||+|++..... .....+.+|..+++.++|++|+++++.+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVV---------KMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred CCceEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 47999999999999999999 5555688999999865321 23355778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.++..|+||||+++++|.+++.+....+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 149 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH--QLGYVHRDIKPDNVLLDKNGHIRLADFGSC 149 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--hCCeEECCCCHHHEEECCCCCEEEEECCce
Confidence 999999999999999999999765577999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCcccccc-----CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
......... ......|++.|+|||++.. ..++.++|+|||||++|+|++|..||...........+...
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~----- 223 (331)
T cd05597 150 LRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH----- 223 (331)
T ss_pred eecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC-----
Confidence 654332211 1122458999999999863 45778999999999999999999999754432111111100
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 302 (349)
.....-......+++.+.+++++||..++.+ |+++.++++|
T Consensus 224 ---------~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 ---------KEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---------CCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000001112236788999999998764443 7899999988
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=304.57 Aligned_cols=268 Identities=27% Similarity=0.392 Sum_probs=203.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||+|+||.||+| .+..++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSV---------TDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CCcccceeeeCCCEEEEEE---------EECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 5889999999999999999 455568899999886532 23345678899999999999999999999876
Q ss_pred C-----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 100 D-----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 100 ~-----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
. ..|+|+||+. ++|.+.+.. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 72 HIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred CccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChHHEEECCCCCEEeccc
Confidence 6 7899999995 578887744 367999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-hhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFL 252 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~ 252 (349)
|++........ .......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.........+..... +..
T Consensus 148 g~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 148 GLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred cceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 99875432221 112224578889999998774 578999999999999999999999987654433333322111 111
Q ss_pred hhhhh----Hhh-hhccccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 253 RDSRR----VLR-IMDTRLGG-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 253 ~~~~~----~~~-~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
..... ... ........ ......++++.+||.+||+.||++|||+.++++|-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 10000 000 00000000 11223467899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=299.45 Aligned_cols=269 Identities=27% Similarity=0.373 Sum_probs=207.3
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
+..++|++.+.||.|+||.||+|.+.+. ....+++.||+|.+..... .....+.+|+.+++++ +||||++++++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccC----CccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 3457999999999999999999965431 2345678899999875432 2345678899999999 68999999998
Q ss_pred EecC-CceEEEEEeCCCCChHHHHhccC----------------------------------------------------
Q 018891 96 CSES-DNRLLVYEFMPKGSLENHLFRSV---------------------------------------------------- 122 (349)
Q Consensus 96 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------- 122 (349)
+... ...++||||+++++|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 7654 56789999999999999885421
Q ss_pred --------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCcc
Q 018891 123 --------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 188 (349)
Q Consensus 123 --------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~ 188 (349)
..++...+..++.|+++||+||| +.+++|+||||.||+++.++.++|+|||++...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 23677788899999999999999 99999999999999999999999999999875432221111
Q ss_pred ccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccC
Q 018891 189 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG 267 (349)
Q Consensus 189 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (349)
.....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......... ........
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-----------------~~~~~~~~ 300 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----------------RRLKEGTR 300 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH-----------------HHHhccCC
Confidence 112234567999999988899999999999999999997 888986543211110 00111111
Q ss_pred CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 268 GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
...+...++++.+++.+||+.||++|||+.+++++|+.+.++
T Consensus 301 ~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 122333466899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=288.47 Aligned_cols=261 Identities=25% Similarity=0.322 Sum_probs=215.0
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhch---HHHHHHHHHHhccCCCccc
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~ 90 (349)
.-..+..++|++++.||+|.-|+||+|. ..+++..+|+|++........ .+...|-++|+.++||.+.
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~---------l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlP 140 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVE---------LRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLP 140 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEE---------ecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccc
Confidence 4456777899999999999999999994 445568999999988765543 4456788999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
.++..|+.+...|+|||||+||+|.....+. .+.+++..+.-++..++-||+||| -.||++|||||+||||.++|+|
T Consensus 141 TLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--mlGivYRDLKPENILvredGHI 218 (459)
T KOG0610|consen 141 TLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--MLGIVYRDLKPENILVREDGHI 218 (459)
T ss_pred hhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--hhceeeccCCcceeEEecCCcE
Confidence 9999999999999999999999999988653 456999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCC---------------------------------CCC---------------------ccccceecC
Q 018891 170 KLSDFGLARDGPTG---------------------------------DNT---------------------HVSTRIVGT 195 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~---------------------------------~~~---------------------~~~~~~~~~ 195 (349)
-|.||+++...... ... ......+||
T Consensus 219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT 298 (459)
T KOG0610|consen 219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT 298 (459)
T ss_pred EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence 99999997532110 000 000115789
Q ss_pred CcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHH
Q 018891 196 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA 275 (349)
Q Consensus 196 ~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (349)
..|+|||++.|..-+.++|.|+||+++|||+.|..||-+.+..+-...++. +...-...+.++
T Consensus 299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-----------------~~l~Fp~~~~vs 361 (459)
T KOG0610|consen 299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-----------------QPLKFPEEPEVS 361 (459)
T ss_pred cccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-----------------CCCcCCCCCcch
Confidence 999999999999999999999999999999999999988776444433332 222222234677
Q ss_pred HHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 018891 276 QAVAAVVLQCLHMDPKNRPS----MVDVLTS 302 (349)
Q Consensus 276 ~~l~~li~~~l~~dp~~Rps----~~~ll~~ 302 (349)
..+++||+++|..||.+|.- +.||-+|
T Consensus 362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 89999999999999999988 8888764
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=300.81 Aligned_cols=241 Identities=26% Similarity=0.381 Sum_probs=190.9
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHH-HHHHhccCCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTE-VIYLGQLRHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| .+..++..||+|++..... .....+..| ..+++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~fg~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLA---------RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 71 (325)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence 47999999999999 4555678899999865432 112233333 3456788999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++||||+++++|.+++... ..+++..+..++.||+.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 72 YFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHeEECCCCCEEEccCCCCccccc
Confidence 9999999999999988543 66889999999999999999999 99999999999999999999999999999864322
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~---------------- 210 (325)
T cd05602 149 HN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN---------------- 210 (325)
T ss_pred CC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh----------------
Confidence 11 112234689999999999999999999999999999999999999975543221111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 300 (349)
. ....++.+++.+.++|.+||+.||.+||++.+.+
T Consensus 211 -~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 211 -K--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -C--CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1 1122345678899999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=293.86 Aligned_cols=264 Identities=30% Similarity=0.435 Sum_probs=205.8
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
+.-++|++.+.||.|+||.||+|.+.. .+....+++|.+.... ......+.+|+.++.++ +||||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~-------~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKK-------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEcc-------CCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 345689999999999999999996432 1223456777765432 23345678899999999 89999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
+..++..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+|
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dlkp~N 154 (303)
T cd05088 77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARN 154 (303)
T ss_pred ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH--hCCccccccchhe
Confidence 999999999999999999999986431 35789999999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcc
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGL 239 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~ 239 (349)
|+++.++.++|+|||++........ ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 231 (303)
T cd05088 155 ILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231 (303)
T ss_pred EEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH
Confidence 9999999999999998853211111 011123456999999988889999999999999999998 999996544321
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
....+ ........+...++.+.+++.+||+.+|++|||+.++++.|..+...+.
T Consensus 232 ~~~~~------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 LYEKL------------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHH------------------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11110 1111112233456789999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.29 Aligned_cols=257 Identities=31% Similarity=0.476 Sum_probs=207.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||.|++|.||+|..+ ++..+++|.+.... .....+.+|+..+++++|+|++++++++.
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~----------~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN----------GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc----------CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 56789999999999999999999543 24679999887543 34567889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.....++|||++++++|.+++.... ..++...+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--~~~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRNYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcchheEEEcCCCCEEECcccc
Confidence 8889999999999999999996543 46899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... .......+..|+|||.+.+..++.++|+||||+++|++++ |..||.+.........+
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----------- 217 (261)
T cd05034 150 ARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV----------- 217 (261)
T ss_pred ceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----------
Confidence 8754321111 1111223567999999998889999999999999999998 99998654422111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
........+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 218 -------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 218 -------ERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred -------HcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 11112223344577899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=313.01 Aligned_cols=265 Identities=22% Similarity=0.346 Sum_probs=196.5
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
...+|++.+.||+|+||.||+| .+..+++.||||.+.... ....+|+.+++.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~---------~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEA---------ICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEE---------EECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 4568999999999999999999 455568899999875432 233479999999999999999887632
Q ss_pred C--------CceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 99 S--------DNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 99 ~--------~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
. ..+++||||+++ +|.+++.. ....+++..++.++.||+.||+||| +.+|+||||||+||+++.++
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH--~~~IiHrDLKp~NILl~~~~ 207 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNT 207 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCcCHHHEEEcCCC
Confidence 1 246789999965 77776642 3467999999999999999999999 99999999999999998665
Q ss_pred -cEEEecccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHH
Q 018891 168 -NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245 (349)
Q Consensus 168 -~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~ 245 (349)
.+||+|||++........ .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.
T Consensus 208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 284 (440)
T PTZ00036 208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284 (440)
T ss_pred CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 699999999975433221 1224678899999988664 68999999999999999999999998765433322222
Q ss_pred hh-hchhhhhhhhHhhh---------hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 246 EW-ADPFLRDSRRVLRI---------MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 246 ~~-~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ..+........... .........+...++++.+||.+||..||.+|||+.++++|
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 21 11111111000000 00000111223356789999999999999999999999975
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=292.10 Aligned_cols=266 Identities=26% Similarity=0.348 Sum_probs=196.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhcc---CCCcccceeeEE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL---RHENLVKLIGYC 96 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~ 96 (349)
+|++.+.||+|+||.||+| .+..+++.||+|.+...... ......+|+.+++.+ +||||+++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred CceEeeEEeecCCeEEEEE---------EECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 5899999999999999999 55566899999988654222 223445566666554 799999999987
Q ss_pred ec-----CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SE-----SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
.. ....++|||++.+ +|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~k 148 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGQVK 148 (288)
T ss_pred ccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEE
Confidence 54 2357899999965 888888553 345899999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|+|||++........ .....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+......
T Consensus 149 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07863 149 LADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 225 (288)
T ss_pred ECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCC
Confidence 999999875432221 12245788899999999889999999999999999999999999765543332222221110
Q ss_pred hh-hhhhhHh----hhhccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FL-RDSRRVL----RIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~-~~~~~~~----~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ....... ........ ....+.+++.+.+++.+||+.||++|||+.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0000000 00000000 01113456788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=287.88 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=207.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
++|++.+.||.|++|.||+|. ...++..+++|.+..... ...+.+|+..++.++|||++++++.+....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~---------~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAI---------HKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEE---------EcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 689999999999999999994 444578899999876543 667889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++++|++.+++|.+++......+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence 999999999999999999766678999999999999999999999 899999999999999999999999999998764
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 213 (256)
T cd06612 150 TDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------- 213 (256)
T ss_pred ccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc--------------
Confidence 33221 12224577889999999888999999999999999999999999975443211111000
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..++..+.+++.+||+.||++|||+.+++++
T Consensus 214 --~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 214 --KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0011112234567789999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=287.29 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=210.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+...+|.+.+.||.|++|.||+|.+... .+....+++|...... ....+.+.+|+.+++.++|||++++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSP------ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecC------CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 4567899999999999999999965321 1234568999886654 34456788999999999999999999988
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.. ...++||||+++++|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 77 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~ 153 (270)
T cd05056 77 TE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE--SKRFVHRDIAARNVLVSSPDCVKLGDFGL 153 (270)
T ss_pred cC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccChheEEEecCCCeEEccCce
Confidence 75 5678999999999999999765567899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... ......++..|+|||.+....++.++|+||||+++|++++ |..||...........+
T Consensus 154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----------- 221 (270)
T cd05056 154 SRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----------- 221 (270)
T ss_pred eeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-----------
Confidence 8754332111 1111223457999999988889999999999999999986 99999765432211111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
....+...+..++..+.+++.+|+..+|.+|||+.++++.|+.+...
T Consensus 222 -------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 222 -------ENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112233456678999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=289.05 Aligned_cols=267 Identities=28% Similarity=0.403 Sum_probs=210.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+.+++|++.+.||+|+||.||+|.+.. .....+..|++|.+.... ......+.+|+.+++.++|||++++++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~-----~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 77 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILID-----EKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC 77 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEec-----CCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 567899999999999999999997643 122347889999886442 23346678899999999999999999987
Q ss_pred ec-CCceEEEEEeCCCCChHHHHhccC-------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 97 SE-SDNRLLVYEFMPKGSLENHLFRSV-------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 97 ~~-~~~~~lv~e~~~~~~L~~~l~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
.. +...++++++.++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCHhhEEEcCCCc
Confidence 65 467889999999999999985532 45889999999999999999999 999999999999999999999
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~ 247 (349)
++|+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..||........ ..
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~- 230 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM----AA- 230 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH----HH-
Confidence 99999999875433222111112234567999999988889999999999999999999 9999965432111 11
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
..........+..+++.+.+++.+||..||++|||+.++++.|.++.+.
T Consensus 231 -------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 231 -------------YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -------------HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 0001111122334577899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=285.30 Aligned_cols=251 Identities=31% Similarity=0.470 Sum_probs=206.7
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||.|++|.||+|... ++.|++|.+..... ....+.+|+.+++.++|+|++++++++..
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-----------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence 4679999999999999999999532 67799999876654 45678889999999999999999999998
Q ss_pred CCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
....++||||+++++|.+++.... ..+++..+..++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccchhcccceEEEeCCCCEEEcccccc
Confidence 889999999999999999986542 36899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
........ ....+..|.|||.+.+..++.++|+||||+++|++++ |..||..........
T Consensus 150 ~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-------------- 210 (256)
T cd05039 150 KEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-------------- 210 (256)
T ss_pred cccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--------------
Confidence 76422211 1223556999999988889999999999999999997 999986543211111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
..........+..+++.+.+++.+||..+|++|||+.++++.|+.+
T Consensus 211 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 211 ----HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----HHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111112233445678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=298.10 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=197.0
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| ....++..||+|++..... .....+..|..++.++ +||+|+++++++...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLV---------RLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL 71 (327)
T ss_pred CeeeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence 47999999999999 4555688999999976532 2334567888888888 699999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
|+||||+++++|..++... ..+++..+..++.||+.||+||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEeCCCCEEEeccccceeccC
Confidence 9999999999999888543 67999999999999999999999 89999999999999999999999999998864222
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.. .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.............. ......
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~----------~~~~~~ 216 (327)
T cd05617 149 PG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY----------LFQVIL 216 (327)
T ss_pred CC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHH----------HHHHHH
Confidence 11 112235689999999999999999999999999999999999999965432211100000 000011
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 302 (349)
.. ....+..++..+.+++.+||+.||++|+++ .++++|
T Consensus 217 ~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 217 EK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred hC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11 122445567889999999999999999984 577665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=290.15 Aligned_cols=249 Identities=27% Similarity=0.364 Sum_probs=205.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||.|++|.||+| ....+++.+++|.+.... ......+.+|+.+++.++|+|++++++.+.++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKA---------IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEE---------EECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 47999999999999999999 445568899999987653 23345678899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++|+||+++++|.+++... .+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH--EEGKIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccccccee
Confidence 9999999999999999988543 7899999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
..... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 148 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~------------- 212 (274)
T cd06609 148 LTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------------- 212 (274)
T ss_pred ecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-------------
Confidence 54332 112234577889999999988899999999999999999999999975442211111110
Q ss_pred hhhccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
......+.. ++.++.+++.+||..+|++|||+++++++
T Consensus 213 -----~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 213 -----NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -----cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111111222 67789999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=286.11 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=204.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||.|++|.||+|.+. ++ ..|++|.+..... ....+.+|+.+++.++||||+++++.+.+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~---------~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWN---------GT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEec---------CC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC
Confidence 4578999999999999999999543 22 3599998875432 34567889999999999999999988754
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
...++||||+++++|.+++.+. ...+++..+..++.|++.||+||| +.+++|+||+|.||+++.++.++|+|||.+
T Consensus 73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred -CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccCcccEEEcCCCcEEeccCCce
Confidence 5689999999999999999653 345789999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+.........+
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~------------ 216 (262)
T cd05071 150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ 216 (262)
T ss_pred eeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH------------
Confidence 754332221 1112335667999999988899999999999999999999 88888654422111110
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
........+..++..+.+++.+|++.||++|||+.++++.|+...
T Consensus 217 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 217 ------ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ------hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 011112234567788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=290.18 Aligned_cols=256 Identities=24% Similarity=0.341 Sum_probs=204.0
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||.|+||.||+| .+..++..|++|.++.........+.+|+..++.++|||++++++.+..
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~ 77 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR 77 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEE---------EEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 3569999999999999999999 5556688999999876654555667889999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.+..++||||+++++|.+++... ..+++..+..++.|++.++.||| ..+++|+||+|+||+++.++.++|+|||.+.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEECcceeee
Confidence 99999999999999999988543 67999999999999999999999 8999999999999999999999999999986
Q ss_pred cCCCCCCCccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
...... .......++..|+|||.+. ...++.++|+|||||++|+|++|..||.............. ..
T Consensus 155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~---~~---- 225 (267)
T cd06645 155 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK---SN---- 225 (267)
T ss_pred EccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc---cC----
Confidence 543221 1122346788999999874 45678899999999999999999999865432111110000 00
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... .......++..+.+++.+||..||++|||+.+++++
T Consensus 226 ------~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 226 ------FQPP-KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ------CCCC-cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 000011345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=295.34 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=206.6
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..+|++.+.||.|++|.||+| .+..+++.|++|.+..........+.+|+.+++.++|+|++++++.+..+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 88 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88 (297)
T ss_pred hhhceeeeeeccCCCeEEEEE---------EECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 479999999999999999999 45556889999998765555556788899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++++|.+++.+ ..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH--~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 89 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred CEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEECcCccceE
Confidence 999999999999999998854 46889999999999999999999 89999999999999999999999999998865
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...... ......+++.|++||.+.+..++.++|+||||+++|++++|..||...........+..
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~------------- 229 (297)
T cd06656 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------- 229 (297)
T ss_pred ccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-------------
Confidence 332221 11224578889999999988899999999999999999999999965432111110000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..++..+.+++.+||..||++||++.+++++
T Consensus 230 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 230 ---NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ---CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111234567789999999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=290.01 Aligned_cols=266 Identities=24% Similarity=0.396 Sum_probs=206.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||+|+||.||+|...+. .....+..|++|.+..... .....+.+|+..++.++||||+++++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 78 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDI----IKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV 78 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEecc----CCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 4568999999999999999999965432 1223456899998764432 2334577899999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhcc---------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRS---------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
......++||||+++++|.+++... ....+...+..++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dikp~nili~~~~ 156 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN--AKKFVHRDLAARNCMVAHDF 156 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCCChheEEEcCCC
Confidence 9989999999999999999999642 123456788899999999999999 99999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~ 246 (349)
.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.........+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~- 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM- 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 999999999875433222111111234567999999988899999999999999999998 788886543221111111
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
.......+..+++.+.+++.+||+.||++|||+.++++.|++..
T Consensus 236 -----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 236 -----------------DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -----------------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00011123345678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=287.17 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=210.8
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
...+|++.+.||+|+||.||+|.+... .......+++|.+..... .....+.+|+..++.++|||++++++++.
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPE-----GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL 79 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecC-----CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457899999999999999999965421 122234689998866543 34466788999999999999999999987
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
. ...++|+||+.+++|.+++.+....+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecccCcceEEEcCCCeEEECCCccc
Confidence 7 7889999999999999999776667999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
................++..|++||.+....++.++|+||||+++|++++ |..||...........+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------------ 224 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL------------ 224 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------------
Confidence 76543222111111223457999999988889999999999999999998 99999765432211111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
........+...+..+.+++.+||..||.+|||+.++++.|.++...
T Consensus 225 ------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 225 ------EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ------hCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11111223344567899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=301.88 Aligned_cols=265 Identities=23% Similarity=0.291 Sum_probs=197.2
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.+...+|++.+.||.|+||.||+| ....++..||+|...... ...|+.++++++||||+++++++
T Consensus 62 ~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~ 126 (357)
T PHA03209 62 VVASLGYTVIKTLTPGSEGRVFVA---------TKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTL 126 (357)
T ss_pred hhhhcCcEEEEEecCCCCeEEEEE---------EECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheE
Confidence 344568999999999999999999 445557889999754332 24689999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
......++|+|++. ++|.+++......+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||.
T Consensus 127 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 127 VSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred EeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEecCcc
Confidence 99999999999995 5888888766678999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhH-------Hhhhc
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL-------VEWAD 249 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~-------~~~~~ 249 (349)
+....... ......|+..|+|||++.+..++.++|+|||||++|+|+++..|+............ .....
T Consensus 204 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~ 280 (357)
T PHA03209 204 AQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280 (357)
T ss_pred ccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence 86422211 112245889999999999999999999999999999999866665433222111110 00000
Q ss_pred ------hhhh---hhhhHhhhhcccc--CC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 ------PFLR---DSRRVLRIMDTRL--GG-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ------~~~~---~~~~~~~~~~~~~--~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..+. ............. +. .....++.++.+||.+||+.||++|||+.++++|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000 0000000000000 00 0011345677889999999999999999999975
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=293.96 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=206.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
.+|++.+.||.|++|.||+| .+..+++.|++|.+..........+.+|+..++.++|||++++++.+...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEE---------EEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 57999999999999999999 555668899999887655555677889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++|+||+++++|.+++.. ..+++..+..++.|++.+++||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH--~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLH--ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCccchhc
Confidence 99999999999999998854 46899999999999999999999 899999999999999999999999999988653
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+...
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~------------- 230 (296)
T cd06655 166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN------------- 230 (296)
T ss_pred ccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-------------
Confidence 32221 112245778899999998888999999999999999999999999765432111111100
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.......+..+++.+.++|.+||..||.+|||+.+++++
T Consensus 231 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 231 ---GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000111234567789999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=284.76 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=205.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|... ++..|++|.+..... ....+.+|+.+++.++|+|++++++++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 45679999999999999999999432 357799998875443 3467888999999999999999998874
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.+..+++||++.+++|.+++... ...++...+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~ 148 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYIHRDLRAANILVSETLCCKIADFGL 148 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHHhEEEcCCCCEEEccCcc
Confidence 46789999999999999988553 356899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.........
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~------------ 215 (260)
T cd05067 149 ARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN------------ 215 (260)
T ss_pred eeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH------------
Confidence 8754322211 1111234567999999988889999999999999999999 9999976543211111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
+........+...+.++.+++.+||+.+|++|||++++++.|+.+
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 216 ------LERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ------HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 111112233445677899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=285.02 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=199.1
Q ss_pred eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
.||+|+||.||+|.+. ...++..+++|++..... ...+.+.+|+.+++.+.||||+++++++. ....++|
T Consensus 2 ~lg~G~~g~v~~~~~~-------~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYK-------MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEe-------cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence 5899999999999653 234578899998865432 23466788999999999999999999875 4577899
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||.||+++.++.++|+|||.+........
T Consensus 74 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~ 150 (257)
T cd05116 74 MELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150 (257)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence 9999999999998543 57899999999999999999999 99999999999999999999999999999875433322
Q ss_pred Ccc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhc
Q 018891 186 THV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263 (349)
Q Consensus 186 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (349)
... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||........... +.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~------------------i~ 212 (257)
T cd05116 151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM------------------IE 212 (257)
T ss_pred eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------------HH
Confidence 111 111223467999999988889999999999999999998 9999975433211111 11
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.......+..+++++.++|.+||+.||++||++.+|.+.|+.+
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 213 SGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1112234456778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=320.03 Aligned_cols=271 Identities=31% Similarity=0.455 Sum_probs=228.3
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhccCCCccccee
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
+..+.....++.+.||+|.||.||.|.+.+.. .......||+|.+... +......|.+|..+++.++||||++++
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~----~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~li 761 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVP----GSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLI 761 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCC----CCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEE
Confidence 45566778899999999999999999876532 1112567999988665 445668899999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhcc------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRS------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
+++.+....+|++||+++|+|..||.+. ...++..+.+.++.+++.|..||+ +++++||||..+|+|+++..
T Consensus 762 Gv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe--~~~fvHRDLAaRNCLL~~~r 839 (1025)
T KOG1095|consen 762 GVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE--SKHFVHRDLAARNCLLDERR 839 (1025)
T ss_pred EeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH--hCCCcCcchhhhheeecccC
Confidence 9999988999999999999999999876 577999999999999999999999 99999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~ 246 (349)
.|||+|||+++...............-...|+|||.+..+.++.++||||||+++||++| |..||.+.++.+....
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~--- 916 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD--- 916 (1025)
T ss_pred cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH---
Confidence 999999999986555544443333234567999999999999999999999999999999 8899977664332221
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.+.. -+...|..+++.+.+++..||+.+|++||++..|++.+..+...
T Consensus 917 --------------~~~g-gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 917 --------------VLEG-GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred --------------HHhC-CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 1122 25667888999999999999999999999999999999888776
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=303.50 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=201.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| ....+++.||+|++..... .....+.+|..++..++||+|+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLV---------QKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 47999999999999999999 5555688999999865422 23456778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..++||||+++++|.+++.+. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH--~~givHrDLkp~NIli~~~~~vkL~DfG~~ 148 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIH--QLGFIHRDIKPDNLLLDAKGHVKLSDFGLC 148 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEccCCCHHHEEECCCCCEEEeeccCC
Confidence 999999999999999999998544 67999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCC---------------------------------ccccceecCCcccCccccccCCCCCccceehhhHHHHH
Q 018891 178 RDGPTGDNT---------------------------------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE 224 (349)
Q Consensus 178 ~~~~~~~~~---------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ 224 (349)
......... .......|++.|+|||++.+..++.++|+|||||++|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilye 228 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeee
Confidence 643221100 00112468999999999999999999999999999999
Q ss_pred HHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 018891 225 LLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS---MVDVLT 301 (349)
Q Consensus 225 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~ 301 (349)
|++|..||...........+..+. ..........+++++.++|.+|+ .||.+|++ +.++++
T Consensus 229 l~tG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 229 MLIGYPPFCSETPQETYRKVMNWK---------------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred cccCCCCCCCCCHHHHHHHHHcCC---------------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 999999997655432222222110 00000001125678999999977 49999984 678887
Q ss_pred H
Q 018891 302 S 302 (349)
Q Consensus 302 ~ 302 (349)
|
T Consensus 293 h 293 (360)
T cd05627 293 H 293 (360)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.15 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=200.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||+|++|.||+| .+..++..|++|.+.... ......+.+|+.++++++|||++++++.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKA---------YHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred CcchheeeeccCCCeEEEEE---------EEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 47899999999999999999 555668899999886542 23345688899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++++|..+ ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 72 NRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLW--SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 999999999999988653 34688899999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............. ....
T Consensus 145 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~----------~~~~ 210 (279)
T cd06619 145 LVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL----------QLLQ 210 (279)
T ss_pred ccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH----------HHHH
Confidence 43221 122467889999999998899999999999999999999999997543221110000 0000
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
...............++++.+++.+||+.||++||++.+++++-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 211 CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred HHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 00001111111233567899999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.40 Aligned_cols=260 Identities=21% Similarity=0.230 Sum_probs=203.7
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
.....++|++.+.||+|+||.||+| .+..+++.+|+|++..... .....+.+|..+++.++||||+++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~---------~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~ 108 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLV---------RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEE---------EECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3445689999999999999999999 5556688999999864322 223456789999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++.+..+...++||||+++++|.+++.. ..+++..+..++.||+.||.||| +.+++||||||+||+++.++.++|+
T Consensus 109 ~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred EEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999998854 45899999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccC----CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
|||++........ .......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...+.......+..
T Consensus 185 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-- 261 (371)
T cd05622 185 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN-- 261 (371)
T ss_pred eCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc--
Confidence 9999876432221 112235689999999998654 378899999999999999999999975442111111110
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTSLE 304 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~l~ 304 (349)
. ...........++..+.++|.+||..++.+ |+++.++++|..
T Consensus 262 ------------~-~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 262 ------------H-KNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred ------------C-CCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 0 000111122357788999999999844433 789999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=286.21 Aligned_cols=251 Identities=24% Similarity=0.450 Sum_probs=203.2
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc---------hHHHHHHHHHHhccCCCcccce
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---------HKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
+|.+.+.||.|++|.||+| .+..++..+++|.+....... .+.+.+|+.++++++||||+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 71 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY 71 (267)
T ss_pred CccccceeecCCCeEEEEE---------EecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 5889999999999999999 444557889999886543221 2457789999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++...+..++|+||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH--~~~ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 72 LGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH--NRGIIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred EEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH--hcCcccccCCHHHEEEcCCCCEEec
Confidence 99999999999999999999999999554 67899999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCC----CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 173 DFGLARDGPTGDN----THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 173 Dfg~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
|||.+........ ........++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .+..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~-- 223 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIFK-- 223 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHHH--
Confidence 9999875532111 111112346788999999988889999999999999999999999997543211 1110
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ........+...+..+.++|++||+.||.+||++.+++++
T Consensus 224 ------------~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 224 ------------I-GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ------------H-hccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 0111223445677889999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=288.80 Aligned_cols=277 Identities=27% Similarity=0.374 Sum_probs=213.0
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.++|++.+.||+|+||.||+|.+.. ...+++..+|+|.+...... ....+.+|+..++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~ 77 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDP-----LGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK 77 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecC-----CCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec
Confidence 4689999999999999999997643 23456889999998766543 45678899999999999999999999876
Q ss_pred --CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 99 --SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
....++||||+++++|.+++......++...+..++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||.
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 78 PGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred CCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 55789999999999999999766557999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccc-cceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+............ ....++..|++||.+.+..++.++|+||||+++|+|++|..|+.............. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---~~~~~~ 232 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA---QGQMIV 232 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccc---cccccH
Confidence 9765422211111 112344569999999888899999999999999999999999865432111100000 000001
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
......+........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111112222222233445668899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.28 Aligned_cols=267 Identities=23% Similarity=0.272 Sum_probs=200.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+.+.+|.+.+.||+|+||.||+| .+...++.|+||.... ..+.+|+.++++++|+||+++++++.
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a---------~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~ 230 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFES---------SHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRV 230 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEE---------EECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEE
Confidence 44668999999999999999999 5555688999995432 23458999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..++||+++. ++|.+++......+++..++.++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++
T Consensus 231 ~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 231 VGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH--GEGIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred ECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 9899999999995 6888888665567999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCc----chhhhHHhhhch---
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG----LAEQTLVEWADP--- 250 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~----~~~~~~~~~~~~--- 250 (349)
................|+..|+|||++.+..++.++|||||||++|+|++|..|+...... .....+......
T Consensus 308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~ 387 (461)
T PHA03211 308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV 387 (461)
T ss_pred eecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence 7543322222222346899999999999999999999999999999999988765432211 111111111000
Q ss_pred h---hhh--h----hhHhhhhccccCCC-------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 F---LRD--S----RRVLRIMDTRLGGQ-------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~---~~~--~----~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. +.. . .............. .....+.++.+||.+||+.||.+|||+.|+|+|
T Consensus 388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000 0 00000000000000 001345689999999999999999999999986
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=301.78 Aligned_cols=266 Identities=23% Similarity=0.288 Sum_probs=200.0
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+...++.||||.+.... ......+.+|+.+++.++||||+++++++
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~ 92 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 92 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEE---------EECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceee
Confidence 3579999999999999999999 555568889999986542 23345677899999999999999999987
Q ss_pred ecC------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SES------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
... ...|+||||+++ +|.+.+. ..++...+..++.|++.||.||| +++++|+||||+||+++.++.++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 93 TPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred cccccccccCeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEECCCCcEE
Confidence 543 357999999965 7777663 34788999999999999999999 99999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh-hc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-AD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~-~~ 249 (349)
|+|||++....... ......++..|+|||++.+..++.++|+|||||++|+|++|+.||.+.........+... ..
T Consensus 167 L~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 243 (364)
T cd07875 167 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243 (364)
T ss_pred EEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999997543221 112246789999999999999999999999999999999999999765543322222111 10
Q ss_pred hhhhhhhhH----hhh---------------hcc---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRDSRRV----LRI---------------MDT---RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~~~~~----~~~---------------~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+........ ... ... ..........+..+.+||.+||+.||.+|||+.++++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 000 000 00001111234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=291.38 Aligned_cols=274 Identities=25% Similarity=0.420 Sum_probs=206.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCC-----cCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccce
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNT-----FAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~-----~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
..++|++.+.||+|+||.||+|...+.. ......+....|++|.+..... .....+.+|+.++++++|+|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 4579999999999999999998653211 0001123345689999876432 234568899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccC-----------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcE
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSV-----------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 161 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Ni 161 (349)
++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA--SLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--hcCeeccccChhhE
Confidence 999999999999999999999999885421 23678889999999999999999 89999999999999
Q ss_pred EEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh--CCccCccccCcc
Q 018891 162 LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GRRALDEDRGGL 239 (349)
Q Consensus 162 lv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt--g~~pf~~~~~~~ 239 (349)
+++.++.++|+|||++................++..|+|||.+.++.++.++|+||||+++|+|++ +..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875433222111122334667999999988889999999999999999998 566776544322
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
....+... . ...........+...++.+.+++.+||..||++|||+.++++.|++
T Consensus 241 ~~~~~~~~----~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIENTGEF----F-------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHh----h-------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 22111110 0 0000001111233456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.64 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=195.1
Q ss_pred eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 29 lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
||+|+||.||++ ....+|+.|++|.+...... ....+..|+.+++.++||||+++.+.+..+...++|
T Consensus 1 lg~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAV---------QVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEE---------EEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 699999999999 55556899999988653222 223456799999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCC
Q 018891 106 YEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~ 184 (349)
|||+++++|.+.+... ...+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence 9999999998887543 346889999999999999999999 9999999999999999999999999999987543322
Q ss_pred CCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhcc
Q 018891 185 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264 (349)
Q Consensus 185 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (349)
. .....++..|+|||++.+..++.++|+|||||++|+|++|..||...........+.. .....
T Consensus 150 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~-------------~~~~~ 213 (277)
T cd05607 150 T---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR-------------RTLED 213 (277)
T ss_pred e---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH-------------Hhhcc
Confidence 1 1224578899999999988899999999999999999999999975433211111110 00000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.. ......+++++.+++.+||+.||++||++.++++.+.
T Consensus 214 ~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 214 EV-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cc-ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 00 0111346778999999999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=292.59 Aligned_cols=268 Identities=25% Similarity=0.307 Sum_probs=206.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||+|+||.||++ .+..++..+++|.+..... .....+.+|+.++++++||||+++++.+..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKV---------LHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEE---------EEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 47999999999999999999 5555688899998865432 2345678899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..++||||+++++|.+++.+. ..+++..+..++.|+++||.||| + .+++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hhCCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 9999999999999999998554 67899999999999999999999 6 589999999999999999999999999886
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh-----
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR----- 253 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~----- 253 (349)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.........
T Consensus 149 ~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 149 QLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 432221 12245788999999998888999999999999999999999999654422221111110000000
Q ss_pred --------------hhhhHhhhhccccCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 254 --------------DSRRVLRIMDTRLGGQYS-KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 254 --------------~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
........... .....+ ..++.++.+++.+||..||++|||+.+++++-.-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 00000000100 011111 1357789999999999999999999999987544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=291.39 Aligned_cols=267 Identities=25% Similarity=0.310 Sum_probs=200.3
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||.|++|.||+| ....++..|++|.+...... ....+.+|+.++++++|||++++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKG---------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred CceEeeEecccCceEEEEE---------EECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 6899999999999999999 45556889999988654322 335677899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+..++||||+. ++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence 99999999996 58888875432 56899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh-hhchh----
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE-WADPF---- 251 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~-~~~~~---- 251 (349)
....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+............ +..+.
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 149 RAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVW 226 (285)
T ss_pred eecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 6532221 111223567889999988654 578899999999999999999999976543222111111 00000
Q ss_pred --hhhhhhHhhhhc---cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 --LRDSRRVLRIMD---TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 --~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
............ ..........+++++.++|.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000 000001122367889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=286.02 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=198.4
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC-
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES- 99 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 99 (349)
|.+.+.||+|+||.||+|.+... +....+++|.++... ......+..|+.+++.++|+||+++++.+...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~-------~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 73 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQD-------DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV 73 (272)
T ss_pred CccccccCcccCceEEEeEEccC-------CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence 45788999999999999965321 223468999886542 33456778899999999999999999876321
Q ss_pred -----CceEEEEEeCCCCChHHHHhc-----cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 100 -----DNRLLVYEFMPKGSLENHLFR-----SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 100 -----~~~~lv~e~~~~~~L~~~l~~-----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
...++++||+.+++|.+++.. ....+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~ 151 (272)
T cd05075 74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNV 151 (272)
T ss_pred cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccchhheEEcCCCCE
Confidence 246899999999999988743 2245889999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~ 248 (349)
+|+|||++................+++.|++||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 228 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR--- 228 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence 9999999876433221111111235667999999998899999999999999999999 788987543221111111
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.......+..++..+.+++.+||+.||++|||+.++++.|+++
T Consensus 229 ---------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 ---------------QGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111122345667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=284.10 Aligned_cols=254 Identities=30% Similarity=0.454 Sum_probs=203.0
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||.|++|.||+|.+.+ +..+++|.+..... ....+.+|+.++++++|++++++++++.
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~- 71 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS- 71 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-
Confidence 45689999999999999999995432 45689998875433 3456889999999999999999999875
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
....+++|||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEEeCCceEEeCCceee
Confidence 45689999999999999998653 345899999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........+
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------------ 216 (260)
T cd05070 150 RLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV------------ 216 (260)
T ss_pred eeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------------
Confidence 7543322111 111234556999999988889999999999999999999 88898654322111111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
........+...+..+.+++.+||..+|.+|||+.++.+.|++
T Consensus 217 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ------ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223345667889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=297.88 Aligned_cols=238 Identities=28% Similarity=0.418 Sum_probs=189.4
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHH-HHHhccCCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEV-IYLGQLRHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~ 102 (349)
+.||.|+||.||+| .+..+++.||+|++...... ....+..|. .+++.++||||+++++.+...+..
T Consensus 1 ~~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLA---------KRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL 71 (321)
T ss_pred CeeeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence 47999999999999 55556889999998654321 223344444 467888999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++||||+++++|...+.. ...+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 72 YFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC
Confidence 999999999999888754 367899999999999999999999 89999999999999999999999999998864222
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.. .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...+....... ..
T Consensus 149 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-----------------i~ 209 (321)
T cd05603 149 PE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDN-----------------IL 209 (321)
T ss_pred CC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHH-----------------Hh
Confidence 11 112234688999999999988999999999999999999999999975432111111 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 297 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 297 (349)
.. ....+...+..+.+++.+||+.||.+||++.
T Consensus 210 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 HK--PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred cC--CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 1223445677899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=292.15 Aligned_cols=256 Identities=19% Similarity=0.211 Sum_probs=200.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||++. ...++..+|+|.+..... .....+.+|..++..++|++|+++++.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVK---------LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEE---------ECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 479999999999999999994 445578899999864321 22344778899999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..++||||+.+++|.+++.+....+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH--~~~iiHrDlkp~Nili~~~~~~kL~DfG~a 149 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADFGSC 149 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCHHHEEECCCCCEEEeecchh
Confidence 999999999999999999999765577999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
........ .......|++.|+|||++. ...++.++|+|||||++|+|++|..||...........+...
T Consensus 150 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~----- 223 (332)
T cd05623 150 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH----- 223 (332)
T ss_pred eecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-----
Confidence 65322211 1112246899999999985 346788999999999999999999999754422211111110
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 302 (349)
............+++++.+|+++||..++.+ |+++.++++|
T Consensus 224 ---------~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 ---------KERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---------CccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0000001112356788999999999765544 6899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=292.51 Aligned_cols=271 Identities=25% Similarity=0.384 Sum_probs=210.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
...++|.+.+.||+|++|.||+|...+... ........+++|.+..... .....+..|+.+++.+ .||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 345789999999999999999996432110 1233466789998875432 3345678899999999 69999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
+...+..++||||+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+||||+|
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~gi~H~dlkp~N 164 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE--SRRCIHRDLAARN 164 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeecccccee
Confidence 998889999999999999999995421 34788899999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcc
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGL 239 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~ 239 (349)
|+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999975433221111111223457999999988899999999999999999999 888886544322
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
....+. .......+..++.++.+++.+||..||++|||+.++++.|+++....
T Consensus 245 ~~~~~~------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 LFKLLR------------------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHH------------------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 111111 11112234456778999999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=283.05 Aligned_cols=248 Identities=30% Similarity=0.478 Sum_probs=200.2
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||.|++|.||+|. ... +..|++|.+...... ....+.+|+.++++++|++|+++++++......++|
T Consensus 1 ~~lg~g~~g~v~~~~---------~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGV---------LKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV 70 (251)
T ss_pred CccccCCCceEEEEE---------EeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence 468999999999994 334 788999988765443 456788999999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
+|++++++|.+++......++...+..++.+++.+|.||| +++++|+||+|+||+++.++.++|+|||.+........
T Consensus 71 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH--~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (251)
T cd05041 71 MELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY 148 (251)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc
Confidence 9999999999999665567899999999999999999999 99999999999999999999999999999875432111
Q ss_pred CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhcc
Q 018891 186 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264 (349)
Q Consensus 186 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (349)
.........+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+ ..
T Consensus 149 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~------------------~~ 210 (251)
T cd05041 149 TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI------------------ES 210 (251)
T ss_pred eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH------------------hc
Confidence 111111223456999999988889999999999999999999 88888655432211111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
......+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus 211 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 211 GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1112234456788999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=283.08 Aligned_cols=253 Identities=33% Similarity=0.503 Sum_probs=201.0
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||+|+||.||+|.+.. ..+.+..+++|.+...... ....+.+|+.+++.+.|||++++++++. .+..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~------~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeec------cCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence 469999999999996542 2234578999998766542 4456888999999999999999999876 4568999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
|||+++++|.+++... ..+++..+..++.|++.+|.||| ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus 74 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 74 MELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLE--SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred EEeCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHh--hcCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999999999654 47899999999999999999999 89999999999999999999999999999875433322
Q ss_pred Cccc-cceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhc
Q 018891 186 THVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263 (349)
Q Consensus 186 ~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (349)
.... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~------------------ 212 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE------------------ 212 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH------------------
Confidence 1111 11122456999999988899999999999999999998 999997654322111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 264 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
.......+..++..+.+++.+||..+|++|||+.++++.|+.+.
T Consensus 213 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 213 SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11112334456788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=283.17 Aligned_cols=251 Identities=28% Similarity=0.419 Sum_probs=199.5
Q ss_pred eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecCCceEEEE
Q 018891 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVY 106 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 106 (349)
.||.|+||.||+|.+.. ...+..|++|.+...... ..+.+.+|+.++++++||||+++++++.. ...++||
T Consensus 2 ~ig~G~~g~v~~~~~~~-------~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKM-------RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEec-------CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEE
Confidence 38999999999996532 234567999988765432 34568899999999999999999998754 5789999
Q ss_pred EeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCC
Q 018891 107 EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 186 (349)
Q Consensus 107 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~ 186 (349)
||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE--GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hcCeeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 999999999998765678999999999999999999999 999999999999999999999999999998754332221
Q ss_pred ccc-cceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhcc
Q 018891 187 HVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264 (349)
Q Consensus 187 ~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (349)
... ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......... .....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------------------~~~~~ 213 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM------------------SFIEQ 213 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH------------------HHHHC
Confidence 111 11122467999999988889999999999999999996 99999755431111 11111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
......+..+++++.+++.+||..||++||++.++.+.|+.+
T Consensus 214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122334456678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=289.11 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=206.3
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..++|++.+.||.|+||.||+|...+. ....++..+++|.+..... .....+.+|+.+++.+.|||++++++++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~ 78 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA 78 (288)
T ss_pred ChHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 457899999999999999999965421 1234567899998875533 23456888999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccC---------------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSV---------------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 156 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di 156 (349)
.+...++|+||+++++|.+++.... ..+++..++.++.|++.||+||| ..+++|+||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH--~~~i~H~dl 156 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDL 156 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCeecccc
Confidence 9899999999999999999986321 24778889999999999999999 899999999
Q ss_pred CCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccc
Q 018891 157 KASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDED 235 (349)
Q Consensus 157 ~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~ 235 (349)
+|.||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998865433222111112234567999999988899999999999999999997 77888654
Q ss_pred cCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 236 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
........+ ........+..++..+.+++.+||+.||++|||+.++++.|++
T Consensus 237 ~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 AHEEVIYYV------------------RDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CHHHHHHHH------------------hcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 321111100 0011112234567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=289.64 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=202.4
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.|++.+.||+|+||.||+| .+..+++.||+|.+...... ....+..|+.+++.++|++++++++.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred CceeeEEeecCCCeEEEEE---------EEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 4788899999999999999 55556889999988654322 22446789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.+..++||||+.+++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 89999999999999999888542 346899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ .....|+..|+|||++.+..++.++|+||+|+++|+|++|..||...............
T Consensus 150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---------- 216 (285)
T cd05630 150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---------- 216 (285)
T ss_pred eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh----------
Confidence 65432221 11246888999999999999999999999999999999999999764432111111110
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
.. ......+..+++++.+|+.+||+.||++||| +.++++|
T Consensus 217 ----~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 217 ----VK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ----hh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00 0011223456778999999999999999999 8899875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=299.28 Aligned_cols=264 Identities=23% Similarity=0.301 Sum_probs=206.8
Q ss_pred CCCcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhccC-
Q 018891 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLR- 85 (349)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~- 85 (349)
++.+...-.+.++.|++++.||+||.+.||++... + ...+|+|.+... .......+.+|+.+|.+|+
T Consensus 349 ~~~~~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s---------~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg 418 (677)
T KOG0596|consen 349 SSSANEIIKVKGREYEILKQIGSGGSSKVFKVLNS---------D-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKG 418 (677)
T ss_pred CCCcCeeEEECcchhhHHHhhcCCCcceeeeeecC---------C-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcC
Confidence 44556677888999999999999999999998432 2 345666755432 4455678999999999995
Q ss_pred CCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC
Q 018891 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165 (349)
Q Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~ 165 (349)
|.+|+.++|+-..++.+|+|||+- ..+|...+.+.....+...+..+..|++.|+.++| +.||+|.||||.|+++ -
T Consensus 419 ~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH--~~gIVHSDLKPANFLl-V 494 (677)
T KOG0596|consen 419 HDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH--QHGIVHSDLKPANFLL-V 494 (677)
T ss_pred CceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH--HhceeecCCCcccEEE-E
Confidence 999999999999999999999976 66999999776555555688889999999999999 9999999999999998 5
Q ss_pred CCcEEEecccccccCCCCCCCccccceecCCcccCccccccC-----------CCCCccceehhhHHHHHHHhCCccCcc
Q 018891 166 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----------HLTPKSDVYSFGVVLLELLSGRRALDE 234 (349)
Q Consensus 166 ~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DiwslG~ll~~lltg~~pf~~ 234 (349)
.|.+||+|||.+...............+||+.|++||.+... ..+.++|||||||++|+|+.|+.||..
T Consensus 495 kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 495 KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 569999999999876555555555557899999999998542 245789999999999999999999964
Q ss_pred ccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHH-HHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 235 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQ-AVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..+ ....+..+.++.-..+++..-+. ++.++++.||.+||.+|||+.++|+|
T Consensus 575 ~~n----------------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 575 IIN----------------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHH----------------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 331 11122222333222222222122 39999999999999999999999974
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=300.25 Aligned_cols=266 Identities=23% Similarity=0.296 Sum_probs=199.5
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+...+..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 85 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEE---------EecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence 3479999999999999999999 5556688999998865432 2345677899999999999999999988
Q ss_pred ecC------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SES------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
... ...++||||+++ ++.+.+. ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDikp~Nill~~~~~~k 159 (355)
T cd07874 86 TPQKSLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_pred eccccccccceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEECCCCCEE
Confidence 543 346999999965 6777663 35888999999999999999999 99999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHH-hhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV-EWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~-~~~~ 249 (349)
|+|||++....... ......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+. ....
T Consensus 160 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (355)
T cd07874 160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236 (355)
T ss_pred EeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999997533221 1222468899999999999999999999999999999999999997654322211111 1111
Q ss_pred hhhhhhh----hHhhhhcc---------------c---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRDSR----RVLRIMDT---------------R---LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~~~----~~~~~~~~---------------~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+...... ........ . .....+...+..+.+||.+||+.||++|||+.++++|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00000000 0 0001112245678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=298.77 Aligned_cols=238 Identities=26% Similarity=0.383 Sum_probs=189.6
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHH-HHhccCCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVI-YLGQLRHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~ 102 (349)
+.||+|+||.||+| .+..+|+.+|+|++..... .....+..|.. +++.++||||+++++.+...+..
T Consensus 1 ~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLA---------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL 71 (325)
T ss_pred CceeeCCCeEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence 46999999999999 5555689999999865422 22233444443 56778999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++||||+.+++|..++.. ...+++..+..++.||+.||+||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 72 YFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLH--SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC
Confidence 999999999999988854 467999999999999999999999 89999999999999999999999999999864322
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
... ......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+.
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~----------------- 209 (325)
T cd05604 149 QSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL----------------- 209 (325)
T ss_pred CCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH-----------------
Confidence 111 1223468999999999999999999999999999999999999997544221111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 297 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 297 (349)
.. ....++..+..+.+++.+||..||.+||++.
T Consensus 210 ~~--~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 210 HK--PLVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred cC--CccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 11 1122334677889999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=289.28 Aligned_cols=273 Identities=26% Similarity=0.418 Sum_probs=209.7
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcC-------CCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCccc
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFA-------PTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~-------~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~ 90 (349)
...+|++.+.||+|+||.||+|........ ......+..|++|.+..... .....+.+|+.++++++|||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 346899999999999999999976432100 12334567799999876533 3456788899999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccC----------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSV----------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
++++++..+...+++||++++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--SLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH--HcCccccccchhc
Confidence 99999999899999999999999999986532 26899999999999999999999 8999999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh--CCccCccccCc
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GRRALDEDRGG 238 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt--g~~pf~~~~~~ 238 (349)
|+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433322222223345678999999988889999999999999999998 67777654422
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
......... ... .........+..++.++.+++.+||+.||++|||+.++++.|.
T Consensus 241 ~~~~~~~~~----~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHF----FRD-------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhc----ccc-------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 211111110 000 0011111123345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=299.59 Aligned_cols=265 Identities=23% Similarity=0.325 Sum_probs=198.8
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||.|+||.||+| .+..++..||+|.+...... ....+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSA---------YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred hhhhhhhheecccCCCeEEEEE---------EECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence 3579999999999999999999 55556889999998654322 335567899999999999999999887
Q ss_pred ecC------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SES------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
... ...+++++++ +++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 84 TPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred cccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhhEEECCCCCEE
Confidence 533 3468999988 7789887743 56999999999999999999999 99999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07878 159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233 (343)
T ss_pred EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998754322 122467889999999876 5688999999999999999999999976543222222221111
Q ss_pred hhhhh-h-----hhHhhhhccccCC------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRD-S-----RRVLRIMDTRLGG------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~-~-----~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... . ............. ......++.+.+||.+||+.||.+|||+.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0 0000000000000 0011234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=288.95 Aligned_cols=268 Identities=26% Similarity=0.351 Sum_probs=203.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||+|++|.||+| ....+++.|++|.+..... ...+.+.+|+.+++.++|+|++++++++..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKC---------RNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred CceeeeeeecccCCeEEEEE---------EECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 47999999999999999999 4555688999998864422 233557789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
....++||||+++++|..++ .....+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFAR 148 (286)
T ss_pred CCEEEEEEeccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCChhhEEEcCCCcEEECccccce
Confidence 99999999999988777766 34457999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+....+.............
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 149 ILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred ecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 65433211 112346778999999866 457889999999999999999999998766443333222211111111000
Q ss_pred Hh-------hhhccccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VL-------RIMDTRLGG-----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~-------~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ......... ....+++..+.+|+.+||+.||++|||+.+++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00 000000000 0012356789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=308.51 Aligned_cols=266 Identities=20% Similarity=0.283 Sum_probs=192.6
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC------CCcccc
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR------HENLVK 91 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~ 91 (349)
...++|++.+.||+|+||+||+| .+...++.||||++..... .......|+.+++.+. |.++++
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a---------~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 195 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEA---------WDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMK 195 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEE---------EEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceee
Confidence 34678999999999999999999 4555688999999864321 2233445666665554 456888
Q ss_pred eeeEEecC-CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCC--
Q 018891 92 LIGYCSES-DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNF-- 167 (349)
Q Consensus 92 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~-- 167 (349)
+++++... .+.++||+++ +++|.+++.+. ..+++..+..++.||+.||.||| + .+|+||||||+||+++.++
T Consensus 196 i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 196 IQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred eEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hcCCeecCCCCHHHEEEecCCcc
Confidence 88888754 4688999988 67888888554 67999999999999999999999 7 5999999999999998765
Q ss_pred --------------cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCc
Q 018891 168 --------------NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 233 (349)
Q Consensus 168 --------------~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~ 233 (349)
.+||+|||.+...... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 4999999987542211 123568999999999999999999999999999999999999998
Q ss_pred cccCcchhhhHHhhhch----hhhh-----hhhHhhhhcc------------ccCC--CCCHHHHHHHHHHHHHhcccCC
Q 018891 234 EDRGGLAEQTLVEWADP----FLRD-----SRRVLRIMDT------------RLGG--QYSKKEAQAVAAVVLQCLHMDP 290 (349)
Q Consensus 234 ~~~~~~~~~~~~~~~~~----~~~~-----~~~~~~~~~~------------~~~~--~~~~~~~~~l~~li~~~l~~dp 290 (349)
+.........+...... +... .......... .... .......+.+.+||.+||+.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 76543332222221110 0000 0000000000 0000 0001124568899999999999
Q ss_pred CCCCCHHHHHHH
Q 018891 291 KNRPSMVDVLTS 302 (349)
Q Consensus 291 ~~Rps~~~ll~~ 302 (349)
++|||+.++++|
T Consensus 427 ~~R~ta~e~L~H 438 (467)
T PTZ00284 427 QKRLNARQMTTH 438 (467)
T ss_pred hhCCCHHHHhcC
Confidence 999999999985
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=288.25 Aligned_cols=274 Identities=26% Similarity=0.437 Sum_probs=206.5
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCC------cC-CCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCccc
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNT------FA-PTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~------~~-~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~ 90 (349)
..++|++.+.||.|+||.||++.+.... +. ....++...+++|.+..... .....+.+|+.+++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 4578999999999999999998543211 00 01233456799998875432 3346788999999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccC----------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSV----------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
++++++..++..++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||||+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--SLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH--HCCeecccCChhe
Confidence 99999999999999999999999999986532 23677889999999999999999 8999999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh--CCccCccccCc
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GRRALDEDRGG 238 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt--g~~pf~~~~~~ 238 (349)
|+++.++.++|+|||++................++..|++||...++.++.++|+|||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875433222111122234567999999888889999999999999999998 77888654432
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
........ ... ..........+..+++.+.+++.+||+.||.+|||+.++++.|++
T Consensus 241 ~~~~~~~~----~~~-------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIENTGE----FFR-------DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHH----HHh-------hccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 21111000 000 000001112234456889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=283.10 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=201.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec-
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE- 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 98 (349)
+|++.+.||.|++|.||++ .+..+++.|++|.+..... .....+.+|+.++++++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLV---------RHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEE---------EEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence 5899999999999999999 4555678899999865432 334567889999999999999999988764
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+...++++||+++++|.+++... ...+++.+++.++.|++.++++|| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--~~~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCchhEEEecCCcEEEecccce
Confidence 44678999999999999988653 356899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... .......+++.|+|||++.+..++.++|+||||+++++|++|..||...+.......+
T Consensus 150 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~------------- 214 (257)
T cd08223 150 RVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI------------- 214 (257)
T ss_pred EEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------
Confidence 7543221 1122345788899999999999999999999999999999999998654321111000
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ......+...++.+.+++.+||+.||++|||+.+++++
T Consensus 215 ----~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 215 ----IE-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----Hh-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 11112345677899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=282.46 Aligned_cols=251 Identities=23% Similarity=0.343 Sum_probs=206.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|+..+.||.|++|.||.+ ....++..+++|.+.... ......+.+|+.++++++|+||+++++++.+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLY---------RRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred CceEeeEecccCCceEEEE---------EEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 5899999999999999998 555668899999876543 33446678999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..+++|||+++++|.+++... ...+++..+..++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~ 149 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISK 149 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChHhEEEeCCCCEEECcCcceE
Confidence 9999999999999999999654 356899999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
....... ......+++.|.|||.+.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~------------- 214 (256)
T cd08221 150 ILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV------------- 214 (256)
T ss_pred Ecccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------------
Confidence 5433221 1223467889999999988888999999999999999999999996543211111111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
. ......+..++.++.+++.+||..+|.+|||+.++++++
T Consensus 215 ----~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 215 ----Q-GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----c-CCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1 111122345678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=287.77 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=203.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||.|++|.||+| ....++..|++|.+.... ......+.+|+.++++++||||+++++.+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKV---------LHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEE---------EEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 47999999999999999999 445568899999886542 22346688899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhcc--CCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS--VQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
+..++||||+++++|..++... ...+++..+..++.|++.||.||| . .+++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 9999999999999999888553 247899999999999999999999 5 5999999999999999999999999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccccC------CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATG------HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
+....... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...........+.
T Consensus 150 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----- 220 (286)
T cd06622 150 SGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----- 220 (286)
T ss_pred cccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH-----
Confidence 86542221 1123567789999998554 34789999999999999999999996533211111111
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
... .......+..++.++.+++.+||+.+|++||++.+++.+-.
T Consensus 221 ---------~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 221 ---------AIV-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred ---------HHh-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 111 11122345568889999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=282.02 Aligned_cols=252 Identities=30% Similarity=0.454 Sum_probs=201.9
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||+|++|.||+|.+.. ..+....|++|.+..... ...+.+.+|+..+++++||||+++++.+.. ...++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWST------SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEec------CCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence 468999999999997642 123345799999987766 456778899999999999999999999988 889999
Q ss_pred EEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCC
Q 018891 106 YEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~ 184 (349)
+||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--hCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence 99999999999996654 56899999999999999999999 9999999999999999999999999999987654322
Q ss_pred CCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 185 NTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 185 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.......+..
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------------- 215 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK---------------- 215 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----------------
Confidence 2111 112345677999999988899999999999999999998 9999965443221111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.......+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 216 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 -EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11111223446778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=288.12 Aligned_cols=268 Identities=23% Similarity=0.315 Sum_probs=204.4
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||.|++|.||+| ....++..|++|.+..... .....+.+|+.++++++|||++++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKA---------KDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred CceEEeecccCCCcEEEEE---------EECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 5899999999999999999 4455588999999876542 2346788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++|+||+ +++|.+++......+++..++.++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~ 148 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH--ANGIMHRDLKPANLLISADGVLKIADFGLARL 148 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence 9999999999 99999998766677999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh-hchhhhhhhh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADPFLRDSRR 257 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 257 (349)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.........+... ..+.......
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 149 FSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred ccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 543321 112224578889999988654 4688999999999999999998888654432222111111 1110000000
Q ss_pred ------Hhhhhcc-ccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 ------VLRIMDT-RLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ------~~~~~~~-~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
....... ... .....+.+..+.++|.+||..||.+|||++++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 000 01112446889999999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=294.96 Aligned_cols=256 Identities=19% Similarity=0.216 Sum_probs=200.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||++ ....++..||+|.+..... .....+.+|..+++.++|++|+.+++.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVV---------KMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred CCceEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 47999999999999999999 4555688999998865321 22344678899999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..|+||||+.+++|.+++.+....+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH--~~~iiHrDlkp~Nill~~~~~~kl~DfG~a 149 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH--QLHYVHRDIKPDNVLLDMNGHIRLADFGSC 149 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCchHHEEEcCCCCEEEEeccce
Confidence 999999999999999999999765578999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCcccccc-----CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
......... ......|++.|+|||++.+ +.++.++|+||||+++|+|++|..||...........+....
T Consensus 150 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~---- 224 (331)
T cd05624 150 LKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE---- 224 (331)
T ss_pred eeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCC----
Confidence 654322211 1122458999999999865 467889999999999999999999997544321111111100
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 302 (349)
..........++++.+.+++.+||..++.+ |+++.++++|
T Consensus 225 ----------~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ----------ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----------CcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000001111345788999999999876554 4689999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=281.37 Aligned_cols=249 Identities=31% Similarity=0.445 Sum_probs=200.6
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE-ec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC-SE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 98 (349)
..+|++.+.||+|++|.||++... +..+++|.+.... ....+.+|+.+++.++|++++++++++ ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-----------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 468999999999999999998543 5678999886543 345678999999999999999999875 45
Q ss_pred CCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
++..++|+||+++++|.+++.+.. ..+++..+..++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccccchheEEEcCCCcEEecCCccc
Confidence 567899999999999999986543 34889999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
........ ....+..|+|||++.+..++.++|+||||+++|+|++ |..||...........
T Consensus 150 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~------------- 211 (256)
T cd05082 150 KEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------- 211 (256)
T ss_pred eeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------------
Confidence 65332211 1223457999999988889999999999999999997 8988864432111111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.........+..+++.+.+++.+|++.+|++|||+.++++.|+++
T Consensus 212 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 212 -----VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111111233456678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=289.86 Aligned_cols=267 Identities=24% Similarity=0.300 Sum_probs=199.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||.|++|.||+| .+..+|..+++|.+...... ....+.+|+.++++++|||++++++++.+.
T Consensus 1 ~y~~~~~l~~g~~~~vy~~---------~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred CceeEEEecccCCeEEEEE---------EECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 5899999999999999999 55556889999988654322 234567899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++|+||++ ++|.+++......+++..++.++.||+.||.||| ..+++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 72 KKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred CceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 99999999996 4888887665577999999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccC-cchhhhHHhhhc-hhhhhhh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRG-GLAEQTLVEWAD-PFLRDSR 256 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~-~~~~~~~~~~~~-~~~~~~~ 256 (349)
...... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+..... ......+..... +......
T Consensus 149 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 149 FGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred cCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 432221 11223567889999988664 478999999999999999999988643322 111111111100 0000000
Q ss_pred hHhhhhccccC---------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLG---------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........... ......+++++.++|.+||+.||.+|||+.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000000 01123456889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=283.17 Aligned_cols=255 Identities=22% Similarity=0.425 Sum_probs=205.3
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch------hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF------QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
+|+..+.||+|++|.||+| .+..++..+++|.+..... .....+.+|+..++.++|+|+++++++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 71 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQA---------RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA 71 (268)
T ss_pred CccccceecCcCceEEEEE---------EEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence 5889999999999999999 5556688999998865431 123567889999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-cEEEecc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDF 174 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-~v~l~Df 174 (349)
+.+.+..++|+||+.+++|.+++.+. .++++..++.++.|++.||.||| +.+++|+||+|.||+++.++ .++|+||
T Consensus 72 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH--~~~i~H~~i~~~nil~~~~~~~~~l~df 148 (268)
T cd06630 72 TCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADF 148 (268)
T ss_pred eccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccc
Confidence 99999999999999999999988543 67899999999999999999999 99999999999999998776 5999999
Q ss_pred cccccCCCCCCC--ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 175 GLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 175 g~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------- 220 (268)
T cd06630 149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-------- 220 (268)
T ss_pred ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH--------
Confidence 998754432111 1111235778899999998888999999999999999999999999644321111111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
............+..+++++.+++.+||..+|.+|||+.+++++
T Consensus 221 ------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 221 ------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11111122234556788899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.97 Aligned_cols=254 Identities=31% Similarity=0.447 Sum_probs=201.8
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||.|++|.||+|.+.+ +..+++|.+.... .....+.+|+.+++.++|++++++++++..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 34689999999999999999995432 2358999876543 234567889999999999999999988754
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+..++||||+.+++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccCcceEEEcCCCeEEECCCccc
Confidence 5689999999999999999653 245788999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
.......... .....++..|+|||...+..++.++|+||||+++|+|++ |..||.+.........+
T Consensus 150 ~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~------------ 216 (260)
T cd05069 150 RLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV------------ 216 (260)
T ss_pred eEccCCcccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------------
Confidence 7543322111 111234567999999988889999999999999999999 89998754421111111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
........+...+..+.+++++||..||.+||++.++++.|++
T Consensus 217 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 217 ------ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ------HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111123345677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=285.56 Aligned_cols=253 Identities=28% Similarity=0.371 Sum_probs=200.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (349)
+.+.|++.+.||.|+||.||+| ....+++.+++|.+.... .....+.+|+..++.+ +|+|++++++.+.
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEE---------EEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 4678999999999999999999 455568899999886543 3345677899999988 6999999999986
Q ss_pred cC------CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 98 ES------DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 98 ~~------~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
.. ...++||||+++++|.+++... ...+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH--~~~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHEEECCCCCEE
Confidence 43 3578999999999999988653 356899999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHH
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~ 245 (349)
|+|||++........ ......++..|+|||++. +..++.++|+||+||++|+|++|..||...........
T Consensus 152 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~-- 227 (272)
T cd06637 152 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-- 227 (272)
T ss_pred EccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--
Confidence 999999875432211 122246788899999885 34578899999999999999999999965432111110
Q ss_pred hhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.............++..+.+|+.+||..||.+|||+.+++++
T Consensus 228 ---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 ---------------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---------------HhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 001111112233466789999999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=285.61 Aligned_cols=254 Identities=28% Similarity=0.387 Sum_probs=205.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||.|++|.||+| .+..+++.+++|.+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKV---------LHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEE---------EEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence 47899999999999999999 5555688999998876543 3446678899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..++++|++++++|.+++......+++..+..++.|++.+++||| + .+++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc--CCCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence 9999999999999999999765578999999999999999999999 8 999999999999999999999999999886
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
........ ...++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ... ..
T Consensus 150 ~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~----------~~ 213 (265)
T cd06605 150 QLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFE----------LL 213 (265)
T ss_pred hhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHH----------HH
Confidence 43221111 145778899999999899999999999999999999999999654321000 000 00
Q ss_pred hhhhccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...... .....+.. ++..+.++|.+||..||++|||+.+++.+
T Consensus 214 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 214 QYIVNE-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred HHHhcC-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011111 11222333 77889999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=283.63 Aligned_cols=258 Identities=26% Similarity=0.367 Sum_probs=206.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||.|++|+||+|. ...++..+++|++..... .....+.+|+..++.++|+|++++++.+...
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAI---------CLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEE---------EcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence 479999999999999999994 444578899999865432 2456788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhcc--CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+..++|+|++++++|.+++... ...+++..+..++.|++.||++|| +.+++|+||+|+||++++++.++|+|||++
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--~~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 9999999999999999998653 246899999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCc--cccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 178 RDGPTGDNTH--VSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 178 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
.......... ......++..|++||.+... .++.++|+||||+++|+|++|..||...+.............+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 225 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP---- 225 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC----
Confidence 7544433221 12234578889999998776 7889999999999999999999999765442221111110000
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..........+++.+.+++.+||..||++|||+.++++|
T Consensus 226 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 ---------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ---------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000123567889999999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=288.45 Aligned_cols=246 Identities=28% Similarity=0.406 Sum_probs=203.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||.|++|.||+|. ...+++.+++|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~---------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVR---------HKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred CceEEEEEeecCCCeEEEEEE---------EcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 479999999999999999994 444588999998865432 23456788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|.||+++.++.++|+|||++
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH--~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 148 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH--SLDIVYRDLKPENLLLDSDGYIKITDFGFA 148 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999999999998554 67999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
...... .....+++.|++||.+.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 149 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------ 211 (290)
T cd05580 149 KRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL------------ 211 (290)
T ss_pred cccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------------
Confidence 764332 122457888999999988888999999999999999999999996544211111110
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. .....+...+..+.+++.+||..||.+|+ ++.+++++
T Consensus 212 -----~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 212 -----E--GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -----c--CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0 11223445578899999999999999998 78888865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=283.74 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=206.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..+|++.+.||.|+||.||+|..... ........+++|.+...... ....+.+|+.++++++|+|++++++++.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 79 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGI----EEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE 79 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccC----CcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence 37899999999999999999976543 23445678999988654433 34678899999999999999999999998
Q ss_pred CCceEEEEEeCCCCChHHHHhccC--------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV--------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~--------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
....++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh--hcCcccCcCccceEEEeCCCcEE
Confidence 889999999999999999986532 16899999999999999999999 99999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~ 249 (349)
++|||++........ .......++..|++||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 158 l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~----- 231 (275)
T cd05046 158 VSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL----- 231 (275)
T ss_pred EcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH-----
Confidence 999998764322111 11112345667999999988888999999999999999998 78888654321111111
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.........+..++..+.+++.+||+.||.+|||+.++++.|.
T Consensus 232 ------------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 ------------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111223346678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.33 Aligned_cols=256 Identities=28% Similarity=0.463 Sum_probs=196.3
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhccCCCcccceeeEEe-cCCceEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKLIGYCS-ESDNRLL 104 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~l 104 (349)
+.||+|+||.||+|.+.. .......+++|.+... .......+.+|+.+++.++|||++++++++. .++..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLID------SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEec------CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence 468999999999996532 2234577999987543 2234567788999999999999999999765 4556899
Q ss_pred EEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCC
Q 018891 105 VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184 (349)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~ 184 (349)
|+||+.+++|.+++.......+...+..++.|+++||+||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 75 VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA--SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999999999765556778888999999999999999 8999999999999999999999999999986432211
Q ss_pred CCcc--ccceecCCcccCccccccCCCCCccceehhhHHHHHHHhC-CccCccccCcchhhhHHhhhchhhhhhhhHhhh
Q 018891 185 NTHV--STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261 (349)
Q Consensus 185 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (349)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++| ..||.......... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~------------------~ 214 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV------------------Y 214 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------------------H
Confidence 1100 1112345679999999888899999999999999999995 55564432211110 0
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
+........+..+++.+.+++.+||..+|++||++.++++.|+++..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 215 LLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11111122233456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=292.71 Aligned_cols=272 Identities=26% Similarity=0.388 Sum_probs=211.1
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
+...+|++.+.||+|+||.||+|.+.+..- ........+++|.+..... .....+.+|+.+++++ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 445689999999999999999996532110 1123345789998875432 2346788899999999 79999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
+...+..++++||+++++|.+++.+.. ..++...+..++.|++.||+||| +.+++|+||+|+|
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH--~~givH~dlkp~N 164 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA--SQKCIHRDLAARN 164 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH--HCCeeccccccce
Confidence 999899999999999999999986421 24777888999999999999999 9999999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcc
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGL 239 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~ 239 (349)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875433221111111223456999999999999999999999999999998 888886544222
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
....+ ........+..++..+.+++.+||+.+|++|||+.++++.|+.+.....
T Consensus 245 ~~~~~------------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 LFKLL------------------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred HHHHH------------------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11111 1111122334566789999999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=295.54 Aligned_cols=268 Identities=30% Similarity=0.436 Sum_probs=221.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc---chhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE---SFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++-.+.+.||+|.||.||+|.+... .......||+|..... .......+.+|.+++++++||||++++++..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~-----~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLK-----NGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cCccccceeecccccEEEEEEEEec-----CCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 4556679999999999999987632 1111222899988753 2445678899999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
...-+++|||++.||+|.+++.+....++..+...++.+.+.||+||| +.+++||||-.+|+|++.++.+||+|||++
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh--~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH--SKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH--HCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999887667999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+........ .....-...|+|||.+..+.|++++||||+|+++||+++ |..||.+....+....+
T Consensus 310 ~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI------------ 375 (474)
T KOG0194|consen 310 RAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI------------ 375 (474)
T ss_pred cCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH------------
Confidence 754311111 101224567999999999999999999999999999999 78899877754333222
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 314 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 314 (349)
.....+...+...+.++..++.+|+..||++|||+.++.+.|+.+......+.
T Consensus 376 -----~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~~ 428 (474)
T KOG0194|consen 376 -----VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAFD 428 (474)
T ss_pred -----HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccccc
Confidence 23444556666788899999999999999999999999999999988866543
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=281.37 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=203.7
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||+|+||.+|.+ ....++..|++|.+.... ......+.+|+.++++++|||++++.+++...
T Consensus 1 ~y~~~~~lg~g~~g~~~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILV---------KSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred CceEEEEeccCCceEEEEE---------EEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 5899999999999999999 455568899999886542 22345688999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..++|+||+.+++|.+++... ...+++..+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 9999999999999999988653 246889999999999999999999 8999999999999999999999999999887
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
....... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||.........
T Consensus 150 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----------------- 210 (256)
T cd08218 150 VLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV----------------- 210 (256)
T ss_pred ecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH-----------------
Confidence 5433221 112245778899999998888999999999999999999999998643221111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... .......+...+.++.++|.+||+.+|.+||++.+++++
T Consensus 211 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 211 LKII-RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHh-cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0011 111122344567889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=282.84 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=200.5
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||.|++|.||+|.+.... .....+..+++|.+..... .....+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~---~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDIL---GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccc---cCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 46899999999999765321 1233457899998765432 3456678899999999999999999999998999999
Q ss_pred EEeCCCCChHHHHhcc------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-----cEEEecc
Q 018891 106 YEFMPKGSLENHLFRS------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-----NAKLSDF 174 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-----~v~l~Df 174 (349)
|||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+||
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--hCCcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999998642 234788999999999999999999 89999999999999999887 8999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
|++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~---------- 225 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH---------- 225 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHH----------
Confidence 99865433222211222345677999999999999999999999999999998 9999865432111111
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
.........+..++..+.+++.+||..+|.+|||+.++++.|++
T Consensus 226 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 226 --------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --------HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111122345677889999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=289.86 Aligned_cols=265 Identities=19% Similarity=0.256 Sum_probs=188.7
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec--CCceE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE--SDNRL 103 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 103 (349)
.+.||+|+||.||+|... ...++..+|+|.+.... ....+.+|+.+++.++||||+++++.+.. +...+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~-------~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 76 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRK-------DGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 76 (317)
T ss_pred ccccccCCCeEEEEEEEc-------cCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence 468999999999999542 23457889999886543 23456789999999999999999998854 35678
Q ss_pred EEEEeCCCCChHHHHhcc--------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE----cCCCcEEE
Q 018891 104 LVYEFMPKGSLENHLFRS--------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKL 171 (349)
Q Consensus 104 lv~e~~~~~~L~~~l~~~--------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv----~~~~~v~l 171 (349)
+||||+. ++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++ +.++.++|
T Consensus 77 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl 153 (317)
T cd07868 77 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKI 153 (317)
T ss_pred EEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEecCCCCcCcEEE
Confidence 9999985 5888877432 235899999999999999999999 9999999999999999 45678999
Q ss_pred ecccccccCCCCCCC-ccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchh------h-
Q 018891 172 SDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE------Q- 242 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~------~- 242 (349)
+|||++......... .......+++.|+|||++.+ ..++.++|+||+||++|+|++|..||.....+... .
T Consensus 154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~ 233 (317)
T cd07868 154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 233 (317)
T ss_pred eecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHH
Confidence 999999754332211 11223567899999999876 45889999999999999999999999754432111 0
Q ss_pred --hHHh-hhchhhhhhhhHhh---------hhccccCC---------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 243 --TLVE-WADPFLRDSRRVLR---------IMDTRLGG---------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 243 --~~~~-~~~~~~~~~~~~~~---------~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
.+.. ...+.......... ........ ......+..+.+||.+||+.||.+|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 234 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred HHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0110 00010000000000 00000000 000112356889999999999999999999997
Q ss_pred H
Q 018891 302 S 302 (349)
Q Consensus 302 ~ 302 (349)
|
T Consensus 314 h 314 (317)
T cd07868 314 D 314 (317)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=287.99 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=207.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+...+|+..+.||+|+||.||+|.+... .......+++|.+...... ....+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~ 78 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPE-----GETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVC 78 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecC-----CCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence 3467899999999999999999965431 1111236789988654332 234577899999999999999999988
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.. ...+++++++++++|.+++......+++..++.++.|++.||.||| +++++|+||||+||+++.++.++|+|||+
T Consensus 79 ~~-~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dikp~Nill~~~~~~kL~Dfg~ 155 (303)
T cd05110 79 LS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGL 155 (303)
T ss_pred cC-CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh--hcCeeccccccceeeecCCCceEEccccc
Confidence 65 4567999999999999999776667899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+................++..|++||.+.+..++.++|+||||+++|+|++ |..||.+.........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~----------- 224 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL----------- 224 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----------
Confidence 976433222111112334567999999988899999999999999999997 89999754321111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
........+..++.++.+++.+|+..+|++||++.++++.|+.+...
T Consensus 225 -------~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 225 -------EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -------HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111122234567899999999999999999999999999998655
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=281.34 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=199.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-----hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+|+..+.||+|++|.||+| .+..++..|++|.+..... .....+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 72 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLC---------YDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC 72 (266)
T ss_pred CCccccceecCCCCEEEEEE---------EEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence 58999999999999999999 5556688999998764321 223557889999999999999999998
Q ss_pred EecC--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 96 CSES--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 96 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+... ...++++||+++++|.+++... ..+++..++.++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH--~~~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 73 LRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLH--SNMIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred EEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 8653 5678999999999999988543 56899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCC-CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 174 FGLARDGPTGDN-THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 174 fg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
||++........ ........++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------------- 216 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------------- 216 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-------------
Confidence 999875432111 111112346788999999988889999999999999999999999997543211
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..............+..+++.+.+++ +||..+|++||+++++++|
T Consensus 217 ----~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 217 ----AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11111111112334556678888998 5777899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=283.42 Aligned_cols=252 Identities=28% Similarity=0.398 Sum_probs=201.8
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.|+..+.||.|+||+||+| ....+++.+|+|.+...... ....+.+|+.+++.++|++++++.+.+..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCAC---------QVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET 71 (285)
T ss_pred CceEEEEEecCCCeEEEEE---------EECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec
Confidence 3778899999999999999 44556889999988654322 23456789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
++..++||||+.+++|.+.+... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 99999999999999999887543 346999999999999999999999 899999999999999999999999999988
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~----------- 215 (285)
T cd05632 150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR----------- 215 (285)
T ss_pred eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-----------
Confidence 65432211 1224578999999999888999999999999999999999999975543211111110
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
.... .....+..++..+.+|+.+||+.||++||+ +.+++.+
T Consensus 216 ---~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 216 ---RVLE-TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---hhhc-cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0000 011223456778999999999999999999 7788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.26 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=206.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..|+..+.||.|++|.||+| .+..++..|++|.+.... ......+.+|+.+++.+.||+++++++.+..+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKG---------IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG 74 (277)
T ss_pred HhhhhhhhcccCCCeEEEEE---------EEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 57889999999999999999 444557899999886543 23456788899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++||||+++++|.+++.. .++++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 75 ~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh--~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 75 TKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCcCCChhhEEEcCCCCEEEccccccee
Confidence 999999999999999998854 56899999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 151 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---------------- 212 (277)
T cd06640 151 LTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL---------------- 212 (277)
T ss_pred ccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----------------
Confidence 433221 11223567789999999888899999999999999999999999976543211110
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.........+..++..+.+++.+||+.+|++||++.+++++-.
T Consensus 213 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 213 --IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred --hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 1111122345567889999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=297.80 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=208.8
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..+....++-||+|+.|-||+|++. ++.||||+++.-. ..++..|++|+||||+.+.+++.
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeecc-----------CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec
Confidence 33344555778999999999999776 5669999775322 36799999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..-.+|||||||..|.|...+.. ...+......+|..+|+.++.||| ...|+|||||.-||||+.+..|||+|||-+
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH--~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLH--LHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred CCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHH--HhhHhhhccCCCceEeeccceEEeccccch
Confidence 99999999999999999999954 478899999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ... ...||..|+|||++.+.+.++++||||||+++|+||||..||.+.........+-
T Consensus 260 ~e~~~~S--TkM-SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG------------ 324 (904)
T KOG4721|consen 260 KELSDKS--TKM-SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG------------ 324 (904)
T ss_pred Hhhhhhh--hhh-hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc------------
Confidence 7543331 111 2579999999999999999999999999999999999999997654322221111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
...+....|..+++-+.-|++.||+-.|..|||+++++.||+.+...
T Consensus 325 -----sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 325 -----SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred -----CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 11223456778899999999999999999999999999999876543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=292.63 Aligned_cols=268 Identities=20% Similarity=0.230 Sum_probs=198.1
Q ss_pred CCcceeeec--CceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 24 CSDYLLGEG--GFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 24 ~~~~~lg~G--~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++.++||+| ++++||++ ....+|+.||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus 1 ~~~~~ig~G~~~~~~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 71 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLA---------RYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 71 (327)
T ss_pred ChhhhccccccceEEEEEE---------eecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Confidence 357789999 67899999 6667799999999876532 2335677899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..++||||+++++|.+++... ...+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+++.||+...
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 72 NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 9999999999999999998653 346899999999999999999999 8999999999999999999999999998654
Q ss_pred cCCCCCCCc-----cccceecCCcccCcccccc--CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 179 DGPTGDNTH-----VSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 179 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
......... ......++..|+|||++.+ ..++.++|+|||||++|+|++|..||.................+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 229 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccc
Confidence 322111100 0112345667999999876 458899999999999999999999997644322111111100000
Q ss_pred hhh-----hhhHh----------------------hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRD-----SRRVL----------------------RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~-----~~~~~----------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..+ ..... ..............+++.+.+|+.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 00000 0000000011223457789999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=278.96 Aligned_cols=256 Identities=27% Similarity=0.444 Sum_probs=204.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.+++ +..+++|.+.... .....+.+|+.+++.++|+|++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 456799999999999999999995432 4568999886543 23456788999999999999999999988
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
. ...+++|||+++++|.+++.+. ...++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--hCCccccccCcceEEEcCCCcEEECCCcc
Confidence 7 7889999999999999998653 345788899999999999999999 89999999999999999999999999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... ......++..|+|||.+....++.++|+||||+++|++++ |..||...........+.
T Consensus 149 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---------- 217 (260)
T cd05073 149 ARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE---------- 217 (260)
T ss_pred eeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh----------
Confidence 8754332211 1111234566999999988889999999999999999998 899997544321111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.......+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 218 --------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 218 --------RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred --------CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 1111122345677899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=280.06 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=208.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||.|++|.||+| .+..++..|++|.+..... .....+..|+..+++++|+|++++++++...
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~---------~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEE---------EEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 47999999999999999999 5555688999999876654 3456788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..++|+||+++++|.+++... ..+++..++.++.|+++++.||| + .+++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh--~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh--ccCCCccCCCCHHHEEECCCCCEEEccCccce
Confidence 9999999999999999999654 77999999999999999999999 8 999999999999999999999999999887
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.............
T Consensus 149 ~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~------------- 213 (264)
T cd06623 149 VLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ------------- 213 (264)
T ss_pred ecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH-------------
Confidence 64332222 123457888999999998889999999999999999999999997654311111111
Q ss_pred hhhhccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... .......+.. ++..+.+++.+||..+|++|||+.+++++
T Consensus 214 -~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 214 -AIC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -HHh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 1111223344 77899999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=290.03 Aligned_cols=254 Identities=27% Similarity=0.347 Sum_probs=205.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|++|.||+| ....+++.+++|.+...... ....+..|+.+++.++|++|+++++.+.
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLV---------RLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred CceEEeeeecCCccEEEEEE---------EEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 47999999999999999999 45556889999998765433 3456788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.....++||||+.+++|.+++... ...+++..+..++.|++.+|+||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChHHeEEcCCCCEEEeecch
Confidence 999999999999999999988653 356899999999999999999999 89999999999999999999999999998
Q ss_pred cccCCCCCCCc---------------------------cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCC
Q 018891 177 ARDGPTGDNTH---------------------------VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229 (349)
Q Consensus 177 ~~~~~~~~~~~---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~ 229 (349)
+.......... ......|+..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 86432221100 011235788899999999888999999999999999999999
Q ss_pred ccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 018891 230 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS----MVDVLTS 302 (349)
Q Consensus 230 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 302 (349)
.||.+......... .............+++.+.+++.+||+.||++||| +.+++.+
T Consensus 230 ~pf~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 230 TPFKGSNRDETFSN-----------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCCCCCchHHHHHH-----------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 99976543221111 11111111112236789999999999999999999 8888875
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=280.26 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=200.9
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-----hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-----FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+|++.+.||+|+||.||.| .+..++..|++|.+.... ......+.+|+.+++.+.||||++++++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~---------~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 72 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLC---------YDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC 72 (265)
T ss_pred CcceEeeEEecCCceEEEEE---------EEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence 58999999999999999999 455568899999875432 1223567889999999999999999998
Q ss_pred EecC--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 96 CSES--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 96 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+.+. ...++||||+++++|.+++... ..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 73 LRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred eccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEecCCCCEEECc
Confidence 8653 4678999999999999988544 56889999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCC-ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 174 FGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 174 fg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------------- 216 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------------- 216 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------------
Confidence 9988754321111 11112357788999999988889999999999999999999999996432111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..............+...+..+.+++.+|+. +|++||++++++++
T Consensus 217 ----~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 217 ----AIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ----HHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1111111122234566778889999999995 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=280.92 Aligned_cols=251 Identities=31% Similarity=0.454 Sum_probs=196.0
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhcc-CCCcccceeeEEecCCceEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLL 104 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 104 (349)
+.||.|+||.||+|.+.+ .+....+++|.+.... ......+.+|+.+++++ +||||+++++++...+..++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK-------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcC-------CCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 368999999999996532 1122457888876432 23446778899999999 79999999999999999999
Q ss_pred EEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 105 VYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 105 v~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
||||+++++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.+
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccccceEEEcCCCeE
Confidence 999999999999985421 24788999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~ 248 (349)
+|+|||++......... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 152 kl~dfgl~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----- 223 (270)
T cd05047 152 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----- 223 (270)
T ss_pred EECCCCCccccchhhhc---cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH-----
Confidence 99999987532111110 11123456999999988889999999999999999997 9999965432111111
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
.........+..++.++.+++.+|+..||.+|||+.++++.|..+.
T Consensus 224 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 -------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------------HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111112233446678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=278.94 Aligned_cols=255 Identities=32% Similarity=0.494 Sum_probs=204.1
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecCCc
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
+++.+.||.|+||.||+|.+... ....+..|++|.+...... ....+.+|+..++.++|+|++++++++...+.
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGL-----SGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCC-----CCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence 46788999999999999966431 1134588999998765443 45678899999999999999999999999899
Q ss_pred eEEEEEeCCCCChHHHHhccCCC-CChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 102 RLLVYEFMPKGSLENHLFRSVQP-ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
.+++||++++++|.+++...... +++..+..++.|++.||++|| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--cCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999998654333 999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
......... ...++..|++||.+.+..++.++|+||||+++++|++ |..||...........+
T Consensus 154 ~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~--------------- 217 (258)
T smart00219 154 YDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL--------------- 217 (258)
T ss_pred ccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------------
Confidence 443221111 1225678999999988889999999999999999998 77887653321111111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
........+...+.++.+++.+||..||++|||+.++++.|
T Consensus 218 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 218 ---KKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---hcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111223344678899999999999999999999999754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=282.19 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=200.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh----------chHHHHHHHHHHhccCCCcccc
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ----------GHKEWLTEVIYLGQLRHENLVK 91 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~ 91 (349)
+|.+.+.||.|++|.||+| ....+++.+++|.+...... ..+.+..|+..++.++|||+++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 72 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLA---------LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ 72 (272)
T ss_pred ceeecceecccCceEEEEE---------eecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence 6889999999999999999 55556889999987542111 1245678999999999999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
+++++...+..++|+||+++++|.+++.+. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred EEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh--hCCeeecCCChhhEEEcCCCeEEE
Confidence 999999999999999999999999998654 67899999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCC--CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
+|||.+................++..|++||.+.... ++.++|+||||+++|++++|..||........ +....
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~- 225 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA---MFKLG- 225 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH---HHHhh-
Confidence 9999987543222111112235678899999987654 78899999999999999999999964332110 11000
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...............++..+.+++.+||..+|.+|||+.++++|
T Consensus 226 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 226 ---------NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ---------ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00001111112223567899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=280.00 Aligned_cols=249 Identities=28% Similarity=0.457 Sum_probs=202.3
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-----hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+|+..+.||+|++|.||+|. ...++..|++|.+..... .....+.+|+.+++.++|+|++++++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGL---------NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE 71 (258)
T ss_pred CccccceeeecCCceEEEEE---------EcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence 58889999999999999994 444578899998765431 2345688999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..+...++++||+++++|.+++.+. ..+++..+..++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~~~ni~~~~~~~~kl~d~~~ 148 (258)
T cd06632 72 REEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFGM 148 (258)
T ss_pred ecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999999999998554 56899999999999999999999 89999999999999999999999999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCC-CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+....... ......++..|++||.+.... ++.++|+||||+++|+|++|..||..........
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~------------- 212 (258)
T cd06632 149 AKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF------------- 212 (258)
T ss_pred ceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH-------------
Confidence 87543322 112245788899999987766 8999999999999999999999997544211110
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...........+..+++.+.+++++||+.+|.+||++.+++.+
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 213 ----KIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----HHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0000011122344567889999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=278.94 Aligned_cols=252 Identities=30% Similarity=0.460 Sum_probs=202.4
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..+|++.+.||.|++|.||+|.+. .+..+++|.+..... ....+.+|+..++.++||+++++++++...
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~----------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL----------EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe----------CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 468999999999999999999543 245799998865432 345678899999999999999999999998
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++|+||+++++|.+++......+++..++.++.|++.++++|| +.+++|+||+|.||+++.++.++|+|||.+..
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 149 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH--HCCccccccccceEEEcCCCeEEECCCcceee
Confidence 9999999999999999998765567899999999999999999999 89999999999999999999999999998865
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
....... ......++..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+.
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------------- 215 (256)
T cd05112 150 VLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN------------- 215 (256)
T ss_pred cccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-------------
Confidence 4322111 1111234567999999988889999999999999999998 899986544322111111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
...+...+...++.+.+++.+||+.+|++|||+.++++.|
T Consensus 216 -----~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 216 -----AGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----CCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1111111233467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.70 Aligned_cols=267 Identities=27% Similarity=0.334 Sum_probs=202.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-----chHHHHHHHHHHhccCCCcccceeeEE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-----GHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+|++.+.||.|++|.||+| ....+++.|++|.+...... ....+..|+.+++.++|+|++++++++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKA---------RDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF 71 (298)
T ss_pred CceeeeeeeeccccEEEEE---------EECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence 5889999999999999999 55556889999998765432 234567899999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..++||||+ +++|.+++......+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nill~~~~~~~l~dfg~ 148 (298)
T cd07841 72 GHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGL 148 (298)
T ss_pred ecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecCCChhhEEEcCCCCEEEcccee
Confidence 9989999999999 88999998655447999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh-hchhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADPFLRD 254 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~ 254 (349)
+........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.........+... ..+....
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 149 ARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226 (298)
T ss_pred eeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence 876433221 1122345778999998854 46788999999999999999998877655432222111111 0110000
Q ss_pred hhh---HhhhhccccC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRR---VLRIMDTRLG-----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~---~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... .......... .......+..+.++|.+||..||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 0000000000 01123456789999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=276.76 Aligned_cols=247 Identities=32% Similarity=0.476 Sum_probs=197.6
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
++||+|++|.||+|.. .++..+++|.+...... ....+.+|+.+++.++|||++++++++...+..++|
T Consensus 1 ~~ig~g~~g~vy~~~~----------~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 70 (250)
T cd05085 1 ELLGKGNFGEVFKGTL----------KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV 70 (250)
T ss_pred CccCCCCCceEEEEEe----------cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence 4689999999999942 23678999988765432 234678899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
|||+++++|.+++......+++..+..++.|++.+|.|+| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 71 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 71 MELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred EECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccChheEEEcCCCeEEECCCccceecccccc
Confidence 9999999999998765567899999999999999999999 99999999999999999999999999998864322211
Q ss_pred CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhcc
Q 018891 186 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264 (349)
Q Consensus 186 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (349)
. ......++..|+|||++.+..++.++|+||||+++|++++ |..||...........+ ..
T Consensus 149 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~------------------~~ 209 (250)
T cd05085 149 S-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV------------------EK 209 (250)
T ss_pred c-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------------------Hc
Confidence 1 1111223456999999988889999999999999999998 89999755432111111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
......+..++..+.+++.+|++.+|++|||+.++++.|.
T Consensus 210 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 210 GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1112233456788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=282.92 Aligned_cols=254 Identities=26% Similarity=0.347 Sum_probs=200.4
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (349)
..++|++.+.||.|++|.||+| ....+++.+++|.+..... ....+.+|+.+++++ .|+|++++++++.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKA---------RHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred chhheeheeeecCCCCeEEEEE---------EECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 3589999999999999999999 4445578899998876543 345688999999999 6999999999986
Q ss_pred cCC------ceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 98 ESD------NRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 98 ~~~------~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
... ..++||||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~~l~p~ni~~~~~~~ 151 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAE 151 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEEccCCe
Confidence 544 489999999999999988542 367899999999999999999999 999999999999999999999
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCcccccc-----CCCCCccceehhhHHHHHHHhCCccCccccCcchhhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 243 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~ 243 (349)
++|+|||.+....... .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...........
T Consensus 152 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 229 (275)
T cd06608 152 VKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK 229 (275)
T ss_pred EEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH
Confidence 9999999886543222 11222457888999998753 3467889999999999999999999964432111111
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+.. ........+...++.+.+++.+||..||++|||+.+++++
T Consensus 230 ~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 IPR----------------NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hhc----------------cCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 000 0000111223467889999999999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=286.76 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=205.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|.+.+.||+|+||.||++ ....++..|++|.+..........+.+|+.+++.++|||++++++.+...
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~ 88 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTA---------IDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG 88 (293)
T ss_pred hhhceeeeEecCCCCeEEEEE---------EEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC
Confidence 379999999999999999999 44445788999998765555556788899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++|+||+++++|.+++.+ ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH--~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~ 164 (293)
T cd06647 89 DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (293)
T ss_pred CcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH--hCCEeeccCCHHHEEEcCCCCEEEccCcceec
Confidence 999999999999999998854 45789999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...... ......+++.|++||.+.+..++.++|+||||+++|++++|..||...........+..
T Consensus 165 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~------------- 229 (293)
T cd06647 165 ITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------- 229 (293)
T ss_pred cccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-------------
Confidence 433221 11223577889999999888899999999999999999999999975443221111110
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..++..+.+++++||..+|++||++.+++.|
T Consensus 230 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 230 ---NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ---CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111234567789999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=280.15 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=202.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.+.......||+|+||.||+| ....++..|++|.+..........+.+|+.+++.++|+||+++++++..+
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 77 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAA---------RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77 (268)
T ss_pred cccCCceEEEecCCceEEEEe---------EecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC
Confidence 345556678999999999999 44556788999988776666667888999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCC--ChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-CCcEEEecccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPI--SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGL 176 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l--~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-~~~v~l~Dfg~ 176 (349)
+..++|+||+++++|.+++......+ ++..+..++.|++.||+||| +.+++|+||+|.||+++. ++.++|+|||.
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 99999999999999999996654555 88889999999999999999 899999999999999976 67899999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCC--CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
+........ ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||..........
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~------------ 221 (268)
T cd06624 156 SKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM------------ 221 (268)
T ss_pred heecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH------------
Confidence 865432211 112235788899999986543 7889999999999999999999996533211100
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
............+..+++++.+++.+||+.+|.+|||+.+++.+
T Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 222 ----FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----hhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00000011223455677889999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=282.37 Aligned_cols=249 Identities=25% Similarity=0.349 Sum_probs=204.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
+|++.+.||.|+||.||+| .+..++..|++|.+..... ...+.+.+|+.++++++||||+++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIV---------QKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred CceEEEEeccCCCceEEEE---------EEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 5899999999999999999 4555688999999875432 234678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
....++|+||+.+++|.+++... .++++..+..++.|++++|.||| ..+++|+||+|+||++++++.++|+|||.+.
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~ 148 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIAT 148 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEEcCCCCEEEeeccccc
Confidence 99999999999999999998554 68999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..............
T Consensus 149 ~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------ 213 (258)
T cd05578 149 KVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK------------ 213 (258)
T ss_pred ccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH------------
Confidence 644332 11224577889999999888899999999999999999999999976554211111110
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM--VDVLT 301 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~~ll~ 301 (349)
... .....+...+..+.++|.+||..||.+||++ .++++
T Consensus 214 ---~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 214 ---QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred ---hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 000 1223445567899999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.32 Aligned_cols=268 Identities=22% Similarity=0.318 Sum_probs=198.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||.|++|.||+| ....+++.|++|.+...... ....+.+|+.+++.++|+||+++++++..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKG---------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75 (291)
T ss_pred cceeEEEEEeecCCeEEEEE---------EEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence 68999999999999999999 44455789999988654322 234566899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++ +|.+++......+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 76 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 76 KTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred CeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence 999999999975 899988765567899999999999999999999 89999999999999999999999999998864
Q ss_pred CCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcc-hhhhHHhh-hchhhhhhh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL-AEQTLVEW-ADPFLRDSR 256 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~ 256 (349)
...... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||....... ....+... ..+......
T Consensus 153 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 153 KSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred cCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 322111 1112345778999998865 457889999999999999999999997554211 11111110 000000000
Q ss_pred hHhh---hhccccCC-------CCCHHHH--HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLR---IMDTRLGG-------QYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~---~~~~~~~~-------~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ........ .....++ ..+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000 00000000 0001122 678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=280.03 Aligned_cols=252 Identities=28% Similarity=0.437 Sum_probs=201.4
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch------hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF------QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
+|++.+.||.|+||.||+|.. .+++.+++|.+..... .....+.+|+..++.++|+||++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~----------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT----------NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70 (265)
T ss_pred CccccceEeccCCeEEEEEEE----------cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence 589999999999999999943 2467899998764321 123457889999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+.+.+..++|+||+++++|.+++.+. ..+++..+..++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg 147 (265)
T cd06631 71 CLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFG 147 (265)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHhEEECCCCeEEeccch
Confidence 99999999999999999999998554 57899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCC----CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 176 LARDGPTGDN----THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 176 ~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
.+........ ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~----- 222 (265)
T cd06631 148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA----- 222 (265)
T ss_pred hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-----
Confidence 8875422111 1111124578889999999888899999999999999999999999975432111110000
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..++.++.+++++||+.+|.+||++.+++++
T Consensus 223 -----------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 223 -----------HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----------ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0011122344577889999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=286.98 Aligned_cols=268 Identities=28% Similarity=0.398 Sum_probs=201.9
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||.|++|.||+|. ...+++.|++|.+...... ..+.+.+|+.+++.++|||++++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCK---------HKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred CceeEeeeeccCCCeEEEEEE---------ECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 479999999999999999994 4445789999987654322 34567789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
++..++|+||+++++|..+... ...+++..+..++.|++.+|+||| +.+++|+||+|+||++++++.++|+|||++.
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~ 148 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEECCCCcEEEEeeeeee
Confidence 9999999999998888776643 356899999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.............
T Consensus 149 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 149 TLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 543322 11222457788999998865 446789999999999999999999997554322222222111111100000
Q ss_pred Hh------hhh-cccc-----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VL------RIM-DTRL-----GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~------~~~-~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ..+ .... .....+.++..+.+++.+||+.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 000 0000 001123457889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=284.62 Aligned_cols=268 Identities=26% Similarity=0.331 Sum_probs=208.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||+|++|+||+| ....++..|++|.+..... .....+.+|+.+++.++||||+++++.+
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKV---------KHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEE---------EEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE
Confidence 45689999999999999999999 4445578899998765432 3346788999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
...+..++||||+++++|.+++.+ .+.+++..+..++.+++.+|.||| + .+++|+||+|+||+++.++.++|+|||
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH--~~~~i~H~dl~p~nil~~~~~~~~l~d~g 149 (284)
T cd06620 73 LNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFG 149 (284)
T ss_pred ecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH--HhcCeeccCCCHHHEEECCCCcEEEccCC
Confidence 999999999999999999998854 367899999999999999999999 5 589999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++....... .....++..|+|||++.+..++.++|+|||||++|++++|..||............. ....
T Consensus 150 l~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~------~~~~ 219 (284)
T cd06620 150 VSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP------MGIL 219 (284)
T ss_pred cccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh------hHHH
Confidence 876432211 112457889999999988899999999999999999999999997554321100000 0000
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
..................++..+.+|+.+||+.||++|||+.+++++..-+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 220 DLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0001111111111111236778999999999999999999999998754433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=302.24 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=213.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
+-|+|+..||.|+||.||+| ....++..-|.|++.-.+....+++..|+.+|..+.||+|+++++.|.-++
T Consensus 32 d~WeIiGELGDGAFGKVyKA---------~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKA---------VNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHhhhcCccchhhhhh---------hcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 45889999999999999999 555567777889888777788899999999999999999999999998889
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
.++++.|||.||-.+..+.+-...+.+.++..+++|++.||.||| +++|+|||||..||+++-+|.++|.|||.+-..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH--s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH--SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh--hcchhhhhccccceEEEecCcEeeecccccccc
Confidence 999999999999999998887789999999999999999999999 999999999999999999999999999988642
Q ss_pred CCCCCCccccceecCCcccCcccccc-----CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
..........+|||+|+|||++.+ .+|+.++||||||+++.+|..+.+|-...++ .
T Consensus 181 --~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----------------M 241 (1187)
T KOG0579|consen 181 --KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------------M 241 (1187)
T ss_pred --hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----------------H
Confidence 222223334789999999998754 5899999999999999999999998765432 2
Q ss_pred hhHhhhhcccc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 RRVLRIMDTRL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..+.++...-. -...|...+..+.+++.+||..||..||++.++++|
T Consensus 242 RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 242 RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 22222222221 123456788899999999999999999999999975
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=288.27 Aligned_cols=270 Identities=27% Similarity=0.314 Sum_probs=202.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++|++.+.||.|++|.||+| ....+++.||+|.+...... ......+|+.++++++|+|++++++++.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRA---------RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred ccceeEeeeeeecCCEEEEEE---------EECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 478999999999999999999 45556889999988654322 2234567999999999999999999987
Q ss_pred cC--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 98 ES--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 98 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
.. +..++||||+.+ +|.+++......+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 77 GKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred cCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCEEECccc
Confidence 54 468999999964 888888665577999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
.+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+..........
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 154 LARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred eeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 9876443221 1112345777999998865 457899999999999999999999998766544333333221111000
Q ss_pred hhh-H------hhhh-c-cccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 255 SRR-V------LRIM-D-TRLG--GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 255 ~~~-~------~~~~-~-~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
... . .... . .... .......++.+.++|.+||+.||++|||+.+++.|-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000 0 0000 0 0000 000112467889999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=278.83 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=193.2
Q ss_pred ceeeecCceeEEEeeecCCCcCC---CCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCceE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAP---TKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRL 103 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~---~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 103 (349)
+.||+|+||.||+|.+....... ........+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999764321000 012345568999887665555567888999999999999999999999888999
Q ss_pred EEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc-------EEEecccc
Q 018891 104 LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-------AKLSDFGL 176 (349)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~-------v~l~Dfg~ 176 (349)
+||||+++++|..++......+++..++.++.|+++||+||| +.+++|+||+|+||+++.++. ++++|||+
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh--hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 999999999999988665567999999999999999999999 999999999999999987664 89999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccc-cCCCCCccceehhhHHHHHHH-hCCccCccccCcchhhhHHhhhchhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELL-SGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
+....... ...++..|+|||.+. +..++.++||||||+++|+|+ +|..||..........
T Consensus 159 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------------ 220 (262)
T cd05077 159 PITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER------------ 220 (262)
T ss_pred CccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH------------
Confidence 86432211 134677899999886 467889999999999999998 5777776433211100
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
...... ......++++.+|+.+||+.||.+||++.+|+++|
T Consensus 221 ------~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 ------FYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ------HHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000000 01122356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=294.11 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=188.2
Q ss_pred eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhcc---CCCcccceeeEEecCCce
Q 018891 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL---RHENLVKLIGYCSESDNR 102 (349)
Q Consensus 29 lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~ 102 (349)
||+|+||+||+| .+..++..||+|++...... .......|..++... .||+|+++++.+......
T Consensus 1 lG~G~~g~Vy~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQV---------RKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEE---------EECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 699999999999 55566889999998654322 222344455666554 699999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
|+||||+.+++|.+++.. ...+++..+..++.||+.||+||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 72 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH--~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 72 YLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLH--KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC
Confidence 999999999999988854 467999999999999999999999 99999999999999999999999999999865322
Q ss_pred CCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (349)
... ......|++.|+|||++.+. .++.++|+|||||++|+|++|..||...........+..
T Consensus 149 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~--------------- 211 (330)
T cd05586 149 DNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF--------------- 211 (330)
T ss_pred CCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc---------------
Confidence 221 12234689999999998654 578999999999999999999999975442211111110
Q ss_pred hccccCCCCC-HHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 018891 262 MDTRLGGQYS-KKEAQAVAAVVLQCLHMDPKNRP----SMVDVLTS 302 (349)
Q Consensus 262 ~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rp----s~~~ll~~ 302 (349)
.. ...+ ..+++++.++|.+||+.||.+|| ++.++++|
T Consensus 212 --~~--~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 212 --GK--VRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --CC--CCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 00 0111 23577899999999999999998 67777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=277.87 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=202.6
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||.|++|.||+| ....+++.+++|.+..... .....+.+|+.+++.++|||++++++.+...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLC---------RRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred CceEEEEecccCceEEEEE---------EEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 5899999999999999999 4445688999998865432 2346688899999999999999999999988
Q ss_pred CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-cEEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-~v~l~Dfg~~ 177 (349)
+..++|||++++++|.+++... ...+++..+..++.|++.+++||| +++++|+||+|+||+++.++ .++|+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~ 149 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEccCCCc
Confidence 9999999999999999999654 345899999999999999999999 99999999999999998654 5799999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+
T Consensus 150 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~------------- 213 (256)
T cd08220 150 KILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI------------- 213 (256)
T ss_pred eecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH-------------
Confidence 76433221 11245788899999998888899999999999999999999999755432111111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ......+..++..+.+++.+||..||++|||+.+++++
T Consensus 214 ----~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 214 ----MS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----Hh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 11112334567889999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=284.13 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=204.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..|+..+.||.|++|.||+| ....++..|++|.+.... ......+.+|+..+++++||||+++++.+..+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKG---------IDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG 74 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEE---------EEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC
Confidence 56888899999999999999 444557889999886543 23345688999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++|+||+++++|.+++.. ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH--~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06642 75 TKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred CceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh--cCCeeccCCChheEEEeCCCCEEEcccccccc
Confidence 999999999999999998843 56899999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--------------- 213 (277)
T cd06642 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI--------------- 213 (277)
T ss_pred ccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh---------------
Confidence 432211 111235678899999999888999999999999999999999998754332111111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
........+..++..+.+++.+||+.+|++|||+.+++++-.
T Consensus 214 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 214 ---PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred ---hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 111111223456778999999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=287.61 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=203.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.+.|.....||.|+||.||++ .+..++..|+||.+........+.+.+|+..++.++|+|++++++.+...
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~ 91 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIA---------TEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG 91 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEE---------EECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC
Confidence 456666788999999999999 55556889999998765555566788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++++|.+++.. ..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 167 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEcCCCCEEEccCcchhh
Confidence 999999999999999998743 46899999999999999999999 89999999999999999999999999998864
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
..... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+ .
T Consensus 168 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--------------~ 231 (292)
T cd06658 168 VSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------------R 231 (292)
T ss_pred ccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------H
Confidence 32221 1122346788999999998888999999999999999999999999754321111100 0
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...... .......+..+.+++.+||..||.+|||+.+++++
T Consensus 232 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 232 DNLPPR--VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred hcCCCc--cccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000010 11123456789999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=278.36 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=204.0
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEec-
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE- 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 98 (349)
+|++.+.||.|++|.||+| .+..++..+++|.+.... ......+..|+.+++.++|||++++++++..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKV---------RRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred CceeeeeeccCCCeEEEEe---------eecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 5899999999999999999 555568899999886543 2334567889999999999999999997753
Q ss_pred -CCceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcC---CCCeeeccCCCCcEEEcCCCcEEE
Q 018891 99 -SDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGL---DANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~---~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
....+++|||+++++|.+++... ...+++..++.++.|++.||.|||.. +.+++|+||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl 151 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEE
Confidence 34678999999999999988643 46789999999999999999999943 468999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+|||++........ ......+++.|+|||.+.+..++.++|+||||+++++|++|..||..........
T Consensus 152 ~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------- 220 (265)
T cd08217 152 GDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLAS--------- 220 (265)
T ss_pred ecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHH---------
Confidence 99999876433321 1222467889999999988889999999999999999999999997654211111
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..........+...+..+.+++.+||+.+|++||++.+++++
T Consensus 221 ---------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 ---------KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111112223455677899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=276.19 Aligned_cols=251 Identities=29% Similarity=0.440 Sum_probs=206.3
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCc
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
+|+..+.||+|++|.||++. ...++..+++|.+..........+.+|+..++.++|++++++++.+..+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKAR---------HKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE 71 (253)
T ss_pred CceeeeeeccCCceEEEEEE---------ECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 58899999999999999994 444688999999977665556778899999999999999999999999999
Q ss_pred eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 102 RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
.++++||+++++|.+++......+++..+..++.|++.+|.+|| ..+++|+||+|+||+++.++.++|+|||.+....
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 149 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh--cCCEecCCCCHHHEEEccCCeEEEeecccccccc
Confidence 99999999999999998665568999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhh
Q 018891 182 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261 (349)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (349)
.... .....++..|++||.+.+..++.++|+||||+++|+|++|..||..............
T Consensus 150 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 211 (253)
T cd05122 150 DTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--------------- 211 (253)
T ss_pred cccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---------------
Confidence 4321 2234578889999999888889999999999999999999999975432111110000
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..++..+.+++.+||+.||++|||+.+++++
T Consensus 212 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 212 -NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000001112236789999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.30 Aligned_cols=262 Identities=22% Similarity=0.334 Sum_probs=205.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA---------~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~ 72 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLA---------YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS 72 (932)
T ss_pred CCeEEEEEEecCCCEEEEEE---------EECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence 58999999999999999999 5555688999999865422 23456889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc----------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS----------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~----------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
+++..++||||++|++|.+++... ....+...+..++.|++.||+||| +.+++||||||+||+++.++
T Consensus 73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--s~GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SKGVLHRDLKPDNILLGLFG 150 (932)
T ss_pred eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH--HCCccccCCchheEEEcCCC
Confidence 999999999999999999988531 123556778899999999999999 89999999999999999999
Q ss_pred cEEEecccccccCCCCCC----------------CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCcc
Q 018891 168 NAKLSDFGLARDGPTGDN----------------THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA 231 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~p 231 (349)
.++|+|||++........ ........|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999875421110 0111124689999999999999999999999999999999999999
Q ss_pred CccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhcC
Q 018891 232 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTS 309 (349)
Q Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~~~ 309 (349)
|........... ..............+++.+.+++.+||..||++|| ++.++++.|+.....
T Consensus 231 F~~~~~~ki~~~----------------~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 231 YRRKKGRKISYR----------------DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred CCCcchhhhhhh----------------hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 975332111100 00000000011135667899999999999999995 677777888877553
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=315.76 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=199.6
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccce
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
..++.-++|++.+.||.|+||.||+| .+..++..+++|.+..... .....+..|+.+++.++||||+++
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLA---------kdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl 77 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLV---------KHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEE---------EECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence 34556679999999999999999999 5555688999998865422 234568889999999999999999
Q ss_pred eeEEec--CCceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCC-----CCeeeccCCCCcEE
Q 018891 93 IGYCSE--SDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLD-----ANVIYRDLKASNVL 162 (349)
Q Consensus 93 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~-----~~i~H~di~~~Nil 162 (349)
+++|.. ...+|+||||+++++|.+++... ...+++..++.++.||+.||.|||+.. .+|+|+||||+|||
T Consensus 78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 998854 35689999999999999988542 357999999999999999999999311 45999999999999
Q ss_pred EcC-----------------CCcEEEecccccccCCCCCCCccccceecCCcccCcccccc--CCCCCccceehhhHHHH
Q 018891 163 LDS-----------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLL 223 (349)
Q Consensus 163 v~~-----------------~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~ 223 (349)
++. .+.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 964 2348999999987543221 1223468999999999854 45789999999999999
Q ss_pred HHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 224 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 224 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+|++|..||........ .+. .+.... .......+.++.+||..||..+|.+|||+.+++.+
T Consensus 235 ELLTGk~PF~~~~~~~q--li~---------------~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 235 ELCSGKTPFHKANNFSQ--LIS---------------ELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHCCCCCCcCCcHHH--HHH---------------HHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 99999999965332110 000 000000 00112356789999999999999999999999964
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=282.66 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=214.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
.-|.++..||.|++|.||+| .+..+|+.+|||.+..+. +.+.+..|+.++++++.|+++++++.|-...
T Consensus 33 EVFDi~~KLGEGSYGSV~KA---------IH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKA---------IHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHHHhcCCcchHHHHH---------HHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 34778899999999999999 888899999999987654 6678889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
.+++|||||..|+..+.+.-.++++++.++..+++.-+.+|.||| ...-+|||||..||+++.+|..||.|||.+..+
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH--~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH--DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH--HHHHHHhhcccccEEEcccchhhhhhccccchh
Confidence 999999999999999999888899999999999999999999999 778899999999999999999999999998654
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
.... ......+|||.|+|||++..-.|+..+||||||++..+|..|++||.+..+-...-.+-....|.++
T Consensus 180 TDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~------- 250 (502)
T KOG0574|consen 180 TDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK------- 250 (502)
T ss_pred hhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC-------
Confidence 3322 2223468999999999999999999999999999999999999999876542222111111111111
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
-|...+.++.++|++||..+|++|-|+.++++|
T Consensus 251 ---------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 ---------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ---------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 234567889999999999999999999999876
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=283.33 Aligned_cols=255 Identities=26% Similarity=0.321 Sum_probs=198.7
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (349)
..++|++.+.||+|++|.||+| .+..++..+++|.+.... .....+..|+.+++.+ +|||++++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~---------~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKV---------LNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred cccceeeeeeeccCCCcEEEEE---------EECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 5679999999999999999999 455568899999876532 2235567889999998 6999999999873
Q ss_pred -----cCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 98 -----ESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 98 -----~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
.++..++||||+++++|.+++.. ....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH--hCCccccCCCHHhEEECCCCCE
Confidence 34568999999999999988742 3356889999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCcccccc-----CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhH
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~ 244 (349)
+|+|||.+........ ......++..|+|||.+.. ..++.++|+|||||++|+|++|..||...........+
T Consensus 164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 9999999875432211 1122458889999998753 45788999999999999999999999654321111000
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.. . .......+..++..+.+++.+||+.||++|||+.+++++.
T Consensus 242 ~~--------------~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 242 PR--------------N--PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cc--------------c--CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0 0000112233466799999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=284.23 Aligned_cols=268 Identities=25% Similarity=0.305 Sum_probs=202.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||.|++|.||+|. ...++..+++|.+...... ....+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRAR---------DKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEE---------ECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 589999999999999999994 4455788999988654322 22346689999999999999999999877
Q ss_pred C--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 99 S--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
. +..++|+||+++ +|.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 76 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 76 SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred cCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence 7 889999999965 899888665567999999999999999999999 89999999999999999999999999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-hhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRD 254 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~ 254 (349)
+........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+..... +....
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 153 AREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred eeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 876443321 11224567889999988654 468899999999999999999999976554332222221111 00000
Q ss_pred hhhH---hh--------hhccccCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRV---LR--------IMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~---~~--------~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... .. ..........+.. +++.+.++|.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00 0000001111222 47789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=283.72 Aligned_cols=269 Identities=28% Similarity=0.385 Sum_probs=203.9
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||.|++|.||+| .+..+++.|++|.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~---------~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKC---------RNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71 (288)
T ss_pred CceeEEEEecccCCeeEEEE---------EeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE
Confidence 47999999999999999999 455558899999886542 2234678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.+..++|+||++++.+..+. .....+++..++.++.|++.||.||| ..+++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~~iv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~ 148 (288)
T cd07833 72 KGRLYLVFEYVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFGFAR 148 (288)
T ss_pred CCEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEEEEeeeccc
Confidence 89999999999876665544 44467999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.........+.............
T Consensus 149 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 149 ALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred ccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 6444332 112224567889999999887 78899999999999999999999997654332222222111110000000
Q ss_pred Hhh---------hhccc----cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLR---------IMDTR----LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~---------~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... ..... .....+..++.++.++|.+||..+|++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 00000 0001122347889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=282.77 Aligned_cols=254 Identities=27% Similarity=0.348 Sum_probs=199.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
...+.|++.+.||.|+||.||+| .+..+++.+++|.+.... .....+..|+.+++++ +|+|++++++++
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEE---------EEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 35689999999999999999999 444567899999886543 2335577888888888 699999999988
Q ss_pred ec------CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 97 SE------SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 97 ~~------~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
.. ....+++|||+++++|.+++... ...+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.+
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--AHKVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCE
Confidence 42 45789999999999999988653 345888889999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhH
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~ 244 (349)
+|+|||++........ ......++..|+|||.+. +..++.++|+||||+++|+|++|..||..........
T Consensus 161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-- 236 (282)
T cd06636 161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-- 236 (282)
T ss_pred EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence 9999998865322211 112245788899999875 3457889999999999999999999996543211110
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..............++..+.++|++||..||.+|||+.+++++
T Consensus 237 ---------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 237 ---------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0111111112233567889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=294.88 Aligned_cols=247 Identities=30% Similarity=0.397 Sum_probs=209.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..|.-++.||.|+||-||-| .+..+.+.||||++.-.. ...+.+++.|+..|+++.|||++.+.++|.
T Consensus 26 klf~dLrEIGHGSFGAVYfA---------rd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL 96 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL 96 (948)
T ss_pred HHHHHHHHhcCCccceeEEe---------eccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee
Confidence 45788899999999999999 777789999999986553 345678999999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.+...++||||| -|+-.+.+.-..+++-+.++..|+.+.+.||+||| +.+.+|||||..||++++.|.|||+|||.+
T Consensus 97 re~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH--S~~~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 97 REHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--SHNRIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred ccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH--HhhHHhhhccccceEecCCCeeeeccccch
Confidence 999999999999 55888888777799999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCcccc---ccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
....+. ...+|||.|+|||++ ..+.|+-++||||||++-.+|.-.++|+.+++---
T Consensus 174 si~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--------------- 232 (948)
T KOG0577|consen 174 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------------- 232 (948)
T ss_pred hhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---------------
Confidence 753322 236899999999987 45789999999999999999999999986654211
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
-++.+.............++.++.+|..||+.-|.+|||.+++++|
T Consensus 233 --ALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 233 --ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --HHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111222222222345778899999999999999999999999875
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=285.78 Aligned_cols=257 Identities=19% Similarity=0.253 Sum_probs=200.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||.|+||.||++ .+..++..|++|.+..... .....+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~---------~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLV---------RHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred CCceEeeEeecCCCeeEEEE---------EECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 47999999999999999999 5556688999998866532 23356778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.++..++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|.||+++.++.++|+|||.+
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~NIll~~~~~~~l~dfg~~ 148 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLS 148 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHEEECCCCCEEEeeCCCc
Confidence 999999999999999999998554 67899999999999999999999 899999999999999999999999999987
Q ss_pred ccCCCCCCC-------------ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhH
Q 018891 178 RDGPTGDNT-------------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244 (349)
Q Consensus 178 ~~~~~~~~~-------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~ 244 (349)
......... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+..........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 531111000 0001134677899999998888999999999999999999999999754432211111
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
... ..........++.++.++|.+||+.||++||+...+.+.|+.
T Consensus 229 ~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISD----------------DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhc----------------ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110 000011112467789999999999999999985444444433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=280.25 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=193.2
Q ss_pred eeeecCceeEEEeeecCCC---------------cCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccce
Q 018891 28 LLGEGGFGCVFKGWIDQNT---------------FAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~---------------~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
.||+|+||.||+|.+.... ...........|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999753211 0001234456789998876655555678889999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-----
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF----- 167 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~----- 167 (349)
++++..+...++||||+++++|..++.+....+++..+..++.|++.||+||| +.+++|+||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE--DKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--cCCccCCCCCcccEEEeccCcccCc
Confidence 99999999999999999999999988665677899999999999999999999 89999999999999997643
Q ss_pred --cEEEecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHH-hCCccCccccCcchhhh
Q 018891 168 --NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELL-SGRRALDEDRGGLAEQT 243 (349)
Q Consensus 168 --~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~ll-tg~~pf~~~~~~~~~~~ 243 (349)
.++++|||.+....... ...++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||...........
T Consensus 160 ~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 160 SPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred cceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 38999999875432211 1246677999998865 56889999999999999985 68888875543221110
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
. ... ...+...++.+.+++.+||+.+|++|||+.++++.|
T Consensus 234 ~------------------~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 234 Y------------------EKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H------------------Hhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0 000 011222345789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.97 Aligned_cols=247 Identities=26% Similarity=0.356 Sum_probs=192.3
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCceEEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVY 106 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 106 (349)
+.||.|+||.||+|......- ........+++|.+........+.+.+|..+++.++|||++++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGD--YGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeeccccc--ccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999996532110 001234568888876655455567888999999999999999999999988999999
Q ss_pred EeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc--------EEEecccccc
Q 018891 107 EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN--------AKLSDFGLAR 178 (349)
Q Consensus 107 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~--------v~l~Dfg~~~ 178 (349)
||+++++|.+++......+++..+..++.|++.||+||| +.+++|+||||+||+++.++. ++++|||.+.
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999999766567899999999999999999999 999999999999999987665 6999999886
Q ss_pred cCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCC-ccCccccCcchhhhHHhhhchhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR-RALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
..... ....++..|+|||.+.+. .++.++|+||||+++|+|++|. .||..........
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------------- 216 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------------- 216 (258)
T ss_pred ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH--------------
Confidence 43221 123467789999998764 5788999999999999999985 5554322211000
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.... +...+...+.++.+++.+||+.||++|||++++++.|
T Consensus 217 ----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 217 ----FYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----HHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0000 1223334557899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=275.75 Aligned_cols=247 Identities=31% Similarity=0.490 Sum_probs=199.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..+|++.+.||+|+||.||++.. .+..+++|.+.... ....+.+|+.+++.++|||++++++++..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 36899999999999999999842 35679999886543 345678899999999999999999998654
Q ss_pred CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..++||||+.+++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccccCcceEEEcCCCcEEECCCccce
Confidence 579999999999999998654 245889999999999999999999 9999999999999999999999999999886
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 149 ~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~------------- 210 (254)
T cd05083 149 VGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV------------- 210 (254)
T ss_pred eccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------------
Confidence 5322211 1223457999999988899999999999999999997 99998755432111111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
........+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus 211 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 211 -----EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -----hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111222234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=276.04 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=207.2
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||.|++|.||++. +..++..+++|.+..... .....+.+|+++++.++|||++++.+.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVR---------RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEE---------EcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 58899999999999999994 444688999999876543 4456688999999999999999999999998
Q ss_pred CceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...++|+|++++++|.+++... ...+++..+..++.+++.||.+|| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~~~H~dl~~~nil~~~~~~~~l~d~~~ 149 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGI 149 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHHeEEcCCCcEEECCccc
Confidence 9999999999999999988664 377999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+....... .......+++.|+|||...+..++.++|+||+|+++++|++|..||...........
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------------- 214 (258)
T cd08215 150 SKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK------------- 214 (258)
T ss_pred eeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH-------------
Confidence 87643332 122234678889999999888899999999999999999999999965442111111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.........+..++..+.+++.+||..+|++|||+.+++++
T Consensus 215 -----~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 215 -----ILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -----HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111223344667889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=277.63 Aligned_cols=258 Identities=29% Similarity=0.431 Sum_probs=200.1
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
|++.+.||+|++|.||+|.+. ...+++..+++|.+.... ....+.+.+|+..++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLK------SEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEee------ccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 678899999999999999654 234568899999886543 233456788999999999999999999875432
Q ss_pred ------ceEEEEEeCCCCChHHHHhcc-----CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 101 ------NRLLVYEFMPKGSLENHLFRS-----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 101 ------~~~lv~e~~~~~~L~~~l~~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
..+++++|+.+++|.+++... ...++...+..++.|++.||+||| +.+++|+||+|+||+++.++.+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~nili~~~~~~ 152 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTV 152 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeecccchhhEEEcCCCCE
Confidence 247889999999998877432 135788999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~ 248 (349)
+|+|||++................+.+.|++||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 229 (273)
T cd05074 153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI--- 229 (273)
T ss_pred EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---
Confidence 9999999876433221111112234567999999988889999999999999999999 888886543211111111
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.......+...++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ---------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ---------------KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011122234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=291.02 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=220.2
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhccCCCcccceeeEEecCCc
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
.+..++||.|.||.||+|.+.. -.++..-.||||.-+.+ .....+.|.+|..+++.++||||+++++++.+ ..
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~-----~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTD-----PEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecc-----cccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 3456789999999999998864 23555667899988764 34456889999999999999999999999986 57
Q ss_pred eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 102 RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
.++|||.++.|.|..|+..+...++......++.||+.||+||| +.++|||||-.+||+|....-|||+|||+++...
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe--SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE--SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH--hhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 89999999999999999888888999999999999999999999 9999999999999999999999999999998755
Q ss_pred CCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 182 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
........ .-.-...|+|||-+....++.++|+|-||++|||++. |..||.+..+.+...
T Consensus 543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~------------------ 603 (974)
T KOG4257|consen 543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG------------------ 603 (974)
T ss_pred ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE------------------
Confidence 44332221 2223566999999999999999999999999999887 999998776544332
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
.++...+.+.|+.+|+.|..|+.+||..+|.+||.+.++...|.++..
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 234455677889999999999999999999999999999999888776
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=274.42 Aligned_cols=253 Identities=24% Similarity=0.411 Sum_probs=208.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|.+.+.||+|++|.||+| ....++..+++|.+..... .....+.+|+..+++++|+|++++++.+...
T Consensus 1 ~~~~~~~i~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLA---------LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred CceeeeEeeecCceEEEEE---------EECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 5888999999999999999 4445688999998866543 3456788999999999999999999999888
Q ss_pred --CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 100 --DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 100 --~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
...++|+|++++++|.+++... ..+++..++.++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh--~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEcCCCCEEEcccccE
Confidence 8899999999999999998655 48999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
................++..|++||.+.+...+.++|+||||+++++|++|..||..... ... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~--------------~ 212 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMA--------------A 212 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHH--------------H
Confidence 765444321112234578889999999888899999999999999999999999976541 000 0
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.............+...+..+.+++.+|+..||.+||++.+++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 213 LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred HHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 011111122233455668899999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=296.64 Aligned_cols=245 Identities=27% Similarity=0.447 Sum_probs=210.4
Q ss_pred eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCceEEEEE
Q 018891 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYE 107 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 107 (349)
+||+|.+|+||.| ++..+...+|||.+........+-+.+|+.+.++++|.||+++++.+.++++.-|.||
T Consensus 582 VLGKGTYG~VYA~---------RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAA---------RDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME 652 (1226)
T ss_pred EeecCceeEEEee---------ccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence 7999999999999 6777789999999987766666778899999999999999999999999999999999
Q ss_pred eCCCCChHHHHhccCCCC--ChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc-CCCcEEEecccccccCCCCC
Q 018891 108 FMPKGSLENHLFRSVQPI--SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGD 184 (349)
Q Consensus 108 ~~~~~~L~~~l~~~~~~l--~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~-~~~~v~l~Dfg~~~~~~~~~ 184 (349)
-++||+|.+.+...=+++ ++..+..+.+||++||.||| .+.|||||||-+|++|+ -.|.+||.|||-+.++. +
T Consensus 653 qVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH--en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--g 728 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH--ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--G 728 (1226)
T ss_pred cCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh--hcceeeccccCCcEEEeeccceEEecccccchhhc--c
Confidence 999999999997766666 89999999999999999999 99999999999999996 47899999999887643 3
Q ss_pred CCccccceecCCcccCccccccC--CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 185 NTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 185 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.+.......||.-|+|||++..+ .|..++|||||||++.+|.||++||-+....... +.+.-
T Consensus 729 inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----------------MFkVG 792 (1226)
T KOG4279|consen 729 INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----------------MFKVG 792 (1226)
T ss_pred CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----------------hhhhc
Confidence 34444557899999999999765 5889999999999999999999999755432211 11222
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
--+...++|..++.+...+|.+|+.+||.+||++.++|.
T Consensus 793 myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 793 MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 223345778899999999999999999999999999995
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=281.30 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=207.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
-..+.|+..+.||.|++|.||+|. ...++..+++|.+..... ....+.+|+..++.++|+|++++++.+.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~---------~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 85 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKAT---------DRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL 85 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEE---------EccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE
Confidence 356789999999999999999994 444578899999876544 4566788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.....++|+||+++++|.+++......++...+..++.|++.+|+||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~ 163 (286)
T cd06614 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH--SQNVIHRDIKSDNILLSKDGSVKLADFGFA 163 (286)
T ss_pred ECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCChhhEEEcCCCCEEECccchh
Confidence 999999999999999999999765448999999999999999999999 899999999999999999999999999988
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ ......++..|++||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~----------- 230 (286)
T cd06614 164 AQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT----------- 230 (286)
T ss_pred hhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 65332211 11223467789999999888899999999999999999999999965443211111110
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
........+..++..+.++|.+||+.+|.+|||+.+++++-
T Consensus 231 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 231 -----KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred -----cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 00001111233678899999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=281.07 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=202.4
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
.+|...+.||.|++|.||++ ....++..+++|.+..........+.+|+.+++.++|||++++++++...+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~ 89 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIA---------TDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD 89 (285)
T ss_pred HhhhcceEeccCCCeEEEEE---------EECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC
Confidence 35666789999999999999 444557889999886655455566889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++|+||+.+++|.+++.. ..+++..+..++.|++.+|++|| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLH--AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 99999999999999998855 56899999999999999999999 899999999999999999999999999987643
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~-------------- 229 (285)
T cd06648 166 SKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD-------------- 229 (285)
T ss_pred ccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh--------------
Confidence 22211 11224578889999999888899999999999999999999999965432111111110
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. .......+..++..+.+++.+||+.+|++|||+.+++++
T Consensus 230 ~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 230 N--LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred c--CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0 000111122366789999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=279.92 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=193.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHH-HhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIY-LGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||+|+||.||+| .+..+|..||+|.+..... .....+..|+.. ++.++|||++++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKM---------RHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred CCceEEEEecccCCeEEEEE---------EEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 47999999999999999999 5566789999998865432 223344455554 666789999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCcEEEcCCCcEEEecc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~-~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++..+++|||++ ++|.+++.. ....+++..++.++.|++.||+||| ++ +++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999996 578777643 2356899999999999999999999 76 9999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCcccccc----CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|.+........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....... ..+
T Consensus 149 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~------ 217 (283)
T cd06617 149 GISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQL------ 217 (283)
T ss_pred ccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHH------
Confidence 99875422211 122357788999998865 456889999999999999999999996432210 000
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...............++.++.++|.+||..+|.+||++.+++++
T Consensus 218 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 218 --------KQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --------HHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111100011112467889999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=285.29 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=202.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
..|.....||.|+||.||+| .+..++..|++|.+..........+.+|+..++.+.|||++++++.+..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 91 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIA---------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE 91 (297)
T ss_pred hhHHhhhhcCCCCceeEEEE---------EEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC
Confidence 45566678999999999999 455568899999986654455567889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++|+||+++++|..++.. ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 92 ~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 92 ELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLH--SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred eEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 99999999999999987743 56899999999999999999999 899999999999999999999999999988643
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
..... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+...
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~------------- 232 (297)
T cd06659 168 SKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS------------- 232 (297)
T ss_pred ccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------------
Confidence 22211 112246788999999998888999999999999999999999999754321111111100
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...........++.+.+++.+||+.+|.+||++.+++++
T Consensus 233 ---~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 233 ---PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000011123456789999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=275.52 Aligned_cols=255 Identities=27% Similarity=0.357 Sum_probs=190.4
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||+|+||.||+|.+.+ ..++..+++|.+..... .....+.+|+..++.++||||+++++.+.+....++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-------GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcC-------CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 468999999999996532 23467799998865532 2334678899999999999999999999988899999
Q ss_pred EEeCCCCChHHHHhccC----CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 106 YEFMPKGSLENHLFRSV----QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
|||+++++|.+++.... ...+...+..++.|++.|++||| +.+++|+||||+||+++.++.++|+|||.+....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999986421 24566778889999999999999 9999999999999999999999999999886432
Q ss_pred CCCCCccccceecCCcccCccccccC-------CCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhh
Q 018891 182 TGDNTHVSTRIVGTRGYAAPEYVATG-------HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
............++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+.......
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~------- 224 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR------- 224 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh-------
Confidence 22211111123456779999988542 35789999999999999996 9999975443221111000
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
...............++.+.+++.+|+ .+|++|||+.+|+..|+
T Consensus 225 ------~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 ------EQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ------cccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 000000111112234567889999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=275.09 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=202.6
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|.+.+.||+|++|.||+| ....++..|++|.+...... ....+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred CceeeeEeecCCCcEEEEE---------EECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 5899999999999999999 44555889999998765443 557788999999999999999999999988
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++|+||+++++|.+++... ..+++..+..++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~ 148 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEEcccccccc
Confidence 9999999999999999988554 56889999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCCcc--ccceecCCcccCccccccCC---CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 180 GPTGDNTHV--STRIVGTRGYAAPEYVATGH---LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 180 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
......... .....++..|++||.+.+.. ++.++|+||||+++|++++|..||.......... ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~-------- 218 (264)
T cd06626 149 LKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FH-------- 218 (264)
T ss_pred cCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--HH--------
Confidence 543322111 11245678899999987766 7889999999999999999999996543211100 00
Q ss_pred hhhHhhhhccccCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYS--KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.........+ ..+++.+.+++.+||+.+|.+|||+.+++.+
T Consensus 219 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 219 -------VGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred -------HhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0001111122 2347788999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=277.22 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=202.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+-|++.+.||.|+||.||+| ....++..+|+|.+..... .....+.+|+..++.++|||++++++.+..+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 74 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 74 (277)
T ss_pred HhhhhheeEeecCCeEEEEE---------EECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC
Confidence 34788999999999999999 4445578999998764432 3345678899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++||||+++++|.+++.. ..++...+..++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 75 ~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06641 75 TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 150 (277)
T ss_pred CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHc--cCCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence 999999999999999998843 56899999999999999999999 99999999999999999999999999998865
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...........+
T Consensus 151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------------- 213 (277)
T cd06641 151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI--------------- 213 (277)
T ss_pred cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH---------------
Confidence 432211 112245778899999998888899999999999999999999999754321111111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..++.++.+++.+||+.+|.+||++.+++++
T Consensus 214 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 214 ---PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111122334567889999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=280.66 Aligned_cols=267 Identities=23% Similarity=0.307 Sum_probs=198.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..+|++.+.||+|++|.||+| ....++..|++|.+...... ....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKG---------ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEE---------EEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 368999999999999999999 55556789999998654332 23456789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
....++|+||+. +++.+++......+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH--GQHILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChHHEEEcCCCcEEEecccccc
Confidence 889999999995 6787777665567888999999999999999999 8999999999999999999999999999886
Q ss_pred cCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh----hchhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW----ADPFLR 253 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~----~~~~~~ 253 (349)
........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....... ..+... ..+...
T Consensus 152 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 152 AKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTED 227 (291)
T ss_pred ccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChh
Confidence 53222111 1223568889999998754 57889999999999999999999997554311 111110 000000
Q ss_pred hh---hhHhhhhccccCCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 254 DS---RRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 254 ~~---~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ...............+ ...+..+.+++.+|+..||++|||+.+++.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 0000000000000000 0124678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=287.78 Aligned_cols=266 Identities=25% Similarity=0.309 Sum_probs=199.9
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||.|++|.||+| .+..++..|++|.+.... ......+.+|+.+++.++|||++++++++
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAA---------YDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF 84 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEE---------EECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence 4689999999999999999999 555668899999886432 22345667899999999999999999988
Q ss_pred ecC------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SES------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
... ...|+||||+. ++|.+.+.. .+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQM---DLDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred ccCCCccccCcEEEEEeccC-CCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEE
Confidence 543 35799999995 488887743 2889999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh-hc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-AD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~-~~ 249 (349)
|+|||.+........ .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...........+... ..
T Consensus 159 L~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 235 (353)
T cd07850 159 ILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGT 235 (353)
T ss_pred EccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999999975433221 12245788899999999999999999999999999999999999765432111111110 00
Q ss_pred hhhhhhhh-------------------Hhhhhcc----ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRDSRR-------------------VLRIMDT----RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~~~~-------------------~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+...-... ....... ......+...++.+.++|.+||+.||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000000 00000122356778999999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=278.48 Aligned_cols=267 Identities=25% Similarity=0.348 Sum_probs=202.6
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
+|++.+.||.|++|.||+| .+..++..|++|.+...... ....+.+|+.+++.++|+|++++++.+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKG---------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN 71 (284)
T ss_pred CceEeeeeccCCceEEEEE---------EECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence 5899999999999999999 55556889999998765432 3456678999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 101 NRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..++||||+++ +|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 99999999975 8888875533 56899999999999999999999 8999999999999999999999999999886
Q ss_pred cCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh-chhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA-DPFLRDSR 256 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 256 (349)
....... ......++..|++||.+.+. .++.++|+||||+++|+|++|..||.+....+....+.... .+......
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07836 149 AFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP 226 (284)
T ss_pred hhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHH
Confidence 5332211 11123467789999988654 56889999999999999999999998765433322222211 11111100
Q ss_pred hHhh---hhccccC------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLR---IMDTRLG------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~---~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ....... ....+.+++.+.+++.+||+.||.+||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 0000000 01123456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=281.01 Aligned_cols=267 Identities=26% Similarity=0.334 Sum_probs=199.8
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||.|++|.||+| .+..++..|+||.+...... ....+.+|+.++++++||||+++++++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred CceeeeeecCCCceEEEEE---------EECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 5899999999999999999 45556889999988654322 335678899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..++||||+. ++|.+++... ...+++..+..++.|++.||+||| ..+++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 99999999995 5888887543 356899999999999999999999 8999999999999999999999999999886
Q ss_pred cCCCCCCCccccceecCCcccCccccccCC-CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh----
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR---- 253 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~---- 253 (349)
....... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+.........
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 149 AFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred hcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 5322211 112234677899999886644 588899999999999999999999765432222111111110000
Q ss_pred ---hhhhHhhhhccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 254 ---DSRRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 254 ---~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.............. ......+++.+.++|.+||+.||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000000 00112356788999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=282.66 Aligned_cols=270 Identities=23% Similarity=0.323 Sum_probs=197.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||.|++|.||+| .+..++..||+|.+...... ....+.+|+.++++++||||+++++++..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKA---------RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred hheEEEEEeecCCCEEEEEE---------EECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 57999999999999999999 55556899999988654322 23445679999999999999999998765
Q ss_pred CC--------ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 99 SD--------NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 99 ~~--------~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
.. ..++||||+. ++|.+.+......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~k 159 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILK 159 (310)
T ss_pred ccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEECCCCcEE
Confidence 43 3499999995 4888888665557899999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCC--ccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 171 LSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
|+|||.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999998754332221 111224567789999988664 4688999999999999999999999765543322222221
Q ss_pred hchhhh----hhhhHh--hhhc--cccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 ADPFLR----DSRRVL--RIMD--TRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~~~~~----~~~~~~--~~~~--~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...... ...... .... ....... ....++.+.++|.+||..||.+|||+.++++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 110000 000000 0000 0000000 00123567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=280.06 Aligned_cols=250 Identities=29% Similarity=0.377 Sum_probs=200.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
...|.+.+.||+|++|.||+| ....+++.|++|.+..... .....+.+|+.+++.++|||++++.+++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~ 84 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFA---------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY 84 (307)
T ss_pred chhhhhheeecCCCCeEEEEE---------EEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 367999999999999999999 4445688999998864322 2335678899999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..++|+||+. +++.+.+......+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 85 ~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH--~~~i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 85 LREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH--SHERIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred EeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEECCCCCEEEeecCc
Confidence 99999999999996 5777777655567999999999999999999999 89999999999999999999999999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
+....... ...++..|+|||.+. ...++.++|+||||+++|+|++|..||.+.........+.
T Consensus 162 ~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~-------- 227 (307)
T cd06607 162 ASLVSPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------- 227 (307)
T ss_pred ceecCCCC------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh--------
Confidence 86533221 235677899999874 4568889999999999999999999996543211111000
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
........+..++..+.+++.+||..||++||++.+++.+..
T Consensus 228 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 228 ---------QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ---------cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 000111112346778999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=278.71 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=199.7
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccC---CCcccceeeEEe
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLR---HENLVKLIGYCS 97 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 97 (349)
.|++.+.||.|++|.||+| .+..++..+++|.+..... .....+.+|+.+++.+. |||++++++.+.
T Consensus 2 ~y~~~~~l~~g~~g~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~ 72 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL 72 (277)
T ss_pred hhhhhhheeccCCceEEEE---------EEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence 5889999999999999999 4455688999998865432 33456778888888886 999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.....++||||+++++|.+++.. ..+++..++.++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh--~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 73 KGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred eCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcCHHHEEEcCCCCEEEccCCce
Confidence 88999999999999999998854 47899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+..
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---------- 216 (277)
T cd06917 149 ALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---------- 216 (277)
T ss_pred eecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc----------
Confidence 76543321 1222457888999998865 4568899999999999999999999975442111110000
Q ss_pred hHhhhhccccCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSK-KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
......+. ..+.++.+++.+||+.||++||++.+++++
T Consensus 217 --------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 217 --------SKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --------CCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00011111 256789999999999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=280.52 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=187.5
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec--CCceEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE--SDNRLL 104 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 104 (349)
..||+|+||.||+|... ....+..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++
T Consensus 7 ~~lG~G~~g~Vy~~~~~-------~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07867 7 CKVGRGTYGHVYKAKRK-------DGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL 77 (317)
T ss_pred eEeccCCCeeEEEEEec-------CCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence 57999999999999642 23356789999886543 23456789999999999999999998853 457789
Q ss_pred EEEeCCCCChHHHHhcc--------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE----cCCCcEEEe
Q 018891 105 VYEFMPKGSLENHLFRS--------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKLS 172 (349)
Q Consensus 105 v~e~~~~~~L~~~l~~~--------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv----~~~~~v~l~ 172 (349)
|+||+. ++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||++ +.++.++|+
T Consensus 78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 999985 4787776421 235888999999999999999999 8999999999999999 456789999
Q ss_pred cccccccCCCCCCC-ccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchh------hhH
Q 018891 173 DFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE------QTL 244 (349)
Q Consensus 173 Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~------~~~ 244 (349)
|||++......... .......+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.....+... ..+
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 99999754332211 11223467889999999876 45789999999999999999999999754432111 000
Q ss_pred Hhh----hchhhhhhhh---------Hhhhhcccc---------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 245 VEW----ADPFLRDSRR---------VLRIMDTRL---------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 245 ~~~----~~~~~~~~~~---------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... ..+....... ......... ........+..+.+|+.+||+.||.+|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0000000000 000000000 000011234568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=278.75 Aligned_cols=266 Identities=26% Similarity=0.338 Sum_probs=204.3
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
|++.+.||.|++|.||+| ....+++.+++|.+...... ....+.+|+..++.++|++++++++++....
T Consensus 1 y~~~~~i~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKA---------RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG 71 (283)
T ss_pred CccceeeecCCCceEEEE---------EcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence 678899999999999999 55566899999988665433 3456778999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++|+||+++ +|.+++......+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH--HCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 99999999965 888888665578999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh-hchhhhhhhhH
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADPFLRDSRRV 258 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 258 (349)
..... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+... ..+........
T Consensus 149 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 149 GSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred CCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 44321 11223567789999998776 7889999999999999999999999765542221111111 11000000000
Q ss_pred hh-------hhccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LR-------IMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~-------~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ....... ......++.++.++|.+||+.||.+||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00 0000000 11224567899999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.51 Aligned_cols=253 Identities=27% Similarity=0.318 Sum_probs=197.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 98 (349)
.++|++.+.||+|++|.||+| ....++..+++|.+.... .....+.+|+.+++++ +|||++++++++..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~---------~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKV---------TNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEE---------EECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 578999999999999999999 455568899999886532 2235567888899988 79999999998864
Q ss_pred C-----CceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 99 S-----DNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 99 ~-----~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
. +..++||||+++++|.+++.. ....+++..++.++.|++.||.||| ..+++|+||+|+||+++.++.++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEE
Confidence 3 358999999999999998753 3457899999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccC-----CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHH
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~ 245 (349)
|+|||++......... .....++..|+|||.+... .++.++|+||||+++|+|++|..||...........+.
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 9999988754322211 1123577889999987543 36789999999999999999999997543211111110
Q ss_pred hhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. .......+...+..+.++|.+||+.||++||++.++++|
T Consensus 247 ~~----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 RN----------------PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cC----------------CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 000011123456689999999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=273.95 Aligned_cols=244 Identities=27% Similarity=0.347 Sum_probs=198.2
Q ss_pred eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 29 lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
||.|++|.||+|. ...++..+++|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++|
T Consensus 1 lg~g~~~~v~~~~---------~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVK---------VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEE---------ECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 6899999999994 444688999999865432 2345688899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
+||+++++|.+++.+. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH--~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~- 147 (262)
T cd05572 72 MEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLH--NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ- 147 (262)
T ss_pred EecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-
Confidence 9999999999998554 56899999999999999999999 8999999999999999999999999999987653332
Q ss_pred CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccc
Q 018891 186 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265 (349)
Q Consensus 186 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (349)
......+++.|++||.+.+..++.++|+||||+++|+|++|..||.....+.. ..........
T Consensus 148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~ 210 (262)
T cd05572 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---------------EIYNDILKGN 210 (262)
T ss_pred --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---------------HHHHHHhccC
Confidence 11224578889999999888899999999999999999999999976542110 0011111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
.....+...++.+.++|.+||+.||++||+ +.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 222334455789999999999999999999 8888874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=275.11 Aligned_cols=254 Identities=29% Similarity=0.358 Sum_probs=188.8
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||+|+||.||+|.... ......+++|.+...... ....+.+|+..++.++||||+++++.+......++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv 73 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHR-------GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLV 73 (269)
T ss_pred CcCCccCCceEEEEEEec-------CCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEE
Confidence 368999999999996432 123567899987654332 335677899999999999999999999998999999
Q ss_pred EEeCCCCChHHHHhccC----CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 106 YEFMPKGSLENHLFRSV----QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
|||+++++|.+++.... ...++..+..++.|++.||+||| +.+++|+||||.||+++.++.++|+|||++....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 74 LEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hcCEecccccHhheEecCCCcEEEeccccccccc
Confidence 99999999999986532 23467788999999999999999 8999999999999999999999999999886432
Q ss_pred CCCCCccccceecCCcccCcccccc-------CCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhh
Q 018891 182 TGDNTHVSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
............++..|+|||++.. ..++.++|+||||+++|+|++ |..||....+..........
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~------ 225 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE------ 225 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc------
Confidence 2211111112234567999998743 356789999999999999999 77888654321111111000
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
..........+..+++.+.+++..|+ .||++|||+.++++.|
T Consensus 226 -------~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 -------QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -------cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00001111223456677888999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=286.45 Aligned_cols=278 Identities=27% Similarity=0.375 Sum_probs=207.6
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|.+.+.||.|++|+||+| .+..++..|++|.+.... ......+.+|+.+++.++|+||+++++++
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~ 73 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSA---------KNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIM 73 (337)
T ss_pred cccceeEEEEeccCCCeEEEEE---------EecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhe
Confidence 3568999999999999999999 555678999999886532 22345567899999999999999999987
Q ss_pred ecC-----CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 97 SES-----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 97 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
... ...++|+||+. ++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 74 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 74 PPPHREAFNDVYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred ecccccccCcEEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEE
Confidence 543 35799999995 6898888544 67999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
+|||++....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+......
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999987643322 11222456888999998765 46889999999999999999999999765432222222211111
Q ss_pred hhhhh------hhHhhhh---ccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhcCCC
Q 018891 251 FLRDS------RRVLRIM---DTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKD 311 (349)
Q Consensus 251 ~~~~~------~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~~~~ 311 (349)
..... ....... ..... ....+++++++.++|.+||+.||++|||+.++++| +..+.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 00000 0000000 00000 01123467889999999999999999999999998 766655433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=273.31 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=213.6
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhch---HHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
++.-++|.++++||+|.||.|.++ +.+.++..+|+|+++++..-.. ..-..|-++|+..+||.+..+.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~---------rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LK 234 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILC---------REKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLK 234 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEE---------eecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhh
Confidence 345578999999999999999999 8888999999999988754333 3456788999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
..|+....+|+||||..||.|.-.+. ....+++..+..+...|+.||.||| +++|++||+|.+|.+++.+|++||.|
T Consensus 235 YsFQt~drlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLH--s~~ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 235 YSFQTQDRLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLH--SRNIVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred hhhccCceEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhh--hCCeeeeechhhhheeccCCceEeee
Confidence 99999999999999999999987673 4477999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||++.... .........+|+|.|+|||++....|..++|.|.+|++||+|++|+.||...........|..
T Consensus 312 FGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------- 382 (516)
T KOG0690|consen 312 FGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------- 382 (516)
T ss_pred cccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh-------
Confidence 99997522 223334457899999999999999999999999999999999999999976554333322221
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
.....|..++++...|+..+|..||.+|. ++.++.+|
T Consensus 383 ------------ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 383 ------------EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ------------hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 11245678899999999999999999994 56777654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=274.48 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=199.8
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc----------hhchHHHHHHHHHHhc-cCCCccc
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES----------FQGHKEWLTEVIYLGQ-LRHENLV 90 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~ 90 (349)
+|++.+.||.|++|.||+|.... ..+..+++|.+.... ......+.+|+.++++ ++|||++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~--------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~ 72 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN--------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV 72 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC--------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence 58899999999999999995432 146789999875322 1223456678887765 6899999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCC
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSN 166 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~ 166 (349)
++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.+|.||| . .+++|+||+|+||+++.+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH--KEKRIVHRDLTPNNIMLGED 150 (269)
T ss_pred eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc--cCCceeecCCCHHHEEECCC
Confidence 999999999999999999999999988743 3456899999999999999999999 6 679999999999999999
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||...........+
T Consensus 151 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~-- 225 (269)
T cd08528 151 DKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI-- 225 (269)
T ss_pred CcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH--
Confidence 999999999987643332 222345788899999999888999999999999999999999998643321111100
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.............++.+.+++.+||+.||++||++.++.+++.
T Consensus 226 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 ---------------VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---------------hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0111111111245678999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=279.17 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=199.9
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
|++.+.||.|++|.||+| .+..+|..|++|.+...... ....+.+|+..++.++||+++++++++...+
T Consensus 1 y~~~~~l~~g~~~~vy~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~ 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKA---------RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN 71 (283)
T ss_pred CchheEecCCCCeEEEEE---------EEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence 788999999999999999 44556889999988654322 2356778999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 101 NRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
..++++||++ ++|.+++.... ..+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH--~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~ 148 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SHRVLHRDLKPQNLLIDREGALKLADFGLARA 148 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCcEEEeecccccc
Confidence 9999999995 58999885543 36899999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh---
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS--- 255 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 255 (349)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...........
T Consensus 149 ~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 149 FGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred cCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhh
Confidence 4322111 1123457889999987654 578899999999999999999999976543222222211110000000
Q ss_pred -hhHhhh---hcc---ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 -RRVLRI---MDT---RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 -~~~~~~---~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...... ... .........++..+.+++.+||+.||++|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 000 00011123456789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=275.74 Aligned_cols=264 Identities=23% Similarity=0.282 Sum_probs=196.8
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccC-CCcccceeeEEecC-
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HENLVKLIGYCSES- 99 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~- 99 (349)
|++.+.||.|++|.||+| ....++..|++|.+...... .......|+..++++. |+|++++++++.+.
T Consensus 1 y~~~~~lg~g~~~~v~~~---------~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 71 (282)
T cd07831 1 YKILGKIGEGTFSEVLKA---------QSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK 71 (282)
T ss_pred CceEeeccccccceEEEE---------EEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence 778899999999999999 45556888999988654222 2233456888888885 99999999999877
Q ss_pred -CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 -DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..++|+||+++ +|.+.+......+++..+..++.|++.||.||| +.+++|+||+|+||+++. +.++|+|||++.
T Consensus 72 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 72 TGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--RNGIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred CCcEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEcC-CCeEEEeccccc
Confidence 889999999964 888888665567899999999999999999999 899999999999999999 999999999987
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh-
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR- 256 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 256 (349)
........ ....++..|+|||.+.. ..++.++|+|||||++|+|++|..||.+.+.......+............
T Consensus 148 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 148 GIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224 (282)
T ss_pred ccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 54332221 12356788999997644 55788999999999999999999999776543322222221110000000
Q ss_pred hHhh--hhccccCC-------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLR--IMDTRLGG-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~--~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ........ .....++..+.++|.+||..||++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 00000000 0112457899999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=285.71 Aligned_cols=278 Identities=27% Similarity=0.379 Sum_probs=203.2
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
+++|++.+.||+|++|.||+| .+..++..|++|.+..... .....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSA---------THKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ccceEEEEEEEecCCeEEEEE---------EEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 579999999999999999999 5555688999999864322 234567789999999999999999988654
Q ss_pred C-----CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 99 S-----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 99 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
. ...++|+|++.+ +|.+.+.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 75 ~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH--~~~ivH~dlkp~Nill~~~~~~kl~d 149 (336)
T cd07849 75 PSFESFNDVYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTNCDLKICD 149 (336)
T ss_pred ccccccceEEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEECCCCCEEECc
Confidence 3 357999999954 88887733 57999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCc-cccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-h
Q 018891 174 FGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-P 250 (349)
Q Consensus 174 fg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~ 250 (349)
||++.......... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+..... +
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~ 229 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99987543322111 1122467888999998654 5688999999999999999999999976442211111111100 0
Q ss_pred hhhhhhh--------HhhhhccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhcCCC
Q 018891 251 FLRDSRR--------VLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKD 311 (349)
Q Consensus 251 ~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~~~~ 311 (349)
....... ............ ..+..++++.+++.+||+.||++|||+.+++++ +.+.....+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~ 303 (336)
T cd07849 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303 (336)
T ss_pred CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCC
Confidence 0000000 000000000000 012346789999999999999999999999987 665554433
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=270.37 Aligned_cols=249 Identities=30% Similarity=0.466 Sum_probs=205.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||+|++|.||+| .+..+++.|++|.+..... .....+.+|+.+++++.|++++++++++...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKG---------LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred CceeeeEEcccCCeEEEEE---------EEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 5889999999999999999 4455578899999876654 3456788999999999999999999999998
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..+++||++++++|.+++... ..+++..++.++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 148 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATK 148 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCHHHEEECCCCCEEEecccccee
Confidence 9999999999999999988554 67999999999999999999999 99999999999999999999999999999976
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
....... .....++..|++||...+..++.++|+|+||+++|+|++|..||...........
T Consensus 149 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~---------------- 210 (254)
T cd06627 149 LNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR---------------- 210 (254)
T ss_pred cCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----------------
Confidence 5443321 1224578889999999888889999999999999999999999965432111100
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. .......+..+++.+.+++.+||..+|++|||+.+++++
T Consensus 211 -~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 211 -IV-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -Hh-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 00 111123345567889999999999999999999999863
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=271.79 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=202.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-----chhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-----SFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+|++.+.||+|++|.||+| .+..++..|++|.+... .......+.+|+.++++++|+||+++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 72 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLC---------YDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72 (264)
T ss_pred CceeeeeeEccCCCeEEEEE---------EEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 58999999999999999999 55566889999987432 12234567889999999999999999999
Q ss_pred EecC--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 96 CSES--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 96 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+... ...++++||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH--~~~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 73 LRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLH--SNMIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred EEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEEcCCCCEEECc
Confidence 8654 4578999999999999988543 56899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCC-ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 174 FGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 174 fg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------- 215 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------------- 215 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------------
Confidence 9998754221111 1111245788899999998888999999999999999999999999653211
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
....+..........+..+++.+.+++.+||. +|..||++.+++.|
T Consensus 216 ---~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 216 ---AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11112222223344567788999999999999 67999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=272.25 Aligned_cols=247 Identities=28% Similarity=0.436 Sum_probs=191.1
Q ss_pred ceeeecCceeEEEeeecCCCcC-CCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFA-PTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~-~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||+|+||.||+|.+...... .........+++|.+...... ...+.+|+.+++.++|||++++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 4689999999999976532100 001223356888877655433 5678899999999999999999999887 778999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-------cEEEecccccc
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-------NAKLSDFGLAR 178 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-------~v~l~Dfg~~~ 178 (349)
|||+++++|.+++......++...+..++.|++.||.||| +.+++|+||||+||+++.++ .++|+|||++.
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh--hCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999999765557899999999999999999999 99999999999999999887 79999999987
Q ss_pred cCCCCCCCccccceecCCcccCccccccC--CCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
..... ....+...|+|||++.+. .++.++|+||||+++|+|++ |..||.............
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---------- 220 (259)
T cd05037 157 TVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---------- 220 (259)
T ss_pred ccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----------
Confidence 54331 113456679999998776 78899999999999999999 577776543211111000
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.. ...+......+.+++.+||..+|.+|||+.++++.|
T Consensus 221 --------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 --------DQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --------cC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 001111127899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=292.07 Aligned_cols=248 Identities=25% Similarity=0.401 Sum_probs=199.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc----chhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE----SFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+-.++..+||+|.|-+||+| .+..+|..||.-.++.. .....+++..|+.+|+.|+||||+++++.|
T Consensus 40 Ry~k~~evLGrGafKtVYka---------~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW 110 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKA---------FDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW 110 (632)
T ss_pred ceeehhhhcccccceeeeec---------cccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence 44466778999999999999 66677888887655443 223347789999999999999999999999
Q ss_pred ecCCc--eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-CCcEEEec
Q 018891 97 SESDN--RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSD 173 (349)
Q Consensus 97 ~~~~~--~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-~~~v~l~D 173 (349)
.+... ..+|+|.+.+|+|..|+.+. +.++...+..|++||++||.|||+..-.|+|||||-+||||+. .|.|||+|
T Consensus 111 ~d~~n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 111 VDTDNKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred ecCCCceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecc
Confidence 87654 78999999999999999665 7799999999999999999999987888999999999999976 58899999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccC-cchhhhHHhhhchhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-GLAEQTLVEWADPFL 252 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~ 252 (349)
+|+|......... ..+|||.|||||++. ..|++.+||||||++|.||+|+.+||..=.+ .+....+.....|
T Consensus 190 LGLAtl~r~s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP-- 262 (632)
T KOG0584|consen 190 LGLATLLRKSHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKP-- 262 (632)
T ss_pred hhHHHHhhccccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCH--
Confidence 9999865443332 268999999999986 8899999999999999999999999964332 1111111111111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
..+.+--.++++++|.+||.. .++|||+.+||.
T Consensus 263 ---------------~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 263 ---------------AALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---------------HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111122257899999999998 999999999996
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=272.30 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=205.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||.|++|.||++ .+..+++.+++|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKV---------KRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred CceEeeeecCCCceeEEEE---------EECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 5889999999999999999 4555688999998865432 3345677899999999999999999999988
Q ss_pred CceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...++|+||+++++|.+++... ...+++..++.++.|++.||+||| +.+++|+||+|.||+++.++.++|+|||+
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~i~h~~l~~~ni~~~~~~~~kl~d~g~ 149 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGI 149 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCCcccCCCCcceEEEecCCcEEEeeccc
Confidence 9999999999999999988552 356899999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+....... .....++..|++||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 150 ~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~-------------- 211 (256)
T cd08530 150 SKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY-------------- 211 (256)
T ss_pred hhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------------
Confidence 87654431 112357888999999998889999999999999999999999997554211111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..........+...+.++.+++.+||..+|++||++.+++++
T Consensus 212 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 212 ----KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111122223445678889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=285.27 Aligned_cols=273 Identities=24% Similarity=0.342 Sum_probs=203.4
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+++|++.+.||.|++|.||+| ....++..|++|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~---------~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hhceeeeeeeecCCCeEEEEE---------EEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 489999999999999999999 5556688999998865422 33456778999999999999999999875
Q ss_pred c----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 98 E----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 98 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
. ....++||||+. ++|.+++.. ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIH--SANVIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEecc
Confidence 3 346799999995 589888844 366999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCC--ccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-
Q 018891 174 FGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD- 249 (349)
Q Consensus 174 fg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~- 249 (349)
||.+......... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.....
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~ 230 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence 9998653322211 11122467888999998765 4688999999999999999999999976554322222111100
Q ss_pred hhhhh--------hhhHhhhhccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 250 PFLRD--------SRRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 250 ~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
+.... .....+....... .......++++.++|.+||+.+|++|||+.+++.+-.-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 00000 0000000000000 01113457889999999999999999999999986444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=275.72 Aligned_cols=245 Identities=28% Similarity=0.420 Sum_probs=195.4
Q ss_pred eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 29 lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
||.|+||+||+| ....+++.|++|.+..... .....+..|+.+++.++||+++++++.+...+..|+|
T Consensus 1 lg~g~~g~vy~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCAC---------QVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEE---------EEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 689999999999 4445688999998865432 2234567899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCC
Q 018891 106 YEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~ 184 (349)
|||+++++|.+++.+.. ..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence 99999999999886542 36899999999999999999999 9999999999999999999999999999887543211
Q ss_pred CCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhcc
Q 018891 185 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264 (349)
Q Consensus 185 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (349)
......++..|++||.+.+..++.++|+||||+++|+|++|..||...........+... ..
T Consensus 150 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~-- 211 (277)
T cd05577 150 ---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR-------------TL-- 211 (277)
T ss_pred ---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc-------------cc--
Confidence 112235677899999998888999999999999999999999999755432111111110 00
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
......+...++.+.++|++||+.||.+|| ++.++++|
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 212 EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 011223445688899999999999999999 77778764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=274.91 Aligned_cols=261 Identities=26% Similarity=0.328 Sum_probs=200.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|+..+.||.|.+|.||+| ....++..+++|.+..... .....+.+|++.++.++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 71 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKC---------RLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE 71 (287)
T ss_pred CceEEEEEeccCCceEEEEE---------EECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence 47899999999999999999 4445688999998875433 3446688999999999999999999988543
Q ss_pred --CceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 100 --DNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 100 --~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
+..++||||+++++|.+++.. ....+++..+..++.|++.||+||| ..+++|+||+|+||+++.++.++|+||
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEecCCeEEEeec
Confidence 468999999999999887643 3456889999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcc-hhhhHHhhhchhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL-AEQTLVEWADPFLR 253 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~ 253 (349)
|++........ ....++..|++||.+.+..++.++|+||||+++|+|++|..||....... .......+...
T Consensus 150 g~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 222 (287)
T cd06621 150 GVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN--- 222 (287)
T ss_pred ccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---
Confidence 99864332211 12346778999999988899999999999999999999999997653210 00001110000
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
... .. +. .........++.+.+++.+||..||++|||+.+++++-.
T Consensus 223 ~~~--~~-~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 223 MPN--PE-LK--DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred CCc--hh-hc--cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 000 00 00 000111235678999999999999999999999998543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=277.76 Aligned_cols=254 Identities=27% Similarity=0.380 Sum_probs=203.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..|...+.||+|+||.||+| ....++..+++|.+..... .....+..|+..++.++|||++++++++.
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~---------~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFA---------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95 (317)
T ss_pred hhhhhhheeccCCCeEEEEE---------EEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45889999999999999999 4445588999998865422 23356788999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.+...++||||+.+ +|.+.+.....++++..+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 96 ~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 96 REHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred eCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcccEEECCCCCEEEecCCCc
Confidence 99999999999965 787777665677999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
...... ....++..|+|||.+. .+.++.++|+||||+++|+|++|..||...........+..
T Consensus 173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------- 238 (317)
T cd06635 173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------- 238 (317)
T ss_pred cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--------
Confidence 643221 1235778899999873 45688899999999999999999999865432111111111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
...........++.+.+++.+||+.+|.+||++.+++++...+...
T Consensus 239 ---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 239 ---------NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ---------ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 0111112234667899999999999999999999999987765544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=272.46 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=201.2
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||.|++|.||+| ....++..+++|.+..... .....+.+|+.+++.++|+|++++++.+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLA---------KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred CceEEEEecCCCcceEEEE---------EEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 5889999999999999999 4555678899998866432 2345677899999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc-EEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-AKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~-v~l~Dfg~~ 177 (349)
...++|+||+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++. ++|+|||.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEcCCCCeEEecccccc
Confidence 99999999999999999886532 35799999999999999999999 899999999999999988864 699999988
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
........ ......+++.|+|||.+.+..++.++|+||||+++++|++|..||...........+
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------------- 214 (257)
T cd08225 150 RQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI------------- 214 (257)
T ss_pred hhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-------------
Confidence 75433221 112245788899999998888999999999999999999999998654321111100
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... .........+.++.+++.+||..+|++|||+.+++++
T Consensus 215 ----~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 215 ----CQG-YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----hcc-cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 0112233456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=280.30 Aligned_cols=271 Identities=23% Similarity=0.297 Sum_probs=197.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
+|++.+.||+|++|.||+|.... .+.+..||+|.+.... ......+.+|+.+++.++|||++++++++..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~-------~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKN-------GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecC-------CCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence 58899999999999999995432 1268899999987633 3334567789999999999999999999988
Q ss_pred C--CceEEEEEeCCCCChHHHHhcc----CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC----CCc
Q 018891 99 S--DNRLLVYEFMPKGSLENHLFRS----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFN 168 (349)
Q Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~----~~~ 168 (349)
. ...++||||+++ +|.+.+... ...+++..++.++.|++.||+||| +.+++|+||+|+||+++. ++.
T Consensus 74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~h~dlkp~Nil~~~~~~~~~~ 150 (316)
T cd07842 74 HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--SNWVLHRDLKPANILVMGEGPERGV 150 (316)
T ss_pred CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--hCCEeeCCCCHHHEEEcCCCCccce
Confidence 7 789999999965 677766432 136899999999999999999999 899999999999999999 899
Q ss_pred EEEecccccccCCCCCC-CccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchh-----
Q 018891 169 AKLSDFGLARDGPTGDN-THVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE----- 241 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~----- 241 (349)
++|+|||++........ ........++..|+|||.+.+ ..++.++|+||||+++++|++|..||.+.......
T Consensus 151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 230 (316)
T cd07842 151 VKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQ 230 (316)
T ss_pred EEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhH
Confidence 99999999875433222 111122456788999998766 45789999999999999999999999866543310
Q ss_pred -hhHHhhhc----hhhhhh------hhHhhhhccccCCCCC-----------HHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 018891 242 -QTLVEWAD----PFLRDS------RRVLRIMDTRLGGQYS-----------KKEAQAVAAVVLQCLHMDPKNRPSMVDV 299 (349)
Q Consensus 242 -~~~~~~~~----~~~~~~------~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (349)
..+..... +..... ...............+ ...+..+.+++.+||+.||++|||+.++
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 231 RDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 00000000 000000 0000000000000111 1344678999999999999999999999
Q ss_pred HHH
Q 018891 300 LTS 302 (349)
Q Consensus 300 l~~ 302 (349)
+++
T Consensus 311 l~~ 313 (316)
T cd07842 311 LEH 313 (316)
T ss_pred hcC
Confidence 865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=277.44 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=201.6
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC-
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES- 99 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 99 (349)
|++.+.||.|++|.||+| ....++..+++|.+.... ......+.+|+.+++.++|+|++++++++...
T Consensus 1 y~~~~~l~~g~~~~vy~~---------~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKA---------RNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred CeeeEEeccCCCeEEEEE---------EECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 778999999999999999 444557899999997663 23345678899999999999999999999887
Q ss_pred -CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 -DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 -~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..++|+||+++ +|.+++......+++..++.++.|++.||+||| ..+++|+||+|+||++++++.++|+|||.+.
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH--SNGILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEEcCCCCEEEcccccee
Confidence 789999999965 898888665568999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh-hhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL-RDSR 256 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~ 256 (349)
........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+........ ....
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 149 PYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred eccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 65443211 1122345778999998765 4578999999999999999999999976554333222222111000 0000
Q ss_pred hHhh---hhccccCCC--------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLR---IMDTRLGGQ--------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~---~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ......... ....++..+.+++++||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 000000000 001136789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=266.75 Aligned_cols=261 Identities=23% Similarity=0.281 Sum_probs=206.0
Q ss_pred hhcccCCcc-eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 19 ATKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~-~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
+.++|.+.. +||-|-.|.|..+ .+..+++++|+|++... ...++|+++.-.. .||||+.++++|
T Consensus 59 itedY~is~qvLG~GinGkV~~C---------~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQC---------VHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhhheehhhhhccccCCceEEE---------EeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence 467787765 8999999999999 67778999999987533 3445777766555 699999999998
Q ss_pred ecC----CceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---CCc
Q 018891 97 SES----DNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFN 168 (349)
Q Consensus 97 ~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~---~~~ 168 (349)
++. ..+.+|||.++||.|...+..+ ...+++.++..|++||..|+.||| +.+|.||||||+|+|.+. +..
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH--~~nIAHRDlKpENLLyt~t~~na~ 202 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH--SMNIAHRDLKPENLLYTTTSPNAP 202 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH--hcchhhccCChhheeeecCCCCcc
Confidence 643 4677999999999999999663 457999999999999999999999 899999999999999965 556
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
+||+|||++...... ........||.|.|||++....|+.+.|+||+|++||-|++|.+||-...........
T Consensus 203 lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgM---- 275 (400)
T KOG0604|consen 203 LKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---- 275 (400)
T ss_pred eEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhH----
Confidence 999999999764332 2223356899999999999999999999999999999999999999654432111111
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
......-...+..+....++++..++|+++|..+|++|.|+.+++.|=+-.+..
T Consensus 276 -------k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 276 -------KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred -------HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 111111122222333467899999999999999999999999999987765554
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=284.05 Aligned_cols=268 Identities=28% Similarity=0.379 Sum_probs=205.4
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|++.+.||.|++|.||+| ....+++.|++|.+.... ....+.+.+|+..++.++|+||+++.+++...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred CceeeeeecCCCCeEEEEE---------EeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 6899999999999999999 555568899999887643 33456788999999999999999999998776
Q ss_pred C-----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 100 D-----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 100 ~-----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
. ..|+||+|++ ++|.+++... ..+++..++.++.|++.||++|| +.+++|+||+|.||+++.++.++|+||
T Consensus 72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH--~~gi~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 72 SPEDFNDVYIVTELME-TDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLH--SANVIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred CcccccceEEEecchh-hhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEccc
Confidence 4 7899999996 4888888544 58999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCC-ccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 175 GLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 175 g~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+........
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 227 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCC
Confidence 999765443210 112224578889999999887 889999999999999999999999987664333222222111111
Q ss_pred hh------hhhHhhhhc---cc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RD------SRRVLRIMD---TR---LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~------~~~~~~~~~---~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ......... .. ........++..+.++|.+||+.+|.+|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 000000000 00 0001123357789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=276.84 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=204.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccC-CCcccceeeEE
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR-HENLVKLIGYC 96 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 96 (349)
++|.+.+.||+|++|.||+| ....++..|++|++..... .....+..|..+++++. ||||+++++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLA---------KEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred CCceEeeeecCCCceEEEEE---------EEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 47999999999999999999 4445688999998865322 23356778999999998 99999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..++..++|||++.+++|.+++.+. ..+++..++.++.|++.||.+|| +.+++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh--~~~~~H~dl~~~ni~i~~~~~~~l~df~~ 148 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH--SKGIIHRDLKPENILLDKDMHIKITDFGT 148 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHeEECCCCCEEecCCcc
Confidence 9999999999999999999999654 57999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCC------------------ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCc
Q 018891 177 ARDGPTGDNT------------------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 238 (349)
Q Consensus 177 ~~~~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~ 238 (349)
+......... .......++..|++||.+....++.++|+||||++++++++|..||......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 228 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence 8754332211 1112245678899999998888999999999999999999999999765421
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM----VDVLTS 302 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~ll~~ 302 (349)
.....+. ......+..+++.+.+++.+||+.||.+|||+ .++++|
T Consensus 229 ~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 229 LTFQKIL-------------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHH-------------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111100 11123344567889999999999999999999 888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=277.10 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=199.7
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCce
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNR 102 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 102 (349)
|.....||.|++|.||++ ....+++.|++|.+..........+.+|+..++.++|+|++++++.+...+..
T Consensus 22 ~~~~~~lg~g~~g~v~~~---------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 92 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIA---------TVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 92 (292)
T ss_pred hhhHHHcCCCCCeEEEEE---------EEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence 344568999999999999 45556889999988655545556788899999999999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++||||+++++|.+++.. ..+++..+..++.|++.+++||| +.+++|+||+|.||+++.++.++|+|||.+.....
T Consensus 93 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH--~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 93 WVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 999999999999987743 46899999999999999999999 89999999999999999999999999998765432
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
... ......++..|++||.+.+..++.++|+||+|+++|+|++|..||...........+. ...
T Consensus 169 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~--------------~~~ 232 (292)
T cd06657 169 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--------------DNL 232 (292)
T ss_pred ccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------hhC
Confidence 211 1122457888999999988888999999999999999999999997543211111110 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... ......+++.+.+++.+||+.||.+||++.+++++
T Consensus 233 ~~~--~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 233 PPK--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred Ccc--cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 000 01123456788999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=277.72 Aligned_cols=268 Identities=22% Similarity=0.299 Sum_probs=197.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||.|++|.||+| ....+++.|++|.+..... .....+.+|+.++++++|||++++++++..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKA---------RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEE---------EecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 57999999999999999999 4555688999998865432 233567789999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-CCcEEEecccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGL 176 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-~~~v~l~Dfg~ 176 (349)
....++||||++ ++|.+.+.... ..+++..+..++.||+.||+||| +.+++|+||+|+||+++. ++.++|+|||+
T Consensus 73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dl~p~nill~~~~~~~kl~dfg~ 149 (294)
T PLN00009 73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGL 149 (294)
T ss_pred CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCcceEEEECCCCEEEEccccc
Confidence 999999999995 47877775432 33678889999999999999999 899999999999999985 55799999999
Q ss_pred cccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh-hchhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADPFLRD 254 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~ 254 (349)
+........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+... ..+....
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 150 ARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET 227 (294)
T ss_pred ccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 865332211 1112356788999998865 45788999999999999999999999765432221111110 0110000
Q ss_pred ---hhhHhhhhc--cccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 ---SRRVLRIMD--TRLGG----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ---~~~~~~~~~--~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
......... ..... ...+..++.+.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00000 0113356789999999999999999999999974
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=268.84 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=187.5
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||+|+||.||+|.+.. ......+++|.+.... ......+.+|...++.++|||++++++.+......++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv 73 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYT-------DTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLV 73 (268)
T ss_pred CcCCCCcCceEEEEEEEc-------CCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEE
Confidence 358999999999985422 2224557778766543 23456788999999999999999999999998899999
Q ss_pred EEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 106 YEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
|||+++++|.+++.+. ....+...+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 74 FEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred EecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCCeeccCCccceEEEcCCccEEecccccccccCc
Confidence 9999999999998653 234667778899999999999999 89999999999999999999999999998753221
Q ss_pred CCCCccccceecCCcccCcccccc-------CCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
...........++..|+|||++.. ..++.++|+||||+++|+|++ +..||...........+..
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-------- 223 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK-------- 223 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh--------
Confidence 111111122456788999998743 245778999999999999997 4667754332111111000
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
...........+...++.+.+++..|+ .+|++||++.++++.|.
T Consensus 224 -----~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 -----DQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -----hcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 000011112223346678899999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=276.21 Aligned_cols=268 Identities=22% Similarity=0.269 Sum_probs=197.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccC-CCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLR-HENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 97 (349)
++|++.+.||.|+||.||+| ....++..|++|.+...... ....+.+|+.+++.+. |||++++++++.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~---------~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~ 71 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH 71 (295)
T ss_pred CCceEeeEecccCCeEEEEE---------EECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence 47999999999999999999 44556889999987654322 3356778999999994 699999999987
Q ss_pred cCCc-----eEEEEEeCCCCChHHHHhcc----CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-CC
Q 018891 98 ESDN-----RLLVYEFMPKGSLENHLFRS----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NF 167 (349)
Q Consensus 98 ~~~~-----~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-~~ 167 (349)
.... .|+||||+++ +|.+++... ...+++..++.++.|++.||.||| ..+++|+||+|+||+++. ++
T Consensus 72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH--~~~i~H~dl~~~nil~~~~~~ 148 (295)
T cd07837 72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKG 148 (295)
T ss_pred ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEecCCC
Confidence 6655 7999999975 788887542 245899999999999999999999 899999999999999998 88
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 149 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 149 LLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred eEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 9999999988754222111 112346778999998765 4578999999999999999999999976543222211111
Q ss_pred hhc-hhhhhh---hhHhhhhccc-----cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 247 WAD-PFLRDS---RRVLRIMDTR-----LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 247 ~~~-~~~~~~---~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... +..... .......... ......+.+++.+.++|.+||..||.+||++.+++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 100 000000 0000000000 0000112467789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=281.84 Aligned_cols=278 Identities=27% Similarity=0.402 Sum_probs=205.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhcc-CCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
...++|++.+.||.|++|.||+|. +..++..+++|.+... .......+..|+.+++++ +||||+++++
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~---------~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~ 74 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAI---------DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEE---------EcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceee
Confidence 346799999999999999999994 4445788999987543 222334567899999999 9999999999
Q ss_pred EEecC--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 95 YCSES--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 95 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++... ...++||||++ ++|..++... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH--~~~i~H~dl~p~nill~~~~~~kl~ 149 (337)
T cd07852 75 VIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH--SGNVIHRDLKPSNILLNSDCRVKLA 149 (337)
T ss_pred eeccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCcEEEe
Confidence 88643 36799999996 5898888543 7888999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCC---ccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 173 DFGLARDGPTGDNT---HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 173 Dfg~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
|||.+......... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.........+....
T Consensus 150 d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~ 229 (337)
T cd07852 150 DFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229 (337)
T ss_pred eccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99998754433221 12223467888999998755 467889999999999999999999997655433222222211
Q ss_pred chhhh-hhhh-----Hhhhhc---cccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhcC
Q 018891 249 DPFLR-DSRR-----VLRIMD---TRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 309 (349)
Q Consensus 249 ~~~~~-~~~~-----~~~~~~---~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~~ 309 (349)
..... .... ....+. .... ....+.++.++.++|.+||+.||.+|||+.+++++ ++++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred CCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 10000 0000 000000 0000 01112257789999999999999999999999986 5555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=270.54 Aligned_cols=251 Identities=23% Similarity=0.280 Sum_probs=195.6
Q ss_pred chhhhhhhcccCCccee--eecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcc
Q 018891 13 SMISKIATKNFCSDYLL--GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENL 89 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 89 (349)
+.+.... ++|++.+.+ |.|+||.||++ .+..++..+++|.+........ |......+ +|||+
T Consensus 7 ~~~~~~~-~~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~i 71 (267)
T PHA03390 7 SELVQFL-KNCEIVKKLKLIDGKFGKVSVL---------KHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNF 71 (267)
T ss_pred HHHHHHH-HhhccccceeecCCCceEEEEE---------EEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCE
Confidence 3344443 578887777 99999999999 5556688999998865432221 22222222 69999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-c
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-N 168 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-~ 168 (349)
+++++.+...+..++||||+++++|.+++... ..+++..+..++.|+++||.||| +.+++|+||+|+||+++.++ .
T Consensus 72 v~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~~~~~~~ 148 (267)
T PHA03390 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRAKDR 148 (267)
T ss_pred EEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEeCCCCe
Confidence 99999999999999999999999999999654 48999999999999999999999 89999999999999999988 9
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
++|+|||.+....... ...++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......... ..
T Consensus 149 ~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~~-- 218 (267)
T PHA03390 149 IYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL--ES-- 218 (267)
T ss_pred EEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH--HH--
Confidence 9999999886532221 1347888999999998899999999999999999999999997543322110 00
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLTS 302 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~ 302 (349)
..... ......+...++.+.++|.+||+.||.+||+ ++++++|
T Consensus 219 ---------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 219 ---------LLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred ---------HHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00111 1111233467889999999999999999996 6999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=275.88 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=195.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccC-CCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLR-HENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 98 (349)
++|+..+.||+|+||.||++ .+..++..+++|.+..... .....+..|+..+.++. |+||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKM---------LHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEE---------EECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 57888999999999999999 5555689999998865432 33456788999999995 9999999999988
Q ss_pred CCceEEEEEeCCCCChHHHH---hc-cCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEec
Q 018891 99 SDNRLLVYEFMPKGSLENHL---FR-SVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l---~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
.+..+++||++. .++.++. .. ....+++..+..++.|++.||+||| + .+++|+||+|+||+++.++.++|+|
T Consensus 75 ~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~d 151 (288)
T cd06616 75 EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCD 151 (288)
T ss_pred CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hcCCeeccCCCHHHEEEccCCcEEEee
Confidence 889999999985 4555433 22 2367999999999999999999999 5 5999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccC---CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
||++......... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ....+....
T Consensus 152 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~-- 224 (288)
T cd06616 152 FGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV-- 224 (288)
T ss_pred cchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc--
Confidence 9998654322211 123467889999998766 688999999999999999999999965431 000100000
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...........+..++.++.+|+.+||+.||++|||+.+++++
T Consensus 225 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 225 ---------KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---------CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000011111223467889999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=289.14 Aligned_cols=266 Identities=26% Similarity=0.425 Sum_probs=228.4
Q ss_pred CCCcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCC
Q 018891 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHE 87 (349)
Q Consensus 9 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~ 87 (349)
.+.....|-+..++.++.++||+|.||.|++|.|. ...++-..||||.+..+... ...+|++|+.++-+++|+
T Consensus 98 ~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt------~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~ 171 (1039)
T KOG0199|consen 98 NPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWT------QPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHP 171 (1039)
T ss_pred CcCCCcceeccHHHHHHHHHhcCcceeeEeecccc------CCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCc
Confidence 45566778888889999999999999999999886 34456678999999877655 567899999999999999
Q ss_pred cccceeeEEecCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC
Q 018891 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 166 (349)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~ 166 (349)
|+++++++..+ ...-+|||.+.+|+|.+.+.+ ....|.......++.||+.|+.||. +++++||||-.+|+++...
T Consensus 172 hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe--skrlvHRDLAARNlllasp 248 (1039)
T KOG0199|consen 172 HLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE--SKRLVHRDLAARNLLLASP 248 (1039)
T ss_pred ceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh--hhhhhhhhhhhhhheeccc
Confidence 99999999876 667899999999999999977 5567888999999999999999999 9999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCccccc-eecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhH
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTL 244 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~-~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~ 244 (349)
..|||+|||+++.+........... ..-...|+|||.+....++.++|+|++|+++|||++ |..||-+-..
T Consensus 249 rtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------- 321 (1039)
T KOG0199|consen 249 RTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------- 321 (1039)
T ss_pred ceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------
Confidence 8999999999998777665544432 223445999999999999999999999999999999 7888876553
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
..+.+.++...+...++.+++++.+++..||..+|.+|||+..|.+
T Consensus 322 -----------~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 322 -----------IQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -----------HHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 3344455566667778999999999999999999999999999973
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=276.72 Aligned_cols=272 Identities=25% Similarity=0.319 Sum_probs=201.9
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
....++|++.+.||.|++|.||+|. ...+++.|++|.+..... .....+.+|+.+++.++|||++++++
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~---------~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~ 73 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKAR---------DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEE---------ECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeh
Confidence 3456799999999999999999994 444578999999865432 23355678999999999999999999
Q ss_pred EEecCC----------ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 95 YCSESD----------NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 95 ~~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
++.... ..++|+||+++ ++...+......+++..+..++.|++.||+||| +.+++|+||+|+||+++
T Consensus 74 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~i~H~dl~p~nili~ 150 (302)
T cd07864 74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH--KKNFLHRDIKCSNILLN 150 (302)
T ss_pred eecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEC
Confidence 886544 78999999976 787877665567999999999999999999999 89999999999999999
Q ss_pred CCCcEEEecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhh
Q 018891 165 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 243 (349)
Q Consensus 165 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~ 243 (349)
+++.++|+|||.+......... ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||...........
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 151 NKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred CCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 9999999999998754333211 1111245677999998865 3568899999999999999999999975543322222
Q ss_pred HHhhhchhhh-hhhhHhh-----------hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 244 LVEWADPFLR-DSRRVLR-----------IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 244 ~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+......... ....... ....... .....++..+.+++.+||+.||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2221110000 0000000 0000000 0112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=294.38 Aligned_cols=280 Identities=22% Similarity=0.282 Sum_probs=190.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCC------CCCCCCc----EEEEEEccccchhchHHHHHHHHHHhccCCC
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAP------TKPGSGI----VVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~------~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ 87 (349)
...++|++.+.||+|+||.||+|.++...... .....+. .++.|.+.. .......+.+|+.++++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 34578999999999999999998654211000 0000011 111122111 112335577899999999999
Q ss_pred cccceeeEEecCCceEEEEEeCCCCChHHHHhccC----CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV----QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
||+++++++...+..|+|++++. ++|.+++.... .......+..++.||+.||.||| +.+|+|+||||+||++
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~gIiHrDLKP~NILl 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DKKLIHRDIKLENIFL 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEE
Confidence 99999999999999999999994 57777764321 23346678889999999999999 8999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhh
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 243 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~ 243 (349)
+.++.++|+|||++......... ......|+..|+|||++.+..++.++|||||||++|+|++|..++...........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999754332211 11225689999999999999999999999999999999998764433222111111
Q ss_pred HHhhhc-------hhhhhhhhHhhhhccccCC----CCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 244 LVEWAD-------PFLRDSRRVLRIMDTRLGG----QYS-----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 244 ~~~~~~-------~~~~~~~~~~~~~~~~~~~----~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+..... ............+...... ..+ ..++.++.++|.+||+.||.+|||+.+++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111110 0000000111111110000 000 1234567889999999999999999999975
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=271.43 Aligned_cols=244 Identities=27% Similarity=0.391 Sum_probs=194.5
Q ss_pred eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 29 lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
||.|++|.||+| ....+++.+++|.+..... .....+.+|+.++++++|||++++++.+......+++
T Consensus 1 lg~g~~~~vy~~---------~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEE---------EECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 689999999999 4445588999999876543 3446678899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
+||+++++|.+++... ..+++..+..++.|++.+|.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 72 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 72 MEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLH--SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcc
Confidence 9999999999988654 47899999999999999999999 99999999999999999999999999998875433221
Q ss_pred C------ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 186 T------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 186 ~------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
. .......++..|++||...+...+.++|+||||+++|++++|..||...........+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------- 215 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------- 215 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 1 112224577889999999888889999999999999999999999975543221111111
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHH
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM---VDVLT 301 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~ 301 (349)
...........+..+.+++.+||+.+|++|||+ .++++
T Consensus 216 ----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 216 ----GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000111111237889999999999999999999 55554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=294.87 Aligned_cols=267 Identities=28% Similarity=0.459 Sum_probs=230.2
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
-++......|.++||.|.||.|++|..+ ...+....||||.++....+ ...+|+.|..++-+++||||+++.+
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk------~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLK------LPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred hhcChhheEEEEEEecccccceeccccc------CCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 4455667789999999999999999765 23345788999999887654 5677999999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
+.....-..||+||++.|+|+.++.++.+.++.-++..+++-|+.++.||- +.++|||||-.+||||+.+-.+|+.||
T Consensus 698 VVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs--dm~YVHRDLAARNILVNsnLvCKVsDF 775 (996)
T KOG0196|consen 698 VVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS--DMNYVHRDLAARNILVNSNLVCKVSDF 775 (996)
T ss_pred EEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh--hcCchhhhhhhhheeeccceEEEeccc
Confidence 999999999999999999999999998899999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCccccceec--CCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchh
Q 018891 175 GLARDGPTGDNTHVSTRIVG--TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~--~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
|+++........ .....-| ...|.|||.+....++.++|+||+|++|||.++ |..||-++++++..
T Consensus 776 GLSRvledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI---------- 844 (996)
T KOG0196|consen 776 GLSRVLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---------- 844 (996)
T ss_pred cceeecccCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----------
Confidence 999865443321 1111112 456999999999999999999999999999887 88999877764443
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
+-+++.++.+-|.++|..|.+|+..||++|..+||.+.+|+..|.++-.+
T Consensus 845 --------kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 845 --------KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred --------HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 33444566677889999999999999999999999999999999998766
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=272.52 Aligned_cols=244 Identities=26% Similarity=0.383 Sum_probs=189.6
Q ss_pred eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHH---HHhccCCCcccceeeEEecCCc
Q 018891 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVI---YLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
.||+|+||.||++ .+..++..+|+|.+...... ....+.+|.. ++....||+++.+.+.+...+.
T Consensus 1 ~lg~G~~g~Vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEE---------EECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 4899999999999 45556889999988654321 1122333433 3333479999999999998899
Q ss_pred eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 102 RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
.++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 99999999999999988544 67999999999999999999999 8999999999999999999999999999886533
Q ss_pred CCCCCccccceecCCcccCccccc-cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 182 TGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
.... ....++..|+|||.+. +..++.++|+||+|+++|+|++|..||.......... +..
T Consensus 149 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~-------------- 209 (279)
T cd05633 149 KKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR-------------- 209 (279)
T ss_pred ccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHH--------------
Confidence 2211 1235788999999886 4568899999999999999999999997543321110 100
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTSL 303 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l 303 (349)
.........+..+++++.++|.+||..||.+|| |+.++++|-
T Consensus 210 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 210 -MTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred -HhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 001112234556788999999999999999999 699988763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=277.42 Aligned_cols=271 Identities=25% Similarity=0.329 Sum_probs=198.1
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++|++.+.||.|++|.||+| .+..+++.+++|.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred cccEEEEEEeccCCCEEEEEE---------EECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 479999999999999999999 45556888999988654322 2345678999999999999999998875
Q ss_pred cC--------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 98 ES--------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 98 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
.. ...++|++|+.+ ++...+......+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.+
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGIL 154 (311)
T ss_pred cccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCCCE
Confidence 43 346899999854 777777655567999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCcc---------ccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcc
Q 018891 170 KLSDFGLARDGPTGDNTHV---------STRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~ 239 (349)
+|+|||++........... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.....
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999875433222111 1123567889999987654 57889999999999999999999997655433
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhcc----ccCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDT----RLGGQYS-------KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
....+.................... ......+ ....+.+.++|.+||+.||++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 2222222111000000000000000 0000001 1233678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=282.48 Aligned_cols=272 Identities=27% Similarity=0.442 Sum_probs=227.6
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhch-HHHHHHHHHHhccCCCccc
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~i~ 90 (349)
..-+.++..+...+++.||+|-||.|.+|...+ +.+||+|.++.+..... ++|..|+++|.+++||||+
T Consensus 529 ~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIv 598 (807)
T KOG1094|consen 529 GPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIV 598 (807)
T ss_pred CcchhhcchhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCee
Confidence 455677888899999999999999999996543 68899999988866654 8899999999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccCCC-CChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQP-ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
.+++++..++.+++|+||++.|+|.+++.++.-+ +.-.....++.||++|++||. +.++|||||.++|++|++++++
T Consensus 599 eLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe--s~nfVHrd~a~rNcLv~~e~~i 676 (807)
T KOG1094|consen 599 ELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE--SLNFVHRDLATRNCLVDGEFTI 676 (807)
T ss_pred EEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH--hhchhhccccccceeecCcccE
Confidence 9999999999999999999999999999776433 355667889999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh--CCccCccccCcchhhhHHhh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt--g~~pf~~~~~~~~~~~~~~~ 247 (349)
||+|||.++.+..++........+-...|+|||.+.-+.++.++|+|++|+++||+++ ...||+..++++.....-.
T Consensus 677 KiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~- 755 (807)
T KOG1094|consen 677 KIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGE- 755 (807)
T ss_pred EecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhh-
Confidence 9999999997777777776666777889999999999999999999999999999765 7788876654333221111
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.+.. -........|.-++..+.+++.+||..+.++|||++++..+|++.
T Consensus 756 ---~~~~-------~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 756 ---FFRD-------QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---hcCC-------CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111 111122344667888999999999999999999999999998864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.88 Aligned_cols=262 Identities=26% Similarity=0.419 Sum_probs=225.0
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
.+.....+||-|.+|.||.|.|+.. .-.||||.++.+. ...+.|+.|..+++.++|||+++++++|..+.
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4566778999999999999988764 4569999887664 45678899999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 101 NRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
-.|||+||+..|+|.+|+.+. ...++.-..++++.||.+|++||. +++++||||-.+|.||.++..||+.|||+++.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999999763 356788888999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
........ .........|.|||-+....++.++|+|+||+++|++.| |..||.+... ...
T Consensus 415 MtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl------------------SqV 475 (1157)
T KOG4278|consen 415 MTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------------SQV 475 (1157)
T ss_pred hcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH------------------HHH
Confidence 43322221 112345677999999999999999999999999999999 6677766542 345
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 313 (349)
+.++++.++.+.|.+|++.+.+|++.||+++|.+||++.++-+.++.++.+-.+.
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSis 530 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSIS 530 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccccc
Confidence 5677788889999999999999999999999999999999999999998775554
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=283.07 Aligned_cols=269 Identities=24% Similarity=0.315 Sum_probs=198.3
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+++|++.+.||.|++|.||+| .+..++..|++|.+........+.+.+|+.+++.++|||++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~---------~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSA---------VDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred CcceEEEEEecCCCCEEEEEE---------EECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 579999999999999999999 55566889999998766555567788899999999999999999776543
Q ss_pred --------------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC
Q 018891 100 --------------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165 (349)
Q Consensus 100 --------------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~ 165 (349)
...++|+||++ ++|.+++.. ..+++..+..++.|+++||.||| +.+++|+||+|+||+++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~givH~dikp~Nili~~ 149 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINT 149 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcC
Confidence 35789999996 588887743 46899999999999999999999 899999999999999974
Q ss_pred -CCcEEEecccccccCCCCCCCc-cccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhh
Q 018891 166 -NFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242 (349)
Q Consensus 166 -~~~v~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~ 242 (349)
++.++|+|||.+.......... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..........
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~ 229 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5578999999987543221111 1112346778999998754 567889999999999999999999997655422222
Q ss_pred hHHhh-hchhhhhhhhH----hhhhc-cccCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 243 TLVEW-ADPFLRDSRRV----LRIMD-TRLGG-----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 243 ~~~~~-~~~~~~~~~~~----~~~~~-~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.+... ........... ..... ..... .....++.++.+++.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 11110 00000000000 00000 00000 0112356789999999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=272.99 Aligned_cols=266 Identities=25% Similarity=0.333 Sum_probs=202.5
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
|++.+.||.|.+|.||+| ....+++.+++|.+.... ......+..|+.+++.++|++++++++++...+
T Consensus 1 y~~~~~ig~g~~~~vy~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKA---------RDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred CeeehcccccCcceEEEe---------eecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 677889999999999999 566668999999987653 223456778999999999999999999999989
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++|+|+++ ++|.+++.+....+++..+..++.|++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 9999999997 5899999765467999999999999999999999 899999999999999999999999999988754
Q ss_pred CCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh-hhhH
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD-SRRV 258 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~ 258 (349)
..... ......++..|+|||.+.+. .++.++|+||||+++|++++|..||...........+.......... ....
T Consensus 149 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 149 GIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred CCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 33221 11123456779999998766 78899999999999999999999997655332222222111100000 0000
Q ss_pred hh------hhccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LR------IMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~------~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ....... ....+..+..+.+++++||..||++||++.+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00 0000000 01112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=273.98 Aligned_cols=255 Identities=28% Similarity=0.361 Sum_probs=201.9
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
.....|...+.||.|++|.||+| ....++..+++|.+.... ......+.+|+.+++.++|+|++++.+
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 82 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEE---------EEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 34566888999999999999999 444557889999876432 223356778999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++......++||||+. +++.+.+......+++..+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 83 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH--~~~i~H~dl~p~nil~~~~~~~kl~df 159 (308)
T cd06634 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDF 159 (308)
T ss_pred EEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHhEEECCCCcEEECCc
Confidence 9999999999999996 5788777555567899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
|++...... ....++..|+|||.+. ...++.++|+||||+++|+|++|..||...........+.
T Consensus 160 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~------ 227 (308)
T cd06634 160 GSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------ 227 (308)
T ss_pred ccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh------
Confidence 988654321 1235778899999874 3567889999999999999999999986543211111111
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
...........++..+.++|++||..+|++||++.+++++-....
T Consensus 228 -----------~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 228 -----------QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -----------hcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 011111123356778999999999999999999999998755443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=279.31 Aligned_cols=271 Identities=24% Similarity=0.309 Sum_probs=199.5
Q ss_pred hcccC-CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc--------------hHHHHHHHHHHhcc
Q 018891 20 TKNFC-SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--------------HKEWLTEVIYLGQL 84 (349)
Q Consensus 20 ~~~y~-~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l 84 (349)
.++|. +.+.||.|++|.||+| .+..+++.||+|.+....... ...+.+|+.+++.+
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 77 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKA---------YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77 (335)
T ss_pred ccchhhhhhcccCCCceeEEEE---------EECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC
Confidence 35665 5678999999999999 455568899999886543221 12467899999999
Q ss_pred CCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
+|+||+++++++...+..++|||++. ++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||+|+||+++
T Consensus 78 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH--~~~i~H~dl~~~nill~ 153 (335)
T PTZ00024 78 KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLH--KWYFMHRDLSPANIFIN 153 (335)
T ss_pred CCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHeEEC
Confidence 99999999999999999999999996 589888844 367899999999999999999999 89999999999999999
Q ss_pred CCCcEEEecccccccCCCCCC------------CccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCcc
Q 018891 165 SNFNAKLSDFGLARDGPTGDN------------THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA 231 (349)
Q Consensus 165 ~~~~v~l~Dfg~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~p 231 (349)
.++.++|+|||.+........ ........++..|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999998875431110 1111123457789999988764 468899999999999999999999
Q ss_pred CccccCcchhhhHHhhhchhhhh----hhhHhhh--hcccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 232 LDEDRGGLAEQTLVEWADPFLRD----SRRVLRI--MDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
|...........+.......... ....... ..... ........++.+.++|.+||+.+|++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 97665433222222211100000 0000000 00000 000112346789999999999999999999999974
Q ss_pred H
Q 018891 303 L 303 (349)
Q Consensus 303 l 303 (349)
-
T Consensus 314 ~ 314 (335)
T PTZ00024 314 E 314 (335)
T ss_pred c
Confidence 3
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=283.65 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=215.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.....|.+.+.||+|.|+.|.+| .+.-++..||||.+...... ....+.+|+++++.++||||++++.+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La---------~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v 123 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLA---------RHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV 123 (596)
T ss_pred ccccceeeeeeeccceeEEEEee---------EecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 34568999999999999999999 77778999999999776433 33557899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
......+|+||||+.++.+++++.++ +...+..+..++.|+++|++||| +++|+|||||++|++++.+-++||+|||
T Consensus 124 ~~t~~~lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH--~k~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 124 IETEATLYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCH--SKNIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred eeecceeEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHh--hcceeccccchhhcccccccceeeeccc
Confidence 99999999999999999999999665 66777999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCC-CccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++..+.... ......|++.|.|||++.+..|+ +.+|+||||+++|.|+.|..||++.+......
T Consensus 201 fS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------------ 265 (596)
T KOG0586|consen 201 FSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------------ 265 (596)
T ss_pred cceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------------
Confidence 998765433 33446799999999999998775 89999999999999999999998766422221
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
..+..++ -++--++.++.++|+++|..+|.+|+++++++++-+.-
T Consensus 266 -----rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 266 -----RVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred -----hheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 1111111 13344567899999999999999999999999876653
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=267.17 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=189.1
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHH-HhccCCCcccceeeEEecCCce
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIY-LGQLRHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~ 102 (349)
+.||.|++|.||+| ....+++.||+|.+...... ....+..|... ....+|+|++++++.+..++..
T Consensus 2 ~~l~~g~~~~v~~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLA---------KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEE---------EecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 57999999999999 55566889999998654322 12233344443 4445899999999999999999
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
++|+||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|.||+++.++.++|+|||++.....
T Consensus 73 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCcEEEeecccceeccc
Confidence 9999999999999988543 67899999999999999999999 89999999999999999999999999998865322
Q ss_pred CCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 183 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.....++..|++||.+.+..++.++|+||||+++|+|++|..||...........+.. .
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------~ 208 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS---------------R 208 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------------c
Confidence 1123467889999999888889999999999999999999999975443221111110 0
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM---VDVLTS 302 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~ 302 (349)
...........+++.+.+++.+||+.||++||++ .++++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 209 RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0001112223567889999999999999999966 566554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=273.14 Aligned_cols=247 Identities=28% Similarity=0.414 Sum_probs=197.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+-|...+.||.|++|.||+| ....++..|++|.+..... .....+.+|+.+++.++|||++++++++.
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~---------~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 91 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFA---------TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL 91 (313)
T ss_pred HHhhcceeeccCCCeEEEEE---------EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 44777888999999999999 4555688999998865432 23356778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.....++||||+. +++.+++.....++++..+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH--~~gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 92 KEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred eCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChhhEEECCCCCEEEeecCCC
Confidence 9999999999995 5788877665677999999999999999999999 899999999999999999999999999988
Q ss_pred ccCCCCCCCccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
...... ....++..|+|||.+. +..++.++|+||||+++|+|++|..||...........+..
T Consensus 169 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------- 234 (313)
T cd06633 169 SKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------- 234 (313)
T ss_pred cccCCC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------
Confidence 642211 1245778899999974 45688899999999999999999999865542111111110
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..........++..+.+++.+||+.+|.+||++.+++.+
T Consensus 235 ---------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 ---------NDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---------cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111123456679999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=270.23 Aligned_cols=265 Identities=26% Similarity=0.381 Sum_probs=198.5
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccC-CCcccceeeEEecCC
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLR-HENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 100 (349)
|++.+.||.|++|.||+|. ...+++.|+||.+...... ......+|+..++++. |+|++++++++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~---------~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLAR---------NKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND 71 (283)
T ss_pred CeeheeeccCCceEEEEEE---------ECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence 7789999999999999994 4445788999988654332 2234457899999998 999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 101 NRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
..++||||+ +++|.+++.... ..+++..+..++.|++.+|.||| +++++|+||+|+||+++.++.++|+|||.+..
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~ 148 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLARE 148 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCCEEEeeccccee
Confidence 999999999 778988886543 47899999999999999999999 89999999999999999999999999999875
Q ss_pred CCCCCCCccccceecCCcccCccccc-cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh--
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR-- 256 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-- 256 (349)
...... .....++..|+|||.+. +..++.++|+||||+++++|++|..||...........+.....+......
T Consensus 149 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 149 IRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred ccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 433221 12245677899999874 445789999999999999999999999776543333222221111111000
Q ss_pred --hHhhhhccccC----C---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 --RVLRIMDTRLG----G---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 --~~~~~~~~~~~----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........... . ......+..+.+++++||+.||++|||+.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000 0 0011225779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=272.25 Aligned_cols=269 Identities=17% Similarity=0.189 Sum_probs=191.0
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhch-----------HHHHHHHHHHh
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-----------KEWLTEVIYLG 82 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~ 82 (349)
.+.++.+++|++.+.||+|+||.||+|.+.+. ...+..+++|.......... .....+...+.
T Consensus 5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~------~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~ 78 (294)
T PHA02882 5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASD------HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78 (294)
T ss_pred eeeccCCCceEEeeEEecCCCceEEEEEEcCC------cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhc
Confidence 45667789999999999999999999965421 11145667775433221110 11223445566
Q ss_pred ccCCCcccceeeEEecCC----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 83 QLRHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 83 ~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
.+.|++++++++...... ..+++++++ ..++.+.+.. ....++..+..++.|++.||+||| +.+++||||||
T Consensus 79 ~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH--~~~iiHrDiKp 154 (294)
T PHA02882 79 NIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIH--EHGISHGDIKP 154 (294)
T ss_pred cCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCH
Confidence 678999999998765433 346778877 3467666633 244678889999999999999999 89999999999
Q ss_pred CcEEEcCCCcEEEecccccccCCCCCCC-----ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCc
Q 018891 159 SNVLLDSNFNAKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 233 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~ 233 (349)
+||+++.++.++|+|||++......... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 155 ~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~ 234 (294)
T PHA02882 155 ENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK 234 (294)
T ss_pred HHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999998754322211 11112358999999999999999999999999999999999999998
Q ss_pred cccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 234 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
+............ .... .+..... ......++.+.+++..|+..+|++||++.++++.|
T Consensus 235 ~~~~~~~~~~~~~--~~~~------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 235 GFGHNGNLIHAAK--CDFI------KRLHEGK---IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred ccccchHHHHHhH--HHHH------HHhhhhh---hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 6632211110000 0000 0000000 01223467899999999999999999999999865
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=267.08 Aligned_cols=280 Identities=21% Similarity=0.254 Sum_probs=204.3
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCC--CcEEEEEEccccch--hchHHHHHHHHHHhccCCCc
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGS--GIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHEN 88 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~--~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ 88 (349)
.+..+.+ ..|+..+.||+|.+|.||+|.-.. ... ...+|||.++.+.. .......+|+.+++.++|||
T Consensus 17 r~rve~l-~~ye~ig~Ig~GTYG~VykA~~~~-------~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~n 88 (438)
T KOG0666|consen 17 RERVEDL-FEYEGIGKIGRGTYGKVYKAVRKN-------TNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPN 88 (438)
T ss_pred hhhHHHH-HHhhccceecccccceeeEeeecc-------CCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCc
Confidence 3444554 589999999999999999994321 112 34689998876532 23456789999999999999
Q ss_pred ccceeeEEec-CCceEEEEEeCCCCChHHHHhcc----CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 89 LVKLIGYCSE-SDNRLLVYEFMPKGSLENHLFRS----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 89 i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
++.+..+|.. +...++++||.+. +|++.|..+ ...++...+..+++||+.++.||| ++-|.||||||.||+|
T Consensus 89 vi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH--~NWvlHRDLKPaNIlv 165 (438)
T KOG0666|consen 89 VISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH--SNWVLHRDLKPANILV 165 (438)
T ss_pred chhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh--hhheeeccCCcceEEE
Confidence 9999999877 7789999999954 899988542 256899999999999999999999 9999999999999999
Q ss_pred cCC----CcEEEecccccccCCCCCCCc-cccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccC
Q 018891 164 DSN----FNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRG 237 (349)
Q Consensus 164 ~~~----~~v~l~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~ 237 (349)
..+ |.|||+|||+++.+...-... .....+-|..|+|||++.+. .|+.+.|+|++||++.||++..+.|.+...
T Consensus 166 mgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 166 MGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred eccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 888 899999999998754433222 12235678899999998875 699999999999999999999998876432
Q ss_pred cchh---------hhHHhhhc-------hhhhhhhhHhhhhccc---cCCCC--C------HHHHHHHHHHHHHhcccCC
Q 018891 238 GLAE---------QTLVEWAD-------PFLRDSRRVLRIMDTR---LGGQY--S------KKEAQAVAAVVLQCLHMDP 290 (349)
Q Consensus 238 ~~~~---------~~~~~~~~-------~~~~~~~~~~~~~~~~---~~~~~--~------~~~~~~l~~li~~~l~~dp 290 (349)
+... ..|++.-. |.+.........+... ..... . ..-++...+|+.+||..||
T Consensus 246 k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP 325 (438)
T KOG0666|consen 246 KIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDP 325 (438)
T ss_pred hcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCc
Confidence 1111 11211111 1111111111111111 11110 0 1123458899999999999
Q ss_pred CCCCCHHHHHHHH
Q 018891 291 KNRPSMVDVLTSL 303 (349)
Q Consensus 291 ~~Rps~~~ll~~l 303 (349)
.+|.|+++.+++.
T Consensus 326 ~kRIta~qAleh~ 338 (438)
T KOG0666|consen 326 IKRITAEQALEHP 338 (438)
T ss_pred hhhccHHHHhccc
Confidence 9999999999864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=268.04 Aligned_cols=265 Identities=24% Similarity=0.337 Sum_probs=196.2
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhcc---CCCcccceeeEEe
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL---RHENLVKLIGYCS 97 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~ 97 (349)
|++.+.||.|++|.||+|.+ ..++..+++|.+...... ....+.+|+.+++++ +|+|++++++++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~---------~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARD---------LNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred CeEEEEecccCceEEEEEEE---------CCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 67889999999999999954 445789999998654322 223455676666555 6999999999998
Q ss_pred cCCc-----eEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 98 ESDN-----RLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 98 ~~~~-----~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
.... .+++||++.+ +|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH--~~~i~h~~l~~~nili~~~~~~~l 148 (287)
T cd07838 72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH--SHRIVHRDLKPQNILVTSDGQVKI 148 (287)
T ss_pred eccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhEEEccCCCEEE
Confidence 7766 8999999965 7888886532 36899999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+.......
T Consensus 149 ~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07838 149 ADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225 (287)
T ss_pred eccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCC
Confidence 99998876433221 112346778999999998889999999999999999999999997655433322222211100
Q ss_pred hhhh-h-hH---hhhhccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDS-R-RV---LRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~-~-~~---~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... . .. ......... ....+..++.+.+++.+||+.||.+||++.+++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 0 00 000000000 11123556888999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=275.01 Aligned_cols=267 Identities=22% Similarity=0.285 Sum_probs=195.0
Q ss_pred ceeeec--CceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecCCce
Q 018891 27 YLLGEG--GFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNR 102 (349)
Q Consensus 27 ~~lg~G--~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 102 (349)
..||.| ++|+||+| .+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~ig~g~~~~~~v~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~ 74 (328)
T cd08226 4 VEIGRGFCNLTSVYLA---------RHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74 (328)
T ss_pred HHhCCcccCceeEEEE---------EEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence 456666 88999999 5666789999999865432 2346678899999999999999999999999999
Q ss_pred EEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 103 LLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
++|+||+.+++|.+++.+. ...+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++++||+.+....
T Consensus 75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 9999999999999988653 345899999999999999999999 8999999999999999999999999998653321
Q ss_pred CCCCCcc-----ccceecCCcccCccccccC--CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc--hh-
Q 018891 182 TGDNTHV-----STRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD--PF- 251 (349)
Q Consensus 182 ~~~~~~~-----~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~--~~- 251 (349)
....... .....++..|++||++.+. .++.++|+|||||++|+|++|..||................. +.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcc
Confidence 1111100 0011235569999998764 478899999999999999999999976543222111110000 00
Q ss_pred ---hhhhhh-----------------Hh-----hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 252 ---LRDSRR-----------------VL-----RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 252 ---~~~~~~-----------------~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
...... .. ...........+..+++.+.+|+++||+.||++|||+.+++++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 000000 00 000011112223457788999999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=280.54 Aligned_cols=265 Identities=25% Similarity=0.345 Sum_probs=200.4
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.+++|++.+.||.|++|.||+| ....++..|++|.+.... ......+.+|+.+++.+.|||++++.+++
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSA---------FDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF 83 (343)
T ss_pred ccCceEEEEEeccCCceEEEEE---------EECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence 4679999999999999999999 455568899999886542 22335567899999999999999999887
Q ss_pred ecCCc------eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SESDN------RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~~~------~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
...+. .++|+|++ +++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH--~~gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07851 84 TPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIH--SAGIIHRDLKPSNIAVNEDCELK 158 (343)
T ss_pred hccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEECCCCCEE
Confidence 65554 89999998 6699998854 57999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||.+.........+.....
T Consensus 159 L~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~ 233 (343)
T cd07851 159 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233 (343)
T ss_pred Ecccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Confidence 9999998754322 122356778999998865 3678899999999999999999999976554322222222111
Q ss_pred hhhhh---------hhhHhhhhccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRD---------SRRVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~---------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... ............... .....++.+.++|++||+.||++|||+.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 000000000110000 112246789999999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=267.38 Aligned_cols=243 Identities=26% Similarity=0.368 Sum_probs=189.2
Q ss_pred eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc---hHHHHHHH---HHHhccCCCcccceeeEEecCCc
Q 018891 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEV---IYLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
.||.|+||.||+| .+..+++.||+|.+....... ...+..|. ..++...||+++++.+.+.....
T Consensus 1 ~ig~g~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 71 (278)
T ss_pred CcccCCCeEEEEE---------EEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence 4899999999999 555568899999886543221 11223333 34445579999999999999999
Q ss_pred eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 102 RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
.++||||+.+++|.+++.. ...+++..+..++.|++.|++||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 72 ~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999999999999988854 367999999999999999999999 8999999999999999999999999999886542
Q ss_pred CCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 182 TGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
.... ....++..|+|||.+.++ .++.++|+||+|+++|+|++|..||............ .
T Consensus 149 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---------------~ 209 (278)
T cd05606 149 KKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------------R 209 (278)
T ss_pred ccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------------H
Confidence 2211 124578899999998754 6889999999999999999999999765322111100 0
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ........+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 210 ~-~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 210 M-TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred H-hhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 0 00111223445678999999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=271.09 Aligned_cols=269 Identities=21% Similarity=0.218 Sum_probs=195.1
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
|.+.+.+|.|+++.|+++ ..++..||+|++... .......+.+|+.+++.++|+||+++++.+...+
T Consensus 4 ~~i~~~~~~~~~v~~~~~-----------~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 72 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKH-----------KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS 72 (314)
T ss_pred hhhhHhhcCCceEEEEEe-----------cCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC
Confidence 344455555555444444 336889999998765 2334567889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 101 NRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
..+++|||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 73 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH--~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~ 150 (314)
T cd08216 73 ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVS 150 (314)
T ss_pred eEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCcceEEEecCCceEEecCcccee
Confidence 999999999999999998653 356899999999999999999999 99999999999999999999999999998864
Q ss_pred CCCCCCC-----ccccceecCCcccCcccccc--CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-hh
Q 018891 180 GPTGDNT-----HVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PF 251 (349)
Q Consensus 180 ~~~~~~~-----~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~~ 251 (349)
....... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||................. ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (314)
T cd08216 151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230 (314)
T ss_pred eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccc
Confidence 4322211 11112346678999999866 3578899999999999999999999976443221110000000 00
Q ss_pred hh-----h-hhhH--------hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 252 LR-----D-SRRV--------LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 252 ~~-----~-~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.. . .... ...............++.++.+++.+||+.||++|||+.+++++-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 00 0 0000 0000111112234566788999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=274.38 Aligned_cols=265 Identities=27% Similarity=0.362 Sum_probs=199.3
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.+++|++.+.||.|+||.||+| .+..++..|++|.+..... .....+..|+.+++.++|||++++.+++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 78 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSA---------RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIF 78 (328)
T ss_pred cccceEEEEeecccCCeEEEEE---------EECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence 5689999999999999999999 5556688999998754322 2345677899999999999999999988
Q ss_pred ec-CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 97 SE-SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 97 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
.. ....++|+|++ +++|.+++.. ..+++..+..++.|+++||.||| +.+++|+||+|.||+++.++.++|+|||
T Consensus 79 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH--~~~iiH~dl~p~Nili~~~~~~~l~dfg 153 (328)
T cd07856 79 ISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFG 153 (328)
T ss_pred ecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEeECCCCCEEeCccc
Confidence 65 56789999998 5688887743 46888899999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
.+....... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.+........
T Consensus 154 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd07856 154 LARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228 (328)
T ss_pred cccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 886432211 12346778999998765 568899999999999999999999997654322222111110000000
Q ss_pred h------hhHhhhhcc-ccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 S------RRVLRIMDT-RLGGQYS-----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~------~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ......... ......+ +.+++.+.++|.+||+.+|++|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000000 0001111 2356789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=276.57 Aligned_cols=265 Identities=23% Similarity=0.327 Sum_probs=199.3
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.+++|++.+.||.|++|.||+| .+..++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 83 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSA---------LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF 83 (343)
T ss_pred cccceEEEEEeeecCCeEEEEE---------EECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence 5789999999999999999999 5555688999998854322 2335577899999999999999999998
Q ss_pred ecCC------ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SESD------NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
..+. ..++||+++ +++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH--~~gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred cCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEE
Confidence 7554 358999998 7789887743 57899999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||.+....... ....+++.|++||.+.+ ..++.++|+||||+++|++++|..||...........+.....
T Consensus 159 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 159 ILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred EeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999987543221 12356788999998876 4578899999999999999999999976543222222221111
Q ss_pred hhhhh---------hhhHhhhhccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRD---------SRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~---------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... .......+...... .....+++.+.++|.+||+.||++|||+.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000001000000 0112456679999999999999999999999954
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=269.19 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=197.0
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
.+..++|++.+.||.|++|.||+|. ...++..|++|.+..... .....+..|+..+... .||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~---------~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~ 81 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMR---------FKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEE---------ECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhhe
Confidence 4455889999999999999999994 444578899999865432 2334456677666666 5999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEec
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
++......++||||+. +++.+.+......+++..+..++.|++.+++||| + .+++|+||+|+||++++++.++|+|
T Consensus 82 ~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~~i~H~dl~p~nill~~~~~~kL~d 158 (296)
T cd06618 82 YFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK--EKHGVIHRDVKPSNILLDASGNVKLCD 158 (296)
T ss_pred eeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--hhCCEecCCCcHHHEEEcCCCCEEECc
Confidence 9999999999999984 4777777555568899999999999999999999 6 5999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCC----CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH----LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
||.+......... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||....... ..+.
T Consensus 159 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~---- 229 (296)
T cd06618 159 FGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVLT---- 229 (296)
T ss_pred cccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHHH----
Confidence 9998654322211 1234677899999986553 7889999999999999999999996432110 0000
Q ss_pred hhhhhhhhHhhhhccc-cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 250 PFLRDSRRVLRIMDTR-LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
...... ........++.++.+++.+||..||.+||++.+++++-.
T Consensus 230 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 230 ----------KILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred ----------HHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 000000 001111235678999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=273.87 Aligned_cols=268 Identities=25% Similarity=0.291 Sum_probs=194.3
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCC--CcEEEEEEccccch--hchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGS--GIVVAIKRLKAESF--QGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~--~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
+|++.+.||.|+||.||++.. ... +..||+|.+..... .....+.+|+.+++++ +||||+++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 71 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARN---------AETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMD 71 (332)
T ss_pred CceEEEEccccCCeEEEEEEe---------CCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeee
Confidence 588999999999999999954 333 78899998865322 2245677899999999 599999999864
Q ss_pred ec----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 97 SE----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 97 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
.. ....+++++++. ++|.+.+.. ...+++..+..++.|++.||.||| ..+++|+||||+||+++.++.++|+
T Consensus 72 ~~~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH--~~givH~dlkp~Nili~~~~~~kl~ 147 (332)
T cd07857 72 IVFPGNFNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIH--SANVLHRDLKPGNLLVNADCELKIC 147 (332)
T ss_pred eeccccCCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHeEEcCCCCEEeC
Confidence 32 245788999885 589888844 467999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCC--ccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 173 DFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 173 Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|||.+......... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.....
T Consensus 148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 227 (332)
T cd07857 148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG 227 (332)
T ss_pred cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence 99998754332211 11122467888999998765 4688999999999999999999999976543222221111110
Q ss_pred -hhhhhhh--------hHhhhhccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 -PFLRDSR--------RVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 -~~~~~~~--------~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+...... ............ ......+..+.+++.+||+.||++|||+.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 000000000000 0112236789999999999999999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=264.91 Aligned_cols=249 Identities=24% Similarity=0.322 Sum_probs=193.6
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccc---cc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA---ES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~---~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+|.+.+.||+|++|.||++.+. ..+..+++|.++. .. ......+..|+.+++.++|||++++++++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDK---------KAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF 71 (260)
T ss_pred CceeeeeecCCCCceEEEEEec---------CCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence 6899999999999999999543 2233344444332 21 12334566788999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
......++|+||+++++|.+++.+ ....+++..++.++.|++.||.||| +.+++|+||+|+||+++. +.++|+|
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i~h~~l~~~nili~~-~~~~l~d 148 (260)
T cd08222 72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRILHRDLKAKNIFLKN-NLLKIGD 148 (260)
T ss_pred hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCccccCCChhheEeec-CCEeecc
Confidence 988899999999999999988853 3357899999999999999999999 899999999999999975 5799999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||.+........ ......+++.|++||.+.+..++.++|+||||+++|+|++|..||....... ...
T Consensus 149 ~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~~~-------- 215 (260)
T cd08222 149 FGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---VVL-------- 215 (260)
T ss_pred cCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH--------
Confidence 998865432221 1122457788999999988888999999999999999999999986433110 000
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... .......+..++.++.++|.+||..||++||++.+++++
T Consensus 216 ------~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 ------RIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------HHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 000 111122345678899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=267.01 Aligned_cols=256 Identities=27% Similarity=0.362 Sum_probs=198.8
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
+|++.+.||.|+||.||.|.... ...+|..|++|.+..... .....+.+|+.+++.+ +|++|+++++.+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~------~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVS------GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 74 (290)
T ss_pred CceeeeeeccCCcceEEEEEecc------CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence 58899999999999999995431 234688899999865432 2235567899999999 599999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..+...++|+||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH--~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 75 QTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred ecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeEECCCCCEEEeeCcc
Confidence 9988999999999999999998554 67899999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccccC--CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
+......... ......++..|++||.+.+. .++.++|+||||+++|+|++|..||...........+..
T Consensus 152 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-------- 222 (290)
T cd05613 152 SKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-------- 222 (290)
T ss_pred ceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH--------
Confidence 8754322111 11124578889999998653 467899999999999999999999964322111111110
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
.... .....+..+++.+.+++.+||..||++|| ++.+++.+
T Consensus 223 -----~~~~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 -----RILK--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----Hhhc--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0000 01123445678899999999999999997 77777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=256.55 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=201.6
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (349)
.++.+++..||.|..|.||++ ....+|...|||.+..... +..++++..+.++... .+|+|++++++|.
T Consensus 91 indl~~l~dlGsGtcG~V~k~---------~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKM---------RFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred hHHhhhHHhhcCCCccceEEE---------EEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 356678889999999999999 5555689999999876543 3456677777766555 4999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.+...++.||.+ +..+..++..-.+++++..+-.+...++.||.||.. +.+|+|||+||+||++++.|++||||||.+
T Consensus 162 ~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 162 TNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred eCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeeccccc
Confidence 999999999988 556777776666889999999999999999999965 789999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCcccccc---CCCCCccceehhhHHHHHHHhCCccCccccC-cchhhhHHhhhchhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRG-GLAEQTLVEWADPFLR 253 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~ 253 (349)
-++-.+..... -.|-+.|+|||.+.. ..|+.++|+||||+++++|.||+.||.+-.. .+....+.+...|.
T Consensus 240 GrlvdSkAhtr---sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~-- 314 (391)
T KOG0983|consen 240 GRLVDSKAHTR---SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL-- 314 (391)
T ss_pred ceeeccccccc---ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC--
Confidence 77655444333 346778999999854 4688999999999999999999999986442 22222222211111
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.......++++++++..||..|+.+||-..++++|
T Consensus 315 --------------L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 --------------LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --------------CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11123478999999999999999999999999974
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=275.24 Aligned_cols=270 Identities=23% Similarity=0.358 Sum_probs=198.9
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++|.+.+.||.|++|.||+| .+..+++.||+|.+..... .....+.+|+.+++.+.||||+++++++.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSA---------IDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred ccceEEEEEeeecCCeEEEEE---------EeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 579999999999999999999 4555688999998865322 22345778999999999999999999886
Q ss_pred cCC------ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 98 ESD------NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 98 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
... ..++|+||+. .+|.+.+ ...+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQ-TDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIH--SAGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred ccccCCCCceEEEEecccc-cCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCEEE
Confidence 543 4589999985 4676654 246899999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD- 249 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~- 249 (349)
+|||++....... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.........+.....
T Consensus 159 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (342)
T cd07879 159 LDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 233 (342)
T ss_pred eeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999986532211 12356788999999866 4678899999999999999999999976543221111111100
Q ss_pred --hhhhhh------hhHhhhhccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhcC
Q 018891 250 --PFLRDS------RRVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 309 (349)
Q Consensus 250 --~~~~~~------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~~ 309 (349)
+.+.+. .............. ..+..+..+.++|.+||+.||++||++.+++.| ++.+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000 00000000000000 012345678999999999999999999999976 7776554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=305.93 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=208.6
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.-+|.....||.|.||.||-| .+..+|+..|+|.+..... .....+.+|+.++..++|||+++++++-.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYta---------vN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTA---------VNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred eeeeccccccCCcceeeeEEe---------ecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence 357888999999999999999 7777899999997765432 33456789999999999999999999998
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..+|.||||++|+|.+.+ +...-.++.....+..|++.|++||| +.|||||||||.||+++.+|.+|++|||.+
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH--~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLH--EHGIVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHH--hcCceecCCCccceeeecCCcEEeecccce
Confidence 889999999999999999988 44466788888999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCC--ccccceecCCcccCccccccC---CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 178 RDGPTGDNT--HVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 178 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
......... .......||+.|+|||++.+. .-.-+.|||||||++.||+||+.||.+.++.-..
T Consensus 1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI----------- 1450 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI----------- 1450 (1509)
T ss_pred eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH-----------
Confidence 875444211 112246899999999999764 3456899999999999999999999765531111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.-.+...-....|..++++-+++|.+||..||++|.++.+|+++
T Consensus 1451 ------My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 ------MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11111111234566799999999999999999999999998874
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=274.78 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=199.2
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
....++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.++++++||||+++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~v~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 13 WEVPERYQNLSPVGSGAYGSVCAA---------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred hhccCceEEEEEeeecCCeEEEEE---------EEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 345689999999999999999999 4455688999998865422 23456778999999999999999999
Q ss_pred EEecC------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 95 YCSES------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 95 ~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
++... ...+++++++ +++|.+.+.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChHHEEEcCCCC
Confidence 87533 3467888877 7789887743 46899999999999999999999 899999999999999999999
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...
T Consensus 159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred EEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999998753221 122457888999998866 56788999999999999999999999765433222222211
Q ss_pred hchh---hh----h--hhhHhhhhccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 248 ADPF---LR----D--SRRVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 248 ~~~~---~~----~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.... .. . ............... .....++.+.++|.+||+.||.+||++.+++.+=
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 1100 00 0 000001011000000 0012466789999999999999999999999763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=298.66 Aligned_cols=254 Identities=23% Similarity=0.265 Sum_probs=209.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
...+||+++++||+|+||.|.++ .+..++..||+|++++... .....|.+|=.+|..-+.+=|+.++.
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lV---------r~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy 142 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALV---------RHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY 142 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEE---------EeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH
Confidence 45689999999999999999999 6777899999999977432 33455778888888888999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
.|.+++++|+||||++||+|..++.+.. .++++.+..++..++-||..+| +.|+|||||||+|||++..|+++|+||
T Consensus 143 AFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH--~mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 143 AFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH--SMGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred HhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH--hccceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999999996654 8999999999999999999999 889999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccc----c-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVA----T-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|.+......+. -.....+|||.|++||++. + +.|+...|.||||+++|+|+.|..||-..+..+-.
T Consensus 220 GsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY-------- 290 (1317)
T KOG0612|consen 220 GSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY-------- 290 (1317)
T ss_pred hhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH--------
Confidence 99977543332 2233478999999999983 3 57899999999999999999999999543321111
Q ss_pred hhhhhhhhHhhhhccccCCCCC--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYS--KKEAQAVAAVVLQCLHMDPKNRPS---MVDVLTS 302 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 302 (349)
.++++-.-...+| .++|....+||.+.+. +|+.|.. ++++..|
T Consensus 291 ---------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 291 ---------GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ---------HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1222222222233 4688999999999885 9999988 9998875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=266.80 Aligned_cols=259 Identities=26% Similarity=0.356 Sum_probs=200.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
+|++.+.||.|++|.||++.... ....+..|++|.+..... .....+.+|+.+++++ +||+++++++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ 74 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG------GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF 74 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec------cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence 58899999999999999986432 234578899998865322 2234577899999999 599999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..+...++||||+++++|.+++... ..+++..+..++.|++++|.||| +.+++|+||+|.||+++.++.++|+|||+
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH--~~~~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 75 QTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred ecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHeEECCCCCEEEEECcc
Confidence 9999999999999999999988543 57899999999999999999999 89999999999999999999999999998
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCC--CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
+.......... .....++..|++||.+.+.. .+.++|+||||+++|+|++|..||...........+..
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-------- 222 (288)
T cd05583 152 SKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-------- 222 (288)
T ss_pred ccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH--------
Confidence 87543322111 11235788899999987654 77899999999999999999999964322111111110
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
.... .....+..++..+.+++.+||+.||++|||+.++.+.|..
T Consensus 223 -----~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 223 -----RILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----HHHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0000 1123344567889999999999999999997766554433
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=262.68 Aligned_cols=241 Identities=29% Similarity=0.404 Sum_probs=195.7
Q ss_pred eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccceeeEEecCCceEEE
Q 018891 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 29 lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 105 (349)
||.|++|.||.+. ...+++.+++|.+...... ....+..|+.+++.++|+|++++++.+..+...++|
T Consensus 1 lg~G~~~~v~~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVR---------KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEE---------ECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 6899999999994 4445789999988765432 345678899999999999999999999999999999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~ 185 (349)
||++++++|.+++... ..+++..+..++.|++.++.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 72 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh--~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~- 147 (250)
T cd05123 72 LEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLH--SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG- 147 (250)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-
Confidence 9999999999999554 56899999999999999999999 8999999999999999999999999999987643322
Q ss_pred CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccc
Q 018891 186 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265 (349)
Q Consensus 186 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (349)
.......++..|++||.+.+...+.++|+||||+++|++++|..||........... ...
T Consensus 148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-----------------~~~-- 207 (250)
T cd05123 148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK-----------------ILK-- 207 (250)
T ss_pred -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-----------------Hhc--
Confidence 112224577889999999888889999999999999999999999965432111100 001
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 018891 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM---VDVLTS 302 (349)
Q Consensus 266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~ 302 (349)
.....+...+..+.+++.+||..||++||++ .+++++
T Consensus 208 ~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 208 DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 1123444557889999999999999999999 666543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=280.29 Aligned_cols=277 Identities=25% Similarity=0.359 Sum_probs=207.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.-|...+.||+|+||.||++ .+..+|+.||||.+.... ....+...+|+++|++++|+|||++.++-+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rg---------rnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~ 83 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRG---------RNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETK 83 (732)
T ss_pred cceeehhhhcCCccceeeee---------cccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcc
Confidence 56778889999999999999 788899999999987754 34557788999999999999999999886543
Q ss_pred ------CceEEEEEeCCCCChHHHHhc--cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc--CCCc-
Q 018891 100 ------DNRLLVYEFMPKGSLENHLFR--SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD--SNFN- 168 (349)
Q Consensus 100 ------~~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~--~~~~- 168 (349)
....+|||||.||+|...+.+ +...+++.+.+.++..+..|+.||| .++|+||||||.||++. ++|.
T Consensus 84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr--En~IvHRDlKP~NIvl~~Gedgq~ 161 (732)
T KOG4250|consen 84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR--ENGIVHRDLKPGNIVLQIGEDGQS 161 (732)
T ss_pred ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH--HcCceeccCCCCcEEEeecCCCce
Confidence 356899999999999999975 4578999999999999999999999 99999999999999984 3333
Q ss_pred -EEEecccccccCCCCCCCccccceecCCcccCccccc-cCCCCCccceehhhHHHHHHHhCCccCccccCcchh-----
Q 018891 169 -AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE----- 241 (349)
Q Consensus 169 -v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~----- 241 (349)
.||+|||.++...... .....+||+.|++||++. .+.|+..+|.||+||++|++.||..||.........
T Consensus 162 IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~ 238 (732)
T KOG4250|consen 162 IYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMW 238 (732)
T ss_pred EEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhh
Confidence 7999999998654443 455678999999999998 488999999999999999999999999654433211
Q ss_pred hhHHhhhchhhhhh-hhHhhhhccccCCCCC----HHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhhhcCCC
Q 018891 242 QTLVEWADPFLRDS-RRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRP--SMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 242 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rp--s~~~ll~~l~~~~~~~~ 311 (349)
..+........-.. .....-+......+.+ +.....+-..+..||..+|.+|. ...+....+.++....-
T Consensus 239 ~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 239 HIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred hhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 11111111000000 0000000000111122 23334456678889999999998 77777777666665543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=236.28 Aligned_cols=267 Identities=25% Similarity=0.318 Sum_probs=212.0
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+|...+.||.|.+|+||+| ++..+++.||+|.+..+. ........+|+-+|+.++|.||+++++..-.+
T Consensus 3 ~ydkmekigegtygtvfka---------rn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKA---------RNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred chHHHHhhcCCcceeeEec---------ccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 5777889999999999999 777789999999876543 33457788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+.+-+|+|+|+ ..|..+...-++.++...+..++.|++++|.++| +.++.|||+||.|.+|+.+|.+||.|||+++.
T Consensus 74 kkltlvfe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fch--shnvlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 74 KKLTLVFEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH--SHNVLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred ceeEEeHHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh--hhhhhhccCCcceEEeccCCcEEecccchhhh
Confidence 99999999995 4899988777788999999999999999999999 99999999999999999999999999999986
Q ss_pred CCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhh-chhhhhhh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWA-DPFLRDSR 256 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 256 (349)
+...- ...+..+.+..|++|.++.+. -|+.+.|+||.||++.++.. |.+.|++.+.+.....++..- .+......
T Consensus 151 fgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 151 FGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred cCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 43322 222335678889999998875 58899999999999999998 666677766555555444322 22222233
Q ss_pred hHhhhhccccCCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
++.+.-+......++ +.+...-++++.++|..+|.+|.|+++.+++
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 333333333222222 3344557899999999999999999998874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=262.86 Aligned_cols=271 Identities=23% Similarity=0.299 Sum_probs=203.6
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-C-C----
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-H-E---- 87 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-~---- 87 (349)
..+++..++|++...+|.|.||.|-.++++ ..+..||||+++.-.. -.+...-|+++|.++. + |
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~---------~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDR---------ETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeec---------CCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCce
Confidence 456788999999999999999999999543 3378899998876432 2344556899999983 2 2
Q ss_pred cccceeeEEecCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc--
Q 018891 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD-- 164 (349)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~-- 164 (349)
-++.+.++|+-.++.++|+|.+ |-++++++.+ +..+++...+..+.+||++++++|| +.+++|.||||+||++.
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--~~kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--DLKLTHTDLKPENILFVSS 228 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--hcceeecCCChheEEEecc
Confidence 3677788899999999999988 7799999976 4567999999999999999999999 99999999999999983
Q ss_pred ------------------CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHH
Q 018891 165 ------------------SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 226 (349)
Q Consensus 165 ------------------~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll 226 (349)
++..|+++|||.+....... ...+.|..|+|||++.+-+|+...|+||+||+++|+.
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 13348999999997643322 3467899999999999999999999999999999999
Q ss_pred hCCccCccccCcchhhhHHhhhchhhhhhhh---Hhhhhccc-c---------------CCC--------CCHHHHHHHH
Q 018891 227 SGRRALDEDRGGLAEQTLVEWADPFLRDSRR---VLRIMDTR-L---------------GGQ--------YSKKEAQAVA 279 (349)
Q Consensus 227 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~---------------~~~--------~~~~~~~~l~ 279 (349)
+|...|..-.+.+-.......-.|....... ..+.+... . ... ........|+
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 9999998766433222222111111111000 00111000 0 000 1122345799
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 018891 280 AVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 280 ~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+|+++||..||.+|+|+.|++.|
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHccCccccccHHHHhcC
Confidence 99999999999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=256.82 Aligned_cols=265 Identities=25% Similarity=0.356 Sum_probs=206.6
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 105 (349)
+.||.|+++.|--+ ....+|..+|||++.+...-...+..+|++.+.+.+ |+||+.++++|+++...|+|
T Consensus 84 e~LGeGAyasVqtc---------v~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTC---------VSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHhcCccceeeeee---------eeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 47999999999988 677789999999998775556678889999999995 99999999999999999999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc---EEEecccccccCCC
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPT 182 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~---v~l~Dfg~~~~~~~ 182 (349)
||.+.||+|...|.+. ..+++.++.++...|+.||.+|| .+||.|||+||+||+....+. |||+||.+......
T Consensus 155 fEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 9999999999999654 78999999999999999999999 999999999999999977655 79999998753222
Q ss_pred CCCC-----ccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccC-------cchhhhHH
Q 018891 183 GDNT-----HVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-------GLAEQTLV 245 (349)
Q Consensus 183 ~~~~-----~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~-------~~~~~~~~ 245 (349)
.... ......+|+..|+|||++. ...|+.+.|+||||+++|-||+|.+||.+.=. .+.=....
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH
Confidence 2221 1122367888899999862 23688999999999999999999999976432 11100000
Q ss_pred hhhchhhhhhhhHhhhhcccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhhcCCCCC
Q 018891 246 EWADPFLRDSRRVLRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT--SLEQLHTSKDMP 313 (349)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~~~~~~~~~ 313 (349)
..+...+++.. ...-.-.++.+..++++.+|..|+.+|.++.+++. .++.+...+..|
T Consensus 312 ----------~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalp 374 (463)
T KOG0607|consen 312 ----------NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALP 374 (463)
T ss_pred ----------HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCC
Confidence 01111111111 11122468899999999999999999999999997 444555555554
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=265.83 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=209.6
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
-.+..+.|+.-++||+|+||.||.+ ....+|..+|.|.+...... .....++|-.+|.+++.+.||.+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~ac---------qvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl 250 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCAC---------QVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL 250 (591)
T ss_pred hhccccceeeeEEEecccccceeEE---------EEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE
Confidence 3455678999999999999999999 56667999999988655433 23446788999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
-..|+..+.+++|+..++||+|.-.|.+ ....+++..+.-++.+|+-+|++|| ..+||+||+||+||++++.|+++|
T Consensus 251 aYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--~~~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 251 AYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--RRRIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred eeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--hcceeeccCChhheeeccCCCeEe
Confidence 9999999999999999999999876754 3357999999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
.|+|++...+.+..- ...+||.+|+|||++.++.|+.+.|.|||||++|+|+.|+.||...........+..
T Consensus 329 SDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr----- 400 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR----- 400 (591)
T ss_pred eccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH-----
Confidence 999999976554432 224899999999999999999999999999999999999999975543222222211
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 297 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 297 (349)
.......+++...++++.++++.+|+.||++|.-.+
T Consensus 401 ----------r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 401 ----------RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ----------HHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 111123456678899999999999999999997554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=291.07 Aligned_cols=254 Identities=30% Similarity=0.417 Sum_probs=189.1
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..+|+.+.+||+|+||.||++ +++-+|+.||||++.... ......+.+|+..|.+++||||++++..|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkV---------RNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE 548 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKV---------RNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE 548 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEE---------eecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence 368999999999999999999 677789999999997764 2344668899999999999999999863310
Q ss_pred --------------------------------------------------------------------------------
Q 018891 99 -------------------------------------------------------------------------------- 98 (349)
Q Consensus 99 -------------------------------------------------------------------------------- 98 (349)
T Consensus 549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~ 628 (1351)
T KOG1035|consen 549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR 628 (1351)
T ss_pred cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence
Q ss_pred -------------------------------C--------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHH
Q 018891 99 -------------------------------S--------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139 (349)
Q Consensus 99 -------------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~ 139 (349)
. ..+||-||||+..++.+++.++...-....+|.++++|++
T Consensus 629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILE 708 (1351)
T ss_pred ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHH
Confidence 0 1357889999887777777543221147889999999999
Q ss_pred HHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC----------------CCCCccccceecCCcccCccc
Q 018891 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT----------------GDNTHVSTRIVGTRGYAAPEY 203 (349)
Q Consensus 140 ~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~----------------~~~~~~~~~~~~~~~~~aPE~ 203 (349)
||+|+| +.|++||||||.|||+++++.|||+|||++..... +......+..+||.-|.|||+
T Consensus 709 GLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 709 GLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 999999 89999999999999999999999999999986210 011112234689999999999
Q ss_pred cccC---CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHH
Q 018891 204 VATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA 280 (349)
Q Consensus 204 ~~~~---~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 280 (349)
+.+. .|+.++|+||||++++||+. ||+..- +....+.......+..+ ..+..+.-+.-..
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~LR~g~iP~~------------~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNLRKGSIPEP------------ADFFDPEHPEEAS 849 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhcccCCCCCC------------cccccccchHHHH
Confidence 8765 49999999999999999985 453211 11111111111111100 1112223345678
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 018891 281 VVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 281 li~~~l~~dp~~Rps~~~ll~ 301 (349)
+|++||+.||.+||||.++|+
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999999996
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=252.05 Aligned_cols=273 Identities=25% Similarity=0.311 Sum_probs=209.3
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.+.|+.+.++|+|.||.||+| ....+|+.|++|++..++. .-.....+|+.+|..++|+|++.++.++.
T Consensus 16 ~~~yek~~kigqGtfgeVFkA---------r~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~ 86 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKA---------RSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (376)
T ss_pred chHHHHHHhcCCchHHHHHHH---------hhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence 468999999999999999999 7777889999997654332 23455678999999999999999988763
Q ss_pred c--------CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 98 E--------SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 98 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
. ....|+||++|+ .+|.-.+......++..++..++.+++++|.|+| ...|+|||+|+.|++|+.+|.+
T Consensus 87 tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH--r~kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 87 TKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH--RNKILHRDMKAANVLITKDGIL 163 (376)
T ss_pred hccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHH--HhhHHhhcccHhhEEEcCCceE
Confidence 2 234799999995 4888888655578999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCcc--ccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 170 KLSDFGLARDGPTGDNTHV--STRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+|.|||+++.+....+... ....+.|..|++||.+.+ ..|+++.|+|+.||++.+|+|+.+.+.+.+.......|..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 9999999976554443322 223566889999999876 5789999999999999999999999998887666655543
Q ss_pred hhchhh-------hhhhhHhhhhccccCC----C-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 247 WADPFL-------RDSRRVLRIMDTRLGG----Q-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 247 ~~~~~~-------~~~~~~~~~~~~~~~~----~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
...... .+..-...+--+.... . -+..-.++..+|+.+||..||.+|+++++++.|-.
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF 317 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence 322111 1111111110000000 0 01112357889999999999999999999998743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=274.97 Aligned_cols=244 Identities=24% Similarity=0.297 Sum_probs=199.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 98 (349)
...|++...+|.|+|+.|-.+ .+..+++..++|++...... ..+|+.++... +|||++++.+.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~---------~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYC---------ESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred chhhccccccCCCCccceeee---------eccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecC
Confidence 578999999999999999998 67778899999999766221 12455444444 79999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE-cCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL-DSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv-~~~~~v~l~Dfg~~ 177 (349)
+.+.|+|||.+.|+-+.+.+... +....++..|+.+|+.|+.||| .+|++||||||+|||+ +..++++|+|||.+
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~--~~~~~e~~~w~~~lv~Av~~LH--~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a 463 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSK--PEFCSEASQWAAELVSAVDYLH--EQGVVHRDLKPGNILLDGSAGHLRLTYFGFW 463 (612)
T ss_pred CceeeeeehhccccHHHHHHHhc--chhHHHHHHHHHHHHHHHHHHH--hcCeeecCCChhheeecCCCCcEEEEEechh
Confidence 99999999999999888888654 2333788899999999999999 8999999999999999 68899999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
...... ......|..|.|||++....|++++|+||||+++|+||+|..||.....+.
T Consensus 464 ~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------------------ 520 (612)
T KOG0603|consen 464 SELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------------------ 520 (612)
T ss_pred hhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------------------
Confidence 765444 222346778999999999999999999999999999999999997655430
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
.+............+++..++||.+||+.||.+||++.+++.|=+.
T Consensus 521 --ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 521 --EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 0111111122236788999999999999999999999999988766
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=254.15 Aligned_cols=220 Identities=22% Similarity=0.275 Sum_probs=177.6
Q ss_pred cCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCceEEEEEeCCC
Q 018891 32 GGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPK 111 (349)
Q Consensus 32 G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 111 (349)
|.+|.||++ .+..+++.+|+|.+..... ...|...+....|||++++++++...+..++||||+++
T Consensus 4 g~~~~v~~~---------~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLV---------MDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG 69 (237)
T ss_pred cccceEEEE---------EEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence 889999999 5666789999999876532 22445555556799999999999999999999999999
Q ss_pred CChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccc
Q 018891 112 GSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191 (349)
Q Consensus 112 ~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~ 191 (349)
++|.+++.+. ..+++..+..++.|+++||.||| +.+++|+||||+||+++.++.++++|||.+........ .
T Consensus 70 ~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~ 141 (237)
T cd05576 70 GKLWSHISKF-LNIPEECVKRWAAEMVVALDALH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----G 141 (237)
T ss_pred CCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc-----c
Confidence 9999988554 56899999999999999999999 89999999999999999999999999997754332211 1
Q ss_pred eecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCC
Q 018891 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS 271 (349)
Q Consensus 192 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (349)
..++..|+|||.+.+..++.++|+||+|+++|+|++|..|+...... .........+
T Consensus 142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------------~~~~~~~~~~ 198 (237)
T cd05576 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------------INTHTTLNIP 198 (237)
T ss_pred CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------------cccccccCCc
Confidence 23466799999998888899999999999999999999887432210 0000111234
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 018891 272 KKEAQAVAAVVLQCLHMDPKNRPSM 296 (349)
Q Consensus 272 ~~~~~~l~~li~~~l~~dp~~Rps~ 296 (349)
..+++.+.++|.+||+.||.+||++
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCC
Confidence 4567889999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=277.31 Aligned_cols=261 Identities=27% Similarity=0.402 Sum_probs=221.7
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
..+..++||+|+||+||+|.|-. ....-..+||||++... .......+.+|+.++.++.|||++++++++..+.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~P-----ege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIP-----EGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST 771 (1177)
T ss_pred hhhhhceeccccceeEEeeeEec-----CCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch
Confidence 45678899999999999997743 33333567899987544 4445678899999999999999999999997654
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
+-||++|+++|+|.+++..++..+-....+.|+.||++|+.||| .++++||||-.+||||.+-+.+|+.|||++..+
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 77999999999999999999899999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
...........-...+.|+|-|.+....|+.++|+||+|+++||++| |..|+.+... ..+.
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~------------------~eI~ 910 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA------------------EEIP 910 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH------------------HHhh
Confidence 55544433332334667999999999999999999999999999999 9999987764 2334
Q ss_pred hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
.+++...+...|+.++.++..++.+||..|+..||+++++...+.++..
T Consensus 911 dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 911 DLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred HHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 4555666677889999999999999999999999999999999988654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.02 Aligned_cols=146 Identities=27% Similarity=0.361 Sum_probs=129.8
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+|. +..+++.||||++..... .....+..|+.+++.++||+|+++++.+.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~---------~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGR---------KKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEE---------ECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 689999999999999999994 445688999999865432 22356778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.....|+||||+.+++|.+++... ..+++..++.++.||+.||.||| ..+|+|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH--~~gIiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLH--RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 999999999999999999988543 56899999999999999999999 899999999999999999999999999987
Q ss_pred c
Q 018891 178 R 178 (349)
Q Consensus 178 ~ 178 (349)
.
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=267.82 Aligned_cols=265 Identities=25% Similarity=0.332 Sum_probs=212.8
Q ss_pred eecCCCCcchhhhhhhcccCC--cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHH
Q 018891 5 IAMSDPSASMISKIATKNFCS--DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIY 80 (349)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~y~~--~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~ 80 (349)
|..+.+..|.-.++.+ =|++ .++||+|.||+||-| .+..+|+.||||++.+.... ....+++|+.+
T Consensus 547 ~s~s~~qiqe~vd~st-vYQif~devLGSGQFG~VYgg---------~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaI 616 (888)
T KOG4236|consen 547 ISVSNCQIQENVDIST-VYQIFADEVLGSGQFGTVYGG---------KHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAI 616 (888)
T ss_pred ccccchhhhhhhhHHH-HHHhhhHhhccCCcceeeecc---------eecccCceeeeeeeecccCCCchHHHHHHHHHH
Confidence 3445555666666543 4555 469999999999999 78888999999999775443 34678899999
Q ss_pred HhccCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 81 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
|+++.||.|+.+.-.|+..+..|+|||.+.| ++.++|.. ..+.+++.....++.||+.||.||| -++|+|+||||+
T Consensus 617 Lq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPE 693 (888)
T KOG4236|consen 617 LQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPE 693 (888)
T ss_pred HHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCch
Confidence 9999999999999999999999999999966 55555544 5578999999999999999999999 999999999999
Q ss_pred cEEEcCC---CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCcccc
Q 018891 160 NVLLDSN---FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 236 (349)
Q Consensus 160 Nilv~~~---~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~ 236 (349)
||++... ..+||||||+++..++..... ..+|||.|+|||++.++.|..+-|+||+|+++|--++|.-||++..
T Consensus 694 NVLLas~~~FPQvKlCDFGfARiIgEksFRr---sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 694 NVLLASASPFPQVKLCDFGFARIIGEKSFRR---SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred heeeccCCCCCceeeccccceeecchhhhhh---hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 9999654 459999999999866654433 3579999999999999999999999999999999999999997543
Q ss_pred CcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 237 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+ ...+|.. ..++ +...-...++....+||..+|+..-.+|-|....+.|
T Consensus 771 d--IndQIQN------------AaFM---yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 771 D--INDQIQN------------AAFM---YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred c--hhHHhhc------------cccc---cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 2 1112211 0111 1111235778899999999999999999999887765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=266.51 Aligned_cols=274 Identities=22% Similarity=0.256 Sum_probs=216.6
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC------
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR------ 85 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------ 85 (349)
..-++.++..+|++....|+|-|++|..| .+..-|..||||+|....... +.=+.|+++|++|+
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra---------~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRA---------RDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPED 492 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeec---------cccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchh
Confidence 34567889999999999999999999999 666667799999997653322 22346899999994
Q ss_pred CCcccceeeEEecCCceEEEEEeCCCCChHHHHhcc--CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
--++++++..|...+++|+|||.+ ..+|.+++.+. ...+....+..++.|++-||..|- .++|+|.||||+||||
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILV 569 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEe
Confidence 357899999999999999999998 67999999763 356888999999999999999999 9999999999999999
Q ss_pred cCC-CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhh
Q 018891 164 DSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242 (349)
Q Consensus 164 ~~~-~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~ 242 (349)
++. ..+||||||.|.......... +..+..|.|||++.|-+|+...|+||+||++|+|.||+..|++.++..+..
T Consensus 570 NE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr 645 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR 645 (752)
T ss_pred ccCcceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence 875 457999999998654443322 334566999999999999999999999999999999999999999988887
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCC-----------------------------------------CCCHHHHHHHHHH
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGG-----------------------------------------QYSKKEAQAVAAV 281 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~l~~l 281 (349)
..+....++........++.+.-+.. .-....-..+.+|
T Consensus 646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL 725 (752)
T KOG0670|consen 646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL 725 (752)
T ss_pred HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence 66655443333222111111111110 1112344679999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018891 282 VLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 282 i~~~l~~dp~~Rps~~~ll~~ 302 (349)
+.+||..||++|.|..+.|+|
T Consensus 726 Ldkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 726 LDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHhccChhhcCCHHHHhcC
Confidence 999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=258.32 Aligned_cols=245 Identities=31% Similarity=0.443 Sum_probs=208.5
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhch---HHHHHHHHHHhcc-CCCcccce
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQL-RHENLVKL 92 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l-~h~~i~~~ 92 (349)
.+...+|.++.+||+|+||.|.+| ...++.+.+|||+++.+..-.. +--..|-++|... +-|.++.+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLa---------erkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~ql 415 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLA---------ERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQL 415 (683)
T ss_pred ceeecccceEEEeccCccceeeee---------cccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHH
Confidence 455679999999999999999999 7778899999999987644322 2234566777666 57889999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
+..|+.-+.+|+||||+.||+|--.|.+ -+.+.+..+..++..|+-+|-+|| ++||++||||.+||+++.+|++||.
T Consensus 416 HScFQTmDRLyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi~ 492 (683)
T KOG0696|consen 416 HSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIA 492 (683)
T ss_pred HHHhhhhhheeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEee
Confidence 9999999999999999999999776744 478999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||.+...-..+.. .....|||.|+|||++...+|..++|.||+|+++|+|+.|+.||++.+.++..+.|.+
T Consensus 493 DFGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e------ 564 (683)
T KOG0696|consen 493 DFGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME------ 564 (683)
T ss_pred ecccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH------
Confidence 99999753333322 2347899999999999999999999999999999999999999998887666665554
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 294 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 294 (349)
.+..+|+.++.+..+++...|...|.+|.
T Consensus 565 -------------hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 -------------HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------------ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 13456788999999999999999999995
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=290.46 Aligned_cols=262 Identities=30% Similarity=0.498 Sum_probs=197.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
..|...+.||+|+||.||+|. ...++..||+|.+...... ...|+..+++++||||+++++++....
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~---------~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGK---------SIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred hhCCcccEEccCCCeeEEEEE---------ECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 467888899999999999994 4445789999988643321 124588899999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC-CCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL-DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
..++||||+++++|.+++. .+++..+..++.|+++|++|||.. +.+++||||||+||+++.++..++. |+....
T Consensus 757 ~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~ 831 (968)
T PLN00113 757 GAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831 (968)
T ss_pred CCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence 9999999999999999983 478899999999999999999932 3489999999999999988877764 554432
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (349)
... .....+++.|+|||++.+..++.++||||+|+++|||++|+.||...... ...+..+....... ....
T Consensus 832 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~-~~~~ 902 (968)
T PLN00113 832 LCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSD-CHLD 902 (968)
T ss_pred ccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCc-cchh
Confidence 111 11125678899999999999999999999999999999999999543221 11222222211111 0111
Q ss_pred hhhccccC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 260 RIMDTRLG--GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 260 ~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
..++.... ...+.....++.+++.+|++.||++|||+.++++.|+++...
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 11122111 122345556788999999999999999999999999988654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=274.06 Aligned_cols=269 Identities=26% Similarity=0.426 Sum_probs=219.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCC-CCCCcEEEEEEccccchh-chHHHHHHHHHHhcc-CCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTK-PGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~-~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
+..++..+.+.||.|.||.|++|...+-. .. ......||+|.++..... +.+.+..|+.+++.+ .|+|++.+++
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~---~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLS---KALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred echhhccccceeecccccceEeEEEeecc---cccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 33445567779999999999999765421 11 123678999998766443 567789999999999 6999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
.+...+..++|+||+..|+|.+++...+ ..++..+.+.++.||+.|++||+ +.+++||||-.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~--~~~~vHRDLAaR 447 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA--SVPCVHRDLAAR 447 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh--hCCccchhhhhh
Confidence 9999889999999999999999997765 34899999999999999999999 899999999999
Q ss_pred cEEEcCCCcEEEecccccccCCCCCCCccccce-ecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccC
Q 018891 160 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI-VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 237 (349)
Q Consensus 160 Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~ 237 (349)
||+++++..+||+|||+++.............. .-...|+|||.+....|+.++|+||+|+++||+++ |..||.+..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~- 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP- 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-
Confidence 999999999999999999854443332211100 02345999999999999999999999999999999 788886532
Q ss_pred cchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 238 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
......+.+....+...|..+++++.++++.||+.+|++||++.++.+.+.....
T Consensus 527 ----------------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 ----------------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred ----------------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1122234566677778888999999999999999999999999999999999543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=243.60 Aligned_cols=237 Identities=31% Similarity=0.444 Sum_probs=192.3
Q ss_pred CceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-hHHHHHHHHHHhccCCCcccceeeEEecCCceEEEEEeCCC
Q 018891 33 GFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPK 111 (349)
Q Consensus 33 ~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 111 (349)
++|.||+|. ..++++.+++|.+....... ...+.+|+..+++++|++++++++++......++++|++++
T Consensus 1 ~~g~v~~~~---------~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLAR---------DKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEE---------ECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence 578999994 44468899999997765544 67888999999999999999999999988999999999999
Q ss_pred CChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccc
Q 018891 112 GSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191 (349)
Q Consensus 112 ~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~ 191 (349)
++|.+++... ..++...++.++.+++.++.+|| +.+++|+||+|.||+++.++.++|+|||.+....... ....
T Consensus 72 ~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~ 145 (244)
T smart00220 72 GDLFDLLKKR-GRLSEDEARFYARQILSALEYLH--SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTT 145 (244)
T ss_pred CCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccc
Confidence 8999988554 34899999999999999999999 8999999999999999999999999999998654432 1122
Q ss_pred eecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCC
Q 018891 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS 271 (349)
Q Consensus 192 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (349)
..++..|++||.+.+..++.++|+|+||++++++++|..||........ ..............
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~ 208 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-----------------LFKKIGKPKPPFPP 208 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-----------------HHHHHhccCCCCcc
Confidence 4577889999999888889999999999999999999999965321111 11111111111111
Q ss_pred HH--HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 272 KK--EAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 272 ~~--~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
.. ++..+.+++.+||..+|++||++.++++
T Consensus 209 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11 6678999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=247.72 Aligned_cols=269 Identities=24% Similarity=0.417 Sum_probs=205.7
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc--CCCccc
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL--RHENLV 90 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~ 90 (349)
-.......++.++.+.||+|.||.||+|.|+ |+.||||++.... ...+.+|.++.+.. +|+||+
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENIL 268 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENIL 268 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhh
Confidence 3445667889999999999999999999998 5679999986543 34556677777764 899999
Q ss_pred ceeeEEecCC----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhc------CCCCeeeccCCCCc
Q 018891 91 KLIGYCSESD----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG------LDANVIYRDLKASN 160 (349)
Q Consensus 91 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~------~~~~i~H~di~~~N 160 (349)
.+++.-..++ .+++|++|.+.|+|+||+.+ ..++...+++++..++.||+|||- -+..|.|||||.+|
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN 346 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN 346 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence 9998765543 57899999999999999965 678999999999999999999992 15569999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCC--CccccceecCCcccCccccccCC----CC--CccceehhhHHHHHHHh-----
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDN--THVSTRIVGTRGYAAPEYVATGH----LT--PKSDVYSFGVVLLELLS----- 227 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~----~~--~~~DiwslG~ll~~llt----- 227 (349)
|+|.+++.+.|+|+|++........ .......+||..|+|||++...- ++ ..+||||||.++||+..
T Consensus 347 ILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g 426 (513)
T KOG2052|consen 347 ILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG 426 (513)
T ss_pred EEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC
Confidence 9999999999999999987555432 22233478999999999986532 22 36999999999999987
Q ss_pred -----CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHH
Q 018891 228 -----GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS-----KKEAQAVAAVVLQCLHMDPKNRPSMV 297 (349)
Q Consensus 228 -----g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ 297 (349)
.+.||.+.-+.+.. +.+... -....+.+...| ...-..+..+++.||..||.-|.|+-
T Consensus 427 gi~eey~~Pyyd~Vp~DPs----------~eeMrk--VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL 494 (513)
T KOG2052|consen 427 GIVEEYQLPYYDVVPSDPS----------FEEMRK--VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL 494 (513)
T ss_pred CEehhhcCCcccCCCCCCC----------HHHHhc--ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence 34566443322111 111111 111222222222 34456788999999999999999999
Q ss_pred HHHHHHHhhhcC
Q 018891 298 DVLTSLEQLHTS 309 (349)
Q Consensus 298 ~ll~~l~~~~~~ 309 (349)
-+-+.|.++.+.
T Consensus 495 riKKtl~~l~~~ 506 (513)
T KOG2052|consen 495 RIKKTLAKLSNS 506 (513)
T ss_pred HHHHHHHHHhcC
Confidence 999999998865
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=248.09 Aligned_cols=275 Identities=28% Similarity=0.405 Sum_probs=205.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhc--cCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ--LRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~ 97 (349)
-...++.+++|+|.||.||+|..+ ++.||||+++.... +.+..|-++.+. ++|+||+.++..-.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-----------CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhc
Confidence 467889999999999999999765 47799999976543 445555555554 48999999998765
Q ss_pred cCC----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhc-------CCCCeeeccCCCCcEEEcCC
Q 018891 98 ESD----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG-------LDANVIYRDLKASNVLLDSN 166 (349)
Q Consensus 98 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~-------~~~~i~H~di~~~Nilv~~~ 166 (349)
... .+++|++|.+.|+|.+++.. ..++......++..+++||+|||. .+..|+|||||.+||||.+|
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 444 78999999999999999965 568999999999999999999993 26679999999999999999
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCC-CC-----CccceehhhHHHHHHHhCCccCccccCcch
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LT-----PKSDVYSFGVVLLELLSGRRALDEDRGGLA 240 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-----~~~DiwslG~ll~~lltg~~pf~~~~~~~~ 240 (349)
++..|+|||++.++............+||..|+|||++.+.. +. .+.||||+|.++|||++....+......+.
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 999999999999877665544444578999999999997653 22 378999999999999996655432111111
Q ss_pred hhhHH-hhh-chhhhhhhhHhhhhccccCCCCCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018891 241 EQTLV-EWA-DPFLRDSRRVLRIMDTRLGGQYSKK-----EAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 241 ~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 312 (349)
..-.. ... .|.+.+. ....+.++.+..++.. ....+++.++.||..||+-|.|+.=+.+.+.++......
T Consensus 433 qlpfe~evG~hPt~e~m--q~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEM--QELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred cCchhHHhcCCCCHHHH--HHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 11111 111 1111111 1122333334333332 235689999999999999999999999999998877654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=264.32 Aligned_cols=254 Identities=27% Similarity=0.360 Sum_probs=206.4
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (349)
..+-|+|...||.|.+|.||++ .+..+++..|+|+..... ...+.+..|+++|+.+ .|||++.++++|.
T Consensus 17 p~d~~ei~evig~Gtygkv~k~---------k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKG---------RHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred CCCccEEEEEEeeccceeEEEE---------eeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 3578999999999999999999 777778888999876654 3345677889999988 5999999999884
Q ss_pred -----cCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 98 -----ESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 98 -----~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
.++.+++|||||.||+.-+++.. ....+.+..+..|++.++.|+.+|| .+.++|||||-.||+++.++.|||
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH--~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH--NNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh--hcceeeecccCceEEEeccCcEEE
Confidence 35689999999999999999864 3467899999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccC-----CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+|||++.-...... .....+|+|+|+|||++... .|+.++|+||||++..+|--|.+|+-++.+-...-.|-.
T Consensus 165 vDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR 242 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 242 (953)
T ss_pred eeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC
Confidence 99998865433322 22336899999999999654 477899999999999999999999876654111111111
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
++......+...+..+.++|..||..|-++||+..++++|
T Consensus 243 ----------------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 ----------------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ----------------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111223356778899999999999999999999998864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=259.54 Aligned_cols=260 Identities=22% Similarity=0.283 Sum_probs=217.2
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCccc
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~ 90 (349)
...++.-.+++++.-||.|+||.|=++..+.. ...+|+|++++.+. ...+.+..|-+++.....|.|+
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIv 483 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIV 483 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHH
Confidence 34456667888999999999999999865432 23578888876543 3445567788999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
+++..|.++.+.|++||-|-||.|+..+. .++.+++..+..++..+++|++||| .++|++|||||+|.+++.+|-+|
T Consensus 484 rLYrTfrd~kyvYmLmEaClGGElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH--~k~iIYRDLKPENllLd~~Gy~K 560 (732)
T KOG0614|consen 484 RLYRTFRDSKYVYMLMEACLGGELWTILR-DRGSFDDYTARFYVACVLEAFEYLH--RKGIIYRDLKPENLLLDNRGYLK 560 (732)
T ss_pred HHHHHhccchhhhhhHHhhcCchhhhhhh-hcCCcccchhhhhHHHHHHHHHHHH--hcCceeccCChhheeeccCCceE
Confidence 99999999999999999999999999884 4588999999999999999999999 99999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|.|||++.....+..... ..|||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++=.....|
T Consensus 561 LVDFGFAKki~~g~KTwT---FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------ 631 (732)
T KOG0614|consen 561 LVDFGFAKKIGSGRKTWT---FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------ 631 (732)
T ss_pred EeehhhHHHhccCCceee---ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------
Confidence 999999987666555443 57999999999999999999999999999999999999999877642222222
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHh
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTSLEQ 305 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~l~~ 305 (349)
+........|..++....+||+++-..+|.+|.- +.+|-+|-+-
T Consensus 632 -----------LkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf 680 (732)
T KOG0614|consen 632 -----------LKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWF 680 (732)
T ss_pred -----------HhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhh
Confidence 2222234567788899999999999999999975 7888888664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=231.11 Aligned_cols=262 Identities=18% Similarity=0.265 Sum_probs=198.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 98 (349)
.++|++.+.+|+|.++.||.| .+..+.++++||++++-. .+.+.+|+.+|+.+. +|||++++++..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg---------~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEG---------INITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred cchHHHHHHHcCccHhhHhcc---------cccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 478999999999999999999 777788999999987643 456789999999996 9999999999865
Q ss_pred C--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-CcEEEeccc
Q 018891 99 S--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFG 175 (349)
Q Consensus 99 ~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-~~v~l~Dfg 175 (349)
. ..+.+|+|+++..+....- ..++...+..++.+++.||.||| +.||.|||+||.|++|+.. -.++|+|||
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCH--S~GImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCH--SMGIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred ccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHH--hcCcccccCCcceeeechhhceeeeeecc
Confidence 4 5678999999887766544 56788899999999999999999 8999999999999999864 459999999
Q ss_pred ccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccC-cchhhhHHhhhc-hhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRG-GLAEQTLVEWAD-PFL 252 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~-~~~~~~~~~~~~-~~~ 252 (349)
++.+...+..... .+.+..|.-||++.. ..|+.+-|+|||||+++.|+..+.||..... .+..-.+...-. ..+
T Consensus 179 LAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 179 LAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred hHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 9987655544322 456777999998754 5789999999999999999999999854332 222222211100 000
Q ss_pred h---------hhhhHhhhhcccc--------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 R---------DSRRVLRIMDTRL--------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~---------~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. -+.....++.... +.....-.+++..+|+.++|..|-.+|||+.|.+.|
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 0111111111111 111112245889999999999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=246.59 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=200.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-------hHHHHHHHHHHhccCCCccc
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-------HKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~ 90 (349)
.+.++|-++.+||+|+|+.||+| .+....+.||+|+-.....+. .+...+|.++.+.|.||.|+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKA---------FDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIV 530 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKA---------FDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIV 530 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHh---------cccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceee
Confidence 45789999999999999999999 677778999999653322111 23467899999999999999
Q ss_pred ceeeEEecC-CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---C
Q 018891 91 KLIGYCSES-DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---N 166 (349)
Q Consensus 91 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~---~ 166 (349)
+++++|.-+ ...|-|.|||+|.+|+-|+..+ +.+++.++..|+.||+.||.||...+..|+|-||||.||++-. -
T Consensus 531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQh-klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQH-KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred eeeeeeeeccccceeeeeecCCCchhHHHHhh-hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccc
Confidence 999999765 4678999999999998888554 7899999999999999999999866788999999999999943 4
Q ss_pred CcEEEecccccccCCCCCCCccc-----cceecCCcccCccccccC----CCCCccceehhhHHHHHHHhCCccCccccC
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVS-----TRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSGRRALDEDRG 237 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~ll~~lltg~~pf~~~~~ 237 (349)
|.+||.|||++............ +...||-.|++||.+.-+ ..+.++|+||+|+++|+++.|+.||.....
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 67999999999765443333222 224688899999987433 457799999999999999999999976543
Q ss_pred cchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 238 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
....-....+ .+. .-..-+..+.++.+...+|++||+.--++|.+..++..
T Consensus 690 QQdILqeNTI-----------lkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 690 QQDILQENTI-----------LKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHHHhhhch-----------hcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 2222111110 000 00001122467889999999999999999998887753
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=245.19 Aligned_cols=133 Identities=26% Similarity=0.378 Sum_probs=112.0
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC--------CCcccc
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR--------HENLVK 91 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~ 91 (349)
+++|.+.++||+|.|++||+|+ +....+.||+|+.+.... -.+..+.|+.+|+++. ..+||+
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLaw---------Dtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAW---------DTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred CceEEEEEeccccccceeEEEe---------eccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 4899999999999999999994 444578999998865422 2345678999999872 347999
Q ss_pred eeeEEe----cCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 92 LIGYCS----ESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 92 ~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
+++.|. .+.+.++|+|++ |.+|..+|.+ ..+.++...+.+|++|++.||.|||+ .++|+|.||||+|||+.
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeee
Confidence 999985 445889999999 7799998876 45789999999999999999999998 89999999999999994
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=262.82 Aligned_cols=268 Identities=18% Similarity=0.232 Sum_probs=168.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE--
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY-- 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-- 95 (349)
...++|++.+.||+|+||.||+|..... ....+..||+|.+...... +.... ..++...+.++..+...
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~-----~~~~~~~vAvK~~~~~~~~--e~~~~--e~l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNK-----QSKKEGKYVLKKATEYGAV--EIWMN--ERVRRACPNSCADFVYGFL 199 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCC-----ccccCcEEEEEEecccchh--HHHHH--HHHHhhchhhHHHHHHhhh
Confidence 3567999999999999999999954321 1122788999987543211 11111 12222222222222211
Q ss_pred ----EecCCceEEEEEeCCCCChHHHHhccCCC-------------------CChHHHHHHHHHHHHHHHHHhcCCCCee
Q 018891 96 ----CSESDNRLLVYEFMPKGSLENHLFRSVQP-------------------ISWPTRVKIAIDVARGLSFLHGLDANVI 152 (349)
Q Consensus 96 ----~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------l~~~~~~~i~~ql~~~l~~lH~~~~~i~ 152 (349)
...+...++|+||+.+++|.+++...... .....+..++.|++.||.||| +.+|+
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIi 277 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIV 277 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence 23456789999999999999988543211 123346689999999999999 89999
Q ss_pred eccCCCCcEEEcC-CCcEEEecccccccCCCCCCCccccceecCCcccCccccccC----------------------CC
Q 018891 153 YRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----------------------HL 209 (349)
Q Consensus 153 H~di~~~Nilv~~-~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~ 209 (349)
||||||+||+++. ++.+||+|||++........ .......+++.|+|||.+... .+
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 9999999999986 57899999999975433221 222335688999999976332 23
Q ss_pred CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCC------CCHHHHHHHHHHHH
Q 018891 210 TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ------YSKKEAQAVAAVVL 283 (349)
Q Consensus 210 ~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~ 283 (349)
+.++|||||||++|+|+++..+++.... .....+...... ............... ..........+||.
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYD----LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCc----HHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 3456999999999999987665432110 000001110000 000001111110000 00111234668999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018891 284 QCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 284 ~~l~~dp~~Rps~~~ll~~ 302 (349)
+||+.||++|||+.++++|
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=240.15 Aligned_cols=258 Identities=26% Similarity=0.332 Sum_probs=197.5
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
++..++.+-+..||.|.||+|++- .+..+|+..|||.+..... .+..+++.|.....+- ++|+|+++++
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM---------~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKM---------LHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhh---------hcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 444566777889999999999998 7888999999999987655 3456677777655554 7999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhc----cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFR----SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
..-.++..++.||.+ ..+|..+-.. ....+++..+-.+.-..+.||.||-. ..+|+|||+||+||+++..|.||
T Consensus 131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEe
Confidence 988889999999999 5577654321 33678999999999899999999965 67899999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc--CCCCCccceehhhHHHHHHHhCCccCccccCcchhhh-HHhh
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT-LVEW 247 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~-~~~~ 247 (349)
|||||.+-.+-.+-.. +...|-..|+|||.+.. +.|+.+||+||||+++||+.||..|+.++......-. ++..
T Consensus 209 LCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g 285 (361)
T KOG1006|consen 209 LCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG 285 (361)
T ss_pred eecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC
Confidence 9999988643222211 12345566999999854 4699999999999999999999999987664211111 1111
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
..|.+.. .......+..+..+|.-||..|...||...++.+
T Consensus 286 dpp~l~~-------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 286 DPPILLF-------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCCeecC-------------cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1111110 1111346788999999999999999999999986
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=240.59 Aligned_cols=269 Identities=25% Similarity=0.338 Sum_probs=223.9
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+...+++..-++-.|.||.||.|.|.+. +.-.+.+.|.+|.++... .-....+.+|...+..+.|||++.+.++
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eE----dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREE----DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeeccc----CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34456788888999999999999988754 344455667788775542 2345678899999999999999999998
Q ss_pred Eec-CCceEEEEEeCCCCChHHHHhc-------cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 96 CSE-SDNRLLVYEFMPKGSLENHLFR-------SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 96 ~~~-~~~~~lv~e~~~~~~L~~~l~~-------~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
..+ ...+++++.+..-++|..++.. ..+.++-.++..++.|++.|++||| +.+++|.||-.+|.+|++.-
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh--~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH--NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH--hcCcccchhhhhcceehhhe
Confidence 754 4678999999988999999972 2245777788899999999999999 99999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~ 246 (349)
+|||+|=.+++.+-+.+.............|++||.+.+..|+.++|+||||+++|||+| |+.|+.+.++.++.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----- 508 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----- 508 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH-----
Confidence 999999999988777666555444566778999999999999999999999999999999 88898766654433
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
..+....+...|-++|++++.++..||..+|++||++.++..-|.+++..
T Consensus 509 -------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 509 -------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 34444556667789999999999999999999999999999999998754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=235.73 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=200.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhcc-CCCcccc
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL-RHENLVK 91 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~ 91 (349)
..+.-++|.++++||+|++..|.++ ....+.+.+|+|+++++-.. +..-...|-.+..+- +||.++.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~---------~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvg 315 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVG 315 (593)
T ss_pred cccccccceeeeeecCcchhhhhhe---------ehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEe
Confidence 3455689999999999999999999 67777899999999876333 233345566666665 7999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
++.+|..+..+++|.||++||+|--.+. ...++++..+..+...|+-||.||| ++||++||||.+|++++..|++||
T Consensus 316 lhscfqtesrlffvieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghikl 392 (593)
T KOG0695|consen 316 LHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKL 392 (593)
T ss_pred hhhhhcccceEEEEEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceee
Confidence 9999999999999999999998865453 3478999999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
.|+|.+......+ ...+...|||.|+|||++.+..|..++|.|+||++|++|+.|+.||+-...+...
T Consensus 393 tdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d---------- 460 (593)
T KOG0695|consen 393 TDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD---------- 460 (593)
T ss_pred cccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc----------
Confidence 9999987533332 2334578999999999999999999999999999999999999999742211111
Q ss_pred hhhhhhHhh-hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 018891 252 LRDSRRVLR-IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295 (349)
Q Consensus 252 ~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 295 (349)
.....-+.+ ++++. ..+|..++-....+++..|+.||.+|..
T Consensus 461 ~ntedylfqvilekq--iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 461 MNTEDYLFQVILEKQ--IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cchhHHHHHHHhhhc--ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 111111111 11111 2345566677888999999999999953
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-31 Score=249.25 Aligned_cols=278 Identities=21% Similarity=0.247 Sum_probs=185.0
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCc-------CCCCCCCCcEEEEEEccccchhchHH--------------HH
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTF-------APTKPGSGIVVAIKRLKAESFQGHKE--------------WL 75 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~-------~~~~~~~~~~vaiK~~~~~~~~~~~~--------------~~ 75 (349)
.+..++|++.++||+|+||.||+|......- .......+..||||.+.......... ..
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 4567899999999999999999996522110 00223456789999986543322222 23
Q ss_pred HHHHHHhccCCCcc-----cceeeEEec--------CCceEEEEEeCCCCChHHHHhccC--------------------
Q 018891 76 TEVIYLGQLRHENL-----VKLIGYCSE--------SDNRLLVYEFMPKGSLENHLFRSV-------------------- 122 (349)
Q Consensus 76 ~e~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~-------------------- 122 (349)
.|+..+.+++|.++ +++++++.. .+..++|+||+++++|.+++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46666666655443 556666542 356799999999999999885321
Q ss_pred ---CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCccc
Q 018891 123 ---QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199 (349)
Q Consensus 123 ---~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 199 (349)
..+++..+..++.|++.+|.||| +.+++|+||||.||+++.++.++|+|||++......... ......+++.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 12356678899999999999999 899999999999999999999999999998654322211 111123478899
Q ss_pred CccccccCC--------------------CC--CccceehhhHHHHHHHhCCc-cCccccCcchhhhHHhhhchhhhhhh
Q 018891 200 APEYVATGH--------------------LT--PKSDVYSFGVVLLELLSGRR-ALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 200 aPE~~~~~~--------------------~~--~~~DiwslG~ll~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+||.+.... +. ...|+||+||++++|+++.. ||.+....... +..+. .+..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~--~~~~~----~~~~ 451 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE--LRQYD----NDLN 451 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH--Hhhcc----chHH
Confidence 999875432 11 24699999999999999875 66533211111 00000 0000
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP---KNRPSMVDVLTSL 303 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~~ll~~l 303 (349)
..................++...+|+.+||..+| .+|+|+.++|+|=
T Consensus 452 ~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 452 RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 0000111111122234567889999999999866 6899999999863
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-33 Score=234.11 Aligned_cols=271 Identities=26% Similarity=0.386 Sum_probs=206.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..+.+-.+.||-|.||.||.+ .+..+|+.|++|++..-. ....+.+.+|+.+|..++|.|++..+++..
T Consensus 52 q~Di~PDRPIGYGAFGVVWsV---------TDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQ 122 (449)
T KOG0664|consen 52 QQDIQPDRPIGYGAFGVVWSV---------TDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQ 122 (449)
T ss_pred cccCCCCCcccccceeEEEec---------cCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcC
Confidence 346777899999999999999 788889999999886542 234577889999999999999999998875
Q ss_pred cC-----CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 98 ES-----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 98 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
-. ..+|+++|.+.. +|...| -+...++.+.+.-+++||+++|.||| +.+|.||||||.|.+|+++..+|||
T Consensus 123 Pph~dfFqEiYV~TELmQS-DLHKII-VSPQ~Ls~DHvKVFlYQILRGLKYLH--sA~ILHRDIKPGNLLVNSNCvLKIC 198 (449)
T KOG0664|consen 123 PANPSFFQELYVLTELMQS-DLHKII-VSPQALTPDHVKVFVYQILRGLKYLH--TANILHRDIKPGNLLVNSNCILKIC 198 (449)
T ss_pred CCCchHHHHHHHHHHHHHh-hhhhee-ccCCCCCcchhhhhHHHHHhhhHHHh--hcchhhccCCCccEEeccCceEEec
Confidence 43 246788888844 777766 45588999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh-ch
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA-DP 250 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~-~~ 250 (349)
|||+++.... +........+-|..|+|||++.+. .|+.+.||||+||++.|++..+..|..-.+-+..+.|.+.- .|
T Consensus 199 DFGLARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP 277 (449)
T KOG0664|consen 199 DFGLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP 277 (449)
T ss_pred ccccccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence 9999986433 333344456778899999999875 68999999999999999999999997766655554444332 23
Q ss_pred hhhhhhhH-----hhhhccccCCC---------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 251 FLRDSRRV-----LRIMDTRLGGQ---------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 251 ~~~~~~~~-----~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
..+..... ...+......+ -+.+-.-+...++..|+.+||++|.+..+.+.++-
T Consensus 278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 33322211 11111111111 01122345677889999999999999999887654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=250.64 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=200.6
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
+..+.-|..++.||-|+||.|.++ .+..+...||.|.+.+...- .......|-.+|..-.++-|++++
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv---------~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy 695 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLV---------RKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY 695 (1034)
T ss_pred hccccceEEEeeecccccceeEEE---------eecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence 334567888999999999999999 66666888999988665332 223456788899999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
..|.+.+.+|+||+|++||++-.++.+. +-|+|..+..++..+.-|+++.| +.|++||||||+||||+.+|++||.|
T Consensus 696 ySFQDkdnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVH--kmGFIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 696 YSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred EEeccCCceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHH--hccceecccCccceEEccCCceeeee
Confidence 9999999999999999999999888765 67899999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCC------------------------c----------------cccceecCCcccCccccccCCCCCcc
Q 018891 174 FGLARDGPTGDNT------------------------H----------------VSTRIVGTRGYAAPEYVATGHLTPKS 213 (349)
Q Consensus 174 fg~~~~~~~~~~~------------------------~----------------~~~~~~~~~~~~aPE~~~~~~~~~~~ 213 (349)
||++..+...... . .....+||+.|+|||++....|+...
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 9998632211100 0 00115799999999999999999999
Q ss_pred ceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 018891 214 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 293 (349)
Q Consensus 214 DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 293 (349)
|.||.|++||+|+.|+.||...++.+-...+..|... +......+++.++.+||.++. .+++.|
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~---------------l~~~~~~~ls~e~~~li~kLc-~sad~R 916 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNF---------------LHIPYQGNLSKEALDLIQKLC-CSADSR 916 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhc---------------cccccccccCHHHHHHHHHHh-cChhhh
Confidence 9999999999999999999888876666555554331 112223456777788887654 467777
Q ss_pred C
Q 018891 294 P 294 (349)
Q Consensus 294 p 294 (349)
.
T Consensus 917 L 917 (1034)
T KOG0608|consen 917 L 917 (1034)
T ss_pred h
Confidence 4
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=259.39 Aligned_cols=245 Identities=28% Similarity=0.396 Sum_probs=185.8
Q ss_pred cCCcceeeecCcee-EEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEecCC
Q 018891 23 FCSDYLLGEGGFGC-VFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~~lg~G~~g~-V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 100 (349)
|.-.+++|.|+.|+ ||+|.+. |+.||||.+-.+.. ....+|+..|+.- .||||++++..-.+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~q 576 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQ 576 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence 44456889999885 5899775 67899998865543 3456899999998 5999999999988889
Q ss_pred ceEEEEEeCCCCChHHHHhccCCC---CChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---C--CcEEEe
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQP---ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---N--FNAKLS 172 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~---l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~---~--~~v~l~ 172 (349)
..||..|.|. .+|.+++...... ...-..+..+.|+++||++|| +.+|+||||||.||+|.. + ..++|.
T Consensus 577 F~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH--sl~iVHRDLkPQNILI~~~~~~~~~ra~iS 653 (903)
T KOG1027|consen 577 FLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH--SLKIVHRDLKPQNILISVPSADGTLRAKIS 653 (903)
T ss_pred eEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH--hcccccccCCCceEEEEccCCCcceeEEec
Confidence 9999999995 5999999663111 111345788899999999999 899999999999999976 3 458999
Q ss_pred cccccccCCCCCCCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHhC-CccCccccCcchhhhHHhhhch
Q 018891 173 DFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg-~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|||++.++........ .....|+.+|+|||++.....+.++|||||||++|+.++| .+||......+.+
T Consensus 654 DfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------- 724 (903)
T KOG1027|consen 654 DFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------- 724 (903)
T ss_pred ccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---------
Confidence 9999988766544222 3346799999999999998888899999999999999996 8899754421111
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+...........-..++ +..+||.+|++++|..||+|.+++.|
T Consensus 725 -------Il~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 725 -------ILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -------hhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 00000000000001122 78999999999999999999999753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=219.49 Aligned_cols=212 Identities=38% Similarity=0.590 Sum_probs=182.6
Q ss_pred eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecCCceEEEEE
Q 018891 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYE 107 (349)
Q Consensus 29 lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 107 (349)
||.|.+|.||++ ....+++.+++|.+...... ....+.+|+..++.++|++++++++++......++++|
T Consensus 1 l~~g~~~~v~~~---------~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLA---------RDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEE---------EecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence 689999999999 44446889999998766443 34678899999999999999999999998889999999
Q ss_pred eCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-CCcEEEecccccccCCCCCCC
Q 018891 108 FMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNT 186 (349)
Q Consensus 108 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-~~~v~l~Dfg~~~~~~~~~~~ 186 (349)
++++++|.+++......++...++.++.+++.++.+|| +.+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~- 148 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS- 148 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-
Confidence 99989999998654357899999999999999999999 889999999999999999 89999999999976544321
Q ss_pred ccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccc
Q 018891 187 HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265 (349)
Q Consensus 187 ~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (349)
......+...|.+||..... .++.++|+|++|++++++
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------- 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------- 187 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence 12224567789999998777 788999999999999999
Q ss_pred cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
..+.+++.+|++.||.+||++.++++++
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3577899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=230.65 Aligned_cols=268 Identities=25% Similarity=0.336 Sum_probs=199.8
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhccCCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
......+|.-++.+|.|.. .|..| .+.-.++.|++|+...+ .....++..+|..++..++|+|+++++
T Consensus 12 ~ftv~~Ry~nL~p~~~g~~-~v~~a---------~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~ 81 (369)
T KOG0665|consen 12 TFTVPKRYVNLKPIGSGAQ-IVVAA---------FDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLL 81 (369)
T ss_pred ceeeeeeeeeecccCCCCc-eEEec---------chhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeee
Confidence 3345678999999999999 77777 66777899999987554 223456778999999999999999999
Q ss_pred eEEecC------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 94 GYCSES------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 94 ~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
.+|.-. ...|+|||++ ..+|.+.+. -.++-..+..++.|++.|+.||| +.+|+||||||+||+|..++
T Consensus 82 n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lh--s~~IihRdLkPsnivv~~~~ 155 (369)
T KOG0665|consen 82 NVFTPQKTLEEFQEVYLVMELM-DANLCQVIL---MELDHETISYILYQMLCGIKHLH--SAGIIHRDLKPSNIVVNSDC 155 (369)
T ss_pred eccCccccHHHHHhHHHHHHhh-hhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHH--hcceeecccCcccceecchh
Confidence 998543 3578999999 458988885 34677789999999999999999 99999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcch-hhhHHh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLVE 246 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~-~~~~~~ 246 (349)
.+|+.|||++...... ...+..+.+..|+|||++.+-.+.+.+||||+||++.+|++|...|.+...=.. .+.+..
T Consensus 156 ~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~ 232 (369)
T KOG0665|consen 156 TLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ 232 (369)
T ss_pred heeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence 9999999999753222 344556788899999999998899999999999999999999999986442111 111110
Q ss_pred hhch---hhhhhh------------hHhhhh-----ccccCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 247 WADP---FLRDSR------------RVLRIM-----DTRLGG--QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 247 ~~~~---~~~~~~------------~~~~~~-----~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...+ +..+.. .....+ +..+.. +.++.-...+++++.+||..||++|.|++++|+|
T Consensus 233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 000000 000000 011111 1111234568899999999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=242.69 Aligned_cols=197 Identities=28% Similarity=0.377 Sum_probs=168.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhch--------HHHHHHHHHHhccC---CCcc
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--------KEWLTEVIYLGQLR---HENL 89 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~e~~~l~~l~---h~~i 89 (349)
.+|...+.+|.|+||.|++| .++.+...|+||.+.++..-.. -.+-.|+.+|..++ |+||
T Consensus 561 s~yttlq~lG~GAyGkV~la---------i~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLA---------IHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred ccceeeeeccccccceEEEe---------eecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 46999999999999999999 5555578899999877643211 11346888888886 9999
Q ss_pred cceeeEEecCCceEEEEEeC-CCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 90 VKLIGYCSESDNRLLVYEFM-PKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
++++++|+++++.|++||.. +|.+|.++|..+ ..+++.++..|++|++.++++|| +.+|+|||||-+|+.++.+|-
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh--~~~ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLH--DQGIVHRDIKDENVIVDSNGF 708 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhcccccc--ccCceecccccccEEEecCCe
Confidence 99999999999999999975 567999999554 77999999999999999999999 999999999999999999999
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCc
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALD 233 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~ 233 (349)
+||+|||.+.....+.. ....||..|.|||++.|..| ...-|||+||+++|.++....||-
T Consensus 709 ~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 709 VKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999875433332 33689999999999988876 467899999999999999988874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-31 Score=211.18 Aligned_cols=218 Identities=26% Similarity=0.329 Sum_probs=174.0
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (349)
-++..++..-...||+|++|.|=+- ++..+|...|+|.+...-. ...++..+|+.+..+. .+|.++.++
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekm---------rh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~Fy 111 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKM---------RHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFY 111 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhhe---------eeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEee
Confidence 3455667777889999999999776 7788899999999877643 3445677788877666 699999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
+.+......++.||.+ ..+|+.+-.+ ....+++..+-+++..+++||.|||+ +..++|||+||.|||++.+|+||
T Consensus 112 Ga~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~vIHRDvKPsNiLIn~~GqVK 189 (282)
T KOG0984|consen 112 GALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLSVIHRDVKPSNILINYDGQVK 189 (282)
T ss_pred hhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-HhhhhhccCCcceEEEccCCcEE
Confidence 9988889999999999 5688765533 56789999999999999999999997 78899999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc----CCCCCccceehhhHHHHHHHhCCccCcccc-CcchhhhHH
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----GHLTPKSDVYSFGVVLLELLSGRRALDEDR-GGLAEQTLV 245 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~ll~~lltg~~pf~~~~-~~~~~~~~~ 245 (349)
+||||.+-.+-.+-.... ..|-..|+|||.+.. ..|+.++||||||+++.||.+++.||+... +.+...+++
T Consensus 190 iCDFGIsG~L~dSiAkt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 190 ICDFGISGYLVDSIAKTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred EcccccceeehhhhHHHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHh
Confidence 999999865433322211 234556999998754 478999999999999999999999997543 333334444
Q ss_pred hh
Q 018891 246 EW 247 (349)
Q Consensus 246 ~~ 247 (349)
+-
T Consensus 267 ee 268 (282)
T KOG0984|consen 267 EE 268 (282)
T ss_pred cC
Confidence 43
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=241.16 Aligned_cols=256 Identities=24% Similarity=0.317 Sum_probs=208.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
-..++|+....+|+|.+|.||+| ++..+++..|+|+++.+-..+..-+.+|+.+++..+||||+.+++.+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKa---------Rd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl 82 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKA---------RDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL 82 (829)
T ss_pred CCccchhheeeecCCcccchhhh---------cccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh
Confidence 45689999999999999999999 788889999999998887777778889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
....++++||||.|++|.+.- ....++++.++...++..+.+++||| +.+=+|||||-.||+++..|.+++.|||.+
T Consensus 83 r~dklwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylh--s~gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 83 RRDKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLH--SQGKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred hhcCcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhh--cCCcccccccccceeecccCceeecccCch
Confidence 999999999999999998843 55689999999999999999999999 889999999999999999999999999987
Q ss_pred ccCCCCCCCccccceecCCcccCcccc---ccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
-.....- ......+|++.|+|||+- ..+.|...+|+|++|+...++--.+.|.....+-.... +.. ..
T Consensus 160 aqitati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-LmT--kS---- 230 (829)
T KOG0576|consen 160 AQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-LMT--KS---- 230 (829)
T ss_pred hhhhhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-Hhh--cc----
Confidence 5432221 112236899999999975 45678899999999999999988888765433211110 000 00
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
..++ ...+-....++.+.+|++.+|..+|++|||++-+|.
T Consensus 231 ------~~qp-p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 231 ------GFQP-PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ------CCCC-CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0000 001112345678899999999999999999998875
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=210.43 Aligned_cols=200 Identities=33% Similarity=0.463 Sum_probs=171.8
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecCCc
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
|.+.+.||.|++|.||++ ....+++.+++|.+...... ....+.+|+..++.++|++++++++++.....
T Consensus 1 ~~~~~~i~~g~~~~v~~~---------~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLA---------RDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEE---------EEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 678899999999999999 44556788999999876554 56778899999999999999999999998899
Q ss_pred eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 102 RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
.++++|++++++|.+++......+++..+..++.+++.++.+|| +.+++|+||++.||+++.++.++|+|||.+....
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH--SLGIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 99999999999999998654333899999999999999999999 8899999999999999999999999999987654
Q ss_pred CCCCCccccceecCCcccCcccc-ccCCCCCccceehhhHHHHHHHhCCccCcc
Q 018891 182 TGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRALDE 234 (349)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~ll~~lltg~~pf~~ 234 (349)
..... ......+...|++||.+ ....++.++|+|+||+++++|++|..||..
T Consensus 150 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 150 RDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred Ccccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 43210 11224567789999998 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=207.03 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=189.0
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeE-E
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGY-C 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~ 96 (349)
..+.|.|.+.||.|.||.+-+| .+.++...+++|.++.+.. ...+|.+|...--.| .|.||+.-++. |
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~---------eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLA---------EHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred hhhhhhHHHHhcccceeeEEee---------eccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 3578999999999999999999 7888899999998877643 456778888776666 59999988775 5
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc--CCCcEEEecc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD--SNFNAKLSDF 174 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~--~~~~v~l~Df 174 (349)
+..+..++++||++.|+|.+-+. ...+.+.....++.|+++||.|+| +.++||||||.+||+|- ...+||||||
T Consensus 92 qt~d~YvF~qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMH--sknlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 92 QTSDAYVFVQEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMH--SKNLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred hcCceEEEeeccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhh--ccchhhcccccceEEEecCCccEEEeeec
Confidence 66677889999999999988663 367889999999999999999999 99999999999999994 3457999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccC-----CCCCccceehhhHHHHHHHhCCccCccccCcchh-hhHHhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWA 248 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~-~~~~~~~ 248 (349)
|..+.....-. .....-.|.+||..... ...+.+|+|+||+++|+++||..||......+.. .....|
T Consensus 168 G~t~k~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w- 241 (378)
T KOG1345|consen 168 GLTRKVGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW- 241 (378)
T ss_pred ccccccCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-
Confidence 99875322211 12234458899876432 2468999999999999999999999733221111 111111
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR---PSMVDVLTSLE 304 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~l~ 304 (349)
.+...... .......++.+..+.++-|..+|++| .++....+-++
T Consensus 242 ----------~~rk~~~~-P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 242 ----------LKRKNPAL-PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred ----------hcccCccC-chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 11111111 11123456788999999999999999 55555554443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=218.08 Aligned_cols=272 Identities=22% Similarity=0.333 Sum_probs=199.5
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
..+...|..+..||.|.|++||+|.... ....++.||+|.+...+ ....+..|++.|..+ .+.||+++.+.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~------~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~ 103 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIE------QDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC 103 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhh------hccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh
Confidence 3445789999999999999999995432 13368899999886654 445688999999999 59999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-CCcEEEecc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDF 174 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-~~~v~l~Df 174 (349)
+..++...+|+||++.....++. ..++..++..+++.++.||.++| ++||+||||||.|++.+. .+.-.|+||
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h--~~GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLH--KNGIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred hccCCeeEEEecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhh--ccCccccCCCccccccccccCCceEEec
Confidence 99999999999999998888877 44678999999999999999999 999999999999999974 567899999
Q ss_pred cccccC-----------------CC--CC--------------CCcc---------ccceecCCcccCcccccc-CCCCC
Q 018891 175 GLARDG-----------------PT--GD--------------NTHV---------STRIVGTRGYAAPEYVAT-GHLTP 211 (349)
Q Consensus 175 g~~~~~-----------------~~--~~--------------~~~~---------~~~~~~~~~~~aPE~~~~-~~~~~ 211 (349)
|++... .. +. .... .....||++|+|||++.. ...++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 998710 00 00 0000 001458999999999865 45788
Q ss_pred ccceehhhHHHHHHHhCCccCccccCcchh-hhHHhh-hchh---------------------hh----hhhhH-hhhhc
Q 018891 212 KSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEW-ADPF---------------------LR----DSRRV-LRIMD 263 (349)
Q Consensus 212 ~~DiwslG~ll~~lltg~~pf~~~~~~~~~-~~~~~~-~~~~---------------------~~----~~~~~-~~~~~ 263 (349)
++|+||.|+++..++++..||.....+... ..+... .... .. ..... ...+.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 999999999999999999999765543222 111110 0000 00 00011 00000
Q ss_pred c-c---cCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 264 T-R---LGGQYS-KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 264 ~-~---~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+ . ...... ...+..+.+|+.+||..||.+|.|+++.|+|
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 0 011111 2234589999999999999999999999975
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=199.04 Aligned_cols=281 Identities=20% Similarity=0.224 Sum_probs=224.4
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCccc
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLV 90 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~ 90 (349)
.+....+.+++|++++.||+|+||.+|+| ....+|+.||||+-.... ....+..|..+.+.++ ...|.
T Consensus 6 ~s~~~~iv~gky~lvrkiGsGSFGdIy~~---------~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP 74 (341)
T KOG1163|consen 6 GSLEELIVGGKYKLVRKIGSGSFGDIYLG---------ISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIP 74 (341)
T ss_pred cchhhheeccceEEEEeecCCchhheeee---------eeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCc
Confidence 34445567889999999999999999999 788899999999765432 3345667888888885 57788
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC---C
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN---F 167 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~---~ 167 (349)
.+..++.+..+-.+||+.+ |-+|.+...-....++...++-++.|++.-++|+| .++++||||||+|+++.-+ .
T Consensus 75 ~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~ 151 (341)
T KOG1163|consen 75 HIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCN 151 (341)
T ss_pred hhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccc
Confidence 8888888888999999998 78999988766688999999999999999999999 9999999999999999643 4
Q ss_pred cEEEecccccccCCCCCCCcccc-----ceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVST-----RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~-----~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~ 242 (349)
.+.|+|||++............. ...||..|.+-....+...+.+.|+-|+|.++.++..|..||.+.......+
T Consensus 152 kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q 231 (341)
T KOG1163|consen 152 KLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ 231 (341)
T ss_pred eEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence 58999999998655544332221 2678999999888888888999999999999999999999999877654444
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCCCCC
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 317 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~ 317 (349)
......+....... ..+..+.|.++...+.-|-..--++-|+...+.+.+..++.+.+.+....
T Consensus 232 KyEkI~EkK~s~~i-----------e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~i 295 (341)
T KOG1163|consen 232 KYEKISEKKMSTPI-----------EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYI 295 (341)
T ss_pred HHHHHHHhhcCCCH-----------HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeE
Confidence 33332222111110 01224567888999999999999999999999999999999988876554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-26 Score=195.86 Aligned_cols=272 Identities=18% Similarity=0.232 Sum_probs=220.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
+.+-.|+++++||+|.||.++.| ..--+++.||||.-+.. .....+..|++..+.| ..++|..++.+.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G---------~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFG 93 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLG---------KNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFG 93 (449)
T ss_pred EecccceeccccccCcceeeecc---------cccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeec
Confidence 55779999999999999999999 77778999999976443 3456677888888888 589999999888
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-----CcEEE
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-----FNAKL 171 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-----~~v~l 171 (349)
.++.+-.+|+|.+ |-+|.|+..-....++...+..++.|++.-++++| .+.++.|||||+|+||... +.+.+
T Consensus 94 qeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH--~k~LIYRDIKPdNFLIGrp~~k~~n~Ihi 170 (449)
T KOG1165|consen 94 QEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH--EKDLIYRDIKPDNFLIGRPGTKDANVIHI 170 (449)
T ss_pred cccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH--hcceeecccCccceeecCCCCCCCceEEE
Confidence 8888888999998 88999988777788999999999999999999999 9999999999999999643 34899
Q ss_pred ecccccccCCCCCCCcccc-----ceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 172 SDFGLARDGPTGDNTHVST-----RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~-----~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+|||++............. ...||..|++-....+...+.+.|+=|||-+++++|.|..||.+..-+...+...+
T Consensus 171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK 250 (449)
T KOG1165|consen 171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK 250 (449)
T ss_pred EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence 9999998655544433222 26799999999999999999999999999999999999999988664333332222
Q ss_pred hhchhhhhhhhHhhhhccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCCCCC
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 317 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~~~ 317 (349)
+-+.+.... +..+.|.++...++-.-..+-.+-|+.+.+...+.++....+......
T Consensus 251 --------------IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~ 310 (449)
T KOG1165|consen 251 --------------IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGE 310 (449)
T ss_pred --------------hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccc
Confidence 222222221 123567788888888888888999999999999999998876654433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=192.67 Aligned_cols=166 Identities=22% Similarity=0.210 Sum_probs=128.1
Q ss_pred CChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccc
Q 018891 112 GSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191 (349)
Q Consensus 112 ~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~ 191 (349)
|+|.+++......+++..++.++.|++.||.||| +.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------- 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH--RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------- 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--hcC------CcccEeEcCccceee--ccceEeecccc-------
Confidence 5889999765577999999999999999999999 666 999999999999999 99886533221
Q ss_pred eecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcc-hhhhHHhhhchhhhhhhhHhhhhcccc--CC
Q 018891 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL-AEQTLVEWADPFLRDSRRVLRIMDTRL--GG 268 (349)
Q Consensus 192 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 268 (349)
..+++.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.. ...... ..
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------------~~~~~~~~~~ 129 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN--------------GMPADDPRDR 129 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH--------------HhccCCcccc
Confidence 247899999999999999999999999999999999999996543211 1111110 000000 00
Q ss_pred CCCHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 269 QYSKKEAQ--AVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 269 ~~~~~~~~--~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
..+...+. .+.+++.+||..||.+|||+.++++++..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11233444 69999999999999999999999999987754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-27 Score=234.97 Aligned_cols=195 Identities=19% Similarity=0.222 Sum_probs=136.2
Q ss_pred CcccceeeEE-------ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 87 ENLVKLIGYC-------SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 87 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
+||+.+++.| ......++++|+. +++|.+++......+++.++..++.||++||+||| +++|+||||||+
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~gIvHrDlKP~ 109 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH--SQGIVVHNVRPS 109 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH--hCCeeeccCCch
Confidence 4666666666 2334567788987 66999999665567999999999999999999999 999999999999
Q ss_pred cEEEcCCCcEE-------------------EecccccccCCCCCC--------------CccccceecCCcccCcccccc
Q 018891 160 NVLLDSNFNAK-------------------LSDFGLARDGPTGDN--------------THVSTRIVGTRGYAAPEYVAT 206 (349)
Q Consensus 160 Nilv~~~~~v~-------------------l~Dfg~~~~~~~~~~--------------~~~~~~~~~~~~~~aPE~~~~ 206 (349)
|||++..+.++ ++|||++........ ........+++.|+|||++.+
T Consensus 110 NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 189 (793)
T PLN00181 110 CFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG 189 (793)
T ss_pred hEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc
Confidence 99997655555 455554432110000 000011347888999999999
Q ss_pred CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhc
Q 018891 207 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL 286 (349)
Q Consensus 207 ~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 286 (349)
..++.++|||||||++|||+++..|+..... .+..... ..... ......+....++.+||
T Consensus 190 ~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~----------~~~~~-----~~~~~~~~~~~~~~~~L 249 (793)
T PLN00181 190 SSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRH----------RVLPP-----QILLNWPKEASFCLWLL 249 (793)
T ss_pred CCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHH----------hhcCh-----hhhhcCHHHHHHHHHhC
Confidence 9999999999999999999998887642210 0000000 00000 00111334668899999
Q ss_pred ccCCCCCCCHHHHHHHHH
Q 018891 287 HMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 287 ~~dp~~Rps~~~ll~~l~ 304 (349)
+.||.+|||+.++++|-.
T Consensus 250 ~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 250 HPEPSCRPSMSELLQSEF 267 (793)
T ss_pred CCChhhCcChHHHhhchh
Confidence 999999999999997643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=199.64 Aligned_cols=265 Identities=23% Similarity=0.234 Sum_probs=201.4
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCC-CcEEEEEEccccchhchHHHHHHHHHHhccC----CCcccceeeEE
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGS-GIVVAIKRLKAESFQGHKEWLTEVIYLGQLR----HENLVKLIGYC 96 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~ 96 (349)
+|.+.+.||+|+||.||.|... .. ...+|+|............+..|..++..+. .+++..+++..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~---------~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G 89 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDK---------SEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHG 89 (322)
T ss_pred ceEEeeeccccCCceEEEEEec---------CCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEec
Confidence 8999999999999999999532 22 4678888776654333336667888888876 36888899888
Q ss_pred -ecCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-----CcE
Q 018891 97 -SESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-----FNA 169 (349)
Q Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-----~~v 169 (349)
......|+||+.+ |.+|.++..... ..++...+..++.|++.+|.++| +.|++||||||.|+++... ..+
T Consensus 90 ~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--~~G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 90 RSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--SKGFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred cCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--hcCcccCCcCHHHeeecCCCCcccceE
Confidence 4777889999988 889999875544 78999999999999999999999 9999999999999999754 359
Q ss_pred EEecccccc--cCCCCCCC--c-c---ccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 170 KLSDFGLAR--DGPTGDNT--H-V---STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 170 ~l~Dfg~~~--~~~~~~~~--~-~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
.|+|||+++ ........ . . .....||..|.++....+...+.+.|+||++.++.+++.|..||.........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999998 32222211 1 1 12245899999999999999999999999999999999999999765543332
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 312 (349)
..+.......... ......+..+..+...+-..+...+|....+...+++...+...
T Consensus 247 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~ 303 (322)
T KOG1164|consen 247 SKFEKDPRKLLTD--------------RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS 303 (322)
T ss_pred HHHHHHhhhhccc--------------cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence 2222211111100 01223455677777777778999999999999999888877533
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-26 Score=218.85 Aligned_cols=254 Identities=21% Similarity=0.255 Sum_probs=183.0
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHH--HhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIY--LGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~--l~~l~h~~i~~~ 92 (349)
.++.. +|...+.||++.|-.|.+|+.+ .|. |+||++-... ......+.++++- .+..++||.+++
T Consensus 19 sd~~~-e~~~~~~LGstRFlKv~r~k~~----------eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPf 86 (1431)
T KOG1240|consen 19 SDLSV-ECHYVENLGSTRFLKVARAKDR----------EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPF 86 (1431)
T ss_pred hcCcc-ceeeecccCchhhhhhhhccCC----------Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccch
Confidence 44443 8999999999999999998433 355 8899885543 2233444443333 444589999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
..+...+...|+|-+|+ ..+|+|.+ ..+.-+..-+..+|+.||+.||..+| ..||||||||.+||||+..+-+.|.
T Consensus 87 qk~~~t~kAAylvRqyv-khnLyDRl-STRPFL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsENILiTSWNW~~Lt 162 (1431)
T KOG1240|consen 87 QKVLVTDKAAYLVRQYV-KHNLYDRL-STRPFLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSENILITSWNWLYLT 162 (1431)
T ss_pred HHHHHhhHHHHHHHHHH-hhhhhhhh-ccchHHHHHHHHHHHHHHHHHHHHHH--HcCccccccccceEEEeeechhhhh
Confidence 99888888899999999 55999998 44466788999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCC-ccc----cceecCCcccCccccccC----------C-CCCccceehhhHHHHHHHh-CCccCccc
Q 018891 173 DFGLARDGPTGDNT-HVS----TRIVGTRGYAAPEYVATG----------H-LTPKSDVYSFGVVLLELLS-GRRALDED 235 (349)
Q Consensus 173 Dfg~~~~~~~~~~~-~~~----~~~~~~~~~~aPE~~~~~----------~-~~~~~DiwslG~ll~~llt-g~~pf~~~ 235 (349)
||..-....-...+ ... ..-..-.||+|||.+... . .+++.||||+||+++|+++ |.+||.-.
T Consensus 163 DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 163 DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 99865422111111 111 112345679999987441 1 5678999999999999999 57777532
Q ss_pred cCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 236 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
++..+......+.+.. +++. .+..++.||..|++.||++|.|+++.|+..
T Consensus 243 -------QL~aYr~~~~~~~e~~---Le~I--------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 243 -------QLLAYRSGNADDPEQL---LEKI--------EDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred -------HHHhHhccCccCHHHH---HHhC--------cCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 2222222211111111 1111 123688999999999999999999999873
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=194.26 Aligned_cols=176 Identities=19% Similarity=0.146 Sum_probs=131.9
Q ss_pred CcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-----hhchHHHHHHHHHHhccC
Q 018891 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-----FQGHKEWLTEVIYLGQLR 85 (349)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~ 85 (349)
.+........++|++.+.||+|+||+||+|.+.. .+++.+|||.+.... ......+.+|+.+|++++
T Consensus 8 ~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~--------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~ 79 (365)
T PRK09188 8 LPGDQIPALSARFVETAVLKRDVFSTVERGYFAG--------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR 79 (365)
T ss_pred CcccccccccCCceEccEEeecCcEEEEEEEEcC--------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc
Confidence 3444445667899999999999999999995432 246778999865331 123456889999999999
Q ss_pred CCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccC-CCCcEEEc
Q 018891 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL-KASNVLLD 164 (349)
Q Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di-~~~Nilv~ 164 (349)
|+++++.+.. .+..|+||||++|++|.. + .. .. ...++.|++++|.||| +.+|+|||| ||+||+++
T Consensus 80 h~~iv~~l~~---~~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH--~~gIiHrDL~KP~NILv~ 146 (365)
T PRK09188 80 GIGVVPQLLA---TGKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLH--RAGITHNDLAKPQNWLMG 146 (365)
T ss_pred CCCCCcEEEE---cCCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHH--HCCCeeCCCCCcceEEEc
Confidence 9999864322 246799999999999963 2 11 11 2467889999999999 899999999 99999999
Q ss_pred CCCcEEEecccccccCCCCCCCccc------cceecCCcccCccccccC
Q 018891 165 SNFNAKLSDFGLARDGPTGDNTHVS------TRIVGTRGYAAPEYVATG 207 (349)
Q Consensus 165 ~~~~v~l~Dfg~~~~~~~~~~~~~~------~~~~~~~~~~aPE~~~~~ 207 (349)
.++.++|+|||++............ ....++..|.+||.+..+
T Consensus 147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999999999865444322221 234567789999988543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=185.84 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=198.4
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
+..+..+|.....|..|+|+|.+++ ++.|++.... .....+|.+|.-.|+-+.||||+++++.+...
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd-----------ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND-----------IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc-----------hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 3455667888999999999988654 5667665432 22346788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe--cccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS--DFGL 176 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~--Dfg~ 176 (349)
.++.++..|++.++|+..+.+.. -.++-.++.+++..++++++|||++..-|.--.|+..+++|+++-+.+|. |--+
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kf 339 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKF 339 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccccee
Confidence 99999999999999999996643 23677889999999999999999876667777899999999998776553 3221
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCC---CccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
+. ........|.|++||.+..++-+ .++|+|||++++|++.|...||.+.++
T Consensus 340 sf---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp---------------- 394 (448)
T KOG0195|consen 340 SF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP---------------- 394 (448)
T ss_pred ee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc----------------
Confidence 11 11123467889999999877654 589999999999999999999976553
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
.+--.++.-+.++..+|++++..+..|+.-||+.||.+||.+..++--|+++.
T Consensus 395 -mecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 395 -MECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -hhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11122344456677889999999999999999999999999999999888764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=213.17 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=185.8
Q ss_pred CCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcc-----ccchhc-hHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-----AESFQG-HKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 24 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~-----~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
....++|.|.+|.|+.+... .....+..|.+. ...... ...+..|+-+-..+.|||++.....+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~---------~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~ 391 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRR---------SDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ 391 (601)
T ss_pred CccceeeecccCceEEEEec---------CCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence 56778999999977666321 112222333221 111111 122556777777789999988887776
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+....+-+|||+++ +|+.++... ..+...++..++.||+.|+.|+| ..|+.|+|+|++|++++.+|.+||+|||.+
T Consensus 392 ~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h--~~GiahrdlK~enll~~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 392 EIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLH--SMGLAHRDLKLENLLVTENGILKIIDFGAA 467 (601)
T ss_pred hcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHH--hcCceeccCccccEEEecCCceEEeecCcc
Confidence 66655556999999 999988553 57899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCC--ccccceecCCcccCccccccCCCCC-ccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 178 RDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTP-KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 178 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
..+...... .......|...|+|||.+.+..|++ ..||||.|++++.|++|+.||......+... ..
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~----------~~ 537 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF----------KT 537 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch----------hh
Confidence 765555444 3444578999999999999999986 5899999999999999999996544332221 00
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
...............+...++...+.+|.+||+.||.+|.|+.+|++
T Consensus 538 ~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 538 NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000000000011123456778999999999999999999999996
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-22 Score=178.99 Aligned_cols=256 Identities=31% Similarity=0.463 Sum_probs=196.4
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCC-cccceeeEEec
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHE-NLVKLIGYCSE 98 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~ 98 (349)
|++.+.||.|.|+.||++... ..+++|.+...... ....+.+|...++.+.|+ +++++.+.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 788899999999999999542 66889988765443 356788999999999888 79999999977
Q ss_pred CCceEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-cEEEeccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDFG 175 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-~v~l~Dfg 175 (349)
....+++++++.++++.+++.... ..++......++.|++.++.++| ..+++|+|+||+||+++..+ .++++|||
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H--~~~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeecCCCCeEEEeccC
Confidence 777899999999999997774433 27999999999999999999999 89999999999999999988 69999999
Q ss_pred ccccCCCCCCCc----cccceecCCcccCcccccc---CCCCCccceehhhHHHHHHHhCCccCccccCc----chhhhH
Q 018891 176 LARDGPTGDNTH----VSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGG----LAEQTL 244 (349)
Q Consensus 176 ~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~----~~~~~~ 244 (349)
.+.......... ......++..|.+||.+.+ .......|+|++|++++++++|..||...... .....+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 227 (384)
T COG0515 148 LAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII 227 (384)
T ss_pred cceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH
Confidence 987544433221 2344678999999999987 57889999999999999999999997655532 111111
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.....+ .................+.+++.+++..+|..|.+..+....
T Consensus 228 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 LELPTP----------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HhcCCc----------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 110000 000000000002223678899999999999999999988875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=177.06 Aligned_cols=179 Identities=13% Similarity=0.107 Sum_probs=138.3
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHH---------HHHHHHHHh
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---------WLTEVIYLG 82 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~ 82 (349)
.+...+++.++|+..++||.|+||.||++. . ++..+|+|++.......... +.+|+..+.
T Consensus 22 ~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~---------~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~ 90 (232)
T PRK10359 22 KEIFDDFLSYNIKTIKVFRNIDDTKVSLID---------T--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTD 90 (232)
T ss_pred HHHHHHHhhCceEEEEEecCCCceEEEEEe---------c--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHH
Confidence 456788999999999999999999999972 2 14569999997654433322 678999999
Q ss_pred ccCCCcccceeeEEecC--------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 018891 83 QLRHENLVKLIGYCSES--------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 154 (349)
Q Consensus 83 ~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~ 154 (349)
++.|++|..+.+++... +..++||||++|.+|.+.. .+++ ....+++.++..+| ..|++|+
T Consensus 91 rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH--~~gi~H~ 159 (232)
T PRK10359 91 RVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLH--QHGMVSG 159 (232)
T ss_pred HHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHH--HcCCccC
Confidence 99999999999886533 3578999999999998863 1232 24568999999999 9999999
Q ss_pred cCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh
Q 018891 155 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227 (349)
Q Consensus 155 di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt 227 (349)
|++|.||+++.+| ++|+|||.......... ....+....+..++|+|+||+++..+..
T Consensus 160 Dikp~Nili~~~g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 160 DPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CCChHHEEEeCCC-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 9999999999988 99999997754311110 0112344556789999999999877653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=199.51 Aligned_cols=258 Identities=19% Similarity=0.207 Sum_probs=191.7
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCccccee
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
-...+.+.+|.|.+.||.|++|.||.| .+.. |+.||||+-+..+.+...-..+-..+|+-.--+.|+++.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a---------~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~ 760 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVA---------THSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHIS 760 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEe---------ecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHH
Confidence 346788999999999999999999999 4444 999999998888776543323333444422256677777
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-------C
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------N 166 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-------~ 166 (349)
..+.-.+.-++|++|.+.|+|.++++ ..+.+++..+..+..|++..+++|| ..+|+||||||+|+++.. .
T Consensus 761 ~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH--~~~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 761 SAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLH--AMGIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred HHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHH--hcceecccCCcceeEeecccCCCCcc
Confidence 77777788899999999999999996 5588999999999999999999999 999999999999999942 2
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
-.++|+|||.+.................+..|-++|+..|+.|++.+|.|+|+.+++-||.|++.=
T Consensus 838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------- 903 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------- 903 (974)
T ss_pred cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------------
Confidence 348999999997655444444455567899999999999999999999999999999999997521
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEA-QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
..+ .....+.. .++.-.. +....++..+|+.|=..=|.+.+|...|+.....
T Consensus 904 -----~~~--g~~~~~~~----~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 904 -----VKN--GSSWMVKT----NFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred -----hcC--Ccceeccc----cchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 000 00000000 0111111 2344677778873333337888888777766543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=174.22 Aligned_cols=234 Identities=20% Similarity=0.310 Sum_probs=152.0
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccC----------C
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLR----------H 86 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~----------h 86 (349)
...+...+.||.|+++.||.+ .+..+++.+++|++..... ...+.+.+|......+. |
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v---------~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~ 81 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEV---------TDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRH 81 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHH
T ss_pred ceEEEEccccccCCceEEEEE---------EEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHh
Confidence 456677889999999999999 7778899999998754432 23455666666555532 2
Q ss_pred CcccceeeEEe---------cCC--------ceEEEEEeCCCCChHHHHhc---cCC---CCChHHHHHHHHHHHHHHHH
Q 018891 87 ENLVKLIGYCS---------ESD--------NRLLVYEFMPKGSLENHLFR---SVQ---PISWPTRVKIAIDVARGLSF 143 (349)
Q Consensus 87 ~~i~~~~~~~~---------~~~--------~~~lv~e~~~~~~L~~~l~~---~~~---~l~~~~~~~i~~ql~~~l~~ 143 (349)
-.++.+.+... ... ..+++|+-. .++|.+++.. ... .+.......+..|+++.+++
T Consensus 82 ~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~ 160 (288)
T PF14531_consen 82 LRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVAN 160 (288)
T ss_dssp H-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred ceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHH
Confidence 23444444332 111 336778877 5588877632 111 23344456677899999999
Q ss_pred HhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccC--------CCCCccce
Q 018891 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--------HLTPKSDV 215 (349)
Q Consensus 144 lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~Di 215 (349)
|| ..|++|+||+|+|++++.+|.+.|+||+........... ...+..|.|||..... .++.+.|.
T Consensus 161 Lh--~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~Da 233 (288)
T PF14531_consen 161 LH--SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDA 233 (288)
T ss_dssp HH--HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHH
T ss_pred Hh--hcceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCH
Confidence 99 899999999999999999999999999988753221111 2345678999976442 46788999
Q ss_pred ehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 018891 216 YSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 293 (349)
Q Consensus 216 wslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 293 (349)
|+||+++|.|+++..||........... .+ ..+. ++|+.++.||..+|+.||.+|
T Consensus 234 W~LG~~ly~lWC~~lPf~~~~~~~~~~~---------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 234 WQLGITLYSLWCGRLPFGLSSPEADPEW---------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHSS-STCCCGGGSTSGG---------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHHHccCCCCCCCccccccc---------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999999999986553222111 11 1233 889999999999999999988
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=163.10 Aligned_cols=138 Identities=18% Similarity=0.183 Sum_probs=107.6
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--c------------------------hHHHHHHHH
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--G------------------------HKEWLTEVI 79 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~e~~ 79 (349)
...||+|++|.||+| ... +|+.||+|++...... . ......|+.
T Consensus 2 ~~~ig~G~~~~Vy~a---------~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 71 (190)
T cd05147 2 NGCISTGKEANVYHA---------TTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR 71 (190)
T ss_pred CCccccccceEEEEE---------ECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence 568999999999999 444 6899999998654221 1 012235899
Q ss_pred HHhccCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHH-hcCCCCeeeccCCC
Q 018891 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL-HGLDANVIYRDLKA 158 (349)
Q Consensus 80 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~l-H~~~~~i~H~di~~ 158 (349)
.+.++.++++..+..+.. ...++||||++|+++...... ...++...+..++.|++.+|.++ | +.+++|+||||
T Consensus 72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP 146 (190)
T cd05147 72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSE 146 (190)
T ss_pred HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCH
Confidence 999998877754443322 233899999988777654433 36789999999999999999999 8 88999999999
Q ss_pred CcEEEcCCCcEEEeccccccc
Q 018891 159 SNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
.||+++ ++.++|+|||++..
T Consensus 147 ~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 147 YNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred HHEEEE-CCcEEEEEcccccc
Confidence 999998 47899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-21 Score=168.34 Aligned_cols=274 Identities=19% Similarity=0.231 Sum_probs=181.8
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCC--------------cCCCC------------CCCCcEEEEEEccc-
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNT--------------FAPTK------------PGSGIVVAIKRLKA- 65 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~--------------~~~~~------------~~~~~~vaiK~~~~- 65 (349)
...+++--++|+|+..||+|+...||.|...... |.+.. ..+.-+.|||.+-.
T Consensus 149 r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~ 228 (598)
T KOG4158|consen 149 RIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF 228 (598)
T ss_pred hhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc
Confidence 3445666789999999999999999998764310 11110 01222455664422
Q ss_pred cchhchHHH----HHHH-----------------HHHh----c-cCCCcccceeeEEe----------------------
Q 018891 66 ESFQGHKEW----LTEV-----------------IYLG----Q-LRHENLVKLIGYCS---------------------- 97 (349)
Q Consensus 66 ~~~~~~~~~----~~e~-----------------~~l~----~-l~h~~i~~~~~~~~---------------------- 97 (349)
+..+....+ .+|+ +.+. + -+||||+.+..+|.
T Consensus 229 ~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~ 308 (598)
T KOG4158|consen 229 EHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWY 308 (598)
T ss_pred ccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceec
Confidence 111111111 1111 0111 1 25999999987663
Q ss_pred -----cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC----c
Q 018891 98 -----ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF----N 168 (349)
Q Consensus 98 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~----~ 168 (349)
+...+|+||..++ .+|.+++.. ...+.....-++.|+++|+.||| +.|+.|||+|.+||++.-+. .
T Consensus 309 p~g~g~~~tlylvMkrY~-~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~ 383 (598)
T KOG4158|consen 309 PSGAGEPKTLYLVMKRYR-QTLREYLWT--RHRSYRTGRVILAQLLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQ 383 (598)
T ss_pred ccccCCCceEEEehhcch-hhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHH--HccchhhcccccceEEEecCCCCcE
Confidence 2346799999884 589999966 45677788889999999999999 99999999999999995332 3
Q ss_pred EEEecccccccCCCCC----CCccccceecCCcccCccccccCC-----C-CCccceehhhHHHHHHHhCCccCccccCc
Q 018891 169 AKLSDFGLARDGPTGD----NTHVSTRIVGTRGYAAPEYVATGH-----L-TPKSDVYSFGVVLLELLSGRRALDEDRGG 238 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~-----~-~~~~DiwslG~ll~~lltg~~pf~~~~~~ 238 (349)
+++.|||.+.-....+ ........-|..+.+|||+....+ . -.++|.|+.|.+.||+++...||-....
T Consensus 384 LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe- 462 (598)
T KOG4158|consen 384 LVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE- 462 (598)
T ss_pred EEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-
Confidence 7999999875322211 111122245788899999875422 1 2479999999999999999999964211
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
+.-... ..++..-..++..+++.+++++...|+.||.+|+|..-.-..|.-...
T Consensus 463 -m~L~~r---------------~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw 516 (598)
T KOG4158|consen 463 -MLLDTR---------------TYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLW 516 (598)
T ss_pred -heechh---------------hhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence 110000 112222345677889999999999999999999988766665554433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=156.69 Aligned_cols=140 Identities=16% Similarity=0.137 Sum_probs=109.9
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---------------------c-----hHHHHHHH
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---------------------G-----HKEWLTEV 78 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------------------~-----~~~~~~e~ 78 (349)
+.+.||+|++|.||+| .+. +|+.||||++...... . ......|.
T Consensus 1 ~~~~ig~G~~~~Vy~a---------~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 70 (190)
T cd05145 1 INGCISTGKEANVYHA---------RTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF 70 (190)
T ss_pred CCceeecCCCcEEEEE---------EcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence 4678999999999999 443 6899999998764211 0 11235788
Q ss_pred HHHhccCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCC
Q 018891 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLK 157 (349)
Q Consensus 79 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~ 157 (349)
..+.++.++++..+..+... ..++||||++|+++...... ...++......++.|++.++.++| . .|++|+|||
T Consensus 71 ~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH--~~~givHrDlk 145 (190)
T cd05145 71 RNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLY--QEAGLVHGDLS 145 (190)
T ss_pred HHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCC
Confidence 99999999887665554433 34899999988755443222 256788899999999999999999 7 999999999
Q ss_pred CCcEEEcCCCcEEEecccccccC
Q 018891 158 ASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 158 ~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
|+||+++ ++.++|+|||++...
T Consensus 146 P~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 146 EYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred hhhEEEE-CCCEEEEEcccceec
Confidence 9999998 789999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=148.12 Aligned_cols=188 Identities=18% Similarity=0.131 Sum_probs=135.8
Q ss_pred CCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc----hHHHHHHHHHHhccC-CCcccceeeEEec
Q 018891 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG----HKEWLTEVIYLGQLR-HENLVKLIGYCSE 98 (349)
Q Consensus 24 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 98 (349)
-....|++|+||+|+.+. . .+.+++.+.+....... ...+.+|+.+|+++. ++++.+++++
T Consensus 5 ~~~~~l~~~~f~~v~~~~---------~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--- 70 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVR---------G--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--- 70 (218)
T ss_pred ccceeecCCCcceEEEee---------c--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence 356789999999999872 2 46778877765543321 125778999999995 5888888876
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccC-CCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL-KASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di-~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+..+++|+|+.|.+|.+.... ....++.|++.+|.++| ..|++|+|| ||.||+++.++.++|+|||++
T Consensus 71 -~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH--~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A 139 (218)
T PRK12274 71 -DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLH--RCGVAHNDLAKEANWLVQEDGSPAVIDFQLA 139 (218)
T ss_pred -cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHH--HCcCccCCCCCcceEEEcCCCCEEEEECCCc
Confidence 456899999999888654311 12357789999999999 999999999 799999999999999999999
Q ss_pred ccCCCCCCC----c--c-----ccceecCCcccCcccccc-CCCC-CccceehhhHHHHHHHhCCccCcccc
Q 018891 178 RDGPTGDNT----H--V-----STRIVGTRGYAAPEYVAT-GHLT-PKSDVYSFGVVLLELLSGRRALDEDR 236 (349)
Q Consensus 178 ~~~~~~~~~----~--~-----~~~~~~~~~~~aPE~~~~-~~~~-~~~DiwslG~ll~~lltg~~pf~~~~ 236 (349)
......... . . .....+.+.++.|+...- ...+ .+.+.++.|+-+|.++|+..+.-+..
T Consensus 140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 754433210 0 0 001224556666654321 1222 56788899999999999998865433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-19 Score=164.09 Aligned_cols=218 Identities=25% Similarity=0.360 Sum_probs=165.8
Q ss_pred HhccCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 81 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
|+.+.|.|+.++++...++...++|.+|+..|+|.+.+......++..-...+++.++.+++|+|.. .-.+|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s-~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS-PIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC-cceeeeeecccc
Confidence 4678999999999999999999999999999999999987778889999999999999999999952 223999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCC-------CCCccceehhhHHHHHHHhCCccCc
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-------LTPKSDVYSFGVVLLELLSGRRALD 233 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~DiwslG~ll~~lltg~~pf~ 233 (349)
.+++..-.+||.|||+.................-...|.|||.+.... .+.+.|+||+|++++++++.+.||.
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 999999999999999987654311111111112344589999986631 4567999999999999999999998
Q ss_pred cccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCH--HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 234 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK--KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
..........+...... ......+..... ..++++..++..||..+|.+||+++.+-..++.+...
T Consensus 160 ~~~~~~~~~eii~~~~~----------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKK----------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccCChHHHHHHHHh----------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 75543333222221000 111112222211 3445799999999999999999999999998887765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=172.47 Aligned_cols=229 Identities=28% Similarity=0.366 Sum_probs=180.9
Q ss_pred eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc--hHHHHHHHHHHhccC-CCcccceeeEEecCCceEE
Q 018891 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLL 104 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 104 (349)
.+|.|.+|.|+++.-- .....|..+++|+........ ......|-.++...+ ||.++++...++.+...++
T Consensus 1 vlg~g~~gkvfLvrk~------~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKA------GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHh------ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 3789999999987321 334567788888776543221 123445677788886 9999999999999999999
Q ss_pred EEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCC
Q 018891 105 VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184 (349)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~ 184 (349)
+.++..++.|...+. ....+.+.....+...++-+++++| +.+++|+|+|++||+++.+|++++.|||++...-...
T Consensus 75 ~ld~~rgg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh--~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLS-KEVMFDELDVAFYLAELALALDHLH--KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred hhhhcccchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcc--hhHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 999999988887773 3366777888888889999999999 9999999999999999999999999999987533322
Q ss_pred CCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhcc
Q 018891 185 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264 (349)
Q Consensus 185 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (349)
.. .|+..|+|||++. ....++|.||+|+++++|++|..||... . ...+..
T Consensus 152 ~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~-----------------~~~Il~- 201 (612)
T KOG0603|consen 152 IA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----T-----------------MKRILK- 201 (612)
T ss_pred hc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----H-----------------HHHHhh-
Confidence 22 5788899999997 6677899999999999999999999750 0 011111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 018891 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 296 (349)
Q Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 296 (349)
.....|...+..+++++..++..+|.+|.-.
T Consensus 202 -~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 -AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1245678899999999999999999999654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-19 Score=151.30 Aligned_cols=145 Identities=16% Similarity=0.108 Sum_probs=109.9
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh------------------------chHHHHH
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------------------------GHKEWLT 76 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~ 76 (349)
.-|.+.+.||.|++|.||+|.+ +..+|+.||+|.+...... ....+..
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~--------~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALD--------FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEK 99 (237)
T ss_pred chHHhCCeeccCcceeEEEEEe--------cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHH
Confidence 3599999999999999999931 4456899999988653210 0123467
Q ss_pred HHHHHhccCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCC-eeecc
Q 018891 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDAN-VIYRD 155 (349)
Q Consensus 77 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~-i~H~d 155 (349)
|+..++++.+.+ +.+...+.. ...++||||+++.+|....... .......+..++.|++.++.+|| +.+ ++|+|
T Consensus 100 E~~~L~~L~~~~-i~~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~g~iiH~D 174 (237)
T smart00090 100 EFRNLQRLYEAG-VPVPKPIAW-RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY--KEGELVHGD 174 (237)
T ss_pred HHHHHHHHHhcC-CCCCeeeEe-cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH--hcCCEEeCC
Confidence 999999996532 222222222 2458999999998876654332 45666677899999999999999 899 99999
Q ss_pred CCCCcEEEcCCCcEEEeccccccc
Q 018891 156 LKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 156 i~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
|||+||+++ ++.++|+|||.+..
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhc
Confidence 999999999 78999999998864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.7e-18 Score=144.94 Aligned_cols=137 Identities=18% Similarity=0.189 Sum_probs=105.4
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-----CCCcccceeeEEe
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-----RHENLVKLIGYCS 97 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~ 97 (349)
+.-.+.||+|++|.||.- . .++.. +||++........+.+.+|+.+++.+ .||||++++++++
T Consensus 4 L~~~~~LG~G~~~~Vy~h---------p--~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~e 71 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAH---------P--EDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVE 71 (210)
T ss_pred cCCcceecCCCceEEEEC---------C--CCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEE
Confidence 445678999999999952 1 12344 68988765444566789999999999 5799999999998
Q ss_pred cCC---ceE-EEEEe--CCCCChHHHHhccCCCCChHHHHHHHHHHHHHH-HHHhcCCCCeeeccCCCCcEEEcC----C
Q 018891 98 ESD---NRL-LVYEF--MPKGSLENHLFRSVQPISWPTRVKIAIDVARGL-SFLHGLDANVIYRDLKASNVLLDS----N 166 (349)
Q Consensus 98 ~~~---~~~-lv~e~--~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l-~~lH~~~~~i~H~di~~~Nilv~~----~ 166 (349)
.+. ..+ +|+|| ..+++|.+++.+ ..+++. ..++.|++.++ +||| +.+|+|+||||+||+++. +
T Consensus 72 t~~g~g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh--~~~IvhrDlKp~NILl~~~~~~~ 145 (210)
T PRK10345 72 TDCGTGYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLL--DNRIVTMELKPQNILCQRISESE 145 (210)
T ss_pred eCCCCeEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHH--HCCEeecCCCHHHEEEeccCCCC
Confidence 874 333 78999 447899999955 345555 35677888777 9999 999999999999999974 3
Q ss_pred CcEEEeccccc
Q 018891 167 FNAKLSDFGLA 177 (349)
Q Consensus 167 ~~v~l~Dfg~~ 177 (349)
+.++|+||+.+
T Consensus 146 ~~~~LiDg~G~ 156 (210)
T PRK10345 146 VIPVVCDNIGE 156 (210)
T ss_pred CcEEEEECCCC
Confidence 37999995433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.8e-19 Score=170.57 Aligned_cols=210 Identities=22% Similarity=0.359 Sum_probs=151.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..+|..++.+..|++|-||.+ .+..+.+++|+| +++...- .+- ++....+|
T Consensus 82 e~df~~IklisngAygavylv---------rh~~trqrfa~k-iNkq~li-----lRn--ilt~a~np------------ 132 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLV---------RHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNP------------ 132 (1205)
T ss_pred ccccceeEeeccCCCCceeee---------eccccccchhhc-ccccchh-----hhc--cccccCCc------------
Confidence 468999999999999999999 677778889984 4433211 000 22222233
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
++| ++-...+ +.-++++... +.+++||| ..+|+|+|+||+|.+|+.-|++|++|||+...
T Consensus 133 ---fvv------gDc~tll-k~~g~lPvdm--------vla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 133 ---FVV------GDCATLL-KNIGPLPVDM--------VLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred ---cee------chhhhhc-ccCCCCcchh--------hHHhHhhc--cCCeecCCCCCCcceeeecccccccchhhhhh
Confidence 333 2222222 3334555444 77999999 89999999999999999999999999999864
Q ss_pred CCCCCCCccc-------------cceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 180 GPTGDNTHVS-------------TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 180 ~~~~~~~~~~-------------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
.......... ....|+|.|+|||++.-..|...+|.|+||+++|+++-|..||.+.++.+....+..
T Consensus 193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 3332211110 114789999999999999999999999999999999999999999887666655544
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 294 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 294 (349)
....|... ...+++++++++.++|..+|..|.
T Consensus 273 d~i~wpE~----------------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DDIEWPEE----------------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhcccccc----------------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 32222221 123567899999999999999994
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=141.48 Aligned_cols=135 Identities=22% Similarity=0.305 Sum_probs=110.9
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--------chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++.||+|++|.||+|.+. |..+++|........ ....+.+|+..+..+.|+++..+..++.
T Consensus 1 ~~~l~~G~~~~vy~~~~~-----------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 69 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDFL-----------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV 69 (211)
T ss_pred CcccccCceEEEEEEeeC-----------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE
Confidence 367999999999999542 566889976543221 1234678999999999999888877777
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.....++||||++|.+|.+.+... . . ....++.+++.+|.++| +.+++|+|++|.||+++ ++.++|+|||.+
T Consensus 70 ~~~~~~lv~e~~~G~~L~~~~~~~-~---~-~~~~i~~~i~~~l~~lH--~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a 141 (211)
T PRK14879 70 DPENFIIVMEYIEGEPLKDLINSN-G---M-EELELSREIGRLVGKLH--SAGIIHGDLTTSNMILS-GGKIYLIDFGLA 141 (211)
T ss_pred eCCCCEEEEEEeCCcCHHHHHHhc-c---H-HHHHHHHHHHHHHHHHH--hCCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence 778889999999999999988542 1 1 78899999999999999 99999999999999999 788999999987
Q ss_pred cc
Q 018891 178 RD 179 (349)
Q Consensus 178 ~~ 179 (349)
..
T Consensus 142 ~~ 143 (211)
T PRK14879 142 EF 143 (211)
T ss_pred cC
Confidence 53
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-17 Score=137.67 Aligned_cols=130 Identities=22% Similarity=0.371 Sum_probs=103.8
Q ss_pred eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--------chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.||+|++|.||+|.+. +..+++|........ ....+.+|+.+++.+.++++..+.-++...
T Consensus 1 ~ig~G~~~~vy~~~~~-----------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 69 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-----------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP 69 (199)
T ss_pred CCCCCceEEEEEeecC-----------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence 4899999999999532 467899975432211 124567899999999888766666566666
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++||||++|++|.+.+... .. .++.+++.+|.++| +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~-~~-------~~~~~i~~~l~~lH--~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEG-ND-------ELLREIGRLVGKLH--KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhc-HH-------HHHHHHHHHHHHHH--HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 7789999999999999877432 11 78899999999999 99999999999999999 78999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=135.25 Aligned_cols=136 Identities=18% Similarity=0.133 Sum_probs=105.3
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh----------------------chHHHHHHHH
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ----------------------GHKEWLTEVI 79 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~ 79 (349)
-|.+.+.||.|++|.||+|. .. +|+.|+||++...... .......|+.
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~---------~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 85 (198)
T cd05144 16 VESLGNQIGVGKESDVYLAL---------DP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA 85 (198)
T ss_pred hhhcCCccccCcceEEEEEE---------cC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence 48999999999999999994 32 5889999986543210 1123567888
Q ss_pred HHhccCCCc--ccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCC
Q 018891 80 YLGQLRHEN--LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 157 (349)
Q Consensus 80 ~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~ 157 (349)
.+..+.+++ +..+++ ....++||||++|.+|...... .....++.+++.++.++| ..+++|+||+
T Consensus 86 ~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh--~~gi~H~Dl~ 152 (198)
T cd05144 86 ALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY--KHGIIHGDLS 152 (198)
T ss_pred HHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH--HCCCCcCCCC
Confidence 888887764 333333 2456899999999988764421 345678899999999999 8999999999
Q ss_pred CCcEEEcCCCcEEEecccccccC
Q 018891 158 ASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 158 ~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
|.||++++++.++|+|||.+...
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred cccEEEcCCCcEEEEECCccccC
Confidence 99999999999999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-16 Score=152.02 Aligned_cols=136 Identities=21% Similarity=0.255 Sum_probs=108.3
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--c------hhchHHHHHHHHHHhccCCCcccce
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--S------FQGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~------~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
..|...+.||+|+||.||++.+.+. .+++|..... . ......+.+|+.+++.++|+++..+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p 401 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTP 401 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCee
Confidence 4456788999999999999865431 2333322111 1 0123457789999999999999888
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
..++......++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+||++ .++.++|+
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH--~~giiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH--KAGIVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH--hCCCccCCCChHHEEE-ECCcEEEE
Confidence 777777777899999999999999884 35778999999999999 9999999999999999 67789999
Q ss_pred ccccccc
Q 018891 173 DFGLARD 179 (349)
Q Consensus 173 Dfg~~~~ 179 (349)
|||++..
T Consensus 470 DFGla~~ 476 (535)
T PRK09605 470 DFGLGKY 476 (535)
T ss_pred eCccccc
Confidence 9998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.1e-17 Score=148.92 Aligned_cols=169 Identities=25% Similarity=0.363 Sum_probs=126.5
Q ss_pred CceEEEEEeCCCCChHHHHhcc--CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRS--VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.++||.|+++...+|.+.+... ....+...+..++.|+..++.| ++.+|+|+||.||+...+..++|+|||+.
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhe
Confidence 3578999999999999999542 3456778899999999999988 58999999999999999999999999998
Q ss_pred ccCCCCC----CCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhh
Q 018891 178 RDGPTGD----NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 178 ~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
....... .........|+..|++||++.+..|+.++||||||+++++++. -...+...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------------- 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------------- 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------------
Confidence 7654443 1223334689999999999999999999999999999999997 22222100
Q ss_pred hhhhhHhhhhccccCCCCCHH---HHHHHHHHHHHhcccCCCCCCCHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKK---EAQAVAAVVLQCLHMDPKNRPSMV 297 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ 297 (349)
..+.......+|+. --+.-..|+.+|+.+.|.+||++.
T Consensus 467 -------~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 467 -------ATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred -------HhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 00000111112211 113455799999999999999443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.2e-17 Score=159.71 Aligned_cols=259 Identities=23% Similarity=0.267 Sum_probs=198.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccC-CCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLR-HENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 95 (349)
....|.+.+.||.|.++.|-.+.. .......++.|.+.... .........|..+-+.+. |.|++..++.
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~--------~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~ 89 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASN--------SRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP 89 (601)
T ss_pred ccccccccccccccccchhhhhhh--------cCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc
Confidence 457899999999999999987632 12335556666665443 222333445667767776 9999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHH-hccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-cEEEec
Q 018891 96 CSESDNRLLVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSD 173 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l-~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-~v~l~D 173 (349)
....+..++++++..|+++.+.+ .......+...+..++.|+..++.|+|. ..++.|+|++|+|.+++..+ .+++.|
T Consensus 90 ~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~~ikP~n~~l~~s~~~l~~~d 168 (601)
T KOG0590|consen 90 SSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHRDIKPSNSLLDESGSALKIAD 168 (601)
T ss_pred cCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccCCCCCccchhccCCCcccCCC
Confidence 99999999999999999999988 4443377888899999999999999996 67899999999999999999 999999
Q ss_pred ccccccCCC-CCCCccccceec-CCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 174 FGLARDGPT-GDNTHVSTRIVG-TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 174 fg~~~~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
||++..... .+.........| ++.|.+||...+. ......|+||.|+++..+++|..||..........
T Consensus 169 f~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------- 240 (601)
T KOG0590|consen 169 FGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------- 240 (601)
T ss_pred chhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--------
Confidence 999987666 444444444677 9999999999885 44678999999999999999999997655432110
Q ss_pred hhhhhhhHhhhhcc--ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FLRDSRRVLRIMDT--RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...... .........++....+++.+++..+|..|.+.+++-..
T Consensus 241 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 241 --------SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred --------eeecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 000001 11122334567788899999999999999999988753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-15 Score=125.66 Aligned_cols=136 Identities=20% Similarity=0.203 Sum_probs=93.8
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc--hHH----------------------HHHHHHH
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKE----------------------WLTEVIY 80 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~----------------------~~~e~~~ 80 (349)
+.+.||+|+||.||+|. .. +++.||||++....... ... ...|...
T Consensus 1 ~~~~lg~G~~g~Vy~a~---------~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 70 (187)
T cd05119 1 VGGPIGTGKEADVYLAL---------DG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRN 70 (187)
T ss_pred CCcccccccceeEEEEE---------CC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHH
Confidence 35789999999999994 33 57889999876532211 111 1245555
Q ss_pred HhccCCCc--ccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCC
Q 018891 81 LGQLRHEN--LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLK 157 (349)
Q Consensus 81 l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~ 157 (349)
+..+.+.. +.+++.. ...++||||++++.+......... . ...+..++.+++.++.++| . .+++|+||+
T Consensus 71 l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh--~~~~ivH~Dl~ 142 (187)
T cd05119 71 LKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLY--REAGLVHGDLS 142 (187)
T ss_pred HHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHh--hccCcCcCCCC
Confidence 55553332 3333332 346899999988433211111100 1 1667889999999999999 7 999999999
Q ss_pred CCcEEEcCCCcEEEeccccccc
Q 018891 158 ASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 158 ~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
|+||+++ ++.++|+|||.+..
T Consensus 143 p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 143 EYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred hhhEEEE-CCcEEEEECccccc
Confidence 9999999 88999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.5e-15 Score=137.91 Aligned_cols=168 Identities=20% Similarity=0.237 Sum_probs=131.5
Q ss_pred CCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHH
Q 018891 50 TKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPT 129 (349)
Q Consensus 50 ~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~ 129 (349)
....++.+|.+..++...........+.+..|+.++||||+++++.++.+...|+|+|.+ .+|..++.+ +....
T Consensus 32 t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~----l~~~~ 105 (690)
T KOG1243|consen 32 TRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE----LGKEE 105 (690)
T ss_pred ceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH----hHHHH
Confidence 455567888888876665444556778899999999999999999999999999999998 467777744 33667
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCC
Q 018891 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL 209 (349)
Q Consensus 130 ~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 209 (349)
....++||+.||.+||. +++++|++|....|+|++.|..||++|.++........ ..........|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 78888999999999975 88999999999999999999999999999875433332 111122333466776543322
Q ss_pred CCccceehhhHHHHHHHhC
Q 018891 210 TPKSDVYSFGVVLLELLSG 228 (349)
Q Consensus 210 ~~~~DiwslG~ll~~lltg 228 (349)
-+.|.|.|||++++++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 457999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.4e-15 Score=118.20 Aligned_cols=134 Identities=22% Similarity=0.137 Sum_probs=108.3
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCC--CcccceeeEEecCCce
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH--ENLVKLIGYCSESDNR 102 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 102 (349)
+.+.||.|.++.||++... +..+++|....... ...+..|...++.+.+ .++.+++.+....+..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS 68 (155)
T ss_pred cceecccccccceEEEEec-----------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence 4678999999999999532 25689998866543 4567788999999865 5888888888877889
Q ss_pred EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 103 LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
++++||+++.++..+ +......++.+++++++++|... .+++|+|++|.||+++..+.++++|||.+..
T Consensus 69 ~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 69 YLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999999988766543 45567778899999999999211 4699999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.8e-14 Score=124.78 Aligned_cols=134 Identities=22% Similarity=0.186 Sum_probs=99.9
Q ss_pred ceee-ecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-------------hhchHHHHHHHHHHhccCCCcc--c
Q 018891 27 YLLG-EGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-------------FQGHKEWLTEVIYLGQLRHENL--V 90 (349)
Q Consensus 27 ~~lg-~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~ 90 (349)
..|| .|+.|+||.+... +..++||.+.... ......+.+|+.++..+.|+++ +
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP 105 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP 105 (239)
T ss_pred ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence 4677 7888888887432 5668888774321 1123457789999999988775 5
Q ss_pred ceeeEEecC-Cc---eEEEEEeCCC-CChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC
Q 018891 91 KLIGYCSES-DN---RLLVYEFMPK-GSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165 (349)
Q Consensus 91 ~~~~~~~~~-~~---~~lv~e~~~~-~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~ 165 (349)
.++++.... .. .++|||+++| .+|.+++.. ..+++. .+.+++.++.+|| +.||+|+||||.||+++.
T Consensus 106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH--~~GI~HrDlkp~NILv~~ 177 (239)
T PRK01723 106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFH--DAGVYHADLNAHNILLDP 177 (239)
T ss_pred eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHH--HCCCCCCCCCchhEEEcC
Confidence 566654332 22 3599999987 688888743 345443 3568999999999 999999999999999999
Q ss_pred CCcEEEeccccccc
Q 018891 166 NFNAKLSDFGLARD 179 (349)
Q Consensus 166 ~~~v~l~Dfg~~~~ 179 (349)
++.++|+|||.+..
T Consensus 178 ~~~v~LIDfg~~~~ 191 (239)
T PRK01723 178 DGKFWLIDFDRGEL 191 (239)
T ss_pred CCCEEEEECCCccc
Confidence 88999999998864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.8e-15 Score=139.30 Aligned_cols=253 Identities=25% Similarity=0.271 Sum_probs=189.5
Q ss_pred hcccCCcceeee--cCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhcc-CCCcccceee
Q 018891 20 TKNFCSDYLLGE--GGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 20 ~~~y~~~~~lg~--G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
...+.+...+|. |.+|.||.+.. ....++..+++|.-+... ......-.+|+...+.+ .|++.++...
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~-------~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRC-------TNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred hhhcccccccccCCCCCceeecccC-------CcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 356778889999 99999999832 116678889999743332 23334445677777777 4999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHH----HHHHHhcCCCCeeeccCCCCcEEEcCC-CcE
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR----GLSFLHGLDANVIYRDLKASNVLLDSN-FNA 169 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~----~l~~lH~~~~~i~H~di~~~Nilv~~~-~~v 169 (349)
.++..+..|+-+|.+ +.+|..+.......++...++..+.+... ||.++| ..+++|.|++|.||++..+ ...
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h--s~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH--SNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC--CCcccccccchhheeccccccee
Confidence 999999999999999 57888888766666899999999999999 999999 9999999999999999999 889
Q ss_pred EEecccccccCCCCCCCcccc---ceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 170 KLSDFGLARDGPTGDNTHVST---RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+++|||+.............. ...+...|++||.. .+-++.+.|+++||.++.+..++..+.......
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------- 333 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------- 333 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC--------
Confidence 999999998766555322222 12567779999965 567788999999999999999988776433110
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
.|.... ......++....+.++...+..|++.+|..|+++..+..
T Consensus 334 ---~W~~~r-------~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 ---SWSQLR-------QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---Cccccc-------cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000000 000111122233456677999999999999999988764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=8e-14 Score=120.46 Aligned_cols=201 Identities=24% Similarity=0.349 Sum_probs=138.7
Q ss_pred HHhccCCCcccceeeEEecCC-----ceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCe
Q 018891 80 YLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANV 151 (349)
Q Consensus 80 ~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i 151 (349)
-|-++-|.|+++++.+|.+.. ...+++||+..+++.+++.+ ....+....-.+|+.||++||.|||+++..+
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 344456999999999986543 46789999999999999965 3466888888999999999999999888889
Q ss_pred eeccCCCCcEEEcCCCcEEEecccccccCCCCCC---CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhC
Q 018891 152 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN---THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228 (349)
Q Consensus 152 ~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg 228 (349)
+|+++..+.|++..+|-++++--.-... ..... ........+.++|.+||.=.....+.++|||++|++..+|.-+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~-h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDST-HPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecccCcccc-chhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999998888753211110 00000 0011124567889999865555667799999999999999887
Q ss_pred CccCccccCcc-hhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 229 RRALDEDRGGL-AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 229 ~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
..--.+..... ....+.. ....+ ....-++++.+|++..|..||++++++-|.
T Consensus 279 Eiq~tnseS~~~~ee~ia~-----------~i~~l-----------en~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN-----------VIIGL-----------ENGLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred eeccCCCcceeehhhhhhh-----------heeec-----------cCccccCcCcccccCCCCCCcchhhhhcCc
Confidence 65322211100 0000000 00000 001234588999999999999999988653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=5e-13 Score=125.59 Aligned_cols=140 Identities=18% Similarity=0.179 Sum_probs=95.3
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhch----------------------------------
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---------------------------------- 71 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------- 71 (349)
.+.||+|++|.||+|... +|+.||||+..+......
T Consensus 122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence 468999999999999643 378999999765321100
Q ss_pred ------HHHHHHHHHHhcc----CCCcccceeeEE-ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHH-
Q 018891 72 ------KEWLTEVIYLGQL----RHENLVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR- 139 (349)
Q Consensus 72 ------~~~~~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~- 139 (349)
-++.+|...+.++ ++.+-+.+-..+ ......++||||++|.+|.+.........+ ...++.+++.
T Consensus 192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~ 268 (437)
T TIGR01982 192 KTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARS 268 (437)
T ss_pred HHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHH
Confidence 0133344444444 222223333333 334567899999999999887643222222 3445555655
Q ss_pred HHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 140 ~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
.+..+| ..|++|+|+||.||+++.++.++++|||++...
T Consensus 269 ~l~ql~--~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 269 FLNQVL--RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHH--hCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 467889 899999999999999999999999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.3e-12 Score=104.91 Aligned_cols=127 Identities=17% Similarity=0.077 Sum_probs=91.7
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCccc-ceeeEEecCCceEE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLV-KLIGYCSESDNRLL 104 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~l 104 (349)
.+.|+.|.++.||++... +..|++|....... ....+..|+..++.+...+++ +++... ....++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~l 68 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVL 68 (170)
T ss_pred eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeE
Confidence 457889999999998432 56799998765432 123456788888887544443 344333 234589
Q ss_pred EEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCC-----eeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 105 VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDAN-----VIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~-----i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
||||++|.++... .. .....+.+++++|+.|| ..+ ++|+|++|.||+++ ++.++++||+.+.
T Consensus 69 v~e~i~G~~l~~~------~~---~~~~~~~~l~~~l~~LH--~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 69 ITEFIEGSELLTE------DF---SDPENLEKIAKLLKKLH--SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEEecCCCccccc------cc---cCHHHHHHHHHHHHHHh--CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999999877542 01 12345678999999999 666 49999999999998 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.7e-12 Score=103.59 Aligned_cols=143 Identities=16% Similarity=0.146 Sum_probs=97.0
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---------------h------hc-hHHH----HHHHH
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---------------F------QG-HKEW----LTEVI 79 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---------------~------~~-~~~~----~~e~~ 79 (349)
...||.|--+.||.|...+.. .....+..+|||+..-.. . .. ...+ ..|++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~---~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNE---TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CCccccCcceEEEEEecCccc---ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence 467999999999999432110 011246789999764210 0 01 1122 37888
Q ss_pred HHhccCC--CcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHH-hcCCCCeeeccC
Q 018891 80 YLGQLRH--ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL-HGLDANVIYRDL 156 (349)
Q Consensus 80 ~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~l-H~~~~~i~H~di 156 (349)
.|+++.. -++..++++ ...++||||+.+..+.....+. ..++......+..+++.++..+ | +.+++|+||
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H--~~glVHGDL 151 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYK--ECNLVHADL 151 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHH--hCCeecCCC
Confidence 9988843 344555543 4567999999764332211111 2355566778889999999998 9 899999999
Q ss_pred CCCcEEEcCCCcEEEeccccccc
Q 018891 157 KASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 157 ~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
++.||++. ++.+.|+|||.+..
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCcee
Confidence 99999996 46899999998865
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-11 Score=99.21 Aligned_cols=142 Identities=23% Similarity=0.261 Sum_probs=109.2
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--------hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--------QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
....+-+|+-+.|+.+.+. |+.++||.-..... -...+..+|.+.|.++.--.|.-+.-++
T Consensus 11 ~l~likQGAEArv~~~~~~-----------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~ 79 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-----------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF 79 (229)
T ss_pred cceeeeccceeeEeeeccC-----------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence 6778899999999998664 67788885432211 1234567899999998766776666677
Q ss_pred ecCCceEEEEEeCCC-CChHHHHhccCCCCChHHH-HHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc---EEE
Q 018891 97 SESDNRLLVYEFMPK-GSLENHLFRSVQPISWPTR-VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKL 171 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~l~~~~~-~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~---v~l 171 (349)
.+...-.++|||++| -++.+++.+....-.++.. ..++.++-+.+.-|| .++++||||..+||++..++. +.+
T Consensus 80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--~ndiiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--DNDIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--hCCeecccccccceEEecCCCcCceEE
Confidence 777788899999977 4788888764443333343 788999999999999 999999999999999966544 589
Q ss_pred eccccccc
Q 018891 172 SDFGLARD 179 (349)
Q Consensus 172 ~Dfg~~~~ 179 (349)
+|||++..
T Consensus 158 Idfgls~~ 165 (229)
T KOG3087|consen 158 IDFGLSSV 165 (229)
T ss_pred Eeecchhc
Confidence 99998864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.1e-11 Score=98.14 Aligned_cols=131 Identities=24% Similarity=0.328 Sum_probs=99.3
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--------chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..+++|+-+.++.+.|. |..+++|.-.+.... ....-.+|.++++++.--.|..+.=++.+
T Consensus 2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD 70 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70 (204)
T ss_pred chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence 45788999999998553 334777743222111 12345679999999866566666556666
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.....++|||++|..|.+++... ...++..+-..+.-|| ..+|+|+||+++||++..++ +.++|||++.
T Consensus 71 ~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH--~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 71 PDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLH--KAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred CCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHH--hcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 67778999999999999988654 2567778888999999 99999999999999997764 9999999986
Q ss_pred c
Q 018891 179 D 179 (349)
Q Consensus 179 ~ 179 (349)
.
T Consensus 140 ~ 140 (204)
T COG3642 140 F 140 (204)
T ss_pred c
Confidence 3
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.4e-11 Score=106.66 Aligned_cols=264 Identities=15% Similarity=0.133 Sum_probs=168.3
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeE-----E
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGY-----C 96 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-----~ 96 (349)
....+.||+|+-+.+|-. ... +. .+.|++.........+.. ..|... .||-+-.-+.+ +
T Consensus 13 i~~gr~LgqGgea~ly~l---------~e~--~d-~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~ 77 (637)
T COG4248 13 IPPGRPLGQGGEADLYTL---------GEV--RD-QVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLH 77 (637)
T ss_pred cCCCccccCCccceeeec---------chh--hc-hhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhh
Confidence 456788999999999865 111 11 346887665444333222 222232 45533221111 1
Q ss_pred --ecCCceEEEEEeCCCCChHHHHhc------cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 97 --SESDNRLLVYEFMPKGSLENHLFR------SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 97 --~~~~~~~lv~e~~~~~~L~~~l~~------~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
.......++|+.+.+..--..+.+ +....++..+++..+.|+.+.+.|| ..|.+-||++++|++|+.++.
T Consensus 78 G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~ 155 (637)
T COG4248 78 GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSK 155 (637)
T ss_pred CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCce
Confidence 122236788888876532222221 3345788889999999999999999 999999999999999999999
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhC-CccCccccCc----
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGG---- 238 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg-~~pf~~~~~~---- 238 (349)
|.|.|-+..... .+.......+|.+.|.+||.-. +-.-+..+|.|.||+++++++.| .+||.+....
T Consensus 156 V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 156 VVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred EEEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 999987655432 2222223357899999999754 33456789999999999999886 9999875531
Q ss_pred -chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHhhhcC
Q 018891 239 -LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM--DPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~--dp~~Rps~~~ll~~l~~~~~~ 309 (349)
..+..|.. ..+.................-..-+++++..|+.+|+.. ++.-|||++.++..|..+...
T Consensus 233 ~p~E~~Ia~---g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 233 NPLETDIAH---GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred Ccchhhhhc---ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11112221 111111111111111111111234678899999999976 467899999999988877665
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.4e-12 Score=121.55 Aligned_cols=143 Identities=13% Similarity=0.115 Sum_probs=92.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc------------------------------
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG------------------------------ 70 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~------------------------------ 70 (349)
.+|.. +.||+|++|+||+|.. ..+|+.||||+..+.-...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l---------~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARL---------KDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEE---------CCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 46776 7999999999999954 3358899999987542110
Q ss_pred ----hHH------HHHHHHHHhcc----CCCcccceeeEEe-cCCceEEEEEeCCCCChHHHHhccCCC-----CChHHH
Q 018891 71 ----HKE------WLTEVIYLGQL----RHENLVKLIGYCS-ESDNRLLVYEFMPKGSLENHLFRSVQP-----ISWPTR 130 (349)
Q Consensus 71 ----~~~------~~~e~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~-----l~~~~~ 130 (349)
.+. +.+|...+.++ .+...+.+-.++. -....++||||++|+++.+.-.-.... +.+..+
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v 269 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGV 269 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHH
Confidence 011 22333333333 2333344434432 245678999999999998743211122 333333
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC----cEEEecccccccCCC
Q 018891 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF----NAKLSDFGLARDGPT 182 (349)
Q Consensus 131 ~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~----~v~l~Dfg~~~~~~~ 182 (349)
..++.| +. ..|++|+|+||.||+++.++ .++++|||.+.....
T Consensus 270 ~~~~~Q-------if--~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 270 EVFFTQ-------VF--RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHH-------HH--hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 333333 34 56999999999999999888 999999999876533
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.3e-12 Score=117.70 Aligned_cols=251 Identities=20% Similarity=0.201 Sum_probs=178.2
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHH--HHHHHHHHhcc-CCCcccceeeEE
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE--WLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
..+|..+..||.|.|+.|+...++ ...+..|++|...........+ -..|+.+...+ .|.+++.+...|
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r--------~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKR--------PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred cCCcceeEEccCCccccceeeeec--------CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc
Confidence 458999999999999999998533 2346778888765543332222 23566666666 488888888888
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-CcEEEeccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFG 175 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-~~v~l~Dfg 175 (349)
......|+--||++++++...+ .-...+++...+.+..|++.++.++| +..++|+|++|.||++..+ +..+++|||
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIH--SKLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccccccCchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhcccccc--chhhhcccccccceeeccchhhhhccccc
Confidence 8888888999999998887666 33366888999999999999999999 9999999999999999886 677899999
Q ss_pred ccccCCCCCCCccccceecCCccc--CccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYA--APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
....+...... ......+. ++.......+..+.|+++||..+.+.+++...-.....
T Consensus 413 ~~t~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------------- 471 (524)
T KOG0601|consen 413 CWTRLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------------- 471 (524)
T ss_pred cccccceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCccccc----------------
Confidence 88642221111 11222333 45555566778899999999999999987643211110
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
-..+.... ....+.....+..+.+.|+..++..||++.++..+.+-.+.
T Consensus 472 -----~~~i~~~~-~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 472 -----SLTIRSGD-TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred -----ceeeeccc-ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 00000000 11223344788899999999999999999998876554443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.8e-10 Score=105.71 Aligned_cols=214 Identities=17% Similarity=0.219 Sum_probs=148.4
Q ss_pred ceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe----cCCceEEEEEeC
Q 018891 34 FGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS----ESDNRLLVYEFM 109 (349)
Q Consensus 34 ~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~ 109 (349)
..+.|++ ...-+|-.|++|.++............-++.++++.|+|++++.++|. .+..+++|++|+
T Consensus 289 ~~Ttyk~---------~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 289 SITTYKA---------TSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred cceeEee---------eeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 3567887 566678899999995544443434445688999999999999999886 345678999999
Q ss_pred CC-CChHHHHhc--------------cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 110 PK-GSLENHLFR--------------SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 110 ~~-~~L~~~l~~--------------~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++ ++|.++-.. ...+.++..+|.++.||..||.++| +.|+..+-|.+.+|+++++-+++|..-
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH--ssGLAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH--SSGLACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH--hcCceeecccHhHeEeeCcceEEEecc
Confidence 75 467665432 1245788999999999999999999 889999999999999999888999877
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
|......... .+| +. -..+-|.=.||.++..|.||..--. ..+...+.-
T Consensus 438 ~i~Dvl~~d~--------------~~~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~--~~d~~~~s~---------- 486 (655)
T KOG3741|consen 438 GIMDVLQEDP--------------TEP--LE---SQQQNDLRDLGLLLLALATGTENSN--RTDSTQSSH---------- 486 (655)
T ss_pred cceeeecCCC--------------Ccc--hh---HHhhhhHHHHHHHHHHHhhcccccc--cccchHHHH----------
Confidence 7665422211 011 11 1235688899999999999854210 000000000
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...+...++.+++++|.-....++++ -++.+++.+
T Consensus 487 ------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 ------------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 01123456677777777777777776 666666654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.3e-12 Score=123.47 Aligned_cols=251 Identities=19% Similarity=0.199 Sum_probs=178.3
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
..+.+.+.+.+.+|.++.++.+ ...++|+..++|+......- ..+....+-.++-...+|.++....-
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~---------~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s 872 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPA---------SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS 872 (1205)
T ss_pred CCccceecccccCCCCcccccC---------CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC
Confidence 4567888889999999999998 66667766666654322111 11112222222222234555554444
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+......+++++++.+++|...+... ...+.......+..+..++++|| ...+.|+|++|.|.++..++..++.||+
T Consensus 873 ~~~rsP~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~--s~~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 873 FPCRSPLPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLH--SSLRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred CCCCCCcchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccc--cchhhcccccccchhhcccCCcccCccc
Confidence 55566788999999999999888543 45666667777778899999999 7779999999999999999999999998
Q ss_pred ccccCCCC---------------------CC---C-----ccccceecCCcccCccccccCCCCCccceehhhHHHHHHH
Q 018891 176 LARDGPTG---------------------DN---T-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 226 (349)
Q Consensus 176 ~~~~~~~~---------------------~~---~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll 226 (349)
........ .. . .......+++.|.+||...+......+|+|++|+++++.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 33211110 00 0 0011246899999999999999999999999999999999
Q ss_pred hCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 018891 227 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 297 (349)
Q Consensus 227 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 297 (349)
+|..||+....+.....+.....++.. .+...+...++++...+..+|.+|..+.
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~~~~p~----------------g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRDIPWPE----------------GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCCCCCCC----------------CccccChhhhhhhhhhhccCchhccCcc
Confidence 999999887776555444433332222 2345567889999999999999998776
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.3e-10 Score=96.35 Aligned_cols=141 Identities=20% Similarity=0.241 Sum_probs=103.5
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCC--CcccceeeEEecC---C
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRH--ENLVKLIGYCSES---D 100 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~ 100 (349)
+.|+.|..+.+|++... +|..+++|....... .....+..|..+++.+.+ ..+.+++.+.... +
T Consensus 4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~ 73 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG 73 (223)
T ss_pred eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence 56899999999998432 256799998765432 134567788999988865 3456666666543 2
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL--------------------------------- 147 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~--------------------------------- 147 (349)
..++||||++|.++.+.+.. ..+++.....++.+++.+|..||+.
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred CceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 56899999999888765421 3466777777888888888888732
Q ss_pred ---------------------CCCeeeccCCCCcEEEcC--CCcEEEeccccccc
Q 018891 148 ---------------------DANVIYRDLKASNVLLDS--NFNAKLSDFGLARD 179 (349)
Q Consensus 148 ---------------------~~~i~H~di~~~Nilv~~--~~~v~l~Dfg~~~~ 179 (349)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 244689999999999988 66789999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.6e-09 Score=91.59 Aligned_cols=122 Identities=16% Similarity=0.123 Sum_probs=87.6
Q ss_pred CcEEEEEEccccchh-----------chHHHHHHHHHHhccCCCcc--cceeeEEec-----CCceEEEEEeCCCC-ChH
Q 018891 55 GIVVAIKRLKAESFQ-----------GHKEWLTEVIYLGQLRHENL--VKLIGYCSE-----SDNRLLVYEFMPKG-SLE 115 (349)
Q Consensus 55 ~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e~~~~~-~L~ 115 (349)
|+.|.||........ ....+.+|...+..+..-+| ..++.+.+. ....++|||++++. +|.
T Consensus 45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~ 124 (268)
T PRK15123 45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE 124 (268)
T ss_pred CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence 567889966433211 01136688888877743333 333444432 23468999999876 788
Q ss_pred HHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-------CCcEEEecccccc
Q 018891 116 NHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------NFNAKLSDFGLAR 178 (349)
Q Consensus 116 ~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-------~~~v~l~Dfg~~~ 178 (349)
+++... ....+......++.+++..+..|| ..|++|+|++++||+++. +..+.|+||+.+.
T Consensus 125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 125 DYCADWATNPPDPRLKRMLIKRVATMVRDMH--AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 887431 244566778899999999999999 999999999999999975 4679999999774
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-10 Score=110.48 Aligned_cols=149 Identities=26% Similarity=0.389 Sum_probs=104.9
Q ss_pred HHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccc-------cceecCCcccCccccccCCC
Q 018891 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-------TRIVGTRGYAAPEYVATGHL 209 (349)
Q Consensus 137 l~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~~~ 209 (349)
...|+.++|+ +.+++|++|.|++|.++.++.+||++|+++............ .-......|.+||.+.+...
T Consensus 108 v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 108 VADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred ccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 4489999998 789999999999999999999999999988643331111111 11234667999999998888
Q ss_pred CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccC
Q 018891 210 TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 289 (349)
Q Consensus 210 ~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 289 (349)
+.++|+||+|+++|.+..+..+............ ................+++++++-+.+++..+
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHhcCC
Confidence 8999999999999999955544322221111111 11111111122234678899999999999999
Q ss_pred CCCCCCHHHHH
Q 018891 290 PKNRPSMVDVL 300 (349)
Q Consensus 290 p~~Rps~~~ll 300 (349)
+..||++..+.
T Consensus 253 ~~~rp~~~~l~ 263 (700)
T KOG2137|consen 253 SAVRPTLDLLL 263 (700)
T ss_pred cccCcchhhhh
Confidence 99999766654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.1e-09 Score=90.04 Aligned_cols=134 Identities=18% Similarity=0.131 Sum_probs=97.8
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----------------------hchHHHHHHHHH
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----------------------QGHKEWLTEVIY 80 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~e~~~ 80 (349)
+.++..||-|--+.||.|.. . +|.+++||.=..... -......+|..+
T Consensus 93 e~iG~~IGvGKEsdVY~~~~---------~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID---------P-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HhhccccccCccceEEEEEC---------C-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 56778999999999999943 2 578899994221100 012335689999
Q ss_pred HhccCCC--cccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 81 LGQLRHE--NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 81 l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
|..+... .+.+++++ +...+|||+++|..|...- ++......++..|+.-+..+- ..|++|+|+++
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~--~~GiVHGDlSe 230 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY--RRGIVHGDLSE 230 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH--HcCccccCCch
Confidence 9998644 67777655 5667999999997765522 234455556666777666666 68999999999
Q ss_pred CcEEEcCCCcEEEecccccc
Q 018891 159 SNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~ 178 (349)
-||+|+++|.++++||-.+.
T Consensus 231 fNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 231 FNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred heEEEecCCCEEEEeCcccc
Confidence 99999999999999997664
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.3e-08 Score=84.38 Aligned_cols=97 Identities=23% Similarity=0.266 Sum_probs=65.2
Q ss_pred HHHHHHHHHhccCCCc--ccceeeEEecCCceEEEEEeCC--CCChHHHHhccCCCCChHHHHHHHHHHHHHHHH-HhcC
Q 018891 73 EWLTEVIYLGQLRHEN--LVKLIGYCSESDNRLLVYEFMP--KGSLENHLFRSVQPISWPTRVKIAIDVARGLSF-LHGL 147 (349)
Q Consensus 73 ~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~-lH~~ 147 (349)
...+|++.|.++..-+ +.+++++. .-++||||++ |..+..+. . ..++......++.+++..+.. +|
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~--~~~~~~~~~~~~~~il~~~~~~~~-- 124 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-D--VDLSPEEPKELLEEILEEIIKMLH-- 124 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-H--CGGGGSTHHHHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-h--ccccchhHHHHHHHHHHHHHHHHH--
Confidence 3568999999997553 45555442 3469999998 65554433 2 112245567778888884444 69
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
..|++|||+++.||+++++ .+.++|||.+..
T Consensus 125 ~~givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 125 KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp CTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred hcCceecCCChhhEEeecc-eEEEEecCccee
Confidence 8999999999999999887 999999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=7.5e-08 Score=81.63 Aligned_cols=105 Identities=25% Similarity=0.267 Sum_probs=80.3
Q ss_pred HHHHHHHHHHhccCC--CcccceeeEEecCC----ceEEEEEeCCCC-ChHHHHhccCCCCChHHHHHHHHHHHHHHHHH
Q 018891 72 KEWLTEVIYLGQLRH--ENLVKLIGYCSESD----NRLLVYEFMPKG-SLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144 (349)
Q Consensus 72 ~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~l 144 (349)
....+|...+..+.. =.+.+++.+.+... ..++|+|++++. +|.+++... ...+......++.+++..++-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHHH
Confidence 456677777776632 22445555554422 347999999874 788888543 2266778889999999999999
Q ss_pred hcCCCCeeeccCCCCcEEEcCCC---cEEEeccccccc
Q 018891 145 HGLDANVIYRDLKASNVLLDSNF---NAKLSDFGLARD 179 (349)
Q Consensus 145 H~~~~~i~H~di~~~Nilv~~~~---~v~l~Dfg~~~~ 179 (349)
| ..|++|+|+++.|||++.++ .+.++||+.+..
T Consensus 135 H--~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 H--DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred H--HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9 99999999999999999887 799999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.8e-08 Score=95.72 Aligned_cols=142 Identities=15% Similarity=0.138 Sum_probs=93.9
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhch----------------------------------H
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH----------------------------------K 72 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------~ 72 (349)
..|+.++-|+||+|.+.+ |+.||||+..+.-.... +
T Consensus 131 ~PiAsASIaQVH~A~L~s----------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLKS----------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEecC----------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 688999999999997653 89999998764211100 0
Q ss_pred ------HHHHHHHHHhcc-----CCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHH
Q 018891 73 ------EWLTEVIYLGQL-----RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141 (349)
Q Consensus 73 ------~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l 141 (349)
++.+|...+.++ +.+++.-+.=+++-.+..+++|||++|..+.+...-....++.+.+.....++.--
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~- 279 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLR- 279 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHH-
Confidence 123344444333 23443333333444567789999999999988754333556655554444333322
Q ss_pred HHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCC
Q 018891 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182 (349)
Q Consensus 142 ~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~ 182 (349)
.+= ..|+.|.|.+|.||+|..+|.+.+.|||.......
T Consensus 280 -q~~--~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 -QLL--RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -HHH--hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 222 34899999999999999999999999999875443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.76 E-value=6.6e-08 Score=81.04 Aligned_cols=144 Identities=16% Similarity=0.138 Sum_probs=96.4
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHH---------HHHHHHHHh
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---------WLTEVIYLG 82 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~ 82 (349)
.+...+++..+|.+.+++-......|.+...+ |..+++|..........+. ..+.+..+.
T Consensus 22 ~~l~~~i~~~~~~~~kv~k~~~r~~ValIei~-----------~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~ 90 (229)
T PF06176_consen 22 LELGEKILDNNYKIIKVFKNTKRNYVALIEID-----------GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTD 90 (229)
T ss_pred HHHHHHHHhCCceEEEeecCCCccEEEEEEEC-----------CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHH
Confidence 34567888999999999999888888776544 5779999876654332222 223333333
Q ss_pred ccCC---CcccceeeE-----EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 018891 83 QLRH---ENLVKLIGY-----CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 154 (349)
Q Consensus 83 ~l~h---~~i~~~~~~-----~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~ 154 (349)
++.. -.+..++-. +.-....+++|||++|..|.+.. .+++ .+...+.+++..+| +.|++||
T Consensus 91 ~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH--~~G~~HG 159 (229)
T PF06176_consen 91 KIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLH--KHGFYHG 159 (229)
T ss_pred HHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHH--HcCCccC
Confidence 3322 222222222 22223456899999998776543 1222 23456778899999 9999999
Q ss_pred cCCCCcEEEcCCCcEEEecccccc
Q 018891 155 DLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 155 di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
|.+|.|++++.+ .++++||+...
T Consensus 160 D~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 160 DPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred CCCcCcEEEECC-cEEEEECcccc
Confidence 999999999865 59999997553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.5e-07 Score=78.62 Aligned_cols=138 Identities=19% Similarity=0.147 Sum_probs=98.3
Q ss_pred eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc------chhchHHHHHHHHHHhccCCCc--ccceeeEEec-
Q 018891 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE------SFQGHKEWLTEVIYLGQLRHEN--LVKLIGYCSE- 98 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~- 98 (349)
--|+|+.+.|+...+.+ ..+-+|.-... .+.....+.+|+..|+.+..-+ +.++. ++..
T Consensus 25 N~~rgG~SgV~r~~~~g-----------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~ 92 (216)
T PRK09902 25 NYRRNGMSGVQCVERNG-----------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAV 92 (216)
T ss_pred CcCCCCcceEEEEEeCC-----------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeee
Confidence 34668999998875432 35777865411 1224567889999998884222 44444 3321
Q ss_pred ----CCceEEEEEeCCC-CChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc--EE
Q 018891 99 ----SDNRLLVYEFMPK-GSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN--AK 170 (349)
Q Consensus 99 ----~~~~~lv~e~~~~-~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~--v~ 170 (349)
.-..+||+|-+++ .+|.+.+.+. ..+.+......++.+++.++..|| +.|+.|+|+.+.||+++.++. +.
T Consensus 93 k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH--~~Gv~Hgdly~khIll~~~g~~~v~ 170 (216)
T PRK09902 93 KIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH--SVNRQHGCCYVRHIYVKTEGKAEAG 170 (216)
T ss_pred ccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHhheeecCCCCeeEE
Confidence 1235799997753 5888877442 235677778899999999999999 999999999999999986667 99
Q ss_pred Eeccccccc
Q 018891 171 LSDFGLARD 179 (349)
Q Consensus 171 l~Dfg~~~~ 179 (349)
++||.-++.
T Consensus 171 lIDlEk~r~ 179 (216)
T PRK09902 171 FLDLEKSRR 179 (216)
T ss_pred EEEhhccch
Confidence 999986653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.65 E-value=6e-07 Score=77.11 Aligned_cols=135 Identities=11% Similarity=0.041 Sum_probs=82.4
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCc--ccceeeEEecCCceEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN--LVKLIGYCSESDNRLL 104 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~l 104 (349)
..||.|..+.||+.. +..+++|...... ......+|.++++.+..-+ +.+++.+....+...+
T Consensus 7 ~~i~~G~t~~~y~~~-------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL 71 (226)
T ss_pred eeecCCCCcceeEec-------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence 568999999999841 3457889876533 3345678999998885332 4666777777777789
Q ss_pred EEEeCCCCC-hHHHH--------------hc-----cC---CCCChHHHHH-H--------------HHHHHHHHHHHhc
Q 018891 105 VYEFMPKGS-LENHL--------------FR-----SV---QPISWPTRVK-I--------------AIDVARGLSFLHG 146 (349)
Q Consensus 105 v~e~~~~~~-L~~~l--------------~~-----~~---~~l~~~~~~~-i--------------~~ql~~~l~~lH~ 146 (349)
||++++|.+ +...+ .+ +. ...+...... + ...+...+.- +.
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~-~~ 150 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE-VP 150 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh-CC
Confidence 999999863 21111 00 00 0111111000 0 0001111111 11
Q ss_pred CCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 147 ~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
....++|+|++|.||++++++ +.++||+.+.
T Consensus 151 ~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 134578999999999999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=7e-07 Score=75.81 Aligned_cols=154 Identities=19% Similarity=0.164 Sum_probs=100.0
Q ss_pred CCCCcchhhhhhhcccCCcceeee---cCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc--------------
Q 018891 8 SDPSASMISKIATKNFCSDYLLGE---GGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-------------- 70 (349)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~lg~---G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------- 70 (349)
.|..+.++..-+.++..+..+.|. |.-+.||+|. .+++..+|+|++.......
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~----------~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~ 101 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAE----------TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFR 101 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeec----------cCCCceEEEEEEehhhhhhhhHHHHHhcChhhh
Confidence 455556666666677777776665 5556889873 2457889999875432110
Q ss_pred -----hH-----HHHHHHHHHhccC--CCcccceeeEEecCCceEEEEEeCCCCCh-HHHHhccCCCCChHHHHHHHHHH
Q 018891 71 -----HK-----EWLTEVIYLGQLR--HENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRSVQPISWPTRVKIAIDV 137 (349)
Q Consensus 71 -----~~-----~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~l~~~~~~~i~~ql 137 (349)
.. -...|+..|+++. +-.+.+++.+.. -.+|||++..... .-.+ ..-++...++..+..++
T Consensus 102 ~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~L--kDv~~e~~e~~~~~~~~ 175 (268)
T COG1718 102 NSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRL--KDVPLELEEAEGLYEDV 175 (268)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCc--ccCCcCchhHHHHHHHH
Confidence 01 1235777777773 344455555443 3599999954311 1111 11233333677777888
Q ss_pred HHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 138 ~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
++.+.-|-. ..++||+||+.-||++. ++.+.+||||.+..
T Consensus 176 v~~~~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 176 VEYMRRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred HHHHHHHHH-hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence 888887761 48999999999999998 78999999998864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.5e-06 Score=74.36 Aligned_cols=136 Identities=18% Similarity=0.126 Sum_probs=79.7
Q ss_pred eeecCc-eeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEecCCceEEEE
Q 018891 29 LGEGGF-GCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLLVY 106 (349)
Q Consensus 29 lg~G~~-g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~ 106 (349)
|..|.. ..||+. ... +..+++|...... ......|+.+++.+. +--+.+++.+...++..++||
T Consensus 6 ~~~g~~~~~v~~~---------~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRL---------DGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEE---------cCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 444444 788987 222 3568889775543 234557888887773 334556677666666789999
Q ss_pred EeCCCCChHHHHh----------------c-cCC-----CCChH--HHHHHHH--------------------HHHHHHH
Q 018891 107 EFMPKGSLENHLF----------------R-SVQ-----PISWP--TRVKIAI--------------------DVARGLS 142 (349)
Q Consensus 107 e~~~~~~L~~~l~----------------~-~~~-----~l~~~--~~~~i~~--------------------ql~~~l~ 142 (349)
++++|.++..... . +.. ++... ....... .+...+.
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 9999987764320 0 000 11100 0000000 0111112
Q ss_pred HHh-----cCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 143 FLH-----GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 143 ~lH-----~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.|- .....++|+|+.|.||++++++.+.|+||+.+.
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 221 003458999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=5e-06 Score=71.55 Aligned_cols=78 Identities=15% Similarity=0.164 Sum_probs=51.9
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCC--cccceeeEE---ecCC
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE--NLVKLIGYC---SESD 100 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~---~~~~ 100 (349)
++.|+.|..+.||++.. .+ ..+++|..... .....+..|..+++.+... .+.+++... ....
T Consensus 2 i~~l~~G~~n~~~~v~~---------~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~ 68 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTT---------DD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG 68 (239)
T ss_dssp EEEEEESSSSEEEEEEE---------TT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred CccCCCCCeeeEEEEEE---------CC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence 46789999999999842 22 37899987655 3445666777777777422 344555433 2233
Q ss_pred ceEEEEEeCCCCChHH
Q 018891 101 NRLLVYEFMPKGSLEN 116 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~ 116 (349)
..+++|++++|.++..
T Consensus 69 ~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 69 FPYLLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEEEEESSEEHHH
T ss_pred cceEEEEEeccccccc
Confidence 4689999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.3e-06 Score=65.98 Aligned_cols=132 Identities=18% Similarity=0.163 Sum_probs=91.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCc
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
.-+..+.|++|.+|.||++.|. |..+++|+-..++ ....+.-|.++|..++-.++-+=+-.+..+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~-- 87 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED-- 87 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh--
Confidence 3456678999999999999776 3468999766554 446677889999888766665544444332
Q ss_pred eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCC-CCcEEEcCCCcEEEeccccccc
Q 018891 102 RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK-ASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~-~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
++.|||+.|.+|.+.-... + .+-+..++++..-|. ..||-|+.|+ |...++.+++.+.|+||..+..
T Consensus 88 -~i~me~i~G~~L~~~~~~~----~----rk~l~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 88 -FIRMEYIDGRPLGKLEIGG----D----RKHLLRVLEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred -hhhhhhhcCcchhhhhhcc----c----HHHHHHHHHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 3569999998887744221 2 222334666666677 7789999987 4455555666999999998873
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=9.5e-06 Score=77.20 Aligned_cols=142 Identities=15% Similarity=0.113 Sum_probs=87.2
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-------------------------------hHH
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-------------------------------HKE 73 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~~ 73 (349)
..+.||..+.|.||+|+.+ +|+.||||+-++.-... .+.
T Consensus 165 ~~~piaaASlaQVhrA~L~----------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~ 234 (538)
T KOG1235|consen 165 DEEPIAAASLAQVHRARLK----------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKS 234 (538)
T ss_pred CcchhhhcchhheEEEEec----------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhh
Confidence 3468999999999999543 28999999865421110 011
Q ss_pred ------HHHHHHHHhc----cCCCc---ccceeeEE-ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHH
Q 018891 74 ------WLTEVIYLGQ----LRHEN---LVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139 (349)
Q Consensus 74 ------~~~e~~~l~~----l~h~~---i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~ 139 (349)
|.+|.+-..+ +.|-+ -+.+-.++ .-....+++|||++|..+.+.-.=....++...+..-+.+...
T Consensus 235 L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~ 314 (538)
T KOG1235|consen 235 LPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL 314 (538)
T ss_pred hHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH
Confidence 2223322222 23333 12222333 2335678999999998776543223355666655544444333
Q ss_pred HHHHHhcCCCCeeeccCCCCcEEEcC----CCcEEEecccccccC
Q 018891 140 GLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDG 180 (349)
Q Consensus 140 ~l~~lH~~~~~i~H~di~~~Nilv~~----~~~v~l~Dfg~~~~~ 180 (349)
-.-+ ..|++|+|-+|.||+|.. ++.+.+.|||+....
T Consensus 315 ~qIf----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 315 EQIF----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHH----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 2222 347999999999999983 677999999998653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.3e-05 Score=69.34 Aligned_cols=31 Identities=23% Similarity=0.259 Sum_probs=25.9
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
...++|+|+++.||+++.++..-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 3458999999999999877656799999774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.12 E-value=7.1e-05 Score=62.62 Aligned_cols=130 Identities=18% Similarity=0.211 Sum_probs=88.2
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc----------------hhchHHHHHHHHHHhccC---
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES----------------FQGHKEWLTEVIYLGQLR--- 85 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~--- 85 (349)
-...||+|+.=.||.--. .....||+..... ........+|+.....+.
T Consensus 5 ~~~~i~~G~~R~cy~HP~------------dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~ 72 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHPD------------DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRR 72 (199)
T ss_pred CCcccccCCCceEEECCC------------CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhcc
Confidence 346799999999987422 2235688887665 112344455555444443
Q ss_pred ---CCcccceeeEEecCCceEEEEEeCC------CCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 018891 86 ---HENLVKLIGYCSESDNRLLVYEFMP------KGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 156 (349)
Q Consensus 86 ---h~~i~~~~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di 156 (349)
+.+|.+++++.+.+..+.+|+|.+. ..+|.+++.+ ..++. .....+ -+...+|- ..+|+.+|+
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~L---~~f~~~l~--~~~Iv~~dl 144 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQAL---DEFKRYLL--DHHIVIRDL 144 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHHH---HHHHHHHH--HcCCeecCC
Confidence 8899999999999999999999763 2378888844 34555 444443 34455666 678999999
Q ss_pred CCCcEEEcCCC----cEEEecc
Q 018891 157 KASNVLLDSNF----NAKLSDF 174 (349)
Q Consensus 157 ~~~Nilv~~~~----~v~l~Df 174 (349)
+|.||++...+ .+.|+|-
T Consensus 145 ~~~NIv~~~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 145 NPHNIVVQRRDSGEFRLVLIDG 166 (199)
T ss_pred CcccEEEEecCCCceEEEEEeC
Confidence 99999995432 4677763
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.09 E-value=0.00012 Score=60.86 Aligned_cols=99 Identities=27% Similarity=0.326 Sum_probs=77.4
Q ss_pred HHHHHHhccCC-CcccceeeEEecCCceEEEEEeCCCCChHHH---HhccCCCCChHHHHHHHHHHHHHHHHHhc-CCCC
Q 018891 76 TEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENH---LFRSVQPISWPTRVKIAIDVARGLSFLHG-LDAN 150 (349)
Q Consensus 76 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~l~~~~~~~i~~ql~~~l~~lH~-~~~~ 150 (349)
.|..+++.+++ +++.++++.+. .++|+|+...+++... + ..-...++..+..++.++++.+.+++. ....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 57888888864 68999999884 3578999976655421 1 111346889999999999999999972 1245
Q ss_pred eeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 151 VIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 151 i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+.-.|++++|+-|+++++++++|.+.+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88999999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.07 E-value=8.6e-05 Score=75.96 Aligned_cols=82 Identities=16% Similarity=0.215 Sum_probs=55.0
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccC-CCcc--cceeeEEecC--
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLR-HENL--VKLIGYCSES-- 99 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~-- 99 (349)
.+.++.|.+..+|+..+.. .+....+++|+...... .....+.+|+.+++.+. |.++ .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~-------~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGN-------GGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECC-------CCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 5678889899999874422 11124678887654322 23456789999999985 6654 5666665543
Q ss_pred -CceEEEEEeCCCCCh
Q 018891 100 -DNRLLVYEFMPKGSL 114 (349)
Q Consensus 100 -~~~~lv~e~~~~~~L 114 (349)
+..|+||||++|..+
T Consensus 116 ~G~~flVME~v~G~~~ 131 (822)
T PLN02876 116 IGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCCceEEEEecCCccc
Confidence 467999999988653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.5e-06 Score=82.36 Aligned_cols=189 Identities=17% Similarity=0.097 Sum_probs=132.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCc-ccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-LVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~ 98 (349)
..-|....-+++|+++.+++. +..++...+ .+.+... ....-++++|.+++||| .+..++-++.
T Consensus 241 ~kws~~fh~fvK~altknpKk---------RptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~ 305 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKK---------RPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDG 305 (829)
T ss_pred ccchHHHHHHHHHHhcCCCcc---------CCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCc
Confidence 345566667788888889887 333333322 4544333 34456889999999999 6666666677
Q ss_pred CCceEEEEEeCCCC-ChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKG-SLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~-~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+....++++++.++ +-...+......+...+...+++.-++.++++| +..-+|+| ||+-++ +..+.+||+..
T Consensus 306 E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~--~~~~~~~d----~~l~s~-~~~~~~~~~v~ 378 (829)
T KOG0576|consen 306 EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH--SSYKVHRD----NILGSE-EEVKLLDFAVP 378 (829)
T ss_pred ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc--cccccCcc----cccccc-cccccccccCC
Confidence 77888999999765 222212122233455566677777888999999 55557887 666654 57899999988
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCc
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 233 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~ 233 (349)
..+.... ......+++.+++||......+....|.|++|.-..++--|..|-.
T Consensus 379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 379 PQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 7655543 2233578999999999999999999999999987777777776654
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.0001 Score=63.67 Aligned_cols=76 Identities=18% Similarity=0.112 Sum_probs=45.4
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCccc-ceeeEEecCCceEE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLV-KLIGYCSESDNRLL 104 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~l 104 (349)
.+.|..|-...+|++...+ +.+..|++|........ .-...+|..+++.+...++. +++.... ..+
T Consensus 3 i~~l~gG~tN~~~~v~~~~--------~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~ 69 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKE--------DNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGL 69 (235)
T ss_pred EEEcCCcccceEEEEEcCC--------CCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcE
Confidence 3567788888999873211 03467889976543221 12234688888887533333 3333222 248
Q ss_pred EEEeCCCCCh
Q 018891 105 VYEFMPKGSL 114 (349)
Q Consensus 105 v~e~~~~~~L 114 (349)
||||++|.++
T Consensus 70 l~e~i~G~~l 79 (235)
T cd05157 70 IYEFIPGRTL 79 (235)
T ss_pred EEEeeCCCcC
Confidence 9999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.7e-05 Score=66.81 Aligned_cols=135 Identities=18% Similarity=0.116 Sum_probs=74.1
Q ss_pred eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcc-cceeeEEecCCceEEEE
Q 018891 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSESDNRLLVY 106 (349)
Q Consensus 28 ~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 106 (349)
.+..|-...+|+.. ..+..+++|..........-...+|..+++.+...++ .+++... . .++|+
T Consensus 3 ~~~~G~tn~~y~~~-----------~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-----------HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEE-----------eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEE
Confidence 35567778888873 2255788897654322211134578888888853333 2333322 1 36899
Q ss_pred EeCCCCChHHH----------H----hc-cC-----CCCChHH-HHHHHHHH---------HHHHHHHhc------CCCC
Q 018891 107 EFMPKGSLENH----------L----FR-SV-----QPISWPT-RVKIAIDV---------ARGLSFLHG------LDAN 150 (349)
Q Consensus 107 e~~~~~~L~~~----------l----~~-~~-----~~l~~~~-~~~i~~ql---------~~~l~~lH~------~~~~ 150 (349)
+|++|.++... + .+ +. .+++... +..+..++ ...+..+-. ....
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 99998765321 1 00 11 1112111 11111111 111222210 0235
Q ss_pred eeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 151 VIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 151 i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+||+|+.|.||++++++ +.++||+.+.
T Consensus 148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 148 PLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 89999999999999876 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00016 Score=60.09 Aligned_cols=126 Identities=29% Similarity=0.397 Sum_probs=85.5
Q ss_pred hcccCCcceeeecCc-eeEEEeeecCCCcCCCCCCCCcEEEEEEccc---cch-------h-----------chHHHHHH
Q 018891 20 TKNFCSDYLLGEGGF-GCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA---ESF-------Q-----------GHKEWLTE 77 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~-g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~---~~~-------~-----------~~~~~~~e 77 (349)
+.+++.++.||.|.. |.||++.++ |..+|||++.. ... . ....|..|
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~-----------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~E 104 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID-----------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCE 104 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC-----------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHH
Confidence 479999999999999 999999876 56799998321 100 0 01124455
Q ss_pred HHH---HhccCCCcc--cceeeEEecC------------------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHH
Q 018891 78 VIY---LGQLRHENL--VKLIGYCSES------------------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIA 134 (349)
Q Consensus 78 ~~~---l~~l~h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~ 134 (349)
-+. |+...+.++ ++++++..-. ....||.||++... .+. ..-+
T Consensus 105 CRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~ 170 (207)
T PF13095_consen 105 CRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDI 170 (207)
T ss_pred HHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHH
Confidence 554 444456677 8888887322 11246777765532 122 2334
Q ss_pred HHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 135 ~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.++.+-+..+| +.||+-+|+++.|.. .-+|+|||.+
T Consensus 171 ~~~~~dl~~~~--k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 171 PQMLRDLKILH--KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHH--HCCeeeccCcccccc-----CCEEEecccC
Confidence 56788888999 999999999999986 2388999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.91 E-value=4.2e-05 Score=77.53 Aligned_cols=197 Identities=22% Similarity=0.253 Sum_probs=133.6
Q ss_pred HHHHHHHhccCCCcccceeeEEecCCceE----EEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 018891 75 LTEVIYLGQLRHENLVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDAN 150 (349)
Q Consensus 75 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~ 150 (349)
.-|...+.+..|+|+..+..+-.+..... +..+++...++...+ ++-..++....+.+..+++++++++| +..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~-q~v~~i~~~~~r~~~~~~~~GL~~~h--~~~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL-QSVGSIPLETLRILHQKLLEGLAYLH--SLS 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH-hhccccCHHHHHHHHHHHhhhHHHHH--Hhc
Confidence 45667778889999999988875543322 445677777787766 44477899999999999999999999 655
Q ss_pred eeeccCCCC---cEEEcCCCcEEEe--cccccccCCCCCCCccccceecCCcccCccccccCCCCC--ccceehhhHHHH
Q 018891 151 VIYRDLKAS---NVLLDSNFNAKLS--DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP--KSDVYSFGVVLL 223 (349)
Q Consensus 151 i~H~di~~~---Nilv~~~~~v~l~--Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~DiwslG~ll~ 223 (349)
..|.-+... +.-++..+.+.+. ||+.....+....... ......+.++|......... ..|+|++|.+..
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 555555544 4444556667776 8887765444333221 23445577777776665554 479999999999
Q ss_pred HHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 224 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 224 ~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.+..+..+-..... .... ++......+.+++.+|+..++++|+++.+++.+.
T Consensus 384 ~~~~~~~i~~~~~~--------------------~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAV--------------------PVSL--------LDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhcCcccccccc--------------------hhhh--------hccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99988754321110 0000 0011112677889999999999999999999765
Q ss_pred Hh
Q 018891 304 EQ 305 (349)
Q Consensus 304 ~~ 305 (349)
-.
T Consensus 436 f~ 437 (1351)
T KOG1035|consen 436 FL 437 (1351)
T ss_pred hc
Confidence 44
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00048 Score=61.98 Aligned_cols=81 Identities=19% Similarity=0.210 Sum_probs=47.3
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcc-cceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv 105 (349)
+.|..|-...+|++...+.. .....+..+++|+..... .......+|..+++.+...++ .+++..+.. .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDED---ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcc---cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cch
Confidence 45666777788988532211 123346789999865543 222345677777777743333 334444432 368
Q ss_pred EEeCCCCChH
Q 018891 106 YEFMPKGSLE 115 (349)
Q Consensus 106 ~e~~~~~~L~ 115 (349)
++|++|.++.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 9999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00039 Score=62.63 Aligned_cols=140 Identities=17% Similarity=0.139 Sum_probs=91.6
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--ch-------------------hch-----HHHHHHH
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SF-------------------QGH-----KEWLTEV 78 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~-------------------~~~-----~~~~~e~ 78 (349)
+-.+|..|--+.||.| ...+|..+|||+++-. .+ ... -....|+
T Consensus 148 inGCiSTGKEANVYHa----------t~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~ 217 (520)
T KOG2270|consen 148 INGCISTGKEANVYHA----------TEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEM 217 (520)
T ss_pred cccccccCccceeEee----------ecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHH
Confidence 4457778888899997 3344667999976421 00 000 1134678
Q ss_pred HHHhccCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 79 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
+-|+++....|.-+--+.. ...+|||+++.....-.-. -..-.++...+..+-.|++.-+.-|-+ .+++||.||+-
T Consensus 218 RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLSE 293 (520)
T KOG2270|consen 218 RNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLSE 293 (520)
T ss_pred HHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccchhh
Confidence 8888886665444433333 2456999999532221111 122456677777777788877777733 88999999999
Q ss_pred CcEEEcCCCcEEEeccccccc
Q 018891 159 SNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
-|+++. +|.+.++|.+.+..
T Consensus 294 fN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 294 FNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred hhheEE-CCEEEEEEcccccc
Confidence 999995 46899999987753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0019 Score=57.89 Aligned_cols=89 Identities=12% Similarity=0.122 Sum_probs=59.6
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCC---Ccc
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH---ENL 89 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i 89 (349)
+..+...+..-.-.+.||.|..+.||..... ++ .+++|..+. ......+..|...|+.+.. -.+
T Consensus 6 ~~~~~~~~~~~~~~~~i~~G~~~~vy~~~~~----------~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpV 72 (297)
T PRK10593 6 AELSHLLGEKLSRVECISEQPYAALWALYDS----------QG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRM 72 (297)
T ss_pred HHHHHHhchhhheeeecCCccceeEEEEEcC----------CC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCc
Confidence 3445555556667778999999999997321 12 466776432 1133567788888888742 356
Q ss_pred cceeeEEec---CCceEEEEEeCCCCCh
Q 018891 90 VKLIGYCSE---SDNRLLVYEFMPKGSL 114 (349)
Q Consensus 90 ~~~~~~~~~---~~~~~lv~e~~~~~~L 114 (349)
.++++++.. .+..++|||+++|.++
T Consensus 73 P~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 73 PTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 677766543 3668999999988654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0021 Score=58.35 Aligned_cols=31 Identities=32% Similarity=0.339 Sum_probs=26.6
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..++||+|+++.||+++.+...-++||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4589999999999999876556899999775
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0013 Score=58.88 Aligned_cols=140 Identities=19% Similarity=0.090 Sum_probs=78.4
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCc--ccceee------EE
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN--LVKLIG------YC 96 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~------~~ 96 (349)
-.+.|..|....+|+.... +..+++|..... ....+..|+.+++.+...+ +.+++. +.
T Consensus 18 ~i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~ 83 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD-----------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLS 83 (296)
T ss_pred heecccCccccceEEEEeC-----------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEee
Confidence 3556777877889987321 235889987652 2344556666666663222 333332 12
Q ss_pred ecCCceEEEEEeCCCCChHH----HH-------h---ccCCCCC--------hHHHH------------HHHHHHHHHHH
Q 018891 97 SESDNRLLVYEFMPKGSLEN----HL-------F---RSVQPIS--------WPTRV------------KIAIDVARGLS 142 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~----~l-------~---~~~~~l~--------~~~~~------------~i~~ql~~~l~ 142 (349)
..++..++|++|++|..+.. .. . .....+. ..... .....+..++.
T Consensus 84 ~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 163 (296)
T cd05153 84 ELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELA 163 (296)
T ss_pred eeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHH
Confidence 33456789999999876532 01 0 0000000 00000 00111222333
Q ss_pred HHh-----cCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 143 FLH-----GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 143 ~lH-----~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
++. ....++||+|++|.||++++++.+.|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 164 RQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 333 113579999999999999988777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0035 Score=58.28 Aligned_cols=77 Identities=18% Similarity=0.124 Sum_probs=49.6
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc------c-hhchHHHHHHHHHHhccC---CCcccceeeE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE------S-FQGHKEWLTEVIYLGQLR---HENLVKLIGY 95 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~~i~~~~~~ 95 (349)
.+.||.|.+..||++.. .+.++.++||.-... . ....+....|.+.|+.+. ...+.+++.+
T Consensus 31 ~~elggGn~N~VyrV~~---------~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~ 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSD---------TEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY 101 (401)
T ss_pred eeEcCCCceEEEEEEEe---------CCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE
Confidence 46789999999999843 222357999975421 1 123455667778787762 2345555555
Q ss_pred EecCCceEEEEEeCCCCC
Q 018891 96 CSESDNRLLVYEFMPKGS 113 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~ 113 (349)
+.+..++|||++++..
T Consensus 102 --D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 102 --DEELAVTVMEDLSDHK 117 (401)
T ss_pred --CCCCCEEEEecCCCcc
Confidence 3355789999997644
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0023 Score=58.73 Aligned_cols=142 Identities=15% Similarity=0.118 Sum_probs=77.9
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCccc-ceeeEEecCCceEEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLV-KLIGYCSESDNRLLV 105 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv 105 (349)
+.|..|-.-.+|++.+.+. ....+..|++|.......... +..+|..+++.+..-++. ++++.+... .|
T Consensus 42 ~~l~gGlTN~~y~v~~~~~-----~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTK-----EGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEcCCcccceeEEEEeCCC-----CCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 3455577788999854321 122357899998765432222 225678888877533333 344554322 58
Q ss_pred EEeCCCCChHHH----------H----hc-cCCC------C-ChHHHHHHHHHH--------------------HHHHHH
Q 018891 106 YEFMPKGSLENH----------L----FR-SVQP------I-SWPTRVKIAIDV--------------------ARGLSF 143 (349)
Q Consensus 106 ~e~~~~~~L~~~----------l----~~-~~~~------l-~~~~~~~i~~ql--------------------~~~l~~ 143 (349)
++|+++.++... + .+ +... . ....+..+..++ +..|..
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999987766421 0 00 0000 1 112222222111 111111
Q ss_pred -Hh--cCCCCeeeccCCCCcEEEcC-CCcEEEecccccc
Q 018891 144 -LH--GLDANVIYRDLKASNVLLDS-NFNAKLSDFGLAR 178 (349)
Q Consensus 144 -lH--~~~~~i~H~di~~~Nilv~~-~~~v~l~Dfg~~~ 178 (349)
+. .....+||+|+++.||++++ ++.+.++||..+.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11 01346899999999999976 4679999998775
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0025 Score=57.48 Aligned_cols=31 Identities=35% Similarity=0.365 Sum_probs=27.6
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..++||+|+++.|++++.++.+.++||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4789999999999999988777899998774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00025 Score=62.77 Aligned_cols=133 Identities=14% Similarity=0.069 Sum_probs=89.4
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-------------------h---chHHHHHHHHH
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-------------------Q---GHKEWLTEVIY 80 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------------~---~~~~~~~e~~~ 80 (349)
+..++.||-|.-+.||.+.+. .|...++|.=..... + ..-....|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf 163 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF 163 (465)
T ss_pred hhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence 567788999999999998432 366677774221100 0 01123456777
Q ss_pred HhccCC--CcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 81 LGQLRH--ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 81 l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
++.+.. --+.+.+++ +..++|||++.|.+|.+.-. .. ..-.+...+...+--|- ..|++|+|++-
T Consensus 164 mkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~----v~---d~~~ly~~lm~~Iv~la--~~GlIHgDFNE 230 (465)
T KOG2268|consen 164 MKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH----VE---DPPTLYDDLMGLIVRLA--NHGLIHGDFNE 230 (465)
T ss_pred HHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee----cC---ChHHHHHHHHHHHHHHH--HcCceecccch
Confidence 777632 223344433 56689999999988866331 11 23344555666777777 78999999999
Q ss_pred CcEEEcCCCcEEEecccccc
Q 018891 159 SNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~ 178 (349)
-||+|.+++.++++||-.+.
T Consensus 231 FNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 231 FNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred heeEEecCCCEEEeechHhh
Confidence 99999999999999997664
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0044 Score=55.65 Aligned_cols=118 Identities=18% Similarity=0.222 Sum_probs=74.8
Q ss_pred CcEEEEEEccc--cchhchHHHHHHHHHHhccCCCc--ccceeeEEecCC--ceEEEEEeCCCCChHHHHhccCCCCChH
Q 018891 55 GIVVAIKRLKA--ESFQGHKEWLTEVIYLGQLRHEN--LVKLIGYCSESD--NRLLVYEFMPKGSLENHLFRSVQPISWP 128 (349)
Q Consensus 55 ~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~ 128 (349)
++++++. .+. ..........+|+.+++.+.--- +...+..+.++. ..|.||+|++|....+.... .+..
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~----~~~~ 122 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPP----ESLG 122 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCc----ccch
Confidence 6778888 432 23334566678888888874322 223344444443 66999999998643332211 1111
Q ss_pred HHHHHH-HHHHHHHHHHhcC--------------------------------------------------------CCCe
Q 018891 129 TRVKIA-IDVARGLSFLHGL--------------------------------------------------------DANV 151 (349)
Q Consensus 129 ~~~~i~-~ql~~~l~~lH~~--------------------------------------------------------~~~i 151 (349)
.+++ ..+.+.|+-||+. ...+
T Consensus 123 --~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~l 200 (321)
T COG3173 123 --RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVL 200 (321)
T ss_pred --HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCcee
Confidence 1222 2566666666630 3457
Q ss_pred eeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 152 IYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 152 ~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+|||+++.|++++.++-+-++||+.+..
T Consensus 201 vHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 201 VHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeCCcccCCEEEeCCCeeEEEecccccc
Confidence 9999999999999988899999998875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0013 Score=59.18 Aligned_cols=105 Identities=16% Similarity=0.159 Sum_probs=72.4
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+..+.|++|++. |+++.. + +.....++..++++.+..++-+.. +-.+-|+|+...||+|+ .|+|.|+||.++
T Consensus 297 e~~y~yl~~kdh-gt~is~-i----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-I----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeee-e----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence 345667888876 666643 2 344667899999999999988874 56678999999999999 899999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 218 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl 218 (349)
+.....+. +....+-.|..+.|.. +..-+||.+
T Consensus 369 Rl~~~q~~-------isy~rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 369 RLSYSQGI-------ISYNRLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred ecccCCce-------eeccccCchhhhcCcc-ceeeeHHHH
Confidence 84222221 1222244555555433 555566653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.011 Score=53.46 Aligned_cols=32 Identities=19% Similarity=0.168 Sum_probs=28.5
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
..++||+|+.++|+++++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0061 Score=55.57 Aligned_cols=29 Identities=21% Similarity=0.263 Sum_probs=25.3
Q ss_pred CeeeccCCCCcEEEcC-CCcEEEecccccc
Q 018891 150 NVIYRDLKASNVLLDS-NFNAKLSDFGLAR 178 (349)
Q Consensus 150 ~i~H~di~~~Nilv~~-~~~v~l~Dfg~~~ 178 (349)
-+||+|+.+.||++++ ++.++++||+.+.
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 3799999999999975 5689999999885
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0028 Score=53.81 Aligned_cols=30 Identities=30% Similarity=0.397 Sum_probs=21.5
Q ss_pred CCeeeccCCCCcEEE-cCCCcEEEecccccc
Q 018891 149 ANVIYRDLKASNVLL-DSNFNAKLSDFGLAR 178 (349)
Q Consensus 149 ~~i~H~di~~~Nilv-~~~~~v~l~Dfg~~~ 178 (349)
.-++|+|+.+.||++ +.++.++|+||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 467899999999999 888999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.015 Score=51.57 Aligned_cols=31 Identities=23% Similarity=0.373 Sum_probs=25.3
Q ss_pred CCeeeccCCCCcEEEcCCCc-EEEeccccccc
Q 018891 149 ANVIYRDLKASNVLLDSNFN-AKLSDFGLARD 179 (349)
Q Consensus 149 ~~i~H~di~~~Nilv~~~~~-v~l~Dfg~~~~ 179 (349)
..++|+|+++.||+++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34799999999999987555 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.015 Score=53.17 Aligned_cols=31 Identities=16% Similarity=0.274 Sum_probs=25.7
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++|||+++.||+++.+ .++++|+..+..
T Consensus 191 ~~~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 191 AETLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred cceeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 5678999999999999776 477999987653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0081 Score=55.50 Aligned_cols=76 Identities=21% Similarity=0.166 Sum_probs=45.7
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccc------cchhchHHHHHHHHHHhccC--CCcccceeeEEe
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA------ESFQGHKEWLTEVIYLGQLR--HENLVKLIGYCS 97 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 97 (349)
.+.||.|....||++.. ...+..|+||.-.. +-.-..++..-|...|+... .|..++-+-++
T Consensus 34 ~~eigdGnlN~VfrV~~---------~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~- 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWD---------EQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF- 103 (409)
T ss_pred eeEcCCCceEEEEEEee---------CCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-
Confidence 56889999999999943 21235688985422 11223455666777777763 45444433233
Q ss_pred cCCceEEEEEeCCC
Q 018891 98 ESDNRLLVYEFMPK 111 (349)
Q Consensus 98 ~~~~~~lv~e~~~~ 111 (349)
+.....+|||+++.
T Consensus 104 D~e~~~~vMEdL~~ 117 (409)
T PRK12396 104 DSVMNCCVMEDLSD 117 (409)
T ss_pred CcHHhhHHHHhCcc
Confidence 23455678888754
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0063 Score=54.13 Aligned_cols=87 Identities=21% Similarity=0.214 Sum_probs=50.3
Q ss_pred cchhhhhhhccc--CCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc---CC
Q 018891 12 ASMISKIATKNF--CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL---RH 86 (349)
Q Consensus 12 ~~~~~~~~~~~y--~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l---~h 86 (349)
.+.++...+.++ +-.+.++.|....+|... .++..+.+|.-... ....+..|..-|+.+ ..
T Consensus 6 ~~~~~~~~~~~~~i~~~~~v~GG~i~~a~~~~-----------~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~ 71 (288)
T PF03881_consen 6 EQQISEQLGADFKITSIEPVSGGDINEAYRLD-----------TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANP 71 (288)
T ss_dssp HHHHHHHHTS-----EEEEE--SSSSEEEEEE-----------TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTT
T ss_pred HHHHHHHhCCCCceeeeEecCCCChhheEEEE-----------CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCC
Confidence 344566666664 445578888899999873 34667899976522 234556677666666 35
Q ss_pred CcccceeeEEecCCceEEEEEeCCCC
Q 018891 87 ENLVKLIGYCSESDNRLLVYEFMPKG 112 (349)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~ 112 (349)
-.+.+++.+....+..++|+||++.+
T Consensus 72 ~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 72 IRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp SBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCCeEEEEEeecCCceEEEEeecCC
Confidence 55778888887777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.047 Score=50.81 Aligned_cols=74 Identities=11% Similarity=0.071 Sum_probs=46.1
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-------hchHHHHHHHHHHhccC---CCcccceee
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-------QGHKEWLTEVIYLGQLR---HENLVKLIG 94 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~~i~~~~~ 94 (349)
..+.||.|....||+.. .. +..++||.-..... -...+...|...|+.+. ...+.+++.
T Consensus 36 ~~~eiggGn~N~VyrV~---------~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~ 104 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVV---------SS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYH 104 (418)
T ss_pred eEEEcCCCceeeEEEEE---------cC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEE
Confidence 45678999999999983 21 34588996542111 12233344566666553 235666776
Q ss_pred EEecCCceEEEEEeCCC
Q 018891 95 YCSESDNRLLVYEFMPK 111 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~ 111 (349)
+.. +..+++||++++
T Consensus 105 ~de--d~~vlvME~L~~ 119 (418)
T PLN02756 105 FDR--TMALIGMRYLEP 119 (418)
T ss_pred ECC--CCCEEEEeecCC
Confidence 665 446789999976
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0046 Score=58.20 Aligned_cols=168 Identities=23% Similarity=0.332 Sum_probs=98.6
Q ss_pred chHHHHHHHHHHhccCCCcccceeeEEecC-CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC
Q 018891 70 GHKEWLTEVIYLGQLRHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148 (349)
Q Consensus 70 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~ 148 (349)
....+......++.+.|++...++++-... ....+|+|++ +.+|.+.+..+. +-. .++. -|
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~---~s~~---------~~--- 86 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKD---ESLL---------AH--- 86 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cch---hhhc---------cc---
Confidence 344566778899999999999999887543 4577899999 779999885542 111 1110 22
Q ss_pred CCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhC
Q 018891 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228 (349)
Q Consensus 149 ~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg 228 (349)
++.|- |++ +.+| -.+.. | |- ...+++|||++|.++.++.-|
T Consensus 87 -~~~~~-----~~~-------~~td-~~~t~------------------~--~~-----~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 87 -GVLHL-----NII-------YITD-HFLTK------------------Y--PS-----PIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred -cccee-----hhh-------hccc-ccccc------------------C--CC-----CCCcchhhhhHHHHHHHHHHh
Confidence 22222 222 2222 00100 0 10 011499999999999999998
Q ss_pred CccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 229 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
...+......+....+.++....... ....... ..-..++.....+..+|+-..|..||...++.+
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~d~~~----~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTDDQEL----LSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccCchhH----HHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 87776555544444444322211111 1100000 112345667888999999999999987666553
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.054 Score=50.34 Aligned_cols=29 Identities=24% Similarity=0.182 Sum_probs=24.5
Q ss_pred CCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 149 ~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..+||.|+.+.||+.+++ .+.++||..+.
T Consensus 227 ~VfCHNDL~~gNIL~~~~-~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ-GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC-CEEEEEecccc
Confidence 567999999999997654 69999998775
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.016 Score=53.27 Aligned_cols=61 Identities=20% Similarity=0.072 Sum_probs=43.1
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
...++-+|..|.++..++.. ...++.....++.--..|+..+-- -.+++|.|++|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~-vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLI-VDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHH-hhcceecccCCCcEEEE
Confidence 44567778889899998854 344555555665555566554432 56899999999999994
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.068 Score=45.45 Aligned_cols=137 Identities=16% Similarity=0.146 Sum_probs=79.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHh---ccCCCcccceeeEEec
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLG---QLRHENLVKLIGYCSE 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~---~l~h~~i~~~~~~~~~ 98 (349)
+.+..+.+.-|.--..|...+. ...+.+|+-..+. ...+..|+.=|+ +-+.-.+.+++.....
T Consensus 17 ~i~er~~v~gG~inea~~v~dg-----------~~~~FvK~n~~~~---~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~ 82 (286)
T COG3001 17 EIKEREEVSGGDINEAWRLRDG-----------TDPFFVKCNQREQ---LSMFTAEADGLELLARSNTITVPKVIAVGAS 82 (286)
T ss_pred hhhcccccCCccccceeEeecC-----------CcceEEEecchhh---HHHHHHHHHHHHHHHhcCCccccceEEecCC
Confidence 3344445555555555554322 4568888654432 234445554444 4455667788888888
Q ss_pred CCceEEEEEeCCCCChH---HH-----Hh---c--------------------------------------------cCC
Q 018891 99 SDNRLLVYEFMPKGSLE---NH-----LF---R--------------------------------------------SVQ 123 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~---~~-----l~---~--------------------------------------------~~~ 123 (349)
..+.|+|++|++-+++. .+ +. . .++
T Consensus 83 ~~~sylVle~L~~~~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~FfaeqRig~qlqlar~r 162 (286)
T COG3001 83 RDHSYLVLEYLPTGPLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAEQRIGWQLQLARER 162 (286)
T ss_pred CCeeEEEEeeccCCCCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHHhhhhHHHHHHHHh
Confidence 89999999999876554 11 10 0 001
Q ss_pred CCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 124 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 124 ~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
.++...+-.++..|.+-|+- |+.+...+||||-..|.....+| ..+.|=
T Consensus 163 g~~f~did~~~~~v~elL~~-hqpqPsLlHGDLW~gN~a~~~~G-Pv~fDP 211 (286)
T COG3001 163 GLTFGDIDAIVEKIQELLAD-HQPQPSLLHGDLWSGNCAFGKDG-PVIFDP 211 (286)
T ss_pred CCCccCHHHHHHHHHHHHhc-CCCCcceeecccccccccccCCC-Ceeecc
Confidence 12333333333333333322 43357799999999999999998 666553
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.083 Score=50.11 Aligned_cols=84 Identities=12% Similarity=0.029 Sum_probs=45.5
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCccc-ceeeEEecCCceE
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLV-KLIGYCSESDNRL 103 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~ 103 (349)
-.+.|..|-.-.+|++...+... ......+..|++++.......-. ...+|..+++.+...++- ++++.+. -+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~-~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETA-NNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GG 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCCC-ccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CC
Confidence 45566677777888886432110 00112256788998755432222 234566666666433333 3344442 24
Q ss_pred EEEEeCCCCCh
Q 018891 104 LVYEFMPKGSL 114 (349)
Q Consensus 104 lv~e~~~~~~L 114 (349)
.|.+|++|.+|
T Consensus 183 ~I~efi~g~~l 193 (442)
T PTZ00296 183 RIEEWLYGDPL 193 (442)
T ss_pred EEEEeeCCccC
Confidence 68899987644
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.001 Score=69.73 Aligned_cols=156 Identities=14% Similarity=0.053 Sum_probs=109.6
Q ss_pred HHHHHHHhccCCCcccceeeEEec--CCceEEEEEeCCCCChHHHHhccC---CCCChHHHHHHHHHHHHHHHHHhcC--
Q 018891 75 LTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRSV---QPISWPTRVKIAIDVARGLSFLHGL-- 147 (349)
Q Consensus 75 ~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~ql~~~l~~lH~~-- 147 (349)
..|...++...|+++.....-... +...+.+++++.+|.+.+.+.++. ..++..-+.....+.+....-+|++
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344445556688888777665532 335578889999999999987643 3344444444444445555665532
Q ss_pred -CCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHH
Q 018891 148 -DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 226 (349)
Q Consensus 148 -~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~ll 226 (349)
+.-.+|.++++-|.+|..+..++++++|+.... .......+...+++.|+.|++...-.++.++|+|..|+.+|...
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 333689999999999999999999999998721 11122223356677888888887778888899999999999998
Q ss_pred hCCccC
Q 018891 227 SGRRAL 232 (349)
Q Consensus 227 tg~~pf 232 (349)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887766
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.3 Score=51.46 Aligned_cols=32 Identities=38% Similarity=0.450 Sum_probs=26.9
Q ss_pred CCCeeeccCCCCcEEEcCCC--cEE-Eeccccccc
Q 018891 148 DANVIYRDLKASNVLLDSNF--NAK-LSDFGLARD 179 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~--~v~-l~Dfg~~~~ 179 (349)
..+++|+|+++.||+++.++ .+. |+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 46799999999999998875 454 999998864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.7 Score=42.05 Aligned_cols=29 Identities=21% Similarity=0.253 Sum_probs=24.4
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..+++|+|+.+.||+++ + .+.++||+.+.
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 45789999999999995 4 57899999775
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.89 E-value=0.049 Score=48.02 Aligned_cols=48 Identities=25% Similarity=0.156 Sum_probs=35.4
Q ss_pred HHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 132 ~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
..+..+-.++.-.+.-..-+||+|+.|+|++.++.+.++|+||..+..
T Consensus 136 ~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 136 KKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344445555555551013589999999999999989999999998853
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.023 Score=46.89 Aligned_cols=29 Identities=21% Similarity=0.242 Sum_probs=25.4
Q ss_pred CCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 149 ~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.-.+|+|+.|.|+++++++ ++++||+.+.
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 3468999999999998887 8899999885
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 349 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-49 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-47 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-45 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-23 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-22 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-22 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-22 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-22 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-22 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-22 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-22 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-22 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-21 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-21 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-21 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-21 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-20 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-20 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-19 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-19 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-19 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-19 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-19 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-19 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-19 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-19 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-18 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-18 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-18 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-18 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-18 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-18 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-18 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-18 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-18 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-17 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-17 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-17 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-16 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-14 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-13 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-11 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-10 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-170
Identities = 111/305 (36%), Positives = 171/305 (56%), Gaps = 30/305 (9%)
Query: 17 KIATKNF------CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA----E 66
K T NF +GEGGFG V+KG+++ VA+K+L A
Sbjct: 21 KNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----------NTTVAVKKLAAMVDIT 69
Query: 67 SFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RSVQP 124
+ + +++ E+ + + +HENLV+L+G+ S+ D+ LVY +MP GSL + L P
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 125 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184
+SW R KIA A G++FLH + + I+RD+K++N+LLD F AK+SDFGLAR
Sbjct: 130 LSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 185 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244
T +++RIVGT Y APE + G +TPKSD+YSFGVVLLE+++G A+DE R Q L
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE---PQLL 243
Query: 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
++ + + + + +D ++ +A+ +V QCLH RP + V L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 305 QLHTS 309
++ S
Sbjct: 303 EMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 443 bits (1143), Expect = e-158
Identities = 116/291 (39%), Positives = 167/291 (57%), Gaps = 17/291 (5%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
+ AT NF +L+G G FG V+KG + G VA+KR ES QG +E+ T
Sbjct: 35 EEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFET 84
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKI 133
E+ L RH +LV LIG+C E + +L+Y++M G+L+ HL+ S +SW R++I
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
I ARGL +LH +I+RD+K+ N+LLD NF K++DFG+++ G D TH+ST +
Sbjct: 145 CIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK 202
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT GY PEY G LT KSDVYSFGVVL E+L R A+ + L EWA
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHN 261
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
+ ++ +I+D L + + + ++CL + ++RPSM DVL LE
Sbjct: 262 -NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 395 bits (1016), Expect = e-138
Identities = 115/294 (39%), Positives = 175/294 (59%), Gaps = 18/294 (6%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWL 75
++A+ NF + +LG GGFG V+KG + G +VA+KRLK E QG + ++
Sbjct: 26 QVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQ 75
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQ---PISWPTRVK 132
TEV + H NL++L G+C RLLVY +M GS+ + L + P+ WP R +
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 133 IAIDVARGLSFLH-GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
IA+ ARGL++LH D +I+RD+KA+N+LLD F A + DFGLA+ D THV+T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA 194
Query: 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDR-GGLAEQTLVEWADP 250
+ GT G+ APEY++TG + K+DV+ +GV+LLEL++G+RA D R + L++W
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
L++ +++ ++D L G Y +E + + V L C P RP M +V+ LE
Sbjct: 255 LLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 2e-84
Identities = 83/319 (26%), Positives = 128/319 (40%), Gaps = 41/319 (12%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL-- 75
+ + G FGCV+K + VA+K + Q W
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDKQ---SWQNE 66
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDN----RLLVYEFMPKGSLENHLFRSVQPISWPTRV 131
EV L ++HEN+++ IG + L+ F KGSL + L +SW
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELC 124
Query: 132 KIAIDVARGLSFLH--------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183
IA +ARGL++LH G + +RD+K+ NVLL +N A ++DFGLA G
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 184 DNTHVSTRIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLSGRRALDEDRGG 238
+ + VGTR Y APE + + D+Y+ G+VL EL S A D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 239 --LAEQTLVEWADPFLRDSRR--VLRIMDTRLGGQYSKKEA-QAVAAVVLQCLHMDPKNR 293
L + + P L D + V + L + K + + +C D + R
Sbjct: 245 YMLPFEEEI-GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 294 PSMVDVLTSLEQLHTSKDM 312
S V + Q+ ++
Sbjct: 304 LSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 5e-76
Identities = 77/344 (22%), Positives = 132/344 (38%), Gaps = 52/344 (15%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE 77
+ N L+G G +G V+KG +D VA+K + Q ++ E
Sbjct: 10 LDLDNLKLLELIGRGRYGAVYKGSLD-----------ERPVAVKVFSFANRQ---NFINE 55
Query: 78 V-IY-LGQLRHENLVKLIGYCSE-----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTR 130
IY + + H+N+ + I LLV E+ P GSL +L W +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSS 113
Query: 131 VKIAIDVARGLSFLH-------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----- 178
++A V RGL++LH + +RDL + NVL+ ++ +SDFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 179 -DGPTGDNTHVSTRIVGTRGYAAPEY-------VATGHLTPKSDVYSFGVVLLELLSGRR 230
G+ + + VGT Y APE + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 231 ALDEDRGG----LAEQTLVEWADPFLRDSRRVLRIMDTRL----GGQYSKKEAQAVAAVV 282
L +A QT V P D + ++ R + + +++ +
Sbjct: 234 DLFPGESVPEYQMAFQTEV-GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 283 LQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAKLHHHHH 326
C D + R + + +L + ++ P HHHHH
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHHH 336
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-69
Identities = 79/310 (25%), Positives = 126/310 (40%), Gaps = 41/310 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG K T +G V+ +K L + + +L EV + L H N
Sbjct: 18 LGKGCFGQAIKV---------THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
++K IG + + E++ G+L + W RV A D+A G+++LH +
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM- 127
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLAR------------DGPTGDNTHVSTRIVGTR 196
N+I+RDL + N L+ N N ++DFGLAR + +VG
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256
+ APE + K DV+SFG+VL E++ A D L +R
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA---DPDYLPRTMDFGLN---VRGFL 240
Query: 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL--HTSKDMPR 314
+ + + ++C +DP+ RPS V + LE L H + +P
Sbjct: 241 DRYCPPNC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
Query: 315 TPPPAKLHHH 324
P +L
Sbjct: 291 GPQLEQLDRG 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 6e-65
Identities = 79/310 (25%), Positives = 132/310 (42%), Gaps = 50/310 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG V K W VAIK++++ES + K ++ E+ L ++ H
Sbjct: 16 VGRGAFGVVCKAKW------------RAKDVAIKQIESESER--KAFIVELRQLSRVNHP 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLEN--HLFRSVQPISWPTRVKIAIDVARGLSFLH 145
N+VKL G C + LV E+ GSL N H + + + + ++G+++LH
Sbjct: 62 NIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 146 GLDAN-VIYRDLKASNVLLDSNFN-AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
+ +I+RDLK N+LL + K+ DFG A D T G+ + APE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEV 174
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
+ + K DV+S+G++L E+++ R+ PF RIM
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRK-------------------PFDEIGGPAFRIMW 215
Query: 264 TRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAK 320
G K + + +++ +C DP RPSM +++ + L + P P +
Sbjct: 216 AVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL--MRYFPGADEPLQ 273
Query: 321 LHHHHHHHNH 330
H
Sbjct: 274 YPCQHSLPPG 283
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 7e-65
Identities = 85/296 (28%), Positives = 137/296 (46%), Gaps = 42/296 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G G FG V + W G VA+K L + F E+L EV + +LR
Sbjct: 45 IGAGSFGTVHRAEW------------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR 92
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR--SVQPISWPTRVKIAIDVARGLSF 143
H N+V +G ++ N +V E++ +GSL L + + + + R+ +A DVA+G+++
Sbjct: 93 HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH + +++R+LK+ N+L+D + K+ DFGL+R + + S GT + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEV 210
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRDSRRVLRIM 262
+ KSDVYSFGV+L EL + + W + + V
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQ---------------QPWGNLNPAQVVAAVGF-K 254
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPP 318
RL + + VAA++ C +P RPS ++ L L S PPP
Sbjct: 255 CKRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA----VPPP 304
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 6e-64
Identities = 76/313 (24%), Positives = 127/313 (40%), Gaps = 87/313 (27%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-------KEWLTEVIY 80
+G+GGFG V KG + + VVAIK L +G +E+ EV
Sbjct: 27 IGKGGFGLVHKGRLVKDKS----------VVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARG 140
+ L H N+VKL G +V EF+P G L + L PI W ++++ +D+A G
Sbjct: 77 MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 141 LSFLHGLDANVIYRDLKASNVLLDS-----NFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
+ ++ + +++RDL++ N+ L S AK++DFGL++ + H + ++G
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGN 189
Query: 196 RGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
+ APE + T K+D YSF ++L +L+G PF
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-------------------PF-- 228
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVL--------------------QCLHMDPKNR 293
+YS + + + + C DPK R
Sbjct: 229 --------------DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
Query: 294 PSMVDVLTSLEQL 306
P ++ L +L
Sbjct: 275 PHFSYIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-62
Identities = 72/284 (25%), Positives = 124/284 (43%), Gaps = 35/284 (12%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G G FG V+KG W VA+K L + + + EV L + R
Sbjct: 32 IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N++ +GY + +V ++ SL +HL S + IA ARG+ +LH
Sbjct: 79 HVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE--- 202
++I+RDLK++N+ L + K+ DFGLA + +H ++ G+ + APE
Sbjct: 138 AK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
+ + +SDVY+FG+VL EL++G+ + + + R S
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIEM--VGRGSLSPDLS- 248
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ + + ++ +CL RPS +L +E+L
Sbjct: 249 ------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 5e-61
Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 43/310 (13%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEV-IY-LGQL 84
+G+G +G V+ G W + VA+K W E IY +
Sbjct: 44 QIGKGRYGEVWMGKWRGEK------------VAVKVFFTTEEA---SWFRETEIYQTVLM 88
Query: 85 RHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARG 140
RHEN++ I + L+ ++ GSL ++L + + +K+A G
Sbjct: 89 RHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSG 146
Query: 141 LSFLHGLDA------NVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 192
L LH + +RDLK+ N+L+ N ++D GLA T +
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 193 VGTRGYAAPEYVATGHLTP-------KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245
VGT+ Y PE V L +D+YSFG++L E+ + +
Sbjct: 207 VGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 246 EWADPFLRDSRRVLRIMDTR--LGGQYSKKEA-QAVAAVVLQCLHMDPKNRPSMVDVLTS 302
+DP D R ++ I R ++S E + + ++ +C +P +R + + V +
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325
Query: 303 LEQLHTSKDM 312
L ++ S+D+
Sbjct: 326 LAKMSESQDI 335
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 8e-60
Identities = 58/293 (19%), Positives = 111/293 (37%), Gaps = 48/293 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G+G FG V+ G W + VAI+ + E K + EV+ Q R
Sbjct: 41 IGKGRFGQVYHGRWHGE-------------VAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
HEN+V +G C + ++ +L + + + + +IA ++ +G+ +LH
Sbjct: 88 HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTRGYAAPE 202
++++DLK+ NV D N ++DFGL G G + APE
Sbjct: 148 AK--GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 203 ---------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
+ SDV++ G + EL + + ++
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK----TQPAEAIIWQMG---T 257
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ L + + ++ ++L C + + RP+ ++ LE+L
Sbjct: 258 GMKPNLSQIGM----------GKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-59
Identities = 80/293 (27%), Positives = 124/293 (42%), Gaps = 51/293 (17%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH----KEWLTEVIYLGQ 83
+G GGFG V++ WI VA+K + + + + E
Sbjct: 15 IGIGGFGKVYRAFWIGDE------------VAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
L+H N++ L G C + N LV EF G L L + I V A+ +ARG+++
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNY 120
Query: 144 LHGLD-ANVIYRDLKASNVLLD--------SNFNAKLSDFGLARDGPTGDNTHVSTRIVG 194
LH +I+RDLK+SN+L+ SN K++DFGLAR+ T + G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSA-AG 176
Query: 195 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLR 253
+ APE + + SDV+S+GV+L ELL+G V + L
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE---------------VPFRGIDGLA 221
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ V L + A ++ C + DP +RPS ++L L +
Sbjct: 222 VAYGVAM-NKLAL--PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 4e-59
Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
L E G ++KG W G + +K LK + +++ E L
Sbjct: 18 LNENHSGELWKGRW------------QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 86 HENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRSVQ-PISWPTRVKIAIDVARGLS 142
H N++ ++G C + + L+ +MP GSL N L + VK A+D+ARG++
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
FLH L+ + L + +V++D + A++S + + S + + APE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPE 178
Query: 203 ---YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259
+D++SF V+L EL++ A+ + +E + R
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVP-------FADLSNMEIGMKVALEGLR-P 230
Query: 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
I + V+ ++ C++ DP RP ++ LE++
Sbjct: 231 TI---------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-59
Identities = 71/308 (23%), Positives = 130/308 (42%), Gaps = 51/308 (16%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEV-IY-LGQL 84
+G+G +G V++G W +N VA+K + + W E +Y L
Sbjct: 15 CVGKGRYGEVWRGSWQGEN------------VAVKIFSSRDEK---SWFRETELYNTVML 59
Query: 85 RHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARG 140
RHEN++ I S + L+ + GSL ++L + + + ++I + +A G
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASG 117
Query: 141 LSFLHGLDA------NVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 192
L+ LH + +RDLK+ N+L+ N ++D GLA T +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 193 VGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246
VGT+ Y APE V + D+++FG+VL E+ G+ E
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR-----MVSNGIVEDYKPP 232
Query: 247 WAD-----PFLRDSRRVLRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD 298
+ D P D R+V+ + R +S ++A ++ +C + +P R + +
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALR 292
Query: 299 VLTSLEQL 306
+ +L ++
Sbjct: 293 IKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 7e-58
Identities = 72/309 (23%), Positives = 130/309 (42%), Gaps = 41/309 (13%)
Query: 28 LLGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEV-IY-LGQL 84
+G+G FG V++G W + VA+K + + W E IY L
Sbjct: 49 SIGKGRFGEVWRGKWRGEE------------VAVKIFSSREER---SWFREAEIYQTVML 93
Query: 85 RHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARG 140
RHEN++ I ++ + LV ++ GSL ++L R ++ +K+A+ A G
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASG 151
Query: 141 LSFLHGLDA------NVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 192
L+ LH + +RDLK+ N+L+ N ++D GLA D T
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211
Query: 193 VGTRGYAAPE----YVATGHL--TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246
VGT+ Y APE + H ++D+Y+ G+V E+ +
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271
Query: 247 WADPFLRDSRRVLRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303
+DP + + R+V+ R S + + +A ++ +C + + R + + + +L
Sbjct: 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331
Query: 304 EQLHTSKDM 312
QL + +
Sbjct: 332 SQLSQQEGI 340
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-51
Identities = 70/294 (23%), Positives = 132/294 (44%), Gaps = 32/294 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V + P + +G VVA+K+L+ + + +++ E+ L L+H+N
Sbjct: 18 LGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 89 LVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+VK G C + R L+ E++P GSL ++L + + I ++ + +G+ +L
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG- 131
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YAAPEY 203
I+RDL N+L+++ K+ DFGL + P + APE
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE--PGESPIFWYAPES 188
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIM 262
+ + SDV+SFGVVL EL + ++ + AE + D + ++ ++
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 263 DT--RLGGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
RL + ++ +C + + RPS D+ ++Q+ +
Sbjct: 246 KNNGRL-------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-51
Identities = 81/289 (28%), Positives = 122/289 (42%), Gaps = 28/289 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRHE 87
LGEG FG V + P +G VA+K LK ES H + E+ L L HE
Sbjct: 29 LGEGHFGKVELC-----RYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
N+VK G C+E L+ EF+P GSL+ +L ++ I+ ++K A+ + +G+ +L
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 202
++RDL A NVL++S K+ DFGL + T + + APE
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD--DRDSPVFWYAPE 199
Query: 203 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261
+ SDV+SFGV L ELL+ L R++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT----VTRLVNT 255
Query: 262 MDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ RL V ++ +C P NR S +++ E L
Sbjct: 256 LKEGKRL----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-51
Identities = 76/308 (24%), Positives = 135/308 (43%), Gaps = 27/308 (8%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V D P +G +VA+K+L+ +++ E+ L L +
Sbjct: 31 LGKGNFGSVELCRYD-----PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85
Query: 89 LVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+VK G + LV E++P G L + L R + + + + +G+ +L
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG- 144
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YAAPEY 203
++RDL A N+L++S + K++DFGLA+ P + +V + + APE
Sbjct: 145 -SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE--PGQSPIFWYAPES 201
Query: 204 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
++ + +SDV+SFGVVL EL + ++ AE + + + R+L ++
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 263 DTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTP---- 316
+ G + A V ++ C P++RPS + L+ L + T
Sbjct: 258 EE--GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTA 315
Query: 317 PPAKLHHH 324
P HH
Sbjct: 316 HPEGKHHS 323
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-51
Identities = 71/293 (24%), Positives = 135/293 (46%), Gaps = 30/293 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V + P + +G VVA+K+L+ + + +++ E+ L L+H+N
Sbjct: 49 LGKGNFGSVEMC-----RYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 89 LVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+VK G C + R L+ E++P GSL ++L + + I ++ + +G+ +L
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG- 162
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG-----YAAP 201
I+RDL N+L+++ K+ DFGL + P + G + AP
Sbjct: 163 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAP 217
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLR 260
E + + SDV+SFGVVL EL + ++ + AE + D + ++
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 261 IMDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
++ RL + + + ++ +C + + RPS D+ ++Q+
Sbjct: 275 LLKNNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 7e-51
Identities = 75/317 (23%), Positives = 129/317 (40%), Gaps = 61/317 (19%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG+G F +FKG + + V +K L + + + +L H+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+LV G C D +LV EF+ GSL+ +L ++ I+ ++++A +A + FL
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE-- 130
Query: 148 DANVIYRDLKASNVLLDSNFN--------AKLSDFGLARDGPTGDNTHVSTRIVGTRGY- 198
+ +I+ ++ A N+LL + KLSD G++ ++
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDILQ 178
Query: 199 -----AAPEYVATG-HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 251
PE + +L +D +SFG L E+ S G + P
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK-------------------PL 219
Query: 252 L-RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310
DS+R L+ + Q +A +A ++ C+ +P +RPS ++ L L T
Sbjct: 220 SALDSQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277
Query: 311 DMPRTPPPAKLHHHHHH 327
+PR HHHHHH
Sbjct: 278 LVPR-----GSHHHHHH 289
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-50
Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 47/289 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
+G G FG VF G NT +VA+K + ++L E L Q H
Sbjct: 122 IGRGNFGEVFSGRLRADNT----------LVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N+V+LIG C++ +V E + G L + T +++ D A G+ +L
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY----AAPE 202
I+RDL A N L+ K+SDFG++R+ G G R APE
Sbjct: 231 -SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQVPVKWTAPE 285
Query: 203 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLR 260
+ G + +SDV+SFG++L E S G P+ S ++
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFSLGAS-------------------PYPNLSNQQTRE 326
Query: 261 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
++ GG+ E AV ++ QC +P RPS + L+ +
Sbjct: 327 FVEK--GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-50
Identities = 85/291 (29%), Positives = 131/291 (45%), Gaps = 28/291 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
LGEG FG V D PT G+G +VA+K LKA+ Q W E+ L L HE
Sbjct: 39 LGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 88 NLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
+++K G C ++ LV E++P GSL ++L R I + A + G+++LH
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLH 151
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG-----YAA 200
+ I+RDL A NVLLD++ K+ DFGLA+ P G + V G + A
Sbjct: 152 AQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYA 205
Query: 201 PEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260
PE + SDV+SFGV L ELL+ + E + + +L
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265
Query: 261 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
G + + + V ++ C + RP+ +++ L+ +H
Sbjct: 266 R-----GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-49
Identities = 79/309 (25%), Positives = 131/309 (42%), Gaps = 48/309 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EWLTEVIYLGQLRH 86
LG G FG V +G + I VAIK LK + + E + E + QL +
Sbjct: 18 LGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+V+LIG C + +LV E G L L + I ++ V+ G+ +L
Sbjct: 70 PYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE- 127
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 203
+ N ++RDL A NVLL + AK+SDFGL++ D+ + + + + APE
Sbjct: 128 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPEC 184
Query: 204 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 261
+ + +SDV+S+GV + E LS G++ P+ + V+
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQK-------------------PYKKMKGPEVMAF 225
Query: 262 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 319
++ G + + A++ C ++RP + V + + S
Sbjct: 226 IEQ--GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS-----LASKV 278
Query: 320 KLHHHHHHH 328
+ HHHHHHH
Sbjct: 279 EGHHHHHHH 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-48
Identities = 68/311 (21%), Positives = 135/311 (43%), Gaps = 44/311 (14%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF 68
P+ +++ + F +LG G FG V+KG + P I VAIK L+ +
Sbjct: 3 APNQALLRILKETEFKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATS 57
Query: 69 QGHK-EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISW 127
E L E + + + ++ +L+G C L+ + MP G L +++ I
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS 116
Query: 128 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 187
+ + +A+G+++L D +++RDL A NVL+ + + K++DFGLA+ + +
Sbjct: 117 QYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 188 VSTRIVGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 243
+ G + + A E + T +SDV+S+GV + EL++ G +
Sbjct: 175 HAE---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------- 218
Query: 244 LVEWADPFL-RDSRRVLRIMDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVD 298
P+ + + I++ RL + V ++ +C +D +RP +
Sbjct: 219 ------PYDGIPASEISSILEKGERL----PQPPICTIDVYMIMRKCWMIDADSRPKFRE 268
Query: 299 VLTSLEQLHTS 309
++ ++
Sbjct: 269 LIIEFSKMARD 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-48
Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 47/294 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FGCV+ G G I A+K L ++LTE I + H
Sbjct: 33 IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 88 NLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N++ L+G C S+ L+V +M G L N + + + + VA+G+ +L
Sbjct: 87 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA- 145
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA------A 200
++RDL A N +LD F K++DFGLARD + + G A
Sbjct: 146 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 200
Query: 201 PEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWADPFLRDS 255
E + T T KSDV+SFGV+L EL++ RG + + +L
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITV----YLLQG 248
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
RR+L+ + V+L+C H + RPS ++++ + + ++
Sbjct: 249 RRLLQPEYCP----------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-47
Identities = 79/308 (25%), Positives = 132/308 (42%), Gaps = 50/308 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRH 86
LG G FG V KG+ VA+K LK E+ E L E + QL +
Sbjct: 25 LGSGNFGTVKKGYY-------QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 77
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+V++IG C ++ +LV E G L +L + + + +++ V+ G+ +L
Sbjct: 78 PYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE- 134
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 203
++N ++RDL A NVLL + AK+SDFGL++ +N + + + + APE
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPVKWYAPEC 191
Query: 204 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 261
+ + KSDV+SFGV++ E S G++ P+ V +
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK-------------------PYRGMKGSEVTAM 232
Query: 262 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 319
++ G + + + ++ C D +NRP V L +
Sbjct: 233 LEK--GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD-------VVN 283
Query: 320 KLHHHHHH 327
+ HHHHHH
Sbjct: 284 EGHHHHHH 291
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-46
Identities = 82/329 (24%), Positives = 134/329 (40%), Gaps = 66/329 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AESFQGHKEWLTEVIYLGQLRH 86
LG+G FG V + + GS + VA+K LK + +E+L E + + H
Sbjct: 31 LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 87 ENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRSVQPISWPTR------VKIA 134
++ KL+G S + +++ FM G L L + + P V+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTLVRFM 143
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 194
+D+A G+ +L N I+RDL A N +L + ++DFGL+R +GD G
Sbjct: 144 VDIACGMEYLS--SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR-----QG 196
Query: 195 TRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTL 244
+ A E +A T SDV++FGV + E+++ RG G+ +
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTPYAGIENAEI 248
Query: 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
+L R+ + + + V ++ QC DPK RPS + LE
Sbjct: 249 YN----YLIGGNRLKQPPECM----------EEVYDLMYQCWSADPKQRPSFTCLRMELE 294
Query: 305 QLHTSKDMPRTPPPA------KLHHHHHH 327
+ + T + HHHHHH
Sbjct: 295 NILGHLSVLSTSQDPLYINIERAHHHHHH 323
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 47/289 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG V G W++++ VAIK ++ E ++++ E + +L H
Sbjct: 16 IGSGQFGLVHLGYWLNKDK-----------VAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
LV+L G C E LV EFM G L ++L + T + + +DV G+++L
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE-- 121
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
+A VI+RDL A N L+ N K+SDFG+ R D+ + T GT+ +A+PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVF 177
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIM 262
+ + KSDV+SFGV++ E+ S G+ P+ + V+ +
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKI-------------------PYENRSNSEVVEDI 218
Query: 263 DTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
T G + K V ++ C P++RP+ +L L ++ S
Sbjct: 219 ST--GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 67/311 (21%), Positives = 136/311 (43%), Gaps = 40/311 (12%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF 68
P+ +++ + F +LG G FG V+KG + P I VAIK L+ +
Sbjct: 3 APNQALLRILKETEFKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATS 57
Query: 69 QGHK-EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISW 127
E L E + + + ++ +L+G C L+ + MP G L +++ I
Sbjct: 58 PKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS 116
Query: 128 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 187
+ + +A+G+++L D +++RDL A NVL+ + + K++DFGLA+ + +
Sbjct: 117 QYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174
Query: 188 VSTRIVGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 243
+ G + + A E + T +SDV+S+GV + EL++ G +
Sbjct: 175 HAE---GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK------------- 218
Query: 244 LVEWADPFL-RDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVL 300
P+ + + I++ G + + V ++++C +D +RP +++
Sbjct: 219 ------PYDGIPASEISSILEK--GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELI 270
Query: 301 TSLEQLHTSKD 311
++
Sbjct: 271 IEFSKMARDPQ 281
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-46
Identities = 79/298 (26%), Positives = 140/298 (46%), Gaps = 38/298 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FG V+KG + + VAIK LKA + + ++L E +GQ H
Sbjct: 52 IGAGEFGEVYKG-----MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+++L G S+ +++ E+M G+L+ L S V + +A G+ +L
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-- 164
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
+ N ++RDL A N+L++SN K+SDFGL+R D+ + G + + APE +
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIM 262
+ T SDV+SFG+V+ E+++ G R P+ S V++ +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER-------------------PYWELSNHEVMKAI 263
Query: 263 DTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPP 318
+ G + A+ +++QC + RP D+++ L++L + D +T
Sbjct: 264 ND--GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 319
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-46
Identities = 82/299 (27%), Positives = 132/299 (44%), Gaps = 39/299 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G G V G + VAIK LKA + + +++L+E +GQ H
Sbjct: 57 IGSGDSGEVCYGR------LRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP 110
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+++L G + ++V E+M GSL+ L + V + V G+ +L
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS-- 168
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
D ++RDL A NVL+DSN K+SDFGL+R + +T G + + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPIRWTAPEAI 226
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIM 262
A + SDV+SFGVV+ E+L+ G R P+ +R V+ +
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGER-------------------PYWNMTNRDVISSV 267
Query: 263 DTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 319
+ G + A+ ++L C H D RP +++ L+ L S + R
Sbjct: 268 EE--GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATV 324
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 4e-46
Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 47/294 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FGCV+ G G I A+K L ++LTE I + H
Sbjct: 97 IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 88 NLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N++ L+G C S+ L+V +M G L N + + + + VA+G+ FL
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA- 209
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG------TRGYAA 200
++RDL A N +LD F K++DFGLARD + V + A
Sbjct: 210 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----A 264
Query: 201 PEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWADPFLRDS 255
E + T T KSDV+SFGV+L EL++ RG + + +L
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFDITV----YLLQG 312
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
RR+L+ + V+L+C H + RPS ++++ + + ++
Sbjct: 313 RRLLQPEYCP----------DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-46
Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 43/292 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLTEVIYLGQL 84
LG+G FG V +G W + G + VA+K LK + + +++ EV + L
Sbjct: 26 LGDGSFGVVRRGEWDAPS-------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
H NL++L G +V E P GSL + L + T + A+ VA G+ +L
Sbjct: 79 DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAP 201
I+RDL A N+LL + K+ DFGL R P D+ +V + + AP
Sbjct: 138 E--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVL 259
E + T + SD + FGV L E+ + G+ P++ + ++L
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQE-------------------PWIGLNGSQIL 234
Query: 260 RIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
+D + G + + E Q + V++QC P++RP+ V + L + +
Sbjct: 235 HKID-KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-45
Identities = 70/286 (24%), Positives = 129/286 (45%), Gaps = 34/286 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
LG G FG V KG + P I V IK ++ +S Q + ++ +G L H
Sbjct: 21 LGSGVFGTVHKG-----VWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
++V+L+G C S + LV +++P GSL +H+ + + + + +A+G+ +L
Sbjct: 76 HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-- 132
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
+ +++R+L A NVLL S +++DFG+A P D + + + + A E +
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS---EAKTPIKWMALESI 189
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
G T +SDV+S+GV + EL++ G GL + + L R+ +
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYA----GLRLAEVPD----LLEKGERLAQPQI 241
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
V V+++C +D RP+ ++ ++
Sbjct: 242 CT----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-45
Identities = 72/290 (24%), Positives = 136/290 (46%), Gaps = 44/290 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LGEG FG V++G + + G I VA+K K + + +++++E + + L H
Sbjct: 20 LGEGFFGEVYEGVYTNHK-------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
++VKLIG E + ++ E P G L ++L R+ + T V ++ + + +++L
Sbjct: 73 PHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 130
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 203
N ++RD+ N+L+ S KL DFGL+R D + TR + +PE
Sbjct: 131 -SINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS--VTRLPIKWMSPES 185
Query: 204 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL-RDSRRVLRI 261
+ T SDV+ F V + E+LS G++ PF +++ V+ +
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ-------------------PFFWLENKDVIGV 226
Query: 262 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
++ G + K + + ++ +C DP +RP +++ SL ++
Sbjct: 227 LEK--GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 78/294 (26%), Positives = 124/294 (42%), Gaps = 47/294 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V+ G + + I AIK L Q + +L E + + L H
Sbjct: 29 IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 88 NLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N++ LIG + + +M G L + + + + + VARG+ +L
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA- 141
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG------TRGYAA 200
+ ++RDL A N +LD +F K++DFGLARD + V T A
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----A 196
Query: 201 PEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEWADPFLRDS 255
E + T T KSDV+SFGV+L ELL+ RG + L FL
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT--------RGAPPYRHIDPFDLTH----FLAQG 244
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
RR+ + ++ V+ QC DP RP+ ++ +EQ+ ++
Sbjct: 245 RRLPQPEYCP----------DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 80/296 (27%), Positives = 138/296 (46%), Gaps = 33/296 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+G G FG V G I VAIK LK + + +++L E +GQ H
Sbjct: 53 VGAGEFGEVCSGR------LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+++L G ++S ++V E+M GSL++ L + + V + +A G+ +L
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS-- 164
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
D ++RDL A N+L++SN K+SDFGL R D+ + G + + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
A T SDV+S+G+VL E++S G R ++ Q +++ + + R+ MD
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY----WEMSNQDVIK----AVDEGYRLPPPMD 274
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 319
A+ ++L C D NRP +++ L++L + + A
Sbjct: 275 C----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSA 320
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 77/303 (25%), Positives = 135/303 (44%), Gaps = 57/303 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRH 86
LGEG FG V +G + G+ + VA+K +K + S + +E+L+E + H
Sbjct: 42 LGEGEFGSVMEG------NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH 95
Query: 87 ENLVKLIGYCSESDNR-----LLVYEFMPKGSLENHLFRS-----VQPISWPTRVKIAID 136
N+++L+G C E ++ +++ FM G L +L S + I T +K +D
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
+A G+ +L + N ++RDL A N +L + ++DFGL++ +GD G
Sbjct: 156 IALGMEYLS--NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-----QGRI 208
Query: 197 G-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVE 246
+ A E +A T KSDV++FGV + E+ + RG G+ + +
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--------RGMTPYPGVQNHEMYD 260
Query: 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+L R+ + D + ++ C DP +RP+ + LE+L
Sbjct: 261 ----YLLHGHRLKQPEDCL----------DELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306
Query: 307 HTS 309
S
Sbjct: 307 LES 309
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-45
Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 51/304 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LGEG FG VF + ++VA+K LK S +++ E L L+H+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDK-----MLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRSVQPISWPTRVKI 133
++V+ G C+E L+V+E+M G L L + P+ + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
A VA G+ +L + ++RDL N L+ K+ DFG++RD + D V
Sbjct: 164 ASQVAAGMVYLA--GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----V 216
Query: 194 GTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEW 247
G R + PE + T +SDV+SFGVVL E+ + G++ L+ ++
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW----YQLSNTEAID- 271
Query: 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
+ R + R V A++ C +P+ R S+ DV L+ L
Sbjct: 272 ---CITQGRELERPRACP----------PEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 308 TSKD 311
+
Sbjct: 319 QAPP 322
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-45
Identities = 78/316 (24%), Positives = 127/316 (40%), Gaps = 55/316 (17%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LG G FG V++G S + VA+K L S Q ++L E + + + H
Sbjct: 38 LGHGAFGEVYEGQVSGMP-----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS------VQPISWPTRVKIAIDVARG 140
+N+V+ IG +S R ++ E M G L++ L + ++ + +A D+A G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 141 LSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
+L + + I+RD+ A N LL AK+ DFG+ARD G
Sbjct: 153 CQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCA 205
Query: 198 Y-----AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEW 247
PE G T K+D +SFGV+L E+ S G + Q ++E
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGYMPYPSKSNQEVLE- 256
Query: 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
F+ R+ + V ++ QC P++RP+ +L +E
Sbjct: 257 ---FVTSGGRMDPPKNCP----------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303
Query: 308 TSKDMPRTPPPAKLHH 323
D+ T P +
Sbjct: 304 QDPDVINTALPIEYGP 319
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-44
Identities = 78/287 (27%), Positives = 128/287 (44%), Gaps = 47/287 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V G W Q VA+K +K E E+ E + +L H
Sbjct: 16 LGSGQFGVVKLGKWKGQ-----------YDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
LVK G CS+ +V E++ G L N+L + + +++ DV G++FL
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE-- 121
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
I+RDL A N L+D + K+SDFG+ R D+ +VS+ GT+ ++APE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSV--GTKFPVKWSAPEVF 177
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIM 262
+ KSDV++FG+++ E+ S G+ P+ + V+ +
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSLGKM-------------------PYDLYTNSEVVLKV 218
Query: 263 DTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
G + + + ++ C H P+ RP+ +L+S+E L
Sbjct: 219 SQ--GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-44
Identities = 71/299 (23%), Positives = 134/299 (44%), Gaps = 55/299 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LG+G FG V++G K VAIK + S + E+L E + +
Sbjct: 33 LGQGSFGMVYEGVAKG-----VVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---------VQPISWPTRVKIAIDV 137
++V+L+G S+ L++ E M +G L+++L + P S +++A ++
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
A G+++L+ ++RDL A N ++ +F K+ DFG+ RD D G +G
Sbjct: 148 ADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGGKG 200
Query: 198 Y-----AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVEW 247
+PE + G T SDV+SFGVVL E+ + GL+ + ++
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQGLSNEQVLR- 251
Query: 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
F+ + + + + + ++ C +PK RPS +++++S+++
Sbjct: 252 ---FVMEGGLLDKPDNCP----------DMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 6e-44
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 47/286 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V G W Q VAIK +K E E++ E + L HE
Sbjct: 32 LGTGQFGVVKYGKWRGQ-----------YDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
LV+L G C++ ++ E+M G L N+L +++ DV + +L
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-- 137
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
++RDL A N L++ K+SDFGL+R D+ + T VG++ ++ PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVL 193
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIM 262
+ KSD+++FGV++ E+ S G+ P+ R + +
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKM-------------------PYERFTNSETAEHI 234
Query: 263 DTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
G + + + V ++ C H RP+ +L+++ +
Sbjct: 235 AQ--GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-44
Identities = 75/294 (25%), Positives = 138/294 (46%), Gaps = 49/294 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G +G V++G W + VA+K LK ++ + +E+L E + +++H
Sbjct: 21 LGGGQYGEVYEGVWKKYSL----------TVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 69
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLH 145
NLV+L+G C+ ++ EFM G+L ++L R Q +S + +A ++ + +L
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 202
N I+RDL A N L+ N K++DFGL+R +T+ + G + + APE
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPE 182
Query: 203 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLR 260
+A + KSDV++FGV+L E+ + G P+ D +V
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------------PYPGIDLSQVYE 223
Query: 261 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312
+++ + + E + V ++ C +P +RPS ++ + E + +
Sbjct: 224 LLEK--DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 7e-44
Identities = 75/291 (25%), Positives = 135/291 (46%), Gaps = 43/291 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G +G V++G W + VA+K LK ++ + +E+L E + +++H
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLH 145
NLV+L+G C+ ++ EFM G+L ++L R Q +S + +A ++ + +L
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
N I+R+L A N L+ N K++DFGL+R TGD + APE +A
Sbjct: 336 --KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 206 TGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIMD 263
+ KSDV++FGV+L E+ + G P+ D +V +++
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMS-------------------PYPGIDLSQVYELLE 433
Query: 264 TRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312
+ + E + V ++ C +P +RPS ++ + E + +
Sbjct: 434 K--DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-44
Identities = 86/295 (29%), Positives = 136/295 (46%), Gaps = 43/295 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V+ G W VAIK LK + +L E + +LRHE
Sbjct: 192 LGQGCFGEVWMGTWNGT-----------TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSFLHG 146
LV+L SE + +V E+M KGSL + L + + + P V +A +A G++++
Sbjct: 240 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 297
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
N ++RDL+A+N+L+ N K++DFGLAR + T + + APE
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALY 355
Query: 207 GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIMDT 264
G T KSDV+SFG++L EL + GR P+ +R VL ++
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRV-------------------PYPGMVNREVLDQVER 396
Query: 265 RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 317
G + +++ ++ QC +P+ RP+ + LE TS + P
Sbjct: 397 --GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-44
Identities = 84/291 (28%), Positives = 134/291 (46%), Gaps = 55/291 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V G + G VA+K +K ++ + +L E + QLRH
Sbjct: 29 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSFLH 145
NLV+L+G E L +V E+M KGSL ++L R + +K ++DV + +L
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 202
N ++RDL A NVL+ + AK+SDFGL ++ S+ + + APE
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPE 184
Query: 203 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLR 260
+ + KSDV+SFG++L E+ S GR P+ R + V+
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRV-------------------PYPRIPLKDVVP 225
Query: 261 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
++ G + + AV V+ C H+D RPS + + LE + T
Sbjct: 226 RVEK--GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-44
Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 55/291 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V G + G VA+K +K ++ + +L E + QLRH
Sbjct: 201 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSFLH 145
NLV+L+G E L +V E+M KGSL ++L R + +K ++DV + +L
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPE 202
N ++RDL A NVL+ + AK+SDFGL ++ S+ + + APE
Sbjct: 307 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPE 356
Query: 203 YVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLR 260
+ + KSDV+SFG++L E+ S GR P+ R + V+
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRV-------------------PYPRIPLKDVVP 397
Query: 261 IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
++ G + + AV V+ C H+D RP+ + + LE + T
Sbjct: 398 RVEK--GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 70/289 (24%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+GEG FG V +G + + VAIK K S +++L E + + Q H
Sbjct: 23 IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
++VKLIG +E+ ++ E G L + L + + + A ++ L++L
Sbjct: 77 HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE-- 133
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEYV 204
++RD+ A NVL+ SN KL DFGL+R D+T+ + + APE +
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS--KGKLPIKWMAPESI 189
Query: 205 ATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIM 262
T SDV+ FGV + E+L G + PF V+ +
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVK-------------------PFQGVKNNDVIGRI 230
Query: 263 DTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
+ G + + +++ +C DP RP ++ L +
Sbjct: 231 EN--GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-43
Identities = 78/307 (25%), Positives = 126/307 (41%), Gaps = 47/307 (15%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LG G FG V++G S + VA+K L S Q ++L E + + + H
Sbjct: 79 LGHGAFGEVYEGQVSGMP-----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS------VQPISWPTRVKIAIDVARG 140
+N+V+ IG +S R ++ E M G L++ L + ++ + +A D+A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 141 LSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
+L + + I+RD+ A N LL AK+ DFG+ARD G
Sbjct: 194 CQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-----KGGCA 246
Query: 198 Y-----AAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 251
PE G T K+D +SFGV+L E+ S G + Q ++E F
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----PSKSNQEVLE----F 298
Query: 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311
+ R+ + V ++ QC P++RP+ +L +E D
Sbjct: 299 VTSGGRMDPPKNCP----------GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348
Query: 312 MPRTPPP 318
+ T P
Sbjct: 349 VINTALP 355
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-43
Identities = 74/305 (24%), Positives = 128/305 (41%), Gaps = 56/305 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LGEG FG VF + + ++VA+K LK + K++ E L L+HE
Sbjct: 23 LGEGAFGKVFLAECYN-----LSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL---------------FRSVQPISWPTRVK 132
++VK G C + D ++V+E+M G L L ++ + +
Sbjct: 78 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
IA +A G+ +L + ++RDL N L+ +N K+ DFG++RD + D
Sbjct: 138 IASQIASGMVYLA--SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----- 190
Query: 193 VGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247
VG + PE + T +SDV+SFGV+L E+ + +Q
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT-----------YGKQ----- 234
Query: 248 ADPF-LRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
P+ + V+ + G + + V V+L C +P+ R ++ ++ L
Sbjct: 235 --PWFQLSNTEVIECITQ--GRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
Query: 305 QLHTS 309
L +
Sbjct: 291 ALGKA 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 65/279 (23%), Positives = 101/279 (36%), Gaps = 45/279 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
LG G +G VFK G + A+KR + F+G K+ L EV ++
Sbjct: 64 RLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSP-FRGPKDRARKLAEVGSHEKV 113
Query: 85 -RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
+H V+L E L E SL+ H + D L+
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH +++ D+K +N+ L KL DFGL + T V G Y APE
Sbjct: 173 LH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPEL 227
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR--I 261
+ + +DV+S G+ +LE+ P + + LR
Sbjct: 228 LQGSY-GTAADVFSLGLTILEVACNMEL------------------PHGGEGWQQLRQGY 268
Query: 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ S E + +V++ L DPK R + +L
Sbjct: 269 LPPEFTAGLS-SELR---SVLVMMLEPDPKLRATAEALL 303
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 86/295 (29%), Positives = 136/295 (46%), Gaps = 43/295 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG+G FG V+ G W VAIK LK + +L E + +LRHE
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-----------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 322
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSFLHG 146
LV+L SE + +V E+M KGSL + L + + + P V +A +A G++++
Sbjct: 323 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 380
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
N ++RDL+A+N+L+ N K++DFGLAR + T + + APE
Sbjct: 381 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALY 438
Query: 207 GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIMDT 264
G T KSDV+SFG++L EL + GR P+ +R VL ++
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRV-------------------PYPGMVNREVLDQVER 479
Query: 265 RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 317
G + +++ ++ QC +P+ RP+ + LE TS + P
Sbjct: 480 --GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 43/290 (14%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LG G FG V +G + I VAIK LK +E + E + QL +
Sbjct: 344 LGCGNFGSVRQGVY--------RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+V+LIG C + +LV E G L L + I ++ V+ G+ +L
Sbjct: 396 PYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE- 453
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 203
+ N ++R+L A NVLL + AK+SDFGL++ D+ + + + + APE
Sbjct: 454 -EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPEC 510
Query: 204 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 261
+ + +SDV+S+GV + E LS G++ P+ + V+
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQK-------------------PYKKMKGPEVMAF 551
Query: 262 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
++ G + + A++ C ++RP + V + + S
Sbjct: 552 IEQ--GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 2e-42
Identities = 68/285 (23%), Positives = 115/285 (40%), Gaps = 34/285 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHE 87
+GEG FG V +G + + VAIK K S +++L E + + Q H
Sbjct: 398 IGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
++VKLIG +E + ++ E G L + L + + + A ++ L++L
Sbjct: 452 HIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE-- 508
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 207
++RD+ A NVL+ SN KL DFGL+R S + + APE +
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APESINFR 567
Query: 208 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIMDTRL 266
T SDV+ FGV + E+L + PF V+ ++
Sbjct: 568 RFTSASDVWMFGVCMWEILM-----------HGVK-------PFQGVKNNDVIGRIEN-- 607
Query: 267 GGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
G + + +++ +C DP RP ++ L +
Sbjct: 608 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-42
Identities = 79/299 (26%), Positives = 141/299 (47%), Gaps = 49/299 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V+ G + VA+K LK S +L E + QL+H+
Sbjct: 21 LGAGQFGEVWMGYYNGHTK-----------VAVKSLKQGSMS-PDAFLAEANLMKQLQHQ 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSFLHG 146
LV+L ++ + ++ E+M GSL + L S ++ + +A +A G++F+
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYAAPEY 203
+ N I+RDL+A+N+L+ + K++DFGLAR DN + T G + + APE
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEA 181
Query: 204 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 261
+ G T KSDV+SFG++L E+++ GR P+ + V++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRI-------------------PYPGMTNPEVIQN 222
Query: 262 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPP 318
++ G + + + + + ++ C P++RP+ + + LE T+ + P P
Sbjct: 223 LER--GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQPQP 279
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-42
Identities = 85/311 (27%), Positives = 131/311 (42%), Gaps = 66/311 (21%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
++GEG FG V K I K G + AIKR+K S H+++ E+ L +L
Sbjct: 32 VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHL---------------FRSVQPISWPTR 130
H N++ L+G C L E+ P G+L + L + +S
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
+ A DVARG+ +L I+RDL A N+L+ N+ AK++DFGL+R +V
Sbjct: 145 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVKK 198
Query: 191 RIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLA 240
T G + A E + T SDV+S+GV+L E++S G G+
Sbjct: 199 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------LGGTPYCGMT 246
Query: 241 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
L E L R+ + ++ V ++ QC P RPS +L
Sbjct: 247 CAELYE----KLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQIL 292
Query: 301 TSLEQLHTSKD 311
SL ++ +
Sbjct: 293 VSLNRMLEERK 303
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-42
Identities = 77/299 (25%), Positives = 141/299 (47%), Gaps = 54/299 (18%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V+ + VA+K +K + +L E + L+H+
Sbjct: 196 LGAGQFGEVWMATYNKHTK-----------VAVKTMK-PGSMSVEAFLAEANVMKTLQHD 243
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTRVKIAIDVARGLSFLHG 146
LVKL ++ + ++ EFM KGSL + L P + + +A G++F+
Sbjct: 244 KLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 301
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YAAPEY 203
N I+RDL+A+N+L+ ++ K++DFGLAR DN + T G + + APE
Sbjct: 302 -QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEA 356
Query: 204 VATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI 261
+ G T KSDV+SFG++L+E+++ GR P+ + V+R
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRI-------------------PYPGMSNPEVIRA 397
Query: 262 MDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS-----KDMP 313
++ G + + E + + ++++C P+ RP+ + + L+ +T+ +++P
Sbjct: 398 LER--GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEIP 454
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-41
Identities = 74/301 (24%), Positives = 123/301 (40%), Gaps = 51/301 (16%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LGE FG V+KG T+ VAIK LK + +E+ E + +L+H
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQA-----VAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL---------------FRSVQPISWPTRV 131
N+V L+G ++ +++ + G L L + P V
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
+ +A G+ +L +V+++DL NVL+ N K+SD GL R+ D +
Sbjct: 132 HLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 192 ----IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 246
I APE + G + SD++S+GVVL E+ S G + G + Q +VE
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY----CGYSNQDVVE 241
Query: 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+R+ + + D V A++++C + P RP D+ + L
Sbjct: 242 ----MIRNRQVLPCPDDCP----------AWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
Query: 307 H 307
Sbjct: 288 G 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 73/306 (23%), Positives = 121/306 (39%), Gaps = 62/306 (20%)
Query: 16 SKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH 71
+ K F D+ L+G GGFG VFK + G IKR+K +
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKA-KHRID--------GKTYVIKRVKYNN---- 48
Query: 72 KEWLTEVIYLGQLRHENLVKLIGYCSESDNRL----------------LVYEFMPKGSLE 115
++ EV L +L H N+V G D + EF KG+LE
Sbjct: 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 116 NHL-FRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174
+ R + + +++ + +G+ ++H +I RDLK SN+ L K+ DF
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDF 166
Query: 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 234
GL + N TR GT Y +PE +++ + D+Y+ G++L ELL
Sbjct: 167 GLVT---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD---- 219
Query: 235 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 294
S+ + D + + KKE ++ + L P++RP
Sbjct: 220 ---------------TAFETSKFFTDLRDGIISDIFDKKEKT----LLQKLLSKKPEDRP 260
Query: 295 SMVDVL 300
+ ++L
Sbjct: 261 NTSEIL 266
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-40
Identities = 75/318 (23%), Positives = 130/318 (40%), Gaps = 78/318 (24%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RH 86
LGEG FG V KP + VA+K LK + + + + ++E+ + + +H
Sbjct: 43 LGEGAFGQVVMAEA--VGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTRV 131
+N++ L+G C++ ++ E+ KG+L +L + +++ V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
+ARG+ +L I+RDL A NVL+ N K++DFGLARD D
Sbjct: 161 SCTYQLARGMEYLA--SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY-----Y 213
Query: 192 IVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAE 241
T G + APE + T +SDV+SFGV++ E+ + G G+
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGIPV 265
Query: 242 QTLVEWADPFLRDSRR----------VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 291
+ L + L++ R + +M C H P
Sbjct: 266 EELFK----LLKEGHRMDKPANCTNELYMMM--------------------RDCWHAVPS 301
Query: 292 NRPSMVDVLTSLEQLHTS 309
RP+ ++ L+++ T
Sbjct: 302 QRPTFKQLVEDLDRILTL 319
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-40
Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 64/311 (20%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
LGEG FG V + KP + VA+K LK + + + + ++E+ + + +
Sbjct: 89 LGEGCFGQVVMAEAVG---IDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTR 130
H+N++ L+G C++ ++ E+ KG+L +L + +++
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
V +ARG+ +L I+RDL A NVL+ N K++DFGLARD D
Sbjct: 206 VSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY----- 258
Query: 191 RIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLA 240
T G + APE + T +SDV+SFGV++ E+ + G G+
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGIP 310
Query: 241 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVD 298
+ L + L++ R MD K + ++ C H P RP+
Sbjct: 311 VEELFK----LLKEGHR----MD--------KPANCTNELYMMMRDCWHAVPSQRPTFKQ 354
Query: 299 VLTSLEQLHTS 309
++ L+++ T
Sbjct: 355 LVEDLDRILTL 365
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-40
Identities = 72/313 (23%), Positives = 124/313 (39%), Gaps = 69/313 (22%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
+GEG FG VF+ + P +VA+K LK E S ++ E + + +
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPF-----TMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS-----------------------VQ 123
N+VKL+G C+ L++E+M G L L
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 124 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183
P+S ++ IA VA G+++L ++RDL N L+ N K++DFGL+R+ +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 184 DNTHVSTRIVGTRGY-----AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG- 237
D PE + T +SDV+++GVVL E+ S G
Sbjct: 228 D-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--------YGL 274
Query: 238 ----GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 293
G+A + ++ ++RD + + + ++ C P +R
Sbjct: 275 QPYYGMAHEEVIY----YVRDGNILACPENCP----------LELYNLMRLCWSKLPADR 320
Query: 294 PSMVDVLTSLEQL 306
PS + L+++
Sbjct: 321 PSFCSIHRILQRM 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 7e-40
Identities = 57/275 (20%), Positives = 104/275 (37%), Gaps = 38/275 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLR 85
+G G F V+KG +D T + VA + + + + + E L L+
Sbjct: 33 EIGRGSFKTVYKG-LDTET--------TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 83
Query: 86 HENLVKLIGYC---SESDNRLLVY-EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
H N+V+ + +++ E M G+L+ +L + + + + +GL
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGL 142
Query: 142 SFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 200
FLH +I+RDLK N+ + + K+ D GLA T + ++GT + A
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEFMA 198
Query: 201 PEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260
PE + DVY+FG+ +LE+ + E + R
Sbjct: 199 PEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQ----------------IYRR 241
Query: 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
+ + K V ++ C+ + R S
Sbjct: 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 68/310 (21%), Positives = 116/310 (37%), Gaps = 59/310 (19%)
Query: 23 FCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEV 78
+ SD+ +LG+G FG V K AIK+++ + L+EV
Sbjct: 4 YASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEV 53
Query: 79 IYLGQLRHENLVKLIGYCSESDNRL-------------LVYEFMPKGSLENHLFRSVQPI 125
+ L L H+ +V+ E N + + E+ G+L + +
Sbjct: 54 MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113
Query: 126 SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR------- 178
++ + LS++H +I+RDLK N+ +D + N K+ DFGLA+
Sbjct: 114 QRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 179 -----DGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRAL 232
++ T +GT Y A E + TGH K D+YS G++ E++
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST- 230
Query: 233 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN 292
+R + L+ R V K E + ++ + DP
Sbjct: 231 GMERVNI------------LKKLRSVSIEFPPDFDDNKMKVEKK----IIRLLIDHDPNK 274
Query: 293 RPSMVDVLTS 302
RP +L S
Sbjct: 275 RPGARTLLNS 284
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-39
Identities = 74/335 (22%), Positives = 127/335 (37%), Gaps = 53/335 (15%)
Query: 8 SDPSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL 63
+ N +++ +G G F V++ G+ VA+K++
Sbjct: 15 QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKV 65
Query: 64 KAESFQGHKE---WLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-- 118
+ K + E+ L QL H N++K E + +V E G L +
Sbjct: 66 QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125
Query: 119 -FRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177
+ + I T K + + L +H V++RD+K +NV + + KL D GL
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLG 183
Query: 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 237
R T + +VGT Y +PE + KSD++S G +L E+ + + D+
Sbjct: 184 RF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241
Query: 238 GLAEQTLVEWADPFLRDSRRVLRIMDTR----LGGQYSKKEAQAVAAVVLQCLHMDPKNR 293
L L +I YS + + +V C++ DP+ R
Sbjct: 242 NL----------YSL-----CKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKR 282
Query: 294 PSMVDVLTSLEQLHTSKDMPRTPPPAKLHHHHHHH 328
P + V +++H + L HHHHHH
Sbjct: 283 PDVTYVYDVAKRMHACTA-------SSLEHHHHHH 310
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 79/323 (24%), Positives = 128/323 (39%), Gaps = 89/323 (27%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRH 86
LGEG FG V K A VA+K LK S ++ L+E L Q+ H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTT-----VAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-----------------------FRSVQ 123
+++KL G CS+ LL+ E+ GSL L +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 124 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183
++ + A +++G+ +L + +++RDL A N+L+ K+SDFGL+RD
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 184 DNTHVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG- 237
D+ + ++G + A E + T +SDV+SFGV+L E+++ G
Sbjct: 204 DSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------LGG 250
Query: 238 ----GLAEQTLVEWADPFLRDSRR----------VLRIMDTRLGGQYSKKEAQAVAAVVL 283
G+ + L L+ R + R+M L
Sbjct: 251 NPYPGIPPERLFN----LLKTGHRMERPDNCSEEMYRLM--------------------L 286
Query: 284 QCLHMDPKNRPSMVDVLTSLEQL 306
QC +P RP D+ LE++
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKM 309
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-39
Identities = 69/330 (20%), Positives = 119/330 (36%), Gaps = 74/330 (22%)
Query: 23 FCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTE 77
+ +D+ LG GGFG VF+ AIKR++ ++ + E
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMRE 53
Query: 78 VIYLGQLRHENLVKLIGYCSESDN---------RLLVY---EFMPKGSLENHLF--RSVQ 123
V L +L H +V+ E + ++ +Y + K +L++ + +++
Sbjct: 54 VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 124 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----- 178
+ I + +A + FLH +++RDLK SN+ + K+ DFGL
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 171
Query: 179 -----DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 233
T VGT+ Y +PE + + K D++S G++L ELL
Sbjct: 172 EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------ 225
Query: 234 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG------GQYSKKEAQAVAAVVLQCLH 287
PF RV + D R Q E +V L
Sbjct: 226 ----------------PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYV----MVQDMLS 265
Query: 288 MDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 317
P RP ++++ + + D P
Sbjct: 266 PSPMERPEAINIIEN--AVFEDLDFPGKTV 293
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-39
Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 60/309 (19%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
LG G FG V + + A + VA+K LK + H+ ++E+ L +
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRT-----VAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 86 HENLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRS---------------VQPISWPT 129
H N+V L+G C++ +++ EF G+L +L ++
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 189
+ + VA+G+ FL I+RDL A N+LL K+ DFGLARD +
Sbjct: 150 LICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD---- 203
Query: 190 TRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244
+ + APE + T +SDV+SFGV+L E+ S L
Sbjct: 204 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGAS-- 249
Query: 245 VEWADPF--LRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVL 300
P+ ++ R + + G + + + +L C H +P RP+ +++
Sbjct: 250 -----PYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 302
Query: 301 TSLEQLHTS 309
L L +
Sbjct: 303 EHLGNLLQA 311
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-38
Identities = 66/307 (21%), Positives = 108/307 (35%), Gaps = 44/307 (14%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
I K++ LGEGGF V G A+KR+ Q +E
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLV---------EGLHDGHFYALKRILCHEQQDREEAQR 75
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRSVQ---PISWPT 129
E H N+++L+ YC L+ F +G+L N + R ++
Sbjct: 76 EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ 135
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 189
+ + + + RGL +H +RDLK +N+LL L D G
Sbjct: 136 ILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 190 TRIV-------GTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239
+ T Y APE + + ++DV+S G VL ++ G D
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253
Query: 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 299
L V + ++S A+ ++ + +DP RP + +
Sbjct: 254 DSVALA------------VQNQLSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLL 297
Query: 300 LTSLEQL 306
L+ LE L
Sbjct: 298 LSQLEAL 304
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 77/320 (24%), Positives = 130/320 (40%), Gaps = 78/320 (24%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RH 86
LGEG FG V + KP VA+K LK++ + + + ++E+ + + +H
Sbjct: 77 LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL---------------FRSVQPISWPTRV 131
+N++ L+G C++ ++ E+ KG+L +L + +S V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
A VARG+ +L I+RDL A NVL+ + K++DFGLARD D
Sbjct: 195 SCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----- 247
Query: 192 IVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAE 241
T G + APE + T +SDV+SFGV+L E+ + G G+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPGVPV 299
Query: 242 QTLVEWADPFLRDSRR----------VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 291
+ L + L++ R + +M C H P
Sbjct: 300 EELFK----LLKEGHRMDKPSNCTNELYMMM--------------------RDCWHAVPS 335
Query: 292 NRPSMVDVLTSLEQLHTSKD 311
RP+ ++ L+++
Sbjct: 336 QRPTFKQLVEDLDRIVALTS 355
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 76/302 (25%), Positives = 133/302 (44%), Gaps = 55/302 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RH 86
LG G FG V + F K + + VA+K LK+ + ++E+ + L +H
Sbjct: 54 LGAGAFGKVVEA----TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------------FRSVQPISWPTRVKI 133
EN+V L+G C+ L++ E+ G L N L + S +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
+ VA+G++FL N I+RD+ A NVLL + AK+ DFGLARD N IV
Sbjct: 170 SSQVAQGMAFLA--SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-----IV 222
Query: 194 GTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248
+ APE + T +SDV+S+G++L E+ S L
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LGLN------ 265
Query: 249 DPF--LRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
P+ + + + +++ G Q ++ + + +++ C ++P +RP+ + + L+
Sbjct: 266 -PYPGILVNSKFYKLVKD--GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322
Query: 305 QL 306
+
Sbjct: 323 EQ 324
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-38
Identities = 75/314 (23%), Positives = 115/314 (36%), Gaps = 75/314 (23%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
LG G FG V + K + + VA+K LK + ++E+ L L
Sbjct: 31 LGAGAFGKVVEATAYGLI-----KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-----------------FRSVQPISWP 128
H N+V L+G C+ L++ E+ G L N L +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 188
+ + VA+G++FL N I+RDL A N+LL K+ DFGLARD N V
Sbjct: 146 DLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 189 STR----IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244
+ APE + T +SDV+S+G+ L EL S G +
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS--------LGSSPYPGM 251
Query: 245 VEWAD--PFLRDSRRVLR----------IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN 292
+ +++ R+L IM C DP
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIM--------------------KTCWDADPLK 291
Query: 293 RPSMVDVLTSLEQL 306
RP+ ++ +E+
Sbjct: 292 RPTFKQIVQLIEKQ 305
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-38
Identities = 74/330 (22%), Positives = 130/330 (39%), Gaps = 61/330 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-H 86
+L EGGF V++ GSG A+KRL + + ++ + EV ++ +L H
Sbjct: 35 VLAEGGFAFVYEA---------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH 85
Query: 87 ENLVKLIGYCSESDNR-------LLVYEFMPKGSLENHL--FRSVQPISWPTRVKIAIDV 137
N+V+ S L+ + KG L L S P+S T +KI
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA---RDGPTGDNTHVSTRIV- 193
R + +H +I+RDLK N+LL + KL DFG A P + +V
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 194 ------GTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244
T Y PE + + K D+++ G +L L +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ--------------- 250
Query: 245 VEWADPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
PF + LRI + G+YS + +++ L ++P+ R S+ +V+
Sbjct: 251 ----HPF--EDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300
Query: 301 TSLEQLHTSKDMPRTPPPAKLHHHHHHHNH 330
L+++ ++++ P +L + +
Sbjct: 301 HQLQEIAAARNVNPKSPITELLEQNGGYGS 330
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-37
Identities = 63/322 (19%), Positives = 116/322 (36%), Gaps = 37/322 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+GEG FG G IK + KE EV L +
Sbjct: 31 KIGEGSFGKAILV---------KSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANM 80
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSF 143
+H N+V+ E+ + +V ++ G L + + + + + L
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
+H D +++RD+K+ N+ L + +L DFG+AR ++ +GT Y +PE
Sbjct: 141 VH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEI 196
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
KSD+++ G VL EL + + A + + + LV +++
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFE----AGSMKNLV----------LKIISGSF 242
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS-LEQLHTSKDMPRTPPPAKLH 322
+ YS + ++V Q +P++RPS+ +L K + +
Sbjct: 243 PPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFC 298
Query: 323 HHHHHHNHHQGIKHTNPPRKTS 344
Q I P +
Sbjct: 299 LKTFSKFGSQPIPAKRPASGQN 320
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 78/319 (24%), Positives = 127/319 (39%), Gaps = 80/319 (25%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RH 86
LG G FG V + +K G I VA+K LK + + ++E+ + QL H
Sbjct: 53 LGSGAFGKVMNATA----YGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL----------------------FRSVQP 124
EN+V L+G C+ S L++E+ G L N+L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 125 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184
+++ + A VA+G+ FL + ++RDL A NVL+ K+ DFGLARD +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 185 NTHVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239
N +V + APE + G T KSDV+S+G++L E+ S G
Sbjct: 227 N-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS--------LGVN 273
Query: 240 AEQTLVEWAD--PFLRDSRRVLR----------IMDTRLGGQYSKKEAQAVAAVVLQCLH 287
+ A+ +++ ++ + IM C
Sbjct: 274 PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM--------------------QSCWA 313
Query: 288 MDPKNRPSMVDVLTSLEQL 306
D + RPS ++ + L
Sbjct: 314 FDSRKRPSFPNLTSFLGCQ 332
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-36
Identities = 64/283 (22%), Positives = 117/283 (41%), Gaps = 39/283 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLR 85
+G G +G K + G ++ K L + + ++EV L +L+
Sbjct: 13 TIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63
Query: 86 HENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHL---FRSVQPISWPTRVKIAIDVARG 140
H N+V+ ++ L +V E+ G L + + + Q + +++ +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 141 LSFLH---GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
L H V++RDLK +NV LD N KL DFGLAR +T + VGT
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPY 181
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257
Y +PE + KSD++S G +L EL + +++ L +
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT----AFSQKELA----------GK 227
Query: 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ R+ +YS + ++ + L++ +RPS+ ++L
Sbjct: 228 IREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEIL 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 46/288 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G GG VF+ +++ + AIK + E + E+ YL +L+
Sbjct: 35 QIGSGGSSKVFQV-LNEK---------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 84
Query: 86 HENL--VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
+ ++L Y +V E L + L + + I R ++ +
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHT 142
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE- 202
+H +++ DLK +N L+ KL DFG+A + V VGT Y PE
Sbjct: 143 IH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 203 ----------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
+ ++PKSDV+S G +L + G+ + ++
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------------ 247
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
++ I+D ++ + + V+ CL DPK R S+ ++L
Sbjct: 248 ----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 60/288 (20%), Positives = 111/288 (38%), Gaps = 46/288 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH--KEWLTEVIYLGQLR 85
+G GG VF+ +++ + AIK + E + E+ YL +L+
Sbjct: 16 QIGSGGSSKVFQV-LNEK---------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 86 H--ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
+ +++L Y +V E L + L + + I R ++ +
Sbjct: 66 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHT 123
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE- 202
+H +++ DLK +N L+ KL DFG+A + V VGT Y PE
Sbjct: 124 IH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 203 ----------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
+ ++PKSDV+S G +L + G+ + ++
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------------ 228
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
++ I+D ++ + + V+ CL DPK R S+ ++L
Sbjct: 229 ----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 68/285 (23%), Positives = 110/285 (38%), Gaps = 31/285 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRHE 87
LG GGFG V + WI Q+T G VAIK+ + E ++E W E+ + +L H
Sbjct: 22 LGTGGFGYVLR-WIHQDT--------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 88 NLVKLI------GYCSESDNRLLVYEFMPKGSLENHLFR--SVQPISWPTRVKIAIDVAR 139
N+V + +D LL E+ G L +L + + + + D++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTR 196
L +LH + +I+RDLK N++L K+ D G A++ + VGT
Sbjct: 133 ALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEF-VGTL 187
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD----PFL 252
Y APE + T D +SFG + E ++G R + + V
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQC-LHMDPKNRPSM 296
D ++ + LQC L + R +
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 39/228 (17%), Positives = 74/228 (32%), Gaps = 21/228 (9%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
++ +K +LLGEG F V++ A +K K +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKN----KQKFVLKVQKPANPWEFYIGTQ 116
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL----FRSVQPISWPTRVK 132
+ L +K + +LV E G+L N + + + +
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLL-----------DSNFNAKLSDFGLARDGP 181
A+ + + +H D +I+ D+K N +L D + L D G + D
Sbjct: 177 FAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 182 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
+ T T G+ E ++ + D + + +L G
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 69/309 (22%), Positives = 117/309 (37%), Gaps = 58/309 (18%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGC-VFKGWIDQNTFAPTKPGSGIVVAIKRLKAES 67
+ S ++ KI +FC +LG G G V++G D VA+KR+ E
Sbjct: 15 ETSVVIVGKI---SFCPKDVLGHGAEGTIVYRGMFD-----------NRDVAVKRILPEC 60
Query: 68 FQGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPIS 126
F EV L + H N+++ + + + E +L+ ++ +
Sbjct: 61 FSFADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHL 116
Query: 127 WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL-----DSNFNAKLSDFGLAR--D 179
+ + GL+ LH L N+++RDLK N+L+ A +SDFGL +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174
Query: 180 GPTGDNTHVSTRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 236
+ S + GT G+ APE + + T D++S G V ++S
Sbjct: 175 VGRHSFSRRSG-VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH----- 228
Query: 237 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAV-----VLQCLHMDPK 291
PF + +R I+ + V + + + MDP+
Sbjct: 229 -------------PFGKSLQRQANIL--LGACSLDCLHPEKHEDVIARELIEKMIAMDPQ 273
Query: 292 NRPSMVDVL 300
RPS VL
Sbjct: 274 KRPSAKHVL 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-34
Identities = 60/311 (19%), Positives = 113/311 (36%), Gaps = 41/311 (13%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WL 75
+ + +LG+G VF+ + T G + AIK SF + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55
Query: 76 TEVIYLGQLRHENLVKLIGY--CSESDNRLLVYEFMPKGSLENHLFR--SVQPISWPTRV 131
E L +L H+N+VKL + + +++L+ EF P GSL L + + +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGDNTH 187
+ DV G++ L + +++R++K N++ D KL+DFG AR+ D+
Sbjct: 116 IVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ 171
Query: 188 VSTRIVGTRGYAAPEYVATGHL--------TPKSDVYSFGVVLLELLSGRRALDEDRGGL 239
+ + GT Y P+ L D++S GV +G G
Sbjct: 172 FVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 240 AEQTLVE----------WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 289
+ ++ + ++ + D + S+ + V+ L D
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290
Query: 290 PKNRPSMVDVL 300
+
Sbjct: 291 QEKCWGFDQFF 301
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 64/303 (21%), Positives = 105/303 (34%), Gaps = 49/303 (16%)
Query: 3 LLIAMSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR 62
+L+ + +G G FG V + D+ T G A+K+
Sbjct: 40 VLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM-KDKQT--------GFQCAVKK 90
Query: 63 LKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV 122
++ E F+ E++ L +V L G E + E + GSL L + +
Sbjct: 91 VRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQM 144
Query: 123 QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLAR--- 178
+ + GL +LH +++ D+KA NVLL S+ A L DFG A
Sbjct: 145 GCLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202
Query: 179 DGPTGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 237
G + I GT + APE V K D++S ++L +L+G
Sbjct: 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHP------ 255
Query: 238 GLAEQTLVEWADPFLRDSRRVLRIMDTR-----LGGQYSKKEAQAVAAVVLQCLHMDPKN 292
W L+I + + A + + L +P +
Sbjct: 256 ---------WTQ--YFRGPLCLKIASEPPPIREIPPSCAP----LTAQAIQEGLRKEPVH 300
Query: 293 RPS 295
R S
Sbjct: 301 RAS 303
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 62/321 (19%), Positives = 112/321 (34%), Gaps = 41/321 (12%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WL 75
+ + +LG+G VF+ + T G + AIK SF + +
Sbjct: 5 STSNHLWLLSDILGQGATANVFR-GRHKKT--------GDLFAIKVFNNISFLRPVDVQM 55
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRL--LVYEFMPKGSLENHLFR--SVQPISWPTRV 131
E L +L H+N+VKL E+ R L+ EF P GSL L + + +
Sbjct: 56 REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGDNTH 187
+ DV G++ L + +++R++K N++ D KL+DFG AR+ D+
Sbjct: 116 IVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQ 171
Query: 188 VSTRIVGTRGYAAPEYVATGHL--------TPKSDVYSFGVVLLELLSGRRALDEDRGGL 239
+ + GT Y P+ L D++S GV +G G
Sbjct: 172 FVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 240 AEQTLVE----------WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 289
+ ++ + ++ + D + S+ + V+ L D
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290
Query: 290 PKNRPSMVDVLTSLEQLHTSK 310
+ +
Sbjct: 291 QEKCWGFDQFFAETSDILHRM 311
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 54/301 (17%), Positives = 102/301 (33%), Gaps = 57/301 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA---ESFQGHKEWLTEVIYLGQL 84
+ GG G ++ +D+N +G V +K L Q + E +L ++
Sbjct: 87 CIAHGGLGWIYLA-LDRNV-------NGRPVVLKGLVHSGDAEAQ--AMAMAERQFLAEV 136
Query: 85 RHENLVKLIGYCSESDNRL-----LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
H ++V++ + +D +V E++ SL+ + + + +++
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILP 193
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
LS+LH ++Y DLK N++L KL D G + GT G+
Sbjct: 194 ALSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGFQ 244
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259
APE + T +D+Y+ G L L L
Sbjct: 245 APE-IVRTGPTVATDIYTVGRTLAALTLDLP-------------------TRNGRYVDGL 284
Query: 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTSKDMPRTPPP 318
D L + ++ + + DP+ R + ++ L + T P
Sbjct: 285 PEDDPVLK------TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338
Query: 319 A 319
Sbjct: 339 R 339
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 46/288 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKR--LKAESFQGHKEWLTEVIYLGQLR 85
+G GG VF+ +++ + AIK L+ Q + E+ YL +L+
Sbjct: 63 QIGSGGSSKVFQV-LNEK---------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 112
Query: 86 HENL--VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
+ ++L Y +V E L + L + + I R ++ +
Sbjct: 113 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHT 170
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE- 202
+H +++ DLK +N L+ KL DFG+A + V VG Y PE
Sbjct: 171 IH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 203 ----------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
+ ++PKSDV+S G +L + G+ + ++
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------------ 275
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
++ I+D ++ + + V+ CL DPK R S+ ++L
Sbjct: 276 ----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 60/275 (21%), Positives = 119/275 (43%), Gaps = 38/275 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+LG+G +G V+ G D + + +AIK + + + E+ L+H+
Sbjct: 29 VLGKGTYGIVYAG-RDLSN--------QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRV--KIAIDVARGLSFLH 145
N+V+ +G SE+ + E +P GSL L P+ + + GL +LH
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 146 GLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
D +++RD+K NVL+++ + K+SDFG ++ + GT Y APE +
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEII 195
Query: 205 ---ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL-R 260
G+ +D++S G ++E+ +G+ + + L + + + +
Sbjct: 196 DKGPRGY-GKAADIWSLGCTIIEMATGKPP---------------FYE--LGEPQAAMFK 237
Query: 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
+ ++ + + + A +L+C DP R
Sbjct: 238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 73/297 (24%), Positives = 123/297 (41%), Gaps = 36/297 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT----EVIYLGQ 83
LG GG V+ D I VAIK + + +E L EV Q
Sbjct: 18 KLGGGGMSTVYLAE-DTIL--------NIKVAIKAIFIP-PREKEETLKRFEREVHNSSQ 67
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
L H+N+V +I E D LV E++ +L ++ S P+S T + + G+
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFTNQILDGIKH 126
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
H D +++RD+K N+L+DSN K+ DFG+A+ T + ++GT Y +PE
Sbjct: 127 AH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQ 183
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-GLAEQTLVEWADPFLRDSRRVLRIM 262
+D+YS G+VL E+L G + + +A + + + D R+ +
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI--- 240
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 319
Q+++ V+L+ D NR + + + L + R
Sbjct: 241 ------------PQSLSNVILRATEKDKANRYKTIQEM--KDDLSSVLHENRANEDV 283
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 64/320 (20%), Positives = 117/320 (36%), Gaps = 73/320 (22%)
Query: 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SF 68
+ M S+ T+ F +G G FG VFK + + G + AIKR K
Sbjct: 2 AMGMKSRYTTE-FHELEKIGSGEFGSVFKC-VKRLD--------GCIYAIKRSKKPLAGS 51
Query: 69 QGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL---FRSVQP 124
+ L EV L +H ++V+ +E D+ L+ E+ GSL + + +R +
Sbjct: 52 VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY 111
Query: 125 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN------------------ 166
+ + V RGL ++H ++++ D+K SN+ +
Sbjct: 112 FKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169
Query: 167 -FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--TGHLTPKSDVYSFGVVLL 223
K+ D G + V G + A E + HL PK+D+++ + ++
Sbjct: 170 KVMFKIGDLGHVT---RISSPQV---EEGDSRFLANEVLQENYTHL-PKADIFALALTVV 222
Query: 224 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT---RLGGQYSKKEAQAVAA 280
P R+ + I R+ S +E
Sbjct: 223 CAAGAE--------------------PLPRNGDQWHEIRQGRLPRIPQVLS-QEFT---E 258
Query: 281 VVLQCLHMDPKNRPSMVDVL 300
++ +H DP+ RPS + ++
Sbjct: 259 LLKVMIHPDPERRPSAMALV 278
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 68/299 (22%), Positives = 117/299 (39%), Gaps = 37/299 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT----EVIYLGQ 83
L+G GG G V++ D +VA+K + + T E G+
Sbjct: 41 LVGRGGMGDVYEAE-DTVR--------ERIVALKLMSET-LSSDPVFRTRMQREARTAGR 90
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
L+ ++V + + E D +L + + L L R P++ P V I + L
Sbjct: 91 LQEPHVVPIHDF-GEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALD 148
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
H A +RD+K N+L+ ++ A L DFG+A T + VGT Y APE
Sbjct: 149 AAH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPE 205
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
+ H T ++D+Y+ VL E L+G D+ + + + A P R +
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGI--- 261
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR-PSMVDVLTSLEQLHTSKDMPRTPPPAK 320
A AV+ + + +P++R + D+ + + D R +
Sbjct: 262 ------------PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDILR 308
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 76/313 (24%), Positives = 126/313 (40%), Gaps = 56/313 (17%)
Query: 7 MSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE 66
MS+ S+++ I ++ ++G G V VAIKR+ E
Sbjct: 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAA-YCAPK--------KEKVAIKRINLE 51
Query: 67 SFQGHKEWL-TEVIYLGQLRHENLVKLIGYCS-ESDNRL-LVYEFMPKGSLENHLFRSVQ 123
Q + L E+ + Q H N+V Y S + L LV + + GS+ + + +
Sbjct: 52 KCQTSMDELLKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSV-LDIIKHIV 108
Query: 124 PISWPTRVK-----IAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175
IA +V GL +LH I+RD+KA N+LL + + +++DFG
Sbjct: 109 AKGEHKSGVLDESTIATILREVLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFG 166
Query: 176 L-ARDGPTGDNTHVSTR--IVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGR-- 229
+ A GD T R VGT + APE + K+D++SFG+ +EL +G
Sbjct: 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
Query: 230 -------RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVV 282
+ L ++ P L + D + +Y K + ++
Sbjct: 227 YHKYPPMKVL---------MLTLQNDPPSLETGVQ-----DKEMLKKYGKSFRKMIS--- 269
Query: 283 LQCLHMDPKNRPS 295
CL DP+ RP+
Sbjct: 270 -LCLQKDPEKRPT 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 33/309 (10%), Positives = 67/309 (21%), Gaps = 62/309 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
L G VF D A+K + E +L
Sbjct: 69 PLRVGDRSVVFLV-RDVER--------LEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 85 RHENLVKLIGYC--------------------------SESDNRLLVYEFM-----PKGS 113
E+ + N LL+ S
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179
Query: 114 LENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173
+ ++ + + R + L +++ N+ + + L D
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGD 237
Query: 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGRRA 231
T YA E++ T + + G+ + +
Sbjct: 238 VSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
Query: 232 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 291
G+ DS L V ++ + L+ D +
Sbjct: 293 FGLVTPGIKGSWKRPSLRVPGTDS----------LAFGSCTPLPDFVKTLIGRFLNFDRR 342
Query: 292 NRPSMVDVL 300
R ++ +
Sbjct: 343 RRLLPLEAM 351
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLTEVIYLGQL 84
LG+G FG V+ A K S ++A+K L + + EV L
Sbjct: 16 PLGKGKFGNVY--------LAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
RH N+++L GY ++ L+ E+ P G++ L + + ++A LS+
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYC 125
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H VI+RD+K N+LL S K++DFG + P + GT Y PE +
Sbjct: 126 HSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGTLDYLPPEMI 179
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGR 229
K D++S GV+ E L G+
Sbjct: 180 EGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-30
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLTEVIYLGQL 84
LLG+G F V++ +G+ VAIK + ++ EV QL
Sbjct: 18 LLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
+H ++++L Y +S+ LV E G + +L V+P S + G+ +L
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H +++RDL SN+LL N N K++DFGLA H T + GT Y +PE
Sbjct: 129 HSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPEIA 184
Query: 205 A-TGHLTPKSDVYSFGVVLLELLSGR 229
+ H +SDV+S G + LL GR
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGR 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 8e-30
Identities = 65/302 (21%), Positives = 118/302 (39%), Gaps = 49/302 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHE 87
LG G G VFK + + G+V+A K + E + + E+ L +
Sbjct: 41 LGAGNGGVVFKV-SHKPS--------GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 88 NLVKLIG-YCSESDNRLLVY---EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
+V G + S+ + + E M GSL+ + + I K++I V +GL++
Sbjct: 92 YIVGFYGAFYSDGE----ISICMEHMDGGSLDQ-VLKKAGRIPEQILGKVSIAVIKGLTY 146
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
L +++RD+K SN+L++S KL DFG++ ++ ++ VGTR Y +PE
Sbjct: 147 LRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMANS-FVGTRSYMSPER 201
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
+ H + +SD++S G+ L+E+ GR + E + ++ R
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261
Query: 264 TRLGGQYSKKEAQAVAAVVLQ-------------------------CLHMDPKNRPSMVD 298
L +L CL +P R +
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321
Query: 299 VL 300
++
Sbjct: 322 LM 323
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-30
Identities = 70/323 (21%), Positives = 121/323 (37%), Gaps = 39/323 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT----EVIYLGQ 83
+LG GG V D VA+K L+A+ + E
Sbjct: 19 ILGFGGMSEVHLAR-DLRD--------HRDVAVKVLRAD-LARDPSFYLRFRREAQNAAA 68
Query: 84 LRHENLVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
L H +V + +V E++ +L + + + P++ +++ D +
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQ 127
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-RIVGTRGY 198
L+F H +I+RD+K +N+++ + K+ DFG+AR N+ T ++GT Y
Sbjct: 128 ALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258
+PE + +SDVYS G VL E+L+G D + V A +R+
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDPIP 238
Query: 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPP 318
L + + AVVL+ L +P+NR + L + P
Sbjct: 239 PSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEM--RADLVRVHNGEPPEAP 288
Query: 319 AKLHHHHHHHNHHQGIKHTNPPR 341
L + + PR
Sbjct: 289 KVLTDAERTSLLSSAAGNLSGPR 311
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 79/307 (25%), Positives = 126/307 (41%), Gaps = 53/307 (17%)
Query: 10 PSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-- 63
+ M + +T F Y +LG+G FG V +G A+K +
Sbjct: 11 ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILC---------KDKITGQECAVKVISK 61
Query: 64 -KAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV 122
+ + + L EV L QL H N++KL + + LV E G L + + S
Sbjct: 62 RQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISR 120
Query: 123 QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARD 179
+ S +I V G++++H +++RDLK N+LL+S + N ++ DFGL+
Sbjct: 121 KRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST- 177
Query: 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239
+ + +GT Y APE V G K DV+S GV+L LLSG
Sbjct: 178 --HFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP--------- 225
Query: 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNR 293
PF + I+ G+Y+ KK +++ ++ + L P R
Sbjct: 226 ----------PFNGANEY--DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMR 273
Query: 294 PSMVDVL 300
S D L
Sbjct: 274 ISARDAL 280
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 79/328 (24%), Positives = 125/328 (38%), Gaps = 57/328 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+GEG +G VFK +++T G +VAIK+ L E+ L Q
Sbjct: 11 IGEGSYGVVFKC-RNRDT--------GQIVAIKKFLESED---DPVIKKIALREIRMLKQ 58
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
L+H NLV L+ LV+E+ ++ + L R + + I + ++F
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAAP 201
H N I+RD+K N+L+ + KL DFG AR GP+ V TR Y +P
Sbjct: 118 CH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE----VATRWYRSP 171
Query: 202 EY-VATGHLTPKSDVYSFGVVLLELLSGR----------------RALDEDRGGLAEQTL 244
E V P DV++ G V ELLSG + L G L +
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL----GDLIPRH- 226
Query: 245 VEWAD----PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ + L ++ A+ ++ CLHMDP R + +L
Sbjct: 227 --QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL-GLLKGCLHMDPTERLTCEQLL 283
Query: 301 TS--LEQLHTSKDMPRTPPPAKLHHHHH 326
E + +D+ + + +
Sbjct: 284 HHPYFENIREIEDLAKEHDKPAENLYFQ 311
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 42/228 (18%), Positives = 83/228 (36%), Gaps = 44/228 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT------------ 76
L +G F + + A+K+ + + +++
Sbjct: 39 LNQGKFNKIILC---EKD--------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 77 -----EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRV 131
E+ + +++E + G + D ++YE+M S+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTC 146
Query: 132 KIAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183
I I V + S++H + N+ +RD+K SN+L+D N KLSDFG +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 184 DNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGR 229
+ GT + PE+ + + K D++S G+ L +
Sbjct: 206 ---KIKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 68/319 (21%), Positives = 115/319 (36%), Gaps = 78/319 (24%)
Query: 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIY 80
S+ +LG G G V Q +F G VA+KR+ + E+
Sbjct: 15 NLVVSEKILGYGSSGTVVF----QGSF------QGRPVAVKRMLIDFCDIALM---EIKL 61
Query: 81 LGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLE------NHLFRSVQPISWPTRVKI 133
L + H N+++ + + E +L+ N +++ + +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------------NFNAKLSDFGLAR-- 178
+A G++ LH L +I+RDLK N+L+ + N +SDFGL +
Sbjct: 121 LRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 179 -DGPTGDNTHVSTRIVGTRGYAAPE-------YVATGHLTPKSDVYSFGVVLLELLSGRR 230
G + T+++ GT G+ APE LT D++S G V +LS +
Sbjct: 179 DSGQSSFRTNLNN-PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 231 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAV--------- 281
PF R I+ G +S E + +
Sbjct: 238 ------------------HPFGDKYSRESNIIR----GIFSLDEMKCLHDRSLIAEATDL 275
Query: 282 VLQCLHMDPKNRPSMVDVL 300
+ Q + DP RP+ + VL
Sbjct: 276 ISQMIDHDPLKRPTAMKVL 294
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 23/228 (10%)
Query: 8 SDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----R 62
+ ++ + + + LG+GGF F+ + + V A K
Sbjct: 28 KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSL 78
Query: 63 LKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV 122
L + E+ L H+++V G+ ++D +V E + SL L +
Sbjct: 79 LLKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRR 135
Query: 123 QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 182
+ ++ P + G +LH VI+RDLK N+ L+ + K+ DFGLA
Sbjct: 136 KALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193
Query: 183 GDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
+ GT Y APE ++ GH + + DV+S G ++ LL G+
Sbjct: 194 DGERK-KV-LCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 238
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 64/351 (18%), Positives = 110/351 (31%), Gaps = 99/351 (28%)
Query: 23 FCSDY----LLGEGGFGCVFK--------------------------------------- 39
+ +D+ +G GGFG VF+
Sbjct: 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63
Query: 40 --------GWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENL 89
W++ + I + + S ++ + +N
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFR--SVQPISWPTRVKIAIDVARGLSFLHGL 147
V + S + + K +L++ + R S++ + I I +A + FLH
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH-- 181
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD----------GPTGDNTHVSTRIVGTRG 197
+++RDLK SN+ + K+ DFGL T VGT+
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257
Y +PE + + + K D++S G++L ELL F R
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLY----------------------SFSTQMER 279
Query: 258 VLRIMDTRLG------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302
V I D R Q +E +V L P RP D++ +
Sbjct: 280 VRIITDVRNLKFPLLFTQKYPQEHM----MVQDMLSPSPTERPEATDIIEN 326
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+LG+GGFG V A +G + A K+L+ + + K L E L ++
Sbjct: 191 VLGKGGFGEVC---------ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI-AIDVARGLS 142
+V L Y E+ + L LV M G L+ H++ Q R A ++ GL
Sbjct: 242 NSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
LH ++YRDLK N+LLD + + ++SD GLA P G R VGT GY APE
Sbjct: 301 DLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GR-VGTVGYMAPE 355
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGR 229
V T D ++ G +L E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 72/330 (21%), Positives = 123/330 (37%), Gaps = 64/330 (19%)
Query: 9 DPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RL 63
+ ++ + + + LG+GGF F+ + + V A K L
Sbjct: 3 EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLL 53
Query: 64 KAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQ 123
+ E+ L H+++V G+ ++D +V E + SL L + +
Sbjct: 54 LKPHQREKMS--MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRK 110
Query: 124 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183
++ P + G +LH VI+RDLK N+ L+ + K+ DFGLA
Sbjct: 111 ALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168
Query: 184 DNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242
+ GT Y APE ++ GH + + DV+S G ++ LL G+
Sbjct: 169 GERK-KV-LCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKP------------ 213
Query: 243 TLVEWADPFLRDSRRVL--RIMDTRLGGQYS-----KKEAQAVAAVVLQCLHMDPKNRPS 295
PF + RI +YS A +++ + L DP RP+
Sbjct: 214 -------PFETSCLKETYLRIKK----NEYSIPKHINPVAA---SLIQKMLQTDPTARPT 259
Query: 296 MVDVLTSLEQLH---TSKDMPRTPPPAKLH 322
+ ++L TS +P P L
Sbjct: 260 INELLN-----DEFFTSGYIPARLPITCLT 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 68/316 (21%), Positives = 109/316 (34%), Gaps = 63/316 (19%)
Query: 11 SASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-- 64
+ M + Y LG G +G V + AIK +K
Sbjct: 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC---------KEKNGHSEKAIKVIKKS 72
Query: 65 ----------AESFQGHKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS 113
++ + E + E+ L L H N++KL + LV EF G
Sbjct: 73 QFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE 132
Query: 114 LENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAK 170
L + + I + G+ +LH N+++RD+K N+LL++ N K
Sbjct: 133 LFEQI-INRHKFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNIK 189
Query: 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 230
+ DFGL+ + +GT Y APE V K DV+S GV++ LL G
Sbjct: 190 IVDFGLSS---FFSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
Query: 231 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQ 284
PF + + I+ G+Y K + ++
Sbjct: 246 -------------------PFGGQNDQ--DIIKKVEKGKYYFDFNDWKNISDEAKELIKL 284
Query: 285 CLHMDPKNRPSMVDVL 300
L D R + + L
Sbjct: 285 MLTYDYNKRCTAEEAL 300
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 75/306 (24%), Positives = 117/306 (38%), Gaps = 52/306 (16%)
Query: 10 PSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
+ M + Y LG G +G V + + AIK ++
Sbjct: 22 ATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLC---------RDKVTHVERAIKIIRK 72
Query: 66 ESFQG--HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQ 123
S + + L EV L L H N++KL + + N LV E G L + +
Sbjct: 73 TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRM 131
Query: 124 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDG 180
+ I V G+++LH N+++RDLK N+LL+S + K+ DFGL+
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA-- 187
Query: 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 240
+N +GT Y APE V K DV+S GV+L LL+G
Sbjct: 188 -VFENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP---------- 235
Query: 241 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRP 294
PF + + I+ G+Y+ K ++ ++ Q L D + R
Sbjct: 236 ---------PFGGQTDQ--EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI 284
Query: 295 SMVDVL 300
S L
Sbjct: 285 SAQQAL 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 53/330 (16%), Positives = 102/330 (30%), Gaps = 71/330 (21%)
Query: 28 LLGEGGFGCVFKGWIDQNT---FA---PTKPGSGIVVAIKRLKAES-----FQGHKEWLT 76
+LG+ + DQ T F P AIK++K E +G K
Sbjct: 85 VLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 77 EVIYLGQLRHENLVKLIGYCSESD-----------NRLLVYEFMPKGSLEN------HLF 119
++L + +LVK +R +Y M + +L+
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS 202
Query: 120 RSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179
+ + + R+++ + V R L+ LH +++ L+ +++LD L+ F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 180 GPTGDNTHVSTRIVGTRGYAAPEYVA----------TGHLTPKSDVYSFGVVLLELLSGR 229
G + RG+A PE A +T D ++ G+ + +
Sbjct: 260 -RDGASAVSPI----GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 230 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 289
P D+ R Q V A++ L
Sbjct: 315 L-------------------PNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYP 351
Query: 290 PKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 319
++R + + + E ++ P
Sbjct: 352 KEDRLLPLQAMETPEYEQLRTELSAALPLY 381
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 7e-29
Identities = 70/281 (24%), Positives = 113/281 (40%), Gaps = 49/281 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEV-IYLGQLRH 86
LG G +G V K + G ++A+KR++A Q K L ++ I + +
Sbjct: 15 LGRGAYGVVEKM-RHVPS--------GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 87 ENLVKLIG-YCSESDNRLLVY---EFMPKGSLEN---HLFRSVQPISWPTRVKIAIDVAR 139
V G E D V+ E M SL+ + Q I KIA+ + +
Sbjct: 66 PFTVTFYGALFREGD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
L LH +VI+RD+K SNVL+++ K+ DFG++ + G + Y
Sbjct: 121 ALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCKPYM 176
Query: 200 APEYVATGHLTP----KSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWADPFLRD 254
APE + KSD++S G+ ++EL R D + + +VE P L
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236
Query: 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
++S + + QCL + K RP+
Sbjct: 237 -------------DKFSAEFVDFTS----QCLKKNSKERPT 260
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-29
Identities = 80/282 (28%), Positives = 120/282 (42%), Gaps = 52/282 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRHE 87
+G+G FG VFKG ID T VVAIK + E + E + E+ L Q
Sbjct: 30 IGKGSFGEVFKG-IDNRT--------QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+ K G D +L ++ E++ GS L P+ I ++ +GL +LH
Sbjct: 81 YVTKYYG-SYLKDTKLWIIMEYLGGGSA-LDLLEP-GPLDETQIATILREILKGLDYLH- 136
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEY 203
I+RD+KA+NVLL + KL+DFG+A G T + VGT + APE
Sbjct: 137 -SEKKIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMAPEV 190
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRIM 262
+ K+D++S G+ +EL G P +VL ++
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGE-------------------PPHSELHPMKVLFLI 231
Query: 263 DT----RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
L G YSK + V CL+ +P RP+ ++L
Sbjct: 232 PKNNPPTLEGNYSKPLKEFVE----ACLNKEPSFRPTAKELL 269
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 19/205 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK---EWLTEVIYLGQL 84
LG+G FG V+ A K + ++A+K L + + E+ L
Sbjct: 21 PLGKGKFGNVY--------LAREK-QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
RH N++++ Y + L+ EF P+G L L + ++A L +
Sbjct: 72 RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYC 130
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H VI+RD+K N+L+ K++DFG + P T + GT Y PE +
Sbjct: 131 HER--KVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRR--T-MCGTLDYLPPEMI 184
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGR 229
K D++ GV+ E L G
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 77/328 (23%), Positives = 130/328 (39%), Gaps = 59/328 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEV-IYLGQLRH 86
+G G +G V K + + + G ++A+KR+++ + K+ L ++ + +
Sbjct: 30 IGRGAYGSVNKM-VHKPS--------GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRSVQPISWPTRV--KIAIDVARGLS 142
+V+ G + + E M S + SV P + KI + + L+
Sbjct: 81 PYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG--DNTHVSTRIVGTRGYAA 200
L + +I+RD+K SN+LLD + N KL DFG++ G ++ TR G R Y A
Sbjct: 140 HLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMA 193
Query: 201 PEYVATGHLTP----KSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWADPFLRDS 255
PE + +SDV+S G+ L EL +GR + + +V+ P L +S
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS 253
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS----------------MVDV 299
++S V CL D RP V+V
Sbjct: 254 E----------EREFSPSFINFVN----LCLTKDESKRPKYKELLKHPFILMYEERAVEV 299
Query: 300 LTSLEQLHTSKDMPRTPPPAKLHHHHHH 327
+ ++ + P HHHHHH
Sbjct: 300 ACYVCKILDQMPATPSSPMYVDHHHHHH 327
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 46/311 (14%), Positives = 94/311 (30%), Gaps = 70/311 (22%)
Query: 28 LLGEGGFGCVFKGWIDQNT---FA---PTKPGSGIVVAIKRLKAESF------------- 68
+LG+ + DQ T F P AIK++K E
Sbjct: 80 VLGQEDPYAYLEA-TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 69 -QGHKEWLTEVIYLGQLRHENLVKLIGYCS--ESDNRLLVYEFM--PKGSLENHLFRSVQ 123
+ H ++ + + + ++++ +R +Y M + L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 124 ---PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180
+ R+++ + V R L+ LH +++ L+ +++LD L+ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 181 PTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFGVVLLELLSGR 229
G +RG+ PE A +T D ++ G+V+ +
Sbjct: 255 RDGARVVS----SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 230 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 289
P +D+ R Q V A++ L
Sbjct: 311 L-------------------PITKDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYP 347
Query: 290 PKNRPSMVDVL 300
++R + +
Sbjct: 348 KEDRLLPLQAM 358
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 73/296 (24%), Positives = 116/296 (39%), Gaps = 52/296 (17%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEW 74
F Y +LG+G FG V K + A+K + KA +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTST 67
Query: 75 L-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKI 133
+ EV L +L H N++KL +S + +V E G L + + + S +I
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARI 126
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 190
V G++++H N+++RDLK N+LL+S + + K+ DFGL+
Sbjct: 127 IKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMK 181
Query: 191 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250
+GT Y APE V G K DV+S GV+L LLSG P
Sbjct: 182 DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP-------------------P 221
Query: 251 FLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
F + I+ G+Y+ + + ++ + L P R + L
Sbjct: 222 FYGKNEY--DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+GEG +G V K +++T G +VAIK+ + + E+ L Q
Sbjct: 33 VGEGSYGMVMKC-RNKDT--------GRIVAIKKFLESDD---DKMVKKIAMREIKLLKQ 80
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
LRHENLV L+ C + LV+EF+ ++ + L + + K + G+ F
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAAP 201
H N+I+RD+K N+L+ + KL DFG AR P V TR Y AP
Sbjct: 140 CH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD----EVATRWYRAP 193
Query: 202 EY-VATGHLTPKSDVYSFGVVLLELLSGR 229
E V DV++ G ++ E+ G
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-28
Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 64/292 (21%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K ++ T G + A K ++ +S + ++++ E+ L H
Sbjct: 27 LGDGAFGKVYKA-KNKET--------GALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI---DVARGLSFLH 145
+VKL+G ++ EF P G+++ + + + T +I + + L+FLH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVVCRQMLEALNFLH 134
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPE 202
+I+RDLKA NVL+ + +L+DFG++ N + +GT + APE
Sbjct: 135 SK--RIIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMAPE 187
Query: 203 YVATGHLT-----PKSDVYSFGVVLLELLSGR---------RALDEDRGGLAEQTLVEWA 248
V + K+D++S G+ L+E+ R L + +
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---------LKIAKSD 238
Query: 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
P L ++S + + L +P+ RPS +L
Sbjct: 239 PPTLLT------------PSKWSVEFRDFLK----IALDKNPETRPSAAQLL 274
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 62/209 (29%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+LG GGFG VF A +G + A K+L + + K + + E L ++
Sbjct: 192 VLGRGGFGEVF---------ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISW--PTRVKI-AIDVARG 140
+V L Y E+ L LV M G + H++ + R + G
Sbjct: 243 HSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 200
L LH N+IYRDLK NVLLD + N ++SD GLA + G GT G+ A
Sbjct: 302 LEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGY-AGTPGFMA 357
Query: 201 PEYVATGHLTPKSDVYSFGVVLLELLSGR 229
PE + D ++ GV L E+++ R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 68/288 (23%), Positives = 123/288 (42%), Gaps = 63/288 (21%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G G V+ +D T G VAI+++ + + + E++ + + ++ N
Sbjct: 28 IGQGASGTVYTA-MDVAT--------GQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK---IAI---DVARGLS 142
+V + D +V E++ GSL + + T + IA + + L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTD--------VVTETCMDEGQIAAVCRECLQALE 130
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYA 199
FLH VI+RD+K+ N+LL + + KL+DFG T ++ +VGT +
Sbjct: 131 FLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRSTMVGTPYWM 183
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRV 258
APE V PK D++S G++ +E++ G P+L ++ R
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE-------------------PPYLNENPLRA 224
Query: 259 LRIMDT----RLGG--QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
L ++ T L + S + +CL MD + R S ++L
Sbjct: 225 LYLIATNGTPELQNPEKLSAIFRDFLN----RCLEMDVEKRGSAKELL 268
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 63/277 (22%), Positives = 106/277 (38%), Gaps = 42/277 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEV-IYLGQLRH 86
+G G G V+K + T G V+A+K+++ + +K L ++ + L
Sbjct: 33 MGSGTCGQVWKM-RFRKT--------GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+V+ G + + + E M E R PI K+ + + + L +L
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG--DNTHVSTRIVGTRGYAAPEYV 204
VI+RD+K SN+LLD KL DFG++ G + R G Y APE +
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRSAGCAAYMAPERI 196
Query: 205 ATGHL-----TPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWADPFLRDSRRV 258
++DV+S G+ L+EL +G+ + +++ P L
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG- 255
Query: 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
+S V CL D + RP
Sbjct: 256 -----------FSGDFQSFVK----DCLTKDHRKRPK 277
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 72/311 (23%), Positives = 111/311 (35%), Gaps = 60/311 (19%)
Query: 10 PSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
S+ + + LG G FG V + SG+ IK +
Sbjct: 7 HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLV---------EERSSGLERVIKTINK 57
Query: 66 ESFQGHKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQ 123
+ Q E + E+ L L H N++K+ + N +V E G E L R V
Sbjct: 58 DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG--E--LLERIVS 113
Query: 124 PISWPTR------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDF 174
+ ++ + L++ H +V+++DLK N+L + K+ DF
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDF 171
Query: 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 234
GLA + ST GT Y APE V +T K D++S GVV+ LL+G
Sbjct: 172 GLAE---LFKSDEHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCL---- 223
Query: 235 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA-----QAVAAVVLQCLHMD 289
PF S + + + ++ Q L D
Sbjct: 224 ---------------PFTGTSLE--EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKD 266
Query: 290 PKNRPSMVDVL 300
P+ RPS VL
Sbjct: 267 PERRPSAAQVL 277
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 79/337 (23%), Positives = 135/337 (40%), Gaps = 70/337 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
LG G + V+KG +++ T G+ VA+K +K + +E + E+ + +
Sbjct: 13 LGNGTYATVYKG-LNKTT--------GVYVALKEVKLD----SEEGTPSTAIREISLMKE 59
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRSVQPISWPTRVK-IAIDVAR 139
L+HEN+V+L + LV+EFM K +++ + VK + +
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRG 197
GL+F H + +++RDLK N+L++ KL DFGLAR P + +V T
Sbjct: 120 GLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLW 173
Query: 198 YAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR----------------RALDEDRGGL 239
Y AP+ V G + D++S G +L E+++G+ + G
Sbjct: 174 YRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM----GTP 228
Query: 240 AEQT------LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 293
E L ++ + R LR L + + + L ++P R
Sbjct: 229 NESLWPSVTKLPKYNPNIQQRPPRDLR---QVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 294 PSMVDVLTSLEQLH---TSKDMPRTPPPAKLHHHHHH 327
S L H + ++ HHHHHH
Sbjct: 286 LSAKQALH-----HPWFAEYYHHASMGGSRSHHHHHH 317
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 61/288 (21%), Positives = 119/288 (41%), Gaps = 63/288 (21%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+GEG G V ++++ G VA+K + Q + EV+ + +H N
Sbjct: 53 IGEGSTGIVCLA-REKHS--------GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK---IAI---DVARGLS 142
+V++ + ++ EF+ G+L + I R+ IA V + L+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD--------IVSQVRLNEEQIATVCEAVLQALA 155
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYA 199
+LH VI+RD+K+ ++LL + KLSDFG + + +VGT +
Sbjct: 156 YLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFC-----AQISKDVPKRKSLVGTPYWM 208
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRV 258
APE ++ + D++S G++++E++ G P+ DS +
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDGE-------------------PPYFSDSPVQA 249
Query: 259 LRIMDT----RLGG--QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
++ + +L + S + + L DP+ R + ++L
Sbjct: 250 MKRLRDSPPPKLKNSHKVSPVLRDFLE----RMLVRDPQERATAQELL 293
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 28/211 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
LGEG F V+K D+NT +VAIK++K K+ L E+ L +
Sbjct: 18 LGEGQFATVYKA-RDKNT--------NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGLS 142
L H N++ L+ N LV++FM LE + + ++ P+ +K + +GL
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLT-PSHIKAYMLMTLQGLE 126
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAA 200
+LH +++RDLK +N+LLD N KL+DFGLA+ P TH ++V TR Y A
Sbjct: 127 YLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV-TRWYRA 180
Query: 201 PE--YVATGHLTPKSDVYSFGVVLLELLSGR 229
PE + A D+++ G +L ELL
Sbjct: 181 PELLFGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 34/214 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G FG V++ ++ G +VAIK++ Q + E+ + +L H N
Sbjct: 62 IGNGSFGVVYQA-KLCDS--------GELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108
Query: 89 LVKLIGY-CSESDNRL-----LVYEFMPK--GSLENHLFRSVQPISWPTRVKIAI-DVAR 139
+V+L + S + + LV +++P+ + H R+ Q + VK+ + + R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP-VIYVKLYMYQLFR 167
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARD-GPTGDNTHVSTRIVGTRG 197
L+++H + +RD+K N+LLD + KL DFG A+ N + +R
Sbjct: 168 SLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY----ICSRY 221
Query: 198 YAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 229
Y APE + AT T DV+S G VL ELL G+
Sbjct: 222 YRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
+GEG +G VFK ++ T +VA+KR++ + E L E+ L +
Sbjct: 10 IGEGTYGTVFKA-KNRET--------HEIVALKRVRLDDD---DEGVPSSALREICLLKE 57
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGLS 142
L+H+N+V+L LV+EF + L+ + + P VK + +GL
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLD-PEIVKSFLFQLLKGLG 115
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAA 200
F H NV++RDLK N+L++ N KL++FGLAR P + +V T Y
Sbjct: 116 FCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRP 169
Query: 201 PEYVATG--HLTPKSDVYSFGVVLLELLSGRRAL 232
P+ V G + D++S G + EL + R L
Sbjct: 170 PD-VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-26
Identities = 68/297 (22%), Positives = 110/297 (37%), Gaps = 56/297 (18%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL 75
+ Y +G G +G V + G+ I A K++ + +
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFK 54
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTR--VK 132
E+ + L H N+++L ++ + LV E G E LF R V + +
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG--E--LFERVVHKRVFRESDAAR 110
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVS 189
I DV +++ H L NV +RDLK N L + + KL DFGLA +
Sbjct: 111 IMKDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMM 165
Query: 190 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249
VGT Y +P+ V G P+ D +S GV++ LL G
Sbjct: 166 RTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYP------------------- 205
Query: 250 PFLRDSRRVLRIMDTRLGGQYSKKEA------QAVAAVVLQCLHMDPKNRPSMVDVL 300
PF + +M G ++ E +++ + L PK R + + L
Sbjct: 206 PFSAPTDS--EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQAL 260
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 77/312 (24%), Positives = 115/312 (36%), Gaps = 80/312 (25%)
Query: 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI 79
F L+G G +G V+KG T G + AIK + +E E+
Sbjct: 23 AGIFELVELVGNGTYGQVYKG-RHVKT--------GQLAAIKVMDVTG-DEEEEIKQEIN 72
Query: 80 YLGQL-RHENLVKLIG-----YCSESDNRL-LVYEFMPKGS----LENHLFRSVQPISWP 128
L + H N+ G D++L LV EF GS ++N ++
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL------ 126
Query: 129 TRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 185
IA ++ RGLS LH VI+RD+K NVLL N KL DFG++
Sbjct: 127 KEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-----AQL 179
Query: 186 THVSTR---IVGTRGYAAPEYVATGHLT-----PKSDVYSFGVVLLELLSGR-------- 229
R +GT + APE +A KSD++S G+ +E+ G
Sbjct: 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239
Query: 230 -RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM 288
RAL + P L+ ++SKK + CL
Sbjct: 240 MRAL---------FLIPRNPAPRLKSK-------------KWSKKFQSFIE----SCLVK 273
Query: 289 DPKNRPSMVDVL 300
+ RP+ ++
Sbjct: 274 NHSQRPATEQLM 285
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 72/296 (24%), Positives = 125/296 (42%), Gaps = 61/296 (20%)
Query: 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVI 79
+ F LGEG +G V+K I + T G +VAIK++ E +E + E+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKA-IHKET--------GQIVAIKQVPVE--SDLQEIIKEIS 76
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI---D 136
+ Q ++VK G ++ + +V E+ GS+ + + + + T +IA
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL---TEDEIATILQS 133
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IV 193
+GL +LH + I+RD+KA N+LL++ +AKL+DFG+A G T + ++
Sbjct: 134 TLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMAKRNTVI 186
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR---------RALDEDRGGLAEQTL 244
GT + APE + +D++S G+ +E+ G+ RA+ +
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI---------FMI 237
Query: 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
P R +S V QCL P+ R + +L
Sbjct: 238 PTNPPPTFRKPEL------------WSDNFTDFVK----QCLVKSPEQRATATQLL 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 57/307 (18%), Positives = 96/307 (31%), Gaps = 56/307 (18%)
Query: 30 GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHE 87
G V + T G V ++R+ E+ E+ H
Sbjct: 36 GFEDLMTVNLA-RYKPT--------GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 88 NLVKLIGYCS-ESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAI---DVARGLS 142
N+V + +DN L +V FM GS + L + IA V + L
Sbjct: 87 NIVPY--RATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMNELA-IAYILQGVLKALD 142
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHVSTRI-VGTRG 197
++H ++R +KAS++L+ + LS + G H + V
Sbjct: 143 YIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 198 YAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR---------RAL-------------- 232
+ +PE + KSD+YS G+ EL +G + L
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260
Query: 233 ----DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM 288
E+ +++ + Y + + V QCL
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320
Query: 289 DPKNRPS 295
+P RPS
Sbjct: 321 NPDARPS 327
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G G V D VAIK+L + FQ K E++ + +
Sbjct: 70 IGSGAQGIVCAA-YDAVL--------DRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVN 119
Query: 86 HENLVKLI-----GYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVA 138
H+N++ L+ E + LV E M + +L + +Q R+ + +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQML 174
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
G+ LH A +I+RDLK SN+++ S+ K+ DFGLAR T + + T V TR Y
Sbjct: 175 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 229
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
APE + D++S G ++ E++ +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 68/295 (23%), Positives = 110/295 (37%), Gaps = 64/295 (21%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLGQ 83
+G+G F V + +G A+K + + ++ E
Sbjct: 32 IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRV--KIAIDVAR-- 139
L+H ++V+L+ S +V+EFM L F V+ +A R
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 140 --GLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVG 194
L + H N+I+RD+K VLL S + KL FG+A G++ V+ VG
Sbjct: 140 LEALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVG 195
Query: 195 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254
T + APE V DV+ GV+L LLSG PF
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL-------------------PFYGT 236
Query: 255 SRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
R+ + + G+Y + A+ +V + L +DP R ++ + L
Sbjct: 237 KE---RLFEGIIKGKYKMNPRQWSHISESAK---DLVRRMLMLDPAERITVYEAL 285
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 54/219 (24%), Positives = 91/219 (41%), Gaps = 37/219 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT----EVIYLGQ 83
LLGEG +G V + D T A+K LK + + E+ L +
Sbjct: 12 LLGEGSYGKVKEVL-DSET--------LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 84 LRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR-- 139
LRH+N+++L+ +E ++ +V E+ G E + SV + + A
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSV------PEKRFPVCQAHGY 114
Query: 140 ------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
GL +LH ++++D+K N+LL + K+S G+A
Sbjct: 115 FCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 194 GTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLSGR 229
G+ + PE +A G T K D++S GV L + +G
Sbjct: 173 GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-26
Identities = 69/335 (20%), Positives = 120/335 (35%), Gaps = 67/335 (20%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G G V D VAIK+L + FQ K E++ + +
Sbjct: 33 IGSGAQGIVCAA-YDAIL--------ERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVN 82
Query: 86 HENLVKLIG-YCSESDNRL-----LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVA 138
H+N++ L+ + + +V E M + +L + +Q R+ + +
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQML 137
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
G+ LH A +I+RDLK SN+++ S+ K+ DFGLAR T + + T V TR Y
Sbjct: 138 CGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 192
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL---------------------DEDRG 237
APE + D++S G ++ E++ L E
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 238 GLAEQTLVEWADPFLRDSRRVLRI------MDTRLGGQYSKKEAQAVAAVVL--QCLHMD 289
L ++ + + D + +A A L + L +D
Sbjct: 252 KLQPT-----VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 290 PKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAKLH 322
R S+ + L + + + PP
Sbjct: 307 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK 341
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW----LTEVIYLGQL 84
G+G FG V G +++T G+ VAIK++ Q + L + L L
Sbjct: 31 AGQGTFGTVQLG-KEKST--------GMSVAIKKV----IQ-DPRFRNRELQIMQDLAVL 76
Query: 85 RHENLVKLI------GYCSESDNRL-LVYEFMPK--GSLENHLFRSVQPISWPTRVKIAI 135
H N+V+L G D L +V E++P + +R P +K+ +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP-PILIKVFL 135
Query: 136 -DVARGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARD-GPTGDNTHVSTRI 192
+ R + LH NV +RD+K NVL++ ++ KL DFG A+ P+ N
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY---- 191
Query: 193 VGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 229
+ +R Y APE + H T D++S G + E++ G
Sbjct: 192 ICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 75/302 (24%), Positives = 118/302 (39%), Gaps = 64/302 (21%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEW 74
F Y +LG+G FG V K + A+K + KA +
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTST 67
Query: 75 L-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTR-- 130
+ EV L +L H N++KL +S + +V E G E LF ++ +
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG--E--LFDEIIKRKRFSEHDA 123
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTH 187
+I V G++++H N+++RDLK N+LL+S + + K+ DFGL+
Sbjct: 124 ARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNT 178
Query: 188 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247
+GT Y APE V G K DV+S GV+L LLSG
Sbjct: 179 KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP----------------- 220
Query: 248 ADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVD 298
PF + I+ G+Y+ +A+ ++ + L P R +
Sbjct: 221 --PFYGKNEY--DILKRVETGKYAFDLPQWRTISDDAK---DLIRKMLTFHPSLRITATQ 273
Query: 299 VL 300
L
Sbjct: 274 CL 275
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
++G GGFG V+ K +G + A+K L + + + L E I L +
Sbjct: 196 IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 246
Query: 85 RHEN---LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARG 140
+ +V + Y + ++L + + M G L HL + S A ++ G
Sbjct: 247 STGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILG 304
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA 200
L +H V+YRDLK +N+LLD + + ++SD GLA D H VGT GY A
Sbjct: 305 LEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--AS-VGTHGYMA 358
Query: 201 PEYVATGHLTPKS-DVYSFGVVLLELLSGR 229
PE + G S D +S G +L +LL G
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 48/215 (22%), Positives = 84/215 (39%), Gaps = 35/215 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+LGEG F V + + AIK L+ + E + +L
Sbjct: 37 ILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 87
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR---- 139
H VKL + + D +L + G L ++ + R
Sbjct: 88 DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIG---------SFDETCTRFYTA 137
Query: 140 ----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
L +LHG +I+RDLK N+LL+ + + +++DFG A+ + VGT
Sbjct: 138 EIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
Query: 196 RGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 229
Y +PE + SD+++ G ++ +L++G
Sbjct: 196 AQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 61/341 (17%), Positives = 108/341 (31%), Gaps = 92/341 (26%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQG 70
Y +G+G +G V + + + AIK +++ + +
Sbjct: 21 LLELQKKYHLKGAIGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKD 71
Query: 71 HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTR 130
+ TEV + +L H N+ +L + LV E G L + L + +
Sbjct: 72 VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131
Query: 131 V---------------------------------------KIAIDVARGLSFLHGLDANV 151
+ I + L +LH +
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GI 189
Query: 152 IYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVS--TRIVGTRGYAAPEYVATG 207
+RD+K N L +N + KL DFGL+++ +N T GT + APE + T
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 208 HL--TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
+ PK D +S GV+L LL G PF + +
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAV-------------------PFPGVNDA--DTISQV 288
Query: 266 LGGQYS--KKEAQAVAA----VVLQCLHMDPKNRPSMVDVL 300
L + ++ ++ L+ + R + L
Sbjct: 289 LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 81/315 (25%), Positives = 126/315 (40%), Gaps = 67/315 (21%)
Query: 6 AMSDPSASMISKIA--TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL 63
++ DP + + K F +G G FG V+ D VVAIK++
Sbjct: 37 SLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA-RDVRN--------SEVVAIKKM 87
Query: 64 KAESFQGHKEW---LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR 120
Q +++W + EV +L +LRH N ++ G LV E+ GS + L
Sbjct: 88 SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV 146
Query: 121 SVQPISWPTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177
+P+ V+IA +GL++LH N+I+RD+KA N+LL KL DFG A
Sbjct: 147 HKKPL---QEVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
Query: 178 RDGPTGDNTHVSTR--IVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRAL 232
+ ++ VGT + APE + G K DV+S G+ +EL
Sbjct: 202 --------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER---- 249
Query: 233 DEDRGGLAEQTLVEWADPFLRD--SRRVLRIMDT----RL-GGQYSKKEAQAVAAVVLQC 285
P L + + L + L G +S+ V C
Sbjct: 250 ----------------KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD----SC 289
Query: 286 LHMDPKNRPSMVDVL 300
L P++RP+ +L
Sbjct: 290 LQKIPQDRPTSEVLL 304
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 64/308 (20%), Positives = 108/308 (35%), Gaps = 53/308 (17%)
Query: 8 SDPSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL 63
+I + Y LG G FG V + T+ +G A K +
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFV 190
Query: 64 KAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQ 123
+ E+ + LRH LV L + + +++YEFM G L +
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250
Query: 124 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGP 181
+S V+ V +GL +H N ++ DLK N++ + + KL DFGL
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308
Query: 182 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241
+ V GT +AAPE + +D++S GV+ LLSG
Sbjct: 309 PKQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS----------- 354
Query: 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKN 292
PF ++ + ++ ++ + + + L DP
Sbjct: 355 --------PFGGENDD--ETLRNVKSCDWNMDDSAFSGISEDGK---DFIRKLLLADPNT 401
Query: 293 RPSMVDVL 300
R ++ L
Sbjct: 402 RMTIHQAL 409
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 83/318 (26%), Positives = 136/318 (42%), Gaps = 48/318 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+GEG +G V D + VAIK++ F+ + L E+ L + R
Sbjct: 35 IGEGAYGMVCSA-YDNLN--------KVRVAIKKISP--FEHQTYCQRTLREIKILLRFR 83
Query: 86 HENLVKLIG----YCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVAR 139
HEN++ + E + +V + M + L ++ Q +S + + R
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKT-QHLS-NDHICYFLYQILR 139
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGTRGY 198
GL ++H ANV++RDLK SN+LL++ + K+ DFGLAR P D+T T V TR Y
Sbjct: 140 GLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 199 AAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLV 245
APE + + T D++S G +L E+LS R + G +++ L
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 246 EWADPFLRDSRRVLRIMDTRLGGQYSKK--EAQAVAAVVLQ-CLHMDPKNRPSMVDVLTS 302
+ +R L + + +++ A + A +L L +P R + L
Sbjct: 258 CIINL---KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 303 --LEQLHTSKDMPRTPPP 318
LEQ + D P P
Sbjct: 315 PYLEQYYDPSDEPIAEAP 332
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 66/300 (22%), Positives = 113/300 (37%), Gaps = 62/300 (20%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL 75
T N + +LG G F VF + +G + A+K +K
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLE 54
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTR--VK 132
E+ L +++HEN+V L + + LV + + G E LF R ++ + +
Sbjct: 55 NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG--E--LFDRILERGVYTEKDASL 110
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVS 189
+ V + +LH +++RDLK N+L + N ++DFGL++ G +
Sbjct: 111 VIQQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 190 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249
+ GT GY APE +A + D +S GV+ LL G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP------------------- 205
Query: 250 PFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
PF ++ ++ + G Y + A+ + L DP R + L
Sbjct: 206 PFYEETES--KLFEKIKEGYYEFESPFWDDISESAK---DFICHLLEKDPNERYTCEKAL 260
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-25
Identities = 63/237 (26%), Positives = 110/237 (46%), Gaps = 32/237 (13%)
Query: 5 IAMSDPSASMISKIATKNFCSDYL----LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAI 60
+ +S + + Y +GEG +G V+K +++ G +VA+
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKA---KDS-------QGRIVAL 50
Query: 61 KRLKAESFQGHKE-----WLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLE 115
KR++ ++ E + E+ L +L H N+V LI LV+EFM K L+
Sbjct: 51 KRIRLDAE---DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLK 106
Query: 116 NHLFRSVQPISWPTRVK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174
L + + +++K + RG++ H +++RDLK N+L++S+ KL+DF
Sbjct: 107 KVLDENKTGLQ-DSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADF 163
Query: 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 229
GLAR G T V T Y AP+ V G + D++S G + E+++G+
Sbjct: 164 GLAR--AFGIPVRSYTHEVVTLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 58/309 (18%), Positives = 105/309 (33%), Gaps = 73/309 (23%)
Query: 17 KIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK 72
++ + Y LG G FG V + + +G V K +
Sbjct: 43 EVKQGSVYDYYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKY 93
Query: 73 EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL------ENHLFRSVQPIS 126
E+ + QL H L+ L + +L+ EF+ G L E++
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE----- 148
Query: 127 WPTRVKIAIDVAR----GLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDG 180
I+ R GL +H ++++ D+K N++ ++ + K+ DFGLA
Sbjct: 149 -----AEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLAT-- 199
Query: 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 240
+ + T +AAPE V + +D+++ GV+ LLSG
Sbjct: 200 -KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS---------- 248
Query: 241 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPK 291
PF + + + EA+ + L +P+
Sbjct: 249 ---------PFAGEDDL--ETLQNVKRCDWEFDEDAFSSVSPEAK---DFIKNLLQKEPR 294
Query: 292 NRPSMVDVL 300
R ++ D L
Sbjct: 295 KRLTVHDAL 303
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-25
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRH 86
LGEG +G V +++ T VA+K + + E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR------- 139
EN+VK G+ E + + L E+ G L + + + + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---------DIGMPEPDAQRFFHQLM 115
Query: 140 -GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
G+ +LHG+ + +RD+K N+LLD N K+SDFGLA + + ++ GT Y
Sbjct: 116 AGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 199 AAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
APE + DV+S G+VL +L+G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 76/331 (22%), Positives = 118/331 (35%), Gaps = 66/331 (19%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----------LTE 77
+ G +G V G +D GI VAIKR+ G L E
Sbjct: 30 ISSGSYGAVCAG-VDS---------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 78 VIYLGQLRHENLVKL----IGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK 132
+ L H N++ L + + + ++L LV E M L + + + P ++
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL-AQVIHDQRIVISPQHIQ 137
Query: 133 -IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
+ GL LH +A V++RDL N+LL N + + DF LAR T
Sbjct: 138 YFMYHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTH 192
Query: 192 IVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRAL------------------ 232
V R Y APE V T D++S G V+ E+ R+AL
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFRGSTFYNQLNKIVEVVG 251
Query: 233 ---DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 289
ED + + A +LR+S + + A+ ++ + L +
Sbjct: 252 TPKIEDVVMFSSPS----ARDYLRNSLSNVPARA--WTAVVPTADPVAL-DLIAKMLEFN 304
Query: 290 PKNRPSMVDVLTS--LEQLHTSKDMPRTPPP 318
P+ R S L E L D+
Sbjct: 305 PQRRISTEQALRHPYFESLFDPLDLTEGLSE 335
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 32/211 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
+GEG +G V+K + G A+K+++ E E + E+ L +
Sbjct: 10 IGEGTYGVVYKA----------QNNYGETFALKKIRLEKE---DEGIPSTTIREISILKE 56
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGLS 142
L+H N+VKL +LV+E + + L+ L + K + + G++
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-SVTAKSFLLQLLNGIA 114
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAA 200
+ H D V++RDLK N+L++ K++DFGLAR P TH IV T Y A
Sbjct: 115 YCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRA 168
Query: 201 PEYVATG--HLTPKSDVYSFGVVLLELLSGR 229
P+ V G + D++S G + E+++G
Sbjct: 169 PD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 66/303 (21%), Positives = 109/303 (35%), Gaps = 60/303 (19%)
Query: 18 IATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL--KAESFQGH 71
I F +Y LG+G F V + K +G A + K S + H
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDH 54
Query: 72 KEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTR- 130
++ E L+H N+V+L SE + L+++ + G L V +
Sbjct: 55 QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEAD 111
Query: 131 -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 186
+ + H + V++R+LK N+LL S KL+DFGLA +
Sbjct: 112 ASHCIQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQ 167
Query: 187 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246
GT GY +PE + D+++ GV+L LL G
Sbjct: 168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP---------------- 211
Query: 247 WADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMV 297
PF + + R+ G Y EA+ ++ + L ++P R +
Sbjct: 212 ---PFWDEDQH--RLYQQIKAGAYDFPSPEWDTVTPEAK---DLINKMLTINPSKRITAA 263
Query: 298 DVL 300
+ L
Sbjct: 264 EAL 266
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
LGEG + V+KG +VA+K ++ E H+E + EV L
Sbjct: 10 LGEGTYATVYKGKSKLT---------DNLVALKEIRLE----HEEGAPCTAIREVSLLKD 56
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGLS 142
L+H N+V L + LV+E++ K L+ +L I+ VK + RGL+
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIIN-MHNVKLFLFQLLRGLA 114
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAA 200
+ H V++RDLK N+L++ KL+DFGLAR PT + +V T Y
Sbjct: 115 YCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRP 168
Query: 201 PEYVATG--HLTPKSDVYSFGVVLLELLSGR 229
P+ + G + + D++ G + E+ +GR
Sbjct: 169 PD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 49/218 (22%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G +G V+K A+K+++ E+ L +L+H N
Sbjct: 29 VGRGTYGHVYKAK-------RKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79
Query: 89 LVKLIG-YCSESDNRL-LVYEFMP---KGSLENHLFRSVQPISWP---TRVK-IAIDVAR 139
++ L + S +D ++ L++++ ++ H VK + +
Sbjct: 80 VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNA----KLSDFGLAR--DGPTGDNTHVSTRIV 193
G+ +LH V++RDLK +N+L+ K++D G AR + P + +V
Sbjct: 140 GIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 194 GTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 229
T Y APE + G H T D+++ G + ELL+
Sbjct: 198 -TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-24
Identities = 68/305 (22%), Positives = 114/305 (37%), Gaps = 69/305 (22%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQG 70
+ F +Y LG+G F V + +G+ A K +L A FQ
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQK 51
Query: 71 HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPT 129
+ E +L+H N+V+L E LV++ + G E LF V +
Sbjct: 52 LE---REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG--E--LFEDIVAREFYSE 104
Query: 130 RV--KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGD 184
+ +++ H +++R+LK N+LL S KL+DFGLA +
Sbjct: 105 ADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVN 159
Query: 185 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244
++ GT GY +PE + + D+++ GV+L LL G
Sbjct: 160 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP-------------- 205
Query: 245 VEWADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPS 295
PF + + R+ G Y EA+ +++ L ++PK R +
Sbjct: 206 -----PFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAK---SLIDSMLTVNPKKRIT 255
Query: 296 MVDVL 300
L
Sbjct: 256 ADQAL 260
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 76/320 (23%), Positives = 120/320 (37%), Gaps = 67/320 (20%)
Query: 9 DPSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--- 61
P + A K F Y ++G G V + +G A+K
Sbjct: 78 GPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIME 128
Query: 62 ----RLKAESFQGHKEWL-TEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLE 115
RL E + +E E L Q+ H +++ LI S LV++ M KG E
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG--E 186
Query: 116 NHLF-RSVQPISWPTR--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172
LF + ++ + I + +SFLH N+++RDLK N+LLD N +LS
Sbjct: 187 --LFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIRLS 242
Query: 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELL 226
DFG + G+ + GT GY APE + D+++ GV+L LL
Sbjct: 243 DFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 227 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA------QAVAA 280
+G PF + ++ + GQY V
Sbjct: 300 AGSP-------------------PFWHRRQI--LMLRMIMEGQYQFSSPEWDDRSSTVKD 338
Query: 281 VVLQCLHMDPKNRPSMVDVL 300
++ + L +DP+ R + L
Sbjct: 339 LISRLLQVDPEARLTAEQAL 358
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 73/318 (22%), Positives = 122/318 (38%), Gaps = 68/318 (21%)
Query: 12 ASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK------ 61
A++ +T F +Y +LG G V + I + T A+K
Sbjct: 4 AALPGSHSTHGFYENYEPKEILGRGVSSVVRRC-IHKPT--------CKEYAVKIIDVTG 54
Query: 62 --RLKAESFQGHKEWL-TEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENH 117
AE Q +E EV L ++ H N+++L + LV++ M KG E
Sbjct: 55 GGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG--E-- 110
Query: 118 LF-RSVQPISWPTR--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174
LF + ++ + KI + + LH N+++RDLK N+LLD + N KL+DF
Sbjct: 111 LFDYLTEKVTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDF 168
Query: 175 GLARDGPTGDNTHVSTRIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSG 228
G + G+ + GT Y APE + D++S GV++ LL+G
Sbjct: 169 GFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
Query: 229 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVV 282
PF + ++ + G Y + V +V
Sbjct: 226 SP-------------------PFWHRKQM--LMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264
Query: 283 LQCLHMDPKNRPSMVDVL 300
+ L + P+ R + + L
Sbjct: 265 SRFLVVQPQKRYTAEEAL 282
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 49/226 (21%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
+G+G FG VFK + T G VA+K++ E+ KE L E+ L
Sbjct: 25 IGQGTFGEVFKA-RHRKT--------GQKVALKKVLMENE---KEGFPITALREIKILQL 72
Query: 84 LRHENLVKLIGYCSESDNRL--------LVYEFMP---KGSLENHLFRSVQPISWPTRVK 132
L+HEN+V LI C + LV++F G L N L + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKR 128
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVST 190
+ + GL ++H +++RD+KA+NVL+ + KL+DFGLAR + T
Sbjct: 129 VMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 191 RIVGTRGYAAPE-------YVATGHLTPKSDVYSFGVVLLELLSGR 229
V T Y PE Y P D++ G ++ E+ +
Sbjct: 187 NRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-24
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT-EVIYLGQLRH 86
LGEG +G V +++ T VA+K + + E + E+ L H
Sbjct: 14 TLGEGAYGEVQLA-VNRVT--------EEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR------- 139
EN+VK G+ E + + L E+ G L + + + + A+
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP---------DIGMPEPDAQRFFHQLM 115
Query: 140 -GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
G+ +LHG+ + +RD+K N+LLD N K+SDFGLA + + ++ GT Y
Sbjct: 116 AGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 199 AAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
APE + DV+S G+VL +L+G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 42/237 (17%)
Query: 10 PSASMISKIATKNFCSDY------LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL 63
P I S Y +LG G FG V K + +G+ +A K +
Sbjct: 72 PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---------EETATGLKLAAKII 122
Query: 64 KAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL------ENH 117
K + +E E+ + QL H NL++L ++ +LV E++ G L E++
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY 182
Query: 118 LFRSVQPISWPTRVKIAIDVAR----GLSFLHGLDANVIYRDLKASNVLLDSNFNA--KL 171
+ I + G+ +H + +++ DLK N+L + K+
Sbjct: 183 NLTELD----------TILFMKQICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKI 230
Query: 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
DFGLAR + V GT + APE V ++ +D++S GV+ LLSG
Sbjct: 231 IDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-24
Identities = 54/214 (25%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G FG VF+ + V AIK++ + + E+ + ++H N
Sbjct: 48 IGNGSFGVVFQA-KLVES--------DEV-AIKKVLQDK----RFKNRELQIMRIVKHPN 93
Query: 89 LVKLIGYCSESDNRL------LVYEFMPK--GSLENHLFRSVQPISWPTRVKIAI-DVAR 139
+V L + + ++ LV E++P+ H + Q + +K+ + + R
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP-MLLIKLYMYQLLR 152
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARD-GPTGDNTHVSTRIVGTRG 197
L+++H + +RD+K N+LLD KL DFG A+ N + +R
Sbjct: 153 SLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSY----ICSRY 206
Query: 198 YAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 229
Y APE + AT + T D++S G V+ EL+ G+
Sbjct: 207 YRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-24
Identities = 64/308 (20%), Positives = 112/308 (36%), Gaps = 61/308 (19%)
Query: 13 SMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF 68
S A+ F +Y LG+G F V + +G+ A K + +
Sbjct: 17 SEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKL 67
Query: 69 QG--HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPIS 126
++ E +L+H N+V+L E LV++ + G L V
Sbjct: 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREF 124
Query: 127 WPTRV--KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGP 181
+ + +++ H +++R+LK N+LL S KL+DFGLA
Sbjct: 125 YSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAI--- 179
Query: 182 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241
+++ GT GY +PE + + D+++ GV+L LL G
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP----------- 228
Query: 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKN 292
PF + + R+ G Y EA+ +++ L ++PK
Sbjct: 229 --------PFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAK---SLIDSMLTVNPKK 275
Query: 293 RPSMVDVL 300
R + L
Sbjct: 276 RITADQAL 283
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-24
Identities = 69/242 (28%), Positives = 107/242 (44%), Gaps = 43/242 (17%)
Query: 5 IAMSDPSASMISKIATKNFCSDYL--LGEGGFGCVF---KGWIDQNTFAPTKPGSGIVVA 59
IA++ K F + L LG+G FG VF K + + + A
Sbjct: 8 IAITHHVKEGHEKADPSQF--ELLKVLGQGSFGKVFLVKK---------ISGSDARQLYA 56
Query: 60 IKRLKAESFQGHKEW--LTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLEN 116
+K LK + + E L ++ H +VKL Y +++ +L L+ +F+ G L
Sbjct: 57 MKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFT 115
Query: 117 HLFRSVQPISWPTRVKIAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFN 168
L + V + + L LH L +IYRDLK N+LLD +
Sbjct: 116 RLSK---------EVMFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGH 164
Query: 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLS 227
KL+DFGL+++ + + GT Y APE V GH T +D +SFGV++ E+L+
Sbjct: 165 IKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLT 221
Query: 228 GR 229
G
Sbjct: 222 GT 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
LGEG +G V + T G +VAIK+++ F L E+ L +
Sbjct: 19 LGEGAYGVVCSA-THKPT--------GEIVAIKKIEP--FDKPLFALRTLREIKILKHFK 67
Query: 86 HENLVKLI----GYCSESDNRL-LVYEFMPKGSLENHLFR--SVQPISWPTRVK-IAIDV 137
HEN++ + E+ N + ++ E M + L R S Q +S ++
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHIQYFIYQT 121
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--------DGPTGDNTHVS 189
R + LHG +NVI+RDLK SN+L++SN + K+ DFGLAR +
Sbjct: 122 LRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 190 TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 229
V TR Y APE + + + DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 55/222 (24%), Positives = 102/222 (45%), Gaps = 39/222 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
LG GG G VF +D + VAIK++ K L E+ + +L
Sbjct: 19 LGCGGNGLVFSA-VDNDC--------DKRVAIKKI---VLTDPQSVKHALREIKIIRRLD 66
Query: 86 HENLVKLI--------------GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRV 131
H+N+VK+ G +E ++ +V E+M + ++ P+
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQ-GPLL-EEHA 122
Query: 132 K-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLAR-DGPTGDNTHV 188
+ + RGL ++H ANV++RDLK +N+ +++ + K+ DFGLAR P +
Sbjct: 123 RLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 189 STRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 229
+ + T+ Y +P ++ + T D+++ G + E+L+G+
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 79/354 (22%), Positives = 150/354 (42%), Gaps = 75/354 (21%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
LG+G +G V+K ID+ T G VVA+K++ ++FQ + E++ L +L
Sbjct: 17 LGKGAYGIVWKS-IDRRT--------GEVVAVKKI-FDAFQNSTDAQRTFREIMILTELS 66
Query: 86 -HENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVARGL 141
HEN+V L+ +++D + LV+++M + + + R+ + P + + + + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRA-NILE-PVHKQYVVYQLIKVI 122
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-------------------DGPT 182
+LH +++RD+K SN+LL++ + K++DFGL+R
Sbjct: 123 KYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 183 GDNTHVSTRIVGTRGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL--------- 232
D+ + T V TR Y APE + + T D++S G +L E+L + +
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIFPGSSTMNQ 239
Query: 233 ------------DEDRGGLAE---QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA 277
+ED + +T++E + + R + T+ K +A
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 278 VA---AVVL--QCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAKLHHH 324
A+ L + L +P R S D L + H + P + +
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN 353
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 71/318 (22%), Positives = 128/318 (40%), Gaps = 53/318 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V ID+ + G VAIK+L + FQ K E++ L ++
Sbjct: 32 VGSGAYGSVCSA-IDKRS--------GEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 86 HENLVKLI-----GYCSESDNRL-LVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVA 138
HEN++ L+ + LV FM + L + + S + +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQYLVYQML 136
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
+GL ++H A V++RDLK N+ ++ + K+ DFGLAR T V TR Y
Sbjct: 137 KGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 189
Query: 199 AAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLV 245
APE + + H D++S G ++ E+L+G+ + + G + +
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA-VAAVVL--QCLHMDPKNRPSMVDVLTS 302
+ D ++ ++ + +++ +A A L + L +D R + LT
Sbjct: 250 KLNDKA---AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306
Query: 303 --LEQLHTSKDMPRTPPP 318
E ++ P
Sbjct: 307 PFFEPFRDPEEETEAQQP 324
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-23
Identities = 67/344 (19%), Positives = 119/344 (34%), Gaps = 76/344 (22%)
Query: 6 AMSDPSASMISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK 61
+ + + S Y LLG GGFG V+ G + + VAIK
Sbjct: 24 CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIK 74
Query: 62 -----RLKAESFQGHKEWLT-EVIYLGQLRHE--NLVKLIGYCSESDNRLLVYEF-MPKG 112
R+ + + EV+ L ++ +++L+ + D+ +L+ E P
Sbjct: 75 HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 134
Query: 113 SLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKL 171
L + + + V + H V++RD+K N+L+D N KL
Sbjct: 135 DLFDFI-TERGALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKL 191
Query: 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR 229
DFG GTR Y+ PE++ H + V+S G++L +++ G
Sbjct: 192 IDFGSG-ALLKDTVYTDF---DGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246
Query: 230 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK-----KEAQAVAAVVLQ 284
PF ++R GQ E Q ++
Sbjct: 247 I-------------------PF-EHDEEIIR-------GQVFFRQRVSSECQ---HLIRW 276
Query: 285 CLHMDPKNRPSMVDVLT--------SLEQLHTSKDMPRTPPPAK 320
CL + P +RP+ ++ ++ +P P+K
Sbjct: 277 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK 320
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-23
Identities = 70/305 (22%), Positives = 123/305 (40%), Gaps = 60/305 (19%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQG 70
K +Y LG G G V ++ T VAI+ + S +
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLA-FERKT--------CKKVAIRIISKRKFAIGSARE 180
Query: 71 HKEWL---TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISW 127
L TE+ L +L H ++K+ + ++++ +V E M G L + + + + +
Sbjct: 181 ADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGN-KRLKE 238
Query: 128 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGD 184
T + + +LH + +I+RDLK NVLL S + K++DFG ++ G+
Sbjct: 239 ATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGE 294
Query: 185 NTHVSTRIVGTRGYAAPEYVATGHL---TPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241
+ + T + GT Y APE + + D +S GV+L LSG
Sbjct: 295 TSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY------------ 341
Query: 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPS 295
PF +V + D G+Y+ + ++ +V + L +DPK R +
Sbjct: 342 -------PPFSEHRTQV-SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT 393
Query: 296 MVDVL 300
+ L
Sbjct: 394 TEEAL 398
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 41/234 (17%)
Query: 15 ISKIATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKA 65
+ + Y LG G F V K + +G+ A K + +A
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRA 52
Query: 66 ESFQGHKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL------ENHL 118
+E + EV L Q+ H N++ L + +L+ E + G L + L
Sbjct: 53 SRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL 112
Query: 119 FRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDF 174
S + G+++LH + + DLK N++L + KL DF
Sbjct: 113 -------SEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163
Query: 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
GLA ++ I GT + APE V L ++D++S GV+ LLSG
Sbjct: 164 GLAH---EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-23
Identities = 60/263 (22%), Positives = 104/263 (39%), Gaps = 41/263 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
+G+G FG V K + + A+K + + E E+ + L
Sbjct: 22 AIGKGSFGKVCIV---------QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQ-PISWPTRVKI-AIDVARGL 141
H LV L Y + + + +V + + G L HL ++V VK+ ++ L
Sbjct: 73 EHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMAL 128
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
+L +I+RD+K N+LLD + + ++DF +A P T + GT+ Y AP
Sbjct: 129 DYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAP 183
Query: 202 EYVA----TGHLTPKSDVYSFGVVLLELLSGRR----ALDEDRGGLAEQTL---VEWADP 250
E + G+ + D +S GV ELL GRR + V +
Sbjct: 184 EMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242
Query: 251 FLRDSRRVLRIM-----DTRLGG 268
+ ++ +L+ + D R
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRFSQ 265
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-23
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 39/217 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
LGEG +G V+K ID T VAIKR++ E +E + EV L +
Sbjct: 42 LGEGTYGEVYKA-IDTVT--------NETVAIKRIRLEHE---EEGVPGTAIREVSLLKE 89
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRSVQPISWPTRVK-IAIDVAR 139
L+H N+++L + L++E+ K ++ + +S +K +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN-----PDVS-MRVIKSFLYQLIN 143
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNA-----KLSDFGLARDGPTGDNTHVSTRIVG 194
G++F H ++RDLK N+LL + + K+ DFGLAR G T +
Sbjct: 144 GVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--AFGIPIRQFTHEII 199
Query: 195 TRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 229
T Y PE + G H + D++S + E+L
Sbjct: 200 TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-23
Identities = 60/295 (20%), Positives = 111/295 (37%), Gaps = 54/295 (18%)
Query: 21 KNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLT 76
K Y LG G FG V + + S K +K +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKG-TDQVLVKK 50
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
E+ L RH N++ L + ++++EF+ + + S ++ V
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIVG 194
V L FLH N+ + D++ N++ + ++ K+ +FG AR GDN + +
Sbjct: 111 VCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFT 165
Query: 195 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254
Y APE ++ +D++S G ++ LLSG PFL +
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN-------------------PFLAE 206
Query: 255 SRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ + +I++ + +Y+ EA V + L + K+R + + L
Sbjct: 207 TNQ--QIIENIMNAEYTFDEEAFKEISIEAM---DFVDRLLVKERKSRMTASEAL 256
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-23
Identities = 72/308 (23%), Positives = 109/308 (35%), Gaps = 47/308 (15%)
Query: 20 TKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW 74
+ F Y +LGEG V + A+K ++ +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRV 57
Query: 75 LTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTR--V 131
EV L Q + H N+++LI + E D LV+E M GS+ L + +
Sbjct: 58 FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEAS 114
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLAR-----DGPTG 183
+ DVA L FLH + +RDLK N+L + K+ DF L +
Sbjct: 115 VVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 184 DNTHVSTRIVGTRGYAAPEYVATGHLTPKS-----DVYSFGVVLLELLSGRRALDEDRGG 238
+T G+ Y APE V D++S GV+L LLSG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV----- 227
Query: 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS--KKEAQAV--AA--VVLQCLHMDPKN 292
D + ++ G+Y K+ + AA ++ + L D K
Sbjct: 228 -GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQ 286
Query: 293 RPSMVDVL 300
R S VL
Sbjct: 287 RLSAAQVL 294
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 69/363 (19%), Positives = 127/363 (34%), Gaps = 89/363 (24%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V+ D+NT VAIK++ F+ K L E+ L +L+
Sbjct: 34 IGRGSYGYVYLA-YDKNT--------EKNVAIKKV-NRMFEDLIDCKRILREITILNRLK 83
Query: 86 HENLVKL----IGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVAR 139
+ +++L I + L +V E S LF++ ++ +K I ++
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLT-EEHIKTILYNLLL 140
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
G +F+H + +I+RDLK +N LL+ + + K+ DFGLAR + +T++ +
Sbjct: 141 GENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 200 AP---------EYVAT------------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 238
+V T + T D++S G + ELL+ ++ D
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 239 ----------LAEQTLVEWADPFLRDSRRVL-RIMDTRLG-------GQYSKKEAQAV-- 278
+ +R L I + +G +K E
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI-IGTPTEDDLKNINKPEVIKYIK 317
Query: 279 -------------------AAVVL--QCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRT 315
+ L L +P R ++ L L+ + K +
Sbjct: 318 LFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFS 377
Query: 316 PPP 318
Sbjct: 378 TKK 380
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLG 82
LG G FG V G Q T G VA+K ++++ G + E+ L
Sbjct: 18 TLGVGTFGKVKIG-EHQLT--------GHKVAVKILNRQKIRSLDVVGKIK--REIQNLK 66
Query: 83 QLRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR- 139
RH +++KL Y + +V E++ G L +++ + ++ AR
Sbjct: 67 LFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICK---------HGRVEEMEARR 115
Query: 140 -------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
+ + H V++RDLK NVLLD++ NAK++DFGL+ G+ S
Sbjct: 116 LFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--- 170
Query: 193 VGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
G+ YAAPE ++ + P+ D++S GV+L LL G
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 35/228 (15%)
Query: 18 IATKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESF 68
+ Y LG G F V K + +G+ A K + +A
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRR 55
Query: 69 QGHKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISW 127
+E + EV L Q+ H N++ L + +L+ E + G E LF +
Sbjct: 56 GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGG--E--LFDFLAQKES 111
Query: 128 PTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDG 180
+ + + G+++LH + + DLK N++L + KL DFGLA +
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
Query: 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
G I GT + APE V L ++D++S GV+ LLSG
Sbjct: 170 EDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-22
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 31/216 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-----LTEVIYLGQ 83
+G G +G V+K D ++ G VA+K ++ + G + EV L +
Sbjct: 17 IGVGAYGTVYKA-RDPHS--------GHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 84 LR---HENLVKLI----GYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IA 134
L H N+V+L+ ++ + ++ LV+E + + L +L ++ P +K +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIV 193
RGL FLH +++RDLK N+L+ S KL+DFGLAR T V V
Sbjct: 127 RQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV----V 180
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
T Y APE + D++S G + E+ +
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 67/206 (32%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LLG+G FG V + +G A+K LK E E LTE L
Sbjct: 155 LLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
RH L L Y ++ +RL V E+ G L HL R R A ++ L +
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDY 263
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH + NV+YRDLK N++LD + + K++DFGL ++G T GT Y APE
Sbjct: 264 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEV 320
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGR 229
+ D + GVV+ E++ GR
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 81/317 (25%), Positives = 133/317 (41%), Gaps = 52/317 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V + D T G+ VA+K+L + FQ K E+ L ++
Sbjct: 37 VGSGAYGSVCAAF-DTKT--------GLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMK 86
Query: 86 HENLVKLI-----GYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVA 138
HEN++ L+ E N + LV M L N++ + Q ++ V+ + +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DL-NNIVKC-QKLT-DDHVQFLIYQIL 142
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
RGL ++H A++I+RDLK SN+ ++ + K+ DFGLAR T V TR Y
Sbjct: 143 RGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWY 195
Query: 199 AAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLV 245
APE + H D++S G ++ ELL+GR + + G + L
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA-VAAVVL--QCLHMDPKNRPSMVDVLTS 302
+ + +R ++ + ++ A AV L + L +D R + L
Sbjct: 256 KISSE---SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 303 --LEQLHTSKDMPRTPP 317
Q H D P P
Sbjct: 313 AYFAQYHDPDDEPVADP 329
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-22
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQG 70
+N Y LG G F V K + +G+ A K R K+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGV 56
Query: 71 HKEWL-TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPT 129
+E + EV L +++H N++ L + +L+ E + G E LF + T
Sbjct: 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGG--E--LFDFLAEKESLT 112
Query: 130 RVKIAIDVAR----GLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGP 181
+ A + + G+ +LH L + + DLK N++L K+ DFGLA
Sbjct: 113 EEE-ATEFLKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--- 166
Query: 182 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
D + I GT + APE V L ++D++S GV+ LLSG
Sbjct: 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-22
Identities = 67/302 (22%), Positives = 103/302 (34%), Gaps = 52/302 (17%)
Query: 18 IATKNFCSDY-------LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG 70
+ F Y LGEG F K S A+K +
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEAN 51
Query: 71 HKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPT 129
++ E+ L H N+VKL + + LV E + G L R + +
Sbjct: 52 TQK---EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSE 105
Query: 130 R--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGD 184
I + +S +H D V++RDLK N+L + N K+ DFG AR
Sbjct: 106 TEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPP 161
Query: 185 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244
+ T YAAPE + D++S GV+L +LSG+
Sbjct: 162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF------------ 209
Query: 245 VEWADPFLRDSRRVLRIMDTRLGGQYS--KKEAQAV--AA--VVLQCLHMDPKNRPSMVD 298
+ + IM G +S + + V A ++ L +DP R M
Sbjct: 210 --QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267
Query: 299 VL 300
+
Sbjct: 268 LR 269
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 43/222 (19%)
Query: 28 LLGEGGFGCVF---KGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW----LTEVIY 80
+LG G +G VF K + +G + A+K LK + + TE
Sbjct: 61 VLGTGAYGKVFLVRK---------ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 81 LGQLRHEN-LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVA 138
L +R LV L Y +++ +L L+ +++ G L HL + R +
Sbjct: 112 LEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQ---------RERFTEHEV 161
Query: 139 R--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
+ L LH L +IYRD+K N+LLDSN + L+DFGL+++ +
Sbjct: 162 QIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 191 RIVGTRGYAAPE---YVATGHLTPKSDVYSFGVVLLELLSGR 229
GT Y AP+ +GH D +S GV++ ELL+G
Sbjct: 220 -FCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 4e-22
Identities = 75/316 (23%), Positives = 133/316 (42%), Gaps = 50/316 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V +D T G VAIK+L FQ K E+ L +R
Sbjct: 33 VGSGAYGAVCSA-VDGRT--------GAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMR 82
Query: 86 HENLVKL--IGYCSESDNRL----LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
HEN++ L + E+ + LV FM G+ L + + + + + +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH-EKLGEDRIQFLVYQMLK 139
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
GL ++H A +I+RDLK N+ ++ + K+ DFGLAR D+ T V TR Y
Sbjct: 140 GLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM--TGYVVTRWYR 192
Query: 200 APEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLVE 246
APE + T D++S G ++ E+++G+ + + + G + +
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252
Query: 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQA-VAAVVL--QCLHMDPKNRPSMVDVLTS- 302
+++ ++ + ++ A AV L + L +D + R + + L
Sbjct: 253 LQSD---EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 303 -LEQLHTSKDMPRTPP 317
E LH ++D P+
Sbjct: 310 YFESLHDTEDEPQVQK 325
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-22
Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 35/215 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWL-TEVIYLG 82
LG G F V K + G+G A K RL + +E + EV L
Sbjct: 13 LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTRVKIAIDVAR-- 139
++RH N++ L + +L+ E + G E LF + S A +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGG--E--LFDFLAEKESLTEDE--ATQFLKQI 117
Query: 140 --GLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGPTGDNTHVSTRIV 193
G+ +LH + + DLK N++L N KL DFG+A G+ I
Sbjct: 118 LDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IF 172
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
GT + APE V L ++D++S GV+ LLSG
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLGQ 83
+GEG +G VFK +N G VA+KR++ ++ +E + EV L
Sbjct: 19 IGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTG---EEGMPLSTIREVAVLRH 67
Query: 84 LR---HENLVKLI----GYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IA 134
L H N+V+L ++ + +L LV+E + + L +L + +P +K +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIV 193
+ RGL FLH V++RDLK N+L+ S+ KL+DFGLAR T V V
Sbjct: 127 FQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----V 180
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
T Y APE + D++S G + E+ +
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 43/160 (26%), Positives = 81/160 (50%), Gaps = 15/160 (9%)
Query: 77 EVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRSVQ--PISWPTRVK 132
E+ L +L H N+VKL+ +++ L +V+E + +G + P+S
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSEDQARF 141
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
D+ +G+ +LH +I+RD+K SN+L+ + + K++DFG++ + G + +S
Sbjct: 142 YFQDLIKGIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSDALLSNT- 197
Query: 193 VGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLSGR 229
VGT + APE ++ DV++ GV L + G+
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 5e-22
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 35/216 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEW---LTEVIYLGQ 83
+LG+GG+G VF Q +G + A+K L KA + K+ E L +
Sbjct: 24 VLGKGGYGKVF-----QVRKVTGA-NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR--- 139
++H +V LI Y ++ +L L+ E++ G L L R D A
Sbjct: 78 VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLER---------EGIFMEDTACFYL 127
Query: 140 -----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 194
L LH +IYRDLK N++L+ + KL+DFGL ++ + G
Sbjct: 128 AEISMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCG 183
Query: 195 TRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
T Y APE + +GH D +S G ++ ++L+G
Sbjct: 184 TIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 74/307 (24%), Positives = 119/307 (38%), Gaps = 66/307 (21%)
Query: 21 KNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-- 74
K +Y LG G G V ++ T VAIK + F
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLA-FERKT--------CKKVAIKIISKRKFAIGSAREA 56
Query: 75 ------LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISW 127
TE+ L +L H ++K+ + ++++ +V E M G E LF + V
Sbjct: 57 DPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGG--E--LFDKVVGNKRL 111
Query: 128 PTRV--KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPT 182
+ + +LH + +I+RDLK NVLL S + K++DFG ++
Sbjct: 112 KEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--IL 167
Query: 183 GDNTHVSTRIVGTRGYAAPE---YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239
G+ + + T + GT Y APE V T D +S GV+L LSG
Sbjct: 168 GETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY---------- 216
Query: 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNR 293
PF +V + D G+Y+ + ++ +V + L +DPK R
Sbjct: 217 ---------PPFSEHRTQV-SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266
Query: 294 PSMVDVL 300
+ + L
Sbjct: 267 FTTEEAL 273
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-22
Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 7 MSDPSASMISKIATKNFCSDYL--LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK 64
++ S+ K+ ++F LG+G FG VF A K + AIK LK
Sbjct: 3 LNKERPSLQIKLKIEDF--ILHKMLGKGSFGKVF--------LAEFK-KTNQFFAIKALK 51
Query: 65 AESFQGHKEW---LTE-VIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLF 119
+ + + E + H L + ++ L V E++ G L H+
Sbjct: 52 KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ 110
Query: 120 RSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179
A ++ GL FLH ++YRDLK N+LLD + + K++DFG+ ++
Sbjct: 111 SC-HKFDLSRATFYAAEIILGLQFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167
Query: 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
GD +T GT Y APE + D +SFGV+L E+L G+
Sbjct: 168 NMLGDAK-TNT-FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-22
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LLG+G FG V + +G A+K L+ E E +TE L
Sbjct: 12 LLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI-AIDVARGLS 142
RH L L Y ++ +RL V E+ G L HL R + + R + ++ L
Sbjct: 63 RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALE 119
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH +V+YRD+K N++LD + + K++DFGL ++G + T + T GT Y APE
Sbjct: 120 YLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKT-FCGTPEYLAPE 175
Query: 203 YVA-TGHLTPKSDVYSFGVVLLELLSGR 229
+ + D + GVV+ E++ GR
Sbjct: 176 VLEDNDY-GRAVDWWGLGVVMYEMMCGR 202
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 9e-22
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 45/219 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLG 82
LG G FG V G + T G VA+K ++++ G E+ L
Sbjct: 23 TLGVGTFGKVKVG-KHELT--------GHKVAVKILNRQKIRSLDVVGKIR--REIQNLK 71
Query: 83 QLRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR- 139
RH +++KL Y + + + +V E++ G L +++ + ++ +R
Sbjct: 72 LFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICK---------NGRLDEKESRR 120
Query: 140 -------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
G+ + H V++RDLK NVLLD++ NAK++DFGL+ G+ S
Sbjct: 121 LFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--- 175
Query: 193 VGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR 229
G+ YAAPE V +G L P+ D++S GV+L LL G
Sbjct: 176 CGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 61/307 (19%), Positives = 108/307 (35%), Gaps = 63/307 (20%)
Query: 17 KIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQG 70
+ DY +LG G G V + +G A+K L + +
Sbjct: 20 EPKKYAVTDDYQLSKQVLGLGVNGKVLEC---------FHRRTGQKCALKLLYDSPKAR- 69
Query: 71 HKEWLTEVIYLGQL-RHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLF-RSVQP 124
EV + Q ++V ++ + L++ E M G L + + R Q
Sbjct: 70 -----QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124
Query: 125 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGP 181
+ +I D+ + FLH N+ +RD+K N+L + + KL+DFG A++
Sbjct: 125 FTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 182 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241
+ T T Y APE + D++S GV++ LL G
Sbjct: 183 QNA---LQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP----------- 227
Query: 242 QTLVEWADPFLRDSRRVL--RIMDTRLGGQYSKKEA------QAVAAVVLQCLHMDPKNR 293
PF ++ + + + GQY + ++ L DP R
Sbjct: 228 --------PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279
Query: 294 PSMVDVL 300
++ +
Sbjct: 280 LTITQFM 286
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 60/302 (19%), Positives = 107/302 (35%), Gaps = 63/302 (20%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL 75
+ F Y +G G + + I + T + A+K + +E
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRC-IHKAT--------NMEFAVKIIDKSKRDPTEE-- 65
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTR--VK 132
I L +H N++ L + +V E M G L + ++ + R
Sbjct: 66 -IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE----LLDKILRQKFFSEREASA 120
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA----KLSDFGLARDGPTGDNTHV 188
+ + + + +LH V++RDLK SN+L ++ DFG A+ +N +
Sbjct: 121 VLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLL 177
Query: 189 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG----RRALDEDRGGLAEQTL 244
T T + APE + D++S GV+L +L+G D+ +
Sbjct: 178 MT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA--- 233
Query: 245 VEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVD 298
RI G++S + +V + LH+DP R +
Sbjct: 234 ---------------RIGS----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAAL 274
Query: 299 VL 300
VL
Sbjct: 275 VL 276
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 67/300 (22%), Positives = 111/300 (37%), Gaps = 62/300 (20%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWL 75
+ LG G V++ + G+ A+K LK K
Sbjct: 48 RDALSDFFEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVR 96
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTR--VK 132
TE+ L +L H N++KL LV E + G L F R V+ + R
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAAD 152
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVS 189
+ +++LH +++RDLK N+L + K++DFGL++ ++ +
Sbjct: 153 AVKQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLM 207
Query: 190 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249
+ GT GY APE + P+ D++S G++ LL G
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE------------------- 248
Query: 250 PFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
PF D R + L +Y A+ +V + + +DPK R + L
Sbjct: 249 PF-YDERGDQFMFRRILNCEYYFISPWWDEVSLNAK---DLVRKLIVLDPKKRLTTFQAL 304
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 28/210 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HE 87
LG G + VF+ + V +K LK K+ E+ L LR
Sbjct: 44 LGRGKYSEVFEAI-NITN--------NEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 88 NLVKL--IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI-DVARGLSFL 144
N++ L I S LV+E + N F+ + ++ + ++ + L +
Sbjct: 92 NIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLTDYDIRFYMYEILKALDYC 146
Query: 145 HGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE- 202
H +++RD+K NV++D + +L D+GLA V +R + PE
Sbjct: 147 HS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVRVASRYFKGPEL 201
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRAL 232
V D++S G +L ++ +
Sbjct: 202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 57/245 (23%), Positives = 95/245 (38%), Gaps = 64/245 (26%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V + D + G A+K++ Q + E+ + L H N
Sbjct: 15 LGTGSFGIVCEV-FDIES--------GKRFALKKV----LQDPRYKNRELDIMKVLDHVN 61
Query: 89 LVKLIGY-------------------------------------CSESDNRL-LVYEFMP 110
++KL+ Y + L ++ E++P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 111 K--GSLENHLFRSVQPISWPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167
+ RS + I + I I + R + F+H + +RD+K N+L++S
Sbjct: 122 DTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHS--LGICHRDIKPQNLLVNSKD 178
Query: 168 NA-KLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLE 224
N KL DFG A+ P+ + + +R Y APE + TP D++S G V E
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAY----ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 225 LLSGR 229
L+ G+
Sbjct: 235 LILGK 239
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 52/234 (22%), Positives = 93/234 (39%), Gaps = 34/234 (14%)
Query: 11 SASMISKIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
+ + +NF + Y LG G F V + +G A K LK
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQC---------ISKSTGQEYAAKFLKK 64
Query: 66 ESFQG--HKEWLTEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RS 121
E L E+ L + ++ L + +L+ E+ G E +F
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG--E--IFSLC 120
Query: 122 VQPISWPTRVKIAIDVAR----GLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDF 174
+ ++ I + + G+ +LH N+++ DLK N+LL + K+ DF
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228
G++R G + I+GT Y APE + +T +D+++ G++ LL+
Sbjct: 179 GMSRK--IGHACELRE-IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-21
Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 22/206 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LG G FG V SG A+K L + K+ L E L +
Sbjct: 48 TLGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
LVKL ++ N +V E++ G + +HL R + S P A + +L
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H L ++IYRDLK N+L+D +++DFG A+ T + GT APE +
Sbjct: 158 HSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEII 210
Query: 205 AT-GHLTPKSDVYSFGVVLLELLSGR 229
+ G+ D ++ GV++ E+ +G
Sbjct: 211 LSKGY-NKAVDWWALGVLIYEMAAGY 235
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 26/213 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
++G G FG V + V A+K L E + E L
Sbjct: 81 VIGRGAFGEVAVV---------KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG 131
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKI-AIDVARGLS 142
+ + L Y + DN L LV ++ G L L + + + ++ +
Sbjct: 132 DSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE-MARFYLAEMVIAID 189
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+H L + ++RD+K N+L+D N + +L+DFG D T S+ VGT Y +PE
Sbjct: 190 SVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVAVGTPDYISPE 246
Query: 203 ------YVATGHLTPKSDVYSFGVVLLELLSGR 229
+ P+ D +S GV + E+L G
Sbjct: 247 ILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGE 278
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLGQ 83
+G+G F V T G VAIK +L S Q EV +
Sbjct: 23 IGKGNFAKVKLA-RHILT--------GREVAIKIIDKTQLNPTSLQKLF---REVRIMKI 70
Query: 84 LRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
L H N+VKL + E++ L L+ E+ G + ++L + + + +
Sbjct: 71 LNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKFRQIVSAV 127
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
+ H +++RDLKA N+LLD++ N K++DFG + + G G YAAP
Sbjct: 128 QYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPPYAAP 182
Query: 202 EYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
E + P+ DV+S GV+L L+SG
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 70/371 (18%), Positives = 133/371 (35%), Gaps = 97/371 (26%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH---KEWLTEVIYLGQLR 85
+G G +G V + D+ VVAIK++ F+ K L E+ L +L
Sbjct: 61 IGTGSYGHVCEA-YDKLE--------KRVVAIKKI-LRVFEDLIDCKRILREIAILNRLN 110
Query: 86 HENLVKL----IGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVK-IAIDVAR 139
H+++VK+ I E + L +V E S LFR+ ++ +K + ++
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLT-ELHIKTLLYNLLV 167
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
G+ ++H A +++RDLK +N L++ + + K+ DFGLAR +N + I
Sbjct: 168 GVKYVH--SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 200 AP--------------EYVAT------------GHLTPKSDVYSFGVVLLELLS------ 227
+V T + T DV+S G + ELL+
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 228 ----GRRAL----DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG-------GQYSK 272
R L ++ ++ + ++ I + LG K
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI-LGTPSEEDIEALEK 344
Query: 273 KEAQAV---------------------AAVVL--QCLHMDPKNRPSMVDVLTS--LEQLH 307
++A+ A+ L + L +P R ++ + L +++
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404
Query: 308 TSKDMPRTPPP 318
++
Sbjct: 405 IAEVETNATEK 415
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-21
Identities = 65/302 (21%), Positives = 113/302 (37%), Gaps = 86/302 (28%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLT-EVIYL 81
LLG+GGFG VF G + + VAIK R+ S EV L
Sbjct: 38 LLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 82 GQLR----HENLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRSVQPISWPTRVKIAID 136
++ H +++L+ + + +LV E +P L +++ + +
Sbjct: 89 WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---------KGPLGEG 139
Query: 137 VAR--------GLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLA---RDGPTGD 184
+R + H V++RD+K N+L+D AKL DFG D P
Sbjct: 140 PSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-- 195
Query: 185 NTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 243
GTR Y+ PE+++ + V+S G++L +++ G
Sbjct: 196 --TDF---DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI------------- 237
Query: 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSK-----KEAQAVAAVVLQCLHMDPKNRPSMVD 298
PF + +L + + A+ + +CL P +RPS+ +
Sbjct: 238 ------PF-ERDQEILE-------AELHFPAHVSPDCCAL---IRRCLAPKPSSRPSLEE 280
Query: 299 VL 300
+L
Sbjct: 281 IL 282
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-21
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 26/214 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
++G G F V +G V A+K + E + E L
Sbjct: 68 VIGRGAFSEVAVV---------KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWP-TRVKIAIDVARGLS 142
+ +L + + +N L LV E+ G L L + + I R +A ++ +
Sbjct: 119 DRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAID 176
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+H L ++RD+K N+LLD + +L+DFG VGT Y +PE
Sbjct: 177 SVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSPE 233
Query: 203 YVATGHLTPKSDVY-------SFGVVLLELLSGR 229
+ P + Y + GV E+ G+
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-20
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 38/214 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQL 84
LG G FG V +G A+K LK E K+ E + L +
Sbjct: 13 TLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 63
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR----- 139
H ++++ G ++ ++ +++ G L + L +S + VA+
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAE 114
Query: 140 ---GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
L +LH ++IYRDLK N+LLD N + K++DFG A+ P T + GT
Sbjct: 115 VCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTP 167
Query: 197 GYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 229
Y APE V+T + D +SFG+++ E+L+G
Sbjct: 168 DYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGY 200
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 30/212 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
++G+G FG V + A+K L+ ++ KE ++E + L
Sbjct: 45 VIGKGSFGKVLLA---------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSV---QPISWPTRVKI-AIDVA 138
++H LV L + ++ ++L V +++ G L HL R +P R + A ++A
Sbjct: 96 VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIA 149
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
L +LH L N++YRDLK N+LLDS + L+DFGL ++ ++T ++ GT Y
Sbjct: 150 SALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEY 205
Query: 199 AAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
APE + + D + G VL E+L G
Sbjct: 206 LAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 48/226 (21%), Positives = 85/226 (37%), Gaps = 41/226 (18%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLT---EVIY 80
LG G FG V W + + V +K ++ + + + E+
Sbjct: 32 LGSGAFGFV---WTAVDKEKNKE------VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS-LENHLFRSVQPISWPTRVKIAIDVAR 139
L ++ H N++K++ LV E G L + R ++ +A
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---------HPRLDEPLAS 133
Query: 140 --------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
+ +L ++I+RD+K N+++ +F KL DFG A G +
Sbjct: 134 YIFRQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF-- 189
Query: 192 IVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDR 236
GT Y APE + + P+ +++S GV L L+ E
Sbjct: 190 -CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
+LG+G FG V + G+ + A+K LK + + + E +
Sbjct: 348 VLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
+ L +L C ++ +RL V E++ G L H+ + + P V A ++A GL
Sbjct: 399 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLF 456
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
FL +IYRDLK NV+LDS + K++DFG+ ++ T + GT Y APE
Sbjct: 457 FLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPE 512
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGR 229
+A D ++FGV+L E+L+G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 41/295 (13%), Positives = 79/295 (26%), Gaps = 59/295 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL 84
G ++ D VA+ + + +E L+ + L ++
Sbjct: 38 FHGGVPPLQFWQAL-DTAL--------DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
+ +++ L+V E++ GSL+ S P ++ +A
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP---VGAIRAMQSLAAAADAA 145
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 204
H A V S V + + + L+ D
Sbjct: 146 H--RAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA------------------------ 179
Query: 205 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264
P+ D+ G L LL R L E + + R +
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDI-- 232
Query: 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 319
++AV + + D R + +L ++Q D P
Sbjct: 233 ----------PFQISAVAARSVQGDGGIRSAS-TLLNLMQQATAVADRTEVLGPI 276
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
+LG+G FG V + G+ + A+K LK + + + E +
Sbjct: 27 VLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
+ L +L C ++ +RL V E++ G L H+ + + P V A ++A GL
Sbjct: 78 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLF 135
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
FL +IYRDLK NV+LDS + K++DFG+ ++ T + GT Y APE
Sbjct: 136 FLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAPE 191
Query: 203 YVA-TGHLTPKSDVYSFGVVLLELLSGR 229
+A + D ++FGV+L E+L+G+
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 26/230 (11%)
Query: 8 SDPSASMISKIATKNFCSDYL--LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
+ + +++ NF +++ LG+G FG V +G + A+K LK
Sbjct: 10 NGIGVNSSNRLGIDNF--EFIRVLGKGSFGKVMLA---------RVKETGDLYAVKVLKK 58
Query: 66 ESFQGHKEW---LTE-VIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFR 120
+ + +TE I H L +L C ++ +RL V EF+ G L H+ +
Sbjct: 59 DVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQK 117
Query: 121 SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180
S + A ++ L FLH +IYRDLK NVLLD + KL+DFG+ ++G
Sbjct: 118 S-RRFDEARARFYAAEIISALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174
Query: 181 PTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
T + GT Y APE + + P D ++ GV+L E+L G
Sbjct: 175 ICNGVT--TATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-20
Identities = 60/317 (18%), Positives = 110/317 (34%), Gaps = 62/317 (19%)
Query: 7 MSDPSASMISKIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK 61
+I DY +LG G G V + + A+K
Sbjct: 43 FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALK 93
Query: 62 RL-KAESFQGHKEWLTEV-IYLGQLRHENLVKLIGYC----SESDNRLLVYEFMPKGSLE 115
L + EV ++ + ++V+++ + L+V E + G L
Sbjct: 94 MLQDCPKAR------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147
Query: 116 NHLF-RSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKL 171
+ + R Q + +I + + +LH + N+ +RD+K N+L S N KL
Sbjct: 148 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKL 205
Query: 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA 231
+DFG A++ + + T T Y APE + D++S GV++ LL G
Sbjct: 206 TDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP- 261
Query: 232 LDEDRGGLAEQTLVEWADPFLRDSRRVL--RIMDTRLGGQYSKKEA------QAVAAVVL 283
PF + + + GQY + V ++
Sbjct: 262 ------------------PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR 303
Query: 284 QCLHMDPKNRPSMVDVL 300
L +P R ++ + +
Sbjct: 304 NLLKTEPTQRMTITEFM 320
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-20
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 44/218 (20%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK-----RLKAESFQGHKEWLTEVIYLG 82
LGEG FG V T VA+K LK E E+ YL
Sbjct: 16 TLGEGSFGKVKLA-THYKT--------QQKVALKFISRQLLKKSDMHMRVE--REISYLK 64
Query: 83 QLRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR- 139
LRH +++KL Y + + +V E+ G L +++ + ++ D R
Sbjct: 65 LLRHPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVE---------KKRMTEDEGRR 112
Query: 140 -------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
+ + H +++RDLK N+LLD N N K++DFGL+ G+ S
Sbjct: 113 FFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--- 167
Query: 193 VGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 229
G+ YAAPE + + P+ DV+S G+VL +L GR
Sbjct: 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-20
Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 39/218 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTEVIYLGQL 84
++G G FG V + V A+K L + + E +
Sbjct: 76 VIGRGAFGEVQLV---------RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 85 RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR---- 139
+V+L Y + D L +V E+MP G L N + + + AR
Sbjct: 127 NSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTA 175
Query: 140 ----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
L +H + I+RD+K N+LLD + + KL+DFG T VGT
Sbjct: 176 EVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGT 232
Query: 196 RGYAAPEYV----ATGHLTPKSDVYSFGVVLLELLSGR 229
Y +PE + G+ + D +S GV L E+L G
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
++G G + V + + A+K +K E ++ TE ++
Sbjct: 16 VIGRGSYAKVLLV---------RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
H LV L C ++++RL V E++ G L H+ R + R A +++ L+
Sbjct: 67 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALN 124
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH +IYRDLK NVLLDS + KL+D+G+ ++G +T ST GT Y APE
Sbjct: 125 YLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TST-FCGTPNYIAPE 180
Query: 203 YVA-TGHLTPKSDVYSFGVVLLELLSGR 229
+ + D ++ GV++ E+++GR
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGR 207
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 54/216 (25%), Positives = 86/216 (39%), Gaps = 41/216 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTEVIYLGQLRH 86
+G G FG D+ T +VA+K + + + + + E+I LRH
Sbjct: 27 DIGSGNFGVARLM-RDKLT--------KELVAVKYIERGAAIDENVQ--REIINHRSLRH 75
Query: 87 ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR------ 139
N+V+ + L ++ E+ G L + + + D AR
Sbjct: 76 PNIVRFKEVI-LTPTHLAIIMEYASGGELYERICN---------AGRFSEDEARFFFQQL 125
Query: 140 --GLSFLHGLDANVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPTGDNTHVSTRIVGT 195
G+S+ H + + +RDLK N LLD + K+ DFG ++ + VGT
Sbjct: 126 LSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 180
Query: 196 RGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR 229
Y APE V +DV+S GV L +L G
Sbjct: 181 PAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTE-VIYLGQ 83
++G G + V + + A++ +K E ++ TE ++
Sbjct: 59 VIGRGSYAKVLLV---------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 84 LRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
H LV L C ++++RL V E++ G L H+ R + R A +++ L+
Sbjct: 110 SNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALN 167
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH +IYRDLK NVLLDS + KL+D+G+ ++G +T ST GT Y APE
Sbjct: 168 YLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TST-FCGTPNYIAPE 223
Query: 203 YVA-TGHLTPKSDVYSFGVVLLELLSGR 229
+ + D ++ GV++ E+++GR
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGR 250
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 6e-19
Identities = 52/217 (23%), Positives = 81/217 (37%), Gaps = 32/217 (14%)
Query: 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 156
S S + E ++ + + VA+G+ FL I+RDL
Sbjct: 162 SASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDL 219
Query: 157 KASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA-----APEYVATGHLTP 211
A N+LL K+ DFGLARD + + APE + T
Sbjct: 220 AARNILLSEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTI 274
Query: 212 KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD--PFLRDSRRVLRIMDTRLGGQ 269
+SDV+SFGV+L E+ S G + + L++ R M
Sbjct: 275 QSDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRLKEGTR----MRAP---D 319
Query: 270 YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
Y+ E + +L C H +P RP+ +++ L L
Sbjct: 320 YTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 40/156 (25%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 29 LGEGGFGCVFKG-WIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-R 85
LG G FG V + + K + VA+K LK + H+ ++E+ L +
Sbjct: 30 LGRGAFGQVIEADAFGID-----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 86 HENLVKLIGYCSESDNRLLV-YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
H N+V L+G C++ L+V EF G+L +L R + +G F
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--------RSKRNEFVPYKTKGARFR 136
Query: 145 HGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179
G D I DLK + S+ ++ S F +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 58/321 (18%), Positives = 103/321 (32%), Gaps = 97/321 (30%)
Query: 10 PSASMISKIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL- 63
P +I DY +LG G G V + + A+K L
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQ 52
Query: 64 KAESFQGHKEWLTEV-IYLGQLRHENLVKLIGYC----SESDNRLLVYEFMPKGSLENHL 118
+ EV ++ + ++V+++ + L+V E + G E L
Sbjct: 53 DCPKAR------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG--E--L 102
Query: 119 F-----RSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAK 170
F R Q + +I + + +LH + N+ +RD+K N+L S N K
Sbjct: 103 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILK 160
Query: 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 230
L+DFG A + Y D++S GV++ LL G
Sbjct: 161 LTDFGFA-------------KETTGEKY-----------DKSCDMWSLGVIMYILLCGYP 196
Query: 231 ALDEDRGGLAEQTLVEWADPFLRDSRRVL--RIMDTRLGGQYS---------KKEAQAVA 279
PF + + + GQY +E +
Sbjct: 197 -------------------PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK--- 234
Query: 280 AVVLQCLHMDPKNRPSMVDVL 300
++ L +P R ++ + +
Sbjct: 235 MLIRNLLKTEPTQRMTITEFM 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 35/216 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH-E 87
+G G FG ++ G D G VAIK ++ H + E ++
Sbjct: 17 IGSGSFGDIYLG-TDIAA--------GEEVAIKLECVKT--KHPQLHIESKIYKMMQGGV 65
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+ + +E D ++V E + SLE+ + S T + +A + + ++H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-- 122
Query: 148 DANVIYRDLKASNVLLDSNFNAK---LSDFGLA---RDGPTGDNTHVSTR----IVGTRG 197
N I+RD+K N L+ + DFGLA RD T H+ R + GT
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH--QHIPYRENKNLTGTAR 180
Query: 198 YAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 229
YA+ + T HL + + D+ S G VL+ G
Sbjct: 181 YAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 49/223 (21%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
L+G+G FG V K + D+ VAIK +K ++F + EV L +
Sbjct: 61 LIGKGSFGQVVKAY-DRVE--------QEWVAIKIIKNKKAF--LNQAQIEVRLLELMNK 109
Query: 87 E------NLVKLIGY-------C--SE--SDNRLLVYEFMPKGSLENHLFRSVQPISWPT 129
+V L + C E S N +Y+ L N FR +S
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN---LYDL-----LRNTNFR---GVSLNL 158
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTH 187
K A + L FL + ++I+ DLK N+LL + + K+ DFG +
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQR 214
Query: 188 VSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGR 229
+ I +R Y +PE V G D++S G +L+E+ +G
Sbjct: 215 IYQYIQ-SRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 51/223 (22%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
++G+G FG V K + D VA+K ++ + F H++ E+ L LR
Sbjct: 104 VIGKGSFGQVVKAY-DHKV--------HQHVALKMVRNEKRF--HRQAAEEIRILEHLRK 152
Query: 87 E------NLVKLIGY-------C--SE--SDNRLLVYEFMPKGSLENHLFRSVQPISWPT 129
+ N++ ++ C E S N +YE + K Q S P
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSMN---LYELIKKNKF--------QGFSLPL 201
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTH 187
K A + + L LH +I+ DLK N+LL + K+ DFG + ++
Sbjct: 202 VRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQR 255
Query: 188 VSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGR 229
V T I +R Y APE V G D++S G +L ELL+G
Sbjct: 256 VYTYIQ-SRFYRAPE-VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 56/235 (23%), Positives = 92/235 (39%), Gaps = 39/235 (16%)
Query: 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQG 70
SM + NF +G G FG + G + T VAIK +K+ + Q
Sbjct: 1 SMGVLMVGPNFRVGKKIGCGNFGELRLG-KNLYT--------NEYVAIKLEPMKSRAPQL 51
Query: 71 HKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTR 130
H E+ + + ++ + +V E + SLE+ + S T
Sbjct: 52 HLEYRFYKQLGSG---DGIPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTV 107
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK-----LSDFGLA---RDGPT 182
+ IAI + + ++H N+IYRD+K N L+ N + DF LA D T
Sbjct: 108 LMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165
Query: 183 GDNTHVSTR----IVGTRGYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 229
H+ R + GT Y + + T HL + + D+ + G + + L G
Sbjct: 166 K--KHIPYREHKSLTGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 50/219 (22%), Positives = 89/219 (40%), Gaps = 39/219 (17%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK--RLKAESFQGHKEWLTEVIYLGQLRH 86
+GEG FG +F+G + VAIK ++++ Q E+ Y
Sbjct: 18 IGEGSFGVIFEG-TNLLN--------NQQVAIKFEPRRSDAPQLRDEYR---TYKLLAGC 65
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+ + + E + +LV + + SLE+ L + S T A + + +H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH- 123
Query: 147 LDANVIYRDLKASNVLLDSNFNAK-----LSDFGLA---RDGPTGDNTHVSTR----IVG 194
+ +++YRD+K N L+ + + DFG+ RD T H+ R + G
Sbjct: 124 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK--QHIPYREKKNLSG 180
Query: 195 TRGYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 229
T Y + + T HL + + D+ + G V + L G
Sbjct: 181 TARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 35/216 (16%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HE 87
+G G FG ++ G + T VAIK ++ H + L E L+
Sbjct: 15 IGSGSFGEIYLG-TNIQT--------NEEVAIKLENVKT--KHPQLLYESKIYRILQGGT 63
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+ + + E D +LV + + SLE+ + +S T + +A + + F+H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-- 120
Query: 148 DANVIYRDLKASNVLLDSNFNAK---LSDFGLA---RDGPTGDNTHVSTR----IVGTRG 197
+ ++RD+K N L+ A + DFGLA RD T H+ R + GT
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH--QHIPYRENKNLTGTAR 178
Query: 198 YAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 229
YA+ V T HL + + D+ S G VL+ L G
Sbjct: 179 YAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 45/224 (20%), Positives = 84/224 (37%), Gaps = 39/224 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G F V+ D VA+K ++ + + E+ L ++
Sbjct: 26 KLGWGHFSTVWLAK-DMVN--------NTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDA 75
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLF----------------RSVQPISWPTRV 131
+ K + +LL + F KG H+ + I
Sbjct: 76 DNTKEDSMGANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 134
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLD------SNFNAKLSDFGLARDGPTGDN 185
+I+ + GL ++H +I+ D+K NVL++ + K++D G A +
Sbjct: 135 QISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YD 189
Query: 186 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 229
H + I TR Y +PE + +D++S ++ EL++G
Sbjct: 190 EHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 37/248 (14%), Positives = 86/248 (34%), Gaps = 41/248 (16%)
Query: 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIK------RL 63
P+ ++++ + + + G +++ +T ++K RL
Sbjct: 31 PTGTVLTDKSGRQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRL 89
Query: 64 KAESFQGHKEWLTEVIY----LGQLRHENLVKLIGY-CSESDNRLLVYEFMPKGSLENHL 118
E + + L + +G+ + R LV + + SL+
Sbjct: 90 FNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQ-SA 147
Query: 119 FRSV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK--LSDF 174
+S + +++A + L FLH + ++ ++ A N+ +D ++ L+ +
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGY 205
Query: 175 GLA---RDGPTGDNTHVSTR------IVGTRGYAAPEYVATGHL----TPKSDVYSFGVV 221
G A HV+ G + + + H + +SD+ S G
Sbjct: 206 GFAFRYCP----SGKHVAYVEGSRSPHEGDLEFIS---MDL-HKGCGPSRRSDLQSLGYC 257
Query: 222 LLELLSGR 229
+L+ L G
Sbjct: 258 MLKWLYGF 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 39/248 (15%), Positives = 96/248 (38%), Gaps = 41/248 (16%)
Query: 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ 69
+I+ +A + +G+GGFGC++ ++ + + +K +++
Sbjct: 24 AVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSD----APCVVKVEPSDNGP 79
Query: 70 -----------GHKEWLTEVIYLGQLRHENLVKLIGY----CSESDNRLLVYEFMPKGSL 114
E + + I +L++ + K G + R ++ + L
Sbjct: 80 LFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DL 138
Query: 115 ENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK--LS 172
+ + + S T +++++ + L ++H + ++ D+KASN+LL+ + L
Sbjct: 139 QKIYEANAKRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLV 196
Query: 173 DFGLA---RDGPTGDNTHVSTR----IVGTRGYAAPEYVATGHL----TPKSDVYSFGVV 221
D+GLA + + GT + + + H + + D+ G
Sbjct: 197 DYGLAYRYCPEGV--HKAYAADPKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGYC 250
Query: 222 LLELLSGR 229
+++ L+G
Sbjct: 251 MIQWLTGH 258
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 55/239 (23%), Positives = 87/239 (36%), Gaps = 67/239 (28%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
LGEG FG V + D VA+K ++ + + E+ L +++
Sbjct: 26 NLGEGTFGKVVECL-DHAR-------GKSQVALKIIRNVGKY--REAARLEINVLKKIKE 75
Query: 87 E------NLVKLIGY-------C--SE--SDNRLLVYEFMPKGSLENHLFRSVQPISWPT 129
+ V + + C E N +EF+ + + QP P
Sbjct: 76 KDKENKFLCVLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNF--------QPYPLPH 124
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-------------------K 170
+A + L FLH + + + DLK N+L ++ +
Sbjct: 125 VRHMAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSG 228
++DFG A T D+ H +T IV TR Y PE V DV+S G +L E G
Sbjct: 183 VADFGSA----TFDHEHHTT-IVATRHYRPPE-VILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 57/244 (23%), Positives = 91/244 (37%), Gaps = 77/244 (31%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
LGEG FG V + D G VA+K +K + + + +E+ L L
Sbjct: 21 TLGEGAFGKVVECI-DHKA-------GGRHVAVKIVKNVDRY--CEAARSEIQVLEHLNT 70
Query: 87 E------NLVKLIGY-------C--SE--SDNRLLVYEFMPKGSLENHLFRSVQPISWPT 129
V+++ + C E + Y+F ++ + F P
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFELLGLS---TYDF-----IKENGFL---PFRLDH 119
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-------------------K 170
K+A + + ++FLH + + DLK N+L + K
Sbjct: 120 IRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLE 224
+ DFG A T D+ H ST +V TR Y APE + + DV+S G +L+E
Sbjct: 178 VVDFGSA----TYDDEHHST-LVSTRHYRAPEVILALGW------SQPCDVWSIGCILIE 226
Query: 225 LLSG 228
G
Sbjct: 227 YYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 53/245 (21%), Positives = 89/245 (36%), Gaps = 75/245 (30%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA-ESFQGHKEWLTEVIYLGQLRH 86
+G+G FG V + A+K ++ + + + E L ++++
Sbjct: 42 KMGDGTFGRVLLCQ-HIDN--------KKYYAVKVVRNIKKY--TRSAKIEADILKKIQN 90
Query: 87 E-----NLVKLIGY-------C--SESDNRLL---VYEFMPKGSLENHLFRSVQPISWPT 129
+ N+VK G C E L +YE + + +
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN---GFHIED 138
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-------------------- 169
I++ + L++L ++ + DLK N+LLD +
Sbjct: 139 IKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 170 -----KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLL 223
KL DFG A T + + + I+ TR Y APE V SD++SFG VL
Sbjct: 197 KSTGIKLIDFGCA----TFKSDYHGS-IINTRQYRAPE-VILNLGWDVSSDMWSFGCVLA 250
Query: 224 ELLSG 228
EL +G
Sbjct: 251 ELYTG 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 45/254 (17%), Positives = 92/254 (36%), Gaps = 48/254 (18%)
Query: 6 AMSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
+M P ++ + + +G GGFG ++ N A +K
Sbjct: 22 SMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLA-FPTNK--------PEKDARHVVKV 72
Query: 66 ESFQGHKEWLTEVIYLGQLRHENLV---------------KLIGY----CSESDNRLLVY 106
E Q + +E+ + ++ ++ + G R +V
Sbjct: 73 EY-QENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVM 131
Query: 107 EFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 166
E + L+ + T +++ I + L ++H + ++ D+KA+N+LL
Sbjct: 132 ERLGI-DLQ-KISGQNGTFKKSTVLQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYK 187
Query: 167 FNAK--LSDFGLA-RDGPTGDNTHVSTR----IVGTRGYAAPEYVATGHL----TPKSDV 215
+ L+D+GL+ R P G++ GT + + + H + +SDV
Sbjct: 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS---LDA-HKGVALSRRSDV 243
Query: 216 YSFGVVLLELLSGR 229
G +L L G+
Sbjct: 244 EILGYCMLRWLCGK 257
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 44/279 (15%), Positives = 82/279 (29%), Gaps = 92/279 (32%)
Query: 104 LVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 162
+V+E + L + +S Q + P KI V +GL +LH +I+ D+K N+L
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENIL 179
Query: 163 L-------------------------------------------------DSNFNAKLSD 173
L K++D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR--- 230
G A T + TR Y + E + +D++S + EL +G
Sbjct: 240 LGNACWV---HKHF--TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
Query: 231 -----ALDEDRGGLAEQTLV------EWAD------------------PFLRDSRRVLRI 261
D +A + + L+ +
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354
Query: 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
++ ++S++EA +L L + P+ R + + L
Sbjct: 355 VEKY---EWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 4e-08
Identities = 47/249 (18%), Positives = 67/249 (26%), Gaps = 73/249 (29%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL--------KAESFQGHKEWLTEVIY 80
+GEG FG VF+ D VAIK + + +E L E+I
Sbjct: 28 IGEGVFGEVFQTIADHTP-----------VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 81 LGQL---------RHENLVKLIG----------------------YCSESDNRL------ 103
+L R E + L S +D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 104 --LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 161
+V EF G + + S T I + L+ +RDL NV
Sbjct: 137 LFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEAS-LRFEHRDLHWGNV 193
Query: 162 LLDSNFNAKLSDFGLARDG---------PTGDNTHVSTRIVGTRGYA---APEYVATGHL 209
LL KL + D T G + E + TG
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG 253
Query: 210 TPKSDVYSF 218
+ D+Y
Sbjct: 254 DYQFDIYRL 262
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 4e-07
Identities = 48/349 (13%), Positives = 98/349 (28%), Gaps = 107/349 (30%)
Query: 52 PGSG-IVVAIKRLKAESFQGHKE----WLTEVIYLGQLRHENLVKLIGYCSESDNRL--- 103
GSG VA+ + Q + WL + C+ + L
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWLN----------------LKNCNSPETVLEML 202
Query: 104 --LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL----SFLHGLDANVIYRDLK 157
L+Y+ P N RS + R+ R L + + L ++ +++
Sbjct: 203 QKLLYQIDP-----NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL---LVLLNVQ 254
Query: 158 ASNVLLDSNFNAKL----SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS 213
+ N + K+ + TH+S ++ + LTP
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL-----------DHHSMT-LTPDE 302
Query: 214 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIMDTRLGGQYSK 272
+ LL + LD L + L +P +R +
Sbjct: 303 --------VKSLLL--KYLDCRPQDLPREVLT--TNPRRLSIIAESIRDGLATWD-NWKH 349
Query: 273 KEAQAVAAVVLQCL-HMDPK----------------NRPSMV-----------DVLTSLE 304
+ ++ L ++P + P+++ DV+ +
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVN 409
Query: 305 QLHTSKDMPRTPPPAKLHHHHHH-----HN------HHQGIKHTNPPRK 342
+LH + + P + + + H + H N P+
Sbjct: 410 KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 349 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.67 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.35 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.74 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.73 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.62 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.57 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.33 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.2 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.99 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.9 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.47 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.98 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.28 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.7 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-56 Score=401.19 Aligned_cols=268 Identities=28% Similarity=0.448 Sum_probs=218.1
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|.+.+.||+|+||.||+|.+... .+..++..||||+++.......+.+.+|+.+|++++||||+++++++.
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4457889999999999999999987542 345568999999998776666788999999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccC--------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSV--------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
+.+..++||||+++|+|.+++.+.. .++++.+++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLV 191 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEE
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecccccHhhEEE
Confidence 9999999999999999999996532 46899999999999999999999 8999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhh
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 242 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~ 242 (349)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+...
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986544433333344578999999999999999999999999999999999 899998765322221
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.+ ....+...|..+++++.+|+.+||+.||++|||+.+++++|+.+.+.
T Consensus 272 ~i------------------~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CI------------------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HH------------------HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HH------------------HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11 11223345667889999999999999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=402.28 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=216.6
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
..++|++.+.||+|+||+||+| .+..+++.||||++.... ....+.+.+|+.+|++++||||++++++
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a---------~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~ 100 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 100 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CccccEEEEEEecccCeEEEEE---------EECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3478999999999999999999 666679999999997543 2345678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
|++++.+|+||||++||+|.+++.+. +.+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 101 FQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 99999999999999999999999654 67999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++...............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--------- 248 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--------- 248 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------
Confidence 99876544444444456899999999999999999999999999999999999999976553222222221
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ....+..+++++.+||.+||+.||++|||+.|++.+
T Consensus 249 --------~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 249 --------L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp --------T--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred --------C--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 1 122345678899999999999999999999997654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=399.90 Aligned_cols=268 Identities=29% Similarity=0.434 Sum_probs=223.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|.+.+.||+|+||.||+|.+... ....++..||||.++.......+.+.+|+.++++++||||+++++++.
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSC----C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCc----ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 4457899999999999999999976532 234568899999998776666788999999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~ 165 (349)
+.+..++||||+++|+|.+++.+. ...+++.++..++.|++.||+||| +++|+||||||+|||++.
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDlKp~NILl~~ 163 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA--SQHFVHRDLATRNCLVGE 163 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccCHhhEEECC
Confidence 999999999999999999999653 246999999999999999999999 899999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhH
Q 018891 166 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTL 244 (349)
Q Consensus 166 ~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~ 244 (349)
++.+||+|||+++...............|++.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..+....+
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i 243 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999975444333333333568999999999999999999999999999999998 89999876543222211
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
. .......|..+++++.+|+.+||+.||++|||+.++.+.|+++..+
T Consensus 244 ~------------------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 T------------------QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp H------------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H------------------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1 1222345667888999999999999999999999999999998765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=405.70 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=214.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
.+|++.+.||+|+||.||+| .+..+|+.||||++........+.+.+|+.+|++++||||++++++|.+++
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a---------~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIA---------TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEEeEEeecCcCeEEEEE---------EECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56999999999999999999 556678999999997766566677889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
.+|+||||++|++|.+++.+ ..+++..+..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||++...
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEECCCCCEEEecCcCceec
Confidence 99999999999999998855 56999999999999999999999 899999999999999999999999999999864
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
.... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 221 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------ 286 (346)
T 4fih_A 221 SKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------ 286 (346)
T ss_dssp CSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS------------
T ss_pred CCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------
Confidence 3322 22234679999999999999999999999999999999999999997654322222221110
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
......+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 287 ----~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 287 ----PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp ----CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122345678899999999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=405.41 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=206.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++++.||+|+||.||+| .+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CCEEEEEEC------CEEEE---------EETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEE---------EECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 58999999999999999999 566678999999986543 2345678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
++.+|+||||++|++|.+++... ...+++..++.++.||+.||+||| +++|+||||||+|||++.+|.+||+|||++
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFGla 172 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCEETTCCGGGEEECTTCCEEECSTTEE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHHHEEECCCCCEEEcccccc
Confidence 99999999999999999999653 346799999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
...... ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 173 ~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----------- 239 (350)
T 4b9d_A 173 RVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS----------- 239 (350)
T ss_dssp SCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-----------
T ss_pred eeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc-----------
Confidence 753221 1112335799999999999999999999999999999999999999986553222222221
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. .....+..+++++.+||.+||+.||++|||+.++++|
T Consensus 240 ------~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 240 ------G-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ------T-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------C-CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1123345678899999999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=396.31 Aligned_cols=256 Identities=23% Similarity=0.282 Sum_probs=214.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
++|++.+.||+|+||.||+| .+..+|+.||||+++.+... .+|+.+++.++||||+++++++.+++
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a---------~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hheEeCcEeccCCCeEEEEE---------EECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56888899999999999999 55667899999999765432 36999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-cEEEeccccccc
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDFGLARD 179 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-~v~l~Dfg~~~~ 179 (349)
.+|+||||++|++|.+++.+. ..+++..+..++.|++.||+||| +++|+||||||+|||++.+| .+||+|||++..
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~ 200 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEECTTSCCEEECCCTTCEE
T ss_pred EEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecccCHHHEEEeCCCCEEEEeeCCCCeE
Confidence 999999999999999999654 67999999999999999999999 99999999999999999987 599999999986
Q ss_pred CCCCCCCc---cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 180 GPTGDNTH---VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 180 ~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
........ ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+.....+
T Consensus 201 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~------ 274 (336)
T 4g3f_A 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP------ 274 (336)
T ss_dssp C------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG------
T ss_pred ccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC------
Confidence 54332211 112246999999999999999999999999999999999999999876654444333321111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
....++.+++.+.+||.+||+.||.+|||+.|++++|......
T Consensus 275 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 275 ----------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp ----------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 0123556788999999999999999999999999999887765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=387.20 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=197.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| .+..+|+.||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLA---------YHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEE---------ECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 58999999999999999999 6667799999999865432 23467889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+.+..|+||||+ +++|.+++.+. ..+++.++..++.||+.||+||| +++|+||||||+||+++.++.+||+|||++
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH--~~~IiHRDiKP~NILl~~~~~vkl~DFGla 159 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLS 159 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTCCEEECCSSCC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCChHHeEECCCCCEEEeecCCC
Confidence 999999999999 67999998654 78999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..
T Consensus 160 ~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~---------- 226 (275)
T 3hyh_A 160 NIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN---------- 226 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------
T ss_pred eecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----------
Confidence 7543322 2233579999999999998876 5799999999999999999999976543222211111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
. ....+..+++++.+||.+||+.||++|||+.++++|=
T Consensus 227 -------~--~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 264 (275)
T 3hyh_A 227 -------G--VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD 264 (275)
T ss_dssp -------T--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred -------C--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence 0 1223456788999999999999999999999999863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=394.12 Aligned_cols=268 Identities=25% Similarity=0.377 Sum_probs=219.9
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCccccee
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
+.++...++++.+.||+|+||.||+|.+.+. .+..+++.||||.++.... ...+.+.+|+.++++++||||++++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~ 95 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGP----APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLL 95 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCC----ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 3445667889999999999999999987542 3445678999999976533 3457799999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhcc---------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
+++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||+||| +.+|+||||||
T Consensus 96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHRDLK~ 173 (308)
T 4gt4_A 96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLAT 173 (308)
T ss_dssp EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSG
T ss_pred eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCccc
Confidence 9999999999999999999999999542 245899999999999999999999 89999999999
Q ss_pred CcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccC
Q 018891 159 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 237 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~ 237 (349)
+|||+++++.+||+|||+++...............|++.|+|||++.++.|+.++|||||||++|||+| |..||.+.+.
T Consensus 174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999975444333333334578999999999999999999999999999999998 8999987653
Q ss_pred cchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 238 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
.+.... +......+.|.++++.+.+|+.+||+.||++|||+.+|+++|+.+
T Consensus 254 ~~~~~~------------------i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 QDVVEM------------------IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHH------------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHH------------------HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222211 112223445677889999999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-55 Score=389.11 Aligned_cols=264 Identities=28% Similarity=0.420 Sum_probs=210.9
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
+..+++++.+.||+|+||+||+|.++ ..||||+++... ....+.+.+|+.++++++||||++++++
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34578899999999999999999653 248999986542 3345678999999999999999999998
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+.+ +.+++||||+++|+|.+++......+++..+..++.|++.||+||| +++|+||||||+|||+++++.+||+|||
T Consensus 101 ~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 101 MTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH--AKNIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp ECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred EEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCccCHHHEEECCCCcEEEeecc
Confidence 765 5789999999999999999776678999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCcccccc---CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
++................||+.|+|||++.+ +.|+.++|||||||++|+|+||+.||.+.+..........
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~------ 251 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG------ 251 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH------
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh------
Confidence 9976544333333344679999999999864 4689999999999999999999999986554222111111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
...........+.++++.+.+|+.+||+.||++|||+.+++++|+.++.+
T Consensus 252 -------~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 252 -------RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -------TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -------cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 01111111234567788999999999999999999999999999988754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=407.93 Aligned_cols=251 Identities=24% Similarity=0.355 Sum_probs=214.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
++|++.+.||+|+||.||+| .+..+|+.||||++........+.+.+|+.+|++++||||++++++|..++
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a---------~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIA---------TVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred HhcEeeeEeccCcCcEEEEE---------EECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 57999999999999999999 566678999999997766566677889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
.+|+||||++||+|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||++...
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH--~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 99999999999999998854 56999999999999999999999 899999999999999999999999999999864
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
.... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 298 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------------ 363 (423)
T 4fie_A 298 SKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL------------ 363 (423)
T ss_dssp CSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC------------
T ss_pred CCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC------------
Confidence 3322 22334689999999999999999999999999999999999999997655322222222110
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
......+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 364 ----~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 364 ----PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ----CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122334578899999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=391.76 Aligned_cols=255 Identities=24% Similarity=0.320 Sum_probs=206.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
+..++|++.+.||+|+||.||+|+.. ....+++.||+|++..... .....+.+|+.++++++||||++++++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKI------SGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEEC------SSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEc------cCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 44578999999999999999999542 2244688999999865432 233467789999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+.+++.+|+||||++|++|.+++.+. ..+++.++..++.||+.||+||| +++|+||||||+|||++.+|.+||+|||
T Consensus 95 ~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH--~~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 95 FQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLH--SLGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EEETTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 99999999999999999999999654 68999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++....... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 172 la~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~--------- 240 (304)
T 3ubd_A 172 LSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--------- 240 (304)
T ss_dssp EEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred cceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc---------
Confidence 997543322 122335799999999999999999999999999999999999999986554322222211
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 302 (349)
. ....+..+++++.+||.+||+.||++|||+ +++++|
T Consensus 241 --------~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 241 --------A--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --------C--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1 123455678899999999999999999984 677764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-54 Score=380.77 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=200.7
Q ss_pred ccc-CCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNF-CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y-~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++| ++.+.||+|+||.||+| .+..++..||+|.+.... ....+.+.+|+.++++++||||++++++|.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~ 95 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEE---------EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 344 78889999999999999 555668999999986543 234567889999999999999999999986
Q ss_pred c----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCcEEEcC-CCcEE
Q 018891 98 E----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLDS-NFNAK 170 (349)
Q Consensus 98 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~--i~H~di~~~Nilv~~-~~~v~ 170 (349)
. ...+|+||||++|++|.+++.+. ..+++..+..++.||+.||+||| +++ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH--~~~~~IiHRDlKp~NILl~~~~g~vK 172 (290)
T 3fpq_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCCCCCGGGEEESSTTSCEE
T ss_pred eccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCCEEecccChhheeEECCCCCEE
Confidence 5 34579999999999999999654 67999999999999999999999 777 999999999999974 78999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchh-hhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~-~~~~~~~~ 249 (349)
|+|||++...... ......||+.|+|||++.+ .|+.++|||||||++|+|+||..||.+....... ..+..
T Consensus 173 l~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~--- 244 (290)
T 3fpq_A 173 IGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--- 244 (290)
T ss_dssp ECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT---
T ss_pred EEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc---
Confidence 9999999753221 2234579999999998865 6999999999999999999999999764432111 11111
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.......+...++++.+||.+||+.||++|||+.++++|
T Consensus 245 --------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 245 --------------GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --------------TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --------------CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001111223456789999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=387.50 Aligned_cols=269 Identities=26% Similarity=0.362 Sum_probs=222.6
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCC-CcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRH-ENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h-~~i~~~~~~ 95 (349)
+..++|++.+.||+|+||.||+|.+.+. .....++.||||.+..... ...+.+.+|+.+|+++.| |||++++++
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCC----CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 4457899999999999999999987643 3445567899999876543 345678899999999965 999999999
Q ss_pred EecC-CceEEEEEeCCCCChHHHHhcc---------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 96 CSES-DNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 96 ~~~~-~~~~lv~e~~~~~~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
+.+. +.+++||||+++|+|.+++... ...+++..+..++.|++.||+||| +++|+||||||+
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH--~~~iiHRDLK~~ 214 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAAR 214 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh--hCCeecCccCcc
Confidence 8654 5689999999999999999642 234899999999999999999999 899999999999
Q ss_pred cEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCc
Q 018891 160 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGG 238 (349)
Q Consensus 160 Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~ 238 (349)
|||+++++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |..||.+....
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986544443333444678999999999999999999999999999999998 89999875532
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
... ...+....+...|..+++++.+++.+||+.||++|||+.+++++|+.+.++
T Consensus 295 ~~~-----------------~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 295 EEF-----------------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHH-----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH-----------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 221 111222233455667788999999999999999999999999999988654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=370.33 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=189.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++++.||+|+||.||+| .+..+|+.||||++...... ..+.+.+|+.++++++||||++++++|.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp HHEEEEEEEEECC--EEEEE---------EETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred hhCEEeeEEecCCCeEEEEE---------EECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 47999999999999999999 55566899999998655433 346788999999999999999999998654
Q ss_pred C------------ceEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC
Q 018891 100 D------------NRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165 (349)
Q Consensus 100 ~------------~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~ 165 (349)
+ .+|+||||+++++|.+++.... ...+...++.++.||++||+||| +++|+||||||+|||++.
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH--~~~IiHRDlKp~NILl~~ 153 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTM 153 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECT
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH--HCcCccccCcHHHeEECC
Confidence 4 3689999999999999996532 22445668899999999999999 899999999999999999
Q ss_pred CCcEEEecccccccCCCCCCCc----------cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccc
Q 018891 166 NFNAKLSDFGLARDGPTGDNTH----------VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDED 235 (349)
Q Consensus 166 ~~~v~l~Dfg~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~ 235 (349)
++.+||+|||++.......... ......||+.|+|||++.+..|+.++|||||||++|+|++ ||...
T Consensus 154 ~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 154 DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp TCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred CCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence 9999999999997654332211 1123579999999999999999999999999999999996 76432
Q ss_pred cCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 236 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ....+.. ... ..........++.+.+||.+||+.||++|||+.++++|
T Consensus 231 ~~--~~~~~~~--------------~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 231 ME--RVRTLTD--------------VRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH--HHHHHHH--------------HHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cH--HHHHHHH--------------Hhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 0011111 000 00011123445678899999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=365.40 Aligned_cols=274 Identities=23% Similarity=0.325 Sum_probs=203.9
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|.+.+.||+|+||.||+|.++ |+.||||++...... ......|+..+.+++||||+++++++.++
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~-----------g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~ 69 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEec
Confidence 468999999999999999999653 678999998754322 22234567777888999999999999765
Q ss_pred C----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCC--------CeeeccCCCCcEEEcCCC
Q 018891 100 D----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDA--------NVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 100 ~----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~--------~i~H~di~~~Nilv~~~~ 167 (349)
+ .+|+||||+++++|.+++.. .++++..+..++.|++.||+||| +. +|+||||||+|||++.++
T Consensus 70 ~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH--~~~~~~~~~~~IiHRDlKp~NILl~~~~ 145 (303)
T 3hmm_A 70 NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLH--MEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHH--CCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--HhhhhccCCCCEeeccCCcccEEECCCC
Confidence 4 47999999999999999955 56899999999999999999999 66 899999999999999999
Q ss_pred cEEEecccccccCCCCCCC--ccccceecCCcccCccccccC------CCCCccceehhhHHHHHHHhCCccCccccCcc
Q 018891 168 NAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATG------HLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~ 239 (349)
.+||+|||++......... .......||+.|+|||++.+. .++.++|||||||++|||+||..||.......
T Consensus 146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~ 225 (303)
T 3hmm_A 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc
Confidence 9999999999754333221 112235799999999998764 35678999999999999999988876543221
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhccccCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS-----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
.-..-.....+... ...........+...+ ...++.+.+|+.+||+.||++|||+.++++.|+++....+
T Consensus 226 ~p~~~~~~~~~~~~--~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 226 LPYYDLVPSDPSVE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CTTTTTSCSSCCHH--HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ccchhcccccchHH--HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence 11000000000000 0111112222222222 3567789999999999999999999999999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=379.22 Aligned_cols=270 Identities=24% Similarity=0.327 Sum_probs=209.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+++|++++.||+|+||.||+| .+..+|+.||||++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a---------~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 123 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSA---------RRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR 123 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCCeEEEEEEecccCeEEEEE---------EECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence 468999999999999999999 566679999999996543 233466789999999999999999999875
Q ss_pred c------CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 98 E------SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 98 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
. .+.+|+||||++ ++|.+++.+ ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NIl~~~~~~~Ki 199 (398)
T 4b99_A 124 PTVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMH--SAQVIHRDLKPSNLLVNENCELKI 199 (398)
T ss_dssp CSSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred cccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCcCcCCCcCccccccCCCCCEEE
Confidence 3 367899999996 579998854 478999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCC--CccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 172 SDFGLARDGPTGDN--THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
+|||++........ ........||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......+....
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 99999976433221 2223346899999999998775 56899999999999999999999998876555544444322
Q ss_pred chhhhhh---------hhHhhhhccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 249 DPFLRDS---------RRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 249 ~~~~~~~---------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
....... ......+...... ...+.+++++.+||.+||..||.+|||+.++|+|
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 2111100 0000001010000 0112356789999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=368.09 Aligned_cols=270 Identities=21% Similarity=0.294 Sum_probs=204.0
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (349)
..++|++.+.||+|+||+||+|..+ .+..+++.||+|.+.... ....+.+|+.+|+.+ +||||++++++|.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~------~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQ------LQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEE------BTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEc------ccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 4678999999999999999999653 234568899999886543 345677899999998 6999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-CcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-~~v~l~Dfg~ 176 (349)
..++.|+||||+++++|.+++ ..+++.++..++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH--~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIH--QFGIVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ECCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999999988 45899999999999999999999 8999999999999999876 7999999999
Q ss_pred cccCCCCCCC--------------------------ccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCC
Q 018891 177 ARDGPTGDNT--------------------------HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 229 (349)
Q Consensus 177 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~ 229 (349)
+......... .......||+.|+|||++.+. .++.++||||+||++|+|++|.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 9754332110 111234799999999999775 5899999999999999999999
Q ss_pred ccCccccCcc-hhhhHHhhhch-hhh-------------------hhhhHhhhh---------------ccccCCCCCHH
Q 018891 230 RALDEDRGGL-AEQTLVEWADP-FLR-------------------DSRRVLRIM---------------DTRLGGQYSKK 273 (349)
Q Consensus 230 ~pf~~~~~~~-~~~~~~~~~~~-~~~-------------------~~~~~~~~~---------------~~~~~~~~~~~ 273 (349)
.||....+.. ....+...... ... +........ ...........
T Consensus 245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 9996544321 11222211100 000 000000000 00000111234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 274 EAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 274 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+++++.+||++||+.||++|||+.|+++|
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 56789999999999999999999999975
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=387.21 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=216.0
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
++|++.+.||+|+||.||+| .+..+|+.||+|.+........+.+.+|+.+|+.++||||++++++|.+.+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~---------~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred cccEEEEEEeeccCeEEEEE---------EECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 68999999999999999999 566679999999997766666678889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC--CcEEEecccccc
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGLAR 178 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~--~~v~l~Dfg~~~ 178 (349)
.+|+||||++||+|.+++......+++.++..++.||+.||.||| +++|+||||||+||+++.+ +.+||+|||++.
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH--~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeccCChhhccccCCCCCCEEEeecccee
Confidence 999999999999999999766678999999999999999999999 8999999999999999854 889999999998
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
...... ......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 306 ~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~----------- 371 (573)
T 3uto_A 306 HLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC----------- 371 (573)
T ss_dssp ECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT-----------
T ss_pred EccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC-----------
Confidence 754322 233457999999999999999999999999999999999999999876543322222211
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...........+++++.+||.+||+.||.+|||+.++++|
T Consensus 372 ----~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 372 ----DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111122234567889999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=380.30 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=207.4
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHH---HHHHHHHHhccCCCcccce
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKE---WLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~---~~~e~~~l~~l~h~~i~~~ 92 (349)
.-++|++.+.||+|+||.||+| .+..+|+.||||++..... ..... ...++.+++.++||||+++
T Consensus 187 slddf~i~k~LG~G~fG~V~la---------~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l 257 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM 257 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCE
T ss_pred chHHeEEEEEEecccCeEEEEE---------EECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEE
Confidence 3478999999999999999999 6667799999999965432 11222 3345677788899999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
+++|.+.+.+|+||||++||+|.+++.+. ..+++..+..++.||+.||+||| +++|+||||||+|||++.+|.+||+
T Consensus 258 ~~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH--~~gIiHRDLKPeNILld~~G~vKL~ 334 (689)
T 3v5w_A 258 SYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRIS 334 (689)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCchHHeEEeCCCCEEec
Confidence 99999999999999999999999999654 67999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
|||++........ ...+||+.|+|||++.+ ..|+.++|+|||||++|+|++|..||.+............
T Consensus 335 DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~----- 405 (689)
T 3v5w_A 335 DLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----- 405 (689)
T ss_dssp CCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH-----
T ss_pred ccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh-----
Confidence 9999986543322 23579999999999964 5799999999999999999999999976543322111110
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
.. ......+..+++++.+||.+||+.||.+|++ +.++++|
T Consensus 406 ---------i~--~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 406 ---------TL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---------HH--HCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---------hc--CCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 01 1112345667899999999999999999998 7888875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=341.33 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=214.0
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||+|+||.||+| .+..+++.||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEE---------EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEE---------EECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 3578999999999999999999 5566789999999977766667788999999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.+..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEECCCCCEEEeeCCCce
Confidence 9999999999999999999865 46899999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.........+..
T Consensus 165 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------------ 230 (297)
T 3fxz_A 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT------------ 230 (297)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------
T ss_pred ecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Confidence 6433322 22335689999999999999999999999999999999999999976543222111111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..+++.+.++|.+||+.||++|||+.++++|
T Consensus 231 ----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 231 ----NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp ----HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111122345677889999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=338.17 Aligned_cols=277 Identities=41% Similarity=0.689 Sum_probs=227.0
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||+|+||.||+|.+. ++..||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred HHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 5689999999999999999999532 378899999887766666788999999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccC---CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSV---QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--CCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999885532 35899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++................|++.|+|||++.+..++.++||||||+++|+|++|..||............. +... ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~-~~~~-~~~~ 262 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE-WAVE-SHNN 262 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHH-HTHH-HHTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHH-Hhhh-cccc
Confidence 9976443333333333568999999999999999999999999999999999999998765543322111 1100 0111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
...............+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 112223334444556788999999999999999999999999999999988764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=338.04 Aligned_cols=287 Identities=23% Similarity=0.346 Sum_probs=222.4
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCccccee
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
...++..++|++.+.||+|+||.||+|.+.. .+..+++.||+|.+........+.+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 77 (295)
T 3ugc_A 3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77 (295)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEECT-----TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcCcCCHHHhhhhheeeccCCEEEEEEEEec-----ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3456778999999999999999999996543 35567899999999877666667889999999999999999999
Q ss_pred eEEec--CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 94 GYCSE--SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 94 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
+++.. ....++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|
T Consensus 78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp EEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEE
T ss_pred EEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHhhEEEcCCCeEEE
Confidence 99854 35689999999999999999776667999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCc-cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 172 SDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......... +.... .
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~-~ 233 (295)
T 3ugc_A 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM-IGNDK-Q 233 (295)
T ss_dssp CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH-HCTTC-C
T ss_pred ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh-hcCcc-c
Confidence 9999997643332211 1112345667999999999999999999999999999999999986533211100 00000 0
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
....................+..+++.+.+++.+||+.||++|||+.++++.|+++..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 234 GQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp THHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00001112222333334455667889999999999999999999999999999998765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=340.24 Aligned_cols=269 Identities=29% Similarity=0.412 Sum_probs=220.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
..+..++|++.+.||+|+||.||+|.+.. ....+..||||.+.... ......+.+|+.++++++||||+++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRV------PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECC------TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEec------CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 45667899999999999999999996542 22345679999987653 334567889999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++...+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEECCCCCEEECCC
Confidence 999999999999999999999999766678999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCc-cccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhh
Q 018891 175 GLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 175 g~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~--------- 266 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS--------- 266 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---------
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---------
Confidence 9998654432211 1112345678999999999999999999999999999999 9999976543222211
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
+........+..+++.+.+++.+||..||++|||+.++++.|+.+....
T Consensus 267 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 267 ---------VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---------HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1112223345567889999999999999999999999999999998763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=341.01 Aligned_cols=265 Identities=28% Similarity=0.426 Sum_probs=218.8
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+| .+..++..||+|.+..........+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~---------~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 77 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKV---------THRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEE---------EETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEE---------EECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence 34689999999999999999999 455568899999887666666778999999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.++..++||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH--SMNIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred cCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCcCeEEECCCCCEEEeecccc
Confidence 999999999999999999999776678999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcc------------ccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHH
Q 018891 178 RDGPTGDNTHV------------STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245 (349)
Q Consensus 178 ~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~ 245 (349)
........... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 235 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN 235 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence 76433322110 013468999999999999999999999999999999999999987644322211000
Q ss_pred hhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
. ..... ...+..+++.+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 236 ~------------~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 236 V------------RGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp H------------HHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred h------------hcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00000 112345567899999999999999999999999999998765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=342.51 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=210.3
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
-++|++.+.||+|+||.||+| .+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 468999999999999999999 556678999999986543 234566889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..|+||||+++++|.+++... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.++|+|||++
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 161 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFS 161 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCCHHHEEEcCCCCEEEeeccCc
Confidence 999999999999999999999654 67999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCC-CccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
....... ......|++.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+..
T Consensus 162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---------- 228 (328)
T 3fe3_A 162 NEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR---------- 228 (328)
T ss_dssp GGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------
T ss_pred eecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 7543322 22335689999999999888775 789999999999999999999986553222221111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ....+..+++++.+|+.+||..||.+|||+.++++|
T Consensus 229 -------~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 229 -------G--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -------C--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -------C--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 112344567889999999999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=335.68 Aligned_cols=273 Identities=26% Similarity=0.376 Sum_probs=217.2
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcc
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENL 89 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i 89 (349)
.|++++..++|++.+.||+|+||.||+| .+..++..||+|.+..... .....+.+|+.++++++||||
T Consensus 3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i 73 (294)
T 4eqm_A 3 HMIGKIINERYKIVDKLGGGGMSTVYLA---------EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73 (294)
T ss_dssp -CCSSCEETTEEEEEEEEEETTEEEEEE---------EETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTB
T ss_pred cchhhHhhccEEEEEEEccCCCEEEEEE---------EECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCC
Confidence 4667888999999999999999999999 5556689999998854322 334678899999999999999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 74 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~Dlkp~Nil~~~~~~~ 150 (294)
T 4eqm_A 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAH--DMRIVHRDIKPQNILIDSNKTL 150 (294)
T ss_dssp CCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCE
T ss_pred ceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCCE
Confidence 99999999999999999999999999999654 67999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
+|+|||++........ .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+...............
T Consensus 151 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~ 229 (294)
T 4eqm_A 151 KIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV 229 (294)
T ss_dssp EECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC
T ss_pred EEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC
Confidence 9999999975433221 112235689999999999999999999999999999999999999976543221111110000
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhcCCCC
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~~~~~~ 312 (349)
+ ......+.++++.+.++|.+||..||.+|| ++.++.+.|+.+......
T Consensus 230 ~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 230 P--------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp C--------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred C--------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 0 000112344678899999999999999998 999999999988766443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=335.90 Aligned_cols=266 Identities=30% Similarity=0.455 Sum_probs=210.0
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
.++..++|++.+.||+|+||.||+|.++ +..||+|++..... ...+.+.+|+.++++++||||++++
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~ 100 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH-----------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEEC-----------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 4566789999999999999999999543 67799999865532 3346688999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCcEEEcCCCcE
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~--i~H~di~~~Nilv~~~~~v 169 (349)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+ ++|+||||+||+++.++.+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~ivH~Dikp~NIll~~~~~~ 178 (309)
T 3p86_A 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--NRNPPIVHRNLKSPNLLVDKKYTV 178 (309)
T ss_dssp EEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH--TSSSCCCCTTCCGGGEEECTTCCE
T ss_pred EEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCEECCCCChhhEEEeCCCcE
Confidence 99999999999999999999999996532 23899999999999999999999 889 9999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
+|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.........
T Consensus 179 kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~------ 250 (309)
T 3p86_A 179 KVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA------ 250 (309)
T ss_dssp EECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH------
T ss_pred EECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------
Confidence 999999987432221 112235689999999999999999999999999999999999999976543221111
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 313 (349)
..........+..+++.+.++|.+||+.||.+|||+.++++.|+.+......|
T Consensus 251 -----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 251 -----------VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp -----------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred -----------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 11122223455677889999999999999999999999999999998875444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=338.10 Aligned_cols=251 Identities=25% Similarity=0.368 Sum_probs=211.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.-++|++.+.||+|+||.||+| .+..+++.||+|++.... ......+.+|..+++.++||||++++++
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 73 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEE
Confidence 3579999999999999999999 555668999999987642 2345678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+...+..|+||||+++++|..++... ..+++..++.++.||+.||.||| +.+++||||||+||+++.+|.++|+|||
T Consensus 74 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~vkL~DFG 150 (337)
T 1o6l_A 74 FQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999999988554 67999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 151 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------- 219 (337)
T 1o6l_A 151 LCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------- 219 (337)
T ss_dssp TCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred chhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 987532222 122335789999999999999999999999999999999999999976543221111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ....+..+++++.+||.+||+.||++|| ++.++++|
T Consensus 220 --------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 220 --------E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --------C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --------C--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1 1223456788999999999999999999 99999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=343.72 Aligned_cols=271 Identities=25% Similarity=0.384 Sum_probs=221.3
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
.+..++|++.+.||+|+||.||+|.+.+.. .....++..||+|.+..... .....+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCS--TTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEeccc--CcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 345679999999999999999999764311 02335678899999976533 3456788999999999 8999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
++...+..|+||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+++|+||||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~ 232 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAAR 232 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGG
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeccccchh
Confidence 9999999999999999999999996542 35889999999999999999999 899999999999
Q ss_pred cEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCc
Q 018891 160 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGG 238 (349)
Q Consensus 160 Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~ 238 (349)
||+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986544333222223456788999999999999999999999999999999 99999765432
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
..... +........+..+++++.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 313 ~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 313 ELFKL------------------LKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp GHHHH------------------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH------------------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22211 111222344556788999999999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=334.26 Aligned_cols=286 Identities=26% Similarity=0.370 Sum_probs=231.3
Q ss_pred cceeecCCCCcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHH
Q 018891 2 YLLIAMSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIY 80 (349)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~ 80 (349)
|..|..........-.+..++|++.+.||+|+||.||+|.+... .+..++..||+|.+..... ...+.+.+|+.+
T Consensus 4 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~ 79 (313)
T 1t46_A 4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79 (313)
T ss_dssp TCCCCTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHH
T ss_pred eEEeccccCCCccccccChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHH
Confidence 34444444445555667788999999999999999999975332 2456688999999876533 345678899999
Q ss_pred Hhcc-CCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCC-----------------CCChHHHHHHHHHHHHHHH
Q 018891 81 LGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQ-----------------PISWPTRVKIAIDVARGLS 142 (349)
Q Consensus 81 l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~l~~~~~~~i~~ql~~~l~ 142 (349)
++++ +||||+++++++...+..++||||+++++|.+++..... .+++..++.++.|++.||.
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 9999 899999999999999999999999999999999965432 4899999999999999999
Q ss_pred HHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHH
Q 018891 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL 222 (349)
Q Consensus 143 ~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll 222 (349)
||| +.+++|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++
T Consensus 160 ~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 237 (313)
T 1t46_A 160 FLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237 (313)
T ss_dssp HHH--HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHH--HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHH
Confidence 999 899999999999999999999999999999865544333333335567889999999999999999999999999
Q ss_pred HHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 223 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 223 ~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
|+|++ |..||.+.......... .........+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 238 ~ellt~g~~p~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 238 WELFSLGSSPYPGMPVDSKFYKM-----------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHTTTCCSSTTCCSSHHHHHH-----------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCCCcccchhHHHHH-----------------hccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999 99999765533222111 1111222334556788999999999999999999999999
Q ss_pred HHHhhhcCC
Q 018891 302 SLEQLHTSK 310 (349)
Q Consensus 302 ~l~~~~~~~ 310 (349)
+|+++....
T Consensus 301 ~L~~~~~~~ 309 (313)
T 1t46_A 301 LIEKQISES 309 (313)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHh
Confidence 999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=337.93 Aligned_cols=272 Identities=28% Similarity=0.386 Sum_probs=219.6
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhcc-CCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (349)
-.+..++|++.+.||+|+||.||+|.+... ...+++..||+|.+.... ......+.+|+.+++++ +||||++++
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 115 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 115 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeecc----ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence 345678999999999999999999975332 234567899999987543 23456788999999999 899999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCC----------------------CCChHHHHHHHHHHHHHHHHHhcCCCCe
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQ----------------------PISWPTRVKIAIDVARGLSFLHGLDANV 151 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~l~~~~~~~i~~ql~~~l~~lH~~~~~i 151 (349)
+++...+..++||||+++++|.+++..... .+++..++.++.|++.||.||| +.++
T Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~i 193 (344)
T 1rjb_A 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSC 193 (344)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred EEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCc
Confidence 999999999999999999999999966432 3789999999999999999999 8999
Q ss_pred eeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCc
Q 018891 152 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR 230 (349)
Q Consensus 152 ~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~ 230 (349)
+|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999976544333333334567888999999999999999999999999999998 999
Q ss_pred cCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 231 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
||.+......... .+........+..+++.+.+++.+||..||.+|||+.+++++|+.+....
T Consensus 274 p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 274 PYPGIPVDANFYK-----------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp SSTTCCCSHHHHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CcccCCcHHHHHH-----------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 9976653222111 11112223344556789999999999999999999999999999987663
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=345.27 Aligned_cols=272 Identities=26% Similarity=0.391 Sum_probs=218.8
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCccccee
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
..++..++|++.+.||+|+||.||+|.+.+. .+..++..||||.+.... ......+.+|+.++++++||||++++
T Consensus 65 ~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~ 140 (367)
T 3l9p_A 65 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI 140 (367)
T ss_dssp SCBCCGGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhcCHhHeEEeeEeeeCCCEEEEEEEEccC----CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3456678999999999999999999976532 245678899999986542 33445688999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccC------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSV------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
+++......++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++
T Consensus 141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~ 218 (367)
T 3l9p_A 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPG 218 (367)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSS
T ss_pred EEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEEecCC
Confidence 99999999999999999999999996532 45899999999999999999999 89999999999999999655
Q ss_pred ---cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhh
Q 018891 168 ---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 243 (349)
Q Consensus 168 ---~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~ 243 (349)
.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...........
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~ 298 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 499999999964322222222223457889999999999999999999999999999998 9999976543222211
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
+........+..+++.+.+|+.+||+.||++|||+.+++++|+.+....
T Consensus 299 ------------------i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 299 ------------------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp ------------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ------------------HHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 1111223334566788999999999999999999999999999988764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=341.15 Aligned_cols=271 Identities=26% Similarity=0.351 Sum_probs=221.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (349)
-.+..++|++.+.||+|+||.||+|.+.+. .+..+++.||||.+..... .....+.+|+.+++++ +||||++++
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccceeeceeecCCCCceEEEEEeccc----cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 345678999999999999999999976432 3566789999999976533 3446788999999999 799999999
Q ss_pred eEEecCC-ceEEEEEeCCCCChHHHHhccCC-------------------------------------------------
Q 018891 94 GYCSESD-NRLLVYEFMPKGSLENHLFRSVQ------------------------------------------------- 123 (349)
Q Consensus 94 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------- 123 (349)
+++...+ ..++||||+++++|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9987755 48999999999999999965422
Q ss_pred ----------------CCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCc
Q 018891 124 ----------------PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 187 (349)
Q Consensus 124 ----------------~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~ 187 (349)
.+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++..........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 1899999999999999999999 8999999999999999999999999999997654443333
Q ss_pred cccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhcccc
Q 018891 188 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 266 (349)
Q Consensus 188 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (349)
......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+......... .+....
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-----------------~~~~~~ 313 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-----------------RLKEGT 313 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-----------------HHHHTC
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH-----------------HHHcCC
Confidence 3344667889999999999999999999999999999998 9999976554322211 111112
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 267 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
....+..+++.+.+++.+||+.||.+|||+.+++++|+.+..+
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 2334455678899999999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=335.59 Aligned_cols=283 Identities=40% Similarity=0.724 Sum_probs=222.6
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccce
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
....+..++|++.+.||+|+||.||+|.. .++..||+|.+...... ....+.+|+.+++.++||||+++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRL----------ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECC----------SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEe----------cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 34567789999999999999999999942 23778999998765432 23467899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccC---CCCChHHHHHHHHHHHHHHHHHhcCCC---CeeeccCCCCcEEEcCC
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSV---QPISWPTRVKIAIDVARGLSFLHGLDA---NVIYRDLKASNVLLDSN 166 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~ql~~~l~~lH~~~~---~i~H~di~~~Nilv~~~ 166 (349)
++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +. +++|+||||+||+++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--DHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH--HSSSSCEECCCCSGGGEEECTT
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEeCCCchhhEEECCC
Confidence 999999999999999999999999996532 34899999999999999999999 88 99999999999999999
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcch-hhhHH
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLV 245 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~-~~~~~ 245 (349)
+.++|+|||++........ .......|++.|+|||++.+..++.++||||||+++|+|++|..||........ .....
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp CCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 9999999999976533322 222234589999999999988999999999999999999999999964221111 11111
Q ss_pred hhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
.+...... ................+...++.+.+++.+||+.||.+|||+.+++++|+......
T Consensus 250 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 250 DWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp HHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred HHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 11111111 11222333344445567888999999999999999999999999999999754443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=327.34 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=215.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eChhhceeeheecCCCccEEEEEEec----------CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34679999999999999999999543 25679999987653 23467889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+.+..++||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred cCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH--hCCeecCCcchheEEEcCCCCEEecccccc
Confidence 999999999999999999999776678999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~----------- 221 (269)
T 4hcu_A 154 RFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------- 221 (269)
T ss_dssp GGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-----------
T ss_pred cccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-----------
Confidence 75432211 11112345677999999999999999999999999999999 999997654322221111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.......+...++.+.+++.+||+.||++|||+.+++++|+++.++
T Consensus 222 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 222 -------TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1122233445678899999999999999999999999999998765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=333.52 Aligned_cols=272 Identities=28% Similarity=0.372 Sum_probs=222.5
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccce
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
..-++..++|++.+.||+|+||.||+|..... ....++..||+|.+.... ......+.+|+.++++++||||+++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 91 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHL----KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETG----GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEecc----CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeE
Confidence 33456688999999999999999999965321 223456899999987543 2345678899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccC-----------------------CCCChHHHHHHHHHHHHHHHHHhcCCC
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSV-----------------------QPISWPTRVKIAIDVARGLSFLHGLDA 149 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~ 149 (349)
++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~ 169 (314)
T 2ivs_A 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EM 169 (314)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH--HT
T ss_pred EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH--HC
Confidence 999999999999999999999999996532 23899999999999999999999 89
Q ss_pred CeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-C
Q 018891 150 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-G 228 (349)
Q Consensus 150 ~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g 228 (349)
+++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999976544333222223456788999999999999999999999999999999 9
Q ss_pred CccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 229 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
..||.+.........+. .......+..+++.+.+++.+||+.||++|||+.+++++|+++..
T Consensus 250 ~~p~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLLK------------------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CCSSTTCCGGGHHHHHH------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHhh------------------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99997655432221111 112233445677899999999999999999999999999999876
Q ss_pred C
Q 018891 309 S 309 (349)
Q Consensus 309 ~ 309 (349)
.
T Consensus 312 ~ 312 (314)
T 2ivs_A 312 K 312 (314)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=339.63 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=210.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh------chHHHHHHHHHHhccCCCcccc
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLRHENLVK 91 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~ 91 (349)
...++|++.+.||+|+||.||+| .+..+|..||+|.+...... ..+.+.+|+.++++++||||++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~---------~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~ 79 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCC
T ss_pred ChhhceEEeeEEeeCcCEEEEEE---------EECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCc
Confidence 34678999999999999999999 55567899999998764332 3467889999999999999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC----
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF---- 167 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~---- 167 (349)
+++++......++||||+++++|.+++.. ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++
T Consensus 80 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 80 LHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSC
T ss_pred EEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEeCCCCCcc
Confidence 99999999999999999999999999954 467999999999999999999999 89999999999999998877
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
.++|+|||++........ .....|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+...
T Consensus 157 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~ 233 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233 (361)
T ss_dssp CEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred CEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 799999999976543322 22356899999999999999999999999999999999999999765533222222211
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... ........+++.+.+||.+||..||.+|||+.++++|
T Consensus 234 ~~~---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 SYD---------------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCC---------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCC---------------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 0000112356789999999999999999999999964
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=326.20 Aligned_cols=261 Identities=27% Similarity=0.387 Sum_probs=215.5
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
++..++|++.+.||+|+||.||+|.+++ +..||+|.+.... .....+.+|+.++++++||||+++++++
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKG----------QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEecC----------ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3457899999999999999999995432 5679999987654 2346688999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..++||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 150 (268)
T 3sxs_A 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGM 150 (268)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred ccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCcCcceEEECCCCCEEEccCcc
Confidence 9999999999999999999999776667999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---------- 219 (268)
T 3sxs_A 151 TRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS---------- 219 (268)
T ss_dssp EEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH----------
T ss_pred ceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH----------
Confidence 9764333211 1122345667999999999899999999999999999999 999997654322211111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.......+...++.+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 220 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 220 --------QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --------TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --------cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1112223344577899999999999999999999999999998765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=346.67 Aligned_cols=263 Identities=25% Similarity=0.402 Sum_probs=216.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||+|+||.||+|.+ ..++..||+|.+..... .....+.+|+.++++++||||+++++++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 181 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRL---------RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEE---------TTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEE---------ecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 4467899999999999999999954 44578999999875432 2334577899999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..++||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 182 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 9989999999999999999999766567999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+................+++.|+|||.+.++.++.++||||||+++|+|++ |..||.+........
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~------------- 326 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE------------- 326 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-------------
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------------
Confidence 875332211111111235667999999998999999999999999999998 999997654322111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.+....+...+..+++.+.+++.+||+.||++|||+.++++.|+++...
T Consensus 327 -----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 327 -----FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1122223344556788999999999999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=334.06 Aligned_cols=275 Identities=23% Similarity=0.280 Sum_probs=211.6
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCccc
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~ 90 (349)
....+...++|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.++++++||||+
T Consensus 13 ~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv 82 (311)
T 3niz_A 13 NLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82 (311)
T ss_dssp --CEECSSCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBC
T ss_pred ceeecchHhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEe
Confidence 3456667799999999999999999999532 3788999998654332 246678999999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
++++++...+..++||||+++ +|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIl~~~~~~~k 159 (311)
T 3niz_A 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALK 159 (311)
T ss_dssp CEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEE
T ss_pred eeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCchHhEEECCCCCEE
Confidence 999999999999999999975 888888776677999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 160 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 237 (311)
T 3niz_A 160 LADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237 (311)
T ss_dssp ECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHC
T ss_pred EccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHC
Confidence 999999976432221 2223468999999999876 5689999999999999999999999988776655544443221
Q ss_pred hhhh-hhh---hHhhhhc-------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLR-DSR---RVLRIMD-------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~-~~~---~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ... ....... ..........+++++.+||.+||+.||++|||+.++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1110 000 0000000 000001122356789999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=335.53 Aligned_cols=256 Identities=20% Similarity=0.256 Sum_probs=212.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|++.+.||+|+||.||+| .+..++..||+|.+.... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhceEeeeEEecCCCeEEEEE---------EECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 579999999999999999999 555668999999987543 3445678999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC--CCcEEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--NFNAKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~--~~~v~l~Dfg~~ 177 (349)
+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++. ++.++|+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 9999999999999999999766668999999999999999999999 899999999999999987 789999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+........
T Consensus 152 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~----- 223 (321)
T 1tki_A 152 RQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD----- 223 (321)
T ss_dssp EECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-----
T ss_pred eECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC-----
Confidence 8654322 22335789999999999988899999999999999999999999976554322222221110000
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
......+++++.+||.+||..||.+|||+.++++|-.-
T Consensus 224 ----------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~ 261 (321)
T 1tki_A 224 ----------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp ----------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred ----------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhh
Confidence 00012456789999999999999999999999987553
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=334.79 Aligned_cols=272 Identities=24% Similarity=0.380 Sum_probs=215.2
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCccc
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~ 90 (349)
......+..++|++.+.||+|+||.||+|.+... ...-..+|++|.+.... ......+.+|+.++++++||||+
T Consensus 6 ~~~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 80 (327)
T 3poz_A 6 QALLRILKETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80 (327)
T ss_dssp CCSSEECCGGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBC
T ss_pred HHHHhhcCHHHcccceEEeeCCCeEEEEEEEcCC-----CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEe
Confidence 3444556678999999999999999999965321 11123457888886543 23457788999999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
++++++... ..++|++++.+++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 81 ~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~Dikp~NIll~~~~~~k 157 (327)
T 3poz_A 81 RLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp CEEEEEESS-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEE
T ss_pred EEEEEEecC-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCChheEEECCCCCEE
Confidence 999999875 578999999999999999877788999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----- 232 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----- 232 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-----
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-----
Confidence 999999976544433333333456778999999999999999999999999999999 99999765543322211
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
........+..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 233 -------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 233 -------------EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------------HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -------------HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11222334455678899999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=333.51 Aligned_cols=274 Identities=19% Similarity=0.217 Sum_probs=221.1
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
..+.+++|++.+.||+|+||.||+| .+..+++.||||++..... ...+.+|+.+++.+ +||||+++++
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~ 72 (330)
T 2izr_A 4 VLMVGPNFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYY 72 (330)
T ss_dssp CCEETTTEEEEEECCC-CTTSEEEE---------EETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEE
T ss_pred eEEEcCCeEEEEEeeccCCceEEEE---------EECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEE
Confidence 3456789999999999999999999 5556689999998865432 33577899999999 8999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc-----E
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-----A 169 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~-----v 169 (349)
++...+..++||||+ +++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++. +
T Consensus 73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~Nill~~~~~~~~~~~ 149 (330)
T 2izr_A 73 FGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVI 149 (330)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTCTTSE
T ss_pred EEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCCHHHeeeccCCCCCCceE
Confidence 999999999999999 89999999766678999999999999999999999 899999999999999999887 9
Q ss_pred EEecccccccCCCCCCCc-----cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhH
Q 018891 170 KLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~ 244 (349)
+|+|||++.......... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+
T Consensus 150 kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~ 229 (330)
T 2izr_A 150 HIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY 229 (330)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH
T ss_pred EEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH
Confidence 999999998643332211 112357899999999999999999999999999999999999999876654443333
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 315 (349)
............. ......+ ++.+++..||..||.+||++.++++.|+++.........
T Consensus 230 ~~i~~~~~~~~~~-----------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 288 (330)
T 2izr_A 230 QKIGDTKRATPIE-----------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFD 288 (330)
T ss_dssp HHHHHHHHHSCHH-----------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHhhhccCCHH-----------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Confidence 3221111110000 0011234 899999999999999999999999999999887665533
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=333.07 Aligned_cols=275 Identities=28% Similarity=0.368 Sum_probs=212.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.+. ++.||||++..... .......|+.++++++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 34579999999999999999999543 57899999876542 2344556899999999999999999998
Q ss_pred cCCc----eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCC----------CeeeccCCCCcEEE
Q 018891 98 ESDN----RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDA----------NVIYRDLKASNVLL 163 (349)
Q Consensus 98 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~----------~i~H~di~~~Nilv 163 (349)
.... .++||||+++++|.+++.. ..+++..++.++.|++.||.||| +. +++|+||||+||++
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH--~~~~~l~~~~~~~ivH~Dlkp~Nill 164 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLH--EDIPGLKDGHKPAISHRDIKSKNVLL 164 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHT--CCEEEETTEEECEEECSCCSGGGEEE
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--hhccccccccCCCEEeCCCChHhEEE
Confidence 7543 6999999999999999955 45999999999999999999999 88 99999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccC-----CCCCccceehhhHHHHHHHhCCccCccccCc
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFGVVLLELLSGRRALDEDRGG 238 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~ll~~lltg~~pf~~~~~~ 238 (349)
+.++.+||+|||++................|++.|+|||++.+. .++.++|||||||++|+|++|..||.+....
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 99999999999999765444333333335789999999999763 4556889999999999999999999876543
Q ss_pred chhhhHHhhhc-hhhhhhhhHhhhhccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 239 LAEQTLVEWAD-PFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 239 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
........... +..... ............. ....++.+.+||.+||+.||++|||+.++++.|+++.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 245 YMLPFEEEIGQHPSLEDM--QEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp CCCTTHHHHCSSCCHHHH--HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hccchhhhhccCCchhhh--hhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 32221111110 111110 0111111111111 2356778999999999999999999999999999987653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=336.66 Aligned_cols=271 Identities=25% Similarity=0.351 Sum_probs=219.7
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
..+..++|++.+.||+|+||.||+|.+.+. ....++..||+|.+..... .....+.+|+.++++++||||+++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCc----CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 356678999999999999999999976532 2234568999999976533 33567889999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccC-----------------------CCCChHHHHHHHHHHHHHHHHHhcCCCCe
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSV-----------------------QPISWPTRVKIAIDVARGLSFLHGLDANV 151 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i 151 (349)
++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.++
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH--~~~i 195 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKF 195 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence 9999999999999999999999996532 57899999999999999999999 8999
Q ss_pred eeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCc
Q 018891 152 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR 230 (349)
Q Consensus 152 ~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~ 230 (349)
+|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++|+||||+++|+|++ |..
T Consensus 196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999875433222222223457888999999999999999999999999999999 999
Q ss_pred cCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 231 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
||.+.........+. .......+..+++.+.+++.+||+.||++|||+.++++.|+++....
T Consensus 276 p~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 276 PYYGMAHEEVIYYVR------------------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TTTTSCHHHHHHHHH------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred cCCCCChHHHHHHHh------------------CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 997654322111111 11112344567788999999999999999999999999999987653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=326.41 Aligned_cols=262 Identities=31% Similarity=0.542 Sum_probs=213.4
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-------hHHHHHHHHHHhcc
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-------HKEWLTEVIYLGQL 84 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l 84 (349)
...+..+..++|++.+.||+|+||.||+| .+..+++.||+|.+....... .+.+.+|+.+++++
T Consensus 10 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 80 (287)
T 4f0f_A 10 KSRLPTLADNEIEYEKQIGKGGFGLVHKG---------RLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80 (287)
T ss_dssp --CCCBCCSTTEEEEEECCCCSSSCEEEE---------EETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC
T ss_pred chhhhhhhhccceehhccccCCceeEEEE---------EEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC
Confidence 44456677899999999999999999999 445568899999986543321 16788999999999
Q ss_pred CCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCcEE
Q 018891 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVL 162 (349)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~--i~H~di~~~Nil 162 (349)
+||||+++++++.... ++||||+++++|.+++......+++..++.++.|++.||+||| +.+ ++|+||||+||+
T Consensus 81 ~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~~~ivH~dikp~Nil 156 (287)
T 4f0f_A 81 NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ--NQNPPIVHRDLRSPNIF 156 (287)
T ss_dssp CCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCSCCSGGGEE
T ss_pred CCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH--hCCCCeecCCCCcceEE
Confidence 9999999999986544 7999999999999999777778999999999999999999999 889 999999999999
Q ss_pred EcCCCc-----EEEecccccccCCCCCCCccccceecCCcccCcccc--ccCCCCCccceehhhHHHHHHHhCCccCccc
Q 018891 163 LDSNFN-----AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDED 235 (349)
Q Consensus 163 v~~~~~-----v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~--~~~~~~~~~DiwslG~ll~~lltg~~pf~~~ 235 (349)
++.++. ++|+|||++..... ......+++.|+|||++ ....++.++|+||||+++|+|++|..||...
T Consensus 157 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 231 (287)
T 4f0f_A 157 LQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231 (287)
T ss_dssp ESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred EeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 988776 99999999874322 12235689999999998 3456788999999999999999999999765
Q ss_pred cCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 236 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
....... .............+..+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus 232 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 232 SYGKIKF---------------INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CCCHHHH---------------HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cccHHHH---------------HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 5322211 1111122233345567788999999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=339.81 Aligned_cols=278 Identities=26% Similarity=0.364 Sum_probs=226.0
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (349)
..+..++|++.+.||+|+||.||+|.+.+.. ......+..||+|++..... .....+.+|+.+++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLD--KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSS--TTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEcccc--ccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 4566789999999999999999999764321 01334567899999876533 3446788999999999 899999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp 219 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAA 219 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCc
Confidence 99999999999999999999999996542 35999999999999999999999 89999999999
Q ss_pred CcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccC
Q 018891 159 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 237 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~ 237 (349)
+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+...
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986544333233333456788999999999999999999999999999999 9999976543
Q ss_pred cchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 018891 238 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315 (349)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 315 (349)
..... .+........+..+++++.+++.+||+.||++|||+.+++++|+++......+..
T Consensus 300 ~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 300 EELFK------------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp HHHHH------------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred HHHHH------------------HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 22111 1112222334456778899999999999999999999999999999877555443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=326.83 Aligned_cols=274 Identities=16% Similarity=0.186 Sum_probs=221.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
.++.+++|++.+.||+|+||.||+| .+..+++.||+|++.... ....+.+|+..++.+ +|++++++++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~ 73 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 73 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEE---------EETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEE---------EECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEe
Confidence 4567889999999999999999999 455568999999886543 234567899999999 7999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc-----E
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-----A 169 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~-----v 169 (349)
++......++||||+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++. +
T Consensus 74 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~~~~~~ 150 (298)
T 1csn_A 74 FGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMI 150 (298)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCE
T ss_pred ecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHEEeccCCCCCCCeE
Confidence 999999999999999 89999999776667999999999999999999999 999999999999999987776 9
Q ss_pred EEecccccccCCCCCCCc-----cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhH
Q 018891 170 KLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~ 244 (349)
+|+|||++.......... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.........+
T Consensus 151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 230 (298)
T 1csn_A 151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230 (298)
T ss_dssp EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence 999999997654432211 122356899999999999999999999999999999999999999876544333322
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 314 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 314 (349)
............ ......+++.+.+++.+||+.||++|||+.++++.|+++....+...
T Consensus 231 ~~~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 231 ERIGEKKQSTPL-----------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HHHHHHHHHSCH-----------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HHHHhhccCccH-----------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 221111000000 00112456789999999999999999999999999999988765543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=336.72 Aligned_cols=287 Identities=24% Similarity=0.330 Sum_probs=226.4
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCccccee
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
+...+..++|++.+.||+|+||.||+|.+.. .+..++..||+|.+........+.+.+|+.++++++||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDP-----LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECT-----TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEecc-----CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 3344567899999999999999999996543 35567899999999877666667789999999999999999999
Q ss_pred eEEe--cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 94 GYCS--ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 94 ~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
+++. .....++||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~kl 168 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKI 168 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChhhEEECCCCCEEE
Confidence 9886 445689999999999999999765567999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCc-cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 172 SDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
+|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.............. .
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~---~ 245 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE---R 245 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc---c
Confidence 9999998654333211 11224577789999999999999999999999999999999999865432111110000 1
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
....................+..+++.+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111112233333444445556778899999999999999999999999999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=326.13 Aligned_cols=281 Identities=21% Similarity=0.298 Sum_probs=217.0
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+..++|++.+.||+|+||.||+| .+..+++.||||++..... .....+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 75 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEE---------EECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 345789999999999999999999 4455688999999876543 345677899999999999999999999
Q ss_pred EecCC--ceEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE----cCCC
Q 018891 96 CSESD--NRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNF 167 (349)
Q Consensus 96 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv----~~~~ 167 (349)
+.... ..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++ +.++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~ 153 (319)
T 4euu_A 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQS 153 (319)
T ss_dssp EECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEECTTSCE
T ss_pred eecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEEeccCCCCc
Confidence 87655 7799999999999999996532 33999999999999999999999 8999999999999999 7788
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccc--------cCCCCCccceehhhHHHHHHHhCCccCccccCcc
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--------TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~ 239 (349)
.++|+|||++......... ....+++.|+|||++. +..++.++|||||||++|+|++|..||.......
T Consensus 154 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 230 (319)
T 4euu_A 154 VYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (319)
T ss_dssp EEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred eEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence 8999999999865443221 2246899999999986 5778999999999999999999999997654433
Q ss_pred hhhhHH-hhhchhhhh-------hhhHhhhh--ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 240 AEQTLV-EWADPFLRD-------SRRVLRIM--DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 240 ~~~~~~-~~~~~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
....+. ......... ........ ........+..+++.+.+++.+||+.||++|||+.+++++..+-.-.
T Consensus 231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 222221 111100000 00000000 11112345678999999999999999999999999999999875544
Q ss_pred CC
Q 018891 310 KD 311 (349)
Q Consensus 310 ~~ 311 (349)
.+
T Consensus 311 ~~ 312 (319)
T 4euu_A 311 GN 312 (319)
T ss_dssp --
T ss_pred CC
Confidence 33
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=325.92 Aligned_cols=265 Identities=24% Similarity=0.352 Sum_probs=206.9
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+..++|++.+.||+|+||.||+|.+.. ....+..|++|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEec------CCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 4567899999999999999999996542 23346789999987543 2345678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+. ++..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 161 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFG 161 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecccccHHHEEECCCCCEEECccc
Confidence 85 46789999999999999999766667999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++......... ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.........+.
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~--------- 231 (281)
T 1mp8_A 162 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE--------- 231 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---------
T ss_pred cccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH---------
Confidence 99764332211 1122345778999999998999999999999999999996 999997655432222111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.......+..+++.+.+++.+||..||++|||+.++++.|+++...
T Consensus 232 ---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 232 ---------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1112234556788999999999999999999999999999988653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=344.83 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=210.7
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccce
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
.+....++|++.+.||+|+||.||+| .+..+++.+|+|.+..... .....+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~---------~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l 75 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEE---------EETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCE
T ss_pred ccccccCCeEEEEEeccCCCeEEEEE---------EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeE
Confidence 45556789999999999999999999 5566789999999865432 344668899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc---CCCcE
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNA 169 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~---~~~~v 169 (349)
++++.+.+..++||||+.+++|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+||+++ .++.+
T Consensus 76 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH--~~givHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 76 HDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp EEEEECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSSTTEEESBSSTTCCE
T ss_pred EEEEEECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEeccCCCCcE
Confidence 99999999999999999999999988654 67999999999999999999999 89999999999999998 46789
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
+|+|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 153 kL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~- 229 (444)
T 3soa_A 153 KLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGA- 229 (444)
T ss_dssp EECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-
T ss_pred EEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCC-
Confidence 9999999976433222 2223578999999999999999999999999999999999999997654322222222110
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..........+++++.+||.+||+.||++|||+.++++|
T Consensus 230 --------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 230 --------------YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --------------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --------------CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001111223567889999999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=339.37 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=206.0
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhcc-CCCcccc
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQL-RHENLVK 91 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~ 91 (349)
..+.-++|++.+.||+|+||.||+| .+..+++.||+|++.... ......+.+|..+++.+ +||||++
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~ 88 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLA---------RVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCC
T ss_pred CCCchhheEEEEEEeeCCCEEEEEE---------EEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceee
Confidence 3455689999999999999999999 555568999999987642 23445677899999988 7999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
+++++...+..|+||||+++++|.+++.+. ..+++..++.++.||+.||+||| +.+|+||||||+||+++.++.++|
T Consensus 89 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCCHHHEEECCCCCEEE
Confidence 999999999999999999999999998654 67999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 166 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----- 238 (353)
T 3txo_A 166 ADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----- 238 (353)
T ss_dssp CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----
T ss_pred ccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc-----
Confidence 9999987532222 222335789999999999999999999999999999999999999976654332222221
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 302 (349)
. ....+..+++++.+||.+||+.||.+||++ .++++|
T Consensus 239 ------------~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 239 ------------D--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp ------------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred ------------C--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 122344567889999999999999999998 788864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=327.00 Aligned_cols=283 Identities=28% Similarity=0.380 Sum_probs=222.9
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccc
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVK 91 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~ 91 (349)
.....+..++|++.+.||+|+||.||+|.+.. .+..+++.||+|.+..... .....+.+|+.+++.++||||++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 87 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDP-----EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECT-----TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCC
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEcc-----ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeee
Confidence 33455667889999999999999999997543 3566789999999875533 34477889999999999999999
Q ss_pred eeeEEecC--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 92 LIGYCSES--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 92 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
+++++... ...++||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp EEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEE
T ss_pred eeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh--cCCcccCCCchheEEEcCCCCE
Confidence 99999876 6789999999999999999776678999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCC-ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 170 KLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
+|+|||++......... .......++..|+|||++.+..++.++|+||||+++|+|++|..|+...... .....
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~ 240 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL-----FLKMI 240 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHH
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH-----Hhhcc
Confidence 99999999765443321 1122245677899999999999999999999999999999999987432210 00000
Q ss_pred ch--hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 249 DP--FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 249 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
.+ ....................+..+++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 00 111112223333334444556778899999999999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=337.94 Aligned_cols=268 Identities=29% Similarity=0.437 Sum_probs=209.1
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
..+..++|++.+.||+|+||.||+|.+. .....+..||||.+.... ......+.+|+.++++++||||+++++
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 113 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLK------LPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CB------CTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEe------cCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3456679999999999999999999543 122457789999987653 234567889999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++...+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 114 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Df 191 (373)
T 2qol_A 114 VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDF 191 (373)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCcceEEEcCCCCEEECcC
Confidence 999999999999999999999999776668999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhh
Q 018891 175 GLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 175 g~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|++........... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...........
T Consensus 192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~--------- 262 (373)
T 2qol_A 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA--------- 262 (373)
T ss_dssp ----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH---------
T ss_pred ccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---------
Confidence 99976433221111 111234667999999999999999999999999999998 9999976543221111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
+........+..++..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 263 ---------i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 263 ---------VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ---------HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---------HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 111122233446678899999999999999999999999999998765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=329.88 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=209.8
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.-++|++.+.||+|+||.||+| .+..+|+.||+|++..... ...+.+.+|..+++.++||||++++++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 74 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT 74 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEE
Confidence 4579999999999999999999 5556689999999876432 345667889999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+.+....|+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.+|.++|+|||
T Consensus 75 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~Dfg 151 (318)
T 1fot_A 75 FQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFG 151 (318)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChheEEEcCCCCEEEeecC
Confidence 99999999999999999999999654 67999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++...... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 152 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~---------- 216 (318)
T 1fot_A 152 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL---------- 216 (318)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----------
T ss_pred cceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 99764322 123568999999999999999999999999999999999999997654322111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
.. ....+..+++++.++|.+||..||++|| ++.++++|
T Consensus 217 -------~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 217 -------NA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp -------HC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -------hC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11 1123455678899999999999999999 89999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=331.86 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=209.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh------chHHHHHHHHHHhccCCCcccc
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLRHENLVK 91 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~ 91 (349)
...++|++.+.||+|+||.||+| .+..++..||+|.+...... ....+.+|+.+++.++||||++
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~ 78 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEE---------EETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccceEeceEEeeCCCeEEEEE---------EECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 34678999999999999999999 55566899999998654322 3567889999999999999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC----
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF---- 167 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~---- 167 (349)
+++++......++||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 79 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 79 LHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSSSC
T ss_pred EEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHH--HCCeEcCCCCHHHEEEecCCCCCC
Confidence 99999999999999999999999999954 467999999999999999999999 89999999999999999887
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
.++|+|||++........ .....|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+...
T Consensus 156 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 232 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232 (326)
T ss_dssp CEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT
T ss_pred CEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc
Confidence 799999999976543222 22346899999999999999999999999999999999999999765432222221111
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. .........+++.+.+||.+||..||++|||+.++++|
T Consensus 233 ~~---------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 NY---------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CC---------------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CC---------------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00000112346789999999999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=335.49 Aligned_cols=256 Identities=25% Similarity=0.319 Sum_probs=206.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||+|+||.||+| .+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 77 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 77 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhceeeeEEecCCCEEEEEE---------EECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 69999999999999999999 45556889999998654332 335678999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 154 (323)
T 3tki_A 78 NIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATV 154 (323)
T ss_dssp SEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCccccccchHHEEEeCCCCEEEEEeeccce
Confidence 999999999999999998844 467999999999999999999999 89999999999999999999999999999975
Q ss_pred CCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
..............|++.|+|||++.+..+ +.++||||||+++|+|++|..||..............
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~------------ 222 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------ 222 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH------------
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh------------
Confidence 433332222334578999999999987765 6789999999999999999999976554322111110
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
...........+++.+.+||.+||+.||++|||+.+++++-+
T Consensus 223 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 223 ----EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp ----TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ----cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 011111112456788999999999999999999999998644
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=337.72 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=208.6
Q ss_pred CcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhcc-CC
Q 018891 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQL-RH 86 (349)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h 86 (349)
.+.....+..++|++.+.||+|+||.||+| .+..+++.||+|.+.... ......+..|..+++.+ +|
T Consensus 7 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~h 77 (345)
T 1xjd_A 7 RPSLQIKLKIEDFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77 (345)
T ss_dssp ---------CTTEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTC
T ss_pred CCCccCCCChHHeEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCC
Confidence 344445667789999999999999999999 555568999999987643 23445677888888877 89
Q ss_pred CcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC
Q 018891 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 166 (349)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~ 166 (349)
|||+++++++...+..|+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.+
T Consensus 78 p~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~ 154 (345)
T 1xjd_A 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKD 154 (345)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTT
T ss_pred CCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCChhhEEECCC
Confidence 99999999999999999999999999999999654 67999999999999999999999 8999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
|.++|+|||++........ ......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 155 g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 232 (345)
T 1xjd_A 155 GHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232 (345)
T ss_dssp SCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 9999999999975322221 12335789999999999999999999999999999999999999976543222221111
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS 302 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~ 302 (349)
. ....+..+++++.+||.+||..||++||++. ++++|
T Consensus 233 -----------------~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 233 -----------------D--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp -----------------C--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred -----------------C--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 0 1223445678899999999999999999997 77654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=338.68 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=212.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|++.+.||+|+||.||+| .+..+++.||+|.+..........+.+|+.+++.++||||+++++++...
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 120 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCEEEEEE---------EECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence 478999999999999999999 55556889999999776555566788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC--CCcEEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--NFNAKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~--~~~v~l~Dfg~~ 177 (349)
...++||||+++++|.+++......+++..++.++.||+.||.||| +.+++|+||||+||+++. ++.++|+|||++
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~~~vkL~DFG~a 198 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLA 198 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeecccchHHeEEecCCCCceEEEecccc
Confidence 9999999999999999999766568999999999999999999999 899999999999999974 567999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+...
T Consensus 199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~---------- 265 (387)
T 1kob_A 199 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------- 265 (387)
T ss_dssp EECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC----------
T ss_pred eecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Confidence 8653322 122346899999999999999999999999999999999999999765432221111110
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
...........+++++.+||.+||+.||++|||+.++++|-
T Consensus 266 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 266 -----DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp -----CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred -----CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 01111223345678899999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=326.64 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=213.3
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.+..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.++++++||||+++++++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~ 88 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC 88 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 456789999999999999999999554 256799999876532 346788999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 166 (283)
T 3gen_A 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGL 166 (283)
T ss_dssp CSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred ecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCccceEEEcCCCCEEEccccc
Confidence 9999999999999999999999775678999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 167 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---------- 235 (283)
T 3gen_A 167 SRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---------- 235 (283)
T ss_dssp GGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH----------
T ss_pred cccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh----------
Confidence 9754322111 1111345677999999999999999999999999999998 999997655322221111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.......+...++.+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 236 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 236 --------QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------cccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1122233445577899999999999999999999999999998754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=331.66 Aligned_cols=271 Identities=28% Similarity=0.415 Sum_probs=201.5
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
.+..++|++.+.||+|+||.||+|.+... ......||+|.+.... ....+.+.+|+.++++++||||+++++
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQE------DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred ccChhHeEEeceecccCCeEEEEEEEccc------CCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence 34578999999999999999999954321 1122479999987652 334577889999999999999999999
Q ss_pred EEecCCce------EEEEEeCCCCChHHHHhccC-----CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 95 YCSESDNR------LLVYEFMPKGSLENHLFRSV-----QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 95 ~~~~~~~~------~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
++...... ++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||++
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~Dikp~NIli 170 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCML 170 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEE
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH--cCCcccCCCCcceEEE
Confidence 99876654 89999999999999985421 26899999999999999999999 8999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhh
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ 242 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~ 242 (349)
+.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+........
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 250 (323)
T 3qup_A 171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250 (323)
T ss_dssp CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence 9999999999999976544333222333456778999999999999999999999999999999 999997655433222
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 313 (349)
.+.. ......+..+++.+.+++.+||+.||++|||+.++++.|+++.......
T Consensus 251 ~~~~------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 251 YLIG------------------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp HHHT------------------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred HHhc------------------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 2211 1122334566788999999999999999999999999999998764433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=326.18 Aligned_cols=268 Identities=24% Similarity=0.302 Sum_probs=206.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||+|+||+||+| .+..+++.||+|.+...... ....+.+|+.++++++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEE---------EECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 58999999999999999999 55556899999998654332 34677899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
++..++||||+++ ++.+.+......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~ 149 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEeecccce
Confidence 9999999999975 677767666678999999999999999999999 8999999999999999999999999999997
Q ss_pred cCCCCCCCccccceecCCcccCccccccCC-CCCccceehhhHHHHHHHhCCccCcccc-CcchhhhHHhhhc-hhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDR-GGLAEQTLVEWAD-PFLRDS 255 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~lltg~~pf~~~~-~~~~~~~~~~~~~-~~~~~~ 255 (349)
...... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..||.... .......+..... +.....
T Consensus 150 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 150 AFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred ecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 643222 1222356899999999997765 7999999999999999999888864332 2222222221111 110100
Q ss_pred hhHhhhhc---------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 RRVLRIMD---------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........ ..........+++.+.+||.+||+.||++|||+.++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000 000112234567889999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=324.95 Aligned_cols=269 Identities=28% Similarity=0.409 Sum_probs=203.7
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcc
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENL 89 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i 89 (349)
.....++..++|++.+.||+|+||.||+|.++ ..+|+|++.... ....+.+.+|+.++++++||||
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESS------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEc------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcE
Confidence 34556788999999999999999999999542 248999886543 2345678899999999999999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
++++++. .....++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 83 v~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~i~H~Dlkp~Nil~~~~~~~ 159 (289)
T 3og7_A 83 LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--AKSIIHRDLKSNNIFLHEDNTV 159 (289)
T ss_dssp CCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCccceEEECCCCCE
Confidence 9999965 556789999999999999999776678999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+|+|||++................+++.|+|||++. +..++.++||||||+++|+|++|..||.+............
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 239 (289)
T 3og7_A 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239 (289)
T ss_dssp EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH
T ss_pred EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc
Confidence 999999987544333333333456899999999986 56788899999999999999999999976543222111111
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
..............+++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 240 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 240 -------------RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -------------HTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------------ccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0000111112334667899999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=338.39 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=208.2
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhcc-CCCcccc
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQL-RHENLVK 91 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~i~~ 91 (349)
..+..++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+..|..+++++ +||||++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~---------~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~ 117 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCC
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCe
Confidence 3455679999999999999999999 55556899999998765322 234577888998887 8999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
+++++...+..|+||||+++++|..++.+. ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.++|
T Consensus 118 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL 194 (396)
T 4dc2_A 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKL 194 (396)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEECCCCCEEE
Confidence 999999999999999999999999988654 67999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||...........
T Consensus 195 ~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------- 264 (396)
T 4dc2_A 195 TDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------- 264 (396)
T ss_dssp CCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------
T ss_pred eecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--------
Confidence 9999997532222 222335799999999999999999999999999999999999999965432111000
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 302 (349)
............ .....+..+++++.+||.+||+.||.+||++ .++++|
T Consensus 265 ~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 265 NTEDYLFQVILE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCHHHHHHHHHH--CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred hhHHHHHHHHhc--cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 000000011111 1223456678899999999999999999985 677764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=330.55 Aligned_cols=270 Identities=24% Similarity=0.378 Sum_probs=212.2
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhccCCCcccce
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
+...+..++|++.+.||+|+||.||+|.+... ...-..+|++|.+... .......+.+|+.+++.++||||+++
T Consensus 8 ~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 82 (327)
T 3lzb_A 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp CCEECCTTTEEEEEEEEECSSEEEEEEEECCT-----TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCC
T ss_pred hhcccCHhHceEEEEeeeCCCeEEEEEEEcCC-----CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEE
Confidence 34445678999999999999999999965321 1112335688877543 33456778899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++... ..++|++++.+++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 83 ~~~~~~~-~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kL~ 159 (327)
T 3lzb_A 83 LGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKIT 159 (327)
T ss_dssp CEEEESS-SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred EEEEecC-CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hCCCcCCCCCHHHEEEcCCCCEEEc
Confidence 9999875 488999999999999999877778999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+
T Consensus 160 DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~------- 232 (327)
T 3lzb_A 160 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------- 232 (327)
T ss_dssp CTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------
T ss_pred cCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------
Confidence 9999976544333333333456778999999999999999999999999999999 99999766543322221
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
........+..++.++.+++.+||..||.+|||+.++++.|+++...
T Consensus 233 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 233 -----------EKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----------HTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----------HcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 12222334456778899999999999999999999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=333.82 Aligned_cols=256 Identities=24% Similarity=0.313 Sum_probs=206.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-----hchHHHHHHHHHHhccCCCcccce
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
...++|++.+.||+|+||.||+| .+..+++.||+|++..... ...+.+.+|+.+++.++||||+++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~ 91 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceEEeeEEeeCCCEEEEEE---------EECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcE
Confidence 44679999999999999999999 5555689999999864322 135678899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc-
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN- 168 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~- 168 (349)
++++...+..|+||||+++++|.+++... ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivHrDlkp~NIl~~~~~~~ 169 (351)
T 3c0i_A 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--DNNIIHRDVKPHCVLLASKENS 169 (351)
T ss_dssp EEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECSSSTT
T ss_pred EEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChHHeEEecCCCC
Confidence 99999999999999999999998887542 245899999999999999999999 899999999999999987655
Q ss_pred --EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 169 --AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 169 --v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
++|+|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.... ....+..
T Consensus 170 ~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~ 246 (351)
T 3c0i_A 170 APVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIK 246 (351)
T ss_dssp CCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHH
T ss_pred CcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHc
Confidence 99999999976543221 222356899999999999999999999999999999999999999764211 0000000
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. .. .........+++.+.+||.+||..||++|||+.++++|
T Consensus 247 ~---~~------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 247 G---KY------------KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp T---CC------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C---CC------------CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00 00000012356789999999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=328.70 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=209.5
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCc
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
.|...+.||+|+||.||+| ....+|+.||||++........+.+.+|+.++++++||||+++++++...+.
T Consensus 46 ~~~~~~~lg~G~~g~V~~a---------~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLA---------REKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE 116 (321)
T ss_dssp HEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hhhccEEeccCCCeEEEEE---------EECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 4778889999999999999 4555688999999977666667788899999999999999999999999999
Q ss_pred eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCC
Q 018891 102 RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 181 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~ 181 (349)
.++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 117 ~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~ 192 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLH--AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 192 (321)
T ss_dssp EEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecc
Confidence 9999999999999998853 57999999999999999999999 8999999999999999999999999999987643
Q ss_pred CCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhh
Q 018891 182 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261 (349)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (349)
.... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...........+.....
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~------------ 258 (321)
T 2c30_A 193 KDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP------------ 258 (321)
T ss_dssp SSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC------------
T ss_pred cCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------
Confidence 3221 12235689999999999999999999999999999999999999976543222111111000
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
........+++.+.+++.+||+.||++|||+.+++++-.
T Consensus 259 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 259 ----PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp ----CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred ----CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 011123356778999999999999999999999998643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=332.53 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=210.7
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.-++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 109 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEE---------EECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3479999999999999999999 5555689999999865432 345678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+.+.+..|+||||+++++|.+++.+. ..+++..++.++.||+.||.||| +.+++||||||+||+++.++.++|+|||
T Consensus 110 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~DFg 186 (350)
T 1rdq_E 110 FKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCccceEEECCCCCEEEcccc
Confidence 99999999999999999999999654 67999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++....... ....|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 187 ~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------- 252 (350)
T 1rdq_E 187 FAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS--------- 252 (350)
T ss_dssp TCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred cceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc---------
Confidence 998643321 235689999999999999999999999999999999999999976543222211111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTSL 303 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~l 303 (349)
. ....+..+++.+.++|.+||+.||.+||+ +.++++|-
T Consensus 253 --------~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 253 --------G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp --------C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --------C--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 1 11234567788999999999999999998 89998763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=333.54 Aligned_cols=266 Identities=25% Similarity=0.385 Sum_probs=213.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||+|+||.||+|.+... ...-..+|++|.+.... ......+.+|+.++++++||||+++++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPE-----GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC 84 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCT-----TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCC-----CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 4467999999999999999999965431 11223458888775443 22334567899999999999999999988
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
. ++..++||||+.+++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH--HTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH--hCCCCCCccchheEEECCCCeEEECCCCc
Confidence 6 46789999999999999999776678999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+................++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.........+.
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------- 231 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---------- 231 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH----------
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH----------
Confidence 987655444433444567889999999999999999999999999999999 999998765433322221
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.......+..++.++.+++.+||..||.+|||+.+++++|+.+...
T Consensus 232 --------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 232 --------KGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp --------TTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred --------cCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1112233344566789999999999999999999999999998654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=333.91 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=210.1
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
....++|++.+.||+|+||.||+| .+..++..||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 95 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEE---------EECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 344679999999999999999999 5555689999999865432 34466889999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC---cEEE
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF---NAKL 171 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~---~v~l 171 (349)
++.+.+..++||||+.+++|.+++... ..+++..++.++.||+.||.||| +.+++|+||||+||+++.++ .++|
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 96 SIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEE
Confidence 999999999999999999999988544 67999999999999999999999 89999999999999998654 5999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+|||++........ .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 173 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~--- 246 (362)
T 2bdw_A 173 ADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGA--- 246 (362)
T ss_dssp CCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC---
T ss_pred eecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC---
Confidence 99999976543221 223568999999999999999999999999999999999999997654322221111100
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
..........+++++.+||.+||..||++|||+.++++|-
T Consensus 247 ------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 286 (362)
T 2bdw_A 247 ------------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286 (362)
T ss_dssp ------------CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred ------------CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 0001111235678899999999999999999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=322.46 Aligned_cols=264 Identities=26% Similarity=0.406 Sum_probs=214.1
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+..++|++.+.||+|+||.||+|.+.. ....+..||+|.+.... ......+.+|+.+++.++||||++++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 81 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTN------HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI 81 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEEC------TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcC------CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4567899999999999999999997642 33456779999987653 3345678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+.. +..++|||++++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 82 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 82 IEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCccceEEECCCCcEEeCccC
Confidence 865 5678999999999999999776677999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++......... ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||...........+..
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-------- 229 (281)
T 3cc6_A 159 LSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-------- 229 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH--------
T ss_pred CCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc--------
Confidence 99764332211 1122346778999999998999999999999999999998 9999975543322211111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
......+..+++.+.+++.+||..||++|||+.+++++|+++..
T Consensus 230 ----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 230 ----------GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 11122344567889999999999999999999999999998765
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=325.06 Aligned_cols=267 Identities=22% Similarity=0.302 Sum_probs=204.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++++++||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~----------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN----------NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE----------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEc----------CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 5899999999999999999943 3478899999865432 234678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.+..++|||++++ +|.+++......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred CCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEeECcccc
Confidence 9999999999975 899988766678999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch-hhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP-FLRDSR 256 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~ 256 (349)
...... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...... ......
T Consensus 149 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 149 AFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (288)
T ss_dssp HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhch
Confidence 543221 11223467999999999876 45899999999999999999999999876543333322221110 000000
Q ss_pred hHhh--hhc-------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLR--IMD-------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~--~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ... ..........+++++.+||.+||+.||++|||+.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 000 000011123467889999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=328.02 Aligned_cols=271 Identities=26% Similarity=0.351 Sum_probs=220.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (349)
..+..++|++.+.||+|+||.||+|.+.+. .+..+++.||+|.+..... .....+.+|+.+++++ +||||++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecC----CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 456678999999999999999999975432 2456789999999876533 3346688999999999 699999999
Q ss_pred eEEecCC-ceEEEEEeCCCCChHHHHhccCC---------------CCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCC
Q 018891 94 GYCSESD-NRLLVYEFMPKGSLENHLFRSVQ---------------PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 157 (349)
Q Consensus 94 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~---------------~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~ 157 (349)
+++...+ ..++||||+++++|.+++..... .+++..++.++.|++.||.||| +.+++|+|||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dik 175 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLA 175 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH--HTTCCCSCCS
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH--hCCcccccCc
Confidence 9987654 58999999999999999965432 2889999999999999999999 8999999999
Q ss_pred CCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCcccc
Q 018891 158 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDR 236 (349)
Q Consensus 158 ~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~ 236 (349)
|+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999976544433333344567889999999999999999999999999999998 999997655
Q ss_pred CcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 237 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
....... .+........+..+++.+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 256 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 256 IDEEFCR-----------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CSHHHHH-----------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhHHHHH-----------------HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 3221111 1111112233445678899999999999999999999999999998764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=332.19 Aligned_cols=276 Identities=27% Similarity=0.389 Sum_probs=215.9
Q ss_pred CcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcc
Q 018891 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENL 89 (349)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i 89 (349)
+...+.++..++|++.+.||+|+||.||+|.+.+. .+..++..||+|.+.... ......+.+|+.++++++||||
T Consensus 20 s~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 95 (327)
T 2yfx_A 20 SISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM----PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95 (327)
T ss_dssp CGGGSCBCCGGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred chhhcccCChhheEEEEEEcCCCCeeEEEEEEcCC----CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCC
Confidence 34556678889999999999999999999965432 145678899999986542 2345678899999999999999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccC------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
+++++++......++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||++
T Consensus 96 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~i~H~dlkp~NIli 173 (327)
T 2yfx_A 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--ENHFIHRDIAARNCLL 173 (327)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEE
T ss_pred CeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--hCCeecCcCCHhHEEE
Confidence 999999999999999999999999999997543 45899999999999999999999 8999999999999999
Q ss_pred cCC---CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcc
Q 018891 164 DSN---FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGL 239 (349)
Q Consensus 164 ~~~---~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~ 239 (349)
+.+ ..++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 174 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 253 (327)
T 2yfx_A 174 TCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE 253 (327)
T ss_dssp SCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred ecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH
Confidence 844 4599999999874333322222233457888999999999999999999999999999998 999997654321
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
....+ ........+..+++.+.++|.+||+.||.+|||+.+++++|+.+....
T Consensus 254 ~~~~~------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 254 VLEFV------------------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHHH------------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHHH------------------hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 11111 111122334566788999999999999999999999999999987753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=335.48 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=211.4
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccc
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVK 91 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~ 91 (349)
..++..++|++.+.||+|+||.||+| .+..+++.||+|++.... ......+.+|+.+++.++||||++
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~---------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~ 79 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIV---------QKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 34566789999999999999999999 555668999999986543 234567889999999999999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
+++++...+..|+||||+.+++|..++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++.++|
T Consensus 80 l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL 156 (384)
T 4fr4_A 80 LWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHI 156 (384)
T ss_dssp EEEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCcHHHeEECCCCCEEE
Confidence 99999999999999999999999999854 467999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCcccccc---CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
+|||++....... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...........+....
T Consensus 157 ~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~ 233 (384)
T 4fr4_A 157 TDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE 233 (384)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH
T ss_pred eccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh
Confidence 9999998653322 2233578999999999864 458899999999999999999999997654433222211110
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLT 301 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~ 301 (349)
......+..+++.+.+||.+||+.||.+||+ +.++++
T Consensus 234 ----------------~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 ----------------TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----------------HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----------------hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0112334567789999999999999999998 777765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.84 Aligned_cols=269 Identities=26% Similarity=0.365 Sum_probs=218.6
Q ss_pred hhhcccCCcc-eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~-~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
+..++|.+.+ .||+|+||.||+|.+. ...++..||+|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYR-------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHhhhhhccccccCceeEEEeEec-------cCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3456788877 9999999999999652 33457889999987653 2345678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+ ..+..++|||++++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 79 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Dfg 155 (287)
T 1u59_A 79 C-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFG 155 (287)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred e-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH--HCCEeeCCCchheEEEcCCCCEEECccc
Confidence 9 456789999999999999999766677999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCc-cccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhh
Q 018891 176 LARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 176 ~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
++.......... ......+++.|+|||++.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i--------- 226 (287)
T 1u59_A 156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI--------- 226 (287)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---------
T ss_pred ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---------
Confidence 997654332211 1112345788999999988889999999999999999998 99999765532222111
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 314 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 314 (349)
........+..+++.+.++|.+||..||++|||+.+++++|+.+..+...+.
T Consensus 227 ---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 227 ---------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp ---------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ---------hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 1112234456678899999999999999999999999999999988755543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=336.08 Aligned_cols=261 Identities=21% Similarity=0.284 Sum_probs=201.9
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.....++|++.+.||+|+||.||+| .+..+++.||+|++.... .....+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~ 84 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEV 84 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEE---------EETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEE---------EECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 3445689999999999999999999 555668999999986543 234667899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc--EEEec
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN--AKLSD 173 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~--v~l~D 173 (349)
+...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++. ++|+|
T Consensus 85 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH--~~~ivH~Dlkp~Nill~~~~~~~~kl~D 161 (361)
T 3uc3_A 85 ILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICD 161 (361)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCSCCCCGGGEEECSSSSCCEEECC
T ss_pred EeeCCEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEcCCCCceEEEee
Confidence 99999999999999999999998554 67999999999999999999999 899999999999999987765 99999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCc-cceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
||++....... ......|++.|+|||++.+..++.+ +|||||||++|+|++|..||.+............
T Consensus 162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~------ 232 (361)
T 3uc3_A 162 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ------ 232 (361)
T ss_dssp CCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH------
T ss_pred cCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH------
Confidence 99986422221 1223568999999999988887655 8999999999999999999976554322221111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
..............+++.+.+||.+||+.||++|||+.++++|-.-
T Consensus 233 -------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 233 -------RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp -------HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred -------HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 1111111111222457889999999999999999999999987443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=330.43 Aligned_cols=272 Identities=27% Similarity=0.375 Sum_probs=219.6
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccce
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKL 92 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (349)
...+..++|++.+.||+|+||.||+|.+... ........||+|.+..... .....+.+|+.+++.+ +||||+++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGL----GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTC----SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCC----CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 4556678999999999999999999965432 2233456899999876532 3456788999999999 89999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhcc-------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRS-------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
++++...+..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~ 193 (333)
T 2i1m_A 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA--SKNCIHRDVAAR 193 (333)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGG
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh--cCCcccCCcccc
Confidence 99999999999999999999999998642 246899999999999999999999 899999999999
Q ss_pred cEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCc
Q 018891 160 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGG 238 (349)
Q Consensus 160 Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~ 238 (349)
||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999999999975433333222233456788999999999999999999999999999998 99999765432
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.....+ .........+..+++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 274 ~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 274 SKFYKL-----------------VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHH-----------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHH-----------------HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 222111 111122223445578899999999999999999999999999987653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=333.87 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=208.5
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.-++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++||||++++++
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~ 77 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3478999999999999999999 5556689999999865422 234578899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+...+..++||||+ +++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 78 ~~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~kl~DFG 153 (336)
T 3h4j_B 78 ITTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCH--RHKIVHRDLKPENLLLDDNLNVKIADFG 153 (336)
T ss_dssp EECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCSTTTEEECTTCCEEECCSS
T ss_pred EEeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCchhhEEEcCCCCEEEEEec
Confidence 99999999999999 67899988654 67999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++........ .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.........+.
T Consensus 154 ~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--------- 221 (336)
T 3h4j_B 154 LSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--------- 221 (336)
T ss_dssp CTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC---------
T ss_pred cceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH---------
Confidence 9975433222 223468999999999988776 689999999999999999999997654322111110
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
......+..+++.+.+||.+||..||.+|||+.+++++-+
T Consensus 222 ----------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 261 (336)
T 3h4j_B 222 ----------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261 (336)
T ss_dssp ----------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred ----------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence 0112234556788999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=324.99 Aligned_cols=267 Identities=27% Similarity=0.436 Sum_probs=207.1
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
.+..++|++.+.||+|+||.||+|.+. .+..++..||+|.+.... ......+.+|+.++++++||||+++++
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 103 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLK------QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEE------CTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEe------ccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence 345689999999999999999999654 233457789999987553 233466889999999999999999999
Q ss_pred EEecCC-----ceEEEEEeCCCCChHHHHhc-----cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 95 YCSESD-----NRLLVYEFMPKGSLENHLFR-----SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 95 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~-----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
++.... ..++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++
T Consensus 104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLR 181 (313)
T ss_dssp EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCSGGGEEEC
T ss_pred EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEc
Confidence 987654 35999999999999999843 3356999999999999999999999 99999999999999999
Q ss_pred CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhh
Q 018891 165 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 243 (349)
Q Consensus 165 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~ 243 (349)
.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 999999999999976544332222233456788999999999999999999999999999999 8899976554322221
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
+. .......+..+++.+.+++.+||..||.+|||+.+++++|+++...
T Consensus 262 ~~------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 262 LL------------------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HH------------------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH------------------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1112233456778899999999999999999999999999998764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=328.58 Aligned_cols=269 Identities=24% Similarity=0.336 Sum_probs=194.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKG---------LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT 74 (317)
T ss_dssp ---------------CEEEEE---------ECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred ccceeEeeEECCCCCEEEEEE---------EECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence 468999999999999999999 5566789999999865533 234678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-----CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-----~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
.+..++||||++ ++|.+++... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCChHHeEEcCCCCEEECc
Confidence 999999999997 5899988643 246899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
||++........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........
T Consensus 152 fg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 152 FGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp CSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999976433221 1223468999999999876 4689999999999999999999999987665443333332211000
Q ss_pred h-hhhhHhh------hhccc--------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 R-DSRRVLR------IMDTR--------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~-~~~~~~~------~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ....... ..... ........+++++.+||.+||+.||++|||+.++++|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 0000000 00000 0001112356789999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=327.97 Aligned_cols=278 Identities=31% Similarity=0.430 Sum_probs=218.6
Q ss_pred hccc-CCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNF-CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y-~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++| ++.+.||+|+||.||++.+.. .+..+++.||+|++..... .....+.+|+.++++++||||+++++++.
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDP-----TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECS-----CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cHHHHhhhheecCCCCeEEEEEEEcc-----CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 4455 999999999999999886643 5566799999999976532 34567889999999999999999999998
Q ss_pred cC--CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 98 ES--DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 98 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
.. ...++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH--~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLH--AQHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred cCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEEcCCCCEEECCcc
Confidence 74 567999999999999999955 45999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCc-cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||......... ...... ....
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~-~~~~ 256 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE--LIGIAQ-GQMT 256 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HHCSCC-HHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh--hhcccc-cchh
Confidence 998654432211 122245677899999999989999999999999999999999998653321110 000000 0111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
................+..+++.+.+||.+||+.||++|||+.++++.|+.+.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 1222333334444555677889999999999999999999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=328.24 Aligned_cols=269 Identities=25% Similarity=0.354 Sum_probs=210.6
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
++..++|++.+.||+|+||.||+|......- .....+..|++|.+........+.+.+|+.++++++||||+++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGD--YGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECG--GGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccc--cccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 4567899999999999999999996542100 00111357999999777666778899999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc--------
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-------- 168 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~-------- 168 (349)
...+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh--hCCeECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999999776566999999999999999999999 899999999999999998887
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
++|+|||.+..... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..|+..............
T Consensus 160 ~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~- 232 (289)
T 4fvq_A 160 IKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE- 232 (289)
T ss_dssp EEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-
T ss_pred eeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-
Confidence 99999998864321 122457888999999987 7789999999999999999996554432221111100000
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 314 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 314 (349)
. ....+...++.+.+++.+||+.||.+|||+.+++++|+++.+....+.
T Consensus 233 ----------------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 233 ----------------D--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp ----------------T--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred ----------------c--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 0 112223345678999999999999999999999999999988765543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=332.07 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=209.1
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhcc-CCCcccce
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQL-RHENLVKL 92 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (349)
.+..++|++.+.||+|+||.||+| .+..+++.||+|++.... ......+..|..+++.+ +||+|+++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l 86 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEE---------EETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeE
Confidence 445679999999999999999999 455568899999987653 23446678899999988 79999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++...+..|+||||++|++|.+++... ..+++..++.++.|++.||.||| +.+++||||||+||+++.+|.++|+
T Consensus 87 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 87 HSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEEeccCCHHHEEEcCCCcEEEE
Confidence 99999999999999999999999998654 67999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 164 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------ 235 (353)
T 2i0e_A 164 DFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------ 235 (353)
T ss_dssp CCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred eCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh------
Confidence 999997532222 122335789999999999999999999999999999999999999976543222222211
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
. ....+..+++++.+||.+||..||.+||+ +.++++|
T Consensus 236 -----------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 236 -----------H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----------C--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----------C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 12234567889999999999999999995 6888876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=325.06 Aligned_cols=268 Identities=26% Similarity=0.328 Sum_probs=204.0
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+.+|+.++++++||||+++++++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKC---------RNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEE---------EeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 68999999999999999999 45556889999988654322 34567889999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+.
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 150 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFAR 150 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCeEEEEEEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCChhhEEEcCCCCEEEeeCCCch
Confidence 9999999999999888887743 467999999999999999999999 8999999999999999999999999999997
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.........+.............
T Consensus 151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 151 LLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp ECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 6433221 1223468899999999876 568999999999999999999999998766544433333221111111100
Q ss_pred Hhhh---h---ccccCCC------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRI---M---DTRLGGQ------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~---~---~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... . ....... ..+.+++.+.+|+.+||+.||++|||+.++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0 0000000 012456789999999999999999999999976
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=335.56 Aligned_cols=273 Identities=19% Similarity=0.224 Sum_probs=207.5
Q ss_pred hhcccCCcceeeec--CceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceee
Q 018891 19 ATKNFCSDYLLGEG--GFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 19 ~~~~y~~~~~lg~G--~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
.+++|++.+.||+| +||.||+| .+..+++.||||.+.... ......+.+|+.+++.++||||+++++
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 93 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEE---------EEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeE
Confidence 35799999999999 99999999 555568999999987653 233466788999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
++...+..++||||+++++|.+++... ...+++..++.++.||+.||+||| +.+|+||||||+||+++.++.++|+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 94 TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 999999999999999999999998653 366999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCC-----CccccceecCCcccCcccccc--CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 174 FGLARDGPTGDN-----THVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 174 fg~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
||.+........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 998754322111 111122467888999999987 5789999999999999999999999987655433322221
Q ss_pred hhchhhhhhhh------------------Hh---------hhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 018891 247 WADPFLRDSRR------------------VL---------RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 299 (349)
Q Consensus 247 ~~~~~~~~~~~------------------~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (349)
...+...+... .. ...........+..+++.+.+||.+||+.||++|||+.++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 11100000000 00 0000000112334567889999999999999999999999
Q ss_pred HHH
Q 018891 300 LTS 302 (349)
Q Consensus 300 l~~ 302 (349)
++|
T Consensus 332 l~h 334 (389)
T 3gni_B 332 LNH 334 (389)
T ss_dssp TTS
T ss_pred hcC
Confidence 986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=317.45 Aligned_cols=267 Identities=39% Similarity=0.661 Sum_probs=212.5
Q ss_pred CCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc----hhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES----FQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 24 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
...+.||+|+||.||+|.+ ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 102 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG 102 (307)
T ss_dssp TTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC
Confidence 3449999999999999954 26789999886532 23356788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhc--cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFR--SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+..++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 180 (307)
T 2nru_A 103 DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLA 180 (307)
T ss_dssp SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEcCCCcEEEeecccc
Confidence 999999999999999999864 2356999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
................|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...........+.... ......
T Consensus 181 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~ 256 (307)
T 2nru_A 181 RASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI---EDEEKT 256 (307)
T ss_dssp EECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHH---HTTSCC
T ss_pred cccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHh---hhhhhh
Confidence 76544333222333568999999998865 57899999999999999999999998766544333222211 111111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
....+.... ...+...++.+.+++.+||+.||.+|||+.+++++|+++..
T Consensus 257 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 257 IEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 122222222 33467888999999999999999999999999999999865
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=327.71 Aligned_cols=270 Identities=27% Similarity=0.433 Sum_probs=213.4
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
..+..++|++.+.||+|+||.||+|.+.. .....+..||+|.+..... .....+.+|+.++++++||||+++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 113 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEec-----CCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 35566889999999999999999997643 1223356799999876532 33456889999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++...+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 114 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp EECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChheEEECCCCcEEECCC
Confidence 999999999999999999999999776678999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCc-cccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhh
Q 018891 175 GLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 175 g~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~--------- 262 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--------- 262 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---------
T ss_pred CcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH---------
Confidence 9997643322111 1111335678999999999999999999999999999999 9999965543211111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
+........+..+++.+.+++.+||+.||++|||+.++++.|+++....
T Consensus 263 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 263 ---------INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ---------HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---------HHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111222334567788999999999999999999999999999988653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=325.89 Aligned_cols=253 Identities=22% Similarity=0.350 Sum_probs=200.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--------------------------ch
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------------------------GH 71 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~ 71 (349)
+..++|++.+.||+|+||.||+| .+..+++.||+|++...... ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEE---------EETTTTEEEEEEEEECC-------------------------------
T ss_pred eeecceEEEeEEeecCCEEEEEE---------EECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchH
Confidence 44579999999999999999999 55566899999998654321 12
Q ss_pred HHHHHHHHHHhccCCCcccceeeEEec--CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCC
Q 018891 72 KEWLTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDA 149 (349)
Q Consensus 72 ~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~ 149 (349)
+.+.+|+.++++++||||+++++++.. ....++||||+++++|.+++. ...+++..++.++.|++.||+||| +.
T Consensus 81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH--~~ 156 (298)
T 2zv2_A 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLH--YQ 156 (298)
T ss_dssp CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH--HC
Confidence 457899999999999999999999986 567899999999999988652 367999999999999999999999 89
Q ss_pred CeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCC---CCCccceehhhHHHHHHH
Q 018891 150 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH---LTPKSDVYSFGVVLLELL 226 (349)
Q Consensus 150 ~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~ll~~ll 226 (349)
+++|+||||+||+++.++.++|+|||++........ ......|++.|+|||++.+.. ++.++||||||+++|+|+
T Consensus 157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred CeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 999999999999999999999999999976433221 222356899999999997665 367899999999999999
Q ss_pred hCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 227 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 227 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+|..||...........+. ...........+++++.++|.+||+.||++|||+.++++|
T Consensus 235 ~g~~pf~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 235 FGQCPFMDERIMCLHSKIK-----------------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HSSCSSCCSSHHHHHHHHH-----------------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HCCCCCCCccHHHHHHHHh-----------------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 9999997543211111111 1111112223567889999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=329.52 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=208.1
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhcc-CCCccccee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQL-RHENLVKLI 93 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (349)
+..++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|..+++++ +||||++++
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~ 76 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLV---------RLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred CchhheEEEEEEEecCCeEEEEE---------EECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEE
Confidence 34579999999999999999999 5555689999999976532 2345577899999888 899999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+++...+..|+||||+++++|.+++.+. ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEEe
Confidence 9999999999999999999999998654 67999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......... ..
T Consensus 154 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---------~~ 222 (345)
T 3a8x_A 154 YGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD---------QN 222 (345)
T ss_dssp GGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------
T ss_pred ccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc---------cc
Confidence 99997532222 12233578999999999999999999999999999999999999996532211100 00
Q ss_pred hhhhH-hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 018891 254 DSRRV-LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS 302 (349)
Q Consensus 254 ~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~ 302 (349)
..... ...... ....+..++..+.+||.+||+.||.+||++ .++++|
T Consensus 223 ~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 223 TEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred cHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 00000 011111 123455678899999999999999999995 677765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=328.05 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=203.3
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hchHHHHHHHHHHhccCCCcc
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQLRHENL 89 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i 89 (349)
...++..++|++.+.||+|+||.||+|... ....+++.||+|++..... .....+.+|+.+++.++||||
T Consensus 10 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i 83 (327)
T 3a62_A 10 GPEKIRPECFELLRVLGKGGYGKVFQVRKV------TGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83 (327)
T ss_dssp ---CCCGGGEEEEEEEEEETTEEEEEEEEC------SSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTB
T ss_pred CCCCCCHHHeEEEEEEEeCCCEEEEEEEEe------ccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCc
Confidence 345667789999999999999999999543 2235689999999876432 234557789999999999999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
+++++++...+..|+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 84 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~ivH~Dlkp~Nill~~~~~~ 160 (327)
T 3a62_A 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLH--QKGIIYRDLKPENIMLNHQGHV 160 (327)
T ss_dssp CCEEEEEECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCTTTEEECTTSCE
T ss_pred cceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEEcccCCHHHeEECCCCcE
Confidence 99999999999999999999999999998654 67899999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
+|+|||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+..
T Consensus 161 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--- 235 (327)
T 3a62_A 161 KLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--- 235 (327)
T ss_dssp EECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---
T ss_pred EEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---
Confidence 9999999864322211 12234689999999999999999999999999999999999999976543222211111
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ....+..+++.+.++|.+||..||.+|| ++.++++|
T Consensus 236 --------------~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 236 --------------C--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --------------T--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --------------C--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1 1223455678899999999999999999 78899875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=328.79 Aligned_cols=273 Identities=26% Similarity=0.386 Sum_probs=219.3
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
.+..++|++.+.||+|+||.||+|.+.... .....++..||+|.+..... .....+.+|+.+++++ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~--~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGID--KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCS--TTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEecccc--ccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 456789999999999999999999764321 01335678999999976532 3456788999999999 8999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA--SQKCIHRDLAAR 186 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGG
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCccc
Confidence 9999999999999999999999996542 24899999999999999999999 899999999999
Q ss_pred cEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCc
Q 018891 160 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGG 238 (349)
Q Consensus 160 Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~ 238 (349)
||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999976544332222222456778999999998899999999999999999999 99999765432
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
.....+ ........+..+++.+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 267 ~~~~~~------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 267 ELFKLL------------------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHHH------------------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHH------------------hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 211111 1111223345677889999999999999999999999999999987533
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=328.36 Aligned_cols=271 Identities=24% Similarity=0.396 Sum_probs=218.6
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCccccee
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
...+..++|++.+.||+|+||.||+|.+.+. ....++..||+|.+..... .....+.+|+.+++.++||||++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 3456678999999999999999999965421 1224578899999875432 3445688999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccC---------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSV---------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
+++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVA 172 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEEC
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCCccCCCccceEEEc
Confidence 99999999999999999999999986421 45789999999999999999999 89999999999999999
Q ss_pred CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhh
Q 018891 165 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 243 (349)
Q Consensus 165 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~ 243 (349)
.++.++|+|||++................+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 252 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 252 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH
Confidence 999999999999875433322222223456888999999999999999999999999999999 8899876543221111
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
+. .......+..+++.+.+++.+||+.||++|||+.+++++|+++...
T Consensus 253 ~~------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 VM------------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HH------------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HH------------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11 1111223456778899999999999999999999999999987553
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=318.43 Aligned_cols=253 Identities=31% Similarity=0.486 Sum_probs=199.9
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hchHHHHHHHHHHhccCCCccccee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
+..++|++.+.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.+++.++||||++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 72 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-----------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-----------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 34579999999999999999999543 67899999865432 2346788999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCC---eeeccCCCCcEEEcC-----
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDAN---VIYRDLKASNVLLDS----- 165 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~---i~H~di~~~Nilv~~----- 165 (349)
+++...+..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+ ++|+||||+||+++.
T Consensus 73 ~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH--~~~~~~i~H~dikp~Nil~~~~~~~~ 148 (271)
T 3dtc_A 73 GVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLH--DEAIVPIIHRDLKSSNILILQKVENG 148 (271)
T ss_dssp EEECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH--HSSSSCCCCSCCSGGGEEESSCCSSS
T ss_pred EEEecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCCceeecCCchHHEEEecccccc
Confidence 999999999999999999999998843 67999999999999999999999 778 899999999999986
Q ss_pred ---CCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhh
Q 018891 166 ---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242 (349)
Q Consensus 166 ---~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~ 242 (349)
++.++|+|||.+........ ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.......
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~- 223 (271)
T 3dtc_A 149 DLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA- 223 (271)
T ss_dssp CCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-
T ss_pred cccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence 67899999999975433222 1246899999999999999999999999999999999999999765422111
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
............+..+++.+.+++.+||+.||.+|||+.+++++|+++
T Consensus 224 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 ----------------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----------------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----------------HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111122223344566778999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=318.64 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=209.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||+|+||.||+| .+..++..+++|.+........+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED 77 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhEEeeeEEeecCCEEEEEE---------EeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4679999999999999999999 4555688999999987766677889999999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE---cCCCcEEEeccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFG 175 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv---~~~~~v~l~Dfg 175 (349)
....++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||++ +.++.++|+|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 78 NTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 99999999999999999988554 67999999999999999999999 8999999999999999 788899999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++........ .....+++.|+|||++.+. ++.++|+||||+++|+|++|..||...........+....
T Consensus 155 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------- 223 (277)
T 3f3z_A 155 LAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT------- 223 (277)
T ss_dssp TCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred cceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC-------
Confidence 9976443322 2234689999999988654 8999999999999999999999997655322222221110
Q ss_pred hhHhhhhccccCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSK----KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...+. .+++.+.++|.+||+.||++|||+.++++|
T Consensus 224 ------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 224 ------------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp ------------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ------------CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111 356789999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.57 Aligned_cols=259 Identities=28% Similarity=0.418 Sum_probs=214.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred chhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4579999999999999999999543 356899999876543 34678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.+..++|||++++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEECCCCCEEEccccccc
Confidence 99999999999999999999776677999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus 153 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~------------ 219 (267)
T 3t9t_A 153 FVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------------ 219 (267)
T ss_dssp GBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------------
T ss_pred ccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh------------
Confidence 5432111 11112345678999999998999999999999999999999 899997654322111111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.......+..+++.+.+++.+||+.||++|||+.+++++|+++..+
T Consensus 220 ------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 220 ------TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------cCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1112223445678899999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.79 Aligned_cols=263 Identities=26% Similarity=0.409 Sum_probs=219.8
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
-++..++|++.+.||+|+||.||+|.+ ..++..||+|.+.... ...+.+.+|+.++++++||||++++++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~---------~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVW---------KKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEE---------GGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEe---------cCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 345678999999999999999999954 4458899999987543 345678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
+...+..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~l~Df 155 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADF 155 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH--HHTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH--HCCccCCCCCcceEEEcCCCCEEEccC
Confidence 99999999999999999999999653 356999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
|++........ .......+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.........+
T Consensus 156 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~--------- 225 (288)
T 3kfa_A 156 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL--------- 225 (288)
T ss_dssp CGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---------
T ss_pred ccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---------
Confidence 99976543222 22223456788999999999999999999999999999999 99999765533222211
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
........+..+++.+.+++.+||..||.+|||+.++++.|+.+...
T Consensus 226 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 226 ---------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11222334456778999999999999999999999999999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=319.32 Aligned_cols=254 Identities=25% Similarity=0.409 Sum_probs=209.7
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
.+..++|++.+.||+|+||.||+| .+..++..||+|++..... .....+.+|+.+++.++||||++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 75 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred eeecccEEEeeEEecCCCeEEEEE---------EEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchh
Confidence 445689999999999999999999 4555688999999865432 2346688999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+++......++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 76 GYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--TTTCEECCCCGGGEEECTTSCEEECS
T ss_pred heEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCEecccCChHhEEEcCCCCEEEEe
Confidence 9999999999999999999999998654 67999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||++....... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 153 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 221 (279)
T 3fdn_A 153 FGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------- 221 (279)
T ss_dssp CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------
T ss_pred ccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-------
Confidence 99886433222 1234689999999999999999999999999999999999999976543222211111
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
.....+..+++.+.+||.+||+.||.+|||+.++++|-.-
T Consensus 222 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~ 261 (279)
T 3fdn_A 222 ------------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261 (279)
T ss_dssp ------------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred ------------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence 1122344567889999999999999999999999987554
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=329.71 Aligned_cols=289 Identities=17% Similarity=0.221 Sum_probs=218.7
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-----------hHHHHHHHHHH
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-----------HKEWLTEVIYL 81 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l 81 (349)
..+.+...++|++.+.||+|+||.||+|.+... .....++.||+|++....... ......|+..+
T Consensus 27 ~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~ 102 (364)
T 3op5_A 27 EIITDMAAAAWKVGLPIGQGGFGCIYLADMNSS----ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102 (364)
T ss_dssp CEEECTTCCEEEEEEECCCC-CCEEEEEEECCS----SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cEeeccCCCeEEEEEEEecCCCeEEEEeeecCc----cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHH
Confidence 334455667999999999999999999976543 234457889999986543211 12344566778
Q ss_pred hccCCCcccceeeEEecC----CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCC
Q 018891 82 GQLRHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 157 (349)
Q Consensus 82 ~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~ 157 (349)
+.++||||+++++++... ...++||||+ +++|.+++......+++..++.++.|++.||+||| +.+++|||||
T Consensus 103 ~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH--~~~iiHrDlk 179 (364)
T 3op5_A 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIK 179 (364)
T ss_dssp TTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCC
T ss_pred hhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeEEecCC
Confidence 888999999999998764 4589999999 99999999776678999999999999999999999 8899999999
Q ss_pred CCcEEEc--CCCcEEEecccccccCCCCCCCc-----cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCc
Q 018891 158 ASNVLLD--SNFNAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 230 (349)
Q Consensus 158 ~~Nilv~--~~~~v~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~ 230 (349)
|+||+++ .++.++|+|||++.......... ......|++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999 88999999999997543322111 1122458999999999999999999999999999999999999
Q ss_pred cCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 231 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
||.+.............. .. ........... ....+++++.+++..||..||++|||+.++++.|+++....
T Consensus 260 Pf~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 260 PWEDNLKDPKYVRDSKIR---YR--ENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp TTGGGTTCHHHHHHHHHH---HH--HCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CccccccCHHHHHHHHHH---hh--hhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 998654332221111100 00 00111111100 01234678999999999999999999999999999999886
Q ss_pred CCCCCC
Q 018891 311 DMPRTP 316 (349)
Q Consensus 311 ~~~~~~ 316 (349)
..+...
T Consensus 332 ~~~~~~ 337 (364)
T 3op5_A 332 GSKDDG 337 (364)
T ss_dssp TCCCCC
T ss_pred CCCcCC
Confidence 666443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=319.99 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=188.7
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred ccceeeeeecCCCceEEEEE---------EEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence 68999999999999999999 4555688999999865432 23467889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nili~~~~~~kl~dfg~~ 159 (278)
T 3cok_A 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLA 159 (278)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHEEEcCCCCEEEEeecce
Confidence 999999999999999999999776678999999999999999999999 899999999999999999999999999998
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
......... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 160 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------ 225 (278)
T 3cok_A 160 TQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------------ 225 (278)
T ss_dssp EECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC------------
T ss_pred eeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh------------
Confidence 764332211 122468899999999998899999999999999999999999997654322111110
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. .....+..++.++.++|.+||+.||++|||+.++++|
T Consensus 226 -----~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 226 -----L--ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp -----S--SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----h--cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0 0112344567889999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=323.55 Aligned_cols=273 Identities=26% Similarity=0.347 Sum_probs=202.6
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-----hchHHHHHHHHHHhcc---CC
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-----QGHKEWLTEVIYLGQL---RH 86 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l---~h 86 (349)
++++..++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.+++.+ +|
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h 73 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEH 73 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEE---------ECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCC
T ss_pred CCcccccceEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCC
Confidence 45677899999999999999999999 6666789999999864321 1224555666666665 59
Q ss_pred CcccceeeEEecCC-----ceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 87 ENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 87 ~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
|||+++++++.... ..++|||++. ++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+|
T Consensus 74 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~N 150 (308)
T 3g33_A 74 PNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH--ANCIVHRDLKPEN 150 (308)
T ss_dssp TTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCTTT
T ss_pred CCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHH
Confidence 99999999997655 4789999996 59999986643 34999999999999999999999 8999999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcch
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 240 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~ 240 (349)
|+++.++.++|+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 151 il~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 227 (308)
T 3g33_A 151 ILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227 (308)
T ss_dssp EEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999975433222 2335689999999999999999999999999999999999999987665444
Q ss_pred hhhHHhhhchhhhhh-hhHh----hhhccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 241 EQTLVEWADPFLRDS-RRVL----RIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 241 ~~~~~~~~~~~~~~~-~~~~----~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...+........... .... ........ ....+.+++.+.+||.+||+.||++|||+.++++|
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 333332211100000 0000 00000000 00112456789999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=315.04 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=210.8
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
.+..++|++.+.||+|+||.||+|.++ +..||+|++.... ....+.+.+|+.++++++||||+++++
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 74 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEE
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEE
Confidence 345679999999999999999999653 6779999987653 234467889999999999999999999
Q ss_pred EEecC--CceEEEEEeCCCCChHHHHhccCC-CCChHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCcEEEcCCCcE
Q 018891 95 YCSES--DNRLLVYEFMPKGSLENHLFRSVQ-PISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 95 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~--i~H~di~~~Nilv~~~~~v 169 (349)
++... ...++||||+++++|.+++..... .+++..++.++.|++.||.||| +.+ ++|+||||+||+++.++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~ 152 (271)
T 3kmu_A 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDMTA 152 (271)
T ss_dssp EECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT--TSSSCCTTCCCSGGGEEECTTSCE
T ss_pred EEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCCCceecCCCccceEEEcCCcce
Confidence 99876 788999999999999999976433 5899999999999999999999 888 9999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCC---ccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+|+|||+...... ....+++.|+|||++.+..++. ++||||||+++|+|++|..||.+.......
T Consensus 153 ~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----- 220 (271)
T 3kmu_A 153 RISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG----- 220 (271)
T ss_dssp EEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-----
T ss_pred eEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-----
Confidence 9999887753211 1235789999999998766554 799999999999999999999765432211
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
............+..+++.+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 221 ------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 221 ------------MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------------HHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11222223334556678899999999999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=326.45 Aligned_cols=294 Identities=23% Similarity=0.342 Sum_probs=221.9
Q ss_pred ecCCCC-cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc
Q 018891 6 AMSDPS-ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL 84 (349)
Q Consensus 6 ~~~~~~-~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l 84 (349)
+|++.. ......+..++|++.+.||+|+||.||+|.+.. .+..+++.||+|.+..........+.+|+.+++++
T Consensus 25 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (326)
T 2w1i_A 25 AMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP-----LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL 99 (326)
T ss_dssp ------------CCCGGGEEEEEEEECCSSEEEEEEEECT-----TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC
T ss_pred HHHHHhcccCccccCHHHceeeeeeccCCCeEEEEEEecc-----ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC
Confidence 454443 333456778899999999999999999996542 24567899999999876656667889999999999
Q ss_pred CCCcccceeeEEecCC--ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEE
Q 018891 85 RHENLVKLIGYCSESD--NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 162 (349)
Q Consensus 85 ~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nil 162 (349)
+||||+++++++...+ ..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+
T Consensus 100 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dikp~NIl 177 (326)
T 2w1i_A 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG--TKRYIHRDLATRNIL 177 (326)
T ss_dssp CCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEE
T ss_pred CCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEE
Confidence 9999999999886543 789999999999999999776677999999999999999999999 899999999999999
Q ss_pred EcCCCcEEEecccccccCCCCCCCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 163 LDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 163 v~~~~~v~l~Dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
++.++.++|+|||++........... .....++..|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 178 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~ 257 (326)
T 2w1i_A 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 257 (326)
T ss_dssp EEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHH
T ss_pred EcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 99999999999999986544322111 11234567799999999888999999999999999999999988643211000
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
........ ..........+........+..+++.+.++|.+||+.||++|||+.++++.|+++..
T Consensus 258 -~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 258 -MIGNDKQG-QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp -HHCTTCCT-HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hhccccch-hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00000000 000011122222223334456778899999999999999999999999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=322.70 Aligned_cols=278 Identities=22% Similarity=0.278 Sum_probs=204.6
Q ss_pred cCCCCcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhc
Q 018891 7 MSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQ 83 (349)
Q Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~ 83 (349)
|........+. ..++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+.+|+.++++
T Consensus 21 ~~~~~~~~~~~-~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~ 90 (309)
T 2h34_A 21 MDGTAESREGT-QFGPYRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGR 90 (309)
T ss_dssp --------------CCEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTT
T ss_pred cccccccCCCc-EeccEEEEEEEcCCCCeeEEEE---------EEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhh
Confidence 44444433333 3579999999999999999999 45556899999998765332 23668899999999
Q ss_pred cCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 84 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
++||||+++++++..++..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||++
T Consensus 91 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~NIl~ 167 (309)
T 2h34_A 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAH--AAGATHRDVKPENILV 167 (309)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEE
T ss_pred cCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCcCCcCCCChHHEEE
Confidence 99999999999999999999999999999999999654 67999999999999999999999 8999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhh
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 243 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~ 243 (349)
+.++.++|+|||++........ .......+++.|+|||++.+..++.++|+||||+++|+|++|..||...........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 246 (309)
T 2h34_A 168 SADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH 246 (309)
T ss_dssp CTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH
T ss_pred cCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH
Confidence 9999999999999875433221 112234688999999999999999999999999999999999999976443211111
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhcCCCCCC
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTSKDMPR 314 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~~~~~~~~ 314 (349)
+.. ........+..+++.+.++|.+||+.||++|| |+.++++.|+.+......++
T Consensus 247 ~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 247 INQ----------------AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp HHS----------------CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred hcc----------------CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 100 00001122345677899999999999999999 99999999999887755443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=343.54 Aligned_cols=253 Identities=27% Similarity=0.380 Sum_probs=202.6
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
.+..++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++||||++++
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~ 214 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILV---------KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEE---------EEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEE
Confidence 345578999999999999999999 5556689999999875422 2335567899999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEe
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
+++...+..++||||+++++|.+++... ..+++..+..++.|++.||+||| + .+|+||||||+||+++.++.++|+
T Consensus 215 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~giiHrDlkp~NIll~~~~~~kl~ 291 (446)
T 4ejn_A 215 YSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKIT 291 (446)
T ss_dssp EEEEETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--HHTCCCCCCCCGGGEEECSSSCEEEC
T ss_pred EEEeeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHh--hcCCEEECCCCHHHEEECCCCCEEEc
Confidence 9999999999999999999999988554 67999999999999999999999 7 899999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 292 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------ 363 (446)
T 4ejn_A 292 DFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------ 363 (446)
T ss_dssp CCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred cCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh------
Confidence 999987532222 122235789999999999999999999999999999999999999976543222211111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ....+..+++++.+||.+||+.||.+|| |+.++++|
T Consensus 364 -----------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 364 -----------E--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----------C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----------C--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 1223455678899999999999999999 99999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=326.70 Aligned_cols=269 Identities=25% Similarity=0.291 Sum_probs=203.8
Q ss_pred hhhcccCCc-ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSD-YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
...++|++. +.||+|+||.||+| .+..+++.||||++..........+.+|+.+++++ +||||++++++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~ 79 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEE---------ECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceeEEecCceecCCceEEEEEE---------EEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 345789885 78999999999999 55667899999999776555667888999999985 79999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc---EEEe
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLS 172 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~---v~l~ 172 (349)
+...+..++||||+++++|.+++... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++. ++|+
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 80 FEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCHHHEEEccCCCcCceEEE
Confidence 99999999999999999999999654 67999999999999999999999 899999999999999988776 9999
Q ss_pred cccccccCCCCCCC-----ccccceecCCcccCcccccc-----CCCCCccceehhhHHHHHHHhCCccCccccCcchhh
Q 018891 173 DFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242 (349)
Q Consensus 173 Dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~ 242 (349)
|||++......... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+........
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 99998654322111 11122458999999999875 568899999999999999999999998765432111
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
......... ............ ...+ ..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 237 ~~~~~~~~~--~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 237 DRGEACPAC--QNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp ----CCHHH--HHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccchhH--HHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000000 000000011111 1112 1356789999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=325.32 Aligned_cols=269 Identities=25% Similarity=0.322 Sum_probs=211.9
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.+..++|++.+.||+|+||.||+| .+..+++.||+|.+..........+.+|+.+++.++||||+++++++
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLV---------EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEE---------EETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEE---------EecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 355789999999999999999999 45556899999998766656667888999999999999999999998
Q ss_pred e----cCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 97 S----ESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 97 ~----~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
. .....++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dlkp~NIl~~~~~~~ 173 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQP 173 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEcCCCCE
Confidence 6 33478899999999999998865 3567999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCcc-------ccceecCCcccCccccccCC---CCCccceehhhHHHHHHHhCCccCccccCcc
Q 018891 170 KLSDFGLARDGPTGDNTHV-------STRIVGTRGYAAPEYVATGH---LTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~ll~~lltg~~pf~~~~~~~ 239 (349)
+|+|||.+........... .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||.......
T Consensus 174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 253 (317)
T 2buj_A 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG 253 (317)
T ss_dssp EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence 9999998865322111100 01134688999999987654 6889999999999999999999996422111
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 312 (349)
.. .............+..+++.+.++|.+||+.||.+|||+.+++++|+.+......
T Consensus 254 ~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 254 DS----------------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp SC----------------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred ch----------------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 00 0000111111222345678899999999999999999999999999998765433
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=323.90 Aligned_cols=276 Identities=29% Similarity=0.401 Sum_probs=209.7
Q ss_pred CCcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCC
Q 018891 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRH 86 (349)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h 86 (349)
+.....+.+..++|++.+.||+|+||.||+|.+.. ..+.+..||+|.+.... ....+.+.+|+.++++++|
T Consensus 7 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h 80 (291)
T 1u46_A 7 PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80 (291)
T ss_dssp ----CCEECCGGGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC
T ss_pred cccccccccchhHeeeeeeecCCCceeEEEEEecc------CCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC
Confidence 33455567788999999999999999999996542 22334579999887543 2345678899999999999
Q ss_pred CcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC
Q 018891 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN 166 (349)
Q Consensus 87 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~ 166 (349)
|||+++++++... ..++|+|++++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.+
T Consensus 81 ~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nili~~~ 157 (291)
T 1u46_A 81 RNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATR 157 (291)
T ss_dssp TTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEET
T ss_pred CCcccEEEEEccC-CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH--hCCcccCCCchheEEEcCC
Confidence 9999999999865 489999999999999999776677999999999999999999999 8999999999999999999
Q ss_pred CcEEEecccccccCCCCCCCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhH
Q 018891 167 FNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTL 244 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~ 244 (349)
+.++|+|||++........... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~- 236 (291)
T 1u46_A 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK- 236 (291)
T ss_dssp TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-
T ss_pred CCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHH-
Confidence 9999999999976544332211 122456778999999998889999999999999999999 9999976543221111
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
..........+..+++.+.+++.+||..||++|||+.++++.|+++.....
T Consensus 237 ----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 237 ----------------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp ----------------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred ----------------HHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 111112223345677899999999999999999999999999999877643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=317.64 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=210.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
...++|++.+.||+|+||.||+| .+..++..||+|++..... .....+.+|+.++++++||||++++++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEE---------EEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence 34689999999999999999999 4555688999999865432 334667899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc---EEEe
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLS 172 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~---v~l~ 172 (349)
+...+..++||||+++++|.+.+... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++. ++|+
T Consensus 74 ~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 74 IQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 99999999999999999999888654 67999999999999999999999 899999999999999987665 9999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||.+........ .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+...
T Consensus 151 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----- 222 (284)
T 3kk8_A 151 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----- 222 (284)
T ss_dssp CCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----
T ss_pred eceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc-----
Confidence 9999976433222 22246899999999999999999999999999999999999999765432222211110
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
...........+++.+.+++.+||+.||++|||+.++++|-.
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (284)
T 3kk8_A 223 ----------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264 (284)
T ss_dssp ----------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHH
T ss_pred ----------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcc
Confidence 001111122356788999999999999999999999998644
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=321.56 Aligned_cols=269 Identities=24% Similarity=0.353 Sum_probs=205.4
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
....++|++.+.||+|+||.||+| .+..++..||+|.+.... ......+.+|+.++++++||||++++
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 98 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEE---------EETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cccccceEEEEeecCCCCceEEEE---------EEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 334578999999999999999999 444568899999987532 23446688999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
+++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp EEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEE
T ss_pred EEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeeCCCCcHHHEEEcCCCCEE
Confidence 999999999999999999999998854 3467899999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|+|||++........ ......+++.|+|||++.+..++.++|+||||+++|+|++|..||.+....... +.
T Consensus 177 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~----- 247 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--LC----- 247 (310)
T ss_dssp ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH--HH-----
T ss_pred EEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH--HH-----
Confidence 999999875433221 122346889999999999999999999999999999999999999754321110 00
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 313 (349)
...............+++++.+++.+||..||.+|||+.++++.|++++.....|
T Consensus 248 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 248 --------KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp --------HHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred --------HHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 0000111111122456788999999999999999999999999999998875554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=321.73 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=208.7
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.....++|++.+.||+|+||.||+| .+..+++.||+|.+..........+.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (304)
T 2jam_A 4 TTNIRKTFIFMEVLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74 (304)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhccceeeeeccCCCCceEEEE---------EECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhh
Confidence 4456789999999999999999999 4555688999999976654455678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE---cCCCcEEEe
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLS 172 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv---~~~~~v~l~ 172 (349)
+...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||++ +.++.++|+
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dikp~NIl~~~~~~~~~~kl~ 151 (304)
T 2jam_A 75 YESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMIT 151 (304)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred cccCCEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCHHHEEEecCCCCCCEEEc
Confidence 99999999999999999999988554 67999999999999999999999 8999999999999999 778899999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||++...... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+...
T Consensus 152 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~----- 222 (304)
T 2jam_A 152 DFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG----- 222 (304)
T ss_dssp SCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC-----
T ss_pred cCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-----
Confidence 99998643221 122346899999999999999999999999999999999999999765432221111110
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
...........+++.+.++|.+||..||++|||+.+++++-.
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~ 264 (304)
T 2jam_A 223 ----------YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW 264 (304)
T ss_dssp ----------CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred ----------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 001111223456788999999999999999999999998644
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=329.28 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=194.2
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+...++|++.+.||+|+||.||+| .+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~ 117 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF 117 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEE---------EECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeE
Confidence 345678999999999999999999 445568899999987543 345677899999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---CCcEEEec
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSD 173 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~---~~~v~l~D 173 (349)
...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++. ++.++|+|
T Consensus 118 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 118 ETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred ecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCCcccEEEecCCCCCCEEEcc
Confidence 9999999999999999999998554 67999999999999999999999 899999999999999975 88999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcch-hhhHHhhhchhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLVEWADPFL 252 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~ 252 (349)
||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||........ ...+..
T Consensus 195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~------ 265 (349)
T 2w4o_A 195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN------ 265 (349)
T ss_dssp CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT------
T ss_pred CccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh------
Confidence 99987543221 12235689999999999999999999999999999999999999975543221 111110
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
............++.++.+||.+||..||++|||+.++++|
T Consensus 266 ---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 266 ---------CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001112224567889999999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=318.40 Aligned_cols=266 Identities=27% Similarity=0.444 Sum_probs=210.9
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEE-
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYC- 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 96 (349)
...+|++.+.||+|+||.||+|.+.. ..+....+++|.+.... ......+.+|+.++++++||||+++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred cceehhhcceeeecCCceEEEEEEec------CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 34689999999999999999996542 23345678999887543 23456788999999999999999999985
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..++..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCchheEEECCCCCEEECcccc
Confidence 4556889999999999999999776678999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCC--ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhh
Q 018891 177 ARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 177 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
+......... .......+++.|+|||.+.+..++.++|+||||+++|+|++ +.+||...........+..
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~------- 247 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------- 247 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT-------
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc-------
Confidence 9754332211 11122456778999999999999999999999999999999 5566655443222221111
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
......+..+++.+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 248 -----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 248 -----------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -----------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1122234456778999999999999999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=318.10 Aligned_cols=272 Identities=20% Similarity=0.260 Sum_probs=212.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE-
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC- 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 96 (349)
..+++|++.+.||+|+||.||+| .+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEE---------EEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec
Confidence 44689999999999999999999 5555689999998654432 23467899999999888777766655
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE---cCCCcEEEec
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSD 173 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv---~~~~~v~l~D 173 (349)
......++|||++ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 75 AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred CCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeeeeccCCCCeEEEec
Confidence 5667789999999 88999999766678999999999999999999999 8999999999999999 7889999999
Q ss_pred ccccccCCCCCCCc-----cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 174 FGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 174 fg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.........+....
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 99997654433211 1223568999999999999999999999999999999999999998766544333333221
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 314 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 314 (349)
......... .....+++.+.+++.+||+.||++|||+.++++.|+++..+.+.+.
T Consensus 232 ~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 232 EKKMSTPIE-----------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHHHHSCHH-----------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred cccccchhh-----------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 111111000 0112346789999999999999999999999999999998766543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.20 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=204.2
Q ss_pred cccCC--cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCS--DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~--~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
+.|.+ .+.||+|+||.||+| .+..++..||+|++........+.+.+|+.++++++||||+++++++..
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a---------~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 157 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKC---------EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES 157 (373)
T ss_dssp GTEEEEEEEECC-----CEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cceeeecceEEecCcCEEEEEE---------EEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 34444 568999999999999 5555689999999987666667788999999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE--cCCCcEEEecccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL--DSNFNAKLSDFGL 176 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv--~~~~~v~l~Dfg~ 176 (349)
.+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++|+|||+
T Consensus 158 ~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~ 235 (373)
T 2x4f_A 158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGL 235 (373)
T ss_dssp SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEETTTTEEEECCCSS
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccccCCHHHEEEecCCCCcEEEEeCCC
Confidence 99999999999999999988766567999999999999999999999 8999999999999999 5677899999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+........ .....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 236 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------- 305 (373)
T 2x4f_A 236 ARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW------- 305 (373)
T ss_dssp CEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-------
T ss_pred ceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-------
Confidence 986543322 2224689999999999999999999999999999999999999976653322222221100
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.........+++++.+||.+||+.||.+|||+.++++|
T Consensus 306 --------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 306 --------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp --------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00111123467889999999999999999999999985
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=336.57 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=212.9
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.++ +..||||.++... ..+.+.+|+.++++++||||+++++++.
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 34578999999999999999999653 5689999997654 4567889999999999999999999986
Q ss_pred cCC-ceEEEEEeCCCCChHHHHhccCC-CCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 98 ESD-NRLLVYEFMPKGSLENHLFRSVQ-PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 98 ~~~-~~~lv~e~~~~~~L~~~l~~~~~-~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
... ..++||||+++++|.+++..... .+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 655 78999999999999999976433 4799999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++........ ...++..|+|||++.+..++.++||||||+++|+|++ |..||.+.........+
T Consensus 335 ~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---------- 399 (450)
T 1k9a_A 335 LTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------- 399 (450)
T ss_dssp TCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----------
T ss_pred Cccccccccc-----CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Confidence 9975332211 1246788999999999999999999999999999998 99999876543322211
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
....+...+..+++.+.++|.+||+.||.+|||+.++++.|+++...
T Consensus 400 --------~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 400 --------EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --------HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11223345567788999999999999999999999999999998765
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=324.91 Aligned_cols=255 Identities=24% Similarity=0.325 Sum_probs=209.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh------chHHHHHHHHHHhccCCCcccc
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLRHENLVK 91 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~ 91 (349)
...++|++.+.||+|+||.||+| .+..++..||+|.+...... ..+.+.+|+.++++++||||++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 79 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhhccEEEeeEeeecCCEEEEEE---------EECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcce
Confidence 34679999999999999999999 55566899999998654322 3567889999999999999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC----
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF---- 167 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~---- 167 (349)
+++++......++||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH--~~~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 80 LHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp EEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCTTSSSC
T ss_pred EEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCChHHEEEecCCCCcC
Confidence 99999999999999999999999999955 367899999999999999999999 89999999999999999888
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
.++|+|||++........ .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+...
T Consensus 157 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 233 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233 (321)
T ss_dssp CEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred CEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence 799999999976543322 12346899999999999999999999999999999999999999765432222211111
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... .....+..+++.+.++|.+||..||++|||+.++++|
T Consensus 234 ~~~---------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 SYD---------------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCC---------------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ccc---------------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000112346789999999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=331.30 Aligned_cols=269 Identities=22% Similarity=0.311 Sum_probs=202.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-hHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||+|+||.||+| .+..+++.||+|.+....... ...+.+|+.++++++||||+++++++...
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKG---------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred CceEEEEEEcCCCCEEEEEE---------EECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence 58999999999999999999 455568899999986543221 12345799999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||++ ++|.+++......+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++..
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 99999999996 4899988776677999999999999999999999 89999999999999999999999999999975
Q ss_pred CCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh----
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD---- 254 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 254 (349)
..... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+..........
T Consensus 150 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 150 KSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp C--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 33222 12223467999999999876 568999999999999999999999998766544443333221111000
Q ss_pred ---hhhHhhhhccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 255 ---SRRVLRIMDTRLGG----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 255 ---~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.............. .....+++++.+||.+||+.||.+|||+.++++|=
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 00000000000000 01124567899999999999999999999999853
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.92 Aligned_cols=267 Identities=23% Similarity=0.339 Sum_probs=203.7
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
+....++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+.+|+.++++++||||+++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~ 77 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLA---------RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCE
T ss_pred cceecCcEEEEEEEccCCCEEEEEE---------EECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceE
Confidence 3456789999999999999999999 55556899999999765332 23567899999999999999999
Q ss_pred eeEEecCCce----EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 93 IGYCSESDNR----LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 93 ~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
++++...... |+||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~Nil~~~~~~ 154 (311)
T 3ork_A 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNA 154 (311)
T ss_dssp EEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEETTSC
T ss_pred EEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCCcCCCCHHHEEEcCCCC
Confidence 9998765543 9999999999999999654 67999999999999999999999 899999999999999999999
Q ss_pred EEEecccccccCCCCCCC-ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 169 AKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
++|+|||++......... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.............
T Consensus 155 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 234 (311)
T 3ork_A 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234 (311)
T ss_dssp EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence 999999999754333221 1122356899999999999999999999999999999999999999765532221111110
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HHHHhhhcC
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL-TSLEQLHTS 309 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll-~~l~~~~~~ 309 (349)
.. .........+++++.++|.+||+.||++||++.+++ +.+......
T Consensus 235 ~~---------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 235 DP---------------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp CC---------------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CC---------------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00 000001123567899999999999999999766655 556555544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.03 Aligned_cols=272 Identities=20% Similarity=0.258 Sum_probs=216.2
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE-
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC- 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 96 (349)
..+++|++.+.||+|+||.||+| .+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEE---------EEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc
Confidence 34689999999999999999999 5555689999998865432 34577899999999988877666655
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc---CCCcEEEec
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSD 173 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~---~~~~v~l~D 173 (349)
......++||||+ +++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++ .++.++|+|
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 151 (296)
T 3uzp_A 75 AEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred CCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHeEEecCCCCCeEEEee
Confidence 5566789999999 88999999766678999999999999999999999 89999999999999994 788999999
Q ss_pred ccccccCCCCCCCc-----cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 174 FGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 174 fg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++|..||.+.........+....
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 3uzp_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence 99997654433211 1223568999999999999999999999999999999999999998755433332222211
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 314 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~ 314 (349)
........ ......+++.+.+++.+||+.||++|||+.++++.|+++....+.+.
T Consensus 232 ~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 286 (296)
T 3uzp_A 232 EKKMSTPI-----------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHHHHSCH-----------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred ccccCCch-----------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence 11111100 00113456789999999999999999999999999999988866653
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=318.86 Aligned_cols=264 Identities=28% Similarity=0.397 Sum_probs=212.5
Q ss_pred hhhhcccCCcc-eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~-~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
.+..++|++.+ .||+|+||.||+|.+. ....+..||+|.+...... ....+.+|+.+++.++||||++++
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 84 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEE-------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred eecchhhhhccCccccccCeeeEeeeec-------CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 34567899998 9999999999999653 2345788999998765332 346788999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+++ ..+..++|||++++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|
T Consensus 85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nil~~~~~~~kl~D 160 (291)
T 1xbb_A 85 GIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISD 160 (291)
T ss_dssp EEE-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred EEE-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHH--hCCeEcCCCCcceEEEeCCCcEEEcc
Confidence 999 557889999999999999999654 67999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchh
Q 018891 174 FGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 174 fg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
||++........... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------- 232 (291)
T 1xbb_A 161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------- 232 (291)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH--------
T ss_pred CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--------
Confidence 999976543322111 111345678999999988889999999999999999999 9999976543221111
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
+........+..+++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 233 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 233 ----------LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ----------HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 111122334556788999999999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=339.48 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=211.6
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
+.+..++|++.+.||+|+||.||+| .+..+|+.||||++..... .....+.+|+.+++.++||||+++
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a---------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l 81 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEE---------EETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3445679999999999999999999 5556689999999865432 234678899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++...+..++||||+++++|.+++.+ ...+++..++.++.||+.||.||| +.+++||||||+||+++.++.++|+
T Consensus 82 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDLkp~NIll~~~~~vkL~ 158 (476)
T 2y94_A 82 YQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCH--RHMVVHRDLKPENVLLDAHMNAKIA 158 (476)
T ss_dssp EEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH--HCCCCcccccHHHEEEecCCCeEEE
Confidence 9999999999999999999999999954 467999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
|||++........ .....|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........+..
T Consensus 159 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----- 230 (476)
T 2y94_A 159 DFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD----- 230 (476)
T ss_dssp CCSSCEECCTTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT-----
T ss_pred eccchhhcccccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-----
Confidence 9999986543222 223468999999999988765 6799999999999999999999976543222211111
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.. ...+..+++++.+||.+||+.||.+|||+.++++|=
T Consensus 231 ------------~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp 268 (476)
T 2y94_A 231 ------------GI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268 (476)
T ss_dssp ------------TC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred ------------CC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence 10 122345677899999999999999999999999863
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=317.33 Aligned_cols=271 Identities=23% Similarity=0.361 Sum_probs=207.2
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhc--cCCCcc
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ--LRHENL 89 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i 89 (349)
+........++|++.+.||+|+||.||+|.+. ++.||+|++.... ......|.+++.. ++||||
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i 93 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-----------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENI 93 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTB
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-----------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCe
Confidence 44556777889999999999999999999543 6789999985443 2333445555544 489999
Q ss_pred cceeeEEecC----CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCC--------CeeeccCC
Q 018891 90 VKLIGYCSES----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDA--------NVIYRDLK 157 (349)
Q Consensus 90 ~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~--------~i~H~di~ 157 (349)
+++++++... ...++||||+++++|.+++.. ..+++..++.++.|++.||.||| +. +++|+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~~~~ivH~Dik 169 (337)
T 3mdy_A 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLH--TEIFSTQGKPAIAHRDLK 169 (337)
T ss_dssp CCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHH--SCBCSTTCBCCEECSCCC
T ss_pred eeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH--HhhhhhccCCCEEecccc
Confidence 9999998876 678999999999999999954 46999999999999999999999 78 99999999
Q ss_pred CCcEEEcCCCcEEEecccccccCCCCCCCcc--ccceecCCcccCccccccCCCCCc------cceehhhHHHHHHHhC-
Q 018891 158 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIVGTRGYAAPEYVATGHLTPK------SDVYSFGVVLLELLSG- 228 (349)
Q Consensus 158 ~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~------~DiwslG~ll~~lltg- 228 (349)
|+||+++.++.++|+|||++........... .....|++.|+|||++.+...... +|||||||++|+|++|
T Consensus 170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence 9999999999999999999975433322211 123468999999999988777665 9999999999999999
Q ss_pred ---------CccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCC
Q 018891 229 ---------RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRP 294 (349)
Q Consensus 229 ---------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rp 294 (349)
..||............. . ............ +..+++.+.+++.+||+.||.+||
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~----------~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (337)
T 3mdy_A 250 VSGGIVEEYQLPYHDLVPSDPSYEDM----------R--EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317 (337)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHH----------H--HHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred CcccccccccccHhhhcCCCCchhhh----------H--HHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC
Confidence 55554432211110000 0 001111111122 237889999999999999999999
Q ss_pred CHHHHHHHHHhhhcCCCC
Q 018891 295 SMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 295 s~~~ll~~l~~~~~~~~~ 312 (349)
|+.+++++|+++.++.+.
T Consensus 318 s~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 318 TALRVKKTLAKMSESQDI 335 (337)
T ss_dssp CHHHHHHHHHHHHHTTTC
T ss_pred CHHHHHHHHHHHHhhccc
Confidence 999999999999987653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=317.79 Aligned_cols=265 Identities=27% Similarity=0.360 Sum_probs=210.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
-.|.+.+.||+|+||.||+|.+.. ....+..+|+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYID------QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEEC------SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred eEEccCceeccCCCceEEEEEEec------CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC
Confidence 355667999999999999996542 233456799998875433 3456788999999999999999999999766
Q ss_pred Cce-EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 100 DNR-LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 100 ~~~-~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+.. ++||||+.+++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++.
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 655 9999999999999999776678999999999999999999999 8999999999999999999999999999997
Q ss_pred cCCCCCC--CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccC-ccccCcchhhhHHhhhchhhhhh
Q 018891 179 DGPTGDN--THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 179 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
....... ........+++.|+|||.+.+..++.++|+||||+++|+|++|..|+ ..........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~------------- 239 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH------------- 239 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-------------
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-------------
Confidence 5433211 11112245678899999999999999999999999999999966554 3332211111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
..........+..+++.+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus 240 -----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 240 -----FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -----HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111111223345567889999999999999999999999999999887643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=339.82 Aligned_cols=271 Identities=24% Similarity=0.342 Sum_probs=189.4
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+..+++.||||++... .....+.+.+|+.+|+.++||||+++++++
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 121 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEA---------YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIV 121 (458)
T ss_dssp SCTTEEECCC-------CEEEE---------EECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred cCCCeEEeeEeeecCCeEEEEE---------EECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 3578999999999999999999 55556899999988653 223456788999999999999999999998
Q ss_pred ec-----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 97 SE-----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 97 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
.. ....|+|||++ +++|.+++.. ...+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||
T Consensus 122 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH--~~~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 122 IPKDVEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CCSCTTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred ecCCcccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHH--hCCcCCCCCChhhEEECCCCCEee
Confidence 43 35789999998 5689998854 467999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCC-------------------------ccccceecCCcccCcccc-ccCCCCCccceehhhHHHHHH
Q 018891 172 SDFGLARDGPTGDNT-------------------------HVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLEL 225 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~ll~~l 225 (349)
+|||++......... .......||+.|+|||++ .+..++.++|||||||++|+|
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999765322211 112235789999999976 566799999999999999999
Q ss_pred Hh-----------CCccCccccCcch--------------------hhhHHhhh-chhhhhh--------hhHhhhhccc
Q 018891 226 LS-----------GRRALDEDRGGLA--------------------EQTLVEWA-DPFLRDS--------RRVLRIMDTR 265 (349)
Q Consensus 226 lt-----------g~~pf~~~~~~~~--------------------~~~~~~~~-~~~~~~~--------~~~~~~~~~~ 265 (349)
++ |..+|.+...... ...+.... .+..... ......+...
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 6666655432100 00010000 0000000 0000000000
Q ss_pred cC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 266 LG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 266 ~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ....+..++++.+||.+||..||++|||+.++++|
T Consensus 358 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp CCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 01123457889999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=316.72 Aligned_cols=255 Identities=26% Similarity=0.357 Sum_probs=207.1
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEE---------EECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc
Confidence 369999999999999999999 4555688999999865433 344678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 153 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLAT 153 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH--hCCeeccCCChHHEEEccCCCEEEeeCCCcc
Confidence 9999999999999999998843 467999999999999999999999 8999999999999999999999999999987
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
...............+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.......... ..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~--------- 222 (276)
T 2yex_A 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWK--------- 222 (276)
T ss_dssp ECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH--HHHH---------
T ss_pred ccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHhh---------
Confidence 5433222222233568899999999987665 678999999999999999999997655322111 1100
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...........+++.+.++|.+||+.||.+|||+.+++++
T Consensus 223 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 223 -----EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -----TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0000111123567789999999999999999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=322.92 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=197.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
.++|++.+.||+|+||.||+| .+..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 75 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 75 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEE---------EETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEE
T ss_pred hhcCceeeEecCCCCeEEEEE---------EEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 368999999999999999999 4555688999999875443 345678899999999999999999998855
Q ss_pred CC---------------------------------------------------------ceEEEEEeCCCCChHHHHhcc
Q 018891 99 SD---------------------------------------------------------NRLLVYEFMPKGSLENHLFRS 121 (349)
Q Consensus 99 ~~---------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~ 121 (349)
.. ..++||||+++++|.+++...
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 155 (332)
T 3qd2_B 76 TPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR 155 (332)
T ss_dssp CCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC
T ss_pred eccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc
Confidence 43 279999999999999999653
Q ss_pred C--CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCC----------ccc
Q 018891 122 V--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT----------HVS 189 (349)
Q Consensus 122 ~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~----------~~~ 189 (349)
. ...+...++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......... ...
T Consensus 156 ~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T 3qd2_B 156 CSLEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233 (332)
T ss_dssp CSGGGSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred cCccchhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence 2 23455568999999999999999 899999999999999999999999999999865443211 111
Q ss_pred cceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCC
Q 018891 190 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ 269 (349)
Q Consensus 190 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (349)
....|++.|+|||++.+..++.++|+||||+++|+|++|..|+.... . ............
T Consensus 234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~---------------~~~~~~~~~~~~ 293 (332)
T 3qd2_B 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----R---------------IITDVRNLKFPL 293 (332)
T ss_dssp CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----H---------------HHHHHHTTCCCH
T ss_pred cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----H---------------HHHHhhccCCCc
Confidence 22468999999999999999999999999999999999876642111 0 000001111111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 270 YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.....++.+.++|.+||+.||++|||+.+++++
T Consensus 294 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 294 LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 224556788999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=319.17 Aligned_cols=261 Identities=23% Similarity=0.362 Sum_probs=215.1
Q ss_pred CcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCC
Q 018891 11 SASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHE 87 (349)
Q Consensus 11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~ 87 (349)
..........++|++.+.||+|+||.||+| .+..+++.|++|.+..... ...+.+.+|+.+++.++||
T Consensus 5 p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 75 (294)
T 2rku_A 5 PEVLVDPRSRRRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75 (294)
T ss_dssp CSEEEETTTTEEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCT
T ss_pred cceeeCCCcccceEEEEEEeecCCEEEEEE---------EECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCC
Confidence 344455667889999999999999999999 5555688999998865432 3346678899999999999
Q ss_pred cccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
||+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++
T Consensus 76 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~ 152 (294)
T 2rku_A 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDL 152 (294)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTC
T ss_pred CEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEcCCC
Confidence 9999999999999999999999999999988544 67999999999999999999999 89999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
.++|+|||.+......... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+.
T Consensus 153 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 228 (294)
T 2rku_A 153 EVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-- 228 (294)
T ss_dssp CEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--
T ss_pred CEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--
Confidence 9999999999764332221 223568899999999998889999999999999999999999997654321111110
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.. ....+..+++.+.+++.+||+.||++|||+.+++++-.
T Consensus 229 ---------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~ 268 (294)
T 2rku_A 229 ---------------KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268 (294)
T ss_dssp ---------------TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred ---------------hc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 00 11234456788999999999999999999999998644
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=328.16 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=202.6
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCC--Ccccce
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRH--ENLVKL 92 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h--~~i~~~ 92 (349)
.+.+++|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++| |||+++
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 74 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN----------EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC----------TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe----------CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEE
Confidence 45688999999999999999999943 237889999886543 2334678899999999976 999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++......++|||+ .+++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||+++ ++.++|+
T Consensus 75 ~~~~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~iiHrDikp~NIll~-~~~~kl~ 149 (343)
T 3dbq_A 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLI 149 (343)
T ss_dssp EEEEECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEE-TTEEEEC
T ss_pred eeeEeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEE-CCcEEEe
Confidence 9999999999999995 578999999654 67999999999999999999999 89999999999999997 6789999
Q ss_pred cccccccCCCCCCCccccceecCCcccCcccccc-----------CCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
|||++................|++.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--- 226 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 226 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---
Confidence 9999976544333222334578999999999865 67888999999999999999999999654321
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
................+...++.+.+|+.+||+.||.+|||+.++++|-.-
T Consensus 227 -------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 227 -------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp -------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -------------HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 111112222222333444556789999999999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=338.13 Aligned_cols=259 Identities=19% Similarity=0.215 Sum_probs=210.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
+..++|++.+.||+|+||.||+| ....+++.||+|++..... .....+.+|..+++.++||||+++++
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~---------~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 141 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVV---------KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEE---------EEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 44579999999999999999999 4455689999999865322 12234778999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++.+.+..|+||||+++++|.+++.+....+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH--QLHYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH--hCCeEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999999765678999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|++........ .......|++.|+|||++. +..++.++|+|||||++|+|++|..||.+.+.......+.....
T Consensus 220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 99976433222 1122357899999999986 56789999999999999999999999986554333322221100
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~ 302 (349)
..........+++++.+||++||+.+|++ ||++.++++|
T Consensus 299 --------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 299 --------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00001112346788999999999988888 9999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=322.18 Aligned_cols=253 Identities=24% Similarity=0.267 Sum_probs=198.9
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhcc-CCCccc
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQL-RHENLV 90 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~ 90 (349)
...++..++|++.+.||+|+||+||+| .+..+++.||||++..... ........|+..+.++ +||||+
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv 120 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEE---------EETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CccchhhhheeeeheeccCCCeEEEEE---------EECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEE
Confidence 345566689999999999999999999 4455688999998765422 2333445556555555 899999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
++++++.+.+..++|||++ +++|.+++......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+|
T Consensus 121 ~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~k 197 (311)
T 3p1a_A 121 RLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCK 197 (311)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECGGGCEE
T ss_pred EEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEecCCCCHHHEEECCCCCEE
Confidence 9999999999999999999 66999988776678999999999999999999999 88999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|+|||++........ .....|++.|+|||++.+ .++.++||||||+++|+|++|..|+.+... ...+
T Consensus 198 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~------ 264 (311)
T 3p1a_A 198 LGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQL------ 264 (311)
T ss_dssp ECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHH------
T ss_pred EccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHH------
Confidence 999999876433222 222458999999998875 789999999999999999999776643211 0000
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.........+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 265 -----------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 265 -----------RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -----------TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----------hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 00000011122456789999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=336.77 Aligned_cols=272 Identities=23% Similarity=0.319 Sum_probs=200.3
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
...++|++.+.||+|+||.||+| .+..+++.||||++... .......+.+|+.+++.++||||++++++
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 93 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLA---------YDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecCCEEEEEEEeecCCEEEEEE---------EECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence 35689999999999999999999 55566899999998653 22345678899999999999999999999
Q ss_pred EecC-----CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 96 CSES-----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 96 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
+... ...|+|||+++ ++|.+++.. ...+++..++.++.||+.||.||| +.+++||||||+||+++.++.+|
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH--~~givHrDlkp~NILl~~~~~~k 169 (432)
T 3n9x_A 94 IIPDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVK 169 (432)
T ss_dssp CCCSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEE
T ss_pred EecCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHeEECCCCCEE
Confidence 9766 56899999985 599998854 467999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCC--------------------ccccceecCCcccCcccc-ccCCCCCccceehhhHHHHHHHhCC
Q 018891 171 LSDFGLARDGPTGDNT--------------------HVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 229 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~--------------------~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~ll~~lltg~ 229 (349)
|+|||++......... .......|++.|+|||++ .+..++.++|||||||++|+|++|.
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 9999999865433211 112346789999999986 5667999999999999999999865
Q ss_pred ccCc-----------cccCcc-----------------hhhhHHhh-hchhhhh-----hhhHhhhhcc-ccCCCC----
Q 018891 230 RALD-----------EDRGGL-----------------AEQTLVEW-ADPFLRD-----SRRVLRIMDT-RLGGQY---- 270 (349)
Q Consensus 230 ~pf~-----------~~~~~~-----------------~~~~~~~~-~~~~~~~-----~~~~~~~~~~-~~~~~~---- 270 (349)
.||. +..... ....+... ..+.... .......... ......
T Consensus 250 ~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (432)
T 3n9x_A 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ 329 (432)
T ss_dssp TTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred cccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHH
Confidence 5543 221100 00000000 0000000 0000011100 000111
Q ss_pred -CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 271 -SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 271 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.+.+++++.+||.+||+.||++|||+.++++|
T Consensus 330 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 330 KYPSISDDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 13467889999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=316.24 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=210.4
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
.+..++|++.+.||+|+||.||+| .+..++..||+|.+..... .....+.+|+.+++.++||||++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 80 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred chhhhhceeeheecCCCCeEEEEE---------EEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEE
Confidence 345579999999999999999999 4555688999999865432 2346788999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+++...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~D 157 (284)
T 2vgo_A 81 NYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIAD 157 (284)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEEcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEEcCCCCEEEec
Confidence 9999999999999999999999998654 57999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||++....... .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 158 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------- 226 (284)
T 2vgo_A 158 FGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN------- 226 (284)
T ss_dssp CTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-------
T ss_pred ccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-------
Confidence 99986543322 1224688999999999999999999999999999999999999976543221111111
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.....+..+++.+.++|.+||..||.+|||+.++++|-
T Consensus 227 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~ 264 (284)
T 2vgo_A 227 ------------VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264 (284)
T ss_dssp ------------TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred ------------cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence 01223455678899999999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=325.14 Aligned_cols=276 Identities=26% Similarity=0.360 Sum_probs=191.0
Q ss_pred cCCCCcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccC
Q 018891 7 MSDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLR 85 (349)
Q Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~ 85 (349)
|+..+......+..++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.++++++
T Consensus 1 m~~~s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~ 71 (303)
T 2vwi_A 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71 (303)
T ss_dssp ------------CCCCCEEEEECC---CCCEEEE---------EC----CEEEEECCC----------------CCCCCC
T ss_pred CCCcccccccccchhhhhhhheeccccceEEEEE---------EECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC
Confidence 5555666667788899999999999999999999 5555688999998865532 33456788999999999
Q ss_pred CCcccceeeEEecCCceEEEEEeCCCCChHHHHhc-------cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-------SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-------~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 72 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dl~p 149 (303)
T 2vwi_A 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--KNGQIHRDVKA 149 (303)
T ss_dssp CTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSG
T ss_pred CCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCCCCCh
Confidence 99999999999999999999999999999999863 2456899999999999999999999 89999999999
Q ss_pred CcEEEcCCCcEEEecccccccCCCCCC---CccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCcc
Q 018891 159 SNVLLDSNFNAKLSDFGLARDGPTGDN---THVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDE 234 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~ 234 (349)
+||+++.++.++|+|||.+........ ........+++.|+|||++.+ ..++.++|+||||+++|+|++|..||..
T Consensus 150 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 150 GNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp GGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999999875443221 111123468999999999876 5689999999999999999999999976
Q ss_pred ccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 235 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...............+.... ..........+++.+.+++.+||+.||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 230 YPPMKVLMLTLQNDPPSLET---------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCGGGHHHHHHTSSCCCTTC--------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CchhhHHHHHhccCCCcccc---------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 55432221111100000000 000111223456789999999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=336.86 Aligned_cols=265 Identities=25% Similarity=0.301 Sum_probs=200.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++|++.+.||+|+||.||+| .+..+++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 131 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 131 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEE---------EETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCCCeEEEEE---------EECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence 578999999999999999999 55566899999998654 2234567889999999999999999999996
Q ss_pred cCC------ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 98 ESD------NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 98 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
... ..|+||||+++ +|.+.+. ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||
T Consensus 132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDlkp~NIll~~~~~~kl 205 (464)
T 3ttj_A 132 PQKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI 205 (464)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred cCCccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChHhEEEeCCCCEEE
Confidence 543 46999999965 5777663 34899999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-h
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-P 250 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~ 250 (349)
+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..... +
T Consensus 206 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 206 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282 (464)
T ss_dssp CCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred EEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999997543321 22335789999999999999999999999999999999999999987664333333322111 1
Q ss_pred hhhhh----hhHhhhhcccc------------------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FLRDS----RRVLRIMDTRL------------------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~~~~----~~~~~~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... ........... ........++++.+||.+||..||++|||+.++++|
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000000 000112237789999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=339.19 Aligned_cols=263 Identities=27% Similarity=0.443 Sum_probs=216.0
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.+..++|++.+.||+|+||.||+|.++. +..||||.+.... ...+.+.+|+.++++++||||+++++++
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~ 252 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 252 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETT----------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECC----------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 4556789999999999999999996542 5679999987654 3467889999999999999999999998
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
. .+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||
T Consensus 253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp C-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred e-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 6 567899999999999999996532 36889999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.........+
T Consensus 330 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---------- 398 (454)
T 1qcf_A 330 LARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------- 398 (454)
T ss_dssp GGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----------
T ss_pred CceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Confidence 99764321110 0111235678999999998999999999999999999999 99999765532222111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 312 (349)
....+...+..+++.+.+++.+||..||++|||+.++++.|+++..+...
T Consensus 399 --------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 399 --------ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp --------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred --------HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 11222334556788999999999999999999999999999999876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=331.66 Aligned_cols=274 Identities=25% Similarity=0.331 Sum_probs=213.1
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCccccee
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
..++..++|++.+.||+|+||.||+| .+..++..||+|.+.... ......+.+|+.+++.++||||++++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 97 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred ccccccccceeeeeecCCCCeEEEEE---------EECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEe
Confidence 34566789999999999999999999 455568999999987653 23456788999999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCcEEEcCCCcEEEe
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~-~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
+++..++..++||||+++++|.+++... ..+++..+..++.|++.||.||| +. +++|+||||+||+++.++.++|+
T Consensus 98 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh--~~~~i~H~dlkp~Nil~~~~~~~kl~ 174 (360)
T 3eqc_A 98 GAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLC 174 (360)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HhCCEEcCCccHHHEEECCCCCEEEE
Confidence 9999999999999999999999999654 57999999999999999999999 75 89999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc---
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD--- 249 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~--- 249 (349)
|||++....... .....+++.|+|||++.+..++.++||||||+++|+|++|..||...........+.....
T Consensus 175 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 175 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250 (360)
T ss_dssp CCCCCHHHHHHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------
T ss_pred ECCCCccccccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccC
Confidence 999886432111 1224689999999999999999999999999999999999999976553332211110000
Q ss_pred ----------------------hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 250 ----------------------PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 250 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
+.......................++.++.+||.+||+.||++|||+.++++|-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 327 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence 0000001111111111112222346778999999999999999999999998644
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=324.51 Aligned_cols=264 Identities=29% Similarity=0.436 Sum_probs=212.1
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcE--EEEEEccccc-hhchHHHHHHHHHHhcc-CCCcccc
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIV--VAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVK 91 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~--vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~ 91 (349)
+.+..++|++.+.||+|+||.||+|... .++.. +++|.+.... ......+.+|+.+++++ +||||++
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIK---------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEE---------ETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCC
T ss_pred ccccHHHccceeeeecCCCceEEEEEEc---------cCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhh
Confidence 3455689999999999999999999543 34554 4899876432 23445688999999999 8999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 156 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di 156 (349)
+++++...+..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dl 168 (327)
T 1fvr_A 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDL 168 (327)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCC
T ss_pred hceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH--hCCccCCCC
Confidence 9999999999999999999999999996542 47999999999999999999999 899999999
Q ss_pred CCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccc
Q 018891 157 KASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDED 235 (349)
Q Consensus 157 ~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~ 235 (349)
||+||+++.++.++|+|||++........ .....+++.|+|||++.+..++.++|+||||+++|+|++ |..||.+.
T Consensus 169 kp~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~ 245 (327)
T 1fvr_A 169 AARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 245 (327)
T ss_dssp SGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ccceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999864322111 112346788999999998889999999999999999998 99999765
Q ss_pred cCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 236 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
........ +........+..+++.+.++|.+||..||.+|||+.+++++|+++.....
T Consensus 246 ~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 246 TCAELYEK------------------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp CHHHHHHH------------------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred cHHHHHHH------------------hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 43221111 11112223445677889999999999999999999999999999988754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=326.19 Aligned_cols=272 Identities=24% Similarity=0.335 Sum_probs=207.3
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 86 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEE---------EETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceeEEEEEecCCCcEEEEE---------EECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence 379999999999999999999 45556889999988655332 3456789999999999999999999987
Q ss_pred c--------CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 98 E--------SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 98 ~--------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
. .+..++||||+++ +|.+.+......+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp EC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCE
T ss_pred ccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCeeCCCCCHHHEEEcCCCCE
Confidence 6 3468999999965 788888776678999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCC--ccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 170 KLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+|+|||++......... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99999999765432221 11223567999999999876 5689999999999999999999999987665444433333
Q ss_pred hhchhhhhh---hhHhhhhc---cccC--CCCCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 247 WADPFLRDS---RRVLRIMD---TRLG--GQYSKK-----EAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 247 ~~~~~~~~~---~~~~~~~~---~~~~--~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
......... ........ .... ...... .++.+.+||.+||+.||++|||+.++++|=
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 313 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 313 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence 211111100 00000000 0000 000011 246789999999999999999999999873
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=342.44 Aligned_cols=262 Identities=25% Similarity=0.417 Sum_probs=218.0
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.+...+|++.+.||+|+||.||+|.+. .++..||||.+.... ...+.+.+|+.++++++||||+++++++
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~---------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~ 285 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWK---------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC 285 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEG---------GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEc---------CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 345678999999999999999999554 347889999997653 3467789999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
......++||||+++++|.+++... ...+++..++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||
T Consensus 286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCChhhEEECCCCcEEEeecc
Confidence 9999999999999999999999753 356899999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+........
T Consensus 364 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~------------ 430 (495)
T 1opk_A 364 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE------------ 430 (495)
T ss_dssp CEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------------
T ss_pred cceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH------------
Confidence 9976432211 11112345678999999999999999999999999999999 999997655322221
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.+....+...+..+++.+.+||.+||+.||++|||+.++++.|+.+...
T Consensus 431 ------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 431 ------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ------HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1122233345567788999999999999999999999999999988654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=315.46 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=213.2
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.+..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 345689999999999999999999643 25679999986543 3456788999999999999999999998
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
.. +..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 78 ~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg 154 (279)
T 1qpc_A 78 TQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFG 154 (279)
T ss_dssp CS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred cC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence 64 56899999999999999996532 36999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.........
T Consensus 155 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----------- 222 (279)
T 1qpc_A 155 LARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----------- 222 (279)
T ss_dssp TCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----------
T ss_pred ccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-----------
Confidence 99764332211 1122345778999999998889999999999999999999 8999976543221111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 312 (349)
+........+..+++.+.+++.+||..||++|||+.++++.|+++......
T Consensus 223 -------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 223 -------LERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp -------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred -------HhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 111122233456778999999999999999999999999999999876443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=328.57 Aligned_cols=272 Identities=24% Similarity=0.275 Sum_probs=199.2
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
.....++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+.+|+.++++++||||++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKA---------IDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEE
T ss_pred cccchhhEEEEEEEEecCCeEEEEE---------EECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEE
Confidence 4445579999999999999999999 55566899999999765432 235567899999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc-----CCCc
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD-----SNFN 168 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~-----~~~~ 168 (349)
+++...+..++||||+++ +|.+++... ..+++..++.++.||+.||.||| +.+++|+||||+||+++ .++.
T Consensus 100 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~~ 175 (329)
T 3gbz_A 100 SVIHHNHRLHLIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPV 175 (329)
T ss_dssp EEEEETTEEEEEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEC-----CCE
T ss_pred EEEecCCEEEEEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCEECCCCCHHHEEEecCCCCccce
Confidence 999999999999999975 999988554 67999999999999999999999 89999999999999994 4556
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
++|+|||++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+...
T Consensus 176 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 176 LKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp EEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 9999999997543221 112234679999999999774 5899999999999999999999999876543333322221
Q ss_pred hc-hhhhhhhhHh------hhhccccCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 AD-PFLRDSRRVL------RIMDTRLGG----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~-~~~~~~~~~~------~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. +......... ......... ..+..+++++.+||.+||+.||++|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 11 0000000000 000000000 0112256789999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=330.27 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=200.6
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHH-HhccCCCcccce
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIY-LGQLRHENLVKL 92 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~-l~~l~h~~i~~~ 92 (349)
.+..++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+..|..+ ++.++||||+++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~---------~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l 104 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLA---------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEE---------EETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCE
T ss_pred CCChhheEEEEEEeeCCCeEEEEE---------EEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCE
Confidence 455689999999999999999999 55556899999998765432 23345556665 567899999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++...+..|+||||++|++|.+++.+. ..+++..++.++.||+.||.||| +.+++||||||+||+++.+|.++|+
T Consensus 105 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~givHrDlkp~NIll~~~g~ikL~ 181 (373)
T 2r5t_A 105 HFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLH--SLNIVYRDLKPENILLDSQGHIVLT 181 (373)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999988654 67899999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 182 DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------ 253 (373)
T 2r5t_A 182 DFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN------ 253 (373)
T ss_dssp CCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH------
T ss_pred eCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------
Confidence 999987532221 122235789999999999999999999999999999999999999976543222221111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV----DVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~----~ll~~ 302 (349)
. ....+..+++.+.+||.+||+.||.+||++. ++++|
T Consensus 254 -----------~--~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 254 -----------K--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp -----------S--CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred -----------c--ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 1 1123445678899999999999999999974 55543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=325.38 Aligned_cols=272 Identities=25% Similarity=0.304 Sum_probs=203.9
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-----hHHHHHHHHHHhccCCCccccee
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-----HKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
..++|++.+.||+|+||.||+| .+..+++.||+|.+....... ...+.+|+.+++.++||||++++
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 78 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL 78 (346)
T ss_dssp -----CEEEEEEEETTEEEEEE---------ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred HhcccEEEeEEeecCCEEEEEE---------EECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence 3579999999999999999999 556678999999987543221 24577899999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+++...+..++||||+++ +|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~kl~D 155 (346)
T 1ua2_A 79 DAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLAD 155 (346)
T ss_dssp EEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCCHHHEEEcCCCCEEEEe
Confidence 999999999999999976 899988776677999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-hh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PF 251 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~~ 251 (349)
||++........ ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+..... +.
T Consensus 156 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 156 FGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233 (346)
T ss_dssp CGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999976433221 22235689999999998664 588999999999999999999999977654333322222111 10
Q ss_pred hhhhhhHhhh---hccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 252 LRDSRRVLRI---MDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 252 ~~~~~~~~~~---~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
.......... ......... ...+++++.+||.+||..||++|||+.++++|-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 0000000000 000000001 1345678999999999999999999999998744
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.56 Aligned_cols=263 Identities=30% Similarity=0.439 Sum_probs=213.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.+++ +..||||.+.... ...+.+.+|+.++++++||||+++++++.
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 249 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 556789999999999999999996543 4569999997654 34567899999999999999999999987
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
. +..++||||+++++|.+++... ...+++..++.++.|++.||+||| +.+++|+||||+||+++.++.+||+|||+
T Consensus 250 ~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 250 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred C-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence 6 6789999999999999999643 356899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.........
T Consensus 327 a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~------------ 393 (452)
T 1fmk_A 327 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ------------ 393 (452)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------------
T ss_pred ceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH------------
Confidence 9754332211 1112345678999999999999999999999999999999 9999976543221111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 313 (349)
+....+...+..+++.+.+++.+||+.||++|||+.++++.|+.+......+
T Consensus 394 ------i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 394 ------VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp ------HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred ------HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 1122233445677889999999999999999999999999999998775544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=327.33 Aligned_cols=271 Identities=23% Similarity=0.287 Sum_probs=209.0
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-----CCc
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-----HEN 88 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~ 88 (349)
..+++..++|++.+.||+|+||.||+| .+..+++.||+|++.... .....+..|..+++.+. |||
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLC---------QHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEE---------EECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCC
Confidence 345677899999999999999999999 455568899999986432 33455677888998886 999
Q ss_pred ccceeeEEecCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC--
Q 018891 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-- 165 (349)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-- 165 (349)
|+++++++...+..++|||++ +++|.+++.... ..+++..+..++.||+.||+||| +.+++|+||||+||+++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--KMSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCTT
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCcccEEEcccc
Confidence 999999999999999999999 889999996643 46999999999999999999999 899999999999999975
Q ss_pred -----------------------CCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHH
Q 018891 166 -----------------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL 222 (349)
Q Consensus 166 -----------------------~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll 222 (349)
++.++|+|||++....... ....|++.|+|||++.+..++.++|||||||++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 7889999999997643322 224689999999999999999999999999999
Q ss_pred HHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHh------hhhc-----cccCC----------------CCCHHHH
Q 018891 223 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL------RIMD-----TRLGG----------------QYSKKEA 275 (349)
Q Consensus 223 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~-----~~~~~----------------~~~~~~~ 275 (349)
|+|++|..||...........+.....+......... .... ..... ......+
T Consensus 250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 9999999999876544333333322221111100000 0000 00000 0000112
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 276 QAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 276 ~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+.+.+||.+||+.||++|||+.++++|
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 678899999999999999999999865
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.72 Aligned_cols=252 Identities=28% Similarity=0.369 Sum_probs=207.1
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
.++|++.+.||+|+||.||+| .+..+++.||||.+..... .....+.+|+.++++++||||+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 123 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 123 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEE---------EEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 456999999999999999999 5555689999999865422 2345688999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..++||||+. ++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||+
T Consensus 124 ~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 200 (348)
T 1u5q_A 124 LREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGS 200 (348)
T ss_dssp EETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred EECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEECCCCCEEEeeccC
Confidence 99999999999996 5888888666678999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
+...... ....|++.|+|||++. +..++.++||||||+++|+|++|..||.+.........+.
T Consensus 201 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~-------- 266 (348)
T 1u5q_A 201 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------- 266 (348)
T ss_dssp CBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--------
T ss_pred ceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--------
Confidence 8754322 1246899999999984 5678999999999999999999999997654211111111
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
........+..+++.+.++|.+||+.||++|||+.+++++-.-.
T Consensus 267 ---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 267 ---------QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp ---------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred ---------hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 11111122345677899999999999999999999999876653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=320.72 Aligned_cols=261 Identities=25% Similarity=0.342 Sum_probs=204.6
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccc
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVK 91 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 91 (349)
.....+...++|++.+.||+|+||.||+| .+..+++.||+|.+.... ....+.+|+.+++.++||||++
T Consensus 20 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~ 88 (314)
T 3com_A 20 EDSLTKQPEEVFDVLEKLGEGSYGSVYKA---------IHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88 (314)
T ss_dssp ----------CEEEEEECC----CEEEEE---------EETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCC
T ss_pred chhhhhcchhhhhhheeeccCCCeEEEEE---------EECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCcc
Confidence 33445667789999999999999999999 445568899999986543 4567889999999999999999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
+++++...+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl 166 (314)
T 3com_A 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--FMRKIHRDIKAGNILLNTEGHAKL 166 (314)
T ss_dssp EEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEE
T ss_pred EEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCCcCCCcCHHHEEECCCCCEEE
Confidence 999999999999999999999999999755678999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+|||.+........ ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 167 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----- 239 (314)
T 3com_A 167 ADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT----- 239 (314)
T ss_dssp CCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-----
T ss_pred eecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-----
Confidence 99999975433211 12234688999999999998999999999999999999999999975442111111100
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
........+..+++.+.++|.+||..||.+|||+.+++++-
T Consensus 240 -----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 240 -----------NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp -----------SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred -----------CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 00111122345678899999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=326.83 Aligned_cols=271 Identities=23% Similarity=0.324 Sum_probs=204.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+..+|+.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 93 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF 93 (367)
T ss_dssp CBSSEEEEEEC------CEEEE---------EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred ecceEEEeEEeeecCCeEEEEE---------EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence 4578999999999999999999 555668999999985542 23346678999999999999999999999
Q ss_pred ecCC------ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SESD------NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
.... ..|+|||++ +++|.+++.. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~k 168 (367)
T 1cm8_A 94 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELK 168 (367)
T ss_dssp CSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEE
T ss_pred ecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCHHHEEEcCCCCEE
Confidence 7653 459999999 7899998855 57999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||++...... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+.....
T Consensus 169 l~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 169 ILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp ECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999999864322 122468999999999877 6799999999999999999999999987664433333332211
Q ss_pred hhhhhh---------hhHhhhhccc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhc
Q 018891 250 PFLRDS---------RRVLRIMDTR---LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 308 (349)
Q Consensus 250 ~~~~~~---------~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~ 308 (349)
...... ......+... .........++.+.+||.+||..||.+|||+.++++| +..+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 110000 0000111110 0111234567889999999999999999999999985 444433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=317.08 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=202.1
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
...++|++.+.||+|+||.||+| .+..++..+|+|.+..... ...+.+.+|+.++++++||||+++++++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 89 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ChhhheeecceeccCCCeEEEEE---------EEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe
Confidence 34689999999999999999999 4555688999999876543 3457788999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE---cCCCcEE
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAK 170 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv---~~~~~v~ 170 (349)
......++||||+++++|.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~ivH~dikp~NIl~~~~~~~~~~k 167 (285)
T 3is5_A 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIK 167 (285)
T ss_dssp ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEEECCCCHHHEEEecCCCCCCEE
Confidence 999999999999999999998854 2367999999999999999999999 8999999999999999 4567899
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|+|||++........ .....+++.|+|||++. ..++.++|+||||+++|+|++|..||.+............
T Consensus 168 l~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~---- 239 (285)
T 3is5_A 168 IIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY---- 239 (285)
T ss_dssp ECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----
T ss_pred EEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc----
Confidence 999999975433221 22356899999999875 5688999999999999999999999976543222111111
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... ......+++.+.+|+.+||+.||++|||+.+++++
T Consensus 240 -----------~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 240 -----------KEPNY-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -----------CCCCC-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -----------CCccc-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01112256789999999999999999999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=325.29 Aligned_cols=264 Identities=22% Similarity=0.244 Sum_probs=205.8
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-----hhchHHHHHHHHHHhccCCC
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-----FQGHKEWLTEVIYLGQLRHE 87 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~ 87 (349)
..+.++ .++|++.+.||+|+||.||+| .+..++..||+|++.... ......+.+|+.++++++||
T Consensus 19 ~~~~~~-~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp 88 (345)
T 3hko_A 19 GSLLEL-QKKYHLKGAIGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88 (345)
T ss_dssp BCHHHH-HHHEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCT
T ss_pred chhhhh-hhheeecceeeecCCeEEEEE---------EECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCC
Confidence 334444 579999999999999999999 455568899999986542 23456788999999999999
Q ss_pred cccceeeEEecCCceEEEEEeCCCCChHHHHhcc---------------------------------------CCCCChH
Q 018891 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS---------------------------------------VQPISWP 128 (349)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------~~~l~~~ 128 (349)
||+++++++.+.+..++||||+++++|.+++... ...+++.
T Consensus 89 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (345)
T 3hko_A 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREK 168 (345)
T ss_dssp TBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHH
T ss_pred CcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHH
Confidence 9999999999999999999999999999988421 1123677
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC--cEEEecccccccCCCCCC--CccccceecCCcccCcccc
Q 018891 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPTGDN--THVSTRIVGTRGYAAPEYV 204 (349)
Q Consensus 129 ~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~--~v~l~Dfg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~ 204 (349)
.++.++.|++.||+||| +.+++|+||||+||+++.++ .++|+|||++........ ........+++.|+|||++
T Consensus 169 ~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 246 (345)
T 3hko_A 169 LISNIMRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246 (345)
T ss_dssp HHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence 88999999999999999 88999999999999998776 899999999975432221 1122335689999999998
Q ss_pred cc--CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHH
Q 018891 205 AT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVV 282 (349)
Q Consensus 205 ~~--~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 282 (349)
.+ ..++.++||||||+++|+|++|..||.+.........+...... ........+++.+.+||
T Consensus 247 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~li 311 (345)
T 3hko_A 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC---------------FENPNYNVLSPLARDLL 311 (345)
T ss_dssp TCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------TTSGGGGGSCHHHHHHH
T ss_pred ccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc---------------cCCcccccCCHHHHHHH
Confidence 65 67889999999999999999999999766543222222211100 00111234678899999
Q ss_pred HHhcccCCCCCCCHHHHHHHH
Q 018891 283 LQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 283 ~~~l~~dp~~Rps~~~ll~~l 303 (349)
.+||+.||.+|||+.+++++=
T Consensus 312 ~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 312 SNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHcCCChhHCCCHHHHhcCh
Confidence 999999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=315.78 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=209.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh------chHHHHHHHHHHhccCCCcccce
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
..++|++.+.||+|+||.||+| .+..+++.||+|.+...... ..+.+.+|+.++++++||||+++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 73 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hhhhhhhHHhhcccCceEEEEE---------EEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeeh
Confidence 4678999999999999999999 45556889999988654322 35678899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC----c
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF----N 168 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~----~ 168 (349)
++++......++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++ .
T Consensus 74 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 74 HDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSSSSCC
T ss_pred hheecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCChHHEEEecCCCCCCc
Confidence 99999999999999999999999999554 67999999999999999999999 89999999999999998877 7
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
++|+|||.+........ .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+....
T Consensus 151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 227 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN 227 (283)
T ss_dssp EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC
T ss_pred eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc
Confidence 99999999976433221 123468899999999999999999999999999999999999997654322221111100
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhcC
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 309 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~~ 309 (349)
..........+++.+.+++.+||..||.+|||+.+++++ ++.+...
T Consensus 228 ---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 228 ---------------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp ---------------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred ---------------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 000000112346789999999999999999999999984 5555444
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=331.84 Aligned_cols=277 Identities=23% Similarity=0.358 Sum_probs=200.5
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc--chhchHHHHHHHHHHhccC-CCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLR-HENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 93 (349)
....++|++.+.||+|+||.||+| .+..+++.||||++... .......+.+|+.+++.+. ||||++++
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~ 75 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKS---------IDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEE---------EETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred CcccCceEEEEEeeeCCCeEEEEE---------EECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeee
Confidence 345679999999999999999999 55566899999988543 2334566788999999997 99999999
Q ss_pred eEEecCC--ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 94 GYCSESD--NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 94 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
+++...+ ..|+||||++ ++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|
T Consensus 76 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 76 NVLRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLH--SGGLLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp EEEECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEEecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--hCCEEeCCCCHHHeEEcCCCCEEe
Confidence 9997544 6899999996 589998854 57899999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCC-------------------CccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCcc
Q 018891 172 SDFGLARDGPTGDN-------------------THVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA 231 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~-------------------~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~p 231 (349)
+|||++........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 99999975432111 111223578999999999876 6789999999999999999999999
Q ss_pred CccccCcchhhhHHhhhc-hhhh-----------hhhh-Hhhhh---ccccCCC------------CCHHHHHHHHHHHH
Q 018891 232 LDEDRGGLAEQTLVEWAD-PFLR-----------DSRR-VLRIM---DTRLGGQ------------YSKKEAQAVAAVVL 283 (349)
Q Consensus 232 f~~~~~~~~~~~~~~~~~-~~~~-----------~~~~-~~~~~---~~~~~~~------------~~~~~~~~l~~li~ 283 (349)
|.+.+.......+..... +... .... ..... ....... ....+++++.+||.
T Consensus 231 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 231 FPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 987665443333322111 0000 0000 00000 0000000 01134678999999
Q ss_pred HhcccCCCCCCCHHHHHHH--HHhhh
Q 018891 284 QCLHMDPKNRPSMVDVLTS--LEQLH 307 (349)
Q Consensus 284 ~~l~~dp~~Rps~~~ll~~--l~~~~ 307 (349)
+||+.||++|||+.++++| +..+.
T Consensus 311 ~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred HhhccCcccCCCHHHHhCCHHHHHhc
Confidence 9999999999999999987 44443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=330.18 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=201.5
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccC--CCcccce
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLR--HENLVKL 92 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~~ 92 (349)
.+.+++|++.+.||+|+||.||+|. +.. ++.||||++.... ......+.+|+.+++++. ||||+++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~---------~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~ 121 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVL---------NEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEE---------CTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred cccCCceEEEEEEccCCCeEEEEEE---------cCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEE
Confidence 3456779999999999999999994 333 7889999986543 234567889999999996 5999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++...+..++||| +.+++|.+++... ..+++..++.++.||+.||.||| +.+|+||||||+||+++ ++.+||+
T Consensus 122 ~~~~~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH--~~~ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 122 YDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp EEEEECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH--TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred EEEEecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCHHHEEEE-CCeEEEE
Confidence 999999999999999 5578999999654 57899999999999999999999 99999999999999995 5799999
Q ss_pred cccccccCCCCCCCccccceecCCcccCcccccc-----------CCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
|||++................|++.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-- 274 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-- 274 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--
Confidence 9999976543332222233568999999999865 368889999999999999999999996543211
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
...............+...+.++.+||.+||+.||.+|||+.+++++-.-
T Consensus 275 --------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 275 --------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp --------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred --------------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 01111122222223333446789999999999999999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=334.10 Aligned_cols=259 Identities=20% Similarity=0.232 Sum_probs=208.7
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
.+..++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|..++..++||+|++++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~---------~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVV---------KMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 345689999999999999999999 4555689999999865322 2234477899999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+++.+.+..|+||||+++++|.+++.+....+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|
T Consensus 128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccCHHHeeecCCCCEEEee
Confidence 9999999999999999999999999765568999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccc-------cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-------TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
||++........ .......|++.|+|||++. +..++.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 206 FGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 206 FGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred chhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999976433222 1112357899999999987 35789999999999999999999999976554332222222
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR---PSMVDVLTS 302 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~ 302 (349)
... .......+..+++++.+||.+||. +|++| |++.++++|
T Consensus 285 ~~~--------------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKE--------------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHH--------------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ccc--------------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 100 000011123567899999999999 99998 599999976
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.19 Aligned_cols=266 Identities=27% Similarity=0.424 Sum_probs=205.9
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEe-c
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCS-E 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~ 98 (349)
..|++.+.||+|+||.||+|.+.. ..+.+..||+|.+.... ......+.+|+.++++++||||+++++++. .
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEE------TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEEC------CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 457788999999999999997542 22234678999886543 234567889999999999999999999864 4
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
++..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++.
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEecCccchheEEECCCCCEEEeeccccc
Confidence 56789999999999999999776677899999999999999999999 8999999999999999999999999999997
Q ss_pred cCCCCCCCc--cccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 179 DGPTGDNTH--VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 179 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.........+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~--------- 311 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------- 311 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT---------
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc---------
Confidence 543322111 1122456778999999999999999999999999999999 6777866554332222111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 312 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~ 312 (349)
......+..+++.+.+++.+||+.||++|||+.++++.|+++......
T Consensus 312 ---------~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 312 ---------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred ---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 111223445678899999999999999999999999999999887543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=325.02 Aligned_cols=256 Identities=26% Similarity=0.347 Sum_probs=184.2
Q ss_pred cccCCc---ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEE
Q 018891 21 KNFCSD---YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYC 96 (349)
Q Consensus 21 ~~y~~~---~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 96 (349)
++|++. +.||+|+||.||+| .+..+++.||+|++... ....+.+|+.+++.+. ||||+++++++
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~ 75 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKC---------VHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF 75 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEE---------EETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hccccccCCCccccCCCeEEEEE---------EECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 456654 78999999999999 55556899999998653 3456678999999996 99999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC---cEEEec
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF---NAKLSD 173 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~---~v~l~D 173 (349)
.+....++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .++|+|
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~~kl~D 152 (325)
T 3kn6_A 76 HDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIID 152 (325)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEC----CEEEECC
T ss_pred EcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCeecCCCHHHEEEecCCCcccEEEec
Confidence 9999999999999999999999654 67999999999999999999999 89999999999999998766 799999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||++........ ......+++.|+|||++.+..++.++||||||+++|+|++|..||..............
T Consensus 153 fg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~------- 223 (325)
T 3kn6_A 153 FGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE------- 223 (325)
T ss_dssp CTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-------
T ss_pred cccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-------
Confidence 999975433221 22235679999999999999999999999999999999999999976543211110000
Q ss_pred hhhhHhhhhcccc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 254 DSRRVLRIMDTRL--GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 254 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.......... .......+++++.+||.+||+.||.+|||+.++++|-
T Consensus 224 ---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 224 ---IMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp ---HHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred ---HHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 0001111111 0111134678899999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=324.93 Aligned_cols=269 Identities=27% Similarity=0.435 Sum_probs=204.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
-++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKC---------RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEE---------EETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEE---------EECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 468999999999999999999 4555689999998855432 23455778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..++||||+++++|.+++. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 171 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLEL-FPNGLDYQVVQKYLFQIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHH-STTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCEEEEEEecCCcchHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHH--HCCEEccCcChheEEEcCCCcEEEEeCCCc
Confidence 9999999999999888887764 4467999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
........ ......+++.|+|||++.+. .++.++||||||+++|+|++|..||.+.........+............
T Consensus 172 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (331)
T 4aaa_A 172 RTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249 (331)
T ss_dssp --------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhh
Confidence 75433221 12234689999999998775 7899999999999999999999999876654333333322111111100
Q ss_pred hHhh---hhc----cccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLR---IMD----TRLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~---~~~----~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ... ...... ..+.+++.+.+||.+||+.||++|||+.++++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 000 000000 112457889999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=331.30 Aligned_cols=280 Identities=21% Similarity=0.294 Sum_probs=217.5
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+.+++|++.+.||+|+||.||+| .+..+++.||||++..... .....+.+|+.++++++||||++++++
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 75 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEE---------EECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEe
Confidence 355789999999999999999999 4555688999999876543 345667899999999999999999999
Q ss_pred EecCC--ceEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE----cCCC
Q 018891 96 CSESD--NRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNF 167 (349)
Q Consensus 96 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv----~~~~ 167 (349)
+.... ..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||++ +.++
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~~~ 153 (396)
T 4eut_A 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQS 153 (396)
T ss_dssp EECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEEEECTTSCE
T ss_pred eccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--HCCEEECCcCHHHEEEeecCCCce
Confidence 98655 6799999999999999996532 33999999999999999999999 8999999999999999 7778
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCcccccc--------CCCCCccceehhhHHHHHHHhCCccCccccCcc
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~ 239 (349)
.++|+|||++........ .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 154 ~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~ 230 (396)
T 4eut_A 154 VYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230 (396)
T ss_dssp EEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred eEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence 899999999976433221 223468999999999865 567789999999999999999999997654322
Q ss_pred hhhhH-Hhhhchhhh-hh------hh--HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 240 AEQTL-VEWADPFLR-DS------RR--VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 240 ~~~~~-~~~~~~~~~-~~------~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
....+ ......... .. .. .............+..+++.+.+++.+||+.||++|||+.++++.++++...
T Consensus 231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred chHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 22211 111110000 00 00 0000001112244578999999999999999999999999999999998876
Q ss_pred C
Q 018891 310 K 310 (349)
Q Consensus 310 ~ 310 (349)
+
T Consensus 311 ~ 311 (396)
T 4eut_A 311 M 311 (396)
T ss_dssp E
T ss_pred e
Confidence 4
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=320.91 Aligned_cols=256 Identities=23% Similarity=0.347 Sum_probs=205.1
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
...++|++.+.||+|+||.||+| .+..++..|++|.+..........+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEE---------EETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCccceeecceeccCCCeEEEEE---------EEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 45689999999999999999999 445568899999998776667788899999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
..+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--SKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh--cCCcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 999999999999999999998766678999999999999999999999 899999999999999999999999999987
Q ss_pred ccCCCCCCCccccceecCCcccCcccc-----ccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~-----~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
...... ........+++.|+|||++ .+..++.++|+||||+++|+|++|..||...........+..
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 236 (302)
T 2j7t_A 165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK------ 236 (302)
T ss_dssp HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------
T ss_pred cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc------
Confidence 431110 0011124588899999998 466788999999999999999999999976543211111111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..++..+.++|.+||..||.+|||+.++++|
T Consensus 237 ----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 237 ----------SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ----------SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ----------cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011112345567889999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=325.19 Aligned_cols=257 Identities=21% Similarity=0.329 Sum_probs=205.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (349)
..++|++.+.||+|+||.||+| .+..+++.||+|++...... ..+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 4679999999999999999999 55566899999998655322 23677788887 7999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC----CcEEEec
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN----FNAKLSD 173 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~----~~v~l~D 173 (349)
+.+..|+||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||||+||++..+ +.++|+|
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH--~~givHrDlkp~NIl~~~~~~~~~~~kl~D 163 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICD 163 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESSSSCSGGGEEECC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCHHHEEEecCCCCcCeEEEEE
Confidence 999999999999999999998554 67999999999999999999999 8999999999999998543 3599999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||++........ ......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+......
T Consensus 164 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~--- 238 (342)
T 2qr7_A 164 FGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--- 238 (342)
T ss_dssp CTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC---
T ss_pred CCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC---
Confidence 999976433222 122346899999999998888899999999999999999999999764332222111111100
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
...........+++++.+||.+||..||++|||+.++++|-.-
T Consensus 239 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~ 281 (342)
T 2qr7_A 239 ---------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281 (342)
T ss_dssp ---------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred ---------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence 0011112234577899999999999999999999999987554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=315.21 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=208.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+..+++|++.+.||+|+||.||+| .+..+++.||+|.+.... ..+.+|+.++++++||||++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~ 72 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKA---------KHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEE---------EETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhccccceeeeeccCCceEEEEE---------EEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeee
Confidence 4556789999999999999999999 444568899999986543 245689999999999999999998
Q ss_pred Eec----------------CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 96 CSE----------------SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 96 ~~~----------------~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
+.. ....++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp 150 (284)
T 2a19_B 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKP 150 (284)
T ss_dssp EEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSG
T ss_pred EeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCH
Confidence 854 34579999999999999999653 367999999999999999999999 89999999999
Q ss_pred CcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCc
Q 018891 159 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 238 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~ 238 (349)
+||+++.++.++|+|||++......... ....+++.|+|||++.+..++.++|+||||+++|+|++|..|+.....
T Consensus 151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 226 (284)
T 2a19_B 151 SNIFLVDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK- 226 (284)
T ss_dssp GGEEEEETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-
T ss_pred HHEEEcCCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-
Confidence 9999999999999999998765443221 224589999999999999999999999999999999999988742110
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
....... ...+..+++.+.++|.+||..||.+|||+.+++++|+.+..+..
T Consensus 227 ------------------~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 227 ------------------FFTDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ------------------HHHHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ------------------HHHHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0000001 11233456789999999999999999999999999999887633
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=333.79 Aligned_cols=257 Identities=21% Similarity=0.241 Sum_probs=208.8
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
...++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|..+++.++||||+++++
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~---------~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLV---------RHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEE---------EECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 34579999999999999999999 5556689999999865322 22345778999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++.+.+..|+||||++|++|.+++.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+||
T Consensus 137 ~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH--~~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 137 AFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999998854 46899999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCC----CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH----LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|++........ .......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+.......+.....
T Consensus 213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~- 290 (410)
T 3v8s_A 213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN- 290 (410)
T ss_dssp TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-
T ss_pred ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-
Confidence 99976433221 1122357999999999997665 78999999999999999999999976553322222221100
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTSL 303 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~l 303 (349)
.........+++++.+||.+||..+|.+ ||++.++++|-
T Consensus 291 --------------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 291 --------------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp --------------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred --------------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 0011112346788999999999999988 99999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=315.68 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=203.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.+. +..||+|.+... ...+.+.+|+..+++++||||+++++++.
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL 71 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 45679999999999999999999653 567999998654 34567889999999999999999999876
Q ss_pred cCCceEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCC---CCeeeccCCCCcEEEcCCCc-EEE
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLD---ANVIYRDLKASNVLLDSNFN-AKL 171 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~---~~i~H~di~~~Nilv~~~~~-v~l 171 (349)
+..++||||+++++|.+++.... ..++...++.++.|++.||+||| + .+++|+||||+||+++.++. ++|
T Consensus 72 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~~~~ivH~dlkp~NIll~~~~~~~kl 147 (307)
T 2eva_A 72 --NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH--SMQPKALIHRDLKPPNLLLVAGGTVLKI 147 (307)
T ss_dssp --TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH--TCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred --CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH--hCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence 45899999999999999996543 24788999999999999999999 7 79999999999999998886 799
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+|||++...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 148 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------- 214 (307)
T 2eva_A 148 CDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-------- 214 (307)
T ss_dssp CCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH--------
T ss_pred cccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH--------
Confidence 999998653222 1224589999999999999999999999999999999999999975443211100
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
...........+..+++.+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 215 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 215 --------WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp --------HHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred --------HHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 001111122334566788999999999999999999999999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=322.75 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=211.9
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
.....++|++.+.||+|+||.||+| .+..+++.|++|.+.... ....+.+.+|+.+++.++||||+++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 106 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcccCCceEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3455689999999999999999999 455568899999986543 2344667899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~kl~ 183 (335)
T 2owb_A 107 HGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIG 183 (335)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred EEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCEecCCCchhEEEcCCCCEEEe
Confidence 99999999999999999999999988554 67999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||++......... .....+++.|+|||++.+..++.++||||||+++|+|++|..||...........+..
T Consensus 184 Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------ 255 (335)
T 2owb_A 184 DFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------ 255 (335)
T ss_dssp CCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------
T ss_pred eccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc------
Confidence 99999765332221 2235689999999999999999999999999999999999999976442211111110
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
. ....+..+++.+.+||.+||+.||++|||+.+++++-.
T Consensus 256 -----------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~ 294 (335)
T 2owb_A 256 -----------N--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294 (335)
T ss_dssp -----------T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred -----------C--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 0 11234456778999999999999999999999998643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=315.75 Aligned_cols=267 Identities=23% Similarity=0.348 Sum_probs=200.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhc--cCCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ--LRHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~ 93 (349)
..+..++|++.+.||+|+||.||+|.++ ++.||+|++.... ...+..|.+++.. ++||||++++
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~ 68 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSWQ-----------GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFI 68 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEEC-----------CEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEE
Confidence 4566889999999999999999999542 6789999986543 3344455555555 7999999999
Q ss_pred eEEec----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC------CCCeeeccCCCCcEEE
Q 018891 94 GYCSE----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL------DANVIYRDLKASNVLL 163 (349)
Q Consensus 94 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~------~~~i~H~di~~~Nilv 163 (349)
+++.. ....++||||+++++|.+++.. ..+++..++.++.|++.||+|||+. +.+++|+||||+||++
T Consensus 69 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill 146 (301)
T 3q4u_A 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146 (301)
T ss_dssp EEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE
T ss_pred EeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE
Confidence 98644 3457899999999999999943 5799999999999999999999932 4689999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCc--cccceecCCcccCccccccC------CCCCccceehhhHHHHHHHhC-------
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATG------HLTPKSDVYSFGVVLLELLSG------- 228 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~ll~~lltg------- 228 (349)
+.++.++|+|||++.......... ......|++.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~ 226 (301)
T 3q4u_A 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226 (301)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence 999999999999986533322211 11224689999999999876 445689999999999999999
Q ss_pred ---CccCccccCcchh-hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 229 ---RRALDEDRGGLAE-QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 229 ---~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
..||......... ..+...... ............+..+++.+.+++.+||+.||++|||+.++++.|+
T Consensus 227 ~~~~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 227 EDYKPPFYDVVPNDPSFEDMRKVVCV--------DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTT--------SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccccccccCCCCcchhhhhHHHhc--------cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 7777654332211 111110000 0000000001123457889999999999999999999999999999
Q ss_pred hh
Q 018891 305 QL 306 (349)
Q Consensus 305 ~~ 306 (349)
++
T Consensus 299 ~i 300 (301)
T 3q4u_A 299 KI 300 (301)
T ss_dssp HH
T ss_pred cc
Confidence 86
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=315.93 Aligned_cols=259 Identities=26% Similarity=0.351 Sum_probs=213.7
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
....+.|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 88 (303)
T 3a7i_A 18 ADPEELFTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88 (303)
T ss_dssp ECGGGTEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CChHHHHHHhhhhcccCCeEEEEE---------EECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 345678999999999999999999 4555688999999865532 345778899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+......++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~kl~Dfg 164 (303)
T 3a7i_A 89 YLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFG 164 (303)
T ss_dssp EEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChheEEECCCCCEEEeecc
Confidence 9999999999999999999998854 57999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++........ ......+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+
T Consensus 165 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----------- 231 (303)
T 3a7i_A 165 VAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI----------- 231 (303)
T ss_dssp TCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-----------
T ss_pred cceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-----------
Confidence 9976433221 122356889999999999999999999999999999999999999754422111111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
........+..++..+.+++.+||+.||++|||+.+++++..-...
T Consensus 232 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 232 -------PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -------HHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -------hcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 1111122344567789999999999999999999999987655443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=336.29 Aligned_cols=257 Identities=25% Similarity=0.316 Sum_probs=208.8
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
...++|++.+.||+|+||.||+| .+..+++.||+|++.... ......+.+|+.++++++||||++++++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 89 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEE---------EETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEE---------EECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 34689999999999999999999 555568999999986542 2345778899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc---CCCcEEEe
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAKLS 172 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~---~~~~v~l~ 172 (349)
+......++||||+.+++|.+.+... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++ .++.++|+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 90 LEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred EEcCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCchHHEEEecCCCCCCEEEE
Confidence 99999999999999999999988654 67999999999999999999999 89999999999999995 45679999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|||++....... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+....
T Consensus 167 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~---- 238 (486)
T 3mwu_A 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK---- 238 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----
T ss_pred ECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----
Confidence 999997543322 1223568999999999875 58999999999999999999999997655432222221110
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
..........+++.+.+||.+||+.||.+|||+.++++|-+-
T Consensus 239 -----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~ 280 (486)
T 3mwu_A 239 -----------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280 (486)
T ss_dssp -----------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred -----------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence 001111224567889999999999999999999999987443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=322.96 Aligned_cols=266 Identities=24% Similarity=0.369 Sum_probs=197.5
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCccccee
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLI 93 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 93 (349)
..++...+|++.+.||+|+||.||+| .+..+++.||+|.+..........+.+|+.+++++. ||||++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~ 92 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEA---------QDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEE---------EETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred eeeccCceEEEEEEEccCCceEEEEE---------EECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcc
Confidence 34566789999999999999999999 445568899999987666566677889999999995 99999999
Q ss_pred eEEe--------cCCceEEEEEeCCCCChHHHHhc--cCCCCChHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCcE
Q 018891 94 GYCS--------ESDNRLLVYEFMPKGSLENHLFR--SVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNV 161 (349)
Q Consensus 94 ~~~~--------~~~~~~lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~--i~H~di~~~Ni 161 (349)
+++. .....++||||+. ++|.+++.. ....+++..++.++.|++.||.||| +.+ ++|+||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~ivH~Dikp~NI 169 (337)
T 3ll6_A 93 SAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENL 169 (337)
T ss_dssp EEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH--TSSSCCBCCCCCGGGC
T ss_pred ccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCEEEccCCcccE
Confidence 9984 3345789999995 689888854 3467999999999999999999999 888 99999999999
Q ss_pred EEcCCCcEEEecccccccCCCCCCCc----------cccceecCCcccCcccc---ccCCCCCccceehhhHHHHHHHhC
Q 018891 162 LLDSNFNAKLSDFGLARDGPTGDNTH----------VSTRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSG 228 (349)
Q Consensus 162 lv~~~~~v~l~Dfg~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~ll~~lltg 228 (349)
+++.++.++|+|||++.......... ......+++.|+|||++ .+..++.++||||||+++|+|++|
T Consensus 170 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp EECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred EECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence 99999999999999997654332211 01124588999999998 566788899999999999999999
Q ss_pred CccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 229 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
..||........ .............+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus 250 ~~p~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 250 QHPFEDGAKLRI---------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp SCCC---------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcchhHHHh---------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999965432111 01111111122344568899999999999999999999999999988
Q ss_pred CCCCC
Q 018891 309 SKDMP 313 (349)
Q Consensus 309 ~~~~~ 313 (349)
..+..
T Consensus 309 ~~~~~ 313 (337)
T 3ll6_A 309 ARNVN 313 (337)
T ss_dssp HTTCC
T ss_pred ccCCC
Confidence 75544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=325.89 Aligned_cols=280 Identities=18% Similarity=0.248 Sum_probs=208.6
Q ss_pred CCcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-----------chHHHHHHH
Q 018891 10 PSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-----------GHKEWLTEV 78 (349)
Q Consensus 10 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~e~ 78 (349)
+.+..+.+..+++|++.+.||+|+||.||+|.+.. ...++..+|+|.+...... ....+.+|+
T Consensus 26 ~~g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~ 99 (345)
T 2v62_A 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTN------KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW 99 (345)
T ss_dssp CTTCEEECTTSCEEEEEEEC------CEEEEEESS------SCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHH
T ss_pred CCCCeeccccCceEEEEeeEeecCCeEEEEEEecC------CCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHH
Confidence 44556667778999999999999999999996542 1225788999988654321 123466788
Q ss_pred HHHhccCCCcccceeeEEec----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 018891 79 IYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 154 (349)
Q Consensus 79 ~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~ 154 (349)
..++.++||||+++++++.. ....++||||+ +++|.+++... ..+++..++.++.|++.||+||| +.+++|+
T Consensus 100 ~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~ 175 (345)
T 2v62_A 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIH--ENEYVHG 175 (345)
T ss_dssp HHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHH--HTTEECS
T ss_pred HhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeCC
Confidence 89999999999999999877 67889999999 89999998654 48999999999999999999999 8999999
Q ss_pred cCCCCcEEEcCCC--cEEEecccccccCCCCCC-----CccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh
Q 018891 155 DLKASNVLLDSNF--NAKLSDFGLARDGPTGDN-----THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 227 (349)
Q Consensus 155 di~~~Nilv~~~~--~v~l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt 227 (349)
||||+||+++.++ .++|+|||++........ ........|++.|+|||++.+..++.++||||||+++|+|++
T Consensus 176 Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 255 (345)
T 2v62_A 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC 255 (345)
T ss_dssp CCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999998887 999999999975432211 111123568999999999999999999999999999999999
Q ss_pred CCccCccccCcchhhhHHhhhchhhhhh-hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 228 GRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
|..||.............. ....... ....... ....+++.+.+++.+||..||++|||+.++++.|+++
T Consensus 256 g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 256 GKLPWEQNLKDPVAVQTAK--TNLLDELPQSVLKWA-------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp SSCTTGGGTTCHHHHHHHH--HHHHHTTTHHHHHHS-------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred CCCCccccccccHHHHHHH--HhhcccccHHHHhhc-------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 9999965432222111110 0000000 0000000 0114567899999999999999999999999999886
Q ss_pred hc
Q 018891 307 HT 308 (349)
Q Consensus 307 ~~ 308 (349)
..
T Consensus 327 ~~ 328 (345)
T 2v62_A 327 GI 328 (345)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=313.52 Aligned_cols=254 Identities=31% Similarity=0.437 Sum_probs=204.3
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.+. +..||+|.+.... ..+.+.+|+.++++++||||+++++++.
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-----------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 45689999999999999999999542 6789999987543 4567889999999999999999999875
Q ss_pred cC-CceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 98 ES-DNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 98 ~~-~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
.. +..++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCcceEEEeCCCcEEEeecc
Confidence 44 57899999999999999996542 23889999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...........+
T Consensus 163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---------- 227 (278)
T 1byg_A 163 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---------- 227 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----------
T ss_pred ccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Confidence 987533221 12346788999999999999999999999999999998 99999765432221111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
........+..+++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 228 --------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 228 --------EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp --------TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------hcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11122334456788999999999999999999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=312.13 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=201.7
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
+.+..++|++.+.||+|+||.||+| .+..+++.|++|.+..... .....+.+|+..++.++||||+++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 76 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcceeccEEEEeeecCCCCeEEEEE---------EECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEE
Confidence 4556689999999999999999999 4455688999999865432 334678899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+
T Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~l~ 153 (276)
T 2h6d_A 77 YQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIA 153 (276)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HHCSSCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCChhhEEECCCCCEEEe
Confidence 99999999999999999999999999654 67999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
|||++........ .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+..
T Consensus 154 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----- 225 (276)
T 2h6d_A 154 DFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG----- 225 (276)
T ss_dssp CCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----
T ss_pred ecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-----
Confidence 9999976433221 123468899999999987765 5899999999999999999999976442211111110
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ....+..++..+.++|.+||+.||.+|||+.++++|
T Consensus 226 ------------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 226 ------------G--VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ------------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------------C--cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 112334567789999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=311.63 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=202.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
..++.|++.+.||+|+||.||+| .+..++..|++|.+.... ......+.+|+.++++++||||++++++
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~---------~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 93 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCceeEEeeeeccCCCCeEEEEe---------EecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 34667999999999999999999 455568899999886543 2345678899999999999999999998
Q ss_pred Eec----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCcEEEc-CCCc
Q 018891 96 CSE----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLD-SNFN 168 (349)
Q Consensus 96 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~--i~H~di~~~Nilv~-~~~~ 168 (349)
+.. ....++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+ ++|+||||+||+++ .++.
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~~~i~H~dikp~Nil~~~~~~~ 170 (290)
T 1t4h_A 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGS 170 (290)
T ss_dssp EEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTSC
T ss_pred eccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH--cCCCCEEECCCCHHHEEEECCCCC
Confidence 865 34589999999999999999654 67999999999999999999999 888 99999999999997 7889
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
++|+|||++....... .....+++.|+|||++. +.++.++|+||||+++|+|++|..||.............
T Consensus 171 ~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--- 242 (290)
T 1t4h_A 171 VKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV--- 242 (290)
T ss_dssp EEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---
T ss_pred EEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH---
Confidence 9999999997533221 22346899999999886 458999999999999999999999997644321111000
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.........+...++.+.++|.+||+.||.+|||+.++++|
T Consensus 243 -------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 243 -------------TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------------TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------------hccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00011111223345689999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=338.79 Aligned_cols=259 Identities=26% Similarity=0.333 Sum_probs=212.6
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
.....++|++.+.||+|+||.||+| .+..+++.||||++.... ......+.+|+.++++++||||+++
T Consensus 21 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 91 (484)
T 3nyv_A 21 TAIFSDRYKGQRVLGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91 (484)
T ss_dssp CCCHHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCcccCceEEeeEEecCCCEEEEEE---------EECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3456689999999999999999999 555668999999986542 2345778899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE---cCCCcE
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNA 169 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv---~~~~~v 169 (349)
++++...+..++||||+.+++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||++ +.++.+
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~ 168 (484)
T 3nyv_A 92 YEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANI 168 (484)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHHHEEEecCCCCCcE
Confidence 99999999999999999999999988554 67999999999999999999999 8999999999999999 567889
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
+|+|||++....... ......|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.........+....
T Consensus 169 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~- 243 (484)
T 3nyv_A 169 RIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK- 243 (484)
T ss_dssp EECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-
T ss_pred EEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-
Confidence 999999997653332 2233568999999999865 68999999999999999999999998765432222221110
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
..........+++.+.+||.+||+.||.+|||+.++++|-+-
T Consensus 244 --------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~ 285 (484)
T 3nyv_A 244 --------------YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI 285 (484)
T ss_dssp --------------CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred --------------CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence 001111224567889999999999999999999999986543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=317.43 Aligned_cols=257 Identities=24% Similarity=0.332 Sum_probs=207.2
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++|++.+.||+|+||.||+| .+..+++.|++|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeehhccCCCCcEEEEE---------EECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 479999999999999999999 455568999999986543 234567889999999999999999999874
Q ss_pred --cCCceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCCCC-----eeeccCCCCcEEEcCCC
Q 018891 98 --ESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLDAN-----VIYRDLKASNVLLDSNF 167 (349)
Q Consensus 98 --~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~-----i~H~di~~~Nilv~~~~ 167 (349)
.....++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHC------CCCCCSGGGEEECSSS
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--cccCCCCeeEEeccchhhEEEcCCC
Confidence 456789999999999999998652 345999999999999999999999 778 99999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
.++|+|||.+....... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+..
T Consensus 154 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~- 230 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE- 230 (279)
T ss_dssp CEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-
T ss_pred CEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-
Confidence 99999999987643221 112234688999999999998999999999999999999999999976543221111111
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
......+..+++.+.++|.+||+.||++|||+.+++++++...
T Consensus 231 -----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 231 -----------------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp -----------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred -----------------cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1112334567789999999999999999999999998765543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=323.88 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=203.9
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--------chHHHHHHHHHHhccCCCccc
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~ 90 (349)
..++|++.+.||+|+||.||+| .+..+++.||+|.+...... ....+.+|+.++++++||||+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv 92 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEE---------EETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBC
T ss_pred cccceEEEeEEEecCCEEEEEE---------EECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEe
Confidence 4579999999999999999999 55566899999998654321 223456799999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCC-ChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 91 KLIGYCSESDNRLLVYEFMPKG-SLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
++++++...+..++|||++.++ +|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~~~~~~ 169 (335)
T 3dls_A 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLR--LKDIIHRDIKDENIVIAEDFTI 169 (335)
T ss_dssp CEEEEEECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCE
T ss_pred eEEEEEeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEEeccCHHHEEEcCCCcE
Confidence 9999999999999999998665 999988544 67999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
+|+|||++........ .....|++.|+|||++.+..+ +.++||||||+++|+|++|..||......
T Consensus 170 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------- 236 (335)
T 3dls_A 170 KLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------- 236 (335)
T ss_dssp EECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------
T ss_pred EEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------
Confidence 9999999976543322 223568999999999988776 78899999999999999999999642210
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
... ....+..+++++.+||.+||+.||++|||+.+++++-
T Consensus 237 -------------~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 -------------VEA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp -------------TTT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred -------------Hhh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000 0112233577899999999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=339.48 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=212.8
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
+..++|++.+.||+|+||.||+| .+..+|+.||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a---------~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 251 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCAC---------QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEE---------EECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence 56788999999999999999999 4555689999999865432 33456789999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
++...+..|+||||++|++|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+||+++.+|.++|+|
T Consensus 252 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH--~~gIvHrDLKPeNILld~~g~vKL~D 329 (576)
T 2acx_A 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISD 329 (576)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEeccCCchheEEEeCCCCeEEEe
Confidence 999999999999999999999988654 245999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||++........ .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+....
T Consensus 330 FGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i----- 401 (576)
T 2acx_A 330 LGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV----- 401 (576)
T ss_dssp CTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH-----
T ss_pred cccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh-----
Confidence 999976543321 223478999999999999999999999999999999999999998755432222221110
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ......+..+++++.+||.+||+.||.+|| ++.++++|
T Consensus 402 --------~--~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 402 --------K--EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --------H--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --------h--cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0 011233456788999999999999999999 78999976
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=321.73 Aligned_cols=262 Identities=17% Similarity=0.198 Sum_probs=207.8
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC---CCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR---HENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~ 92 (349)
..+..++|++.+.||+|+||.||+|.+... .+..+++.||+|++..... ..+..|..+++.++ |++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDL----NDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCC----cccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhh
Confidence 445678899999999999999999965432 2456688999999876543 34556666666665 9999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhc----cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFR----SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--- 165 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~--- 165 (349)
++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||+||| +.+|+||||||+||+++.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH--~~~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH--DCEIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCSGGGEEECGGGT
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh--hCCeecCCCCHHHEEeccccc
Confidence 9999999999999999999999999964 3467999999999999999999999 999999999999999988
Q ss_pred --------CCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccC
Q 018891 166 --------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 237 (349)
Q Consensus 166 --------~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~ 237 (349)
++.+||+|||++................|++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 899999999999654333333333446789999999999999999999999999999999999999964432
Q ss_pred cchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhcC
Q 018891 238 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR-PSMVDVLTSLEQLHTS 309 (349)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-ps~~~ll~~l~~~~~~ 309 (349)
.... ...... . ...++.+.+++..||+.+|.+| |++.++.+.|+++...
T Consensus 291 ~~~~--------------------~~~~~~-~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 291 GECK--------------------PEGLFR-R--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp TEEE--------------------ECSCCT-T--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred Ccee--------------------echhcc-c--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 1110 000000 0 0125678899999999999999 6888888888887765
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=330.53 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=197.8
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--------chHHHHHHHHHHhccC
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYLGQLR 85 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~ 85 (349)
.......++|++.+.||+|+||.||+| .+..+++.||+|++...... ....+.+|+.++++++
T Consensus 128 ~~~~~~~~~y~~~~~LG~G~~g~V~~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 198 (419)
T 3i6u_A 128 VYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198 (419)
T ss_dssp GSCHHHHTTEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC
T ss_pred ccchhhhccEEEEeEEeeCCCeEEEEE---------EECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC
Confidence 344566789999999999999999999 55556899999998654221 1224778999999999
Q ss_pred CCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC
Q 018891 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165 (349)
Q Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~ 165 (349)
||||+++++++.. +..++||||+++++|.+++.. ...+++..++.++.|++.||+||| +.+++|+||||+||+++.
T Consensus 199 hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 199 HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSS 274 (419)
T ss_dssp CTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESS
T ss_pred CCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEec
Confidence 9999999999865 558999999999999998854 477999999999999999999999 899999999999999975
Q ss_pred CC---cEEEecccccccCCCCCCCccccceecCCcccCcccccc---CCCCCccceehhhHHHHHHHhCCccCccccCcc
Q 018891 166 NF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 239 (349)
Q Consensus 166 ~~---~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~ 239 (349)
++ .++|+|||++....... ......|++.|+|||++.+ ..++.++|+||||+++|+|++|..||.......
T Consensus 275 ~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 275 QEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp SSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred CCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 44 49999999997643322 2223568999999999853 567889999999999999999999997654322
Q ss_pred hhh-hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 240 AEQ-TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 240 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... .+........ ......+++.+.+||.+||+.||++|||+.++++|
T Consensus 352 ~~~~~i~~~~~~~~---------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 352 SLKDQITSGKYNFI---------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CHHHHHHTTCCCCC---------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhcCCCCCC---------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 211 1111000000 00012356789999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=312.72 Aligned_cols=254 Identities=20% Similarity=0.270 Sum_probs=203.4
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hchHHHHHHHHHHhccCCCcccceeeE
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.++|++.+.||+|+||.||+| .+..++..|++|++..... .....+.+|+.++++++||||++++++
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEV---------LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEE---------EBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccceeEeeEEecCCCeEEEEE---------EECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence 479999999999999999999 5556689999999876532 234678899999999999999999999
Q ss_pred E--ecCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 96 C--SESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 96 ~--~~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
+ ......++||||++++ |.+++.. ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--SQGIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCcccEEEcCCCcEEee
Confidence 8 4456889999999775 7776654 3467999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCC--CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|||.+................+++.|+|||++.+... +.++|+||||+++|+|++|..||.+.........+..
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~---- 227 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK---- 227 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc----
Confidence 9999986544333333334568999999999876543 6799999999999999999999976442211111111
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
. ....+..+++.+.++|.+||..||.+|||+.+++++-.
T Consensus 228 -------------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 266 (305)
T 2wtk_C 228 -------------G--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266 (305)
T ss_dssp -------------C--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHH
T ss_pred -------------C--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 0 11234456788999999999999999999999998744
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.75 Aligned_cols=273 Identities=20% Similarity=0.269 Sum_probs=217.3
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCC-CcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRH-ENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~ 96 (349)
..+++|++.+.||+|+||.||+| .+..+++.||||++..... ...+..|+.+++.++| +++..+..++
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a---------~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~ 72 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLG---------TNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG 72 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEE---------EETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEE---------EECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 45789999999999999999999 4455688999998765432 2346789999999976 5555566666
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE---cCCCcEEEec
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSD 173 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv---~~~~~v~l~D 173 (349)
......++||||+ +++|.+++......+++..++.++.||+.||.||| +.+|+|+||||+|||+ +.++.++|+|
T Consensus 73 ~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~gIvHrDIKP~NILl~~~~~~~~vkL~D 149 (483)
T 3sv0_A 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (483)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred eeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCEeecccCcceEEEecCCCCCeEEEEe
Confidence 7777889999999 88999999766678999999999999999999999 8999999999999999 5888999999
Q ss_pred ccccccCCCCCCCc-----cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 174 FGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 174 fg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
||++.......... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (483)
T ss_dssp CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence 99997654433211 1123568999999999999999999999999999999999999998876544444333322
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCCCC
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 315 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~~~ 315 (349)
......... .....+++++.+|+..||+.||++||++.+|++.|+++......+..
T Consensus 230 ~~~~~~~~~-----------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~ 285 (483)
T 3sv0_A 230 EKKVATSIE-----------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFD 285 (483)
T ss_dssp HHHHHSCHH-----------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCS
T ss_pred hccccccHH-----------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCcc
Confidence 221111100 01123467899999999999999999999999999999887665543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=326.52 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=196.6
Q ss_pred hcccCCc-ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhc-cCCCcccceeeEEe
Q 018891 20 TKNFCSD-YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ-LRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~ 97 (349)
.++|.+. +.||.|+||.||+| .+..+++.||||++... ..+.+|+.++.+ .+||||+++++++.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~---------~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~ 125 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE 125 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccceeccceeeeccCeEEEEE---------EECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEe
Confidence 3567666 79999999999999 55566899999998532 345677877644 48999999999986
Q ss_pred c----CCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---CCcE
Q 018891 98 E----SDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNA 169 (349)
Q Consensus 98 ~----~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~---~~~v 169 (349)
. ....|+||||+++++|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+||+++. ++.+
T Consensus 126 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~~~~~~~ 203 (400)
T 1nxk_A 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAIL 203 (400)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSTTCCE
T ss_pred ecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCcCcceEEEecCCCCccE
Confidence 5 567899999999999999996642 46999999999999999999999 899999999999999987 7889
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
||+|||++....... ......|++.|+|||++.+..++.++|||||||++|+|++|..||.+.............
T Consensus 204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-- 278 (400)
T 1nxk_A 204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR-- 278 (400)
T ss_dssp EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH--
T ss_pred EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH--
Confidence 999999997543222 122356899999999999999999999999999999999999999765532211111000
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
...............+++++.+||.+||+.||++|||+.++++|-.-..
T Consensus 279 ---------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 279 ---------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp ---------HHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---------HHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 0000000111112356788999999999999999999999999866543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=334.97 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=203.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+..++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 105 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF 105 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEE---------EETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEE---------EECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4568999999999999999999 555668899999987643 23456788999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC---CcEEEec
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN---FNAKLSD 173 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~---~~v~l~D 173 (349)
......++||||+.+++|.+.+... ..+++..++.++.||+.||.||| +.+++||||||+||+++.. +.++|+|
T Consensus 106 ~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 182 (494)
T 3lij_A 106 EDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVD 182 (494)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCChhhEEEeCCCCCCcEEEEE
Confidence 9999999999999999999988554 67999999999999999999999 8999999999999999764 4599999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||++....... ......|++.|+|||++. +.++.++|||||||++|+|++|..||.+.........+.....
T Consensus 183 fG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---- 254 (494)
T 3lij_A 183 FGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY---- 254 (494)
T ss_dssp CTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred CCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----
Confidence 99987643322 222356899999999886 5689999999999999999999999987654332222221100
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.........+++.+.+||.+||+.||.+|||+.++++|
T Consensus 255 -----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 255 -----------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -----------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -----------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00111123467889999999999999999999999976
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=335.63 Aligned_cols=257 Identities=25% Similarity=0.320 Sum_probs=206.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-------------hchHHHHHHHHHHhcc
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-------------QGHKEWLTEVIYLGQL 84 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l 84 (349)
...++|++.+.||+|+||.||+| .+..++..||+|++..... ...+.+.+|+.+++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~---------~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 103 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLC---------KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEE---------EETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC
T ss_pred CcccceEEEeEecccCCeEEEEE---------EECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC
Confidence 35689999999999999999999 5555688999999865432 2246688999999999
Q ss_pred CCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
+||||+++++++......++||||+++++|.+++... ..+++..++.++.||+.||.||| +.+++|+||||+||+++
T Consensus 104 ~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLE 180 (504)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEES
T ss_pred CCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCcHHHEEEe
Confidence 9999999999999999999999999999999988654 67999999999999999999999 89999999999999998
Q ss_pred CCC---cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 165 SNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 165 ~~~---~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
.++ .++|+|||++........ .....|++.|+|||++. +.++.++|||||||++|+|++|..||.+.......
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 256 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 776 699999999976543322 22356899999999886 56899999999999999999999999876543332
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
..+....... .......+++++.+||.+||+.||.+|||+.++++|-+-
T Consensus 257 ~~i~~~~~~~---------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 305 (504)
T 3q5i_A 257 KKVEKGKYYF---------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305 (504)
T ss_dssp HHHHHCCCCC---------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHcCCCCC---------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence 2222110000 000012356789999999999999999999999987543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=340.33 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=210.5
Q ss_pred cCCcc-eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 23 FCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 23 y~~~~-~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
+.+.+ .||+|+||.||+|.+.. ..++..||||+++.... ...+.+.+|+.++++++||||+++++++.. +
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRM-------RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEEC-------SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred eeEcCcEEecCCCcEEEEEEEec-------CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 33444 79999999999997642 23467899999976533 356788999999999999999999999976 5
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++||||+++++|.+++......+++..++.++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 799999999999999999766677999999999999999999999 899999999999999999999999999999764
Q ss_pred CCCCCCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 181 PTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 181 ~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
........ .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~--------------- 551 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--------------- 551 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH---------------
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---------------
Confidence 33221111 111234678999999999999999999999999999998 9999987654322211
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
+....+...+..+++.+.+++.+||+.||++|||+.++++.|+.+..+..
T Consensus 552 ---i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 552 ---IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp ---HHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred ---HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 11222344556788899999999999999999999999999999876643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=329.06 Aligned_cols=269 Identities=23% Similarity=0.284 Sum_probs=206.6
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc------CCCcc
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL------RHENL 89 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i 89 (349)
.+....+|++.+.||+|+||.||+| .+..+++.||||++.... .....+.+|+.+++.+ +|+||
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a---------~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~i 161 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKA---------YDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNV 161 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEE---------EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCB
T ss_pred CCcccCcEEEEEEcccCccEEEEEE---------EECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCE
Confidence 4556678999999999999999999 555568999999987643 2334556677777666 57899
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
+++++.+...+..++|||++. ++|.+++.... ..+++..++.++.||+.||+||| +.+|+|+||||+||+++.++.
T Consensus 162 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NILl~~~~~ 238 (429)
T 3kvw_A 162 IHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGR 238 (429)
T ss_dssp CCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HHTEECSCCSGGGEEESSTTS
T ss_pred EEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEccCCC
Confidence 999999999999999999995 58999886643 45999999999999999999999 899999999999999999887
Q ss_pred --EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 169 --AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 169 --v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 239 ~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 239 SGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313 (429)
T ss_dssp CCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999997543322 224689999999999999999999999999999999999999987765444333332
Q ss_pred hhchhhh----hhhhHhhhhccccC----------------------------C--------CCCHHHHHHHHHHHHHhc
Q 018891 247 WADPFLR----DSRRVLRIMDTRLG----------------------------G--------QYSKKEAQAVAAVVLQCL 286 (349)
Q Consensus 247 ~~~~~~~----~~~~~~~~~~~~~~----------------------------~--------~~~~~~~~~l~~li~~~l 286 (349)
....... ........+..... . ..+...++.+.+||.+||
T Consensus 314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L 393 (429)
T 3kvw_A 314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL 393 (429)
T ss_dssp HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence 2111000 00000001000000 0 001112577999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 018891 287 HMDPKNRPSMVDVLTS 302 (349)
Q Consensus 287 ~~dp~~Rps~~~ll~~ 302 (349)
+.||++|||+.++++|
T Consensus 394 ~~dP~~Rpta~e~L~H 409 (429)
T 3kvw_A 394 EWDPAVRMTPGQALRH 409 (429)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred CCChhhCCCHHHHhCC
Confidence 9999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=311.64 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=201.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCCc
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDN 101 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 101 (349)
+|.....||+|+||.||+| .+..++..||+|.+..........+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAG---------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp TTSSBCEEEECSSSEEEEE---------EETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEeecCcEEEEEE---------EECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3444449999999999999 4555688999999877665566778899999999999999999999999999
Q ss_pred eEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-CCcEEEecccccc
Q 018891 102 RLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLAR 178 (349)
Q Consensus 102 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-~~~v~l~Dfg~~~ 178 (349)
.++|||++++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++. ++.++|+|||.+.
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH--hCCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 999999999999999996543 35678889999999999999999 899999999999999987 8899999999997
Q ss_pred cCCCCCCCccccceecCCcccCccccccCC--CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
....... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||..........
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-------------- 235 (295)
T 2clq_A 172 RLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-------------- 235 (295)
T ss_dssp ESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH--------------
T ss_pred ccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH--------------
Confidence 6433221 122346889999999987653 7889999999999999999999996543211100
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
............+..+++.+.+++.+||+.||++|||+.+++++
T Consensus 236 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 236 --FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp --HHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred --HhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00001112233455678899999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=317.48 Aligned_cols=261 Identities=20% Similarity=0.296 Sum_probs=208.8
Q ss_pred chhhhhhhcccCCc-ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhcc-CCCc
Q 018891 13 SMISKIATKNFCSD-YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL-RHEN 88 (349)
Q Consensus 13 ~~~~~~~~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~ 88 (349)
+.... ..++|.+. +.||+|+||.||+| .+..+++.||+|++...... ....+.+|+.+++.+ .|||
T Consensus 21 ~~~~~-~~~~y~~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 90 (327)
T 3lm5_A 21 QSMEN-FNNFYILTSKELGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90 (327)
T ss_dssp BCHHH-HHHHEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTT
T ss_pred HHHHh-hhhEEeeccceeCCCCCeEEEEE---------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCC
Confidence 33444 45688887 89999999999999 45556899999998765332 356788999999999 5799
Q ss_pred ccceeeEEecCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC--
Q 018891 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-- 165 (349)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-- 165 (349)
|+++++++...+..++||||+++++|.+++... ...+++..++.++.|++.||+||| +.+++|+||||+||+++.
T Consensus 91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH--~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEESCBT
T ss_pred EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCeecCcCChHHEEEecCC
Confidence 999999999999999999999999999988543 367999999999999999999999 899999999999999988
Q ss_pred -CCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhH
Q 018891 166 -NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244 (349)
Q Consensus 166 -~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~ 244 (349)
++.++|+|||++........ .....+++.|+|||++.+..++.++|+||||+++|+|++|..||...........+
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 245 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI 245 (327)
T ss_dssp TBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH
Confidence 78999999999986533222 22346899999999999999999999999999999999999999765532222211
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
.. ............+++.+.++|.+||+.||.+|||+.++++|-
T Consensus 246 ~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 246 SQ---------------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp HH---------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred Hh---------------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 11 111112223345678899999999999999999999999763
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=314.05 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=192.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
+..++|++.+.||+|+||.||+| .+..+++.||+|.+...... ....+.++...++.++||||++++++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~ 74 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKM---------RHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEE---------EecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeee
Confidence 55789999999999999999999 55556899999998765322 22334455566888899999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCcEEEcCCCcEEE
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~-~i~H~di~~~Nilv~~~~~v~l 171 (349)
+...+..++||||+++ +|.+++.. ....+++..++.++.|++.||.||| +. +++|+||||+||+++.++.++|
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl 151 (290)
T 3fme_A 75 LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKM 151 (290)
T ss_dssp EECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHSCCCCCCCSGGGCEECTTCCEEB
T ss_pred eeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hcCCeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999975 88777643 4578999999999999999999999 87 9999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCcccc----ccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
+|||++........ .....+++.|+|||++ .+..++.++|+||||+++|+|++|..||........
T Consensus 152 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------- 221 (290)
T 3fme_A 152 CDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ------- 221 (290)
T ss_dssp CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-------
T ss_pred eecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-------
Confidence 99999875433222 1224688999999996 556788999999999999999999999975332111
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..............+..+++.+.+++.+||+.||++|||+.++++|
T Consensus 222 ---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 222 ---------QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---------HHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---------HHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1111111111122233567889999999999999999999999984
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=336.25 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=211.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
+..++|++.+.||+|+||.||+| .+..+|+.||+|++..... .....+.+|..++++++||||+++++
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a---------~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 252 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFAC---------QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 45689999999999999999999 5555689999999865432 23467889999999999999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
++......|+||||++|++|.+++... ...+++..++.++.||+.||.||| +.+|+||||||+||+++.+|.++|
T Consensus 253 ~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~gIvHrDLKP~NILl~~~g~vkL 330 (543)
T 3c4z_A 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRI 330 (543)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--HcCCcccCCChHHEEEeCCCCEEE
Confidence 999999999999999999999988653 346999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+|||++......... .....|++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..
T Consensus 331 ~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~----- 403 (543)
T 3c4z_A 331 SDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----- 403 (543)
T ss_dssp CCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH-----
T ss_pred eecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH-----
Confidence 999999865433221 2234789999999999999999999999999999999999999976543222211111
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 302 (349)
..... ....+..+++.+.+||.+||+.||++||++ .++++|
T Consensus 404 --------~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 404 --------RVLEQ--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp --------HHHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred --------HHhhc--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 01111 123445678899999999999999999964 777764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=325.98 Aligned_cols=272 Identities=23% Similarity=0.296 Sum_probs=207.9
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-------
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR------- 85 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------- 85 (349)
...+++..++|++.+.||+|+||.||+| .+..+++.||||++.... .....+.+|+.+++.+.
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLS---------WDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDP 98 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCG
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEE---------EecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCC
Confidence 3445667789999999999999999999 455568999999987542 33456778999998885
Q ss_pred -CCcccceeeEEe----cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCC
Q 018891 86 -HENLVKLIGYCS----ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKA 158 (349)
Q Consensus 86 -h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~-~i~H~di~~ 158 (349)
|+||+++++.+. .....++|||++ +++|.+.+... ...+++..++.++.||+.||.||| +. +++||||||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~givHrDikp 175 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKP 175 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECCCCSG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HhCCEecCCCCH
Confidence 788999999987 556789999999 55666666543 367999999999999999999999 87 999999999
Q ss_pred CcEEEcCCC-------------------------------------------------cEEEecccccccCCCCCCCccc
Q 018891 159 SNVLLDSNF-------------------------------------------------NAKLSDFGLARDGPTGDNTHVS 189 (349)
Q Consensus 159 ~Nilv~~~~-------------------------------------------------~v~l~Dfg~~~~~~~~~~~~~~ 189 (349)
+||+++.++ .++|+|||++...... .
T Consensus 176 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~ 250 (397)
T 1wak_A 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----F 250 (397)
T ss_dssp GGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----S
T ss_pred HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----C
Confidence 999999776 7999999999764332 1
Q ss_pred cceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhh------hHHhhhchhhhhhh----hHh
Q 018891 190 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ------TLVEWADPFLRDSR----RVL 259 (349)
Q Consensus 190 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~------~~~~~~~~~~~~~~----~~~ 259 (349)
....+++.|+|||++.+..++.++|||||||++|+|++|..||.......... .+............ ...
T Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 251 TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 22468999999999999999999999999999999999999998655433211 11111000000000 000
Q ss_pred hhhcc-------------------ccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 260 RIMDT-------------------RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 260 ~~~~~-------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... ......+...++.+.+||.+||+.||++|||+.++++|
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000 00113457788999999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=318.61 Aligned_cols=280 Identities=22% Similarity=0.317 Sum_probs=201.9
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
..+..++|++.+.||+|+||.||+|.+ +++.||+|++....... .....++..++.++||||+++++.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~ 75 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVG 75 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheec
Confidence 345568999999999999999999954 26789999986543221 112234444556899999999975
Q ss_pred Eec-----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCC---------CeeeccCCCCcE
Q 018891 96 CSE-----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDA---------NVIYRDLKASNV 161 (349)
Q Consensus 96 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~---------~i~H~di~~~Ni 161 (349)
+.. ....++||||+++++|.+++.. ...++..++.++.|++.||.||| +. +++|+||||+||
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH--~~~~~~~~~~~~ivH~Dikp~Ni 151 (336)
T 3g2f_A 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLH--TELPRGDHYKPAISHRDLNSRNV 151 (336)
T ss_dssp EEEECTTSCEEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHH--CCBCCGGGCBCCEECSSCSGGGE
T ss_pred ccccccCCCceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHH--hhhccccccccceeecccccceE
Confidence 532 2356899999999999999955 34588999999999999999999 88 999999999999
Q ss_pred EEcCCCcEEEecccccccCCCCCC------CccccceecCCcccCcccccc-------CCCCCccceehhhHHHHHHHhC
Q 018891 162 LLDSNFNAKLSDFGLARDGPTGDN------THVSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVLLELLSG 228 (349)
Q Consensus 162 lv~~~~~v~l~Dfg~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~ll~~lltg 228 (349)
+++.++.+||+|||++........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 152 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 999999999999999976543221 111122468999999999976 3556789999999999999999
Q ss_pred CccCccccC-cchhhhHHhh--hchhhhhhhhHhhhhccccCCC------CCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 018891 229 RRALDEDRG-GLAEQTLVEW--ADPFLRDSRRVLRIMDTRLGGQ------YSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 299 (349)
Q Consensus 229 ~~pf~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (349)
..||..... ......+... ..+....... .......+.. ....+++.+.+||.+||+.||++|||+.++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQV--LVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHH--HHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHh--hhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 777644332 1111111110 0111111100 0111111111 124578899999999999999999999999
Q ss_pred HHHHHhhhcCCCCC
Q 018891 300 LTSLEQLHTSKDMP 313 (349)
Q Consensus 300 l~~l~~~~~~~~~~ 313 (349)
++.|+++......-
T Consensus 310 l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 310 EERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHHHCCCC-
T ss_pred HHHHHHHHHHHHhc
Confidence 99999998775443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=323.85 Aligned_cols=270 Identities=24% Similarity=0.320 Sum_probs=207.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
+++|++.+.||+|+||.||+| .+..++..||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSA---------YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cccEEEEEEeecCCCeEEEEE---------EECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 479999999999999999999 4555689999999875432 334678899999999999999999999865
Q ss_pred C-----CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 99 S-----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 99 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
. ...++|||+++ ++|.+++.. ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++|+|
T Consensus 97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLME-TDLYKLLKT--QHLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp SSTTTCCCEEEEEECCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred CCccccceEEEEEcccC-cCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCChHhEEECCCCCEEEEe
Confidence 4 46899999996 489998854 56999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCc-cccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 174 FGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 174 fg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
||++.......... ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99997643322211 1223578999999998654 558999999999999999999999998776655544443322111
Q ss_pred hhhhhh------Hhhhhcc-ccCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 252 LRDSRR------VLRIMDT-RLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 252 ~~~~~~------~~~~~~~-~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
...... ....... ..... ....+++++.+||.+||+.||++|||+.++++|=
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 110000 0000000 00000 1134567899999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=313.65 Aligned_cols=262 Identities=18% Similarity=0.252 Sum_probs=202.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 98 (349)
.++|++.+.||+|+||.||+| .+..+++.||+|++... ....+.+|+.++++++ ||||+++++++..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCceEEEEEecccCCeEEEEE---------EECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 578999999999999999999 45556889999998643 3466889999999997 9999999999987
Q ss_pred --CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-cEEEeccc
Q 018891 99 --SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDFG 175 (349)
Q Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-~v~l~Dfg 175 (349)
....++||||+++++|.+++. .+++..++.++.|++.||+||| +.+++|+||||+||+++.++ .++|+|||
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg 176 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWG 176 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence 667899999999999999873 4899999999999999999999 89999999999999999776 89999999
Q ss_pred ccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcch-hhhHHhh-hchhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLVEW-ADPFL 252 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~-~~~~~~~-~~~~~ 252 (349)
++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+... ..+..
T Consensus 177 ~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~ 253 (330)
T 3nsz_A 177 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253 (330)
T ss_dssp TCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred CceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchh
Confidence 9976443322 222468889999999877 6789999999999999999999999954432211 1111110 00000
Q ss_pred hhh---------hhHhh--------hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RDS---------RRVLR--------IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~~---------~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... ..... ..........+..+++++.+||.+||+.||++|||+.++++|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 00000 001111122233467899999999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=326.53 Aligned_cols=265 Identities=24% Similarity=0.348 Sum_probs=190.8
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+..+|+.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 97 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAA---------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 97 (367)
T ss_dssp EETTEEEEEECC----CCEEEE---------EETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred CCCceEEeeEEeecCCeEEEEE---------EECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3579999999999999999999 555678999999986542 23456778999999999999999999998
Q ss_pred ecC------CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SES------DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
... ...++|++++ +++|.+++.. ..+++..+..++.||+.||.||| +.+++|+||||+||+++.++.++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH--~~givH~Dlkp~NIll~~~~~~k 172 (367)
T 2fst_X 98 TPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELK 172 (367)
T ss_dssp CSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEE
T ss_pred ecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeCCCCHhhEEECCCCCEE
Confidence 653 5679999999 6799888844 67999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||++...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.....
T Consensus 173 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 247 (367)
T 2fst_X 173 ILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 247 (367)
T ss_dssp ECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred Eeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999753321 223568999999999877 6789999999999999999999999987665433333332211
Q ss_pred hhhhh---------hhhHhhhhccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRD---------SRRVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~---------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... .......+....... .....++.+.+||.+||..||.+|||+.++++|
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 10000 000001111100000 112346789999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=322.58 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=200.9
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
...++|++.+.||+|+||.||+| .+..+++.||+|++...... ..+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEV---------FDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEE---------EETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccceEEEEEEEEeccCEEEEEE---------EECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheee
Confidence 45679999999999999999999 55566899999988654322 237999999999999999999984
Q ss_pred c--------------------------------------CCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHH
Q 018891 98 E--------------------------------------SDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAID 136 (349)
Q Consensus 98 ~--------------------------------------~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~q 136 (349)
. ....++||||+++ +|.+.+.. ....+++..++.++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 3 3348899999975 77776643 4477999999999999
Q ss_pred HHHHHHHHhcCCCCeeeccCCCCcEEEc-CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccC-CCCCccc
Q 018891 137 VARGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSD 214 (349)
Q Consensus 137 l~~~l~~lH~~~~~i~H~di~~~Nilv~-~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~D 214 (349)
|+.||.||| +.+++|+||||+||+++ .++.++|+|||++......... ....+++.|+|||++.+. .++.++|
T Consensus 150 i~~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~D 224 (383)
T 3eb0_A 150 LFRAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSID 224 (383)
T ss_dssp HHHHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred HHHHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchh
Confidence 999999999 99999999999999997 6889999999999864333222 224678999999998765 5899999
Q ss_pred eehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-hhhhhhhhHhhhhc---------cccCCCCCHHHHHHHHHHHHH
Q 018891 215 VYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRDSRRVLRIMD---------TRLGGQYSKKEAQAVAAVVLQ 284 (349)
Q Consensus 215 iwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~ 284 (349)
||||||++|+|++|..||.+.........+..... +............. .......+..+++++.+||.+
T Consensus 225 iwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (383)
T 3eb0_A 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ 304 (383)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence 99999999999999999987665444333332211 11111110000000 000011234467789999999
Q ss_pred hcccCCCCCCCHHHHHHH
Q 018891 285 CLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 285 ~l~~dp~~Rps~~~ll~~ 302 (349)
||+.||++|||+.++++|
T Consensus 305 ~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 305 ILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HCCSSGGGSCCHHHHHTS
T ss_pred HccCChhhCCCHHHHhcC
Confidence 999999999999999964
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=322.76 Aligned_cols=279 Identities=13% Similarity=0.154 Sum_probs=209.4
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccc-----
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVK----- 91 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~----- 91 (349)
+..+++|++.+.||+|+||.||+|....... ......++.||+|.+... ..+.+|+.++++++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~-~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~ 111 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLT-CDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKL 111 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCcc-ccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhh
Confidence 3446899999999999999999996542100 001114788999998654 35678999999999999988
Q ss_pred ----------eeeEEec-CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 92 ----------LIGYCSE-SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 92 ----------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
+++++.. +...++||||+ +++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dikp~ 188 (352)
T 2jii_A 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH--ENEYVHGNVTAE 188 (352)
T ss_dssp TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCCGG
T ss_pred ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH--hCCccCCCCCHH
Confidence 5666655 67889999999 99999999654 367999999999999999999999 899999999999
Q ss_pred cEEEcCCC--cEEEecccccccCCCCCCCc-----cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccC
Q 018891 160 NVLLDSNF--NAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 232 (349)
Q Consensus 160 Nilv~~~~--~v~l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf 232 (349)
||+++.++ .++|+|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 89999999997543322111 112246899999999999999999999999999999999999999
Q ss_pred ccccCcchhhhHHhhhchhhhhhhhHhhhhcccc-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 233 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
......... +....... ........ .......+++.+.+++.+||..||++|||+.++++.|+++....+
T Consensus 269 ~~~~~~~~~--~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 269 TNCLPNTED--IMKQKQKF-------VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGGTTCHHH--HHHHHHHH-------HHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCcCHHH--HHHHHHhc-------cCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 865422111 11100000 00000000 000112356889999999999999999999999999999988765
Q ss_pred CC
Q 018891 312 MP 313 (349)
Q Consensus 312 ~~ 313 (349)
..
T Consensus 340 ~~ 341 (352)
T 2jii_A 340 VS 341 (352)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.07 Aligned_cols=268 Identities=23% Similarity=0.287 Sum_probs=198.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+..+++.||||++.... ......+.+|+.+++.++||||+++++++
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 93 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVF 93 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhheeEeeeeEecCCEEEEEE---------EECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEee
Confidence 3479999999999999999999 555568999999986532 23446678999999999999999999999
Q ss_pred ecCC------ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SESD------NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
...+ ..++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 94 TPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp CSCCSTTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEE
T ss_pred ccccccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHH--HCCeecccCCHHHEEEcCCCCEE
Confidence 7654 67999999965 7888774 45899999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD- 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~- 249 (349)
|+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 168 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999997543221 12235689999999999999999999999999999999999999987654332222221100
Q ss_pred hh---hhhh-hh---------------Hhhhhccc---cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 250 PF---LRDS-RR---------------VLRIMDTR---LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 250 ~~---~~~~-~~---------------~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
+. .... .. ........ .....+...++.+.+||.+||..||++|||+.++++|=.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 321 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 321 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcc
Confidence 00 0000 00 00000000 000112345788999999999999999999999998643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=313.02 Aligned_cols=275 Identities=23% Similarity=0.381 Sum_probs=213.6
Q ss_pred CCCCcchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhc--cC
Q 018891 8 SDPSASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQ--LR 85 (349)
Q Consensus 8 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~ 85 (349)
.+..+........++|++.+.||+|+||.||+|.++ ++.||+|.+.... ...+.+|..+++. ++
T Consensus 29 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~ 94 (342)
T 1b6c_B 29 GSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLR 94 (342)
T ss_dssp CSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECGGG---HHHHHHHHHHHHHSCCC
T ss_pred CCCCceeecccccccEEEEeeecCCCCcEEEEEEEc-----------CccEEEEEeCchh---HHHHHHHHHHHHHhhcC
Confidence 334455667778899999999999999999999542 6789999986543 3456677888777 68
Q ss_pred CCcccceeeEEecCC----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC------CCCeeecc
Q 018891 86 HENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL------DANVIYRD 155 (349)
Q Consensus 86 h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~------~~~i~H~d 155 (349)
||||+++++++.... ..++||||+++++|.+++.+ ..+++..++.++.|++.||.|||.. +.+++|+|
T Consensus 95 h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~D 172 (342)
T 1b6c_B 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172 (342)
T ss_dssp CTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSC
T ss_pred CCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCC
Confidence 999999999998775 78999999999999999955 4689999999999999999999932 36899999
Q ss_pred CCCCcEEEcCCCcEEEecccccccCCCCCCCc--cccceecCCcccCccccccCC------CCCccceehhhHHHHHHHh
Q 018891 156 LKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGH------LTPKSDVYSFGVVLLELLS 227 (349)
Q Consensus 156 i~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~ll~~llt 227 (349)
|||+||+++.++.++|+|||++.......... ......+++.|+|||++.+.. ++.++||||||+++|+|++
T Consensus 173 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 99999999999999999999987543332211 112346899999999987653 3368999999999999999
Q ss_pred C----------CccCccccCcchh-hhHHhhhchhhhhhhhHhhhhccccCCCC-----CHHHHHHHHHHHHHhcccCCC
Q 018891 228 G----------RRALDEDRGGLAE-QTLVEWADPFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPK 291 (349)
Q Consensus 228 g----------~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~ 291 (349)
| ..||......... ..+.. ........... ...+++.+.+|+.+||+.||+
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRK-------------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 319 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHH-------------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGG
T ss_pred ccCcCCcccccccCccccCcCcccHHHHHH-------------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChh
Confidence 9 6777654332111 11111 01111111122 236788999999999999999
Q ss_pred CCCCHHHHHHHHHhhhcCCC
Q 018891 292 NRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 292 ~Rps~~~ll~~l~~~~~~~~ 311 (349)
+|||+.+++++|+++.....
T Consensus 320 ~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 320 ARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp GSCCHHHHHHHHHHHHHTTC
T ss_pred hCCCHHHHHHHHHHHHHHhc
Confidence 99999999999999987754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=330.38 Aligned_cols=241 Identities=17% Similarity=0.221 Sum_probs=190.1
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc---chhchHHHHHHH---HHHhccCCCccccee
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE---SFQGHKEWLTEV---IYLGQLRHENLVKLI 93 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~---~~l~~l~h~~i~~~~ 93 (349)
.++|++.+.||+|+||.||+| .+..+++.||||++... .....+.+.+|+ ..+++++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~ 142 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEE---------EC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEE---------EECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence 578999999999999999999 55566899999998743 223456788899 555556899999998
Q ss_pred -------eEEecCC-----------------ceEEEEEeCCCCChHHHHhccCCCCCh-------HHHHHHHHHHHHHHH
Q 018891 94 -------GYCSESD-----------------NRLLVYEFMPKGSLENHLFRSVQPISW-------PTRVKIAIDVARGLS 142 (349)
Q Consensus 94 -------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~l~~-------~~~~~i~~ql~~~l~ 142 (349)
+++...+ ..|+||||+ +++|.+++... ..+++ ..++.++.|++.||+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~ 220 (377)
T 3byv_A 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLA 220 (377)
T ss_dssp HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHH
Confidence 6666543 278999999 57999999653 33444 788889999999999
Q ss_pred HHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccC-----------CCCC
Q 018891 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----------HLTP 211 (349)
Q Consensus 143 ~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~ 211 (349)
||| +.+|+|+||||+||+++.++.+||+|||++..... ......| +.|+|||++.+. .++.
T Consensus 221 ~LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 292 (377)
T 3byv_A 221 SLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF 292 (377)
T ss_dssp HHH--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred HHH--hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence 999 89999999999999999999999999999975322 2223456 899999999887 8999
Q ss_pred ccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCC
Q 018891 212 KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 291 (349)
Q Consensus 212 ~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 291 (349)
++|||||||++|+|++|..||.+.........+.. ....+++++.+||.+||+.||+
T Consensus 293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 293 SFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR-----------------------SCKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC------CCSGGGGS-----------------------SCCCCCHHHHHHHHHHTCSSGG
T ss_pred hhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh-----------------------hccCCCHHHHHHHHHHcCCCch
Confidence 99999999999999999999976543222111110 1124567899999999999999
Q ss_pred CCCCHHHHHHH
Q 018891 292 NRPSMVDVLTS 302 (349)
Q Consensus 292 ~Rps~~~ll~~ 302 (349)
+|||+.+++++
T Consensus 350 ~Rpt~~e~l~h 360 (377)
T 3byv_A 350 DRLLPLQAMET 360 (377)
T ss_dssp GCCCHHHHHTS
T ss_pred hCCCHHHHhhC
Confidence 99999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=309.62 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=206.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---------hhchHHHHHHHHHHhccC-CC
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---------FQGHKEWLTEVIYLGQLR-HE 87 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~ 87 (349)
...++|++.+.||+|++|.||+| .+..+++.||+|.+.... ....+.+.+|+.+++++. ||
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~ 84 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred chhhccceeeeecCCCceEEEEE---------EEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 34589999999999999999999 555668999999986543 122356778999999995 99
Q ss_pred cccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
||+++++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDM 161 (298)
T ss_dssp TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTC
T ss_pred CEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCcceEEEcCCC
Confidence 9999999999999999999999999999999654 67999999999999999999999 89999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccc------cCCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA------TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
.++|+|||.+........ .....+++.|+|||++. ...++.++|+||||+++|+|++|..||.........
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 238 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238 (298)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH
Confidence 999999999976443322 22346889999999885 456788999999999999999999999765432221
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..+... ...........+++.+.+++.+||+.||++|||+.++++|
T Consensus 239 ~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 239 RMIMSG---------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHHT---------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhcC---------------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 111110 0001111224567889999999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=319.26 Aligned_cols=256 Identities=26% Similarity=0.379 Sum_probs=204.9
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--------hchHHHHHHHHHHhcc-CCC
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--------QGHKEWLTEVIYLGQL-RHE 87 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~ 87 (349)
....++|++.+.||+|++|.||+| ....+|+.||||++..... ...+.+.+|+.+++++ +||
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a---------~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp 160 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred hhhhhhcccceEEecCCCEEEEEE---------EECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 334578999999999999999999 4445688999998865431 1135577899999999 799
Q ss_pred cccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
||+++++++......++||||+++++|.+++... ..+++..+..++.|++.||.||| +.|++|+||||+||+++.++
T Consensus 161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH--~~gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH--ANNIVHRDLKPENILLDDNM 237 (365)
T ss_dssp TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTC
T ss_pred CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEECCCC
Confidence 9999999999999999999999999999998654 67999999999999999999999 89999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCcccccc------CCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
.++|+|||++........ .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 238 ~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 314 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML 314 (365)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999999999876543322 223568999999999863 35788999999999999999999999764432222
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..+........ ......+++.+.++|.+||+.||++|||+.++++|
T Consensus 315 ~~i~~~~~~~~---------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 RMIMEGQYQFS---------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHTCCCCC---------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhCCCCCC---------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111000000 00001345679999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=338.79 Aligned_cols=263 Identities=30% Similarity=0.436 Sum_probs=215.6
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.+++ +..||||++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 456789999999999999999996543 4569999987654 34567899999999999999999999987
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
+ +..++||||+.+++|.+++... ...+++..++.++.||+.||+||| +++++|+||||+||+++.++.+||+|||+
T Consensus 333 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 333 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp S-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred e-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 6 6789999999999999999643 356899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+....+....
T Consensus 410 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~------------ 476 (535)
T 2h8h_A 410 ARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ------------ 476 (535)
T ss_dssp TTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH------------
T ss_pred ceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------------
Confidence 975432110 00111235677999999999999999999999999999999 9999976543221111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 313 (349)
+....+...+..+++.+.+||.+||+.||++|||+.+|++.|+.+......+
T Consensus 477 ------i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 477 ------VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp ------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred ------HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 1122233445667889999999999999999999999999999998775544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=323.08 Aligned_cols=271 Identities=25% Similarity=0.318 Sum_probs=201.2
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-----------chHHHHHHHHHHhcc
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-----------GHKEWLTEVIYLGQL 84 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l 84 (349)
.....++|++.+.||+|+||.||+|. +.. +..||||.+...... ..+.+.+|+.+++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~---------~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 86 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGV---------DSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEE---------CTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEE---------CCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC
Confidence 44567899999999999999999994 322 788999988653221 126788999999999
Q ss_pred CCCcccceeeEEec-----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 85 RHENLVKLIGYCSE-----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 85 ~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
+||||+++++++.. ....++||||++ ++|.+++......+++..++.++.|++.||.||| +.+++|+||||+
T Consensus 87 ~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~ 163 (362)
T 3pg1_A 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH--EAGVVHRDLHPG 163 (362)
T ss_dssp CCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGG
T ss_pred CCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCcCEecCCChH
Confidence 99999999999843 335799999997 5888888776678999999999999999999999 899999999999
Q ss_pred cEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCc
Q 018891 160 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 238 (349)
Q Consensus 160 Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~ 238 (349)
||+++.++.++|+|||++........ .....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+....
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp GEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999974322221 223568889999999877 67899999999999999999999999876644
Q ss_pred chhhhHHhhhchh-hhhh-----hhHhhhhccccC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 239 LAEQTLVEWADPF-LRDS-----RRVLRIMDTRLG-------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 239 ~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.....+....... .... ............ .......++.+.+||.+||+.||++|||+.++++|
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 4333333221111 0000 000000000000 01123346789999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=310.73 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=200.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
..++|++.+.||+|+||.||+| .+..+++.||+|.+..... .....+.+|+..+..+ +||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~ 79 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSA 79 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEE---------EEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeee
Confidence 3579999999999999999999 4555688999999875432 3446678899999999 89999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhcc---CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-----
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRS---VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF----- 167 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~----- 167 (349)
+...+..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~ivH~Dikp~NIl~~~~~~~~~~ 157 (289)
T 1x8b_A 80 WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAA 157 (289)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEC--------
T ss_pred eecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeecCCCHHHEEEcCCCCCccc
Confidence 99999999999999999999999653 266899999999999999999999 89999999999999998444
Q ss_pred --------------cEEEecccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccC
Q 018891 168 --------------NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRAL 232 (349)
Q Consensus 168 --------------~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf 232 (349)
.++|+|||.+........ ..+++.|+|||++.+. .++.++||||||+++|+|++|..|+
T Consensus 158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp ------------CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 799999999876543221 3488999999999766 5667999999999999999998776
Q ss_pred ccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 233 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... ... .........+..+++.+.++|.+||+.||++|||+.++++|
T Consensus 232 ~~~~~---~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 232 RNGDQ---WHE------------------IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSSHH---HHH------------------HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cchhH---HHH------------------HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 43210 000 01111123445667889999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=344.41 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=210.3
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhcc-CCCccccee
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQL-RHENLVKLI 93 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~ 93 (349)
+..++|++.+.||+|+||.||+| .+..+++.||||++.... ......+..|..++..+ +||+|+.++
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~---------~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~ 408 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLS---------ERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEE---------EESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred ccccceEEEEEEccCCCEEEEEE---------EECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 34568999999999999999999 455568999999987542 23446677899999988 799999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+++...+.+|+||||+++++|.+++... ..+++..++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|
T Consensus 409 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~gIiHrDLKp~NILl~~~g~ikL~D 485 (674)
T 3pfq_A 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIAD 485 (674)
T ss_dssp EECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTSEECCCCCSTTEEECSSSCEEECC
T ss_pred EEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeEeccCChhhEEEcCCCcEEEee
Confidence 9999999999999999999999999654 67999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 174 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 174 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
||++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 486 FGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~------- 556 (674)
T 3pfq_A 486 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------- 556 (674)
T ss_dssp CTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS-------
T ss_pred cceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh-------
Confidence 999975332222 22335799999999999999999999999999999999999999987553322222221
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS 302 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~ 302 (349)
. ....+..+++++.+||++||+.||++||++ .++++|
T Consensus 557 ----------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 557 ----------H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ----------S--CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ----------C--CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 1 123455678899999999999999999998 788764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=316.69 Aligned_cols=256 Identities=25% Similarity=0.335 Sum_probs=200.7
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--------hchHHHHHHHHHHhccCCC
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--------QGHKEWLTEVIYLGQLRHE 87 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~ 87 (349)
.....++|++.+.||+|+||.||+| .+..+++.||||.+..... .....+.+|+.++++++||
T Consensus 5 ~~~l~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 75 (322)
T 2ycf_A 5 PKALRDEYIMSKTLGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75 (322)
T ss_dssp CHHHHHHEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCT
T ss_pred hhhhhhceeEeeEEecCCCEEEEEE---------EEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCC
Confidence 3556789999999999999999999 5555689999999865432 1223477899999999999
Q ss_pred cccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 88 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
||+++++++... ..++||||+++++|.+++.. ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++
T Consensus 76 ~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 76 CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQE 151 (322)
T ss_dssp TBCCEEEEEESS-SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSS
T ss_pred CCceEeeEEcCC-ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCCHHHEEEecCC
Confidence 999999998765 48999999999999998854 467999999999999999999999 89999999999999998766
Q ss_pred c---EEEecccccccCCCCCCCccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 168 N---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 168 ~---v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
. ++|+|||++...... .......+++.|+|||++. +..++.++||||||+++|+|++|..||.........
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 228 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228 (322)
T ss_dssp SSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH
T ss_pred CCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH
Confidence 5 999999999764322 1122346899999999874 567889999999999999999999999765432221
Q ss_pred -hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 242 -QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 242 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..+........ ......+++.+.++|.+||..||++|||+.++++|
T Consensus 229 ~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 229 KDQITSGKYNFI---------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHHTCCCCC---------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhCccccC---------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11111000000 00012346789999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=322.61 Aligned_cols=270 Identities=19% Similarity=0.232 Sum_probs=207.5
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhch-----------------HHHHHHH
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-----------------KEWLTEV 78 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~-----------------~~~~~e~ 78 (349)
.+...++|++.+.||+|+||.||+|.. +++.||+|.+........ ..+.+|+
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 94 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHH
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHH
Confidence 344568999999999999999999953 488999999875533221 7788999
Q ss_pred HHHhccCCCcccceeeEEecCCceEEEEEeCCCCChHHH------Hhcc-CCCCChHHHHHHHHHHHHHHHHHhcCC-CC
Q 018891 79 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENH------LFRS-VQPISWPTRVKIAIDVARGLSFLHGLD-AN 150 (349)
Q Consensus 79 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~ 150 (349)
.++++++||||+++++++...+..++||||+++++|.++ +... ...+++..++.++.|++.||.||| + .+
T Consensus 95 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~ 172 (348)
T 2pml_X 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKN 172 (348)
T ss_dssp HHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH--HTSC
T ss_pred HHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh--ccCC
Confidence 999999999999999999999999999999999999998 5432 477999999999999999999999 7 99
Q ss_pred eeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccC-CCCC-ccceehhhHHHHHHHhC
Q 018891 151 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTP-KSDVYSFGVVLLELLSG 228 (349)
Q Consensus 151 i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~DiwslG~ll~~lltg 228 (349)
++|+||+|+||+++.++.++|+|||.+...... ......+++.|+|||++.+. .++. ++|+||||+++|+|++|
T Consensus 173 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999764332 22235689999999999877 5665 99999999999999999
Q ss_pred CccCccccCc-chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 229 RRALDEDRGG-LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 229 ~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..||...... .....+.............................+++.+.+||.+||+.||.+|||+.++++|
T Consensus 249 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 249 VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999866542 1111111110000000000000000000011124567889999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.95 Aligned_cols=253 Identities=27% Similarity=0.370 Sum_probs=198.9
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 97 (349)
..++|++.+.||+|+||.||+| .+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKG---------RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEE---------EECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 4679999999999999999999 445568899999986543 3456788999999999 7999999999997
Q ss_pred c------CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 98 E------SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 98 ~------~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
. .+..++||||+++++|.+++... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEECTTCCEE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCcHHHEEEcCCCCEE
Confidence 6 46789999999999999999653 357899999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHH
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~ 245 (349)
|+|||++........ ......+++.|+|||++. +..++.++||||||+++|+|++|..||...........+.
T Consensus 170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred EeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 999999875432211 122346899999999986 5678899999999999999999999996544221111111
Q ss_pred hhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..+++.+.++|.+||..||.+|||+.++++|
T Consensus 248 -----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 248 -----------------RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -----------------HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -----------------cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111233457789999999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=307.81 Aligned_cols=260 Identities=25% Similarity=0.325 Sum_probs=209.3
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcc
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENL 89 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i 89 (349)
+.+......++|++.+.||+|++|.||+| .+..+++.||+|++..... .....+.+|+.++++++||||
T Consensus 13 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~---------~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 83 (287)
T 2wei_A 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83 (287)
T ss_dssp HHHHTHHHHHHEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTB
T ss_pred chhHHHHHhhcceeeEEEcCCCCEEEEEE---------EEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCc
Confidence 44556677789999999999999999999 4455688999999865432 345778899999999999999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC---
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--- 166 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~--- 166 (349)
+++++++...+..++|||++++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.+
T Consensus 84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dl~p~NIlv~~~~~~ 160 (287)
T 2wei_A 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKD 160 (287)
T ss_dssp CCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESCSSTT
T ss_pred cEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCChhhEEEecCCCc
Confidence 99999999999999999999999999988654 57999999999999999999999 8999999999999999764
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+.++|+|||++........ .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.........+..
T Consensus 161 ~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (287)
T 2wei_A 161 CDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236 (287)
T ss_dssp CCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 4699999999875433222 122357888999998865 488999999999999999999999976543222111111
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ..........+++.+.++|.+||..||++|||+.+++++
T Consensus 237 ~~---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 237 GK---------------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CC---------------CCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CC---------------CCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 000011113457789999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=313.35 Aligned_cols=271 Identities=22% Similarity=0.290 Sum_probs=209.8
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCC------c
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE------N 88 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~ 88 (349)
.+++..++|++.+.||+|+||.||+|... ..+++.||+|++.... .....+.+|+.+++.++|+ +
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~ 78 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDH--------KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFR 78 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTC
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEec--------CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCcee
Confidence 45677889999999999999999999532 3458899999986543 3345677888888888654 5
Q ss_pred ccceeeEEecCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC--
Q 018891 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-- 165 (349)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-- 165 (349)
++++++++...+..++||||+ +++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||||+||+++.
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp~Nil~~~~~ 155 (339)
T 1z57_A 79 CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSD 155 (339)
T ss_dssp BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCCC
T ss_pred eEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHHEEEeccc
Confidence 999999999999999999999 789999986543 46899999999999999999999 899999999999999987
Q ss_pred -----------------CCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhC
Q 018891 166 -----------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 228 (349)
Q Consensus 166 -----------------~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg 228 (349)
++.++|+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 230 (339)
T 1z57_A 156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230 (339)
T ss_dssp EEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred cccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhC
Confidence 6679999999997643322 224689999999999999999999999999999999999
Q ss_pred CccCccccCcchhhhHHhhhchhhhhhh------------------------hHhhhhcc-ccCCCCCHHHHHHHHHHHH
Q 018891 229 RRALDEDRGGLAEQTLVEWADPFLRDSR------------------------RVLRIMDT-RLGGQYSKKEAQAVAAVVL 283 (349)
Q Consensus 229 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~-~~~~~~~~~~~~~l~~li~ 283 (349)
..||...........+.....+...... ........ ..........++.+.+||.
T Consensus 231 ~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 310 (339)
T 1z57_A 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQ 310 (339)
T ss_dssp SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHH
T ss_pred CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHH
Confidence 9999876544333333222111100000 00000000 0011223467889999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018891 284 QCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 284 ~~l~~dp~~Rps~~~ll~~ 302 (349)
+||+.||.+|||+.++++|
T Consensus 311 ~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 311 KMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHTCSSTTTSCCHHHHTTS
T ss_pred HHhCcCcccccCHHHHhcC
Confidence 9999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=338.01 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=206.1
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecCCceEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLL 104 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 104 (349)
+.||+|+||.||+|.+. ....+..||||+++.... ...+.+.+|+.++++++||||+++++++.. +..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~-------~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEE-------CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CEeccCCCEEEEEEEEc-------CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 47999999999999653 334578899999876533 235778999999999999999999999964 56899
Q ss_pred EEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCC
Q 018891 105 VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184 (349)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~ 184 (349)
||||+++++|.+++.. ...+++..++.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++.......
T Consensus 447 v~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH--~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHH--HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999999999954 467999999999999999999999 8999999999999999999999999999997654332
Q ss_pred CC-ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 185 NT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 185 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+........ .+
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~------------------~i 585 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA------------------ML 585 (635)
T ss_dssp -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH------------------HH
T ss_pred cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------------------HH
Confidence 21 11122345778999999999999999999999999999998 999997665422221 22
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
........+..+++++.+||.+||+.||++|||+.++++.|+++...
T Consensus 586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 22233445567788999999999999999999999999999988643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=320.12 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=208.1
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hchHHHHHHHHHHhcc-CCCcccce
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQL-RHENLVKL 92 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~i~~~ 92 (349)
+..++|++.+.||+|+||.||+|... ....+++.||||++..... .....+.+|+.+++.+ +||||+++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 124 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEc------ccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEE
Confidence 34479999999999999999999653 1234689999999875432 2334566789999999 69999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++...+..++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 125 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 125 HYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp EEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEES
T ss_pred EEEEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEECCCCcEEEe
Confidence 99999999999999999999999999654 67999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCcccccc--CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|||++........ .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+...
T Consensus 202 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--- 277 (355)
T 1vzo_A 202 DFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--- 277 (355)
T ss_dssp CSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH---
T ss_pred eCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH---
Confidence 9999975432221 11223568999999999976 34788999999999999999999999765433222222110
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTSLE 304 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l~ 304 (349)
... .....+..++..+.+||.+||..||.+|| |+.+++++..
T Consensus 278 ----------~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 278 ----------ILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp ----------HHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred ----------Hhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 000 11234456778899999999999999999 9999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=315.33 Aligned_cols=273 Identities=25% Similarity=0.319 Sum_probs=201.4
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
+...+++|++.+.||+|+||.||+| .+..+++.||+|.+........+.+.+|+.++++++||||++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 76 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEE---------EETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCccCCceeEEEEeccCCCeEEEEE---------EECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEe
Confidence 4456789999999999999999999 5555689999999877666666788899999999999999999998
Q ss_pred Ee--------------cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcE
Q 018891 96 CS--------------ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 161 (349)
Q Consensus 96 ~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Ni 161 (349)
+. .....++||||++ ++|.+++.. ..+++..++.++.|++.||+||| +.+++|+||||+||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Ni 151 (320)
T 2i6l_A 77 LGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANL 151 (320)
T ss_dssp ECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGE
T ss_pred ccccccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHH--hCCEecCCCCHHHE
Confidence 73 3467899999997 599998843 57999999999999999999999 89999999999999
Q ss_pred EEc-CCCcEEEecccccccCCCCCC-CccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCc
Q 018891 162 LLD-SNFNAKLSDFGLARDGPTGDN-THVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 238 (349)
Q Consensus 162 lv~-~~~~v~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~ 238 (349)
+++ .++.++|+|||++........ ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....
T Consensus 152 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 231 (320)
T 2i6l_A 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL 231 (320)
T ss_dssp EEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence 997 567899999999976432211 111222456888999998865 67889999999999999999999999876543
Q ss_pred chhhhHHhhhchhhh-hhhhHh--------hhhcccc--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 239 LAEQTLVEWADPFLR-DSRRVL--------RIMDTRL--GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.....+......... ...... ....... .......+++++.++|.+||+.||++|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 333222221110000 000000 0000000 000113457889999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=307.81 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=196.3
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..++|++.+.||+|+||.||+| .+..+++.||+|.+... ......+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ccccchhhheeccCCcEEEEEE---------EEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHh
Confidence 3579999999999999999999 55556899999998653 2345678899999999999999999998754
Q ss_pred -------------CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC
Q 018891 99 -------------SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165 (349)
Q Consensus 99 -------------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~ 165 (349)
.+..++||||+++++|.+++......+++..++.++.|++.||+||| +.+++|+||+|+||+++.
T Consensus 74 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~i~H~dlkp~Nil~~~ 151 (303)
T 1zy4_A 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDE 151 (303)
T ss_dssp CCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECT
T ss_pred hcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH--hCCeecccCCHHhEEEcC
Confidence 35679999999999999999766567889999999999999999999 899999999999999999
Q ss_pred CCcEEEecccccccCCCCCC------------CccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccC
Q 018891 166 NFNAKLSDFGLARDGPTGDN------------THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRAL 232 (349)
Q Consensus 166 ~~~v~l~Dfg~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf 232 (349)
++.++|+|||++........ ........+++.|+|||++.+. .++.++|+||||+++|+|++ ||
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~ 228 (303)
T 1zy4_A 152 SRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PF 228 (303)
T ss_dssp TSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred CCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---cc
Confidence 99999999999875432210 1112235688999999999764 68999999999999999998 44
Q ss_pred ccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 233 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... ....... ............+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~--~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 229 STGME--RVNILKK------------LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp SSHHH--HHHHHHH------------HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCchh--HHHHHHh------------ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 32110 0000000 00011112223445567789999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=319.19 Aligned_cols=264 Identities=25% Similarity=0.354 Sum_probs=202.5
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+.+++.++||||+++++++
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 110 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF 110 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ccccEEEEeEEecCCCeEEEEE---------EECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence 4579999999999999999999 5556689999999876432 2346788999999999999999999999
Q ss_pred ecCCce------EEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SESDNR------LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~~~~------~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
...+.. ++||||+. ++|.+++. ..+++..++.++.|++.||+||| +.+++|+||||+||+++.++.++
T Consensus 111 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 111 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp CSCSSSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEE
T ss_pred eccCCcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCcCHHHeEECCCCCEE
Confidence 877655 99999996 58888762 45999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||++...... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.........+.....
T Consensus 185 L~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 185 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp ECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999754322 122467999999999877 6889999999999999999999999987654433333322111
Q ss_pred hhhhh---------hhhHhhhhccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLRD---------SRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~~---------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... .............. .....+++.+.+||.+||+.||++|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 11000 00000111111000 0112457889999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=323.26 Aligned_cols=255 Identities=12% Similarity=0.038 Sum_probs=185.3
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHH---HHHhccCCCccccee
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEV---IYLGQLRHENLVKLI 93 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~i~~~~ 93 (349)
..+|++.+.||+|+||.||+| .+..+++.||+|++..... .....+.+|+ ..|+. +||||++++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~ 130 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDR 130 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------
T ss_pred ceeeeeeeeccCCCCEEEEEE---------EECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhc
Confidence 456999999999999999999 4455689999999977543 2345566774 55555 799988754
Q ss_pred -------eEEecC-----------------CceEEEEEeCCCCChHHHHhccCCCCChHHH------HHHHHHHHHHHHH
Q 018891 94 -------GYCSES-----------------DNRLLVYEFMPKGSLENHLFRSVQPISWPTR------VKIAIDVARGLSF 143 (349)
Q Consensus 94 -------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~------~~i~~ql~~~l~~ 143 (349)
+++... ...|+||||++ ++|.+++......++...+ ..++.||+.||+|
T Consensus 131 ~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~ 209 (371)
T 3q60_A 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209 (371)
T ss_dssp -CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred eeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHH
Confidence 444333 23799999998 7999999765455666666 7888999999999
Q ss_pred HhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCcccccc--CCCCCccceehhhHH
Q 018891 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVV 221 (349)
Q Consensus 144 lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~l 221 (349)
|| +.+|+||||||+||+++.++.+||+|||++...... .....+++.|+|||++.+ ..++.++|||||||+
T Consensus 210 LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~i 282 (371)
T 3q60_A 210 LQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282 (371)
T ss_dssp HH--HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHH
T ss_pred HH--HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHH
Confidence 99 899999999999999999999999999999864321 112356799999999987 679999999999999
Q ss_pred HHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 018891 222 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301 (349)
Q Consensus 222 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 301 (349)
+|+|++|..||.+......... ... .................+++.+.+||.+||+.||++|||+.++++
T Consensus 283 l~elltg~~Pf~~~~~~~~~~~----~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 283 IYRVWCLFLPFGLVTPGIKGSW----KRP------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHHHHSSCSTTBCCTTCTTCC----CBC------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHHHHhCCCCCCCcCcccccch----hhh------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999999987643211100 000 000000111111222456789999999999999999999999986
Q ss_pred H
Q 018891 302 S 302 (349)
Q Consensus 302 ~ 302 (349)
|
T Consensus 353 h 353 (371)
T 3q60_A 353 T 353 (371)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=312.18 Aligned_cols=274 Identities=21% Similarity=0.263 Sum_probs=208.4
Q ss_pred cchhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCc---
Q 018891 12 ASMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN--- 88 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--- 88 (349)
....+++..++|++.+.||+|+||.||+|.... ..+..||+|++.... .....+.+|+.+++.++|++
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~ 80 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHA--------RGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKEN 80 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETT--------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTS
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecC--------CCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCC
Confidence 345677788999999999999999999995322 224789999987542 33456778889888886555
Q ss_pred ---ccceeeEEecCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE-
Q 018891 89 ---LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL- 163 (349)
Q Consensus 89 ---i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv- 163 (349)
++.+.+++...+..++|||++ ++++.+++... ...+++..++.++.||+.||.||| +.+++|+||||+||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH--~~~ivH~Dlkp~NIll~ 157 (355)
T 2eu9_A 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILFV 157 (355)
T ss_dssp CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEES
T ss_pred ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEEEe
Confidence 899999999999999999999 55777777554 357999999999999999999999 9999999999999999
Q ss_pred ------------------cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHH
Q 018891 164 ------------------DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 225 (349)
Q Consensus 164 ------------------~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~l 225 (349)
+.++.++|+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 232 (355)
T 2eu9_A 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232 (355)
T ss_dssp CCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHH
Confidence 567889999999997643322 224689999999999999999999999999999999
Q ss_pred HhCCccCccccCcchhhhHHhhhchhhhhhh------------------------hHhhhhcc-ccCCCCCHHHHHHHHH
Q 018891 226 LSGRRALDEDRGGLAEQTLVEWADPFLRDSR------------------------RVLRIMDT-RLGGQYSKKEAQAVAA 280 (349)
Q Consensus 226 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~-~~~~~~~~~~~~~l~~ 280 (349)
++|..||...........+.....+...... ........ ..........+..+.+
T Consensus 233 ~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 312 (355)
T 2eu9_A 233 YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312 (355)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHH
Confidence 9999999876543333322222111100000 00000000 0011223456788999
Q ss_pred HHHHhcccCCCCCCCHHHHHHH
Q 018891 281 VVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 281 li~~~l~~dp~~Rps~~~ll~~ 302 (349)
||.+||+.||++|||+.++++|
T Consensus 313 li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 313 LMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHhcCChhhCcCHHHHhcC
Confidence 9999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=336.60 Aligned_cols=264 Identities=24% Similarity=0.351 Sum_probs=213.0
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
.+..++|++.+.||+|+||.||+|.+.. ....+..||+|.+.... ....+.+.+|+.++++++||||++++++
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMS------PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECC------SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEec------CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3456789999999999999999997642 22346789999986543 2344678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+. ++..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCCccccccchHhEEEeCCCCEEEEecC
Confidence 85 46789999999999999999766667999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+.
T Consensus 537 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~--------- 606 (656)
T 2j0j_A 537 LSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE--------- 606 (656)
T ss_dssp CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---------
T ss_pred CCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------
Confidence 99764332211 1122346778999999999999999999999999999997 999997654322211111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
.......+..+++.+.+++.+||..||++|||+.++++.|+++..
T Consensus 607 ---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 607 ---------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111233455678899999999999999999999999999998864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=309.79 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=201.0
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccC--CCcccc
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLR--HENLVK 91 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~--h~~i~~ 91 (349)
..+.+++|++.+.||+|+||.||+|. +. +++.||+|.+.... ......+.+|+.++++++ ||||++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~---------~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~ 92 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVL---------NE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEE---------CT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred eeeccceEEEEEEecCCCCEEEEEEE---------cC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence 44667899999999999999999994 32 37889999986543 234567889999999996 599999
Q ss_pred eeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 92 LIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
+++++...+..++||| +.+++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++. +.++|
T Consensus 93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 93 LYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEEET-TEEEE
T ss_pred EEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCcccEEEEC-CeEEE
Confidence 9999999999999999 5578999999654 67899999999999999999999 899999999999999964 79999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCcccccc-----------CCCCCccceehhhHHHHHHHhCCccCccccCcch
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 240 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~ 240 (349)
+|||++................+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI- 246 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-
Confidence 99999976543332222233568999999999865 467889999999999999999999996543211
Q ss_pred hhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 241 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
...............+...++.+.+++.+||+.||.+|||+.+++++-.-
T Consensus 247 ---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 247 ---------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp ---------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred ---------------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 11111222222223344456789999999999999999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=319.38 Aligned_cols=264 Identities=24% Similarity=0.320 Sum_probs=197.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
..+|++.+.||+|+||.||+| .+..+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~---------~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEE---------EECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEecc
Confidence 347999999999999999999 4455688999998865422 223699999999999999999988432
Q ss_pred ------CceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-CcE
Q 018891 100 ------DNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNA 169 (349)
Q Consensus 100 ------~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-~~v 169 (349)
.+.++||||+++ ++.+.+.. ....+++..++.++.||+.||.||| +.+|+||||||+||+++.+ +.+
T Consensus 120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~NILl~~~~~~~ 196 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVL 196 (420)
T ss_dssp ETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCSGGGEEEETTTTEE
T ss_pred CCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEeCCCCeE
Confidence 236799999975 66665542 3477999999999999999999999 9999999999999999965 568
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh-
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW- 247 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~- 247 (349)
||+|||++......... ....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+...
T Consensus 197 kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~l 273 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273 (420)
T ss_dssp EECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999864333221 235689999999998765 7899999999999999999999999876543333222221
Q ss_pred hchhhhhhhhHhhhhccccCC---------CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 ADPFLRDSRRVLRIMDTRLGG---------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..+.................. ..+..+++++.+||.+||..||.+|||+.++++|
T Consensus 274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 111111111100000000000 0123457889999999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=317.00 Aligned_cols=271 Identities=26% Similarity=0.322 Sum_probs=204.6
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
...++|++.+.||+|+||.||+| .+..+++.||||.+..... .....+.+|+.++++++||||+++++++
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 78 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSA---------THKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred ccccceEEeeEEcCCCCeEEEEE---------EECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeee
Confidence 45689999999999999999999 4555689999999865432 3345678999999999999999999987
Q ss_pred ecC-----CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 97 SES-----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 97 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
... ...++|||++. ++|.+++.. ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++|
T Consensus 79 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH--~~~ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 79 RPDSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLH--GSNVIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp CCSCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEE
T ss_pred cccccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHHHeEEcCCCcEEE
Confidence 654 67899999996 589998855 57999999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCc--------cccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhh
Q 018891 172 SDFGLARDGPTGDNTH--------VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~ 242 (349)
+|||++.......... ......|++.|+|||++.+ ..++.++|+|||||++|+|++|..||.+........
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 233 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 9999997654322111 1112467999999998764 678999999999999999999999998765433322
Q ss_pred hHHhhhchhh-hh------hhhHhhhhcc---ccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 243 TLVEWADPFL-RD------SRRVLRIMDT---RLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 243 ~~~~~~~~~~-~~------~~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.+........ .. .......... .... .....+++++.+||.+||+.||++|||+.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 2222111000 00 0000000000 0000 0113467889999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=311.70 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=202.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||.||+| .+..+|+.||||.+..... .....+.+|+.+++.++||||+++++++
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 92 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVF 92 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred cCceEEEeeeEecCCCeEEEEE---------EECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheE
Confidence 3579999999999999999999 5556689999999865432 2346678999999999999999999999
Q ss_pred ecCCc------eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SESDN------RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~~~------~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
..... .++||||+. ++|.+++. ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 93 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH--~~~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 93 TPASSLRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIH--SAGVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp CSCSSGGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSSCCGGGEEECTTCCEE
T ss_pred ecccccccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HCCcccCCCCHHHEeECCCCcEE
Confidence 87654 499999996 58887663 35999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||++...... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.+.........+.....
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 241 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 241 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHC
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998753221 122467899999999877 6789999999999999999999999987654333222222111
Q ss_pred hhhh-------h--hhhHhhhhccccC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 250 PFLR-------D--SRRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 250 ~~~~-------~--~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... . ............. ......+++.+.+||.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0 0000011111111 12234568899999999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=313.30 Aligned_cols=271 Identities=22% Similarity=0.238 Sum_probs=204.8
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CC-----cc
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HE-----NL 89 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i 89 (349)
++...++|++.+.||+|+||.||+| .+..+++.||||++.... .....+..|+.+++.+. |+ ++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i 118 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKA---------YDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYI 118 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGB
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEE---------EEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeE
Confidence 3445679999999999999999999 455568999999987543 23455667888887774 44 59
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc--CC
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD--SN 166 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~--~~ 166 (349)
+++++++...+..++|||++++ +|.+++.... ..+++..+..++.|++.||.|||+...+|+||||||+||+++ .+
T Consensus 119 v~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 119 VHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp CCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTS
T ss_pred EEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCC
Confidence 9999999999999999999964 9999986643 569999999999999999999993236899999999999995 47
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+.++|+|||++....... ....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 198 ~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp CCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 789999999997653321 224689999999999999999999999999999999999999987665443333332
Q ss_pred hhchhhh----hhhhHhhhhccc-----------------------------------------cCCCCCHHHHHHHHHH
Q 018891 247 WADPFLR----DSRRVLRIMDTR-----------------------------------------LGGQYSKKEAQAVAAV 281 (349)
Q Consensus 247 ~~~~~~~----~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~l 281 (349)
....... ........+... ..........+.+.+|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 352 (382)
T 2vx3_A 273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352 (382)
T ss_dssp HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence 2111000 000000000000 0001122345689999
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 018891 282 VLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 282 i~~~l~~dp~~Rps~~~ll~~ 302 (349)
|.+||+.||++|||+.++++|
T Consensus 353 i~~mL~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 353 ILRMLDYDPKTRIQPYYALQH 373 (382)
T ss_dssp HHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHhcCCChhhCCCHHHHhcC
Confidence 999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.76 Aligned_cols=270 Identities=26% Similarity=0.363 Sum_probs=202.5
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhcc---CCCccccee
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL---RHENLVKLI 93 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~ 93 (349)
..++|++.+.||+|+||.||+|... ..+++.||+|.+...... ....+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDL--------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred chhceeeeeeecccccEEEEEEEec--------CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 3579999999999999999999532 245789999988654322 223445666666655 899999999
Q ss_pred eEEe-----cCCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 94 GYCS-----ESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 94 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
+++. .....++||||++ ++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~gi~H~dlkp~Nili~~~~ 157 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSG 157 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTC
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCHHHeEEcCCC
Confidence 9986 4567899999997 59999986543 45999999999999999999999 89999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
.++|+|||++...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||.+.........+...
T Consensus 158 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 158 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp CEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 9999999998753321 1222356889999999999999999999999999999999999999876543333322221
Q ss_pred hc-hhhhhhhh----Hhhhhc---cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 AD-PFLRDSRR----VLRIMD---TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~-~~~~~~~~----~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. +....... ...... ..........+++.+.+||.+||..||++|||+.++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11 00000000 000000 000111234567889999999999999999999999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.82 Aligned_cols=273 Identities=22% Similarity=0.340 Sum_probs=200.6
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
++....+|++.+.||+|+||.||+|... .++. +|+|++...... ..+|+.+++.++||||++++++
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~---------~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~ 100 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLV---------ESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAF 100 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEET---------TTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEEC---------CCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEE
Confidence 4455678999999999999999999543 3344 788877543221 1369999999999999999999
Q ss_pred EecCCc------eEEEEEeCCCCChHHHHh---ccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc-C
Q 018891 96 CSESDN------RLLVYEFMPKGSLENHLF---RSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD-S 165 (349)
Q Consensus 96 ~~~~~~------~~lv~e~~~~~~L~~~l~---~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~-~ 165 (349)
+...+. .++||||++++ +.+.+. .....+++..++.++.|++.||+||| +.+++||||||+||+++ .
T Consensus 101 ~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~ivHrDlkp~Nill~~~ 177 (394)
T 4e7w_A 101 FYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--SIGICHRDIKPQNLLLDPP 177 (394)
T ss_dssp EEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETT
T ss_pred EEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--HCCccCCCCCHHHEEEcCC
Confidence 854433 78999999764 444332 23467999999999999999999999 89999999999999998 7
Q ss_pred CCcEEEecccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhH
Q 018891 166 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244 (349)
Q Consensus 166 ~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~ 244 (349)
++.+||+|||++......... ....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+
T Consensus 178 ~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i 254 (394)
T 4e7w_A 178 SGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEI 254 (394)
T ss_dssp TTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999765333222 224679999999998765 5899999999999999999999999876654433333
Q ss_pred Hhhhc-hhhhhhhhHhh-hhccccC--------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhc
Q 018891 245 VEWAD-PFLRDSRRVLR-IMDTRLG--------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 308 (349)
Q Consensus 245 ~~~~~-~~~~~~~~~~~-~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~ 308 (349)
..... +.......... ....... ...+..+++++.+||.+||+.||.+|||+.++++| +..+..
T Consensus 255 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 255 IKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 32211 11111100000 0000000 01123366789999999999999999999999986 444433
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=312.00 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=203.7
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
-.+..++|++.+.||+|+||.||+|.+++ .+++|.+..... .....+.+|+.++++++||||++++
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 95 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEE
Confidence 44566899999999999999999996532 389998865422 2334567899999999999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
+++...+..++||||+++++|.+++......+++..++.++.|++.||.||| +.+++|+||+|+||+++ ++.++|+|
T Consensus 96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 96 GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp EEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH--HTTCCCCCCCSTTEEEC---CCEECC
T ss_pred EEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCChhhEEEe-CCCEEEee
Confidence 9999999999999999999999999776667999999999999999999999 89999999999999998 67999999
Q ss_pred ccccccCCCCC---CCccccceecCCcccCcccccc---------CCCCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 174 FGLARDGPTGD---NTHVSTRIVGTRGYAAPEYVAT---------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 174 fg~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
||++....... .........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99876432211 1111222458889999999864 35788999999999999999999999765432222
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
..+.. .......+..++..+.+++.+||..||++|||+.++++.|+++....
T Consensus 253 ~~~~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 253 WQMGT-----------------GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHT-----------------TCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHhcc-----------------CCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111 01111112245677999999999999999999999999999988764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=309.77 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=183.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHH-HHhccCCCccccee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVI-YLGQLRHENLVKLI 93 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~i~~~~ 93 (349)
-++..++|++.+.||+|+||.||+| .+..+++.||||.+..... .....+..|+. +++.++||||++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKM---------VHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEE---------EETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred cccCHHHhhehheeccCCCEEEEEE---------EEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeee
Confidence 3456689999999999999999999 4555689999999876432 23334455555 77778999999999
Q ss_pred eEEecCCceEEEEEeCCCCChHHHHhc----cCCCCChHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCcEEEcCCCc
Q 018891 94 GYCSESDNRLLVYEFMPKGSLENHLFR----SVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~l~~~~~~~i~~ql~~~l~~lH~~~~-~i~H~di~~~Nilv~~~~~ 168 (349)
+++...+..++||||+++ +|.+++.. ....+++..+..++.|++.||.||| +. +++|+||||+||+++.++.
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~~ivH~dlkp~NIll~~~~~ 164 (327)
T 3aln_A 88 GALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGN 164 (327)
T ss_dssp EEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH--HHHSCCCSCCCGGGEEEETTTE
T ss_pred eEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh--ccCCEeECCCCHHHEEEcCCCC
Confidence 999999999999999975 88877753 2467999999999999999999999 87 9999999999999999999
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCcccc----ccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhH
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~ 244 (349)
++|+|||++........ .....+++.|+|||++ .+..++.++||||||+++|+|++|..||......... +
T Consensus 165 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~ 239 (327)
T 3aln_A 165 IKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--L 239 (327)
T ss_dssp EEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------
T ss_pred EEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--H
Confidence 99999999875433221 1223688999999998 4567899999999999999999999999754321000 0
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ................+++.+.+|+.+||+.||++|||+.+++++
T Consensus 240 ~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 240 TQ-----------VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CC-----------CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HH-----------HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00 000000011111223467889999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=310.89 Aligned_cols=264 Identities=20% Similarity=0.256 Sum_probs=181.1
Q ss_pred cchhhhhhhcccCCcc-eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCccc
Q 018891 12 ASMISKIATKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 12 ~~~~~~~~~~~y~~~~-~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 90 (349)
+........++|++.+ .||+|+||.||+| .+..+++.||+|++.... ....+....++.+.||||+
T Consensus 19 p~~~~~~~~~~y~i~~~~lG~G~~g~V~~~---------~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~ 85 (336)
T 3fhr_A 19 PEPKKYAVTDDYQLSKQVLGLGVNGKVLEC---------FHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIV 85 (336)
T ss_dssp -CCBCSCGGGTEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBC
T ss_pred CCCCCccccceeEecceeeeeCCCeEEEEE---------EECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChH
Confidence 3444556678999955 6999999999999 555568999999985432 1222333445667999999
Q ss_pred ceeeEEec----CCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC
Q 018891 91 KLIGYCSE----SDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 165 (349)
Q Consensus 91 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~ 165 (349)
++++++.. ....++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~dlkp~NIll~~ 163 (336)
T 3fhr_A 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHRDVKPENLLYTS 163 (336)
T ss_dssp CEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEESC
T ss_pred HHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEEe
Confidence 99999876 445899999999999999997643 46999999999999999999999 899999999999999976
Q ss_pred ---CCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhh
Q 018891 166 ---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242 (349)
Q Consensus 166 ---~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~ 242 (349)
++.++|+|||++....... .....+++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 164 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 239 (336)
T 3fhr_A 164 KEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239 (336)
T ss_dssp SSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh
Confidence 4459999999997543222 123467999999999988889999999999999999999999997655322211
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
..... ...............+++.+.+||.+||+.||.+|||+.++++|-.-
T Consensus 240 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~ 291 (336)
T 3fhr_A 240 GMKRR-----------IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291 (336)
T ss_dssp ----------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred hHHHh-----------hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence 11100 00000011111224567889999999999999999999999986543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=307.99 Aligned_cols=276 Identities=24% Similarity=0.313 Sum_probs=194.8
Q ss_pred chhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccce
Q 018891 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 13 ~~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
........++|++.+.||+|+||.||+| .+..+++.||||.+.... .......+++..++.++||||+++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~ 84 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLG---------KEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQL 84 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEE---------EETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCE
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccH
Confidence 3345556689999999999999999999 455568899999885542 233456678888899999999999
Q ss_pred eeEEecCCc-------eEEEEEeCCCCChHHHHh---ccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEE
Q 018891 93 IGYCSESDN-------RLLVYEFMPKGSLENHLF---RSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 162 (349)
Q Consensus 93 ~~~~~~~~~-------~~lv~e~~~~~~L~~~l~---~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nil 162 (349)
++++...+. .++||||+++ +|.+.+. .....+++..++.++.|++.||.|||..+.+++|+||||+||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIl 163 (360)
T 3e3p_A 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL 163 (360)
T ss_dssp EEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEE
T ss_pred HHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEE
Confidence 999865433 7899999976 5554443 2456789999999999999999999944579999999999999
Q ss_pred EcC-CCcEEEecccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcch
Q 018891 163 LDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 240 (349)
Q Consensus 163 v~~-~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~ 240 (349)
++. ++.++|+|||++......... ....+++.|+|||++.+. .++.++|||||||++|+|++|..||.+......
T Consensus 164 l~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 240 (360)
T 3e3p_A 164 VNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240 (360)
T ss_dssp EETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH
Confidence 997 899999999999765433222 224578999999998665 489999999999999999999999987665444
Q ss_pred hhhHHhhhchhhhhhh-hHh------hhhc------cccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 241 EQTLVEWADPFLRDSR-RVL------RIMD------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 241 ~~~~~~~~~~~~~~~~-~~~------~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...+............ ... .... ...........++++.+||.+||+.||.+|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 3333322111100000 000 0000 000011122357889999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.29 Aligned_cols=266 Identities=20% Similarity=0.317 Sum_probs=201.6
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-----------C
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-----------H 86 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h 86 (349)
+..++|++.+.||+|+||.||+| .+..+++.||+|++.... .....+.+|+.+++++. |
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLA---------KDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred ccCCeEEEEEeeeecCCeEEEEE---------EecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhcccc
Confidence 45679999999999999999999 455568999999987543 23456778888888875 8
Q ss_pred CcccceeeEEecCC----ceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCc
Q 018891 87 ENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASN 160 (349)
Q Consensus 87 ~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~-~i~H~di~~~N 160 (349)
|||+++++++...+ ..++|||++ +++|.+++... ...+++..++.++.||+.||.||| +. +++|+||||+|
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH--~~~~ivH~Dikp~N 162 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPEN 162 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH--HTTCEECSCCSGGG
T ss_pred chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH--hcCCEEecCCChHH
Confidence 99999999987644 789999999 88999998653 356999999999999999999999 87 99999999999
Q ss_pred EEEc------CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCcc
Q 018891 161 VLLD------SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 234 (349)
Q Consensus 161 ilv~------~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~ 234 (349)
|+++ ..+.++|+|||++....... ....+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred eEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 9994 44479999999997643322 224689999999999999999999999999999999999999986
Q ss_pred ccCcch---hhh---HHhhhchh----hhhhhh---------------------HhhhhccccCCCCCHHHHHHHHHHHH
Q 018891 235 DRGGLA---EQT---LVEWADPF----LRDSRR---------------------VLRIMDTRLGGQYSKKEAQAVAAVVL 283 (349)
Q Consensus 235 ~~~~~~---~~~---~~~~~~~~----~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~l~~li~ 283 (349)
...... ... +....... ...... ..... ......+..+++.+.+||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHG
T ss_pred CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh--hhcccCCcchHHHHHHHHH
Confidence 543211 111 11100000 000000 00000 0112356788999999999
Q ss_pred HhcccCCCCCCCHHHHHHHH
Q 018891 284 QCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 284 ~~l~~dp~~Rps~~~ll~~l 303 (349)
+||+.||++|||+.++++|=
T Consensus 316 ~~L~~dP~~Rpt~~ell~hp 335 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNHP 335 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTCG
T ss_pred HHhccCccccCCHHHHhhCh
Confidence 99999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=316.41 Aligned_cols=275 Identities=19% Similarity=0.243 Sum_probs=188.0
Q ss_pred hhcccCC-cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCS-DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~-~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..+.|++ .++||+|+||.||+|.+. +..++..||+|.+.... ....+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~-------~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRK-------DGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFL 88 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEES-------SSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEc-------cCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 3456777 558999999999999643 33457889999997543 2346778999999999999999999995
Q ss_pred --cCCceEEEEEeCCCCChHHHHhcc--------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE----
Q 018891 98 --ESDNRLLVYEFMPKGSLENHLFRS--------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---- 163 (349)
Q Consensus 98 --~~~~~~lv~e~~~~~~L~~~l~~~--------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv---- 163 (349)
.....++||||+.+ +|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||++
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH--~~~ivH~Dlkp~NIll~~~~ 165 (405)
T 3rgf_A 89 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEG 165 (405)
T ss_dssp ETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECCSS
T ss_pred cCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCEeCCCcCHHHeEEecCC
Confidence 46788999999964 888877531 135999999999999999999999 8999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCC-ccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcch-
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA- 240 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~- 240 (349)
+.++.++|+|||++......... .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+......
T Consensus 166 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 245 (405)
T 3rgf_A 166 PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245 (405)
T ss_dssp TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence 67789999999999764332111 12223578999999999887 4589999999999999999999999976543211
Q ss_pred --------hhhHHhh-hchhhhh---------hhhHhhhhccccCCCC---------CHHHHHHHHHHHHHhcccCCCCC
Q 018891 241 --------EQTLVEW-ADPFLRD---------SRRVLRIMDTRLGGQY---------SKKEAQAVAAVVLQCLHMDPKNR 293 (349)
Q Consensus 241 --------~~~~~~~-~~~~~~~---------~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~R 293 (349)
...+... ..+.... ................ ....++.+.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R 325 (405)
T 3rgf_A 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 325 (405)
T ss_dssp -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence 1111110 0000000 0000000000000000 00125678999999999999999
Q ss_pred CCHHHHHHHHHh
Q 018891 294 PSMVDVLTSLEQ 305 (349)
Q Consensus 294 ps~~~ll~~l~~ 305 (349)
||+.++++|=.-
T Consensus 326 ~ta~e~L~hp~f 337 (405)
T 3rgf_A 326 ITSEQAMQDPYF 337 (405)
T ss_dssp CCHHHHHTSGGG
T ss_pred CCHHHHhcChhh
Confidence 999999987443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=307.75 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=193.9
Q ss_pred hhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh------chHHHHHHHHHHhcc----
Q 018891 15 ISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQL---- 84 (349)
Q Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l---- 84 (349)
..+...++|++.+.||+|+||.||+| .+..+++.||+|.+...... ....+.+|+.+++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 95 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAG---------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEE---------ECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSC
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEE---------EEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccC
Confidence 35566789999999999999999999 55666899999998665332 122345688888888
Q ss_pred CCCcccceeeEEecCCceEEEEEe-CCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 85 RHENLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
+||||+++++++...+..++|+|+ +.+++|.+++... ..+++..++.++.|++.||.||| +.+++|+||+|+||++
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILI 172 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HHTEECCCCSGGGEEE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCChhhEEE
Confidence 899999999999988999999999 7889999999654 67999999999999999999999 8999999999999999
Q ss_pred c-CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCC-CccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 164 D-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 164 ~-~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
+ .++.++|+|||++....... .....+++.|+|||++.+..+. .++||||||+++|+|++|..||.....
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 244 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---- 244 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----
Confidence 9 88999999999987654322 2234588999999998776664 589999999999999999999964310
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 303 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l 303 (349)
+.. .....+..+++.+.++|.+||+.||++|||+.+++++-
T Consensus 245 --~~~-------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 245 --ILE-------------------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp --HHH-------------------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred --Hhh-------------------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000 01123345678899999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=302.80 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=183.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
-++|++.+.||+|+||.||+| .+..+++.||+|.+...... ....+.++..+++.++||||+++++++.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 94 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKM---------RFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94 (318)
T ss_dssp GGGEEEEEEC------CEEEE---------EETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccceeeecCCeeEEEE---------EEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 468999999999999999999 44456889999998654322 2233445556788889999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDA-NVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~-~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
..+..++||||+ ++.+..+.......+++..++.++.|++.||.||| +. +++|+||+|+||+++.++.++|+|||+
T Consensus 95 ~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 95 TNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--HHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH--hhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999999999 55666665544578999999999999999999999 75 999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
+........ .....+++.|+|||++. +..++.++||||||+++|+|++|..||......... +..
T Consensus 172 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~----- 241 (318)
T 2dyl_A 172 SGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV--LTK----- 241 (318)
T ss_dssp C-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HHH-----
T ss_pred chhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH--HHH-----
Confidence 865433221 22246899999999984 457889999999999999999999999754321110 000
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... ...........+++++.++|.+||+.||.+|||+.+++++
T Consensus 242 ------~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 242 ------VLQ--EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ------HHH--SCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ------Hhc--cCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 0000111123467889999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=309.17 Aligned_cols=248 Identities=21% Similarity=0.390 Sum_probs=201.2
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh------chHHHHHHHHHHhccC--
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLR-- 85 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~-- 85 (349)
...+...++|++.+.||+|+||.||+| .+..+++.||+|.+...... ....+.+|+.+++++.
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 106 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEE---------EETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSS
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccC
Confidence 345566789999999999999999999 45556899999998665322 1234567899999996
Q ss_pred CCcccceeeEEecCCceEEEEEeCCC-CChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 86 HENLVKLIGYCSESDNRLLVYEFMPK-GSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 86 h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
|+||+++++++...+..++|+|++.+ ++|.+++... ..+++..++.++.|++.||.||| +.+++|+||||+||+++
T Consensus 107 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH--~~~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILID 183 (320)
T ss_dssp SCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEE
T ss_pred CCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeCCCCHHHEEEe
Confidence 59999999999999999999999975 8999998654 67999999999999999999999 89999999999999998
Q ss_pred -CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhh
Q 018891 165 -SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242 (349)
Q Consensus 165 -~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~ 242 (349)
.++.++|+|||++....... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 254 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----- 254 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred CCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----
Confidence 78899999999987644322 122468999999999877665 6789999999999999999999964320
Q ss_pred hHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+.. . ....+..+++.+.++|.+||+.||++|||+.+++++
T Consensus 255 -~~~-----------------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 -IIR-----------------G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHH-----------------C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hhc-----------------c--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 011233456789999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=293.35 Aligned_cols=241 Identities=16% Similarity=0.119 Sum_probs=190.7
Q ss_pred hhh-hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCccc
Q 018891 15 ISK-IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLV 90 (349)
Q Consensus 15 ~~~-~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~ 90 (349)
.++ +..++|++.+.||+|+||.||+| .+..+++.||||++...... ....+.+|+..+++++||||+
T Consensus 24 ~g~~~~~~~y~i~~~lg~G~~g~Vy~a---------~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv 94 (286)
T 3uqc_A 24 PGARIANGRYRLLIFHGGVPPLQFWQA---------LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94 (286)
T ss_dssp TTCEETTTTEEEEEEEEBSTTCEEEEE---------EETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred CCCEEecCcEEEEEEEcccCCeEEEEE---------EecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcc
Confidence 344 66789999999999999999999 45556899999999765432 236788999999999999999
Q ss_pred ceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
++++++...+..|+||||++|++|.+++.. . ....++..++.|++.||.||| +.+++|+||||+||+++.++.++
T Consensus 95 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH--~~givH~Dikp~NIll~~~g~~k 169 (286)
T 3uqc_A 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAH--RAGVALSIDHPSRVRVSIDGDVV 169 (286)
T ss_dssp CEEEEEEETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCSGGGEEEETTSCEE
T ss_pred eeeEEEEECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHH--HCCCccCCCCcccEEEcCCCCEE
Confidence 999999999999999999999999999843 2 356678999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|++++ |++ .++.++|||||||++|+|++|..||.+................
T Consensus 170 l~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 220 (286)
T 3uqc_A 170 LAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAG 220 (286)
T ss_dssp ECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTS
T ss_pred EEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhcc
Confidence 98543 222 3678999999999999999999999876542211000000000
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
..... ......+++.+.++|.+||+.||++| |+.++++.|+++.....
T Consensus 221 ~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 221 QPIEP------------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CBCCH------------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCCCh------------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00000 01123467789999999999999999 99999999999887643
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.42 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=191.9
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
..+.+.+|.+.+.||+|+||+||.. ...+++.||||.+...... .+.+|+.+++.+ +||||+++++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~----------~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~ 85 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYR----------GMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFC 85 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEE----------EESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEE----------EEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEE
Confidence 4456678999999999999996543 1224788999998654333 235799999999 7999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-----CcE
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-----FNA 169 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-----~~v 169 (349)
++.+....|+|||++. ++|.+++.......++..++.++.|++.||.||| +.+|+||||||+||+++.+ ..+
T Consensus 86 ~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDlKp~NIll~~~~~~~~~~~ 162 (432)
T 3p23_A 86 TEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--SLNIVHRDLKPHNILISMPNAHGKIKA 162 (432)
T ss_dssp EEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH--HTTCCCCCCSTTSEEECCCBTTTBCCE
T ss_pred EEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH--HCcCEeCCCCHHHEEEecCCCCCceeE
Confidence 9999999999999996 5999999776666777788899999999999999 8999999999999999542 247
Q ss_pred EEecccccccCCCCCCC-ccccceecCCcccCccccc---cCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhH
Q 018891 170 KLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTL 244 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~ 244 (349)
+|+|||++......... .......|++.|+|||++. +..++.++|||||||++|+|++ |..||...........+
T Consensus 163 kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~ 242 (432)
T 3p23_A 163 MISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242 (432)
T ss_dssp EECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT
T ss_pred EEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh
Confidence 89999999765433211 1222356899999999997 4567789999999999999999 89998644321111100
Q ss_pred HhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.. ............+..+.+||.+||+.||.+|||+.++++|
T Consensus 243 ~~----------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 243 GA----------------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TC----------------CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cc----------------CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 00 0000111124567789999999999999999999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=320.29 Aligned_cols=280 Identities=24% Similarity=0.320 Sum_probs=207.3
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
...++|++.+.||+|+||.||+| .+..+|..||||.+... .......+.+|+.++++++||||+++++++
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla---------~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~ 81 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCC---------CCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECC
T ss_pred CCCCCeEEEEEEeeCCCeEEEEE---------EECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeee
Confidence 34479999999999999999999 66677899999998764 333456788999999999999999999987
Q ss_pred ec------CCceEEEEEeCCCCChHHHHhccC--CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCc
Q 018891 97 SE------SDNRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN 168 (349)
Q Consensus 97 ~~------~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~ 168 (349)
.. .+..++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.+++|+||+|+||+++.++.
T Consensus 82 ~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH--s~gIVHrDLKP~NILl~~~g~ 159 (676)
T 3qa8_A 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQ 159 (676)
T ss_dssp TTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH--HTTBCCCCCCSTTEEEECCSS
T ss_pred cccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCCCccCCCCHHHeEeecCCC
Confidence 55 677899999999999999996532 36999999999999999999999 899999999999999997765
Q ss_pred ---EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchh-hhH
Q 018891 169 ---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTL 244 (349)
Q Consensus 169 ---v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~-~~~ 244 (349)
++|+|||.+........ .....+++.|+|||++.+..++.++|+||||+++|+|++|..||......... ..+
T Consensus 160 ~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i 236 (676)
T 3qa8_A 160 RLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236 (676)
T ss_dssp SCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC
T ss_pred ceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh
Confidence 89999999986543322 22356899999999999999999999999999999999999999653211000 000
Q ss_pred Hhhhchhh---hhhhhHhhh-hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHhhhcCCC
Q 018891 245 VEWADPFL---RDSRRVLRI-MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD-----VLTSLEQLHTSKD 311 (349)
Q Consensus 245 ~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-----ll~~l~~~~~~~~ 311 (349)
........ ......... ............+++.+.++|.+||..||++|||+.+ +.+.++++...+-
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ki 312 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCE
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhccc
Confidence 00000000 000000000 0001112344568899999999999999999999988 5677777777653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=307.97 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=190.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
.....+.|.+.+.||+|+||+||.+. ..+|+.||||.+.... ...+.+|+.+++++ +||||+++++
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~----------~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~ 76 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG----------SFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYC 76 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE----------ESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE----------EECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEE
Confidence 33456778888999999999998652 1247899999886543 34567899999886 8999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCC------CChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC--
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQP------ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-- 166 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-- 166 (349)
++...+..++|||+++ ++|.+++...... .++..++.++.|++.||+||| +.+++|+||||+||+++.+
T Consensus 77 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivHrDLkp~NILl~~~~~ 153 (434)
T 2rio_A 77 SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSR 153 (434)
T ss_dssp EEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEECCHH
T ss_pred EEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH--HCCccccCCChHhEEEecCcc
Confidence 9999999999999996 5999999653211 134456789999999999999 8999999999999999754
Q ss_pred -----------CcEEEecccccccCCCCCCCc--cccceecCCcccCcccccc-------CCCCCccceehhhHHHHHHH
Q 018891 167 -----------FNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVLLELL 226 (349)
Q Consensus 167 -----------~~v~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~ll~~ll 226 (349)
+.++|+|||++.......... ......|++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ell 233 (434)
T 2rio_A 154 FTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233 (434)
T ss_dssp HHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHH
T ss_pred cccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHH
Confidence 479999999998654432211 1223568999999999865 56889999999999999999
Q ss_pred h-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 227 S-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 227 t-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+ |..||....... ..+.... .............+++++.+||.+||+.||.+|||+.++++|
T Consensus 234 t~g~~Pf~~~~~~~--~~i~~~~------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 234 SKGKHPFGDKYSRE--SNIIRGI------------FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTSCCTTCSTTTHH--HHHHHTC------------CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hCCCCCCCCchhhH--HHHhcCC------------CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 9 999996543211 1111000 000011112345788999999999999999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=319.08 Aligned_cols=246 Identities=21% Similarity=0.332 Sum_probs=196.2
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~ 94 (349)
+++..++|++.+.||+|+||.||+|.+.. .+++.||||.+.... ......+.+|+.++++++||||+++++
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~--------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 146 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRN--------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGG--------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcC--------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEee
Confidence 45667899999999999999999995432 147889999886543 234456789999999999999999999
Q ss_pred EEecCCc-----eEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 95 YCSESDN-----RLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 95 ~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
++...+. .|+||||+++++|.+++.. .+++..++.++.||+.+|.||| +.+|+|+||||+||+++.+ .+
T Consensus 147 ~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH--~~giiHrDlkp~NIll~~~-~~ 220 (681)
T 2pzi_A 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH--SIGLVYNDLKPENIMLTEE-QL 220 (681)
T ss_dssp EEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSS-CE
T ss_pred eEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCCeecccChHHeEEeCC-cE
Confidence 9987665 6999999999999887633 7999999999999999999999 8999999999999999875 89
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
||+|||++...... ....|++.|+|||++.+.. +.++||||||+++|+|++|..||.+.......
T Consensus 221 kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-------- 285 (681)
T 2pzi_A 221 KLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-------- 285 (681)
T ss_dssp EECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------
T ss_pred EEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc--------
Confidence 99999999764332 2346899999999987654 88999999999999999999888653221100
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHhhh
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLTSLEQLH 307 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~l~~~~ 307 (349)
........++.+.++|.+||+.||.+||+ ++++.+.|..+.
T Consensus 286 -----------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 -----------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -----------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00011234578999999999999999995 556666666553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=288.00 Aligned_cols=232 Identities=20% Similarity=0.279 Sum_probs=180.7
Q ss_pred hhcccCCc-ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHH-hccCCCcccceeeEE
Q 018891 19 ATKNFCSD-YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYL-GQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~-~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~ 96 (349)
..++|.+. +.||+|+||.||+| .+..+++.||+|.+... ....+|+.++ +..+||||+++++++
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~---------~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEE---------EEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhh
Confidence 34567776 88999999999999 45556889999998542 3456788877 555899999999998
Q ss_pred ec----CCceEEEEEeCCCCChHHHHhccC-CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---CCc
Q 018891 97 SE----SDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFN 168 (349)
Q Consensus 97 ~~----~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~---~~~ 168 (349)
.. ....++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++. ++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESSSSTTCC
T ss_pred hhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEecCCCCCc
Confidence 76 677899999999999999997643 46999999999999999999999 899999999999999998 788
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
++|+|||++.... +..++.++|+|||||++|+|++|..||...............
T Consensus 159 ~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~- 213 (299)
T 3m2w_A 159 LKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR- 213 (299)
T ss_dssp EEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-
T ss_pred EEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-
Confidence 9999999885421 244677899999999999999999999755432111100000
Q ss_pred chhhhhhhhHhhhhccccCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 305 (349)
... .....+ ..+++++.++|.+||+.||.+|||+.++++|-.-
T Consensus 214 -------------~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~ 260 (299)
T 3m2w_A 214 -------------IRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260 (299)
T ss_dssp -------------SCT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred -------------Hhh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhh
Confidence 000 000111 2357889999999999999999999999986543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=301.93 Aligned_cols=242 Identities=17% Similarity=0.225 Sum_probs=181.7
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCC-Ccc------
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRH-ENL------ 89 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i------ 89 (349)
.++|.+.+.||+|+||.||+| .+..+|+.||||++..... ...+.+.+|+.+++.+.| ++.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a---------~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~ 147 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred ceeEEEecccccCCCEEEEEE---------EecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence 356888999999999999999 4555688999999874322 235778899999999876 221
Q ss_pred ---cceeeE------------Eec-----CCceEEEEEeCCCCChHHHHh------ccCCCCChHHHHHHHHHHHHHHHH
Q 018891 90 ---VKLIGY------------CSE-----SDNRLLVYEFMPKGSLENHLF------RSVQPISWPTRVKIAIDVARGLSF 143 (349)
Q Consensus 90 ---~~~~~~------------~~~-----~~~~~lv~e~~~~~~L~~~l~------~~~~~l~~~~~~~i~~ql~~~l~~ 143 (349)
+...+. +.. ....+++|+.. +++|.+++. .....+++..++.++.|++.||+|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 226 (413)
T 3dzo_A 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226 (413)
T ss_dssp TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence 111111 111 22456777766 679998884 223557888999999999999999
Q ss_pred HhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCcccc----------ccCCCCCcc
Q 018891 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV----------ATGHLTPKS 213 (349)
Q Consensus 144 lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~ 213 (349)
|| +.+|+||||||+||+++.++.+||+|||++...... .....| +.|+|||++ .+..++.++
T Consensus 227 LH--~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 298 (413)
T 3dzo_A 227 LH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF 298 (413)
T ss_dssp HH--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred HH--hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence 99 899999999999999999999999999998753322 223456 899999999 555688899
Q ss_pred ceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 018891 214 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 293 (349)
Q Consensus 214 DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 293 (349)
|||||||++|+|++|..||...........+ +. ....+++.+.+||.+||+.||++|
T Consensus 299 DvwSlGvil~elltg~~Pf~~~~~~~~~~~~-----------------~~------~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 299 DTWTLGLAIYWIWCADLPNTDDAALGGSEWI-----------------FR------SCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG-----------------GS------SCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHHHHHHCCCCCCCcchhhhHHHH-----------------Hh------hcccCCHHHHHHHHHHccCChhhC
Confidence 9999999999999999999765432211111 00 011345789999999999999999
Q ss_pred CCHHHHHHH
Q 018891 294 PSMVDVLTS 302 (349)
Q Consensus 294 ps~~~ll~~ 302 (349)
||+.+++++
T Consensus 356 pt~~~~l~~ 364 (413)
T 3dzo_A 356 LLPLQAMET 364 (413)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHHhC
Confidence 998777653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=286.00 Aligned_cols=246 Identities=20% Similarity=0.187 Sum_probs=184.7
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--------hchHHHHHHHHHHhccC---
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--------QGHKEWLTEVIYLGQLR--- 85 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~--- 85 (349)
.+..++|++.+.||+|+||.||+|.+ +++.||||++..... ...+.+.+|+.+++.++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~ 84 (336)
T 2vuw_A 16 CLPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84 (336)
T ss_dssp HSCHHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGG
T ss_pred hcccccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhh
Confidence 34568999999999999999999954 368899999876532 22367788888888885
Q ss_pred ------CCcccceee-----------------EEec-------------CCceEEEEEeCCCCChHHHHhccCCCCChHH
Q 018891 86 ------HENLVKLIG-----------------YCSE-------------SDNRLLVYEFMPKGSLENHLFRSVQPISWPT 129 (349)
Q Consensus 86 ------h~~i~~~~~-----------------~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~ 129 (349)
||||+++.+ ++.. .+..|+||||++++++.+.+.+ ..+++..
T Consensus 85 ~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~ 162 (336)
T 2vuw_A 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLAT 162 (336)
T ss_dssp GCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHH
T ss_pred ccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHH
Confidence 555555544 4443 6789999999999877776633 5689999
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC--------------------cEEEecccccccCCCCCCCccc
Q 018891 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--------------------NAKLSDFGLARDGPTGDNTHVS 189 (349)
Q Consensus 130 ~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~--------------------~v~l~Dfg~~~~~~~~~~~~~~ 189 (349)
++.++.||+.||+|||+ +.+|+||||||+||+++.++ .+||+|||++.....
T Consensus 163 ~~~i~~qi~~aL~~lH~-~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------- 234 (336)
T 2vuw_A 163 AKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------- 234 (336)
T ss_dssp HHHHHHHHHHHHHHHHH-HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------
T ss_pred HHHHHHHHHHHHHHHHH-hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------
Confidence 99999999999999993 36999999999999999887 899999999975432
Q ss_pred cceecCCcccCccccccCCCCCccceehhhHH-HHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh--hhcccc
Q 018891 190 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV-LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR--IMDTRL 266 (349)
Q Consensus 190 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~l-l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 266 (349)
....|++.|+|||++.+.. +.++|||||+++ .+++++|..||.+.... ..+ ...... ......
T Consensus 235 ~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~----------~~~~~~~~~~~~~~ 300 (336)
T 2vuw_A 235 GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYL----------TDKMLKQMTFKTKC 300 (336)
T ss_dssp TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHH----------HHHHHHTCCCSSCC
T ss_pred CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh---hHH----------HHhhhhhhccCccc
Confidence 1347899999999998766 889999998777 77788899988432100 000 000000 011111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH-HH
Q 018891 267 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL-TS 302 (349)
Q Consensus 267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll-~~ 302 (349)
....+..+++++.+||.+||+.| |+.+++ +|
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 11223578999999999999977 999998 64
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=251.67 Aligned_cols=170 Identities=21% Similarity=0.143 Sum_probs=126.6
Q ss_pred CCcEEEEEEccccc----------hhchHHHHHHHHHHhcc-CCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccC
Q 018891 54 SGIVVAIKRLKAES----------FQGHKEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV 122 (349)
Q Consensus 54 ~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 122 (349)
.|+.+++|.+.... ....+.+.+|+.+|+++ .|+||+++++++++++..||||||++|++|.++|...
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~- 336 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG- 336 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-
Confidence 57889999886532 12335688999999999 7999999999999999999999999999999999654
Q ss_pred CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCcc
Q 018891 123 QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202 (349)
Q Consensus 123 ~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE 202 (349)
+++++. .++.||+.||+|+| ++||+||||||+|||++.+|.+||+|||++....... ......+||+.|+|||
T Consensus 337 ~~l~~~---~I~~QIl~AL~ylH--~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE 409 (569)
T 4azs_A 337 EEIDRE---KILGSLLRSLAALE--KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNE 409 (569)
T ss_dssp CCCCHH---HHHHHHHHHHHHHH--HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHH
T ss_pred CCCCHH---HHHHHHHHHHHHHH--HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHH
Confidence 667654 57899999999999 9999999999999999999999999999997643322 2233467999999999
Q ss_pred ccccCCCCCccceehhhHHHHHHHhCCccC
Q 018891 203 YVATGHLTPKSDVYSFGVVLLELLSGRRAL 232 (349)
Q Consensus 203 ~~~~~~~~~~~DiwslG~ll~~lltg~~pf 232 (349)
++.+ .+..++|+|++|++++.+.++..++
T Consensus 410 ~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 410 LFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HC------------------CCCCTTHHHH
T ss_pred HhCC-CCCCcccccccccchhhhccccchh
Confidence 9865 4567899999999998887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-26 Score=220.17 Aligned_cols=185 Identities=17% Similarity=0.220 Sum_probs=140.0
Q ss_pred CCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--------chHHHHHHHHHHhccCCCcccceeeE
Q 018891 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------GHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 24 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
...+.||+|+||.||+|.+. +..+++|........ ..+.+.+|+.++++++||||+++..+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-----------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 407 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-----------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF 407 (540)
T ss_dssp ---------CCEEEEEEECS-----------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-----------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence 34568999999999999443 456888875432211 13457899999999999999966666
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+...+..++||||+++++|.+++.. +..++.|++++|.||| +++|+||||||+||+++. .+||+|||
T Consensus 408 ~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH--~~gIiHrDiKp~NILl~~--~~kL~DFG 474 (540)
T 3en9_A 408 DVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH--KNDVIHNDLTTSNFIFDK--DLYIIDFG 474 (540)
T ss_dssp EEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH--HTTEECTTCCTTSEEESS--SEEECCCT
T ss_pred EEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH--HCcCccCCCCHHHEEECC--eEEEEECc
Confidence 6677788999999999999998844 5689999999999999 899999999999999998 99999999
Q ss_pred ccccCCCCCCCc-----cccceecCCcccCcccccc--CCCCCccceehhhHHHHHHHhCCccC
Q 018891 176 LARDGPTGDNTH-----VSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRAL 232 (349)
Q Consensus 176 ~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~ll~~lltg~~pf 232 (349)
++.......... ......||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 998653321111 1123578999999999976 56778889999888777777666554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=186.37 Aligned_cols=144 Identities=15% Similarity=0.102 Sum_probs=114.1
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch------------------hchHHHHHHHHHHhc
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF------------------QGHKEWLTEVIYLGQ 83 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~ 83 (349)
.|.+.+.||+|+||.||+|.+ .+|+.||+|.+..... .....+.+|+.++++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~----------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeccCCCceEEEEEe----------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 344559999999999999943 4588999999864322 124567899999999
Q ss_pred cCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEE
Q 018891 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 84 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv 163 (349)
++ | +++.+++.. +..++||||++|++|.+ + . ......++.|++.||.||| +.+++|+||||+||++
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l-~------~~~~~~i~~qi~~~l~~lH--~~giiHrDlkp~NILl 226 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-V-R------VENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLV 226 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-C-C------CSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEE
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-c-c------hhhHHHHHHHHHHHHHHHH--HCCCEeCCCCHHHEEE
Confidence 98 4 666665544 56799999999999988 4 1 1345679999999999999 8999999999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccc
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 205 (349)
+ ++.++|+|||++.. +..+.|||.+.
T Consensus 227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9 99999999999863 33467888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.8e-19 Score=157.43 Aligned_cols=140 Identities=18% Similarity=0.092 Sum_probs=104.5
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcE--EEEEEccccchh------------------------chHHHH
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIV--VAIKRLKAESFQ------------------------GHKEWL 75 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~--vaiK~~~~~~~~------------------------~~~~~~ 75 (349)
-|++.+.||+|+||.||+|.+ ..+|.. ||||++...... ....+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~---------~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADG---------VFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEE---------EETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEE---------cCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 367889999999999999954 234778 999986543111 113577
Q ss_pred HHHHHHhccCCCcccceeeEEecCCceEEEEEeCCC-C----ChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCC
Q 018891 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPK-G----SLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDAN 150 (349)
Q Consensus 76 ~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~ 150 (349)
+|+..++.+.|+++..+.-+.. +..++||||+.+ + +|.+.... .++..+..++.|++.+|.|||. +.+
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~--~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~-~~g 191 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY--MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ-EAE 191 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE--ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH-TSC
T ss_pred HHHHHHHHHHhCCCCCCeEEEc--CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH-HCC
Confidence 8999999998776422222211 367899999942 3 67665432 2356788999999999999994 469
Q ss_pred eeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 151 VIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 151 i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
++|+||||.||+++. .++|+|||++..
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999999988 899999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-17 Score=151.76 Aligned_cols=136 Identities=13% Similarity=0.115 Sum_probs=96.6
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--------------chHH--------HHHHHHH
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--------------GHKE--------WLTEVIY 80 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------~~~~--------~~~e~~~ 80 (349)
|++.+.||.|++|.||+|. + .+|+.||||+++..... .... ...|...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~---------d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVA---------D-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp SEEEEEEEECSSEEEEEEE---------C-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEE---------C-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 8999999999999999994 3 24889999987532110 0111 1245566
Q ss_pred HhccCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 81 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 81 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
|.++.+.++.... .+.. ...++||||++|.+|.+.. .......++.|++.+|.+|| +.|++||||||.|
T Consensus 167 L~rL~~~gv~vp~-p~~~-~~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH--~~gIVHrDLKp~N 235 (397)
T 4gyi_A 167 MKALYEEGFPVPE-PIAQ-SRHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLA--KHGLIHGDFNEFN 235 (397)
T ss_dssp HHHHHHTTCSCCC-EEEE-ETTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTS
T ss_pred HHHHHhcCCCCCe-eeec-cCceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHH--HCCCcCCCCCHHH
Confidence 6666433332221 1221 2347999999998886543 12245678899999999999 8999999999999
Q ss_pred EEEcCCC----------cEEEeccccccc
Q 018891 161 VLLDSNF----------NAKLSDFGLARD 179 (349)
Q Consensus 161 ilv~~~~----------~v~l~Dfg~~~~ 179 (349)
||+++++ .+.||||+.+..
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEEeCCCCcccccccccceEEEEeCCccc
Confidence 9998876 389999998864
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=9.3e-13 Score=114.82 Aligned_cols=145 Identities=13% Similarity=0.005 Sum_probs=111.0
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceee
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIG 94 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 94 (349)
..++ ..|++...++.|+.+.||++. .. +..+++|............+.+|...++.+. +..+.++++
T Consensus 10 ~~~l-~~~~~~~~~~g~s~~~v~~~~---------~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~ 77 (263)
T 3tm0_A 10 KKLI-EKYRCVKDTEGMSPAKVYKLV---------GE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH 77 (263)
T ss_dssp HHHH-TTSEEEECCSCCSSSEEEEEE---------CS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEE
T ss_pred HHHh-ccceeEeeccCCCCCeEEEEE---------CC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEE
Confidence 4444 469999999999999999983 21 4679999887543233445778899998884 667888898
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC--------------------------
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-------------------------- 148 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-------------------------- 148 (349)
++...+..|+|||+++|.+|.+.+. +......++.++.+++..||+..
T Consensus 78 ~~~~~~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 78 FERHDGWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp EEEETTEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred EEecCCceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 8888888999999999999887531 12234577889999999999410
Q ss_pred -------------------------------CCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 149 -------------------------------ANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 149 -------------------------------~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=2.9e-11 Score=104.90 Aligned_cols=135 Identities=16% Similarity=0.097 Sum_probs=94.9
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCc--ccceeeEEecC
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN--LVKLIGYCSES 99 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~ 99 (349)
+|.+....+.|..+.||++.. .+|..+++|..... ....+..|+..++.+.+.+ +.+++.+....
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~----------~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA----------QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC----------TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCceEecccCCCCceEEEEec----------CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 455544444666699999832 23567999987554 2234567888888874334 45678888777
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD------------------------------- 148 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~------------------------------- 148 (349)
+..++||||++|.+|. . .. .+ ...++.++++.|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~-~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--S-SH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp SCEEEEEECCSSEETT--T-SC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCEEEEEecCCcccC--c-Cc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 7889999999998873 2 11 11 2356778888888888321
Q ss_pred -------------------------CCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 149 -------------------------ANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 149 -------------------------~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..++|+|++|.||+++.++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 129999999999999877666799999774
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=1.8e-10 Score=102.49 Aligned_cols=182 Identities=20% Similarity=0.196 Sum_probs=118.6
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCc--ccceeeEEecCC--
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HEN--LVKLIGYCSESD-- 100 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~-- 100 (349)
.+.++.|....||++ +..+++|..... .....+.+|...++.+. +.. +.+++......+
T Consensus 25 i~~~~~G~~n~v~~v--------------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~ 88 (304)
T 3sg8_A 25 IEISGEGNDCIAYEI--------------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY 88 (304)
T ss_dssp CCEEEECSSEEEEES--------------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred eEecCCCCcceEEEE--------------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence 556899999999997 345889986433 33466788999998873 333 233333332222
Q ss_pred -ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 018891 101 -NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL-------------------------------- 147 (349)
Q Consensus 101 -~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-------------------------------- 147 (349)
..|+||++++|.++..... ..++..+...++.+++..+..||+.
T Consensus 89 ~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 89 QMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp SCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred CcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 3489999999988875432 3466777778888888888888831
Q ss_pred ------------------------CCCeeeccCCCCcEEEcC--CCcEEEecccccccCCCCCCCccccceecCCcc---
Q 018891 148 ------------------------DANVIYRDLKASNVLLDS--NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY--- 198 (349)
Q Consensus 148 ------------------------~~~i~H~di~~~Nilv~~--~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~--- 198 (349)
...++|+|+++.||+++. ++.+.++||+.+........ . ......
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l---~~~~~~~~~ 239 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---F---ISLMEDDEE 239 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---H---HTTCCTTTS
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---H---HHHHhhccc
Confidence 134799999999999988 45678999998864222100 0 000001
Q ss_pred cCcccccc-----CCC---------CCccceehhhHHHHHHHhCCccC
Q 018891 199 AAPEYVAT-----GHL---------TPKSDVYSFGVVLLELLSGRRAL 232 (349)
Q Consensus 199 ~aPE~~~~-----~~~---------~~~~DiwslG~ll~~lltg~~pf 232 (349)
..|+.... +.. ....+.|+++.++|.+.+|..+|
T Consensus 240 ~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 240 YGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12221110 111 11258899999999999998876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=3.6e-10 Score=103.06 Aligned_cols=142 Identities=15% Similarity=0.185 Sum_probs=103.2
Q ss_pred CCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcc--ccc-hhchHHHHHHHHHHhccC--CCcccceeeEEec
Q 018891 24 CSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AES-FQGHKEWLTEVIYLGQLR--HENLVKLIGYCSE 98 (349)
Q Consensus 24 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~ 98 (349)
...+.|+.|.++.||++... +..+++|... ... ......+.+|+.+++.+. +..+.+++.++.+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~ 109 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCED 109 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECC
T ss_pred ceEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCC
Confidence 34667899999999998432 3468899776 332 123346778999998886 4557778887766
Q ss_pred C---CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC----------------------------
Q 018891 99 S---DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL---------------------------- 147 (349)
Q Consensus 99 ~---~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~---------------------------- 147 (349)
. +..|+|||+++|.++.+.. ...++......++.+++.+|+.||+.
T Consensus 110 ~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3dxp_A 110 ESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY 186 (359)
T ss_dssp TTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred CCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence 5 4589999999998775422 13467888889999999999999942
Q ss_pred ----------------------------CCCeeeccCCCCcEEEcCCCc--EEEeccccccc
Q 018891 148 ----------------------------DANVIYRDLKASNVLLDSNFN--AKLSDFGLARD 179 (349)
Q Consensus 148 ----------------------------~~~i~H~di~~~Nilv~~~~~--v~l~Dfg~~~~ 179 (349)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 146899999999999987753 68999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=2.8e-07 Score=81.91 Aligned_cols=136 Identities=20% Similarity=0.140 Sum_probs=92.5
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCC---cccceeeEEe-cCC
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE---NLVKLIGYCS-ESD 100 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~ 100 (349)
-.+.++.|....||+. +..+++|.... ......+..|..+|+.+.+. .+.+++.+.. ..+
T Consensus 23 ~v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g 86 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDG 86 (306)
T ss_dssp CEEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTS
T ss_pred eeeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCC
Confidence 3567888888899987 45688997432 23346678899999998642 2455555553 455
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL--------------------------------- 147 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~--------------------------------- 147 (349)
..++||++++|.++..... ..++......++.++...|+.||+.
T Consensus 87 ~~~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~ 163 (306)
T 3tdw_A 87 NPFVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL 163 (306)
T ss_dssp CEEEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred ceEEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence 6899999999988876321 2234444555555555555555521
Q ss_pred -------------------------CCCeeeccCCCCcEEEcC---CCc-EEEeccccccc
Q 018891 148 -------------------------DANVIYRDLKASNVLLDS---NFN-AKLSDFGLARD 179 (349)
Q Consensus 148 -------------------------~~~i~H~di~~~Nilv~~---~~~-v~l~Dfg~~~~ 179 (349)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235699999999999987 455 48999987753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=4.9e-07 Score=78.61 Aligned_cols=134 Identities=18% Similarity=0.127 Sum_probs=94.7
Q ss_pred eeeecCce-eEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEecCCceEEE
Q 018891 28 LLGEGGFG-CVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLLV 105 (349)
Q Consensus 28 ~lg~G~~g-~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv 105 (349)
.+..|..+ .||+. .....+..+++|.-... ....+.+|...|+.+. +-.+.+++.++.+.+..++|
T Consensus 31 ~~~~G~S~~~v~rl---------~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 31 RDNVGQSGATIYRL---------YGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp EEECSSSSCEEEEE---------ECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred EccCCCcCCeEEEE---------EecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 34445554 68886 33444667889976543 3456778888888774 33366778888888889999
Q ss_pred EEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 018891 106 YEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL-------------------------------------- 147 (349)
Q Consensus 106 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-------------------------------------- 147 (349)
|++++|.++.+..... ......+..++...|..||+.
T Consensus 99 me~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T 4gkh_A 99 TTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNG 173 (272)
T ss_dssp EECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTT
T ss_pred EEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccc
Confidence 9999998887765321 233445666777777777731
Q ss_pred ------------------CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 ------------------DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ------------------~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
...++|+|+++.||+++.++.+-|+||+.+.
T Consensus 174 ~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 174 WPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1126899999999999987777899998774
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.9e-06 Score=78.05 Aligned_cols=87 Identities=2% Similarity=-0.135 Sum_probs=52.2
Q ss_pred ccee-eecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccC-C--CcccceeeEEec
Q 018891 26 DYLL-GEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLR-H--ENLVKLIGYCSE 98 (349)
Q Consensus 26 ~~~l-g~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~ 98 (349)
.+.| +.|....+|+....... .....+..+++|...... ......+.+|...++.+. + -.+.+++.+..+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~---~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQ---DGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEE---TTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred EEECCCCCccceEEEEEEeccc---CCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4567 78888899987432000 000015678899765433 111234567777777763 2 345666766655
Q ss_pred C---CceEEEEEeCCCCChH
Q 018891 99 S---DNRLLVYEFMPKGSLE 115 (349)
Q Consensus 99 ~---~~~~lv~e~~~~~~L~ 115 (349)
. +..++|||+++|.++.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=1.2e-05 Score=74.02 Aligned_cols=77 Identities=17% Similarity=0.138 Sum_probs=47.4
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-------hchHHHHHHHHHHhccC-C-Cccc-ceee
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-------QGHKEWLTEVIYLGQLR-H-ENLV-KLIG 94 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~-h-~~i~-~~~~ 94 (349)
..+.||.|..+.||++. ....+..+++|....... .....+..|...++.+. . +..+ +++.
T Consensus 34 ~~~~lg~G~~n~vyrv~---------~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~ 104 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIY---------DQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY 104 (397)
T ss_dssp EEEECCSSSSEEEEEEE---------C----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE
T ss_pred EEEECCCCceEEEEEEE---------ECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEE
Confidence 35688999999999984 223357799997643211 12344567888887763 2 3333 4443
Q ss_pred EEecCCceEEEEEeCCCC
Q 018891 95 YCSESDNRLLVYEFMPKG 112 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~ 112 (349)
+ +....++|||++++.
T Consensus 105 ~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 105 S--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp E--ETTTTEEEECCCTTS
T ss_pred E--cCCccEEEEEeCCCc
Confidence 3 344568999999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.10 E-value=1.3e-05 Score=66.23 Aligned_cols=141 Identities=13% Similarity=0.037 Sum_probs=93.8
Q ss_pred CChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCCCCccccc
Q 018891 112 GSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191 (349)
Q Consensus 112 ~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~ 191 (349)
.+|.+.+.....++++.++|.++.|.+.+|..+-. +..-...=+.|..|++..+|.|-+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 47999998888999999999999999999887721 11222444567899999999988864 1110
Q ss_pred eecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCC
Q 018891 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS 271 (349)
Q Consensus 192 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (349)
.....+.+||... ...+.+.=|||||+++|..+-...|- ..+
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e------------------------------------~eE 139 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE------------------------------------NEE 139 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT------------------------------------TEE
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc------------------------------------ccc
Confidence 1122367888652 34456778999999999998654432 123
Q ss_pred HHHHHHHHHHHHHhccc-------------------------CCCCCCCHHHHHHHHHh
Q 018891 272 KKEAQAVAAVVLQCLHM-------------------------DPKNRPSMVDVLTSLEQ 305 (349)
Q Consensus 272 ~~~~~~l~~li~~~l~~-------------------------dp~~Rps~~~ll~~l~~ 305 (349)
..+++.|-.||..|... .+..|++++++++....
T Consensus 140 ~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~ 198 (229)
T 2yle_A 140 RELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA 198 (229)
T ss_dssp ECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred hhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence 34667788888888755 23578889888876544
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.5e-05 Score=69.01 Aligned_cols=31 Identities=23% Similarity=0.249 Sum_probs=27.9
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888889999998774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.93 E-value=0.0001 Score=64.54 Aligned_cols=87 Identities=14% Similarity=0.198 Sum_probs=60.6
Q ss_pred hhhhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCC---ccc
Q 018891 14 MISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE---NLV 90 (349)
Q Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~ 90 (349)
-+..+.+.+..-...+|.|..+.||+.... +|+.|++|+...........+..|...|+.+... .+.
T Consensus 8 ~~~~l~G~~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP 77 (288)
T 3f7w_A 8 RVTELTGREVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVP 77 (288)
T ss_dssp HHHHHHCCCEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSC
T ss_pred HHHHhcCCCeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcc
Confidence 345566778888899999999999998543 4778999987655444455677898888887421 233
Q ss_pred ceeeEEecCCceEEEEEeCCCCCh
Q 018891 91 KLIGYCSESDNRLLVYEFMPKGSL 114 (349)
Q Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L 114 (349)
+++.+ +..++||||+++...
T Consensus 78 ~v~~~----~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 78 QVAGW----DDRTLAMEWVDERPP 97 (288)
T ss_dssp CEEEE----ETTEEEEECCCCCCC
T ss_pred eEEec----cCceEEEEeecccCC
Confidence 33332 234789999976643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00015 Score=63.97 Aligned_cols=74 Identities=7% Similarity=0.083 Sum_probs=43.7
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcc-cceeeEEecCCc
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSESDN 101 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~ 101 (349)
+.-.+.|+.|....+|++ ..+++|+....... .....+|...++.+...++ .+++.. ..+.
T Consensus 20 ~~~i~~l~gG~tN~~~~~---------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~ 81 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA---------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPAT 81 (301)
T ss_dssp CCSCEEEESCSSEEEEEE---------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTT
T ss_pred ccceeEcCCcccccccee---------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCC
Confidence 334788999999999997 23788977653211 1112356666666632222 344433 3334
Q ss_pred eEEEEEeC-CCCCh
Q 018891 102 RLLVYEFM-PKGSL 114 (349)
Q Consensus 102 ~~lv~e~~-~~~~L 114 (349)
-++|++|+ +|.++
T Consensus 82 ~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 82 GVMVTRYIAGAQTM 95 (301)
T ss_dssp CCEEEECCTTCEEC
T ss_pred CEEEEeecCCCccC
Confidence 57899999 77655
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00036 Score=61.77 Aligned_cols=87 Identities=14% Similarity=0.056 Sum_probs=61.2
Q ss_pred hhhhhhhcccC--CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC---CCc
Q 018891 14 MISKIATKNFC--SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR---HEN 88 (349)
Q Consensus 14 ~~~~~~~~~y~--~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~ 88 (349)
.+....+..+. -.+.|+.|....+|+... .+..+++|..... ....+..|...|+.+. ...
T Consensus 27 ~L~~~lg~~~~i~~~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~ 92 (312)
T 3jr1_A 27 VLAEQFGAYYFIKHKEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSIN 92 (312)
T ss_dssp HHHHHHSSCCCCCEEEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSB
T ss_pred HHHHHhCCCcceeeeEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCC
Confidence 33444444433 346789999999999832 2457889976543 3456778888888773 356
Q ss_pred ccceeeEEecCCceEEEEEeCCCCCh
Q 018891 89 LVKLIGYCSESDNRLLVYEFMPKGSL 114 (349)
Q Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L 114 (349)
+.+++.+....+..++||||+++.++
T Consensus 93 VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 93 VPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp CCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred cceEEEEeecCCceEEEEEeccCCCC
Confidence 77788887777789999999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00049 Score=63.66 Aligned_cols=31 Identities=16% Similarity=0.216 Sum_probs=27.7
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
...++|||+++.||+++.++ +.++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 67899999999999998876 99999998864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00039 Score=63.30 Aligned_cols=146 Identities=17% Similarity=0.187 Sum_probs=80.4
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEecCCceEE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLL 104 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 104 (349)
.+.|..|....+|++...+.. .....++..+++|+.... ........+|..+++.+. +.-..+++..+.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~--~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHL--PSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTS--CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCc--cccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 356777888899998543210 011224578999986432 234456668888888874 2223455555543 29
Q ss_pred EEEeCCCCChHHH----------H----hc-cC------CCCC--hHHHHHHHHHHHH-------------------HHH
Q 018891 105 VYEFMPKGSLENH----------L----FR-SV------QPIS--WPTRVKIAIDVAR-------------------GLS 142 (349)
Q Consensus 105 v~e~~~~~~L~~~----------l----~~-~~------~~l~--~~~~~~i~~ql~~-------------------~l~ 142 (349)
|+||++|.+|... + .+ +. .... ...+..+..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999988655311 1 00 00 1111 2344444443321 122
Q ss_pred H----Hh--cCCCCeeeccCCCCcEEEcCC----CcEEEecccccc
Q 018891 143 F----LH--GLDANVIYRDLKASNVLLDSN----FNAKLSDFGLAR 178 (349)
Q Consensus 143 ~----lH--~~~~~i~H~di~~~Nilv~~~----~~v~l~Dfg~~~ 178 (349)
. |. .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 22 113468999999999999876 689999998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0027 Score=56.36 Aligned_cols=29 Identities=24% Similarity=0.273 Sum_probs=25.2
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
...++|+|+++.||+++ + .+.++||+.+.
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 45689999999999998 4 89999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0014 Score=58.35 Aligned_cols=32 Identities=28% Similarity=0.297 Sum_probs=27.6
Q ss_pred CCCeeeccCCCCcEEEcCC----CcEEEeccccccc
Q 018891 148 DANVIYRDLKASNVLLDSN----FNAKLSDFGLARD 179 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~----~~v~l~Dfg~~~~ 179 (349)
...++|+|+++.||+++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4679999999999999874 6799999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00088 Score=62.12 Aligned_cols=81 Identities=16% Similarity=0.117 Sum_probs=48.3
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcc-cceeeEEecCCceEE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSESDNRLL 104 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~l 104 (349)
.+.|+.|....+|++...+... .....+..+++|+..... ....+..|..+++.+...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~--~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCcc--ccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4567788889999985432100 011235779999874321 12455578888887743233 455555432 38
Q ss_pred EEEeCCCCCh
Q 018891 105 VYEFMPKGSL 114 (349)
Q Consensus 105 v~e~~~~~~L 114 (349)
|++|++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0016 Score=57.70 Aligned_cols=31 Identities=35% Similarity=0.296 Sum_probs=26.3
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3578999999999999887666899998764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0017 Score=60.57 Aligned_cols=75 Identities=15% Similarity=0.009 Sum_probs=44.3
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcc-cceeeEEecCCceEE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENL-VKLIGYCSESDNRLL 104 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~l 104 (349)
.+.|+.|....+|++... +.+..+++|+....... .-...+|..+++.+...++ .+++..+. + .+
T Consensus 113 i~~lsgG~tN~~y~v~~~---------~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~ 178 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDM---------SKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GR 178 (458)
T ss_dssp EEEECC--CEEEEEEEET---------TTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred EEEcCCCeEeEEEEEEEC---------CCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence 456788888999998432 12467889987443211 1112468888888754444 45555552 2 35
Q ss_pred EEEeCCCCCh
Q 018891 105 VYEFMPKGSL 114 (349)
Q Consensus 105 v~e~~~~~~L 114 (349)
|++|++|.+|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0021 Score=58.18 Aligned_cols=83 Identities=10% Similarity=-0.022 Sum_probs=41.9
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCc-ccceeeEEecCCceEE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN-LVKLIGYCSESDNRLL 104 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~l 104 (349)
.+.|+.|....+|++...+... ......+..+++|+....... ......|..+++.+...+ ..+++... . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~-~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETA-NNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHH-TTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred EEEeCCcccceEEEEEeCCCCc-ccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence 4567778888999985431000 000112367889987543221 112346677777664223 33455443 2 368
Q ss_pred EEEeCCCCCh
Q 018891 105 VYEFMPKGSL 114 (349)
Q Consensus 105 v~e~~~~~~L 114 (349)
|++|++|.++
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0076 Score=53.89 Aligned_cols=31 Identities=19% Similarity=0.212 Sum_probs=27.2
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
...++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 3568999999999999988889999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.47 E-value=0.06 Score=49.54 Aligned_cols=82 Identities=11% Similarity=-0.040 Sum_probs=45.3
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEecCCceEE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLL 104 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 104 (349)
.+.+..|-...+|++....... .....+..+++++..... ...-+..+|..+++.+. +.-..++++.+. -+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESM--SLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcc--cccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 4566777788899986432100 001125779999865432 21112346777777763 222334444332 368
Q ss_pred EEEeCCCCCh
Q 018891 105 VYEFMPKGSL 114 (349)
Q Consensus 105 v~e~~~~~~L 114 (349)
|++|++|.+|
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.98 E-value=0.021 Score=52.22 Aligned_cols=30 Identities=23% Similarity=0.259 Sum_probs=25.1
Q ss_pred CeeeccCCCCcEEE------cCCCcEEEeccccccc
Q 018891 150 NVIYRDLKASNVLL------DSNFNAKLSDFGLARD 179 (349)
Q Consensus 150 ~i~H~di~~~Nilv------~~~~~v~l~Dfg~~~~ 179 (349)
.+||+|+.+.||++ ++++.+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46899999999999 4466799999998853
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.28 E-value=0.63 Score=38.35 Aligned_cols=115 Identities=10% Similarity=0.103 Sum_probs=77.4
Q ss_pred CCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHH-HHhcCCCCeeeccCCCCcEEE
Q 018891 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS-FLHGLDANVIYRDLKASNVLL 163 (349)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~-~lH~~~~~i~H~di~~~Nilv 163 (349)
.||++ ...+-..++.+.+.++.-+++.-+..+ ...+..+.++++.+|+.... +++ .-+|--++|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~----~r~tf~l~P~NL~f 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSA----RRLIFIVCPENLMF 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCS----SSEECCCCGGGEEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhh----CceeEEEeCceEEE
Confidence 68888 445556666666666654343333344 45788899999999998877 555 45788999999999
Q ss_pred cCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCc
Q 018891 164 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 233 (349)
Q Consensus 164 ~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~ 233 (349)
+.++.+++.-.|+... ++|.-+ +..-=+-++=|++..++.++..|.
T Consensus 118 ~~~~~p~i~hRGi~~~-------------------lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 118 NRALEPFFLHVGVKES-------------------LPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CTTCCEEESCCEETTT-------------------BSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCCCcEEEEEcCCccc-------------------CCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999998876532 333211 111112255678888888887774
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.70 E-value=0.64 Score=38.17 Aligned_cols=124 Identities=7% Similarity=0.099 Sum_probs=80.3
Q ss_pred HHHHHhccCCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 018891 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 156 (349)
Q Consensus 77 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di 156 (349)
|+.+|.. .+|+++.. .+-..++...+.++.-+.+.=+..+ ...+....++++.+|+....+++ .=+|--+
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i----k~~~~~eKlr~l~ni~~l~~~~~----~r~tf~L 105 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI----KSFTKNEKLRYLLNIKNLEEVNR----TRYTFVL 105 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG----GGSCHHHHHHHHHHGGGGGGGGG----SSEECCC
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH----HhcCHHHHHHHHHHHHHHHHHhc----CceEEEE
Confidence 3444433 68888877 4555555555554443322112223 45788899999999999886665 3478899
Q ss_pred CCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCcc
Q 018891 157 KASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 234 (349)
Q Consensus 157 ~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~ 234 (349)
+|+|++++.++.+++.-.|+... ++|. .++...-+-..=|++..+++++..|..
T Consensus 106 ~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 106 APDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp SGGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred ecceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999999987776432 2221 111112223556888899999888853
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 349 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-76 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-66 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-65 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-64 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-64 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-62 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-55 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-54 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-49 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (598), Expect = 2e-76
Identities = 71/290 (24%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG V+KG K + V + + A + Q + + EV L + RH
Sbjct: 15 RIGSGSFGTVYKG----------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N++ +GY + +V ++ SL +HL + IA A+G+ +LH
Sbjct: 65 NILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 121
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT- 206
++I+RDLK++N+ L + K+ DFGLA +H ++ G+ + APE +
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 207 --GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT 264
+ +SDVY+FG+VL EL++G+ +Q + +L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDLS------- 232
Query: 265 RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 314
+ +A+ ++ +CL RP +L S+E L ++ +P+
Sbjct: 233 ----KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL--ARSLPK 276
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 3e-67
Identities = 66/279 (23%), Positives = 112/279 (40%), Gaps = 33/279 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG G FG V G VAIK +K E E++ E + L HE
Sbjct: 12 LGTGQFGVVKYGKWR----------GQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 60
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
LV+L G C++ ++ E+M G L N+L +++ DV + +L
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--S 118
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH 208
++RDL A N L++ K+SDFGL+R D S ++ PE +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 209 LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRIMDTRLG 267
+ KSD+++FGV++ E+ S + P+ R + + L
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM------------------PYERFTNSETAEHIAQGLR 219
Query: 268 GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
++ V ++ C H RP+ +L+++ +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (538), Expect = 3e-67
Identities = 75/301 (24%), Positives = 136/301 (45%), Gaps = 38/301 (12%)
Query: 19 ATKNFCSDY---------LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SF 68
A + F + ++G G FG V G + I VAIK LK+ +
Sbjct: 15 AVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIKTLKSGYTE 68
Query: 69 QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWP 128
+ +++L+E +GQ H N++ L G ++S +++ EFM GSL++ L ++ +
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 188
V + +A G+ +L D N ++RDL A N+L++SN K+SDFGL+R +
Sbjct: 129 QLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186
Query: 189 STRIVG---TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245
T +G + APE + T SDV+S+G+V+ E++S D
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---------- 236
Query: 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305
++ V+ ++ A+ ++L C D +RP ++ +L++
Sbjct: 237 -------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 306 L 306
+
Sbjct: 290 M 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-67
Identities = 77/314 (24%), Positives = 129/314 (41%), Gaps = 37/314 (11%)
Query: 18 IATKNFC-SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWL 75
+ N +D LG G FG V +G I VAIK LK + + +E +
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMM 57
Query: 76 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI 135
E + QL + +V+LIG C +++ +LV E G L L + I ++
Sbjct: 58 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 116
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVG 194
V+ G+ +L + N ++RDL A NVLL + AK+SDFGL++ G +
Sbjct: 117 QVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 195 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254
+ APE + + +SDV+S+GV + E LS + P+ +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK------------------PYKKM 216
Query: 255 S-RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313
V+ ++ + + + A++ C ++RP + V + +
Sbjct: 217 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR--ACYYSLA 274
Query: 314 RTPPPAKLHHHHHH 327
HHHHHH
Sbjct: 275 SKVEG---HHHHHH 285
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-66
Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 31/278 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G G FG V G+ + VAIK ++ E ++++ E + +L H
Sbjct: 13 IGSGQFGLVHLGYWL----------NKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPK 61
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
LV+L G C E LV+EFM G L ++L + T + + +DV G+++L +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--E 119
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH 208
A VI+RDL A N L+ N K+SDFG+ R D ST +A+PE +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 209 LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGG 268
+ KSDV+SFGV++ E+ S + E+R + D R+ RL
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENR----------SNSEVVEDISTGFRLYKPRL-- 226
Query: 269 QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ V ++ C P++RP+ +L L ++
Sbjct: 227 -----ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 5e-66
Identities = 79/286 (27%), Positives = 128/286 (44%), Gaps = 29/286 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRH 86
++G G FGCV+ G + N G I A+K L + G ++LTE I + H
Sbjct: 34 VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 87 ENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
N++ L+G C S+ L+V +M G L N + + + + VA+G+ FL
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIVGTRGYAAPEY 203
++RDL A N +LD F K++DFGLARD D+ H T + A E
Sbjct: 148 --SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
+ T T KSDV+SFGV+L EL++ D + L+ R +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD------VNTFDITVYLLQGRRLLQ---- 255
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
+ + V+L+C H + RPS ++++ + + ++
Sbjct: 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 7e-66
Identities = 74/302 (24%), Positives = 140/302 (46%), Gaps = 26/302 (8%)
Query: 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHK-EW 74
++I ++G G FG V+KG + + + VAIK LKA + + ++
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKT-----SSGKKEVPVAIKTLKAGYTEKQRVDF 56
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIA 134
L E +GQ H N+++L G S+ +++ E+M G+L+ L S V +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIV 193
+A G+ +L + N ++RDL A N+L++SN K+SDFGL+R + T+ ++
Sbjct: 117 RGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
+ APE ++ T SDV+SFG+V+ E+++ +
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------------L 217
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313
+ V++ ++ A+ +++QC + RP D+++ L++L + D
Sbjct: 218 SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
Query: 314 RT 315
+T
Sbjct: 278 KT 279
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 1e-65
Identities = 70/297 (23%), Positives = 132/297 (44%), Gaps = 31/297 (10%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTE 77
+ + + LG G +G V++G + VA+K LK ++ + +E+L E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKE 63
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV-QPISWPTRVKIAID 136
+ +++H NLV+L+G C+ ++ EFM G+L ++L Q +S + +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
++ + +L N I+RDL A N L+ N K++DFGL+R GD
Sbjct: 124 ISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 180
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256
+ APE +A + KSDV++FGV+L E+ + + D
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----------------IDLS 223
Query: 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313
+V +++ + + + V ++ C +P +RPS ++ + E + +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-65
Identities = 67/305 (21%), Positives = 131/305 (42%), Gaps = 35/305 (11%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
+G+G FG V++G G VA+K + + E+ LRHEN
Sbjct: 11 IGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHEN 58
Query: 89 LVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
++ I ++ + LV ++ GSL ++L R ++ +K+A+ A GL+ L
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHL 116
Query: 145 H------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGTR 196
H + +RDLK+ N+L+ N ++D GLA + +T VGT+
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 197 GYAAPEYVAT------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250
Y APE + ++D+Y+ G+V E+ + +DP
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 251 FLRDSRRVL--RIMDTRLGGQYSKKEA-QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
+ + R+V+ + + + ++ EA + +A ++ +C + + R + + + +L QL
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 308 TSKDM 312
+ +
Sbjct: 297 QQEGI 301
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-65
Identities = 71/283 (25%), Positives = 125/283 (44%), Gaps = 33/283 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V+ G+ + VA+K LK S +L E + QL+H+
Sbjct: 20 RLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQ 68
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQPISWPTRVKIAIDVARGLSFLHG 146
LV+L ++ + ++ E+M GSL + L S ++ + +A +A G++F+
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
+ N I+RDL+A+N+L+ + K++DFGLAR + + APE +
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINY 184
Query: 207 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 266
G T KSDV+SFG++L E+++ R +E +R
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD----------- 233
Query: 267 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309
+ + ++ C P++RP+ + + LE T+
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 6e-65
Identities = 68/309 (22%), Positives = 121/309 (39%), Gaps = 41/309 (13%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLT 76
+ +F LG G G VFK + SG+V+A K + E + +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQIIR 53
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAID 136
E+ L + +V G + E M GSL+ L ++ I K++I
Sbjct: 54 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIA 112
Query: 137 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 196
V +GL++L +++RD+K SN+L++S KL DFG++ ++ VGTR
Sbjct: 113 VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 167
Query: 197 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL------------ 244
Y +PE + H + +SD++S G+ L+E+ GR + E
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227
Query: 245 ---------VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA----VVLQCLHMDPK 291
+ R + ++D + K + + V +CL +P
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
Query: 292 NRPSMVDVL 300
R + ++
Sbjct: 288 ERADLKQLM 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 2e-64
Identities = 76/303 (25%), Positives = 125/303 (41%), Gaps = 50/303 (16%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQL-R 85
+LG G FG V + K G I VA+K LK ++ +E ++E+ + QL
Sbjct: 44 VLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 99
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR----------------------SVQ 123
HEN+V L+G C+ S L++E+ G L N+L +
Sbjct: 100 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159
Query: 124 PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183
+++ + A VA+G+ FL + ++RDL A NVL+ K+ DFGLARD +
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 184 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 243
N V + APE + G T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265
Query: 244 LVEWADPFLRDSRR--VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 301
P+ +++ + + ++ C D + RPS ++ +
Sbjct: 266 ------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 302 SLE 304
L
Sbjct: 320 FLG 322
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 4e-64
Identities = 85/312 (27%), Positives = 139/312 (44%), Gaps = 37/312 (11%)
Query: 10 PSASMISK----IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKA 65
P ++K I ++ + LG+G FG V+ G + T VAIK LK
Sbjct: 2 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT----------RVAIKTLK- 50
Query: 66 ESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RSVQP 124
+ +L E + +LRHE LV+L SE + +V E+M KGSL + L + +
Sbjct: 51 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKY 109
Query: 125 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184
+ P V +A +A G++++ N ++RDL+A+N+L+ N K++DFGLAR +
Sbjct: 110 LRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DN 166
Query: 185 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244
+ APE G T KSDV+SFG++L EL + R
Sbjct: 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--------- 217
Query: 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
+R VL ++ + +++ ++ QC +P+ RP+ + LE
Sbjct: 218 --------MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
Query: 305 QLHTSKDMPRTP 316
TS + P
Sbjct: 270 DYFTSTEPQYQP 281
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 4e-64
Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 39/285 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G FG V G G VA+K +K ++ + +L E + QLRH
Sbjct: 14 TIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 60
Query: 88 NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLF-RSVQPISWPTRVKIAIDVARGLSFLH 145
NLV+L+G E L +V E+M KGSL ++L R + +K ++DV + +L
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
N ++RDL A NVL+ + AK+SDFGL ++ + +T + APE +
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALR 173
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
+ KSDV+SFG++L E+ S R + V+ ++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPR-----------------IPLKDVVPRVEKG 216
Query: 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310
AV V+ C H+D RPS + + LE + T +
Sbjct: 217 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-64
Identities = 64/287 (22%), Positives = 128/287 (44%), Gaps = 30/287 (10%)
Query: 25 SDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK-AESFQGHKEWLTEVI 79
+++ +LG G FG V+KG + P I VAIK L+ A S + +KE L E
Sbjct: 9 TEFKKIKVLGSGAFGTVYKG-----LWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 80 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
+ + + ++ +L+G C L+ + MP G L +++ I + + +A+
Sbjct: 64 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 122
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
G+++L D +++RDL A NVL+ + + K++DFGLA+ + + + +
Sbjct: 123 GMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259
A E + T +SDV+S+GV + EL++ + + +
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-----------------IPASEIS 223
Query: 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
I++ V ++++C +D +RP +++ ++
Sbjct: 224 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 6e-64
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 41/298 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQL-R 85
LG G FG V + + K + + VA+K LK + +E ++E+ L L
Sbjct: 30 TLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRS-----------------VQPISWP 128
H N+V L+G C+ L++ E+ G L N L R +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 188
+ + VA+G++FL N I+RDL A N+LL K+ DFGLARD N V
Sbjct: 146 DLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 189 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248
+ APE + T +SDV+S+G+ L EL S +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------------ 251
Query: 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ +++ + + ++ C DP RP+ ++ +E+
Sbjct: 252 ----PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (516), Expect = 8e-64
Identities = 69/302 (22%), Positives = 123/302 (40%), Gaps = 47/302 (15%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRHE 87
+GEG FG VF+ +VA+K LK E+ ++ E + + +
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEP----FTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-----------------------SVQP 124
N+VKL+G C+ L++E+M G L L P
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 125 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184
+S ++ IA VA G+++L + ++RDL N L+ N K++DFGL+R+ + D
Sbjct: 137 LSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 185 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 244
+ PE + T +SDV+++GVVL E+ S G+A + +
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY---GMAHEEV 251
Query: 245 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304
+ + +RD + + + ++ C P +RPS + L+
Sbjct: 252 IYY----VRDGNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 305 QL 306
++
Sbjct: 298 RM 299
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-63
Identities = 60/277 (21%), Positives = 111/277 (40%), Gaps = 34/277 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN 88
LG+G FG V+K + ++ A K + +S + ++++ E+ L H N
Sbjct: 20 LGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 89 LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD 148
+VKL+ +N ++ EF G+++ + +P++ + L++LH D
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--D 128
Query: 149 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-- 206
+I+RDLKA N+L + + KL+DFG++ +GT + APE V
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCET 186
Query: 207 ---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
K+DV+S G+ L+E+ E + + P L R
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW----- 241
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ + +CL + R + +L
Sbjct: 242 -----------SSNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-62
Identities = 66/284 (23%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 23 FCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLTE 77
F D+ LGEG +G V + VA+K + + + E
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKE 53
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDV 137
+ L HEN+VK G+ E + + L E+ G L + + + P + +
Sbjct: 54 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQL 112
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
G+ +LH + +RD+K N+LLD N K+SDFGLA + + ++ GT
Sbjct: 113 MAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 198 YAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256
Y APE + DV+S G+VL +L+G D+ E + + +L +
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 230
Query: 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
++ A A++ + L +P R ++ D+
Sbjct: 231 KI----------------DSAPLALLHKILVENPSARITIPDIK 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-62
Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 29/293 (9%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEW 74
I K+ LG+G FG V +G D + G + VA+K LK + + ++
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIA 134
+ EV + L H NL++L G +V E P GSL + L + T + A
Sbjct: 59 IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIV 193
+ VA G+ +L I+RDL A N+LL + K+ DFGL R P D+ +V
Sbjct: 118 VQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
+ APE + T + SD + FGV L E+ + + + +
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDK 229
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ R+ R D Q + V++QC P++RP+ V + L +
Sbjct: 230 EGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-62
Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 33/284 (11%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQ 83
D LG G FG V KG+ VA+K LK E+ E L E + Q
Sbjct: 12 DKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
L + +V++IG C E+++ +LV E G L +L ++ + + +++ V+ G+ +
Sbjct: 65 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKY 122
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPE 202
L ++N ++RDL A NVLL + AK+SDFGL++ +N + T + APE
Sbjct: 123 LE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 203 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLRI 261
+ + KSDV+SFGV++ E S + P+ V +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQK------------------PYRGMKGSEVTAM 222
Query: 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 305
++ + + ++ C D +NRP V L
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-61
Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 21 KNFC-SDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHK 72
+ + D+ LG+G FG V+ + S ++A+K L
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEH 51
Query: 73 EWLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVK 132
+ EV LRH N+++L GY ++ L+ E+ P G++ L + +
Sbjct: 52 QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTAT 110
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 192
++A LS+ H VI+RD+K N+LL S K++DFG + P+ T +
Sbjct: 111 YITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---- 164
Query: 193 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252
GT Y PE + K D++S GV+ E L G+ PF
Sbjct: 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-------------------PFE 205
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
++ + +R+ + + ++ + L +P RP + +VL
Sbjct: 206 ANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 3e-61
Identities = 69/278 (24%), Positives = 111/278 (39%), Gaps = 41/278 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
+G G FG V+ + VVAIK++ Q +++W + EV +L +LR
Sbjct: 23 IGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N ++ G LV E+ + + +P+ + +GL++LH
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH 132
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
N+I+RD+KA N+LL KL DFG A + VGT + APE +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAPEVIL 184
Query: 206 T---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262
G K DV+S G+ +EL + L A + + P L+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ--------- 235
Query: 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
S ++ V CL P++RP+ +L
Sbjct: 236 --------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-60
Identities = 61/282 (21%), Positives = 105/282 (37%), Gaps = 38/282 (13%)
Query: 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQ 83
D +G G F V+KG + + VA L+ + + E L
Sbjct: 14 DIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 64
Query: 84 LRHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
L+H N+V+ + +LV E M G+L+ +L R + + + +
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILK 123
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
GL FLH +I+RDLK N+ + + K+ D GLA + ++GT +
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258
APE DVY+FG+ +LE+ + E + +
Sbjct: 180 MAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYR------------ 223
Query: 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
R+ + K V ++ C+ + R S+ D+L
Sbjct: 224 -RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-60
Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 46/311 (14%)
Query: 13 SMISKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGH 71
++ + + ++GEG FG V K I ++ G + AIKR+K S H
Sbjct: 2 TIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDH 54
Query: 72 KEWLTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---------- 120
+++ E+ L +L H N++ L+G C L E+ P G+L + L +
Sbjct: 55 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114
Query: 121 -----SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175
+ +S + A DVARG+ +L I+RDL A N+L+ N+ AK++DFG
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFG 172
Query: 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDED 235
L+R T + A E + T SDV+S+GV+L E++S
Sbjct: 173 LSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229
Query: 236 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
T E + + R + V ++ QC P RPS
Sbjct: 230 ------MTCAELYEKLPQGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPS 272
Query: 296 MVDVLTSLEQL 306
+L SL ++
Sbjct: 273 FAQILVSLNRM 283
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-59
Identities = 58/273 (21%), Positives = 114/273 (41%), Gaps = 31/273 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G+G G V+ +G VAI+++ + + + E++ + + ++
Sbjct: 27 KIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N+V + D +V E++ GSL + + + + + + L FLH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH-- 133
Query: 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 207
VI+RD+K+ N+LL + + KL+DFG + +VGT + APE V
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRK 191
Query: 208 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG 267
PK D++S G++ +E++ G + A + P L++ ++
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL--------- 242
Query: 268 GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ + +CL MD + R S ++L
Sbjct: 243 -------SAIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 1e-58
Identities = 67/283 (23%), Positives = 115/283 (40%), Gaps = 39/283 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLR 85
+G G +G K + G ++ K L S + ++EV L +L+
Sbjct: 11 TIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 86 HENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRSV---QPISWPTRVKIAIDVARG 140
H N+V+ + N L V E+ G L + + + Q + +++ +
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 141 LSFLH---GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
L H V++RDLK +NV LD N KL DFGLAR +T + VGT
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPY 179
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257
Y +PE + KSD++S G +L EL + + E A +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-------SQKELA-------GK 225
Query: 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ R+ +YS + ++ + L++ +RPS+ ++L
Sbjct: 226 IREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-58
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 28/280 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-WLTEVIYLGQLRH 86
+GEG FG V +G + VAIK K + +E +L E + + Q H
Sbjct: 14 CIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
++VKLIG +E + ++ E G L + L + + + A ++ L++L
Sbjct: 68 PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE- 125
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
++RD+ A NVL+ SN KL DFGL+R + +++ + APE +
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINF 183
Query: 207 GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL 266
T SDV+ FGV + E+L + +E +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--------------- 228
Query: 267 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ +++ +C DP RP ++ L +
Sbjct: 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 5e-58
Identities = 73/299 (24%), Positives = 134/299 (44%), Gaps = 33/299 (11%)
Query: 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRL-KAESFQGHKEWLT 76
+A + LG+G FG V++G K VAIK + +A S + E+L
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 77 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF---------RSVQPISW 127
E + + ++V+L+G S+ L++ E M +G L+++L + P S
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 128 PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 187
+++A ++A G+++L+ ++RDL A N ++ +F K+ DFG+ RD D
Sbjct: 133 SKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 188 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247
+ + + +PE + G T SDV+SFGVVL E+ + + EQ L
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRFV 248
Query: 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ L D + ++ C +PK RPS +++++S+++
Sbjct: 249 MEGGLLD---------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 185 bits (470), Expect = 2e-56
Identities = 72/326 (22%), Positives = 115/326 (35%), Gaps = 33/326 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V + T+ +G A K + + E+ + LRH
Sbjct: 33 ELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
LV L + + +++YEFM G L + +S V+ V +GL +H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 148 DANVIYRDLKASNVLLDSNFN--AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
+ N ++ DLK N++ + + KL DFGL + V+T GT +AAPE
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 198
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
+ +D++S GV+ LLSG + D LR+ + MD
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----------DDETLRNVKSCDWNMDDS 247
Query: 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAKLHH 323
S + + + L DP R ++ L L + + P
Sbjct: 248 AFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
Query: 324 HHHHHNHHQGIKHTNPPRKTSITNSK 349
+ PP S
Sbjct: 304 RDSIKTKYDAWPEPLPPLGRISNYSS 329
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-55
Identities = 70/296 (23%), Positives = 124/296 (41%), Gaps = 38/296 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQL-R 85
LGEG FG V KP VA+K LK+++ + + ++E+ + + +
Sbjct: 20 PLGEGAFGQVVLAE--AIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF---------------RSVQPISWPTR 130
H+N++ L+G C++ ++ E+ KG+L +L + +S
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 131 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 190
V A VARG+ +L I+RDL A NVL+ + K++DFGLARD D +T
Sbjct: 138 VSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 191 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 250
+ APE + T +SDV+SFGV+L E+ + +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG--------------- 240
Query: 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
+ +++ + ++ C H P RP+ ++ L+++
Sbjct: 241 --VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 6e-55
Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 40/297 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-HKEWLTEVIYLGQLRH 86
LG G FG V + F K + VA+K LK + H+ ++E+ L + H
Sbjct: 20 PLGRGAFGQVIEADA----FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 75
Query: 87 E-NLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFR---------------SVQPISWPT 129
N+V L+G C++ L ++ EF G+L +L ++
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 130 RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 189
+ + VA+G+ FL I+RDL A N+LL K+ DFGLARD +
Sbjct: 136 LICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 190 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249
+ APE + T +SDV+SFGV+L E+ S + + E
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG------VKIDEEFC 247
Query: 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
L++ R+ + + +L C H +P RP+ +++ L L
Sbjct: 248 RRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 2e-54
Identities = 54/294 (18%), Positives = 104/294 (35%), Gaps = 34/294 (11%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKE 73
K ++F +LGEG F V + + AIK L+
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54
Query: 74 WLTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKI 133
E + +L H VKL + + + G L ++ + +
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFY 113
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
++ L +LH +I+RDLK N+LL+ + + +++DFG A+ + V
Sbjct: 114 TAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT Y +PE + SD+++ G ++ +L++G PF
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP-------------------PFRA 212
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307
+ ++ +L + +K +V + L +D R ++
Sbjct: 213 GNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 3e-53
Identities = 62/325 (19%), Positives = 113/325 (34%), Gaps = 35/325 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V + + +G V K + E+ + QL H
Sbjct: 36 ELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 86
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
L+ L + +L+ EF+ G L + + +S + GL +H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 148 DANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
+ ++++ D+K N++ ++ + K+ DFGLA + T +AAPE V
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVD 201
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
+ +D+++ GV+ LLSG + L + V R
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPF--------------AGEDDLETLQNVKRCDWEF 247
Query: 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAKLHH 323
+S +A + L +P+ R ++ D L L+ H ++ P ++ +
Sbjct: 248 DEDAFSSVSPEAK-DFIKNLLQKEPRKRLTVHDALEHPWLKGDH--SNLTSRIPSSRYNK 304
Query: 324 HHHHHNHHQGIKHTNPPRKTSITNS 348
P I N
Sbjct: 305 IRQKIKEKYADWPAPQPAIGRIANF 329
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 172 bits (437), Expect = 2e-52
Identities = 65/289 (22%), Positives = 122/289 (42%), Gaps = 36/289 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG---HKEWLTEVIYLGQL 84
+LG GG V VA+K L+A+ + + + E L
Sbjct: 14 ILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 64
Query: 85 RHENLVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARG 140
H +V + +V E++ +L + + + P++ +++ D +
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRAIEVIADACQA 123
Query: 141 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYA 199
L+F H +I+RD+K +N+++ + K+ DFG+AR +G++ + ++GT Y
Sbjct: 124 LNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259
+PE + +SDVYS G VL E+L+G D + V A +R+
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDPIPP 234
Query: 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLH 307
L + + AVVL+ L +P+NR + ++ L ++H
Sbjct: 235 SARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 4e-50
Identities = 62/333 (18%), Positives = 121/333 (36%), Gaps = 52/333 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G FG V + + S K +K + E+ L RH
Sbjct: 12 DLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHR 61
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
N++ L + ++++EF+ + + S ++ V V L FLH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH-- 119
Query: 148 DANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
N+ + D++ N++ + ++ K+ +FG AR GDN + + Y APE
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQ 176
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL--RIMD 263
++ +D++S G ++ LLSG PFL ++ + + IM+
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGIN-------------------PFLAETNQQIIENIMN 217
Query: 264 TRLG--GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT------SLEQLHTSKDMPRT 315
+ K+ + V + L + K+R + + L +E++ T
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK------ 271
Query: 316 PPPAKLHHHHHHHNHHQGIKHTNPPRKTSITNS 348
H ++H + + + S +
Sbjct: 272 VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGA 304
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-49
Identities = 63/277 (22%), Positives = 104/277 (37%), Gaps = 37/277 (13%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE----WLTEVIYLGQ 83
+LG+G FG VF + AIK LK + + + + +
Sbjct: 9 MLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 59
Query: 84 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSF 143
H L + +N V E++ G L H+ +S A ++ GL F
Sbjct: 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQF 118
Query: 144 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
LH ++YRDLK N+LLD + + K++DFG+ ++ GD GT Y APE
Sbjct: 119 LH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174
Query: 204 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD 263
+ D +SFGV+L E+L G+ PF L
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQS-------------------PFHGQDEEELFHSI 215
Query: 264 TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
Y + + ++++ +P+ R + +
Sbjct: 216 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 5e-49
Identities = 73/308 (23%), Positives = 114/308 (37%), Gaps = 31/308 (10%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-----WLTEVIYLG 82
LGEG F V+K + +VAIK++K K+ L E+ L
Sbjct: 5 FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 83 QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLS 142
+L H N++ L+ N LV++FM LE + + ++ + +GL
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 114
Query: 143 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 202
+LH +++RDLK +N+LLD N KL+DFGLA+ G T V TR Y APE
Sbjct: 115 YLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPE 170
Query: 203 YVATGHL-TPKSDVYSFGVVLLELLSGRRALDED---------RGGLAEQTLVEWADPFL 252
+ + D+++ G +L ELL L D L T +W D
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSK 310
+ + ++ +P R + L
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290
Query: 311 DMPRTPPP 318
+ P P
Sbjct: 291 PGCQLPRP 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 9e-49
Identities = 77/316 (24%), Positives = 129/316 (40%), Gaps = 30/316 (9%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH-KEWLTEVIYLGQLRH 86
+GEG +G V + + + VAIK++ Q + + L E+ L + RH
Sbjct: 15 YIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSV--QPISWPTRVKIAIDVARGLSFL 144
EN++ + + ++ + L++ + Q +S + RGL ++
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 145 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEY 203
H ANV++RDLK SN+LL++ + K+ DFGLAR P D+T T V TR Y APE
Sbjct: 126 H--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 204 VATGHL-TPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLVEWADP 250
+ T D++S G +L E+LS R + G +++ L +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHT 308
R+ L + + ++ + L +P R + L LEQ +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 309 SKDMPRTPPPAKLHHH 324
D P P K
Sbjct: 304 PSDEPIAEAPFKFDME 319
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 2e-48
Identities = 62/293 (21%), Positives = 112/293 (38%), Gaps = 46/293 (15%)
Query: 20 TKNFCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE-W 74
++ Y +LG G F V + +VAIK + ++ +G +
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSM 54
Query: 75 LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIA 134
E+ L +++H N+V L + L+ + + G L + + + ++
Sbjct: 55 ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLI 113
Query: 135 IDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVSTR 191
V + +LH D +++RDLK N+L D + +SDFGL++ D V +
Sbjct: 114 FQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLST 168
Query: 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251
GT GY APE +A + D +S GV+ LL G PF
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP-------------------PF 209
Query: 252 LRDSRRVL--RIM--DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
++ L +I+ + Y + + + + DP+ R + L
Sbjct: 210 YDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 160 bits (405), Expect = 1e-47
Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 58/302 (19%)
Query: 23 FCSDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---------Q 69
F +Y +LG G V + + A+K + +
Sbjct: 1 FYENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQE 51
Query: 70 GHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWP 128
+ L EV L ++ H N+++L + LV++ M KG L ++L +S
Sbjct: 52 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEK 110
Query: 129 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 188
KI + + LH N+++RDLK N+LLD + N KL+DFG + D
Sbjct: 111 ETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEK 165
Query: 189 STRIVGTRGYAAPEYVATGHL------TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242
+ GT Y APE + + D++S GV++ LL+G
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------ 213
Query: 243 TLVEWADPFLRDSRRVL--RIM--DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD 298
PF + ++ IM + + G + V +V + L + P+ R + +
Sbjct: 214 -------PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 266
Query: 299 VL 300
L
Sbjct: 267 AL 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (409), Expect = 3e-47
Identities = 64/282 (22%), Positives = 103/282 (36%), Gaps = 39/282 (13%)
Query: 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEV 78
+F ++G GGFG V+ K +G + A+K L + QG L E
Sbjct: 5 DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55
Query: 79 I---YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAI 135
I + +V + D + + M G L HL + S A
Sbjct: 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAA 114
Query: 136 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 195
++ GL +H + V+YRDLK +N+LLD + + ++SD GLA D VGT
Sbjct: 115 EIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 168
Query: 196 RGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254
GY APE + G +D +S G +L +LL G + + + +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 228
Query: 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 296
+ + +++ L D R
Sbjct: 229 PDSF----------------SPELRSLLEGLLQRDVNRRLGC 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 8e-46
Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 31/290 (10%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVI---YLGQ 83
+GEG +G VFK +N G VA+KR++ ++ + + EV +L
Sbjct: 15 IGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 84 LRHENLVKLIGYCSESDNR-----LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVA 138
H N+V+L C+ S LV+E + + + T + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
RGL FLH V++RDLK N+L+ S+ KL+DFGLAR T +V T Y
Sbjct: 127 RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWY 181
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVEWADPFLRDSRR 257
APE + D++S G + E+ + + L P D R
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 258 VLRIMDTRLGGQYSKKEAQAVAAV-------VLQCLHMDPKNRPSMVDVL 300
+ + + ++ + V + +L+CL +P R S L
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 1e-45
Identities = 52/287 (18%), Positives = 95/287 (33%), Gaps = 32/287 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+G G FG ++ G T +G VAIK ++ H + E ++
Sbjct: 14 KIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGG 62
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+ I +C + ++ + SLE+ + S T + +A + + ++H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-- 120
Query: 148 DANVIYRDLKASNVL---LDSNFNAKLSDFGLAR-----DGPTGDNTHVSTRIVGTRGYA 199
N I+RD+K N L + DFGLA+ + + GT YA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 259
+ + + D+ S G VL+ G + Q ++ + VL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 260 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
K A + C + ++P + L
Sbjct: 241 C-----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (392), Expect = 3e-45
Identities = 68/280 (24%), Positives = 113/280 (40%), Gaps = 47/280 (16%)
Query: 25 SDY----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE---WLTE 77
D+ LG G FG V +G A+K LK E K+ E
Sbjct: 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54
Query: 78 VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDV 137
+ L + H ++++ G ++ ++ +++ G L R Q P A +V
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEV 113
Query: 138 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
L +LH ++IYRDLK N+LLD N + K++DFG A+ P T + GT
Sbjct: 114 CLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPD 166
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257
Y APE V+T D +SFG+++ E+L+G PF +
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT-------------------PFYDSNTM 207
Query: 258 VL--RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 295
+I++ L ++ + V ++ + + D R
Sbjct: 208 KTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLG 245
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-44
Identities = 63/307 (20%), Positives = 116/307 (37%), Gaps = 44/307 (14%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW------LTEVIYL 81
LG G F V K + +G+ A K +K + + EV L
Sbjct: 17 ELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 82 GQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
+++H N++ L + +L+ E + G L + L + ++ + + G+
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGV 126
Query: 142 SFLHGLDANVIYRDLKASNVLLDSN----FNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 197
+LH + + DLK N++L K+ DFGLA G+ I GT
Sbjct: 127 YYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257
+ APE V L ++D++S GV+ LLSG D +++
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---------------KQETLA 226
Query: 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPR- 314
+ ++ +Y + + + L DPK R ++ D L ++ T + +
Sbjct: 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSA 286
Query: 315 -TPPPAK 320
+ P +
Sbjct: 287 WSHPQFE 293
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-44
Identities = 63/308 (20%), Positives = 117/308 (37%), Gaps = 56/308 (18%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKE------WLTEVIYL 81
LLG GGFG V+ G + + VAIK ++ + E EV+ L
Sbjct: 11 LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 82 GQLR--HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
++ +++L+ + D+ +L+ E + V
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
+ H + V++RD+K N+L+D N KL DFG V T GTR Y
Sbjct: 122 AVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVY 175
Query: 199 AAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257
+ PE++ + + V+S G++L +++ G PF D
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI-------------------PFEHDE-- 214
Query: 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT-SKDMPRTP 316
I+ ++ + ++ + ++ CL + P +RP+ ++ H +D+
Sbjct: 215 --EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN-----HPWMQDVLLPQ 265
Query: 317 PPAKLHHH 324
A++H H
Sbjct: 266 ETAEIHLH 273
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-43
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 24/285 (8%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLR 85
+GEG +G V+K +G VVA+K+++ ++ + E+ L +L
Sbjct: 9 KIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
H N+VKL+ + LV+EF+ + + ++ I P + +GL+F H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
V++RDLK N+L+++ KL+DFGLAR + +V A +
Sbjct: 120 --SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLG 176
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDED----------RGGLAEQTLVEWADPFLRDS 255
+ + D++S G + E+++ R D R +V + D
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ + + + +++ Q LH DP R S L
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-43
Identities = 55/298 (18%), Positives = 110/298 (36%), Gaps = 44/298 (14%)
Query: 17 KIATKNFCSDY-----LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGH 71
+I DY +LG G G V + + A+K L+
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQ-----DC 48
Query: 72 KEWLTEV-IYLGQLRHENLVKLIGYC----SESDNRLLVYEFMPKGSLENHLF-RSVQPI 125
+ EV ++ + ++V+++ + L+V E + G L + + R Q
Sbjct: 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 126 SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPT 182
+ +I + + +LH N+ +RD+K N+L S KL+DFG A++ +
Sbjct: 109 TEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166
Query: 183 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 242
++ T Y APE + D++S GV++ LL G + G
Sbjct: 167 HNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP 223
Query: 243 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ + +R+ + ++ V ++ L +P R ++ + +
Sbjct: 224 GM-----------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (375), Expect = 5e-43
Identities = 45/289 (15%), Positives = 88/289 (30%), Gaps = 34/289 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
+GEG FG +F+G T + VAIK S + E L
Sbjct: 12 RIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGC 60
Query: 88 NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL 147
+ + Y + ++ + SLE+ L + S T A + + +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-- 118
Query: 148 DANVIYRDLKASNVLLDSNFN-----AKLSDFGLAR-----DGPTGDNTHVSTRIVGTRG 197
+ +++YRD+K N L+ + + DFG+ + + GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 198 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257
Y + + + D+ + G V + L G + +Q + R
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306
L + + ++ P + ++
Sbjct: 239 ELC-----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-42
Identities = 69/283 (24%), Positives = 108/283 (38%), Gaps = 36/283 (12%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW-- 74
K+ +F LLG+G FG V + +G A+K L+ E E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51
Query: 75 -LTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKI 133
+TE L RH L L D V E+ G L HL R + +
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFY 110
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 193
++ L +LH +V+YRD+K N++LD + + K++DFGL ++G + T
Sbjct: 111 GAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFC 166
Query: 194 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253
GT Y APE + D + GVV+ E++ GR PF
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL-------------------PFYN 207
Query: 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 296
L + ++ + + +++ L DPK R
Sbjct: 208 QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-42
Identities = 64/298 (21%), Positives = 118/298 (39%), Gaps = 38/298 (12%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG--HKEWLTEVIYLGQLRH 86
+G+G FG VFK +G VA+K++ E+ + L E+ L L+H
Sbjct: 18 IGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 87 ENLVKLIGYCSESDNR--------LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVA 138
EN+V LI C + LV++F + + ++ +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-LVKFTLSEIKRVMQMLL 127
Query: 139 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS--TRIVGTR 196
GL ++H +++RD+KA+NVL+ + KL+DFGLAR N+ + T V T
Sbjct: 128 NGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 197 GYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDR------------GGLAEQT 243
Y PE + P D++ G ++ E+ + + + G + +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA-VVLQCLHMDPKNRPSMVDVL 300
+ L + +++ ++ + A ++ + L +DP R D L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (366), Expect = 8e-42
Identities = 58/284 (20%), Positives = 109/284 (38%), Gaps = 26/284 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRH 86
+GEG +G V+K + G A+K+++ E + E+ L +L+H
Sbjct: 10 IGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
N+VKL +LV+E + L+ L + T + + G+++ H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 206
D V++RDLK N+L++ K++DFGLAR + IV A + +
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGS 175
Query: 207 GHLTPKSDVYSFGVVLLELLSGRRALDEDRG---------GLAEQTLVEWADPF-LRDSR 256
+ D++S G + E+++G L W + L
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ + + K ++ ++ + L +DP R + L
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 1e-40
Identities = 66/316 (20%), Positives = 117/316 (37%), Gaps = 39/316 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
++G G FG V++ SG +VAIK++ Q + E+ + +L H
Sbjct: 27 VIGNGSFGVVYQA---------KLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHC 73
Query: 88 NLVKLIGYCSESDNR------LLVYEFMPKGSLEN--HLFRSVQPISWPTRVKIAIDVAR 139
N+V+L + S + LV +++P+ H R+ Q + + R
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 198
L+++H + +RD+K N+LLD + KL DFG A+ + I
Sbjct: 134 SLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYR 189
Query: 199 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258
A T DV+S G VL ELL G+ D G +++ R+ R
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 259 L----------RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQL 306
+ +I + + A+ + L P R + ++ ++L
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
Query: 307 HT-SKDMPRTPPPAKL 321
+ +P L
Sbjct: 310 RDPNVKLPNGRDTPAL 325
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-39
Identities = 66/286 (23%), Positives = 108/286 (37%), Gaps = 28/286 (9%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRH 86
+GEG +G VFK + +VA+KR++ + L E+ L +L+H
Sbjct: 10 IGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 87 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG 146
+N+V+L LV+EF + + + + + +GL F H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH- 118
Query: 147 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-YVA 205
NV++RDLK N+L++ N KL++FGLAR + + V T Y P+
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFG 175
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRG----------GLAEQTLVEWADPF-LRD 254
+ D++S G + EL + R L L T +W L D
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 300
+ T K ++ L +P R S + L
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-39
Identities = 61/313 (19%), Positives = 125/313 (39%), Gaps = 40/313 (12%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AESFQGHKEWLTEVIYLGQLR 85
+G G +G V +G VAIK+L +S K E+ L +R
Sbjct: 25 PVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 86 HENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
HEN++ L+ + + LV FM G+ L + + + + + +
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH-EKLGEDRIQFLVYQMLK 132
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
GL ++H A +I+RDLK N+ ++ + K+ DFGLAR ++ ++ +V A
Sbjct: 133 GLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRA 186
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLVEW 247
+ T D++S G ++ E+++G+ + + + G + +
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
Query: 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQ 305
++ + L ++ + + ++ + L +D + R + + L E
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
Query: 306 LHTSKDMPRTPPP 318
LH ++D P+
Sbjct: 307 LHDTEDEPQVQKY 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 4e-37
Identities = 61/269 (22%), Positives = 99/269 (36%), Gaps = 39/269 (14%)
Query: 29 LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEW---LTEVIYLGQLR 85
LG G FG V SG A+K L + K+ L E L +
Sbjct: 49 LGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 86 HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLH 145
LVKL ++ N +V E++ G + +HL R S P A + +LH
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH 158
Query: 146 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 205
++IYRDLK N+L+D +++DFG A+ T + GT APE +
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIIL 211
Query: 206 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 265
+ D ++ GV++ E+ +G PF D +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP-------------------PFFADQPIQIYEKIVS 252
Query: 266 LGGQYSKKEAQAVAAVVLQCLHMDPKNRP 294
++ + + ++ L +D R
Sbjct: 253 GKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (324), Expect = 3e-35
Identities = 51/297 (17%), Positives = 104/297 (35%), Gaps = 45/297 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-H 86
LG G + VF+ + V +K LK K+ E+ L LR
Sbjct: 42 KLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKILENLRGG 89
Query: 87 ENLVKLIGYCSESDNRL--LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFL 144
N++ L + +R LV+E + + Q ++ ++ + L +
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYC 145
Query: 145 HGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 203
H +++RD+K NV++D + +L D+GLA G V +R + PE
Sbjct: 146 H--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPEL 200
Query: 204 VAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV------EWADPFLRDSR 256
+ D++S G +L ++ + + + E ++
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 257 RVLRIMDTRLGGQYSKKEAQAVAA-------------VVLQCLHMDPKNRPSMVDVL 300
L + G++S+K + + + L D ++R + + +
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-33
Identities = 66/310 (21%), Positives = 122/310 (39%), Gaps = 36/310 (11%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK--AESFQGHKEWLTEVIYLGQLR 85
+G G +G V + +G+ VA+K+L +S K E+ L ++
Sbjct: 25 PVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 86 HENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGL 141
HEN++ L+ + + + + G+ N++ + Q ++ + + RGL
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGL 134
Query: 142 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 201
++H A++I+RDLK SN+ ++ + K+ DFGLAR +V+TR A
Sbjct: 135 KYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW----YRAPE 188
Query: 202 EYVATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRGGLAEQTLVEWAD 249
+ H D++S G ++ ELL+GR + + G + L + +
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLH 307
R+ + L M ++ + L +D R + L Q H
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
Query: 308 TSKDMPRTPP 317
D P P
Sbjct: 309 DPDDEPVADP 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-33
Identities = 71/291 (24%), Positives = 115/291 (39%), Gaps = 40/291 (13%)
Query: 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLK----AESFQGHK 72
K+ +NF +LG G +G VF + +G + A+K LK + + +
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVR------KISGHDTGKLYAMKVLKKATIVQKAKTTE 73
Query: 73 EWLTEVIYLGQLRHE-NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRV 131
TE L +R LV L L+ +++ G L HL + + +
Sbjct: 74 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQ 132
Query: 132 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 191
++ L LH +IYRD+K N+LLDSN + L+DFGL+++ + +
Sbjct: 133 IYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYD 189
Query: 192 IVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249
GT Y AP+ V G D +S GV++ ELL+G
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS------------------- 230
Query: 250 PFLRDSRR--VLRIMDTRLGGQ--YSKKEAQAVAAVVLQCLHMDPKNRPSM 296
PF D + I L + Y ++ + ++ + L DPK R
Sbjct: 231 PFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-32
Identities = 63/324 (19%), Positives = 117/324 (36%), Gaps = 51/324 (15%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE--SFQGHKEWLTEVIYLGQLR 85
+G G G V + VAIK+L + K E++ + +
Sbjct: 24 PIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 86 HENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVAR 139
H+N++ L+ + E + LV E M + + + +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLC 130
Query: 140 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 199
G+ LH A +I+RDLK SN+++ S+ K+ DFGLAR T + + T V TR Y
Sbjct: 131 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 200 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS---- 255
APE + D++S G ++ E++ + ++E +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 256 -------------------RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 296
++ +++K +A ++ + L +DP R S+
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 297 VDVLTS--LEQLHTSKDMPRTPPP 318
D L + + ++ PP
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQ 329
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 2e-29
Identities = 55/318 (17%), Positives = 109/318 (34%), Gaps = 56/318 (17%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHE 87
LG G F V+ + VA+K ++ + + E+ L ++
Sbjct: 20 KLGWGHFSTVWLAK---------DMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDA 69
Query: 88 NLVKLIGYCSESDNRLLVY---------------EFMPKGSLENHLFRSVQPISWPTRVK 132
+ K + +LL + E + + L + I +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 133 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTR 191
I+ + GL ++H +I+ D+K NVL++ L +A G T
Sbjct: 130 ISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 192 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR----------ALDEDRGGLAE 241
+ TR Y +PE + +D++S ++ EL++G D+D
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 242 QTLVEWADPFLRDSRRVLRIMDTR-------------------LGGQYSKKEAQAVAAVV 282
+ L E LR+ + ++R ++SK EA+ ++ +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 283 LQCLHMDPKNRPSMVDVL 300
L +DP+ R ++
Sbjct: 309 SPMLQLDPRKRADAGGLV 326
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.4 bits (174), Expect = 3e-15
Identities = 23/166 (13%), Positives = 44/166 (26%), Gaps = 35/166 (21%)
Query: 28 LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES----------FQGHKEWLTE 77
L+GEG VF +K K G +
Sbjct: 7 LMGEGKESAVFNC----------YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56
Query: 78 VIYLGQLRHENLVKLIGYCS----ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKI 133
I + L KL G + ++ E + L ++
Sbjct: 57 AIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEV 108
Query: 134 AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179
+ ++ + +++ DL NVL+ + DF + +
Sbjct: 109 LDMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 349 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.29 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.14 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.23 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.52 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=388.37 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=214.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
++|++.+.||+|+||+||+| .+..+|+.||||++........+.+.+|+.++++++||||+++++++..++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a---------~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEE---------EBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccEEEEEEecCcCcEEEEE---------EECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 58999999999999999999 566678999999998766666778999999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..|+||||+++++|.+++.+ ..+++..+..++.||+.||.||| ++||+||||||+||+++.++.+||+|||++...
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH--HCCCcccCCcHHHeEECCCCcEeeccchhheee
Confidence 99999999999999998754 56999999999999999999999 899999999999999999999999999999865
Q ss_pred CCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR 260 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (349)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 167 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-------------- 230 (293)
T d1yhwa1 167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------------- 230 (293)
T ss_dssp CSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------
T ss_pred ccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh--------------
Confidence 33322 22335799999999999999999999999999999999999999976543222111111
Q ss_pred hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 261 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..+++++.+||.+||+.||++|||+.++++|
T Consensus 231 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 231 --NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp --HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred --CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111223445678899999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=385.87 Aligned_cols=254 Identities=26% Similarity=0.335 Sum_probs=208.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
++|++.+.||+|+||.||+| .+..+|+.||||++..... ...+.+.+|+.++++++||||+++++++.++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~ 75 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG 75 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred cceEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence 58999999999999999999 5556689999999866533 2345688999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..|+||||+++++|.+++. ....+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||++..
T Consensus 76 ~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH--~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~ 152 (271)
T d1nvra_ 76 NIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATV 152 (271)
T ss_dssp TEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ceeEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH--HcCCccCcccHHHEEECCCCCEEEccchhhee
Confidence 99999999999999999984 4468999999999999999999999 89999999999999999999999999999986
Q ss_pred CCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
..............||+.|+|||++.+..+ +.++|||||||++|+|++|..||..............
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~------------ 220 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK------------ 220 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH------------
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHh------------
Confidence 543333333344679999999999988776 5789999999999999999999976553222211111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...........+++++.+||.+||+.||++|||+.++++|
T Consensus 221 ----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 221 ----EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ----TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111112234567889999999999999999999999874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=380.66 Aligned_cols=248 Identities=25% Similarity=0.422 Sum_probs=211.3
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
-++|++.+.||+|+||+||+| .+..+++.||+|++.... ......+.+|+.++++++||||+++++++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 75 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 75 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEE---------EECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 368999999999999999999 555668999999986542 23456788999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.+++..|+||||+++++|.+++.+. ..+++..+..++.||++||+||| +++|+||||||+||+++.++.+||+|||+
T Consensus 76 ~~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 76 HDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred EECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeeeeeeccccceecCCCCEeecccce
Confidence 9999999999999999999999654 67999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~---------- 218 (263)
T d2j4za1 153 SVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR---------- 218 (263)
T ss_dssp CSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT----------
T ss_pred eeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc----------
Confidence 97543322 2235689999999999999999999999999999999999999976543222211111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.....+..+++++.+||.+||+.||++|||+.++++|
T Consensus 219 ---------~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 219 ---------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---------TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---------CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1122345678899999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=386.48 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=212.9
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecCC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSESD 100 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 100 (349)
+.|++++.||+|+||.||+| .+..+++.||+|++........+.+.+|+.++++++||||+++++++.+++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cCeEEeEEEeeCCCcEEEEE---------EECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 46899999999999999999 555668999999997766666678889999999999999999999999999
Q ss_pred ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccC
Q 018891 101 NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 180 (349)
Q Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~ 180 (349)
..++||||+++++|.+++.+....+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||++...
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH--~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 999999999999999998766678999999999999999999999 899999999999999999999999999998643
Q ss_pred CCCCCCccccceecCCcccCccccc-----cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 181 PTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
... ........|++.|+|||++. +..|+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 161 ~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~-------- 230 (288)
T d2jfla1 161 TRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS-------- 230 (288)
T ss_dssp HHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS--------
T ss_pred CCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--------
Confidence 211 11122357899999999984 456889999999999999999999999876543333222221
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.......+..+++++.+||.+||+.||++|||+.++++|
T Consensus 231 --------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 231 --------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223345678899999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-54 Score=376.44 Aligned_cols=264 Identities=28% Similarity=0.407 Sum_probs=210.0
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
+..++|++.+.||+|+||+||+|.++ ..||||++.... ....+.+.+|+.++++++||||++++++
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~ 72 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence 34578999999999999999999543 249999986543 3345778899999999999999999998
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+.+ +..++||||+++++|.+++......+++..+..++.|+++||+||| +++|+||||||+||+++.++.+||+|||
T Consensus 73 ~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH--~~~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 73 STA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp ECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred Eec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh--cCCEeccccCHHHEEEcCCCCEEEcccc
Confidence 754 5789999999999999999776678999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCcccccc---CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
++................||+.|+|||++.+ ..++.++|||||||++|+|+||..||.+.+..........
T Consensus 150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~------ 223 (276)
T d1uwha_ 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG------ 223 (276)
T ss_dssp CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH------
T ss_pred ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh------
Confidence 9976544333333344678999999999864 3578899999999999999999999987654222211111
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
...........+.++++++.+|+.+||+.||++|||+.+++++|+.+.++
T Consensus 224 -------~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 224 -------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -------HTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------cCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 00011111123456778999999999999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-54 Score=382.77 Aligned_cols=255 Identities=20% Similarity=0.285 Sum_probs=211.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
..++|++++.||+|+||.||+| .+..+++.||||++.... ......+.+|+.++++++||||++++++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~ 76 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 76 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEE
Confidence 3478999999999999999999 555668999999986543 2344678899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+.+++..|+||||+++++|.+++... +.+++..++.++.|++.||+||| +++|+||||||+||++++++.++|+|||
T Consensus 77 ~~~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 77 FQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhc--cccEEcCcCCccccccCCCceEEecccc
Confidence 99999999999999999999988554 78999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
++................||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--------- 224 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--------- 224 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT---------
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc---------
Confidence 99875544433333446799999999999999999999999999999999999999976543222211111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
. ....+..+++++.+||.+||+.||++|||++|++++-+
T Consensus 225 --------~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 225 --------L--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp --------T--CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred --------C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 1 12234567889999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=377.56 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=199.2
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++|++.+.||+|+||.||+| .+..+|+.||+|.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 73 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 73 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEE
T ss_pred chhCEEeEEEecCCCeEEEEE---------EECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 368999999999999999999 5566789999999876532 33466889999999999999999999885
Q ss_pred c--CCceEEEEEeCCCCChHHHHhc---cCCCCChHHHHHHHHHHHHHHHHHhcCCCC-----eeeccCCCCcEEEcCCC
Q 018891 98 E--SDNRLLVYEFMPKGSLENHLFR---SVQPISWPTRVKIAIDVARGLSFLHGLDAN-----VIYRDLKASNVLLDSNF 167 (349)
Q Consensus 98 ~--~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~-----i~H~di~~~Nilv~~~~ 167 (349)
+ ++.+|+||||+++++|.+++.+ ....+++..++.++.|++.||.||| +.+ |+||||||+||+++.++
T Consensus 74 ~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH--~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--RRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp C----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HHCC---------CCGGGEEECTTS
T ss_pred eCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HhcCCCCCEEeCcCchhhcCcCCCC
Confidence 4 4568999999999999999864 3467999999999999999999999 554 99999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 152 ~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~- 228 (269)
T d2java1 152 NVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE- 228 (269)
T ss_dssp CEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-
T ss_pred cEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-
Confidence 999999999986533222 22235789999999999999999999999999999999999999976543222211111
Q ss_pred hchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
......+..+++++.+||.+||+.||++|||+.++++|
T Consensus 229 -----------------~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 229 -----------------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11123455678899999999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=372.06 Aligned_cols=258 Identities=28% Similarity=0.421 Sum_probs=206.4
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.++++++||||+++++++..+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 478999999999999999999653 25679999997643 3456789999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++++|.+++......+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||++..
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh--ccceeecccchhheeecCCCCeEecccchhee
Confidence 9999999999999999999777678999999999999999999999 89999999999999999999999999999976
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhC-CccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
....... ......|++.|+|||++.+..++.++||||||+++|+|+|+ ..||...+.......
T Consensus 151 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~--------------- 214 (263)
T d1sm2a_ 151 VLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------------- 214 (263)
T ss_dssp ---------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH---------------
T ss_pred ccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH---------------
Confidence 4333222 12235688999999999999999999999999999999995 444543332111111
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
+....+...+..+++++.+|+.+||+.||++|||+++++++|+++.++
T Consensus 215 ---i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 215 ---ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ---HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 111222334556678899999999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-53 Score=376.11 Aligned_cols=266 Identities=27% Similarity=0.415 Sum_probs=209.6
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||+|+||+||+|.+.. .......||||.+..... ...+.+.+|+.+|++++||||+++++++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKL------PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeC------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 335789999999999999999996542 122345789998865433 3456789999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
...+..++||||+++++|.+++......+++.++..++.|+++||.||| +++++||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFGl 174 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGL 174 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh--hCCCccCccccceEEECCCCcEEECCccc
Confidence 9999999999999999999998776678999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccc---cceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhh
Q 018891 177 ARDGPTGDNTHVS---TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 177 ~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
+............ ....+++.|+|||.+.++.++.++|||||||++|+|+| |..||.+........
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~---------- 244 (299)
T d1jpaa_ 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVIN---------- 244 (299)
T ss_dssp ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----------
T ss_pred ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHH----------
Confidence 9765433222111 12357889999999999999999999999999999998 899997655322211
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.+....+...+.++++.+.+|+.+||+.||++|||+.++++.|+++.++
T Consensus 245 --------~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 245 --------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --------HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1112223345567788999999999999999999999999999988654
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-54 Score=385.88 Aligned_cols=273 Identities=25% Similarity=0.337 Sum_probs=212.8
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||+|+||+||+| .+..+|+.||+|+++.... .....+.+|+.+|++++||||++++++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 73 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEE---------EETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 45789999999999999999999 5556789999999876533 3346788999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCC-CCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~-~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
.+.+..|+||||+++++|.+++.+. ..+++..+..++.|++.||.||| + ++|+||||||+||+++.++.+||+|||
T Consensus 74 ~~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH--~~~~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 74 YSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HHHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--HhCCEEccccCHHHeeECCCCCEEEeeCC
Confidence 9999999999999999999999654 67999999999999999999999 6 489999999999999999999999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc------
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD------ 249 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~------ 249 (349)
++....... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.............
T Consensus 151 la~~~~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 151 VSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp CCHHHHHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CccccCCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 997532221 1235799999999999999999999999999999999999999977554322111110000
Q ss_pred -------------------hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 018891 250 -------------------PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQL 306 (349)
Q Consensus 250 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~ 306 (349)
+........................+.++.+||.+||+.||++|||+.|+++| +++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00000001111111111111112356789999999999999999999999986 5443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.5e-53 Score=384.37 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=215.2
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
-++|++.+.||+|+||.||+| .+..+|+.||||++........+.+.+|+.+|++++||||+++++++.++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~---------~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 95 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 95 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEE---------EETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET
T ss_pred ccCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 368999999999999999999 55567899999999877666677889999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC--CCcEEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS--NFNAKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~--~~~v~l~Dfg~~ 177 (349)
+..|+||||++|++|.+++.+....+++..+..++.||+.||.||| +++++||||||+||+++. ++.+||+|||++
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH--hcCCeeeeechhHeeeccCCCCeEEEeecchh
Confidence 9999999999999999999766678999999999999999999999 899999999999999964 678999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 174 ~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------- 240 (350)
T d1koaa2 174 AHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC---------- 240 (350)
T ss_dssp EECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred eeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC----------
Confidence 8643322 223367899999999999999999999999999999999999999766533222222211
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...........+++++.+||.+||+.||++|||+.++++|
T Consensus 241 -----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 241 -----DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -----CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -----CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111122234567889999999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.8e-53 Score=384.40 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=216.1
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|++.+.||+|+||.||+| .+..+|+.||||++..........+.+|+.+|++++||||++++++|.++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred ccceEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 468999999999999999999 55667899999999876656667788999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc--CCCcEEEeccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD--SNFNAKLSDFGLA 177 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~--~~~~v~l~Dfg~~ 177 (349)
+..|+||||++|++|.+++.....++++.+++.++.||+.||.||| ++||+||||||+|||++ .++.+||+|||++
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH--~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla 176 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSTTCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeecccccccccccccCCCeEEEeecccc
Confidence 9999999999999999988776678999999999999999999999 89999999999999997 6789999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~----------- 242 (352)
T d1koba_ 177 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR----------- 242 (352)
T ss_dssp EECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH-----------
T ss_pred eecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 8654332 22335789999999999999999999999999999999999999976554322222211
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
............+++++.+||.+||+.||++|||+.++++|
T Consensus 243 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 243 ----CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ----CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ----CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111223345678899999999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-53 Score=379.13 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=197.7
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+.++|++.+.||+|+||+||+| .+..+++.||||++...... ....+.+|+.++++++||||+++++++.
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEE---------EETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEE---------EECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4678999999999999999999 55566899999998765433 3355778999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc---CCCcEEEecc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSDF 174 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~---~~~~v~l~Df 174 (349)
+++..|+||||++|++|.+++.+ ...+++..+..++.||+.||+||| +++++||||||+||++. .++.+||+||
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH--~~~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred ECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhh--hceeeeEEecccceeecccCCCceEEEecc
Confidence 99999999999999999999955 468999999999999999999999 89999999999999995 4788999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+..
T Consensus 155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-------- 223 (307)
T d1a06a_ 155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-------- 223 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT--------
T ss_pred ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc--------
Confidence 9997543322 22335799999999999999999999999999999999999999976543222222211
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.........+.++++++.+||.+||+.||++|||+.|+++|
T Consensus 224 -------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 224 -------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -------cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111223345678899999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7e-53 Score=372.91 Aligned_cols=262 Identities=26% Similarity=0.408 Sum_probs=218.5
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||+||+|.+ ..+++.||||+++... ...+.+.+|+.++++++||||+++++++.
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~---------~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVW---------KKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEE---------GGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEE---------CCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 4567999999999999999999954 4457899999987653 34567899999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhc-cCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFR-SVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
+++..++||||+++++|.+++.. ....+++..+..++.|+++||+||| +++|+||||||+|||+++++.+||+|||+
T Consensus 84 ~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 84 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred eCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH--HCCcccCccccCeEEECCCCcEEEccccc
Confidence 99999999999999999999865 3467899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+....... ........+++.|+|||++.++.++.++|||||||++|+|++|..||.......
T Consensus 162 a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~----------------- 223 (287)
T d1opja_ 162 SRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------- 223 (287)
T ss_dssp TTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----------------
T ss_pred eeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-----------------
Confidence 97643322 222233467889999999999999999999999999999999777764322211
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.....+....+...+..+++++.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 224 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 11122223334455667888999999999999999999999999999987654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=378.02 Aligned_cols=263 Identities=29% Similarity=0.406 Sum_probs=216.4
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
..++|++.+.||+|+||+||+|.+.+. ........||+|.+.... ......+.+|+.+++++ +||||+++++++
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGI----SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESC----SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCC----CcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 447899999999999999999977543 233445679999886543 23456788999999998 899999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccC----------------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSV----------------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYR 154 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~ 154 (349)
...+..++||||+++++|.+++.+.. ..+++..++.++.|++.||+||| +++|+||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH--~~~IiHR 188 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHR 188 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH--HTTEEET
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH--hCCeeec
Confidence 99999999999999999999996542 34889999999999999999999 8999999
Q ss_pred cCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCc
Q 018891 155 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALD 233 (349)
Q Consensus 155 di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~ 233 (349)
||||+||+++.++.+||+|||++................||+.|+|||++.++.++.++|||||||++|+|++ |..||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999976544444434445678999999999999999999999999999999998 899997
Q ss_pred cccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 018891 234 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 304 (349)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 304 (349)
+.+....... .+....+...+..+++++.+||.+||+.||++|||+.+|+++|.
T Consensus 269 ~~~~~~~~~~-----------------~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYK-----------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHHHHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHH-----------------HHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 6554322221 12222334456677889999999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=363.74 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=217.0
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|++.+.||+|+||+||+|+++ ++..||||.++.... ..+.+.+|+.++++++||||+++++++.++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 479999999999999999999653 367899999876543 456789999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..++||||+++++|.+++......+++..+..++.|+++||+||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH--~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH--HTTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh--hcCcccccccceeEEEcCCCcEEECcchhhee
Confidence 9999999999999999998777778999999999999999999999 89999999999999999999999999999975
Q ss_pred CCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhH
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRV 258 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (349)
....... ......+++.|+|||.+.+..++.++||||||+++|+|+| |..||.+.+..+....+
T Consensus 150 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-------------- 214 (258)
T d1k2pa_ 150 VLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------- 214 (258)
T ss_dssp CSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--------------
T ss_pred ccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH--------------
Confidence 4433222 2223568889999999999999999999999999999998 89999766543222211
Q ss_pred hhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 018891 259 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 306 (349)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 306 (349)
....+...|..+++.+.+|+.+||+.||++|||+.+++++|.++
T Consensus 215 ----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 215 ----AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----HhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12223445566778999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=366.35 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=199.4
Q ss_pred ccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc--hhchHHHHHHHHHHhccCCCcccceeeEEec-
Q 018891 22 NFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES--FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE- 98 (349)
Q Consensus 22 ~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 98 (349)
.|++.+.||+|+||+||+| .+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 10 y~~~~~~iG~G~fg~Vy~~---------~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 80 (270)
T ss_dssp EEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred EEEeeeEEecCcCcEEEEE---------EECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence 4478889999999999999 555568899999986543 2344678899999999999999999999864
Q ss_pred ---CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCcEEEc-CCCcEEEe
Q 018891 99 ---SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDAN--VIYRDLKASNVLLD-SNFNAKLS 172 (349)
Q Consensus 99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~--i~H~di~~~Nilv~-~~~~v~l~ 172 (349)
...+|+||||+++++|.+++.+. ..+++..+..++.||+.||+||| +++ |+||||||+||+++ .++.+||+
T Consensus 81 ~~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH--~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 81 VKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLH--TRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred cccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHH--HCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 34579999999999999999654 67999999999999999999999 777 99999999999996 57899999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchh-hhHHhhhchh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWADPF 251 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~-~~~~~~~~~~ 251 (349)
|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....... ..+..
T Consensus 158 DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~----- 227 (270)
T d1t4ha_ 158 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS----- 227 (270)
T ss_dssp CTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-----
T ss_pred ecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-----
Confidence 99999753222 1223579999999998865 5999999999999999999999999754432211 11111
Q ss_pred hhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.......+...++++.+||.+||+.||++|||+.|+++|
T Consensus 228 ------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 228 ------------GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ------------TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------------CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 001111223456789999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-52 Score=368.93 Aligned_cols=262 Identities=27% Similarity=0.383 Sum_probs=215.8
Q ss_pred hcccCCcce-eeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYL-LGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~-lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++|.+.+. ||+|+||.||+|.++ ..+++..||||+++... ....+.+.+|+.++++++||||+++++++.
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~-------~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYR-------MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEe-------cCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 467888885 999999999999763 23346789999987543 334577899999999999999999999986
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
. +..++||||+++++|.+++......+++..+..++.|++.||+||| +++++||||||+||+++.++.+||+|||++
T Consensus 80 ~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 80 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp S-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred c-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--hCCeecCcCchhheeeccCCceeeccchhh
Confidence 5 5689999999999999998776678999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhh
Q 018891 178 RDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 178 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
........... .....|++.|+|||++.++.++.++|||||||++|+|+| |..||.+.+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~------------ 224 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------ 224 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH------------
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH------------
Confidence 86544332211 122457889999999999999999999999999999998 8999986654322211
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
+....+...+..+++++.+|+.+||+.||++|||+.++++.|+.+..+
T Consensus 225 ------i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 225 ------IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 122233455677889999999999999999999999999999876643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=374.43 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=213.2
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
-++|++++.||+|+||.||+| .+..+|+.||||++.... ......+.+|+.+|++++||||+++++++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~---------~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 74 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence 368999999999999999999 566678999999997543 23456788999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.+.+..|+||||++|++|.+++.+. ..+++..++.++.||+.||+||| +++|+||||||+||+++.+|.+||+|||+
T Consensus 75 ~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH--~~~iiHRDlKP~NILl~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 75 QTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGL 151 (337)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhh--hcCccccccCHHHeEecCCCCEEEeeccc
Confidence 9999999999999999999998654 67999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+....... .......||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+.+.......+..
T Consensus 152 a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~---------- 219 (337)
T d1o6la_ 152 CKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM---------- 219 (337)
T ss_dssp CBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------
T ss_pred ccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc----------
Confidence 98643322 223346799999999999999999999999999999999999999987653222211111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
.....|..+++++.+||.+||+.||.+|++ +.++++|
T Consensus 220 ---------~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 220 ---------EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---------CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---------CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 112345667889999999999999999994 8999886
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=367.06 Aligned_cols=269 Identities=26% Similarity=0.421 Sum_probs=213.1
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~ 95 (349)
++..+.|++.++||+|+||.||+|.++.. .......||||.+...... ....+.+|+.++++++||||++++++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTS-----SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCC-----CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 34567899999999999999999977542 2223467999998654333 34568899999999999999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 175 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg 175 (349)
+.+.+..++||||+.++++.+++......+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH--~~~iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc--ccccccCccccceEEECCCCeEEEcccc
Confidence 99999999999999999999988777788999999999999999999999 8999999999999999999999999999
Q ss_pred ccccCCCCCCCc-cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 176 LARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 176 ~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
++.......... ......|++.|+|||++.++.++.++|||||||++|+|+++..|+.......
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--------------- 220 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------------- 220 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---------------
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH---------------
Confidence 997643332211 1222457889999999999999999999999999999999766654322111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
.....+....+...+.++++.+.+|+.+||+.||++|||+.++++.|+++.+.
T Consensus 221 --~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 221 --EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp --HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11122223334455667888999999999999999999999999999988764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=370.00 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=210.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch------hchHHHHHHHHHHhccCCCcccce
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF------QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
..++|++.+.||+|+||.||+| .+..+|+.||||++..... ...+.+.+|+.++++++||||+++
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~---------~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~ 78 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 78 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEE---------EETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCEEEeEEEecCCCeEEEEE---------EECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcE
Confidence 3578999999999999999999 5556789999999865322 234678899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC----c
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF----N 168 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~----~ 168 (349)
++++.+.+..|+||||+++++|.+++.+. ..+++..++.++.|++.||+||| +.+++||||||+||+++.++ .
T Consensus 79 ~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH--~~~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 79 HEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp EEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSSSSCC
T ss_pred EEEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhh--hcceeecccccceEEEecCCCcccc
Confidence 99999999999999999999999999654 67999999999999999999999 89999999999999998876 4
Q ss_pred EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 169 AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 169 v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
+||+|||++........ .....+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 156 vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 232 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN 232 (293)
T ss_dssp EEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC
T ss_pred eEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999976543322 223568999999999999999999999999999999999999998655333222222110
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
. ......+..+++++.+||.+||+.||++|||+.++++|
T Consensus 233 ~---------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 Y---------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C---------------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---------------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011123456789999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=365.57 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=212.3
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.+++ +..||||++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~----------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNG----------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECC----------CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 356799999999999999999996542 5689999987543 34567899999999999999999999875
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
+ +..++||||+++++|.+++... ...+++..+..++.|+++||.||| +++|+||||||+||++++++.+||+|||+
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH--~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCccchhheeeecccceeeccccc
Confidence 4 5679999999999999987543 246999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCc-cccCcchhhhHHhhhchhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVEWADPFLRDS 255 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~ 255 (349)
+........ .......+++.|+|||++.++.++.++|||||||++|+|+||..|+. .......
T Consensus 156 a~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~--------------- 219 (272)
T d1qpca_ 156 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------------- 219 (272)
T ss_dssp CEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---------------
T ss_pred eEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH---------------
Confidence 986543322 11223467889999999999999999999999999999999666553 3222111
Q ss_pred hhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcC
Q 018891 256 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 309 (349)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 309 (349)
...+....+...+..+++++.+|+.+||+.||++|||+.++++.|+++.++
T Consensus 220 ---~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 220 ---IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 111222233445567788999999999999999999999999999998764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-52 Score=372.06 Aligned_cols=247 Identities=27% Similarity=0.365 Sum_probs=205.4
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..|++++.||+|+||.||+| .+..+++.||||++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEE---------EECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 45999999999999999999 5566689999999865432 23456889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+++..|+||||+.+++|..++. ...++++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a 162 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred ECCEEEEEEEecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHH--hCCEeccCCCcceEEECCCCCEEEeecccc
Confidence 9999999999999988876664 3478999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCcccccc---CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 254 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (349)
...... ....||+.|+|||++.+ +.|+.++|||||||++|+|++|..||.+.........+.
T Consensus 163 ~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~--------- 227 (309)
T d1u5ra_ 163 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--------- 227 (309)
T ss_dssp BSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---------
T ss_pred cccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------
Confidence 754322 22569999999999864 468899999999999999999999997654322111111
Q ss_pred hhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 255 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 228 --------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 228 --------QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp --------HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --------hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1111122234567899999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=362.42 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=207.8
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..++|++.+.||+|+||.||+|.+.. ....+..||||.+..... ...+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~------~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 78 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMS------PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 78 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC------C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEec------CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35799999999999999999997642 234467899999865433 34567889999999999999999999986
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
++..++||||+++++|.+++......+++..++.++.||++||.||| +++++||||||+||+++.++.+||+|||++
T Consensus 79 -~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 79 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred -cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc--ccCeeccccchhheeecCCCcEEEccchhh
Confidence 46789999999999999988777778999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 156 ~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~----------- 223 (273)
T d1mp8a_ 156 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE----------- 223 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-----------
T ss_pred eeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-----------
Confidence 76433222 12223467889999999999999999999999999999998 889997765433322221
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
.......+..+++.+.+||.+||+.||++|||+.+++++|+++.+
T Consensus 224 -------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 224 -------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 122234566788899999999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=362.24 Aligned_cols=252 Identities=29% Similarity=0.412 Sum_probs=205.4
Q ss_pred ceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEecCCceEE
Q 018891 27 YLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSESDNRLL 104 (349)
Q Consensus 27 ~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 104 (349)
+.||+|+||+||+|.+. ....++.||||+++.... ...+.+.+|+.++++++||||+++++++.. +..++
T Consensus 13 k~iG~G~fG~Vy~~~~~-------~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQ-------MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEE-------CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred CCcccCCCeEEEEEEEc-------cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence 47999999999999763 233568899999865432 234678999999999999999999999865 56799
Q ss_pred EEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCCC
Q 018891 105 VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 184 (349)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~ 184 (349)
||||+++++|.+++.+. ..+++..+..++.||+.||+||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 85 vmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH--~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHH--hCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 99999999999998554 67999999999999999999999 8999999999999999999999999999998654433
Q ss_pred CCcc-ccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhhHhhhh
Q 018891 185 NTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM 262 (349)
Q Consensus 185 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (349)
.... .....|++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+... .+
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~------------------~i 223 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA------------------ML 223 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH------------------HH
T ss_pred cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH------------------HH
Confidence 2221 222468899999999999999999999999999999998 899998655322211 11
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 263 DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
....+...+..+++++.+|+.+||+.||++|||+.++++.|+...
T Consensus 224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 222334556678899999999999999999999999998888764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-51 Score=367.53 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=210.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++.+.||+|+||+||+| .+..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a---------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 74 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEE---------EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence 68999999999999999999 555668999999986542 234567889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
+.+..|+||||++|++|..++... ..+++..+..++.||+.||+||| +++|+||||||+||+++.+|.+||+|||++
T Consensus 75 ~~~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 75 DAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eCCeeeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhc--cCcEEccccCchheeEcCCCCEEEecCccc
Confidence 999999999999999999988544 67899999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 152 ~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----------- 215 (316)
T d1fota_ 152 KYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------- 215 (316)
T ss_dssp EECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----------
T ss_pred eEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc-----------
Confidence 8654322 235799999999999999999999999999999999999999976543222221111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ....+..+++++.+++.+||..||.+|+ |++++++|
T Consensus 216 ------~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 216 ------A--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ------C--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------C--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1 1234456778899999999999999996 99999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-51 Score=363.93 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=208.2
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---chHHHHHHHHHHhccCCCccccee
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---GHKEWLTEVIYLGQLRHENLVKLI 93 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~ 93 (349)
..+.++|++.+.||+|+||.||+| .+..+++.||||++...... ....+.+|+.+++.++||||++++
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~ 73 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCccceeEEeEEEeeCCCeEEEEE---------EECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccc
Confidence 345789999999999999999999 55667899999999765332 345688999999999999999999
Q ss_pred eEEecCC----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 94 GYCSESD----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 94 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
+++...+ ..|+||||++|++|.+++... ..+++.++..++.||+.||+||| +.+++||||||+||+++.++.+
T Consensus 74 ~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH--~~~iiHrDiKP~NIll~~~~~~ 150 (277)
T d1o6ya_ 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAV 150 (277)
T ss_dssp EEEEEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTSCE
T ss_pred ceeeeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHH--hCCccCccccCcccccCccccc
Confidence 9987654 378999999999999988554 67999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCC-ccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 170 KLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
+++|||.+......... .......|++.|+|||++.+..++.++|||||||++|+|+||..||.+.+.......+...
T Consensus 151 ~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~- 229 (277)
T d1o6ya_ 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE- 229 (277)
T ss_dssp EECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-
T ss_pred eeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc-
Confidence 99999988654333221 2223357899999999999999999999999999999999999999765532222111110
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhh
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLH 307 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~ 307 (349)
..........++++++.++|.+||+.||.+|| |++++++.|.+++
T Consensus 230 --------------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 230 --------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --------------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --------------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00001112345678899999999999999998 8999999998875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=368.32 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=211.3
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
+.++|++++.||+|+||+||+| .+..+++.||+|.++.... ....+.+|+.+|+.++||||+++++++.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~---------~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~ 72 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFES 72 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEE---------EECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4578999999999999999999 5666789999999976543 34567899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC--CcEEEecccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGL 176 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~--~~v~l~Dfg~ 176 (349)
++..|+||||++|++|.+++.+....+++.+++.++.||+.||.||| +.+|+||||||+||+++.+ +.++|+|||+
T Consensus 73 ~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH--~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HcCCCcccccccceeecCCCceEEEEcccch
Confidence 99999999999999999999766568999999999999999999999 8999999999999999854 4799999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+...... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 151 ~~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~------ 221 (321)
T d1tkia_ 151 ARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT------ 221 (321)
T ss_dssp CEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------
T ss_pred hhccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------
Confidence 9764332 2233357899999999999999999999999999999999999999876543332222221100
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
........+++++.+||.+||..||++|||+.++++|
T Consensus 222 ---------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 222 ---------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112357789999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-51 Score=364.90 Aligned_cols=263 Identities=24% Similarity=0.382 Sum_probs=212.8
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
..+|++++.||+|+||+||+|.+... ......+||+|.+.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPE-----GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCC-----CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35799999999999999999965431 11223478999886543 3345778999999999999999999999986
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
+..+++++++.+++|.+++......+++..++.++.|++.||+||| +++|+||||||+||+++.++.+||+|||++.
T Consensus 83 -~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH--~~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 83 -STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp -SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred -CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH--HcCcccCcchhhcceeCCCCCeEeeccccce
Confidence 4677888999999999998877788999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
...............|++.|+|||++.++.++.++|||||||++|+|+| |..||.+.+.......+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i------------- 226 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------------- 226 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH-------------
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------------
Confidence 7655444333333568999999999999999999999999999999998 78888766543322222
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
....+...+..+++.+.+|+.+||+.||++|||+.+++++|..+..
T Consensus 227 -----~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 227 -----EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1223344556778899999999999999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-51 Score=369.09 Aligned_cols=246 Identities=24% Similarity=0.322 Sum_probs=210.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++|++++.||+|+||.||+| .+..+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a---------~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 111 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLV---------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEE---------EECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence 68999999999999999999 555668999999986542 234467889999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.....++|||++.+++|..++.+. ..+++..++.++.||+.||.||| +.+|+||||||+|||++.+|.+||+|||++
T Consensus 112 ~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH--~~~iiHRDIKP~NILl~~~g~ikL~DFG~a 188 (350)
T d1rdqe_ 112 DNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred cccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCEecCcCCHHHcccCCCCCEEeeeceee
Confidence 999999999999999999998654 67999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 257 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (349)
....... ....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 189 ~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----------- 252 (350)
T d1rdqe_ 189 KRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----------- 252 (350)
T ss_dssp EECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------
T ss_pred eeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc-----------
Confidence 8653322 235799999999999999999999999999999999999999976543222211111
Q ss_pred HhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 258 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
. ....+..+++++.+||++||+.||.+|+ |+.++++|
T Consensus 253 ------~--~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 253 ------G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ------C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ------C--CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1 1223456788999999999999999994 89999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=360.64 Aligned_cols=266 Identities=29% Similarity=0.412 Sum_probs=210.3
Q ss_pred hhhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHHHHHHHHHhccCCCcccce
Q 018891 16 SKIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEWLTEVIYLGQLRHENLVKL 92 (349)
Q Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~ 92 (349)
+-+..++|++.+.||+|+||.||+|.++. ..+....||||++..... ...+.+.+|+.++++++||||+++
T Consensus 3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~------~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~ 76 (273)
T d1u46a_ 3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDA------PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 76 (273)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEEC------TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred eEEchHHeEEEEEEecCCCeEEEEEEEEC------CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 44556899999999999999999997653 233456799998865432 234678899999999999999999
Q ss_pred eeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 93 IGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
++++.+ ...++||||++++++.+++......+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 77 ~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 77 YGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp EEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEEEETTEEEEC
T ss_pred EEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh--hCCEeeeeecHHHhccccccceeec
Confidence 999965 5778999999999999988777678999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccc-cceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhch
Q 018891 173 DFGLARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 250 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~ 250 (349)
|||++............ ....++..|+|||.+.+..++.++||||||+++|+|+| |..||.+.+......
T Consensus 154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~-------- 225 (273)
T d1u46a_ 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-------- 225 (273)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH--------
T ss_pred cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH--------
Confidence 99999875444332222 22456778999999999999999999999999999998 899997655322221
Q ss_pred hhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 251 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
.......+...+..+++.+.+||.+||+.||++|||+.+|++.|.+.+
T Consensus 226 ---------~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 226 ---------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp ---------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ---------HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 222233334455677889999999999999999999999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-50 Score=360.89 Aligned_cols=265 Identities=25% Similarity=0.350 Sum_probs=218.2
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
..++|++.+.||+|+||.||+|.+.+. .+..++..||||++...... ....+.+|+.++++++||||+++++++.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETS----STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCC----ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 457899999999999999999987543 34556789999999765433 3467899999999999999999999999
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-----------------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-----------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 154 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-----------------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~ 154 (349)
..+..++|||++++++|.+++... ...+++..++.++.|++.||+||| +.+++||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH--~~~ivHr 164 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHR 164 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCS
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc--cCCeEee
Confidence 999999999999999999998532 134889999999999999999999 8999999
Q ss_pred cCCCCcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCC-ccCc
Q 018891 155 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR-RALD 233 (349)
Q Consensus 155 di~~~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~-~pf~ 233 (349)
||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++|. .||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999997543333333333456888999999999999999999999999999999986 5676
Q ss_pred cccCcchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 234 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
+....+.... +........+.++++++.+|+.+||+.||++|||+.++++.|+++.
T Consensus 245 ~~~~~e~~~~------------------v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHEEVIYY------------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHHHHHHH------------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHHHHHHH------------------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 5543222211 1122233456677889999999999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-50 Score=368.06 Aligned_cols=250 Identities=25% Similarity=0.348 Sum_probs=205.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch---hchHHH---HHHHHHHhccCCCcccceee
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF---QGHKEW---LTEVIYLGQLRHENLVKLIG 94 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~---~~e~~~l~~l~h~~i~~~~~ 94 (349)
++|++.+.||+|+||.||+| .+..+|+.||||++..... .....+ ..++.+++.++||||+++++
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~---------~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~ 74 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY 74 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred HhCeeeeEEecCCCeEEEEE---------EECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence 68999999999999999999 5566789999999865322 122223 34577888889999999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++...+..|+||||++|++|.+++.+. ..+++..++.++.||+.||+||| +.+++||||||+|||++.+|.+||+||
T Consensus 75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH--~~~iiHrDlKP~NILl~~~g~iKl~DF 151 (364)
T d1omwa3 75 AFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDL 151 (364)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECSSSCEEECCC
T ss_pred EEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHH--HCCccceeeccceeEEcCCCcEEEeee
Confidence 999999999999999999999999654 67899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 253 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~ 253 (349)
|++........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............
T Consensus 152 Gla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~------- 220 (364)
T d1omwa3 152 GLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------- 220 (364)
T ss_dssp TTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-------
T ss_pred ceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------
Confidence 99986543322 23569999999999864 5689999999999999999999999987554332211111
Q ss_pred hhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 018891 254 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS 302 (349)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~ 302 (349)
........+..+++++.+||.+||+.||++||| ++++++|
T Consensus 221 ---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 221 ---------TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---------SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---------cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111122344567889999999999999999999 7999876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.4e-50 Score=354.50 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=209.4
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh---------chHHHHHHHHHHhccC-CCcc
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ---------GHKEWLTEVIYLGQLR-HENL 89 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~~i 89 (349)
.++|++.+.||+|+||+||+| .+..+++.||||++...... ..+.+.+|+.++++++ ||||
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~---------~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI 72 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred cccCEEceEEecCcCeEEEEE---------EECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe
Confidence 368999999999999999999 55567899999998654321 1245778999999996 9999
Q ss_pred cceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 90 VKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
+++++++.+++..|+||||+++++|.+++... ..+++..+..++.||+.||+||| +++++||||||+||+++.++.+
T Consensus 73 v~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH--~~~ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEECTTCCE
T ss_pred EEEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HcCCcccccccceEEEcCCCCe
Confidence 99999999999999999999999999999654 68999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCcccccc------CCCCCccceehhhHHHHHHHhCCccCccccCcchhhh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 243 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~ 243 (349)
||+|||++........ .....|++.|.|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......
T Consensus 150 kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~ 226 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226 (277)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence 9999999986544322 233578999999999853 3567899999999999999999999987653322222
Q ss_pred HHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 244 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
+... ..........++++++.+||.+||+.||++|||+.++++|
T Consensus 227 i~~~---------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSG---------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHT---------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhC---------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2211 0111222334678899999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=361.84 Aligned_cols=268 Identities=26% Similarity=0.348 Sum_probs=208.4
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
+..++|++.+.||+|+||.||+|.+... .+..+++.||||.+..... ...+.+.+|...+.++ +|+||+.++++
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGI----DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEEST----TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCC----CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3457899999999999999999987543 3455678999999875433 3345677788888777 68999999998
Q ss_pred EecC-CceEEEEEeCCCCChHHHHhcc---------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 018891 96 CSES-DNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 159 (349)
Q Consensus 96 ~~~~-~~~~lv~e~~~~~~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~ 159 (349)
+... ...++||||+++++|.+++... ...+++..+..++.|+++||+||| +++|+||||||+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH--~~~ivHrDlKp~ 163 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAAR 163 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH--hCCCcCCcCCcc
Confidence 7654 4689999999999999999643 235889999999999999999999 899999999999
Q ss_pred cEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCC-ccCccccCc
Q 018891 160 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR-RALDEDRGG 238 (349)
Q Consensus 160 Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~-~pf~~~~~~ 238 (349)
||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+++. .||.+....
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999997654444433344467899999999999999999999999999999999864 577654432
Q ss_pred chhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 239 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
.... ..+....+...+..+++++.+++.+||+.||++|||+.+++++|+++.+
T Consensus 244 ~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 EEFC-----------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHH-----------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH-----------------HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2211 1112222334556678899999999999999999999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=364.81 Aligned_cols=249 Identities=25% Similarity=0.407 Sum_probs=207.1
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc---hhchHHHHHHHHHHh-ccCCCcccceeeEE
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES---FQGHKEWLTEVIYLG-QLRHENLVKLIGYC 96 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~ 96 (349)
++|++.+.||+|+||+||+| .+..+++.||||++.... ......+..|..++. .++||||+++++++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~---------~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~ 72 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEE---------EECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence 58999999999999999999 566679999999997542 223445566666654 68999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
.+++..|+||||+++++|.+++... ..+++.++..++.||+.||+||| +++++||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH--~~~iiHrDikp~NiL~~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 73 QTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGM 149 (320)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH--HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCcccceeecCCCceeccccch
Confidence 9999999999999999999999654 67999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 150 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~---------- 217 (320)
T d1xjda_ 150 CKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM---------- 217 (320)
T ss_dssp CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----------
T ss_pred hhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc----------
Confidence 97543322 222335789999999999999999999999999999999999999986553222211111
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS 302 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~ 302 (349)
.....+..+++++.+||.+||+.||++|||+. ++++|
T Consensus 218 ---------~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 218 ---------DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp ---------CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---------CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 11234556788999999999999999999996 77653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=355.24 Aligned_cols=262 Identities=31% Similarity=0.442 Sum_probs=209.7
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
+..++|++.+.||+|+||.||+|.++. +..||||++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 82 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe
Confidence 345799999999999999999996542 3579999997554 34577999999999999999999999985
Q ss_pred cCCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 176 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~ 176 (349)
+ +..++||||+++|+|..++... ...+++.+++.++.|++.||+||| +.+++||||||+||+++.++.+||+|||+
T Consensus 83 ~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 83 E-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp S-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred c-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh--hhheecccccceEEEECCCCcEEEcccch
Confidence 4 5689999999999999888643 356999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 177 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
+......... ......+++.|+|||.+.++.++.++||||||+++|+|++|..||.......
T Consensus 160 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~----------------- 221 (285)
T d1fmka3 160 ARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----------------- 221 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------
T ss_pred hhhccCCCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----------------
Confidence 9764333221 2223568999999999999999999999999999999999766654332211
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCC
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 311 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 311 (349)
.....+....+...+..+++++.+++.+||+.||++|||+.++++.|+...++..
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 1111112223344566788899999999999999999999999999999887754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=357.69 Aligned_cols=264 Identities=24% Similarity=0.273 Sum_probs=200.1
Q ss_pred CcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhc-----hHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 25 SDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQG-----HKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 25 ~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.+++||+|+||+||+| .+..+|+.||||++....... ...+.+|+.++++++||||+++++++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~ 72 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 72 (299)
T ss_dssp EEEEEEEETTEEEEEE---------ECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cceEeccCcCeEEEEE---------EECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence 4678999999999999 666679999999987653322 24578999999999999999999999999
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+..|+||||+.++++.... .....+++..+..++.||+.||+||| +++++||||||+||+++.++.+||+|||++..
T Consensus 73 ~~~~ivmE~~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH--~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 73 SNISLVFDFMETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS 149 (299)
T ss_dssp TCCEEEEECCSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred CceeehhhhhcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh--ccceecccCCcceEEecCCCccccccCccccc
Confidence 9999999999887665544 55578999999999999999999999 89999999999999999999999999999975
Q ss_pred CCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhch-hhhhh--
Q 018891 180 GPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP-FLRDS-- 255 (349)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~-- 255 (349)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+...... .....
T Consensus 150 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 150 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred cCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 433322 1223578999999998865 46799999999999999999999999876654433333321110 00000
Q ss_pred -hhHhhhhccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 -RRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 -~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
............... ...+++++.+||.+||+.||++|||+.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000000000000001 12356789999999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-50 Score=356.64 Aligned_cols=268 Identities=26% Similarity=0.345 Sum_probs=204.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.++++++||||+++++++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEE---------EECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 58999999999999999999 5666789999999966533 235678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHH-hccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHL-FRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l-~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.+..|+||||+.++ +..++ ......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||.+
T Consensus 73 ~~~~~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH--~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLA 149 (298)
T ss_dssp TTEEEEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECSTTHH
T ss_pred ccceeEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh--cCCEEccccCchheeecccCcceeccCCcc
Confidence 99999999999664 44444 345577999999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCC-CCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-hhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRDS 255 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~ 255 (349)
....... .......|++.|+|||++.... ++.++|+|||||++|+|++|..||.+.+.......+..... +.....
T Consensus 150 ~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 150 RAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 7643322 2233357899999999877665 57899999999999999999999986654332222221111 000000
Q ss_pred hhHhh---hhcc---ccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 RRVLR---IMDT---RLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~~~~~---~~~~---~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... .... .... .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 0000 0000 0112345789999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=350.14 Aligned_cols=251 Identities=31% Similarity=0.441 Sum_probs=203.9
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec-
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE- 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 98 (349)
-++|++.+.||+|+||.||+|.++ |..||||+++.+. ..+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 468999999999999999999653 5679999997543 44678899999999999999999998854
Q ss_pred CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEeccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 177 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~ 177 (349)
.+..++||||+++++|.+++.+. ...+++..++.++.||+.||.||| +.+++||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH--~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc--cCceeccccchHhheecCCCCEeecccccc
Confidence 46689999999999999999653 245899999999999999999999 899999999999999999999999999999
Q ss_pred ccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcchhhhHHhhhchhhhhhh
Q 018891 178 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSR 256 (349)
Q Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (349)
....... ....++..|+|||.+.++.++.++||||||+++|+|+| |..||...........
T Consensus 151 ~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~------------- 212 (262)
T d1byga_ 151 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR------------- 212 (262)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-------------
T ss_pred eecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-------------
Confidence 7543322 12357888999999999999999999999999999998 6777765543222221
Q ss_pred hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 257 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
+....+.+.+..+++.+.+||.+||+.||.+|||+.+++++|+++.+
T Consensus 213 -----i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 213 -----VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 12223445566778899999999999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=354.00 Aligned_cols=267 Identities=27% Similarity=0.388 Sum_probs=221.3
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
+..++|++.+.||+|+||.||+|.+... .+..++..||||.++.... .....+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4568999999999999999999987543 3456788999999976543 3445688999999999 69999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccC-----------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSV-----------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
+.+....++||||+++++|.+++.... ..+++..+..++.||+.|++||| +++++||||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH--~~~ivHrDLKp 173 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAA 173 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSG
T ss_pred EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccccc
Confidence 999999999999999999999986432 35899999999999999999999 89999999999
Q ss_pred CcEEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccC
Q 018891 159 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 237 (349)
Q Consensus 159 ~Nilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~ 237 (349)
+||+++.++.++++|||.+................+++.|+|||.+.++.++.++||||||+++|+|+| |.+||.+...
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655444444444678999999999999999999999999999999999 4555544443
Q ss_pred cchhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 018891 238 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 307 (349)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 307 (349)
..... ..+....+...+..+++.+.+||.+||+.||++|||+.++++.|++..
T Consensus 254 ~~~~~-----------------~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 254 DSKFY-----------------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp SHHHH-----------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHH-----------------HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 22221 122223344455667889999999999999999999999999998654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=360.63 Aligned_cols=256 Identities=20% Similarity=0.280 Sum_probs=201.5
Q ss_pred hhhhcccCCcc-eeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhcc-CCCcccceee
Q 018891 17 KIATKNFCSDY-LLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQL-RHENLVKLIG 94 (349)
Q Consensus 17 ~~~~~~y~~~~-~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 94 (349)
+..-++|++.+ .||+|+||.||+| .+..+++.||||++.. ...+.+|+.++.++ +||||+++++
T Consensus 7 ~~i~~~y~i~~~~lG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~ 72 (335)
T d2ozaa1 7 NAIIDDYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVD 72 (335)
T ss_dssp SCGGGTEEEEEEEEEECSSCEEEEE---------EETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred CCcccCEEEeeEEeeeccCeEEEEE---------EECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEE
Confidence 33457898875 6999999999999 5556689999999853 24566788886554 8999999999
Q ss_pred EEec----CCceEEEEEeCCCCChHHHHhcc-CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---C
Q 018891 95 YCSE----SDNRLLVYEFMPKGSLENHLFRS-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---N 166 (349)
Q Consensus 95 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~---~ 166 (349)
+|.+ +..+|+||||++||+|.+++.+. ...+++.+++.++.||+.||+||| +.+|+||||||+||+++. +
T Consensus 73 ~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH--~~~iiHRDiKp~NIll~~~~~~ 150 (335)
T d2ozaa1 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPN 150 (335)
T ss_dssp EEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEESCSSTT
T ss_pred EEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH--HcCCcccccccccccccccccc
Confidence 9865 46789999999999999999654 357999999999999999999999 899999999999999975 5
Q ss_pred CcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHh
Q 018891 167 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 246 (349)
Q Consensus 167 ~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~ 246 (349)
+.+||+|||++........ .....|++.|+|||++.+..|+.++|||||||++|+|++|..||.+.........+..
T Consensus 151 ~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~ 227 (335)
T d2ozaa1 151 AILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227 (335)
T ss_dssp CCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred ccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH
Confidence 5799999999976544332 2235799999999999999999999999999999999999999977654332222111
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... .............+++++.+||.+||+.||++|||+.++++|
T Consensus 228 ~i~-----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIR-----------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCC-----------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHh-----------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 000000111124578899999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=353.64 Aligned_cols=269 Identities=26% Similarity=0.382 Sum_probs=215.6
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh-chHHHHHHHHHHhcc-CCCcccceeeE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ-GHKEWLTEVIYLGQL-RHENLVKLIGY 95 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~ 95 (349)
+..++|++.+.||+|+||.||+|...+..- .....+..||||+++..... ....+.+|...+.++ +||||++++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~--~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCc--ccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 356899999999999999999997654210 12344568999999765443 346678888888888 79999999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccC---------------CCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCc
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSV---------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASN 160 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~N 160 (349)
+.+++..++||||+++++|.+++.... ..+++..++.++.||+.||+||| +.+++||||||+|
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH--~~~ivHrDiKp~N 165 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARN 165 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh--hCCEEeeeecccc
Confidence 999999999999999999999996432 45899999999999999999999 8999999999999
Q ss_pred EEEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHh-CCccCccccCcc
Q 018891 161 VLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGL 239 (349)
Q Consensus 161 ilv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~llt-g~~pf~~~~~~~ 239 (349)
|+++.++.+||+|||++................+++.|+|||.+.++.++.++||||||+++|+|++ |..||.+.....
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999999986555444444444678889999999999999999999999999999998 688886544322
Q ss_pred hhhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 240 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
.. ..+....+...+..+++++.+||.+||+.||.+|||+.++++.|+++..
T Consensus 246 ~~------------------~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 LF------------------KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH------------------HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH------------------HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11 1122233344556678899999999999999999999999999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=348.28 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=209.3
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhccCCCcccceeeEEec-CCceE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE-SDNRL 103 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 103 (349)
.++||+|+||+||+|.+.. ..+....||||.++.. .......+.+|+.++++++||||+++++++.. ++..+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~------~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLD------NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred ceEEeecCCeEEEEEEEEC------CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 5689999999999997642 1223457899998643 33455779999999999999999999999765 46789
Q ss_pred EEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccccCCCC
Q 018891 104 LVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 183 (349)
Q Consensus 104 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~~~~~ 183 (349)
+||||+++++|.+++......++...++.++.|++.||.||| +.+|+||||||+||++++++.+||+|||++......
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH--~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc--ccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 999999999999999777777889999999999999999999 899999999999999999999999999999865443
Q ss_pred CCCc--cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhhhhhhhHhhh
Q 018891 184 DNTH--VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 261 (349)
Q Consensus 184 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (349)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......... ...
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~-----------------~~~ 246 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----------------TVY 246 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C-----------------HHH
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH-----------------HHH
Confidence 3222 122356789999999999999999999999999999999988887543321110 011
Q ss_pred hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 262 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
+....+...+..+++.+.+|+.+||+.||++|||+.|++++|+++..+-
T Consensus 247 i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 1112233445667789999999999999999999999999999998763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=354.84 Aligned_cols=275 Identities=24% Similarity=0.328 Sum_probs=205.5
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh--chHHHHHHHHHHhcc---CCCcccceee
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ--GHKEWLTEVIYLGQL---RHENLVKLIG 94 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~ 94 (349)
.++|++++.||+|+||+||+|... ..+++.||||++...... ....+.+|+.+++.+ +||||+++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~--------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDL--------KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET--------TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEE--------CCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 479999999999999999999432 223678999998654322 223455666666655 7999999999
Q ss_pred EEec-----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcE
Q 018891 95 YCSE-----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 95 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v 169 (349)
++.. ....+++||+++++.+..........+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH--~~~ivHrDiKp~NILi~~~~~~ 155 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQI 155 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCE
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEEecCCCccEEEEcCCCCe
Confidence 9853 34678999999887666555556678999999999999999999999 8999999999999999999999
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
+|+|||.+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 156 kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 232 (305)
T d1blxa_ 156 KLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232 (305)
T ss_dssp EECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence 9999999864322 2223346799999999999999999999999999999999999999987665443333332211
Q ss_pred hhhh-hhh-------hHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 018891 250 PFLR-DSR-------RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLH 307 (349)
Q Consensus 250 ~~~~-~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~ 307 (349)
.... ... .................+++.+.+||.+||+.||++|||+.|+++| ++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 1000 000 0000000001112234567889999999999999999999999986 44443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=352.37 Aligned_cols=262 Identities=29% Similarity=0.421 Sum_probs=210.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-chhchHHHHHHHHHHhcc-CCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-SFQGHKEWLTEVIYLGQL-RHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 96 (349)
.-++|++.+.||+|+||.||+|.++.. +....||||.+... .....+.+.+|+.+|+++ +||||+++++++
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKD-------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEET-------TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCC-------CeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 348999999999999999999965421 11235778877543 333456788999999998 799999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhcc---------------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcE
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRS---------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 161 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Ni 161 (349)
.+.+..++||||+++++|.+++... ...+++..+..++.|++.||.||| +.+++||||||+||
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH--~~~iiHrDlkp~NI 158 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNI 158 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGE
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh--cCCccccccccceE
Confidence 9999999999999999999998543 367999999999999999999999 89999999999999
Q ss_pred EEcCCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCc-cCccccCcch
Q 018891 162 LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR-ALDEDRGGLA 240 (349)
Q Consensus 162 lv~~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~-pf~~~~~~~~ 240 (349)
|++.++.+||+|||++......... ....++..|+|||.+.++.++.++||||||+++|+|++|.. ||.+.+....
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999754332222 22458899999999999999999999999999999999764 5654442221
Q ss_pred hhhHHhhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 241 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
. ..+....+...+..+++++.+||.+||+.||++|||+.+++++|+++.+..
T Consensus 236 ~------------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 Y------------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp H------------------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred H------------------HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1 111222334456678889999999999999999999999999999987653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=352.09 Aligned_cols=242 Identities=22% Similarity=0.405 Sum_probs=199.0
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh------chHHHHHHHHHHhccC--CCcccc
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------GHKEWLTEVIYLGQLR--HENLVK 91 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~ 91 (349)
.++|++.+.||+|+||.||+| .+..+|+.||||++...... ....+.+|+.++++++ ||||++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~ 73 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CCeEEEeEEEeeCCCeEEEEE---------EECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccE
Confidence 468999999999999999999 55566899999998654321 1233568999999986 899999
Q ss_pred eeeEEecCCceEEEEEeCCC-CChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCC-CcE
Q 018891 92 LIGYCSESDNRLLVYEFMPK-GSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNA 169 (349)
Q Consensus 92 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~-~~v 169 (349)
+++++.+.+..++|||++.+ +++.+++.+. ..+++.+++.++.||+.||+||| +++|+||||||+||+++.+ +.+
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH--~~~iiHrDiKp~NIll~~~~~~v 150 (273)
T d1xwsa_ 74 LLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGEL 150 (273)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCSGGGEEEETTTTEE
T ss_pred EEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCCccccCcccceEEecCCCeE
Confidence 99999999999999999975 5777777543 68999999999999999999999 8999999999999999854 789
Q ss_pred EEecccccccCCCCCCCccccceecCCcccCccccccCCC-CCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh
Q 018891 170 KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 248 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~ 248 (349)
||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... +..
T Consensus 151 kl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~-- 218 (273)
T d1xwsa_ 151 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR-- 218 (273)
T ss_dssp EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--
T ss_pred EECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhh--
Confidence 999999997643322 223569999999999987665 5779999999999999999999964320 100
Q ss_pred chhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 249 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.....+..+++++.+||.+||+.||++|||+.++++|
T Consensus 219 -----------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------------cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0112334567889999999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=349.68 Aligned_cols=267 Identities=25% Similarity=0.405 Sum_probs=218.8
Q ss_pred hhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch-hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 18 IATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF-QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
+..++|++.+.||+|+||.||+|.+++. .....+..||||+++.... .....+.+|+.++++++||||+++++++
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~----~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCc----ccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 4458999999999999999999976532 2233467899999975432 3445688999999999999999999999
Q ss_pred ecCCceEEEEEeCCCCChHHHHhcc---------CCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC
Q 018891 97 SESDNRLLVYEFMPKGSLENHLFRS---------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF 167 (349)
Q Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~ 167 (349)
...+..++||||+++++|.+++... ...++...+..++.|+++||.||| +++|+||||||+||++++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH--~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH--HTTCBCSCCSGGGEEECTTC
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh--hCCeeeceEcCCceeecCCc
Confidence 9999999999999999999988532 145788999999999999999999 89999999999999999999
Q ss_pred cEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCC-ccCccccCcchhhhHHh
Q 018891 168 NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR-RALDEDRGGLAEQTLVE 246 (349)
Q Consensus 168 ~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~-~pf~~~~~~~~~~~~~~ 246 (349)
.+||+|||++................+++.|+|||.+.++.++.++|+||||+++|+|+||. .||.+.+..+....+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~- 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 99999999997654443333333456899999999999999999999999999999999984 7776554322222211
Q ss_pred hhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhc
Q 018891 247 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 308 (349)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 308 (349)
.......+..+++.+.+++.+||+.||++|||+.+++++|++..+
T Consensus 250 -----------------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 -----------------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----------------hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 122344556778899999999999999999999999999988644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-48 Score=346.07 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=203.2
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++.+.||+|+||+||+|.++ +|+.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 58999999999999999999542 478899999866533 235788999999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
++..+++|+++.++.+.. +......+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||.+.
T Consensus 72 ~~~~~i~~e~~~~~~~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKL-LDVCEGGLESVTAKSFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp SSCEEEEEECCSEEHHHH-HHTSTTCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred CCceeEEEEeehhhhHHH-HHhhcCCcchhhhHHHHHHHHHHHHHhc--cCcEEecCCCCceeeEcCCCCEEecccccce
Confidence 999999999997655555 4455688999999999999999999999 8999999999999999999999999999997
Q ss_pred cCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhh-chhhhhhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA-DPFLRDSR 256 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 256 (349)
....... ......+++.|.|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.... .+......
T Consensus 149 ~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 149 AFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (286)
T ss_dssp HHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhcc
Confidence 6433222 2223468899999999865 457899999999999999999999997665433222222111 11111000
Q ss_pred hHhh---------hhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 257 RVLR---------IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 257 ~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... .............+++++.+||++||+.||++|||+.|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000011112234467889999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=348.82 Aligned_cols=272 Identities=22% Similarity=0.331 Sum_probs=203.7
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEE
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYC 96 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 96 (349)
..++|++++.||+|+||+||+| .+..+|+.||||++..... ...+.+.+|+.+|++++||||++++++|
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~ 86 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF 86 (346)
T ss_dssp CBSSEEEEEEC------CEEEE---------EETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred cCCcEEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEe
Confidence 4689999999999999999999 5556689999999975432 3346788999999999999999999999
Q ss_pred ecCC------ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 97 SESD------NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 97 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
...+ ..|+||||+ +.+|...+.. ..+++..++.++.||+.||.||| ++||+||||||+||+++.++.++
T Consensus 87 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH--~~~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 87 TPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEE
T ss_pred ccCccccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHH--hCCCcccccCcchhhcccccccc
Confidence 7654 469999999 6677776643 57999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
++|||++....... ....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 162 l~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 236 (346)
T d1cm8a_ 162 ILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236 (346)
T ss_dssp ECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccC
Confidence 99999998643322 23568999999999876 4578999999999999999999999987654333322222111
Q ss_pred hhhh---------hhhhHhhhhcccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhcC
Q 018891 250 PFLR---------DSRRVLRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 309 (349)
Q Consensus 250 ~~~~---------~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~~ 309 (349)
.... ............. .......+++++.+||.+||..||.+|||+.++++| ++.+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 1000 0000111111111 112234567889999999999999999999999987 6555444
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=339.30 Aligned_cols=275 Identities=24% Similarity=0.322 Sum_probs=203.6
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEecC
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSES 99 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 99 (349)
.++|.+.+.||+|+||.||+|.++ |+.||||++...... ......|+..+++++||||+++++++...
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-----------g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~ 69 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-----------GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKD 69 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC-----------CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeC
Confidence 578999999999999999999643 678999998654322 22233466666778999999999998765
Q ss_pred C----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC------CCCeeeccCCCCcEEEcCCCcE
Q 018891 100 D----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL------DANVIYRDLKASNVLLDSNFNA 169 (349)
Q Consensus 100 ~----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~------~~~i~H~di~~~Nilv~~~~~v 169 (349)
+ ..++||||+++++|.+++.+ ..+++..++.++.|++.||+|+|+. +.+|+||||||+||+|+.++.+
T Consensus 70 ~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 70 NGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred CCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 4 47899999999999999965 4689999999999999999999932 2599999999999999999999
Q ss_pred EEecccccccCCCCCCCc--cccceecCCcccCccccccCC------CCCccceehhhHHHHHHHhCCccCccccCcchh
Q 018891 170 KLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGH------LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 241 (349)
Q Consensus 170 ~l~Dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~------~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~ 241 (349)
||+|||++.......... ......|++.|+|||++.+.. ++.++|||||||++|+|+||..||.........
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 999999987654333211 122357899999999987653 456899999999999999999888654432211
Q ss_pred hhHHhhhchhhhhhhhHhhhhccccCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCC
Q 018891 242 QTLVEWADPFLRDSRRVLRIMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 310 (349)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 310 (349)
........+.... ..........+... +......+.+|+.+||+.||++|||+.++++.|+++....
T Consensus 228 ~~~~~~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 228 YYDLVPSDPSVEE--MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TTTTSCSSCCHHH--HHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhcccccchHHH--HHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 1111000011111 11111222222222 2346678999999999999999999999999999987653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-46 Score=333.95 Aligned_cols=272 Identities=17% Similarity=0.177 Sum_probs=216.7
Q ss_pred hhhhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeE
Q 018891 17 KIATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGY 95 (349)
Q Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 95 (349)
++.+++|++.+.||+|+||.||+| .+..+|+.||||++.... ....+.+|++.++.++ |++++.++++
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a---------~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~ 69 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF 69 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEE---------EETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred CCCCCceEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEE
Confidence 356789999999999999999999 555568999999875543 2334667888888886 5899999999
Q ss_pred EecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC-----CCcEE
Q 018891 96 CSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-----NFNAK 170 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~-----~~~v~ 170 (349)
+..+...++|||++ +++|.+++......++...+..++.|++.||+||| +.||+||||||+||+++. ++.++
T Consensus 70 ~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH--~~giiHrDiKp~Nili~~~~~~~~~~vk 146 (293)
T d1csna_ 70 GQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIY 146 (293)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECCSSSTTTTCEE
T ss_pred eecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH--HCCceeccCCccceeecCcccccCCceE
Confidence 99999999999999 67999988776678999999999999999999999 999999999999999964 56799
Q ss_pred EecccccccCCCCCCCc-----cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHH
Q 018891 171 LSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 245 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~ 245 (349)
|+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...........
T Consensus 147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 147 VVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp ECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred EcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 99999998654332211 1223579999999999999999999999999999999999999998766544433222
Q ss_pred hhhchhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018891 246 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313 (349)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 313 (349)
......... .......++|+++.+++..|+..+|++||++..+.+.|+++..+.+..
T Consensus 227 ~i~~~~~~~-----------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~ 283 (293)
T d1csna_ 227 RIGEKKQST-----------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283 (293)
T ss_dssp HHHHHHHHS-----------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHhccCCC-----------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCC
Confidence 211100000 000112345678999999999999999999999999999887665444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=340.20 Aligned_cols=270 Identities=23% Similarity=0.323 Sum_probs=200.4
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++++.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.+|++++|||++++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~ 80 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 80 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence 79999999999999999999 5556689999999865432 345678899999999999999999998754
Q ss_pred --------CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEE
Q 018891 99 --------SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 170 (349)
Q Consensus 99 --------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~ 170 (349)
.+..++|||++.++.+. ........+++..++.++.|++.||.||| +++|+||||||+||+++.++.++
T Consensus 81 ~~~~~~~~~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH--~~~ivHrDlKp~NILl~~~~~~k 157 (318)
T d3blha1 81 KASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLK 157 (318)
T ss_dssp ----------CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTSCEE
T ss_pred ccccccccCceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhc--cCCEEecCcCchheeecCCCcEE
Confidence 34689999999765544 44456678999999999999999999999 89999999999999999999999
Q ss_pred EecccccccCCCCCCC--ccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh
Q 018891 171 LSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 247 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~ 247 (349)
|+|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999754432221 112225689999999998765 6899999999999999999999999876554444333332
Q ss_pred hchhhhhhh------hHhhhhccccCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 248 ADPFLRDSR------RVLRIMDTRLGGQYS-------KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 248 ~~~~~~~~~------~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
......... ............... ...++++.+||.+||+.||++|||+.|+++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 211111000 000000000000000 1124578899999999999999999999976
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=334.80 Aligned_cols=270 Identities=19% Similarity=0.234 Sum_probs=207.1
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCccc-ceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLV-KLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~ 97 (349)
.+++|++.+.||+|+||.||+| .+..+|+.||||++..... ...+..|..+++.++|++++ .+..++.
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a---------~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~ 73 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA 73 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEE---------EETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEE---------EECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe
Confidence 3578999999999999999999 4555689999998765432 23467899999999876655 4555667
Q ss_pred cCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcC---CCcEEEecc
Q 018891 98 ESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDF 174 (349)
Q Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~---~~~v~l~Df 174 (349)
..+..++|||++ ++++.+.+......+++..+..++.|++.||+||| +++|+||||||+||+++. +..++|+||
T Consensus 74 ~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 74 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred cCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH--HCCeeeccCCHhhccccccCCCceeeeecc
Confidence 777889999999 55777777666678999999999999999999999 899999999999999864 446999999
Q ss_pred cccccCCCCCCCc-----cccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 175 GLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 175 g~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 9998654433221 12235799999999999999999999999999999999999999987665444333332211
Q ss_pred hhhhhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhcCCCCC
Q 018891 250 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 313 (349)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 313 (349)
....... .....++|+++.+++.+||+.||++||++.++.+.|+++..+....
T Consensus 231 ~~~~~~~-----------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 231 KKMSTPI-----------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp HHHHSCH-----------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred ccCCCCh-----------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 1111100 0112346688999999999999999999999999888876554433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=344.11 Aligned_cols=271 Identities=25% Similarity=0.330 Sum_probs=200.4
Q ss_pred hhcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccc-hhchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 19 ATKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAES-FQGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 19 ~~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
++++|++++.||+|+||+||+| .+..+|+.||||++.... ....+.+.+|+.+|++++||||+++++++.
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~ 76 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSA---------YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIR 76 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEE---------EETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred cCCCeEEEEEEeeccCeEEEEE---------EECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEe
Confidence 3568999999999999999999 555668999999987543 234567889999999999999999999986
Q ss_pred cCC----ceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEec
Q 018891 98 ESD----NRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 173 (349)
Q Consensus 98 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~D 173 (349)
... ..+++++++.+++|.+++.. ..+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||+|
T Consensus 77 ~~~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH--~~~iiHRDIKp~NILl~~~~~~kl~D 152 (345)
T d1pmea_ 77 APTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICD 152 (345)
T ss_dssp CSSTTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred eccccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCcCCCCCcceEEECCCCCEEEcc
Confidence 543 22444555668999999954 47999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCC-ccccceecCCcccCccccc-cCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhh-hch
Q 018891 174 FGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADP 250 (349)
Q Consensus 174 fg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~-~~~ 250 (349)
||++......... .......|++.|+|||++. +..++.++||||+||++|+|++|..||.+............. ..+
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~ 232 (345)
T d1pmea_ 153 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232 (345)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCC
Confidence 9999754333221 1223467899999999984 456789999999999999999999999776543222222111 111
Q ss_pred hhhhh--------hhHhhhhccccCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FLRDS--------RRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
..... ............. .....+++++.+|+.+||+.||.+|||+.++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 0000000000000 0112446789999999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-47 Score=343.16 Aligned_cols=268 Identities=24% Similarity=0.342 Sum_probs=200.6
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCcccceeeEEec--
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHENLVKLIGYCSE-- 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 98 (349)
-+|+..++||+|+||+||+| .+..+|+.||||++...... ..+|+.+|++++||||++++++|..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~ 86 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSG 86 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEE---------EETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred CCcEeeeEEeeCcCeEEEEE---------EECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecC
Confidence 47999999999999999999 55567899999998654322 2379999999999999999999843
Q ss_pred ----CCceEEEEEeCCCCChHHHHh---ccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-cEE
Q 018891 99 ----SDNRLLVYEFMPKGSLENHLF---RSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAK 170 (349)
Q Consensus 99 ----~~~~~lv~e~~~~~~L~~~l~---~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-~v~ 170 (349)
..+.++||||++++ +.+.+. .....+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+|
T Consensus 87 ~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH--~~~IiHrDiKp~NILl~~~~~~~k 163 (350)
T d1q5ka_ 87 EKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLK 163 (350)
T ss_dssp -CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECCCCCGGGEEECTTTCCEE
T ss_pred ccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCcceEEEecCCCcee
Confidence 23478999999765 433332 24567999999999999999999999 99999999999999999775 899
Q ss_pred EecccccccCCCCCCCccccceecCCcccCcccccc-CCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc
Q 018891 171 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 249 (349)
Q Consensus 171 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~ 249 (349)
|+|||++........ .....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 164 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g 240 (350)
T d1q5ka_ 164 LCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 240 (350)
T ss_dssp ECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred EecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999976433222 223578999999998765 5789999999999999999999999987654433333322111
Q ss_pred -hhhhhhhhHhhh-hccc--------cCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhh
Q 018891 250 -PFLRDSRRVLRI-MDTR--------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLH 307 (349)
Q Consensus 250 -~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~ 307 (349)
+........... .... .........++++.+||.+||..||++|||+.|+++| ++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 111111000000 0000 0011223567889999999999999999999999986 55544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.4e-46 Score=336.80 Aligned_cols=262 Identities=19% Similarity=0.266 Sum_probs=201.6
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEec
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSE 98 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 98 (349)
.++|++++.||+|+||+||+| .+..+++.||||+++... .+.+.+|+.+|++++ ||||+++++++..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a---------~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~ 101 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKD 101 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEE---------EECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEe
Confidence 468999999999999999999 556678999999986543 456788999999995 9999999999874
Q ss_pred --CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCC-cEEEeccc
Q 018891 99 --SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF-NAKLSDFG 175 (349)
Q Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~-~v~l~Dfg 175 (349)
....++||||+.+++|.... +.+++..+..++.||+.||.||| ++||+||||||+|||++.++ .++|+|||
T Consensus 102 ~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH--~~gIvHrDiKp~NILi~~~~~~vkl~DFG 175 (328)
T d3bqca1 102 PVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWG 175 (328)
T ss_dssp TTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTTEEEECCGG
T ss_pred cCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh--hcccccccccccceEEcCCCCeeeecccc
Confidence 45789999999999987654 56999999999999999999999 89999999999999998655 69999999
Q ss_pred ccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchh-hhHHhhhc-hhh
Q 018891 176 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWAD-PFL 252 (349)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~-~~~~~~~~-~~~ 252 (349)
++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||......... ..+..... +..
T Consensus 176 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~ 252 (328)
T d3bqca1 176 LAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252 (328)
T ss_dssp GCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHH
T ss_pred cceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchh
Confidence 9976543322 2335689999999998765 5799999999999999999999999765542221 11111110 000
Q ss_pred hhhh---------hHhhh--------hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 253 RDSR---------RVLRI--------MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 253 ~~~~---------~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ..... ............+++++.+||++||+.||++|||++|+|+|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000 01111122234567889999999999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=333.30 Aligned_cols=268 Identities=23% Similarity=0.271 Sum_probs=207.5
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEec
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCSE 98 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 98 (349)
++|++++.||+|+||+||+| .+..+++.||||+++.... .....+.+|+.+++.++||||+++++++..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~---------~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEE---------EETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCCEeeeEEecCcCeEEEEE---------EECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 58999999999999999999 5556789999999865433 335678899999999999999999999999
Q ss_pred CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 99 SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
....++|++++.+++|..++ .....+++..+..++.|++.||+||| +++|+||||||+||+++.++.++|+|||.+.
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH--~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~ 149 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHH--HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred ccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhh--cCCEeeecccCcccccccCCceeeeecchhh
Confidence 99999999999888887766 44578999999999999999999999 8999999999999999999999999999998
Q ss_pred cCCCCCCCccccceecCCcccCccccccCC-CCCccceehhhHHHHHHHhCCccCccccCcch-hhhHHhhhchhh-hhh
Q 018891 179 DGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDRGGLA-EQTLVEWADPFL-RDS 255 (349)
Q Consensus 179 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~-~~~ 255 (349)
........ .....+++.|.|||.+.+.. ++.++|||||||++|+|++|..||....+... ...+.....+.. ...
T Consensus 150 ~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 150 AFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred cccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 65433322 22245778899999887654 68999999999999999999999754333221 122211111100 000
Q ss_pred hhHhhh---------hccccCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 256 RRVLRI---------MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 256 ~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
...... ............+++.+.+||++||+.||.+|||++|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00111122334567889999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=338.50 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=209.2
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch----hchHHHHHHHHHHhccCC-Ccccceee
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF----QGHKEWLTEVIYLGQLRH-ENLVKLIG 94 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h-~~i~~~~~ 94 (349)
-++|++.+.||+|+||+||+|... ....+|+.||||.++.... ...+.+.+|+.++++++| |||+++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~------~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKI------SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEEC------SSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEEC------ccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence 378999999999999999999542 2345689999999865432 234567789999999966 89999999
Q ss_pred EEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEecc
Q 018891 95 YCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF 174 (349)
Q Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~Df 174 (349)
++.+....+++|||+.+++|.+++... ..+++..+..++.||+.||.|+| +.+++||||||+||+++.++.++|+||
T Consensus 97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH--~~~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 97 AFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred eeccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhh--cCCEEeccCCccceeecCCCCEEEeec
Confidence 999999999999999999999998654 67889999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCCCccccceecCCcccCccccccC--CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchhh
Q 018891 175 GLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 252 (349)
Q Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~~ 252 (349)
|++......... ......|++.|++||.+.+. .++.++|||||||++|+|++|..||.+.........+.....
T Consensus 174 G~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~--- 249 (322)
T d1vzoa_ 174 GLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--- 249 (322)
T ss_dssp SEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH---
T ss_pred cchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc---
Confidence 999764333222 22335789999999998654 467899999999999999999999987665444333322110
Q ss_pred hhhhhHhhhhccccCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 018891 253 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS 302 (349)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~ 302 (349)
......+..+++++.+||.+||+.||.+|| |++|+++|
T Consensus 250 ------------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 250 ------------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ------------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 111234556789999999999999999999 48999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=339.92 Aligned_cols=265 Identities=25% Similarity=0.299 Sum_probs=195.0
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
-++|++++.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.++++++||||++++++|.
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~---------~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~ 86 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEE---------EETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred cCCeEEEEEeecCcCeEEEEE---------EECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEe
Confidence 368999999999999999999 5566799999999975432 33456889999999999999999999995
Q ss_pred c------CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEE
Q 018891 98 E------SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 171 (349)
Q Consensus 98 ~------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l 171 (349)
. ....|+||||+.++ +.+.+. ..+++..++.++.|++.||.||| +.||+||||||+||+++.++.+++
T Consensus 87 ~~~~~~~~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH--~~giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 87 PQKTLEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp SCCSTTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEE
T ss_pred cccccccCceeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhh--hcccccccCCccccccccccceee
Confidence 3 36789999999664 545442 46899999999999999999999 899999999999999999999999
Q ss_pred ecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhc-h
Q 018891 172 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-P 250 (349)
Q Consensus 172 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~-~ 250 (349)
+|||++....... ......+|+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.......+..... +
T Consensus 161 ~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~ 237 (355)
T d2b1pa1 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_dssp CCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred echhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCC
Confidence 9999887543322 22335689999999999999999999999999999999999999986654333222221110 0
Q ss_pred hhh----hhhhH---------------hhhhcccc---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 251 FLR----DSRRV---------------LRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 251 ~~~----~~~~~---------------~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
... ..... ........ ........++++.+||++||..||++|||++|+|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000 00000000 111123567899999999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=337.99 Aligned_cols=265 Identities=23% Similarity=0.308 Sum_probs=200.4
Q ss_pred hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccch--hchHHHHHHHHHHhccCCCcccceeeEEe
Q 018891 20 TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESF--QGHKEWLTEVIYLGQLRHENLVKLIGYCS 97 (349)
Q Consensus 20 ~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 97 (349)
.++|++.+.||+|+||+||+| .+..+|+.||||++..... .....+.+|+.+|++++|||++++++++.
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a---------~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~ 87 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAA---------FDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEE---------EETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CCCeEEEEEEecCCCeEEEEE---------EECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 578999999999999999999 5566799999999976532 34456889999999999999999999985
Q ss_pred c-----CCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEcCCCcEEEe
Q 018891 98 E-----SDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 172 (349)
Q Consensus 98 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~~~~~v~l~ 172 (349)
. +...+++++++.+++|.+++.. ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.++++
T Consensus 88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH--~~giiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp SCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH--HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred eccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHH--hCCCcccccCCcccccccccccccc
Confidence 3 2344566677779999998843 57999999999999999999999 8999999999999999999999999
Q ss_pred cccccccCCCCCCCccccceecCCcccCccccccC-CCCCccceehhhHHHHHHHhCCccCccccCcchhhhHHhhhchh
Q 018891 173 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 251 (349)
Q Consensus 173 Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~ll~~lltg~~pf~~~~~~~~~~~~~~~~~~~ 251 (349)
|||.+..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 164 dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 164 DFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238 (348)
T ss_dssp CC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999865322 22235688899999987665 46889999999999999999999998766544433333221111
Q ss_pred hhhh------hhHhhh---hccccCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 018891 252 LRDS------RRVLRI---MDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 252 ~~~~------~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 302 (349)
.... ...... ........ ....+++++.+||++||+.||++|||+.|+++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 1000 000000 00000000 012356789999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-40 Score=303.84 Aligned_cols=272 Identities=19% Similarity=0.267 Sum_probs=192.9
Q ss_pred hhhhh-hcccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC--------
Q 018891 15 ISKIA-TKNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-------- 85 (349)
Q Consensus 15 ~~~~~-~~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-------- 85 (349)
+++.. .++|++++.||+|+||+||+| .+..+|+.||||+++.+.. ..+.+.+|+.+++.++
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~---------~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~ 75 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLA---------KDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKED 75 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEE---------EETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEE---------EECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhh
Confidence 45543 357999999999999999999 5566789999999976542 2356677888887774
Q ss_pred ---CCcccceeeEEecC--CceEEEEEeCCCCCh-HHHH-hccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 018891 86 ---HENLVKLIGYCSES--DNRLLVYEFMPKGSL-ENHL-FRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 158 (349)
Q Consensus 86 ---h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L-~~~l-~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~ 158 (349)
|+||+++++++... ...++++.+...... .... ......+++..+..++.|++.||+|||+ ..||+||||||
T Consensus 76 ~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp 154 (362)
T d1q8ya_ 76 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKP 154 (362)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSG
T ss_pred hcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCCh
Confidence 57899999887543 455666666544332 2222 2345678999999999999999999993 38999999999
Q ss_pred CcEEEcCCCc------EEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhhHHHHHHHhCCccC
Q 018891 159 SNVLLDSNFN------AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 232 (349)
Q Consensus 159 ~Nilv~~~~~------v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~ll~~lltg~~pf 232 (349)
+||+++.++. ++++|||.+....... ....|++.|+|||++.+..++.++|+||+||++++|++|+.||
T Consensus 155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 155 ENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred hHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence 9999986653 9999999987543322 2256899999999999999999999999999999999999999
Q ss_pred ccccCcchh---hhHHhhhc-------hhhhhhhhHhhhhc---------c----------ccCCCCCHHHHHHHHHHHH
Q 018891 233 DEDRGGLAE---QTLVEWAD-------PFLRDSRRVLRIMD---------T----------RLGGQYSKKEAQAVAAVVL 283 (349)
Q Consensus 233 ~~~~~~~~~---~~~~~~~~-------~~~~~~~~~~~~~~---------~----------~~~~~~~~~~~~~l~~li~ 283 (349)
......... ..+..... .............. . ..........++++.+||.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309 (362)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence 754432111 11111000 00000000000000 0 0112345678899999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 018891 284 QCLHMDPKNRPSMVDVLTS 302 (349)
Q Consensus 284 ~~l~~dp~~Rps~~~ll~~ 302 (349)
+||..||.+|||++|+|+|
T Consensus 310 ~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp GGGCSSTTTCBCHHHHHTC
T ss_pred HHCCCChhHCcCHHHHhcC
Confidence 9999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=4.7e-23 Score=169.93 Aligned_cols=167 Identities=15% Similarity=0.094 Sum_probs=115.9
Q ss_pred cCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchh------------------chHHHHHHHHHHhcc
Q 018891 23 FCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQ------------------GHKEWLTEVIYLGQL 84 (349)
Q Consensus 23 y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l 84 (349)
+.+.+.||+|+||+||+|.. .+|+.||||++...... .......|...+.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~----------~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 71 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS----------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 71 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE----------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred chhCCEeeeCcceEEEEEEC----------CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc
Confidence 34678999999999999943 24788999986532110 112345678889999
Q ss_pred CCCcccceeeEEecCCceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCcEEEc
Q 018891 85 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 164 (349)
Q Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~~~~i~H~di~~~Nilv~ 164 (349)
.|.+++..+++. ..+++||++++..+.+ ++...+..++.|++.++.||| +.+++|+||||+||+++
T Consensus 72 ~~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH--~~giiHrDiKP~NILv~ 137 (191)
T d1zara2 72 QGLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY--HRGIVHGDLSQYNVLVS 137 (191)
T ss_dssp TTSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH--HTTEECSCCSTTSEEEE
T ss_pred cCCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh--hCCEEEccCChhheeee
Confidence 999988877653 2379999998754432 455567889999999999999 89999999999999998
Q ss_pred CCCcEEEecccccccCCCCCCCccccceecCCcccCccccccCCCCCccceehhh
Q 018891 165 SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFG 219 (349)
Q Consensus 165 ~~~~v~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG 219 (349)
++ .++|+|||.+...............+. ...+ +..+.|+..+|+||+.
T Consensus 138 ~~-~~~liDFG~a~~~~~~~~~~~l~rd~~----~~~~-~f~r~y~~~~d~~s~~ 186 (191)
T d1zara2 138 EE-GIWIIDFPQSVEVGEEGWREILERDVR----NIIT-YFSRTYRTEKDINSAI 186 (191)
T ss_dssp TT-EEEECCCTTCEETTSTTHHHHHHHHHH----HHHH-HHHHHHCCCCCHHHHH
T ss_pred CC-CEEEEECCCcccCCCCCcHHHHHHHHH----HHHH-HHcCCCCCcccHHHHH
Confidence 65 589999999875322211100000000 0001 1246678899999964
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=5.5e-08 Score=82.19 Aligned_cols=141 Identities=12% Similarity=-0.020 Sum_probs=95.9
Q ss_pred cccCCcceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEecC
Q 018891 21 KNFCSDYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSES 99 (349)
Q Consensus 21 ~~y~~~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 99 (349)
..|+..+..+.++.+.||+... .+..+++|............+.+|...++.+. +--+.+++.+...+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred hceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 4677776655555678998732 24557889876655444555667888777663 33356677777778
Q ss_pred CceEEEEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 018891 100 DNRLLVYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHGL-------------------------------- 147 (349)
Q Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~~-------------------------------- 147 (349)
+..++||++++|.++.+.... ......++.++...++.||+.
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred CceEEEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 889999999999887664421 112333455556666666620
Q ss_pred -------------------------CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 -------------------------DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 -------------------------~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
...++|+|+++.||++++++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987667799998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.29 E-value=1.3e-05 Score=71.47 Aligned_cols=78 Identities=13% Similarity=0.030 Sum_probs=46.6
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEcccc-------chhchHHHHHHHHHHhccC--CCc-ccceeeE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAE-------SFQGHKEWLTEVIYLGQLR--HEN-LVKLIGY 95 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~ 95 (349)
.+.||.|....||++ ....+++.+++|.-... ......+...|...|+.+. .|. +.+++.+
T Consensus 31 ~~eig~G~~N~vfrV---------~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~ 101 (392)
T d2pula1 31 CQEIGDGNLNYVFHI---------YDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS 101 (392)
T ss_dssp EEECCSSSSEEEEEE---------EC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred EEEeCCCceEeEEEE---------EeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE
Confidence 457899999999998 44445678999964321 1112334556777777662 233 3344432
Q ss_pred EecCCceEEEEEeCCCCCh
Q 018891 96 CSESDNRLLVYEFMPKGSL 114 (349)
Q Consensus 96 ~~~~~~~~lv~e~~~~~~L 114 (349)
+....++|||++++..+
T Consensus 102 --d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 102 --DTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp --ETTTTEEEECCCTTSEE
T ss_pred --cCCCCEEEEeccCCccc
Confidence 34566899999977544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.14 E-value=8e-06 Score=68.02 Aligned_cols=129 Identities=17% Similarity=0.104 Sum_probs=80.0
Q ss_pred eeeecC-ceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC--CCcccceeeEEecCCceEE
Q 018891 28 LLGEGG-FGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR--HENLVKLIGYCSESDNRLL 104 (349)
Q Consensus 28 ~lg~G~-~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~l 104 (349)
.+..|. .+.||+... ..+..+++|........ .+..|...++.+. .-.+.+++.+..+.+..++
T Consensus 17 ~~~~G~s~~~v~r~~~----------~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA----------QGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEEC----------TTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred EcCCcccCCeEEEEEe----------CCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence 344454 367898732 23566888976554322 3456666666653 2235666777777788999
Q ss_pred EEEeCCCCChHHHHhccCCCCChHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 018891 105 VYEFMPKGSLENHLFRSVQPISWPTRVKIAIDVARGLSFLHG-------------------------------------- 146 (349)
Q Consensus 105 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~ql~~~l~~lH~-------------------------------------- 146 (349)
||++++|.++.+.. ... ...+.++...|+.||+
T Consensus 84 v~~~i~G~~~~~~~------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSH------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 154 (255)
T ss_dssp EEECCSSEETTTSC------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEeeecccccccc------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhh
Confidence 99999887653311 111 1122233344444441
Q ss_pred ------------------CCCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 147 ------------------LDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 147 ------------------~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
....++|+|++|.||+++.+..+-|+||+.+.
T Consensus 155 ~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 155 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 02237999999999999987667899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.23 E-value=0.0007 Score=59.84 Aligned_cols=81 Identities=15% Similarity=0.073 Sum_probs=50.1
Q ss_pred cceeeecCceeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccC-CCcccceeeEEecCCceEE
Q 018891 26 DYLLGEGGFGCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLR-HENLVKLIGYCSESDNRLL 104 (349)
Q Consensus 26 ~~~lg~G~~g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l 104 (349)
++.|+.|-.-.+|++....... ........|++++.... .......+|..+++.+. +.-..++++++.+ ++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 3567888888999986544321 11234566777776532 23344567888888874 3333456666543 58
Q ss_pred EEEeCCCCCh
Q 018891 105 VYEFMPKGSL 114 (349)
Q Consensus 105 v~e~~~~~~L 114 (349)
|++|++|.++
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.03 E-value=0.0051 Score=52.52 Aligned_cols=132 Identities=14% Similarity=0.103 Sum_probs=73.1
Q ss_pred eeEEEeeecCCCcCCCCCCCCcEEEEEEccccchhchHHHHHHHHHHhccCCCc--cccee-----eEEecCCceEEEEE
Q 018891 35 GCVFKGWIDQNTFAPTKPGSGIVVAIKRLKAESFQGHKEWLTEVIYLGQLRHEN--LVKLI-----GYCSESDNRLLVYE 107 (349)
Q Consensus 35 g~V~~a~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~-----~~~~~~~~~~lv~e 107 (349)
-.||++. ..+|..|++|+..... ...+.+..|...+..|...+ +.... ..+..++..+.+++
T Consensus 36 N~vy~v~----------~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 36 NRVYQFQ----------DEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SEEEEEC----------CTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred ceeEEEE----------cCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 4788873 2357789999876542 34566777877777763111 11111 12344566788999
Q ss_pred eCCCCChH-----HH------Hh-------c----cC-------------------CCCChHH---HHHHHHHHHHHHHH
Q 018891 108 FMPKGSLE-----NH------LF-------R----SV-------------------QPISWPT---RVKIAIDVARGLSF 143 (349)
Q Consensus 108 ~~~~~~L~-----~~------l~-------~----~~-------------------~~l~~~~---~~~i~~ql~~~l~~ 143 (349)
+++|..+. .+ +. . .. ..++... ....+.++...+.-
T Consensus 105 ~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 184 (325)
T d1zyla1 105 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 184 (325)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 98765331 00 00 0 00 1111111 22223333333332
Q ss_pred H--hcCCCCeeeccCCCCcEEEcCCCcEEEeccccccc
Q 018891 144 L--HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 179 (349)
Q Consensus 144 l--H~~~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~~ 179 (349)
+ .....+++|+|+++.||+++++ ..++||+-+..
T Consensus 185 ~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 185 HWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp HCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred hccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 2 1124578999999999999743 45899997763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.52 E-value=0.018 Score=48.52 Aligned_cols=31 Identities=35% Similarity=0.296 Sum_probs=27.9
Q ss_pred CCCeeeccCCCCcEEEcCCCcEEEecccccc
Q 018891 148 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR 178 (349)
Q Consensus 148 ~~~i~H~di~~~Nilv~~~~~v~l~Dfg~~~ 178 (349)
..+++|+|+.++||+++++...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 6789999999999999988777899999775
|